Citrus Sinensis ID: 012825
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 455 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SCS2 | 601 | CDPK-related kinase 5 OS= | yes | no | 0.964 | 0.730 | 0.798 | 0.0 | |
| P53681 | 602 | CDPK-related protein kina | N/A | no | 0.951 | 0.719 | 0.768 | 0.0 | |
| Q9LET1 | 577 | CDPK-related kinase 7 OS= | no | no | 0.918 | 0.724 | 0.702 | 1e-179 | |
| O80673 | 576 | CDPK-related kinase 1 OS= | no | no | 0.916 | 0.723 | 0.696 | 1e-177 | |
| Q10KY3 | 600 | Calcium/calmodulin-depend | yes | no | 0.813 | 0.616 | 0.783 | 1e-176 | |
| Q9LJL9 | 599 | CDPK-related kinase 2 OS= | no | no | 0.936 | 0.711 | 0.665 | 1e-173 | |
| Q9FX86 | 606 | CDPK-related kinase 8 OS= | no | no | 0.942 | 0.707 | 0.652 | 1e-171 | |
| Q9ZUZ2 | 595 | CDPK-related kinase 3 OS= | no | no | 0.936 | 0.715 | 0.610 | 1e-147 | |
| Q9FIM9 | 594 | CDPK-related kinase 4 OS= | no | no | 0.819 | 0.627 | 0.642 | 1e-138 | |
| Q9SG12 | 594 | CDPK-related kinase 6 OS= | no | no | 0.819 | 0.627 | 0.655 | 1e-134 |
| >sp|Q9SCS2|CAMK5_ARATH CDPK-related kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 740 bits (1910), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/456 (79%), Positives = 400/456 (87%), Gaps = 17/456 (3%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S++S D +N+P+PA+ + P+ S +N E Q N
Sbjct: 1 MGLCTSKPNSSNS----DQTPARNSPLPASESVKPSSSSVNGEDQCVTTTNN-------- 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 49 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 107
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN +AIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 108 ARRHGSVKPNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 168 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
++ S LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHRSYSTEAD+WS+GVI YILLC
Sbjct: 288 EDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLC 347
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
GSRPFWARTESGIFRAVLKADPSFD+ PWP LSSEARDFVKRLLNKDPRKRLTAAQALSH
Sbjct: 348 GSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSH 407
Query: 417 PWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
PWIK+SND KVP+D+++FKLM+AY+RSSSLRKAALR
Sbjct: 408 PWIKDSNDAKVPMDILVFKLMRAYLRSSSLRKAALR 443
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P53681|CRK_DAUCA CDPK-related protein kinase OS=Daucus carota GN=CRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 707 bits (1826), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/462 (76%), Positives = 386/462 (83%), Gaps = 29/462 (6%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPA------PSPLNAESQSNNNRTNVK 54
MG+C SKPS P+ DL N +T +P N T +P P + +Q NN
Sbjct: 1 MGICVSKPS-----PEPDL-HNHHTSIPVNDTSLPPQDNSIPPKDIAIPAQDNNKPP--- 51
Query: 55 GNDDAVIEGKKSPFFPFYSPSPAHYFFSKKS----SPARSSANSTPNRFFKRPFPPPSPA 110
GKKSPF PFYSPSPAH+ FSKKS SPA S+NSTP R F PFPPPSPA
Sbjct: 52 --------GKKSPFLPFYSPSPAHFLFSKKSPAVGSPAAGSSNSTPKRLF--PFPPPSPA 101
Query: 111 KHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGY 170
KHIKA ARRHGSVKPNEAAIPE +E + AGL+KSFGFSK F +K+E+GEEVGRGHFGY
Sbjct: 102 KHIKAAWARRHGSVKPNEAAIPENNEVDGGAGLDKSFGFSKKFGSKFEVGEEVGRGHFGY 161
Query: 171 TCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230
TC AKFKKGE KGQ VAVKVIPK KMTTAIAIEDVRREVKILRALTGHNNLV+F+DA+ED
Sbjct: 162 TCRAKFKKGEFKGQDVAVKVIPKAKMTTAIAIEDVRREVKILRALTGHNNLVQFYDAFED 221
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN
Sbjct: 222 HTNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 281
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 350
FLF +KDE+S LKAIDFGLSD+V+PDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI
Sbjct: 282 FLFKSKDEDSQLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 341
Query: 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA 410
+YILLCGSRPFWARTESGIFRAVLKA+ SFDE PWPS+SSEA+DFVKRLLNKDPRKR+TA
Sbjct: 342 SYILLCGSRPFWARTESGIFRAVLKANLSFDEPPWPSVSSEAKDFVKRLLNKDPRKRMTA 401
Query: 411 AQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
AQAL H WIKNSND+K PLD+++FKLMK YMRSS LRKAALR
Sbjct: 402 AQALCHSWIKNSNDIKFPLDILVFKLMKVYMRSSPLRKAALR 443
|
Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LET1|CAMK7_ARATH CDPK-related kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 627 bits (1616), Expect = e-179, Method: Compositional matrix adjust.
Identities = 317/451 (70%), Positives = 358/451 (79%), Gaps = 33/451 (7%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC+ KP S KN P+ P S A
Sbjct: 1 MGLCHGKPIEQQS---------KNLPISNEIEETPKNSSQKA------------------ 33
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARR 120
KS FPFYSPSP F + + SS +STP R FKRPFPPPSPAKHI+A+LARR
Sbjct: 34 ----KSSGFPFYSPSPLPSLFKTSPAVSSSSVSSTPLRIFKRPFPPPSPAKHIRALLARR 89
Query: 121 HGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE 180
HGSVKPNEA+IPEGSE E GL+K FGFSK FA+ YE+ EVGRGHFGYTC+AK KKG
Sbjct: 90 HGSVKPNEASIPEGSECE--VGLDKKFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGS 147
Query: 181 LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240
LKGQ VAVKVIPK KMTTAIAIEDVRREVKILRALTGH NLV+F+DA+ED +NVY+VMEL
Sbjct: 148 LKGQDVAVKVIPKSKMTTAIAIEDVRREVKILRALTGHKNLVQFYDAFEDDENVYIVMEL 207
Query: 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300
C+GGELLD+IL RGGKY+E DAK VMIQIL+VVA+CHLQGVVHRDLKPENFLFTTKDE+S
Sbjct: 208 CQGGELLDKILQRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKPENFLFTTKDESS 267
Query: 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRP 360
LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHR+Y TEAD+WSIGVIAYILLCGSRP
Sbjct: 268 PLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRP 327
Query: 361 FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
FWAR+ESGIFRAVLKA+P+F+EAPWPSLS +A DFVKRLLNKD RKRLTAAQAL HPW+
Sbjct: 328 FWARSESGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQALCHPWLV 387
Query: 421 NSNDVKVPLDVIIFKLMKAYMRSSSLRKAAL 451
S+++K+P D+II+KL+K Y+ SSSLRK+AL
Sbjct: 388 GSHELKIPSDMIIYKLVKVYIMSSSLRKSAL 418
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80673|CAMK1_ARATH CDPK-related kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 622 bits (1604), Expect = e-177, Method: Compositional matrix adjust.
Identities = 314/451 (69%), Positives = 358/451 (79%), Gaps = 34/451 (7%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MG+C+ KP S KS + + P N P PA
Sbjct: 1 MGICHGKPVEQQS--KSLPVSGETNEAPTNSQP-PA------------------------ 33
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARR 120
KS FPFYSPSP F K S SS +STP R FKRPFPPPSPAKHI+A LARR
Sbjct: 34 ----KSSGFPFYSPSPVPSLF-KSSPSVSSSVSSTPLRIFKRPFPPPSPAKHIRAFLARR 88
Query: 121 HGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE 180
+GSVKPNE +IPEG E E GL+KSFGFSK FA+ YE+ EVGRGHFGYTC+AK KKG
Sbjct: 89 YGSVKPNEVSIPEGKECE--IGLDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGS 146
Query: 181 LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240
LKGQ+VAVKVIPK KMTTAIAIEDV REVK+LRALTGH NLV+F+DA+ED +NVY+VMEL
Sbjct: 147 LKGQEVAVKVIPKSKMTTAIAIEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMEL 206
Query: 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300
C+GGELLD+IL RGGKY+EDDAK VM+QIL+VVA+CHLQGVVHRDLKPENFLF+TKDE S
Sbjct: 207 CKGGELLDKILQRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETS 266
Query: 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRP 360
LKAIDFGLSD+V+PDERLNDIVGSAYYVAPEVLHR+Y TEAD+WSIGVIAYILLCGSRP
Sbjct: 267 PLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRP 326
Query: 361 FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
FWARTESGIFRAVLKA+P+F+EAPWPSLS EA DFVKRLLNKD RKRLTAAQAL HPW+
Sbjct: 327 FWARTESGIFRAVLKAEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLV 386
Query: 421 NSNDVKVPLDVIIFKLMKAYMRSSSLRKAAL 451
S+++K+P D+II+KL+K Y+ S+SLRK+AL
Sbjct: 387 GSHELKIPSDMIIYKLVKVYIMSTSLRKSAL 417
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3. Confers thermotolerance; involved in the heat-shock-mediated calmodulin-dependent signal transduction leading to the activation of heat-shock transcription factors (HSFs); phosphorylates HSFA1A. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10KY3|CAMK1_ORYSJ Calcium/calmodulin-dependent serine/threonine-protein kinase 1 OS=Oryza sativa subsp. japonica GN=CAMK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 617 bits (1590), Expect = e-176, Method: Compositional matrix adjust.
Identities = 293/374 (78%), Positives = 331/374 (88%), Gaps = 4/374 (1%)
Query: 69 FPFYSPSPAHYFFSKKSSPARSSANSTPNRF-FKRPFPPPSPAKHIKAVLARRHGSVKPN 127
FPFY PSP S K SPA SS STP R FKRPFPPPSPAKHI+A+LARRHGSVKPN
Sbjct: 61 FPFYLPSPLPAS-SYKGSPANSSVASTPARGGFKRPFPPPSPAKHIRALLARRHGSVKPN 119
Query: 128 EAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVA 187
EA+IPE EP L+K FGFS+HFA KYELG EVGRGHFGYTCAA KKGELKG VA
Sbjct: 120 EASIPESGEP--GVALDKGFGFSRHFAAKYELGREVGRGHFGYTCAATCKKGELKGDDVA 177
Query: 188 VKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELL 247
VKVIPK KMTTAIAIEDVRREV+IL +L GH+NLV+F+DAYED +NVY+VMELC+GGELL
Sbjct: 178 VKVIPKAKMTTAIAIEDVRREVRILSSLAGHSNLVQFYDAYEDEENVYIVMELCKGGELL 237
Query: 248 DRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307
DRIL+RGGKY+E+DAK VM QIL+V +FCHLQGVVHRDLKPENFLF++KDENS +K IDF
Sbjct: 238 DRILARGGKYSEEDAKVVMRQILSVASFCHLQGVVHRDLKPENFLFSSKDENSAMKVIDF 297
Query: 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTES 367
GLSDFV+PDERLNDIVGSAYYVAPEVLHRSY TEAD+WSIGVI YILLCGSRPFWARTES
Sbjct: 298 GLSDFVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIVYILLCGSRPFWARTES 357
Query: 368 GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427
GIFRAVLKADPSF+EAPWP+LS+EA+DFV+RLLNKD RKR+TAAQAL HPWI+ + +VK+
Sbjct: 358 GIFRAVLKADPSFEEAPWPTLSAEAKDFVRRLLNKDYRKRMTAAQALCHPWIRGTEEVKL 417
Query: 428 PLDVIIFKLMKAYM 441
PLD+II++LM+AY+
Sbjct: 418 PLDMIIYRLMRAYI 431
|
Possesses kinase activity in vitro. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
| >sp|Q9LJL9|CAMK2_ARATH CDPK-related kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 608 bits (1569), Expect = e-173, Method: Compositional matrix adjust.
Identities = 308/463 (66%), Positives = 356/463 (76%), Gaps = 37/463 (7%)
Query: 1 MGLCNSKPSS----NSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGN 56
MG C SKPSS N +PK +++N ++ PA+ P SP+ +
Sbjct: 1 MGGCTSKPSSSVKPNPYAPKDAVLQNDDS-TPAH----PGKSPVRSSPAV---------- 45
Query: 57 DDAVIEGKKSPFFPFYSPSPAHYFFSKKSSPA---RSSANSTPNRFFKRPFPPPSPAKHI 113
K SPFFPFY+PSPA + +K S STP R R F PPSPA+HI
Sbjct: 46 -------KASPFFPFYTPSPARHRRNKSRDGGGGESKSVTSTPLRQLARAFHPPSPARHI 98
Query: 114 KAVLARRHGSVKPNEAAIPEGSEPEPA-----AGLNKSFGFSKHFANKYELGEEVGRGHF 168
+ VL RR + EAA+P + + GL+K FGFSK ++ ELGEE+GRGHF
Sbjct: 99 RDVLRRRK---EKKEAALPAARQQKEEEEREEVGLDKRFGFSKELQSRIELGEEIGRGHF 155
Query: 169 GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228
GYTC+AKFKKGELK Q+VAVKVIPK KMT+AI+IEDVRREVKILRAL+GH NLV+F+DA+
Sbjct: 156 GYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVRREVKILRALSGHQNLVQFYDAF 215
Query: 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKP 288
ED NVY+VMELC GGELLDRIL+RGGKY+EDDAKAV+IQILNVVAFCHLQGVVHRDLKP
Sbjct: 216 EDNANVYIVMELCGGGELLDRILARGGKYSEDDAKAVLIQILNVVAFCHLQGVVHRDLKP 275
Query: 289 ENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIG 348
ENFL+T+K+ENS+LK IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY+TEADVWSIG
Sbjct: 276 ENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADVWSIG 335
Query: 349 VIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL 408
VIAYILLCGSRPFWARTESGIFRAVLKADPSFDE PWPSLS EA+DFVKRLL KDPRKR+
Sbjct: 336 VIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPSLSFEAKDFVKRLLYKDPRKRM 395
Query: 409 TAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAAL 451
TA+QAL HPWI + +P D++IFK +KAY+RSSSLRKAAL
Sbjct: 396 TASQALMHPWIAGYKKIDIPFDILIFKQIKAYLRSSSLRKAAL 438
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FX86|CAMK8_ARATH CDPK-related kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 603 bits (1554), Expect = e-171, Method: Compositional matrix adjust.
Identities = 306/469 (65%), Positives = 356/469 (75%), Gaps = 40/469 (8%)
Query: 1 MGLCNSKPSSNSS-----SPKSDLIR-NKNTPVPANGTPIPAPSPLNAESQSNNNRTNVK 54
MG C SKPS++S +P +D + + P +PIP PS
Sbjct: 1 MGGCTSKPSTSSGRPNPFAPGNDYPQIDDFAPDHPGKSPIPTPS---------------- 44
Query: 55 GNDDAVIEGKKSPFFPFYSPSPAHYFFSKK----SSPARSSANSTPNRFFKRPFPPPSPA 110
K SPFFPFY+PSPA + +K S STP R +R F PPSPA
Sbjct: 45 -------AAKASPFFPFYTPSPARHRRNKSRDVGGGGESKSLTSTPLRQLRRAFHPPSPA 97
Query: 111 KHIKAVLARRHGSVKPNEAAIPEGSEPEP------AAGLNKSFGFSKHFANKYELGEEVG 164
KHI+A L RR G + + + + + P GL+K FGFSK F ++ ELGEE+G
Sbjct: 98 KHIRAALRRRKGKKEAALSGVTQLTTEVPQREEEEEVGLDKRFGFSKEFHSRVELGEEIG 157
Query: 165 RGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKF 224
RGHFGYTC+AKFKKGELKGQ VAVK+IPK KMTTAIAIEDVRREVKIL+AL+GH NLV+F
Sbjct: 158 RGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIAIEDVRREVKILQALSGHKNLVQF 217
Query: 225 FDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHR 284
+DA+ED NVY+ MELCEGGELLDRIL+RGGKY+E+DAK V+IQILNVVAFCH QGVVHR
Sbjct: 218 YDAFEDNANVYIAMELCEGGELLDRILARGGKYSENDAKPVIIQILNVVAFCHFQGVVHR 277
Query: 285 DLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADV 344
DLKPENFL+T+K+ENS LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY+TEADV
Sbjct: 278 DLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADV 337
Query: 345 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDP 404
WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE PWP LSS+A+DFVKRLL KDP
Sbjct: 338 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFLSSDAKDFVKRLLFKDP 397
Query: 405 RKRLTAAQALSHPWIKNSN-DVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
R+R++A+QAL HPWI+ N D+ +P D++IF+ MKAY+RSSSLRKAALR
Sbjct: 398 RRRMSASQALMHPWIRAYNTDMNIPFDILIFRQMKAYLRSSSLRKAALR 446
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUZ2|CAMK3_ARATH CDPK-related kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1340), Expect = e-147, Method: Compositional matrix adjust.
Identities = 273/447 (61%), Positives = 331/447 (74%), Gaps = 21/447 (4%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNT-PVPANGTPIPAPSPLNAESQSNN--NRTNVKGND 57
MG C K N S + N T V +G I +P+N N +N
Sbjct: 1 MGQCYGK--VNQSKQNGEEEANTTTYVVSGDGNQIQPLTPVNYGRAKNTPARSSNPSPWP 58
Query: 58 DAVIEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
G SP SPSPA STP RFF+RPFPPPSPAKHIKA L
Sbjct: 59 SPFPHGSASPLPSGVSPSPAR--------------TSTPRRFFRRPFPPPSPAKHIKASL 104
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFK 177
+R G VKP E IPE EP L+KSFG+ K+F KYELG+EVGRGHFG+TC+ + K
Sbjct: 105 IKRLG-VKPKEGPIPEERGTEPEQSLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSGRGK 163
Query: 178 KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVV 237
KG++K +AVK+I K KMTTAIAIEDVRREVK+L++L+GH L+K++DA ED +NVY+V
Sbjct: 164 KGDIKDHPIAVKIISKAKMTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACEDANNVYIV 223
Query: 238 MELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297
MELC+GGELLDRIL+RGGKY EDDAKA+++QIL VV+FCHLQGVVHRDLKPENFLFT+
Sbjct: 224 MELCDGGELLDRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPENFLFTSSR 283
Query: 298 ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCG 357
E+S LK IDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSYS EAD+WSIGVI YILLCG
Sbjct: 284 EDSDLKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILLCG 343
Query: 358 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
SRPFWARTESGIFR VL+ +P++D+ PWPS SSE +DFVKRLLNKD RKR++A QAL+HP
Sbjct: 344 SRPFWARTESGIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMSAVQALTHP 403
Query: 418 WIKNSNDVKVPLDVIIFKLMKAYMRSS 444
W+++ + V +PLD++I+KL+KAY+ ++
Sbjct: 404 WLRDDSRV-IPLDILIYKLVKAYLHAT 429
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3 an GLN1-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIM9|CAMK4_ARATH CDPK-related kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 491 bits (1263), Expect = e-138, Method: Compositional matrix adjust.
Identities = 252/392 (64%), Positives = 313/392 (79%), Gaps = 19/392 (4%)
Query: 70 PFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSV-KPNE 128
PF SP PA SPAR TP R FK PFPPPSPAK I A L RR G+ +P +
Sbjct: 56 PFQSPLPA----GVAPSPAR-----TPGRKFKWPFPPPSPAKPIMAALRRRRGAPPQPRD 106
Query: 129 AAIPEGSEPEPAAG--------LNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE 180
IPE SE G L+K+FGF K+F KYELG+EVGRGHFG+TC AK KKG+
Sbjct: 107 EPIPEDSEDVVDHGGDSGGGERLDKNFGFGKNFEGKYELGKEVGRGHFGHTCWAKAKKGK 166
Query: 181 LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240
+K Q VAVK+I K KMT+ ++IEDVRREVK+L+AL+GH ++VKF+D YED DNV+VVMEL
Sbjct: 167 MKNQTVAVKIISKAKMTSTLSIEDVRREVKLLKALSGHRHMVKFYDVYEDADNVFVVMEL 226
Query: 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300
CEGGELLDRIL+RGG+Y E DAK +++QIL+ AF HLQGVVHRDLKPENFLFT+++E++
Sbjct: 227 CEGGELLDRILARGGRYPEVDAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSRNEDA 286
Query: 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRP 360
+LK IDFGLSDF+R D+RLND+VGSAYYVAPEVLHRSYSTEAD+WSIGVI+YILLCGSRP
Sbjct: 287 ILKVIDFGLSDFIRYDQRLNDVVGSAYYVAPEVLHRSYSTEADMWSIGVISYILLCGSRP 346
Query: 361 FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
F+ RTES IFR VL+A+P+F++ PWPS+S A+DFVKRLLNKD RKR+TAAQAL+HPW++
Sbjct: 347 FYGRTESAIFRCVLRANPNFEDMPWPSISPTAKDFVKRLLNKDHRKRMTAAQALAHPWLR 406
Query: 421 NSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
+ N + LD ++KL+K+Y+R+S R++AL+
Sbjct: 407 DENP-GLLLDFSVYKLVKSYIRASPFRRSALK 437
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SG12|CAMK6_ARATH CDPK-related kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 477 bits (1228), Expect = e-134, Method: Compositional matrix adjust.
Identities = 255/389 (65%), Positives = 315/389 (80%), Gaps = 16/389 (4%)
Query: 70 PFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSV-KPNE 128
PF SP PA SPAR TP R FK PFPPPSPAK I A L RR G+ P +
Sbjct: 58 PFQSPLPA----GVAPSPAR-----TPGRKFKWPFPPPSPAKPIMAALRRRRGTAPHPRD 108
Query: 129 AAIPEGSEPEPAAG-----LNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKG 183
IPE SE + G L+K+FGF+K+F KYELG EVGRGHFG+TC AK KKG++KG
Sbjct: 109 GPIPEDSEAGGSGGGIGERLDKNFGFAKNFEGKYELGREVGRGHFGHTCWAKAKKGKIKG 168
Query: 184 QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG 243
Q VAVK+I K KMT+A++IEDVRREVK+L+AL+GH+++VKF+D +ED+DNV+VVMELCEG
Sbjct: 169 QTVAVKIISKSKMTSALSIEDVRREVKLLKALSGHSHMVKFYDVFEDSDNVFVVMELCEG 228
Query: 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303
GELLD IL+RGG+Y E +AK +++QIL+ AF HLQGVVHRDLKPENFLFT+K+E++VLK
Sbjct: 229 GELLDSILARGGRYPEAEAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSKNEDAVLK 288
Query: 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWA 363
IDFGLSD+ R D+RLND+VGSAYYVAPEVLHRSYSTEAD+WSIGVI+YILLCGSRPF+
Sbjct: 289 VIDFGLSDYARFDQRLNDVVGSAYYVAPEVLHRSYSTEADIWSIGVISYILLCGSRPFYG 348
Query: 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423
RTES IFR VL+A+P+FD+ PWPS+S A+DFVKRLLNKD RKR+TAAQAL+HPW+++ N
Sbjct: 349 RTESAIFRCVLRANPNFDDLPWPSISPIAKDFVKRLLNKDHRKRMTAAQALAHPWLRDEN 408
Query: 424 DVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
+ LD I+KL+K+Y+R+S R+AAL+
Sbjct: 409 P-GLLLDFSIYKLVKSYIRASPFRRAALK 436
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 455 | ||||||
| 224081597 | 607 | CPK related kinase 5 [Populus trichocarp | 0.971 | 0.728 | 0.820 | 0.0 | |
| 224096786 | 606 | CPK related protein kinase 7 [Populus tr | 0.967 | 0.726 | 0.816 | 0.0 | |
| 297816306 | 597 | hypothetical protein ARALYDRAFT_485401 [ | 0.956 | 0.728 | 0.802 | 0.0 | |
| 16904214 | 601 | calcium/calmodulin-dependent protein kin | 0.964 | 0.730 | 0.798 | 0.0 | |
| 15229785 | 601 | CDPK-related kinase [Arabidopsis thalian | 0.964 | 0.730 | 0.798 | 0.0 | |
| 73761697 | 617 | CDPK-related protein kinase [Gossypium h | 0.991 | 0.730 | 0.823 | 0.0 | |
| 16904226 | 602 | calcium/calmodulin-dependent protein kin | 0.964 | 0.729 | 0.785 | 0.0 | |
| 449460636 | 621 | PREDICTED: CDPK-related protein kinase-l | 0.975 | 0.714 | 0.774 | 0.0 | |
| 334185866 | 632 | CDPK-related kinase [Arabidopsis thalian | 0.964 | 0.694 | 0.747 | 0.0 | |
| 1706130 | 602 | RecName: Full=CDPK-related protein kinas | 0.951 | 0.719 | 0.768 | 0.0 |
| >gi|224081597|ref|XP_002306462.1| CPK related kinase 5 [Populus trichocarpa] gi|222855911|gb|EEE93458.1| CPK related kinase 5 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 758 bits (1958), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/458 (82%), Positives = 399/458 (87%), Gaps = 16/458 (3%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MG+C SKPS NS+ I+ K+ +P N T P P A + N+T V+
Sbjct: 1 MGICTSKPSPNSTLFSPVAIQAKDNSIPTNDTA--KPDPATASLNDHTNKTTVE------ 52
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARS------SANSTPNRFFKRPFPPPSPAKHIK 114
KKSP FPFYSPSPAH FFSKKSSPARS SANSTP RFFKRPFPPPSPAKHI+
Sbjct: 53 -PVKKSPLFPFYSPSPAHRFFSKKSSPARSPARNAASANSTPKRFFKRPFPPPSPAKHIR 111
Query: 115 AVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAA 174
AVLARRHGSVKPNEAAIPEGSE GL+KSFGFSKHF NKYELG+EVGRGHFGYTC A
Sbjct: 112 AVLARRHGSVKPNEAAIPEGSE-TGGEGLDKSFGFSKHFGNKYELGDEVGRGHFGYTCQA 170
Query: 175 KFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234
KFKKGELKGQQVAVKVIPK KMTTAIAIEDVRREVKILRALTGHNNLV F+DAYED DNV
Sbjct: 171 KFKKGELKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALTGHNNLVHFYDAYEDHDNV 230
Query: 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294
Y+VMELCEGGELLDRIL+RGGKY+EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT
Sbjct: 231 YIVMELCEGGELLDRILARGGKYSEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 290
Query: 295 TKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYIL 354
+KDENS LKAIDFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIAYIL
Sbjct: 291 SKDENSQLKAIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYIL 350
Query: 355 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
LCGSRPFWARTESGIFRAVLKADPSFDE PWPSLS EA+DFVK+LLNKDPRKRLTAAQAL
Sbjct: 351 LCGSRPFWARTESGIFRAVLKADPSFDETPWPSLSPEAKDFVKQLLNKDPRKRLTAAQAL 410
Query: 415 SHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
SHPWIKNSND+KVPLD+ IFKLMKAYMRS+SLRKAAL+
Sbjct: 411 SHPWIKNSNDLKVPLDLHIFKLMKAYMRSTSLRKAALK 448
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224096786|ref|XP_002310736.1| CPK related protein kinase 7 [Populus trichocarpa] gi|222853639|gb|EEE91186.1| CPK related protein kinase 7 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1931), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/457 (81%), Positives = 395/457 (86%), Gaps = 17/457 (3%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MG+C SKPS NS+ I+ + +P TP P P N Q NN T ++
Sbjct: 1 MGICTSKPSPNSTLSSPIAIQANDNSIPTKDTPRPDPRTPNVNDQ--NNSTGLES----- 53
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARS------SANSTPNRFFKRPFPPPSPAKHIK 114
KKSPF F+SPSPAHYFFSKKSSPARS SANSTP R FKRPFPPPSPAKHI+
Sbjct: 54 --VKKSPF-NFFSPSPAHYFFSKKSSPARSPARNAASANSTPKRLFKRPFPPPSPAKHIR 110
Query: 115 AVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAA 174
AVLARRHGSVKPNEA IPEG E E AAGL KSFGFSKHF NKYELG+EVGRGHFGYTC A
Sbjct: 111 AVLARRHGSVKPNEATIPEGGEAE-AAGLVKSFGFSKHFGNKYELGDEVGRGHFGYTCQA 169
Query: 175 KFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234
KFKKGELKGQQVAVKVIPK KMTTAIAIEDVRREV ILRAL GHNNLV+F+DAYED DNV
Sbjct: 170 KFKKGELKGQQVAVKVIPKAKMTTAIAIEDVRREVNILRALNGHNNLVQFYDAYEDHDNV 229
Query: 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294
Y+VMELCEGGELLDRIL+RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT
Sbjct: 230 YIVMELCEGGELLDRILARGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 289
Query: 295 TKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYIL 354
+KDE+S LKAIDFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSY TEADVWSIGVIAYIL
Sbjct: 290 SKDEDSQLKAIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYGTEADVWSIGVIAYIL 349
Query: 355 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
LCGSRPFWARTESGIFRAVLKADPSFDE PWPSLS EA+DFVKRLLNKDPRKRLTAAQAL
Sbjct: 350 LCGSRPFWARTESGIFRAVLKADPSFDETPWPSLSPEAKDFVKRLLNKDPRKRLTAAQAL 409
Query: 415 SHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAAL 451
SHPWIK+SN+VKVPLD++I KLMKAYMRSSSLRKAAL
Sbjct: 410 SHPWIKSSNEVKVPLDILILKLMKAYMRSSSLRKAAL 446
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297816306|ref|XP_002876036.1| hypothetical protein ARALYDRAFT_485401 [Arabidopsis lyrata subsp. lyrata] gi|297321874|gb|EFH52295.1| hypothetical protein ARALYDRAFT_485401 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1913), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/456 (80%), Positives = 399/456 (87%), Gaps = 21/456 (4%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S P SD I +N+P+PA+ + P S SN ++ N
Sbjct: 1 MGLCTSKPNS----PNSDQIPARNSPLPASESVKP--------SSSNEDQCVTTNN---- 44
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 45 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 103
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN AAIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 104 ARRHGSVKPNSAAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 163
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 164 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 223
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 224 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 283
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
++ S LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHRSYSTEAD+WS+GVI YILLC
Sbjct: 284 EDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLC 343
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
GSRPFWARTESGIFRAVLKADPSFD+ PWP LSSEARDFVKRLLNKDPRKRLTAAQALSH
Sbjct: 344 GSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSH 403
Query: 417 PWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
PWIK+SN+ KVPLD+++FKLM+AY+RSSSLRKAALR
Sbjct: 404 PWIKDSNNAKVPLDILVFKLMRAYLRSSSLRKAALR 439
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|16904214|gb|AAL30814.1|AF435446_1 calcium/calmodulin-dependent protein kinase CaMK1 [Arabidopsis thaliana] gi|2154715|emb|CAA70572.1| CDPK-related protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 740 bits (1911), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/456 (79%), Positives = 400/456 (87%), Gaps = 17/456 (3%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S++S D +N+P+PA+ + P+ S +N E Q N
Sbjct: 1 MGLCTSKPNSSNS----DQTPARNSPLPASESVKPSSSSVNGEDQCVTTTNN-------- 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 49 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 107
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN +AIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 108 ARRHGSVKPNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 168 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
++ S LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHRSYSTEAD+WS+GVI YILLC
Sbjct: 288 EDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLC 347
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
GSRPFWARTESGIFRAVLKADPSFD+ PWP LSSEARDFVKRLLNKDPRKRLTAAQALSH
Sbjct: 348 GSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSH 407
Query: 417 PWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
PWIK+SND KVP+D+++FKLM+AY+RSSSLRKAALR
Sbjct: 408 PWIKDSNDAKVPMDILVFKLMRAYLRSSSLRKAALR 443
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15229785|ref|NP_190622.1| CDPK-related kinase [Arabidopsis thaliana] gi|75337058|sp|Q9SCS2.1|CAMK5_ARATH RecName: Full=CDPK-related kinase 5; Short=AtCRK5; AltName: Full=Calcium/calmodulin-dependent protein kinase 1 gi|6561993|emb|CAB62482.1| CDPK-related protein kinase [Arabidopsis thaliana] gi|332645155|gb|AEE78676.1| CDPK-related kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 740 bits (1910), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/456 (79%), Positives = 400/456 (87%), Gaps = 17/456 (3%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S++S D +N+P+PA+ + P+ S +N E Q N
Sbjct: 1 MGLCTSKPNSSNS----DQTPARNSPLPASESVKPSSSSVNGEDQCVTTTNN-------- 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 49 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 107
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN +AIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 108 ARRHGSVKPNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 168 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
++ S LKAIDFGLSD+VRPDERLNDIVGSAYYVAPEVLHRSYSTEAD+WS+GVI YILLC
Sbjct: 288 EDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSVGVIVYILLC 347
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
GSRPFWARTESGIFRAVLKADPSFD+ PWP LSSEARDFVKRLLNKDPRKRLTAAQALSH
Sbjct: 348 GSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKRLTAAQALSH 407
Query: 417 PWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
PWIK+SND KVP+D+++FKLM+AY+RSSSLRKAALR
Sbjct: 408 PWIKDSNDAKVPMDILVFKLMRAYLRSSSLRKAALR 443
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|73761697|gb|AAZ83348.1| CDPK-related protein kinase [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1899), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/459 (82%), Positives = 404/459 (88%), Gaps = 8/459 (1%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPV---PANGTPIPAPSPLNAESQSNNNRTNVKGND 57
MGLC SKPS N S + I +N + P + + P P +N++ K +
Sbjct: 1 MGLCTSKPSPNPSDSTNASINTRNNDIYRKPNSVSASPLPDGVNSKEDQGKQGEEEKESS 60
Query: 58 DAVIEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
+ EGKKSPFFPFYSPSPAHY FSKKS PARSS NSTP RFF+RPFPPPSPAKHI+AVL
Sbjct: 61 NPNNEGKKSPFFPFYSPSPAHYLFSKKS-PARSSTNSTPKRFFRRPFPPPSPAKHIRAVL 119
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA----GLNKSFGFSKHFANKYELGEEVGRGHFGYTCA 173
ARRHGSVKPNEAAIPEGS+ E A GL+KSFGFSKHF +KYELG+EVGRGHFGYTC
Sbjct: 120 ARRHGSVKPNEAAIPEGSDAEAAGATGTGLDKSFGFSKHFGSKYELGDEVGRGHFGYTCT 179
Query: 174 AKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233
AKFKKGELKGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GH+NLV+F+DAYED DN
Sbjct: 180 AKFKKGELKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHSNLVQFYDAYEDHDN 239
Query: 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293
VY+VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF
Sbjct: 240 VYIVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 299
Query: 294 TTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYI 353
T+KDENS LKAIDFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYI
Sbjct: 300 TSKDENSQLKAIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYI 359
Query: 354 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 413
LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA
Sbjct: 360 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 419
Query: 414 LSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
LSHPWIK NDVKVPLD++IFKLMKAY+RSSSLRKAALR
Sbjct: 420 LSHPWIKKYNDVKVPLDILIFKLMKAYLRSSSLRKAALR 458
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|16904226|gb|AAL30820.1|AF435452_1 calcium/calmodulin-dependent protein kinase CaMK3 [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1896), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/456 (78%), Positives = 398/456 (87%), Gaps = 17/456 (3%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MG C SKPS+ S + V +G P S + + N+++T ND+
Sbjct: 1 MGACTSKPSNFSVD---------DITVAGDGAIFPVKSGPSNDDDVNSHQTK---NDEPS 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARR 120
+ GKKSPFFPFYSPSPAHY FSKKS +S+NSTP RFFKRPFPPPSPAKHI+++LARR
Sbjct: 49 V-GKKSPFFPFYSPSPAHYLFSKKSPATNASSNSTPMRFFKRPFPPPSPAKHIRSLLARR 107
Query: 121 HGSVKPNEAAIPEGSEPE----PAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
HG+VKPNE+AIPEG+E E AGL+KSFGFSK+F NKYE+GEEVGRGHFGYTC AKF
Sbjct: 108 HGTVKPNESAIPEGNESEVGDGGGAGLDKSFGFSKNFVNKYEMGEEVGRGHFGYTCKAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKGE+KGQ+VAVKVIPK KMTTAIAIEDVRREVKILRALTGHNNLVKF+DAYED +NVY+
Sbjct: 168 KKGEVKGQEVAVKVIPKSKMTTAIAIEDVRREVKILRALTGHNNLVKFYDAYEDPNNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTEDDAK+VMIQIL VVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEDDAKSVMIQILKVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 356
DEN+ LKAIDFGLSDFV+PDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC
Sbjct: 288 DENAQLKAIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLC 347
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
GSRPFWARTESGIFRAVLKADPSFDE PWP+LSSEA+DFVKRLLNKDPRKR+TAAQAL H
Sbjct: 348 GSRPFWARTESGIFRAVLKADPSFDEQPWPTLSSEAKDFVKRLLNKDPRKRMTAAQALGH 407
Query: 417 PWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
PWIKNS++++ PLD++IFKLMKAYMRSS+LRKAALR
Sbjct: 408 PWIKNSHNMEEPLDILIFKLMKAYMRSSALRKAALR 443
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460636|ref|XP_004148051.1| PREDICTED: CDPK-related protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 730 bits (1885), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/470 (77%), Positives = 393/470 (83%), Gaps = 26/470 (5%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNK----------NTPVPANGTPIPAPSPL-----NAESQ 45
MGLCNSKPS P SDL K N+ P + T + SPL N
Sbjct: 1 MGLCNSKPS-----PNSDLFAEKSGSRTPNEGSNSTQPNSVTAMGGASPLPPSSENGRDG 55
Query: 46 SNNNRTNVKGNDDAVIEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKR 102
NR N D V KKSPFFPFYSPSPAHY FSKKS SPA +SANSTP RFF++
Sbjct: 56 RAGNRRNESHEMDNV---KKSPFFPFYSPSPAHYLFSKKSPARSPANASANSTPKRFFRK 112
Query: 103 PFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEE 162
PFPPPSPAKHI+AVLARRHGSVKPNE +IPEG+E E GL+K+FGFSKH +KYELGEE
Sbjct: 113 PFPPPSPAKHIRAVLARRHGSVKPNEVSIPEGTEAEGVTGLDKNFGFSKHLGSKYELGEE 172
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
VGRGHFGYTCAAKFKKGELKGQQVAVK+IPK KMTTAIAIEDVRREVKIL++L+GH NLV
Sbjct: 173 VGRGHFGYTCAAKFKKGELKGQQVAVKIIPKSKMTTAIAIEDVRREVKILKSLSGHKNLV 232
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
F+DAYED DNVY+VMELCEGGELLDRILSRGGKYTE+DA+AVM QIL VVAFCHLQGVV
Sbjct: 233 NFYDAYEDHDNVYIVMELCEGGELLDRILSRGGKYTEEDARAVMTQILYVVAFCHLQGVV 292
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEA 342
HRDLKPENFLFT++DENS LKAIDFGLSDF +PDERLNDIVGSAYYVAPEVLHRSYSTEA
Sbjct: 293 HRDLKPENFLFTSRDENSPLKAIDFGLSDFAKPDERLNDIVGSAYYVAPEVLHRSYSTEA 352
Query: 343 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK 402
DVWSIGVIAYILLCGSRPFWARTESGIF+AVLKADP FDE PWPSLSSEA+DFVKRLL K
Sbjct: 353 DVWSIGVIAYILLCGSRPFWARTESGIFKAVLKADPIFDEPPWPSLSSEAKDFVKRLLVK 412
Query: 403 DPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
DPRKR++AAQALSHPWIKNS DVK PLD++IFKLMK YMRSS LRKAALR
Sbjct: 413 DPRKRMSAAQALSHPWIKNSMDVKAPLDILIFKLMKIYMRSSYLRKAALR 462
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334185866|ref|NP_001190048.1| CDPK-related kinase [Arabidopsis thaliana] gi|332645156|gb|AEE78677.1| CDPK-related kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1868), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/487 (74%), Positives = 400/487 (82%), Gaps = 48/487 (9%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAV 60
MGLC SKP+S++S D +N+P+PA+ + P+ S +N E Q N
Sbjct: 1 MGLCTSKPNSSNS----DQTPARNSPLPASESVKPSSSSVNGEDQCVTTTNN-------- 48
Query: 61 IEGKKSPFFPFYSPSPAHYFFSKKS---SPARSSANSTPNRFFKRPFPPPSPAKHIKAVL 117
EGKKSPFFPFYSPSPAHYFFSKK+ SPA +S NSTP RFFKRPFPPPSPAKHI+AVL
Sbjct: 49 -EGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVL 107
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAA-GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
ARRHGSVKPN +AIPEGSE E GL+KSFGFSK FA+KYELG+EVGRGHFGYTCAAKF
Sbjct: 108 ARRHGSVKPNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKF 167
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
KKG+ KGQQVAVKVIPK KMTTAIAIEDVRREVKILRAL+GHNNL F+DAYED DNVY+
Sbjct: 168 KKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAYEDHDNVYI 227
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
VMELCEGGELLDRILSRGGKYTE+DAK VMIQILNVVAFCHLQGVVHRDLKPENFLFT+K
Sbjct: 228 VMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLKPENFLFTSK 287
Query: 297 DENSVLKAIDFGLSDFVRP-------------------------------DERLNDIVGS 325
++ S LKAIDFGLSD+VRP DERLNDIVGS
Sbjct: 288 EDTSQLKAIDFGLSDYVRPGKALRLYAICKLRFQNLETSICLYALTIAFADERLNDIVGS 347
Query: 326 AYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
AYYVAPEVLHRSYSTEAD+WS+GVI YILLCGSRPFWARTESGIFRAVLKADPSFD+ PW
Sbjct: 348 AYYVAPEVLHRSYSTEADIWSVGVIVYILLCGSRPFWARTESGIFRAVLKADPSFDDPPW 407
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSS 445
P LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK+SND KVP+D+++FKLM+AY+RSSS
Sbjct: 408 PLLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKDSNDAKVPMDILVFKLMRAYLRSSS 467
Query: 446 LRKAALR 452
LRKAALR
Sbjct: 468 LRKAALR 474
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1706130|sp|P53681.1|CRK_DAUCA RecName: Full=CDPK-related protein kinase; AltName: Full=PK421 gi|1103386|emb|CAA58750.1| CDPK-related protein kinase [Daucus carota] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1826), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/462 (76%), Positives = 386/462 (83%), Gaps = 29/462 (6%)
Query: 1 MGLCNSKPSSNSSSPKSDLIRNKNTPVPANGTPIPA------PSPLNAESQSNNNRTNVK 54
MG+C SKPS P+ DL N +T +P N T +P P + +Q NN
Sbjct: 1 MGICVSKPS-----PEPDL-HNHHTSIPVNDTSLPPQDNSIPPKDIAIPAQDNNKPP--- 51
Query: 55 GNDDAVIEGKKSPFFPFYSPSPAHYFFSKKS----SPARSSANSTPNRFFKRPFPPPSPA 110
GKKSPF PFYSPSPAH+ FSKKS SPA S+NSTP R F PFPPPSPA
Sbjct: 52 --------GKKSPFLPFYSPSPAHFLFSKKSPAVGSPAAGSSNSTPKRLF--PFPPPSPA 101
Query: 111 KHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGY 170
KHIKA ARRHGSVKPNEAAIPE +E + AGL+KSFGFSK F +K+E+GEEVGRGHFGY
Sbjct: 102 KHIKAAWARRHGSVKPNEAAIPENNEVDGGAGLDKSFGFSKKFGSKFEVGEEVGRGHFGY 161
Query: 171 TCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230
TC AKFKKGE KGQ VAVKVIPK KMTTAIAIEDVRREVKILRALTGHNNLV+F+DA+ED
Sbjct: 162 TCRAKFKKGEFKGQDVAVKVIPKAKMTTAIAIEDVRREVKILRALTGHNNLVQFYDAFED 221
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN
Sbjct: 222 HTNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 281
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 350
FLF +KDE+S LKAIDFGLSD+V+PDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI
Sbjct: 282 FLFKSKDEDSQLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 341
Query: 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA 410
+YILLCGSRPFWARTESGIFRAVLKA+ SFDE PWPS+SSEA+DFVKRLLNKDPRKR+TA
Sbjct: 342 SYILLCGSRPFWARTESGIFRAVLKANLSFDEPPWPSVSSEAKDFVKRLLNKDPRKRMTA 401
Query: 411 AQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
AQAL H WIKNSND+K PLD+++FKLMK YMRSS LRKAALR
Sbjct: 402 AQALCHSWIKNSNDIKFPLDILVFKLMKVYMRSSPLRKAALR 443
|
Source: Daucus carota Species: Daucus carota Genus: Daucus Family: Apiaceae Order: Apiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 455 | ||||||
| TAIR|locus:2103655 | 577 | AT3G56760 [Arabidopsis thalian | 0.804 | 0.634 | 0.770 | 1.9e-151 | |
| TAIR|locus:2063197 | 576 | CRK1 "AT2G41140" [Arabidopsis | 0.804 | 0.635 | 0.758 | 4.6e-150 | |
| TAIR|locus:2012232 | 606 | AT1G49580 [Arabidopsis thalian | 0.751 | 0.564 | 0.766 | 1.8e-142 | |
| TAIR|locus:2094053 | 599 | AT3G19100 [Arabidopsis thalian | 0.745 | 0.565 | 0.772 | 2.3e-142 | |
| TAIR|locus:2062764 | 595 | CRK3 "AT2G46700" [Arabidopsis | 0.749 | 0.573 | 0.702 | 3.6e-135 | |
| TAIR|locus:2082931 | 594 | AT3G49370 [Arabidopsis thalian | 0.751 | 0.575 | 0.667 | 4.9e-127 | |
| TAIR|locus:2152876 | 594 | AT5G24430 [Arabidopsis thalian | 0.751 | 0.575 | 0.653 | 1.9e-125 | |
| TAIR|locus:2827826 | 571 | CPK16 "AT2G17890" [Arabidopsis | 0.676 | 0.539 | 0.584 | 3.2e-97 | |
| TAIR|locus:2156947 | 523 | CPK28 "calcium-dependent prote | 0.687 | 0.598 | 0.560 | 1.3e-91 | |
| TAIR|locus:2177023 | 528 | CPK17 "calcium-dependent prote | 0.639 | 0.551 | 0.536 | 2e-81 |
| TAIR|locus:2103655 AT3G56760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1460 (519.0 bits), Expect = 1.9e-151, Sum P(2) = 1.9e-151
Identities = 285/370 (77%), Positives = 323/370 (87%)
Query: 84 KSSPA--RSSANSTXXXXXXXXXXXXXXAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAA 141
K+SPA SS +ST AKHI+A+LARRHGSVKPNEA+IPEGSE E
Sbjct: 51 KTSPAVSSSSVSSTPLRIFKRPFPPPSPAKHIRALLARRHGSVKPNEASIPEGSECE--V 108
Query: 142 GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA 201
GL+K FGFSK FA+ YE+ EVGRGHFGYTC+AK KKG LKGQ VAVKVIPK KMTTAIA
Sbjct: 109 GLDKKFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQDVAVKVIPKSKMTTAIA 168
Query: 202 IEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
IEDVRREVKILRALTGH NLV+F+DA+ED +NVY+VMELC+GGELLD+IL RGGKY+E D
Sbjct: 169 IEDVRREVKILRALTGHKNLVQFYDAFEDDENVYIVMELCQGGELLDKILQRGGKYSEVD 228
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
AK VMIQIL+VVA+CHLQGVVHRDLKPENFLFTTKDE+S LKAIDFGLSD+VRPDERLND
Sbjct: 229 AKKVMIQILSVVAYCHLQGVVHRDLKPENFLFTTKDESSPLKAIDFGLSDYVRPDERLND 288
Query: 322 IVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
IVGSAYYVAPEVLHR+Y TEAD+WSIGVIAYILLCGSRPFWAR+ESGIFRAVLKA+P+F+
Sbjct: 289 IVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARSESGIFRAVLKAEPNFE 348
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYM 441
EAPWPSLS +A DFVKRLLNKD RKRLTAAQAL HPW+ S+++K+P D+II+KL+K Y+
Sbjct: 349 EAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQALCHPWLVGSHELKIPSDMIIYKLVKVYI 408
Query: 442 RSSSLRKAAL 451
SSSLRK+AL
Sbjct: 409 MSSSLRKSAL 418
|
|
| TAIR|locus:2063197 CRK1 "AT2G41140" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1445 (513.7 bits), Expect = 4.6e-150, Sum P(2) = 4.6e-150
Identities = 280/369 (75%), Positives = 321/369 (86%)
Query: 84 KSSPA-RSSANSTXXXXXXXXXXXXXXAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAG 142
KSSP+ SS +ST AKHI+A LARR+GSVKPNE +IPEG E E G
Sbjct: 51 KSSPSVSSSVSSTPLRIFKRPFPPPSPAKHIRAFLARRYGSVKPNEVSIPEGKECE--IG 108
Query: 143 LNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI 202
L+KSFGFSK FA+ YE+ EVGRGHFGYTC+AK KKG LKGQ+VAVKVIPK KMTTAIAI
Sbjct: 109 LDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQEVAVKVIPKSKMTTAIAI 168
Query: 203 EDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA 262
EDV REVK+LRALTGH NLV+F+DA+ED +NVY+VMELC+GGELLD+IL RGGKY+EDDA
Sbjct: 169 EDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCKGGELLDKILQRGGKYSEDDA 228
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
K VM+QIL+VVA+CHLQGVVHRDLKPENFLF+TKDE S LKAIDFGLSD+V+PDERLNDI
Sbjct: 229 KKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPLKAIDFGLSDYVKPDERLNDI 288
Query: 323 VGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
VGSAYYVAPEVLHR+Y TEAD+WSIGVIAYILLCGSRPFWARTESGIFRAVLKA+P+F+E
Sbjct: 289 VGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKAEPNFEE 348
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMR 442
APWPSLS EA DFVKRLLNKD RKRLTAAQAL HPW+ S+++K+P D+II+KL+K Y+
Sbjct: 349 APWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLVGSHELKIPSDMIIYKLVKVYIM 408
Query: 443 SSSLRKAAL 451
S+SLRK+AL
Sbjct: 409 STSLRKSAL 417
|
|
| TAIR|locus:2012232 AT1G49580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1393 (495.4 bits), Expect = 1.8e-142, P = 1.8e-142
Identities = 269/351 (76%), Positives = 305/351 (86%)
Query: 110 AKHIKAVLARRHGS-------VKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEE 162
AKHI+A L RR G V +P+ E E GL+K FGFSK F ++ ELGEE
Sbjct: 97 AKHIRAALRRRKGKKEAALSGVTQLTTEVPQREEEEEV-GLDKRFGFSKEFHSRVELGEE 155
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRGHFGYTC+AKFKKGELKGQ VAVK+IPK KMTTAIAIEDVRREVKIL+AL+GH NLV
Sbjct: 156 IGRGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIAIEDVRREVKILQALSGHKNLV 215
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+F+DA+ED NVY+ MELCEGGELLDRIL+RGGKY+E+DAK V+IQILNVVAFCH QGVV
Sbjct: 216 QFYDAFEDNANVYIAMELCEGGELLDRILARGGKYSENDAKPVIIQILNVVAFCHFQGVV 275
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEA 342
HRDLKPENFL+T+K+ENS LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY+TEA
Sbjct: 276 HRDLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEA 335
Query: 343 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK 402
DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE PWP LSS+A+DFVKRLL K
Sbjct: 336 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFLSSDAKDFVKRLLFK 395
Query: 403 DPRKRLTAAQALSHPWIKNSN-DVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
DPR+R++A+QAL HPWI+ N D+ +P D++IF+ MKAY+RSSSLRKAALR
Sbjct: 396 DPRRRMSASQALMHPWIRAYNTDMNIPFDILIFRQMKAYLRSSSLRKAALR 446
|
|
| TAIR|locus:2094053 AT3G19100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1392 (495.1 bits), Expect = 2.3e-142, P = 2.3e-142
Identities = 268/347 (77%), Positives = 302/347 (87%)
Query: 110 AKHIKAVLARRHGSVKPNEAAIPEG-----SEPEPAAGLNKSFGFSKHFANKYELGEEVG 164
A+HI+ VL RR + EAA+P E GL+K FGFSK ++ ELGEE+G
Sbjct: 95 ARHIRDVLRRRK---EKKEAALPAARQQKEEEEREEVGLDKRFGFSKELQSRIELGEEIG 151
Query: 165 RGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKF 224
RGHFGYTC+AKFKKGELK Q+VAVKVIPK KMT+AI+IEDVRREVKILRAL+GH NLV+F
Sbjct: 152 RGHFGYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVRREVKILRALSGHQNLVQF 211
Query: 225 FDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHR 284
+DA+ED NVY+VMELC GGELLDRIL+RGGKY+EDDAKAV+IQILNVVAFCHLQGVVHR
Sbjct: 212 YDAFEDNANVYIVMELCGGGELLDRILARGGKYSEDDAKAVLIQILNVVAFCHLQGVVHR 271
Query: 285 DLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADV 344
DLKPENFL+T+K+ENS+LK IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY+TEADV
Sbjct: 272 DLKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEADV 331
Query: 345 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDP 404
WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE PWPSLS EA+DFVKRLL KDP
Sbjct: 332 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPSLSFEAKDFVKRLLYKDP 391
Query: 405 RKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAAL 451
RKR+TA+QAL HPWI + +P D++IFK +KAY+RSSSLRKAAL
Sbjct: 392 RKRMTASQALMHPWIAGYKKIDIPFDILIFKQIKAYLRSSSLRKAAL 438
|
|
| TAIR|locus:2062764 CRK3 "AT2G46700" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1307 (465.1 bits), Expect = 3.6e-135, Sum P(2) = 3.6e-135
Identities = 241/343 (70%), Positives = 295/343 (86%)
Query: 110 AKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFG 169
AKHIKA L +R G VKP E IPE EP L+KSFG+ K+F KYELG+EVGRGHFG
Sbjct: 97 AKHIKASLIKRLG-VKPKEGPIPEERGTEPEQSLDKSFGYGKNFGAKYELGKEVGRGHFG 155
Query: 170 YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229
+TC+ + KKG++K +AVK+I K KMTTAIAIEDVRREVK+L++L+GH L+K++DA E
Sbjct: 156 HTCSGRGKKGDIKDHPIAVKIISKAKMTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACE 215
Query: 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPE 289
D +NVY+VMELC+GGELLDRIL+RGGKY EDDAKA+++QIL VV+FCHLQGVVHRDLKPE
Sbjct: 216 DANNVYIVMELCDGGELLDRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPE 275
Query: 290 NFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGV 349
NFLFT+ E+S LK IDFGLSDF+RPDERLNDIVGSAYYVAPEVLHRSYS EAD+WSIGV
Sbjct: 276 NFLFTSSREDSDLKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGV 335
Query: 350 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
I YILLCGSRPFWARTESGIFR VL+ +P++D+ PWPS SSE +DFVKRLLNKD RKR++
Sbjct: 336 ITYILLCGSRPFWARTESGIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMS 395
Query: 410 AAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
A QAL+HPW+++ + V +PLD++I+KL+KAY+ ++ LR+AAL+
Sbjct: 396 AVQALTHPWLRDDSRV-IPLDILIYKLVKAYLHATPLRRAALK 437
|
|
| TAIR|locus:2082931 AT3G49370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1229 (437.7 bits), Expect = 4.9e-127, Sum P(2) = 4.9e-127
Identities = 233/349 (66%), Positives = 293/349 (83%)
Query: 110 AKHIKAVLARRHGSVK-PNEAAIPEGSEPEPAAG-----LNKSFGFSKHFANKYELGEEV 163
AK I A L RR G+ P + IPE SE + G L+K+FGF+K+F KYELG EV
Sbjct: 89 AKPIMAALRRRRGTAPHPRDGPIPEDSEAGGSGGGIGERLDKNFGFAKNFEGKYELGREV 148
Query: 164 GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVK 223
GRGHFG+TC AK KKG++KGQ VAVK+I K KMT+A++IEDVRREVK+L+AL+GH+++VK
Sbjct: 149 GRGHFGHTCWAKAKKGKIKGQTVAVKIISKSKMTSALSIEDVRREVKLLKALSGHSHMVK 208
Query: 224 FFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVH 283
F+D +ED+DNV+VVMELCEGGELLD IL+RGG+Y E +AK +++QIL+ AF HLQGVVH
Sbjct: 209 FYDVFEDSDNVFVVMELCEGGELLDSILARGGRYPEAEAKRILVQILSATAFFHLQGVVH 268
Query: 284 RDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEAD 343
RDLKPENFLFT+K+E++VLK IDFGLSD+ R D+RLND+VGSAYYVAPEVLHRSYSTEAD
Sbjct: 269 RDLKPENFLFTSKNEDAVLKVIDFGLSDYARFDQRLNDVVGSAYYVAPEVLHRSYSTEAD 328
Query: 344 VWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKD 403
+WSIGVI+YILLCGSRPF+ RTES IFR VL+A+P+FD+ PWPS+S A+DFVKRLLNKD
Sbjct: 329 IWSIGVISYILLCGSRPFYGRTESAIFRCVLRANPNFDDLPWPSISPIAKDFVKRLLNKD 388
Query: 404 PRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
RKR+TAAQAL+HPW+++ N + LD I+KL+K+Y+R+S R+AAL+
Sbjct: 389 HRKRMTAAQALAHPWLRDENPGLL-LDFSIYKLVKSYIRASPFRRAALK 436
|
|
| TAIR|locus:2152876 AT5G24430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1214 (432.4 bits), Expect = 1.9e-125, Sum P(2) = 1.9e-125
Identities = 230/352 (65%), Positives = 292/352 (82%)
Query: 110 AKHIKAVLARRHGSV-KPNEAAIPEGSEP------EPAAG--LNKSFGFSKHFANKYELG 160
AK I A L RR G+ +P + IPE SE + G L+K+FGF K+F KYELG
Sbjct: 87 AKPIMAALRRRRGAPPQPRDEPIPEDSEDVVDHGGDSGGGERLDKNFGFGKNFEGKYELG 146
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+EVGRGHFG+TC AK KKG++K Q VAVK+I K KMT+ ++IEDVRREVK+L+AL+GH +
Sbjct: 147 KEVGRGHFGHTCWAKAKKGKMKNQTVAVKIISKAKMTSTLSIEDVRREVKLLKALSGHRH 206
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+VKF+D YED DNV+VVMELCEGGELLDRIL+RGG+Y E DAK +++QIL+ AF HLQG
Sbjct: 207 MVKFYDVYEDADNVFVVMELCEGGELLDRILARGGRYPEVDAKRILVQILSATAFFHLQG 266
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYST 340
VVHRDLKPENFLFT+++E+++LK IDFGLSDF+R D+RLND+VGSAYYVAPEVLHRSYST
Sbjct: 267 VVHRDLKPENFLFTSRNEDAILKVIDFGLSDFIRYDQRLNDVVGSAYYVAPEVLHRSYST 326
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
EAD+WSIGVI+YILLCGSRPF+ RTES IFR VL+A+P+F++ PWPS+S A+DFVKRLL
Sbjct: 327 EADMWSIGVISYILLCGSRPFYGRTESAIFRCVLRANPNFEDMPWPSISPTAKDFVKRLL 386
Query: 401 NKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
NKD RKR+TAAQAL+HPW+++ N + LD ++KL+K+Y+R+S R++AL+
Sbjct: 387 NKDHRKRMTAAQALAHPWLRDENPGLL-LDFSVYKLVKSYIRASPFRRSALK 437
|
|
| TAIR|locus:2827826 CPK16 "AT2G17890" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 966 (345.1 bits), Expect = 3.2e-97, P = 3.2e-97
Identities = 183/313 (58%), Positives = 240/313 (76%)
Query: 142 GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA 201
G FG++K F ++Y +G+ +G G FGYT A KK G +VAVK I K KMT IA
Sbjct: 93 GKRVDFGYAKDFDHRYTIGKLLGHGQFGYTYVATDKK---TGDRVAVKKIDKAKMTIPIA 149
Query: 202 IEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR-GGKYTED 260
+EDV+REVKIL+ALTGH N+V+F++A+ED ++VY+VMELCEGGELLDRIL+R +Y+E
Sbjct: 150 VEDVKREVKILQALTGHENVVRFYNAFEDKNSVYIVMELCEGGELLDRILARKDSRYSER 209
Query: 261 DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320
DA V+ Q+L V A CHL+G+VHRD+KPENFLF + +E+S LKA DFGLSDF++P ++ +
Sbjct: 210 DAAVVVRQMLKVAAECHLRGLVHRDMKPENFLFKSTEEDSPLKATDFGLSDFIKPGKKFH 269
Query: 321 DIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380
DIVGSAYYVAPEVL R E+DVWSIGVI+YILLCG RPFW +TE GIF+ VLK P F
Sbjct: 270 DIVGSAYYVAPEVLKRRSGPESDVWSIGVISYILLCGRRPFWDKTEDGIFKEVLKNKPDF 329
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV-KVPLDVIIFKLMKA 439
PWP++S+ A+DFVK+LL KDPR RLTAAQALSHPW++ D ++P+D+ + M+
Sbjct: 330 RRKPWPTISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQ 389
Query: 440 YMRSSSLRKAALR 452
+++ S L++ ALR
Sbjct: 390 FVKFSRLKQFALR 402
|
|
| TAIR|locus:2156947 CPK28 "calcium-dependent protein kinase 28" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 913 (326.5 bits), Expect = 1.3e-91, P = 1.3e-91
Identities = 180/321 (56%), Positives = 229/321 (71%)
Query: 134 GSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK 193
GS P G FG+SK F + Y +G+ +G G FGYT A + G +VAVK + K
Sbjct: 42 GSIP---CGKRTDFGYSKDFHDHYTIGKLLGHGQFGYTYVAIHRPN---GDRVAVKRLDK 95
Query: 194 HKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR 253
KM IA+EDV+REV+IL AL+GH N+V+F +A+ED D VY+VMELCEGGELLDRILS+
Sbjct: 96 SKMVLPIAVEDVKREVQILIALSGHENVVQFHNAFEDDDYVYIVMELCEGGELLDRILSK 155
Query: 254 -GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312
G +Y+E DA V+ Q+L V CHL G+VHRD+KPENFLF + +S LKA DFGLSDF
Sbjct: 156 KGNRYSEKDAAVVVRQMLKVAGECHLHGLVHRDMKPENFLFKSAQLDSPLKATDFGLSDF 215
Query: 313 VRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372
++P +R +DIVGSAYYVAPEVL R E+DVWSIGVI YILLCG RPFW RTE GIF+
Sbjct: 216 IKPGKRFHDIVGSAYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPFWDRTEDGIFKE 275
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS-NDVKVPLDV 431
VL+ P F PW ++S A+DFVK+LL KDPR RLTAAQALSH W++ N +P+D+
Sbjct: 276 VLRNKPDFSRKPWATISDSAKDFVKKLLVKDPRARLTAAQALSHAWVREGGNATDIPVDI 335
Query: 432 IIFKLMKAYMRSSSLRKAALR 452
+ ++ ++R S L++ ALR
Sbjct: 336 SVLNNLRQFVRYSRLKQFALR 356
|
|
| TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 817 (292.7 bits), Expect = 2.0e-81, P = 2.0e-81
Identities = 161/300 (53%), Positives = 204/300 (68%)
Query: 157 YELGEEVGRGHFGYT--CAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
Y LG+E+GRG FG T C K G Q A K I K K+ IEDVRREV+I+
Sbjct: 73 YSLGKELGRGQFGVTHLCTQK-----ATGHQFACKTIAKRKLVNKEDIEDVRREVQIMHH 127
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
LTG N+V+ AYED +V++VMELC GGEL DRI+++G Y+E A +++ I+ +V
Sbjct: 128 LTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKG-HYSERAAASLLRTIVQIVH 186
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
CH GV+HRDLKPENFL KDENS LKA DFGLS F +P E DIVGSAYY+APEVL
Sbjct: 187 TCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEVL 246
Query: 335 HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394
R Y EAD+WSIGV+ YILLCG PFWA +E+GIF A+L+ F PWPS+S +A+D
Sbjct: 247 KRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSISPQAKD 306
Query: 395 FVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK-VPLDVIIFKLMKAYMRSSSLRKAALRV 453
VK++LN DP++RLTAAQ L+HPWIK + VPLD + +K + ++ +K ALRV
Sbjct: 307 LVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFKKVALRV 366
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SCS2 | CAMK5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7982 | 0.9648 | 0.7304 | yes | no |
| P53681 | CRK_DAUCA | 2, ., 7, ., 1, 1, ., 1 | 0.7683 | 0.9516 | 0.7192 | N/A | no |
| Q10KY3 | CAMK1_ORYSJ | 2, ., 7, ., 1, 1, ., 1, 7 | 0.7834 | 0.8131 | 0.6166 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | CRK5 | CPK related kinase 5 (607 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | grail3.0049009101 | elongation factor 1-alpha; This protein promotes the GTP-dependent binding of aminoacyl-tRNA to [...] (450 aa) | • | 0.510 | |||||||
 | grail3.0049008501 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (449 aa) | • | 0.510 | |||||||
 | grail3.0028013201 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (447 aa) | • | 0.510 | |||||||
 | grail3.0022037901 | elongation factor 1-alpha; This protein promotes the GTP-dependent binding of aminoacyl-tRNA to [...] (449 aa) | • | 0.510 | |||||||
 | grail3.0022037501 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (449 aa) | • | 0.510 | |||||||
 | eugene3.00102124 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (450 aa) | • | 0.510 | |||||||
 | estExt_Genewise1_v1.C_LG_VIII1205 | RecName- Full=Elongation factor 1-alpha;; This protein promotes the GTP-dependent binding of am [...] (450 aa) | • | 0.510 | |||||||
 | eugene3.00770028 | hypothetical protein (487 aa) | • | 0.423 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 455 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-104 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-91 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-64 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-63 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-61 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-59 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-58 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-56 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-53 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-53 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-52 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-50 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-48 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-47 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-47 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-47 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-46 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-45 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-44 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-44 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-43 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-43 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-43 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-42 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-42 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-40 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-39 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-39 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-39 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-38 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-38 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-38 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-37 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-37 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-37 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-36 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-36 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-35 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-34 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-34 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-33 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-33 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-33 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-33 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-32 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-32 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-32 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-32 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-31 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-31 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-31 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-31 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-30 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-30 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-30 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-30 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-30 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-30 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-30 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-30 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-29 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-29 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-29 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-29 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-29 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-29 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-29 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-29 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-29 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-28 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-28 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-28 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-28 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-28 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-28 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-28 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-27 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-27 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-27 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-27 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-27 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-26 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-26 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-26 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-26 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-26 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-26 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-26 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-26 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-26 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-26 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-26 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-26 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-25 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-25 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-25 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-25 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-25 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-25 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-24 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-24 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-24 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-24 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-24 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-24 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-23 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-23 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-23 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-23 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-23 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-23 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-23 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-23 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-22 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-22 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-22 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-22 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-22 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-22 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-22 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-22 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-21 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-21 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-21 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-21 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-21 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-21 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-20 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-20 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-20 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-20 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-19 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-19 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-18 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-16 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-14 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-09 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-06 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-06 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 8e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 3e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.004 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 311 bits (798), Expect = e-104
Identities = 116/265 (43%), Positives = 165/265 (62%), Gaps = 13/265 (4%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
YE+ E++G G FG A+ KK G+ VA+KVI K K+ E + RE+KIL+ L
Sbjct: 1 YEILEKLGEGSFGKVYLARDKK---TGKLVAIKVIKKKKIKKDR--ERILREIKILKKL- 54
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V+ +D +ED D +Y+VME CEGG+L D + RG + +ED+A+ + QIL+ + +
Sbjct: 55 KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYL 113
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-H 335
H +G+VHRDLKPEN L DE+ +K DFGL+ + P E+L VG+ Y+APEVL
Sbjct: 114 HSKGIVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG 170
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWPSLSSEARD 394
+ Y D+WS+GVI Y LL G PF + +F+ + K P F P +S EA+D
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWDISPEAKD 229
Query: 395 FVKRLLNKDPRKRLTAAQALSHPWI 419
+++LL KDP KRLTA +AL HP+
Sbjct: 230 LIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 277 bits (711), Expect = 2e-91
Identities = 121/269 (44%), Positives = 159/269 (59%), Gaps = 15/269 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
YEL ++G G FG AK K G+ VAVK++ K + RRE++ILR L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGT---GKIVAVKILKKRSEKSKKDQTA-RREIRILRRL- 55
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V+ DA+ED D++Y+VME CEGG+L D LSRGG +ED+AK + +QIL + +
Sbjct: 56 SHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFD-YLSRGGPLSEDEAKKIALQILRGLEYL 114
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL- 334
H G++HRDLKPEN L DEN V+K DFGL+ ++ L VG+ +Y+APEVL
Sbjct: 115 HSNGIIHRDLKPENILL---DENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFDEAPWPSLSS 390
Y + DVWS+GVI Y LL G PF + R +L FDE W S S
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSHPWI 419
EA+D +K+ LNKDP KR TA + L HPW
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 1e-64
Identities = 92/258 (35%), Positives = 140/258 (54%), Gaps = 46/258 (17%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G FG A+ KK G++VA+K+I K ++ + E++ RE++IL+ L H N+V
Sbjct: 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSSLL--EELLREIEILKKLN-HPNIV 54
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K + +ED +++Y+VME CEGG L D + GK +ED+ +++QIL + + H G++
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLH--RSYS 339
HRDLKPEN L +N +K DFGLS + D+ L IVG+ Y+APEVL YS
Sbjct: 115 HRDLKPENILLD--SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
++D+WS+GVI Y L E +D ++++
Sbjct: 173 EKSDIWSLGVILYEL-----------------------------------PELKDLIRKM 197
Query: 400 LNKDPRKRLTAAQALSHP 417
L KDP KR +A + L H
Sbjct: 198 LQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 3e-63
Identities = 91/261 (34%), Positives = 136/261 (52%), Gaps = 17/261 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + K G+ A+KV+ K K+ +E E IL + H +V
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K A++ + +Y+V+E GGEL LS+ G+++E+ A+ +I+ + + H G++
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSH-LSKEGRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + +K DFGL+ + R N G+ Y+APEVL Y
Sbjct: 116 YRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D WS+GV+ Y +L G PF+A I+ +LK F E LS EARD + LL
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLL 228
Query: 401 NKDPRKRLTAAQA---LSHPW 418
KDP KRL + A +HP+
Sbjct: 229 QKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 2e-61
Identities = 83/270 (30%), Positives = 143/270 (52%), Gaps = 18/270 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KYE+ +++G+G FG ++ G+ +K I M+ ED EVKIL+ L
Sbjct: 1 KYEIIKQIGKGSFG--KVYLVRRKS-DGKLYVLKEIDLSNMS-EKEREDALNEVKILKKL 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNV 272
H N++K+++++E+ + +VME +GG+L +I + G + E+ +Q+
Sbjct: 57 N-HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIVGSAYYVAP 331
+ + H + ++HRD+KP+N T+ ++K DFG+S + L +VG+ YY++P
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNG---LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LS 389
E+ ++ Y+ ++D+WS+G + Y L PF + +LK P PS S
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----PPIPSQYS 228
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
SE R+ V LL KDP +R + AQ L P+I
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 3e-59
Identities = 93/266 (34%), Positives = 145/266 (54%), Gaps = 16/266 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+E+ E++G+G FG A+ K+ G++VA+KVI E + E++IL+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLESKE---KKEKIINEIQILKKC 54
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VK++ +Y D +++VME C GG L D + S TE V ++L + +
Sbjct: 55 K-HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH 335
H G++HRD+K N L T+ E +K IDFGLS + + N +VG+ Y++APEV++
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN 170
Query: 336 R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-ADPSFDEAPWPSLSS-EA 392
Y +AD+WS+G+ A L G P+ +E +A+ K A P S E
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEF 227
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPW 418
+DF+K+ L K+P KR TA Q L HP+
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 6e-58
Identities = 88/274 (32%), Positives = 141/274 (51%), Gaps = 24/274 (8%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
++ GE +GRG FG Y K G+ +AVK + + +E + RE++IL
Sbjct: 1 EWTRGELLGRGSFGSVYLALDK-----DTGELMAVKSVELSGDSEE-ELEALEREIRILS 54
Query: 214 ALTGHNNLVKFFDAY--EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
+L H N+V+++ + E+ + + + +E GG L +L + GK E + QIL
Sbjct: 55 SLQ-HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQILE 112
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---DFVRPDERLNDIVGSAYY 328
+A+ H G+VHRD+K N L D + V+K DFG + + E + G+ Y+
Sbjct: 113 GLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW-P 386
+APEV+ Y AD+WS+G + G P W+ + + A L S E P P
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP-WSELGNPM--AALYKIGSSGEPPEIP 226
Query: 387 S-LSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
LS EA+DF+++ L +DP+KR TA + L HP++
Sbjct: 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 7e-56
Identities = 96/270 (35%), Positives = 149/270 (55%), Gaps = 22/270 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y+LG+ +GRG FG KG G VA+K I K+ A++ + +E+ +L+
Sbjct: 1 NYQLGDLIGRGAFG-----VVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLK 54
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L H N+VK+ + E +D++Y+++E E G L +I+ + G + E + Q+L +
Sbjct: 55 NLK-HPNIVKYIGSIETSDSLYIILEYAENGSLR-QIIKKFGPFPESLVAVYVYQVLQGL 112
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPE 332
A+ H QGV+HRD+K N L TTKD V+K DFG++ + + +VG+ Y++APE
Sbjct: 113 AYLHEQGVIHRDIKAANIL-TTKDG--VVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169
Query: 333 VLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWPS-LS 389
V+ S ST +D+WS+G LL G+ P++ + +FR V D P P +S
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-----QDDHPPLPEGIS 224
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
E +DF+ + KDP R TA Q L HPWI
Sbjct: 225 PELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 184 bits (466), Expect = 1e-53
Identities = 96/321 (29%), Positives = 161/321 (50%), Gaps = 30/321 (9%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
Y + ++G G FG A+ +K VA+KV+ K + + +E RE++IL +L
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK------LVALKVLAKKLESKSKEVERFLREIQILASL 54
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI--LSRGGKYTEDDAKAVMIQILNVV 273
N+VK +D ++D ++Y+VME +GG L D + + R G +E +A ++ QIL+ +
Sbjct: 55 NHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-------PDERLNDIVGSA 326
+ H +G++HRD+KPEN L + V+K IDFGL+ + + VG+
Sbjct: 115 EYLHSKGIIHRDIKPENILLD--RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 327 YYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPF----WARTESGIFRAVLKADP 378
Y+APEVL S+ +D+WS+G+ Y LL G PF + S + +L+
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 379 SFDEAPW-----PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVII 433
+P +S A D +K+LL KDP+ RL+++ LSH + + + L ++
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
Query: 434 FKLMKAYMRSSSLRKAALRVS 454
A +R S +S
Sbjct: 293 KPDDSAPLRLSLPPSLEALIS 313
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 8e-53
Identities = 83/290 (28%), Positives = 146/290 (50%), Gaps = 37/290 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ ++ G+ +G G F AK K+ ++ A+K++ K ++ ++ V+ E ++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKET---NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTR 57
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L GH ++K + ++D +N+Y V+E GELL I G E + +IL +
Sbjct: 58 LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSL-DEKCTRFYAAEILLALE 116
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----------------- 317
+ H +G++HRDLKPEN L D++ +K DFG + + P+
Sbjct: 117 YLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 318 ----RLNDIVGSAYYVAPEVLHRSYSTEA-DVWSIGVIAYILLCGSRPFWARTESGIFRA 372
R VG+A YV+PE+L+ + ++ D+W++G I Y +L G PF E F+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA----AQALSHPW 418
+LK + SF P+ +A+D +++LL DP+ RL + +HP+
Sbjct: 234 ILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-52
Identities = 92/274 (33%), Positives = 132/274 (48%), Gaps = 23/274 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+ +G +G AK KK G A+KVI K M ++ V E IL +V
Sbjct: 1 ISKGAYGRVFLAK-KK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K + +++ N+Y+VME GG+L +L G ED A+ + +I+ + + H G++
Sbjct: 57 KLYYSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDF---------VRPDERLNDIVGSAYYVAPEV 333
HRDLKP+N L D N LK DFGLS ++ IVG+ Y+APEV
Sbjct: 116 HRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 334 -LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
L + +S D WS+G I Y L G PF T IF+ +L + E +S EA
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEA 230
Query: 393 RDFVKRLLNKDPRKRLTAAQA---LSHPWIKNSN 423
D + +LL DP KRL A +HP+ K +
Sbjct: 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 1e-50
Identities = 86/270 (31%), Positives = 141/270 (52%), Gaps = 20/270 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+EL +G+G FG C + + + A+K + K K ++ +V E +IL+ L
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN 58
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNVVAF 275
H LV + +++D +N+Y+V++L GG+L R LS+ K++E+ K + +I+ + +
Sbjct: 59 -HPFLVNLWYSFQDEENMYLVVDLLLGGDL--RYHLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL- 334
H +G++HRD+KP+N L DE + DF ++ V PD G+ Y+APEVL
Sbjct: 116 LHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC 172
Query: 335 HRSYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDEAPWPSLSSE 391
+ YS D WS+GV AY L G RP+ + I AD + + S+E
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY----PATWSTE 228
Query: 392 ARDFVKRLLNKDPRKRL--TAAQALSHPWI 419
A D + +LL +DP+KRL +HP+
Sbjct: 229 AIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-48
Identities = 99/300 (33%), Positives = 148/300 (49%), Gaps = 56/300 (18%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKILRA 214
Y++ +++G G FG A+ K+ G+ VA+K + K K + E+ REVK LR
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKE---TGELVAIKKM-KKKFYS---WEECMNLREVKSLRK 53
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVV 273
L H N+VK + + + D +Y V E EG L + R GK +E ++++ QIL +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
A H G HRDLKPEN L + + V+K DFGL+ +R D V + +Y APE+
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169
Query: 334 L--HRSYSTEADVWSIGVIA---YILLCGSRP-FWARTESG-IFR--AVLKADPSFDEAP 384
L SYS+ D+W++G I Y L RP F +E +++ +VL + +
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTL----RPLFPGSSEIDQLYKICSVLG---TPTKQD 222
Query: 385 W--------------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
W P+ S EA D +K +L DP+KR TA+QAL HP+
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-47
Identities = 98/310 (31%), Positives = 151/310 (48%), Gaps = 62/310 (20%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV----R--REV 209
+YEL + +G G +G C+A K+ G++VA+K I +D+ R RE+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISN-------VFDDLIDAKRILREI 50
Query: 210 KILRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
K+LR L H N++ D + ED ++VY+V EL E L +++ T+D +
Sbjct: 51 KLLRHL-RHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQPLTDDHIQY 107
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----LN 320
+ QIL + + H V+HRDLKP N L + N LK DFGL+ V PDE L
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 321 DIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWA--------------- 363
+ V + +Y APE+L Y+ D+WS+G I LL +P +
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPLFPGRDYIDQLNLIVEVL 223
Query: 364 --RTESGI-------FRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTA 410
+E + R LK+ P + P P S EA D ++++L DP+KR+TA
Sbjct: 224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA 283
Query: 411 AQALSHPWIK 420
+AL+HP++
Sbjct: 284 DEALAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (419), Expect = 1e-47
Identities = 92/298 (30%), Positives = 142/298 (47%), Gaps = 51/298 (17%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKI 211
YE E++G G +G A+ KK G+ VA+K I TA+ RE+ +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDNEEEGIPSTAL------REISL 51
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRIL-SRGGKYTEDDAKAVMIQIL 270
L+ L H N+VK D +Y+V E C+ L + L R G + + K++M Q+L
Sbjct: 52 LKELK-HPNIVKLLDVIHTERKLYLVFEYCD--MDLKKYLDKRPGPLSPNLIKSIMYQLL 108
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYV 329
+A+CH ++HRDLKP+N L + + VLK DFGL+ F P V + +Y
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR 165
Query: 330 APEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVL-----KADP 378
APE+L + YST D+WS+G I ++ G F +E IF+ +L ++ P
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILGTPTEESWP 224
Query: 379 SFDEAPW-----------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+ P P L E D + ++L +P KR++A +AL HP+
Sbjct: 225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 4e-47
Identities = 83/276 (30%), Positives = 136/276 (49%), Gaps = 26/276 (9%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E + +G G FG + K G+ A+K++ K K+ +E V E +IL+++
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H LV + +++D N+Y+VME GGEL L + G++ E A+ Q++ + +
Sbjct: 60 -HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV-LH 335
H +V+RDLKPEN L D + +K DFG + V R + G+ Y+APE+ L
Sbjct: 118 HSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRV--KGRTYTLCGTPEYLAPEIILS 172
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---PSFDEAPWPSLSSEA 392
+ Y D W++G++ Y +L G PF+ I+ +L+ PSF S +A
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF-------FSPDA 225
Query: 393 RDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
+D ++ LL D KRL +HPW +
Sbjct: 226 KDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 88/280 (31%), Positives = 138/280 (49%), Gaps = 32/280 (11%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+++ G ++G G FG YT GEL +AVK I I+++ E+K+L
Sbjct: 1 RWQRGNKIGGGTFGKVYTAV-NLDTGEL----MAVKEIRIQDNDPKT-IKEIADEMKVLE 54
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA--KAVMIQILN 271
L H NLVK++ + VY+ ME C GG L + L G+ D+ + +Q+L
Sbjct: 55 LLK-HPNLVKYYGVEVHREKVYIFMEYCSGGTLEE--LLEHGR-ILDEHVIRVYTLQLLE 110
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-----RPDERLNDIVGSA 326
+A+ H G+VHRD+KP N D N V+K DFG + + E + + G+
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167
Query: 327 YYVAPEVLHRSYSTE----ADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPS 379
Y+APEV+ AD+WS+G + + G RP W+ ++ +F P
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGHKPP 226
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
++ LS E +DF+ R L DP+KR TA++ L HP++
Sbjct: 227 IPDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 5e-45
Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 18/270 (6%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP-KHKMTTAIAIEDVRREVKILRALT 216
E + +G+G G + K G+ A+K I + + RE+K LR+
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGDEEF---RKQLLRELKTLRS-C 56
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+VK + A+ + +V+E +GG L +L + GK E + QIL + +
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQILKGLDYL 115
Query: 277 HLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDIVGSAYYVAPEVL 334
H + ++HRD+KP N L +K E +K DFG+S + ++ N VG+ Y++PE +
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERI 172
Query: 335 H-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS--LSSE 391
SYS AD+WS+G+ G PF + F +++A P+ S E
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF-ELMQAICDGPPPSLPAEEFSPE 231
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
RDF+ L KDP+KR +AA+ L HP+IK
Sbjct: 232 FRDFISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 5e-44
Identities = 80/276 (28%), Positives = 132/276 (47%), Gaps = 24/276 (8%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVKI 211
Y+ E++G G G A + G++VA+K + K I E+ I
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQNKELII------NEILI 68
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
++ H N+V ++D+Y D ++VVME +GG L D I + E V ++L
Sbjct: 69 MKDCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ 127
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVA 330
+ + H Q V+HRD+K +N L + +K DFG + + + N +VG+ Y++A
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMA 184
Query: 331 PEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFDEAPWP 386
PEV+ R Y + D+WS+G++ + G P+ E +F K P
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL--REPPLRALFLITTKGIPPLKNPE-- 240
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422
S E +DF+ + L KDP KR +A + L HP++K +
Sbjct: 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 5e-44
Identities = 86/267 (32%), Positives = 129/267 (48%), Gaps = 14/267 (5%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+ + +G FG AK + G A+KV+ K M + +V+ E I+
Sbjct: 2 KPISKGAFGSVYLAKKR---STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+ K + +++ D +Y+VME GG+ I + GG ED AK + +++ V H +G
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYST 340
++HRD+KPEN L D+ LK DFGLS R VG+ Y+APE +
Sbjct: 118 IIHRDIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDD 171
Query: 341 EA-DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
+ D WS+G + + L G PF A T +F +L ++ E S EA D + RL
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231
Query: 400 LNKDPRKRLTA---AQALSHPWIKNSN 423
L DP KRL A + SHP+ K+ N
Sbjct: 232 LCMDPAKRLGANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 1e-43
Identities = 78/275 (28%), Positives = 135/275 (49%), Gaps = 24/275 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQV--AVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+G G FG + + ++K + A+K + K + E + E +IL H
Sbjct: 1 LGVGGFG-----RVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEIL-EECNHPF 54
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+VK + ++D +Y++ME C GGEL IL G + E A+ + ++ + H +G
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWT-ILRDRGLFDEYTARFYIACVVLAFEYLHNRG 113
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYS 339
+++RDLKPEN L D N +K +DFG + ++ ++ G+ YVAPE+ L++ Y
Sbjct: 114 IIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD 170
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDEAPWPS-LSSEARDFV 396
D WS+G++ Y LL G PF E I+ +LK + + +P+ + A+D +
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---GKLEFPNYIDKAAKDLI 227
Query: 397 KRLLNKDPRKRLTAAQA-----LSHPWIKNSNDVK 426
K+LL ++P +RL + H W +
Sbjct: 228 KQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWEG 262
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 2e-43
Identities = 93/306 (30%), Positives = 140/306 (45%), Gaps = 59/306 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--------TAIAIEDVRR 207
+YE G+++G G + A+ K+ G+ VA+K I + TA+ R
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTAL------R 51
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGG-ELL--DRILSRGGKYTEDDAKA 264
E+K+L+ L H N++ D + N+ +V E E E + D+ + T D K+
Sbjct: 52 EIKLLQELK-HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV----LTPADIKS 106
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
M+ L + + H ++HRDLKP N L + VLK DFGL+ F P+ ++ V
Sbjct: 107 YMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQV 163
Query: 324 GSAYYVAPEVLH--RSYSTEADVWSIGVI-AYILLCGSRPFWARTE-----SGIFRA--- 372
+ +Y APE+L R Y D+WS+G I A +LL PF IF A
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL--RVPFLPGDSDIDQLGKIFEALGT 221
Query: 373 -------VLKADPS---FDEAPWPSL-------SSEARDFVKRLLNKDPRKRLTAAQALS 415
+ + P F P L S +A D ++RLL +P KR+TA QAL
Sbjct: 222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281
Query: 416 HPWIKN 421
HP+ N
Sbjct: 282 HPYFSN 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 9e-43
Identities = 94/295 (31%), Positives = 136/295 (46%), Gaps = 44/295 (14%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKILRA 214
Y+ ++G G +G A+ K L G+ VA+K K K+ RE+K+L+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDK---LTGEIVAIK---KIKLRFESEGIPKTALREIKLLKE 54
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N++K D + ++Y+V E + +L I R E K+ + Q+L +A
Sbjct: 55 LN-HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPEV 333
FCH G++HRDLKPEN L T VLK DFGL+ R V + +Y APE+
Sbjct: 113 FCHSHGILHRDLKPENLLINT---EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPEL 169
Query: 334 LHRS--YSTEADVWSIGVIAYILLCGSRPFWARTE-----SGIF---------------- 370
L YST D+WS+G I LL RP + IF
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228
Query: 371 --RAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
R + P P P+ S +A D + ++L+ DP KR+TA QAL+HP+
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 93/293 (31%), Positives = 139/293 (47%), Gaps = 39/293 (13%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y++ +G G G AK ++ G+ VA+K + ++ I RE+K L+A
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLEGGIP-NQALREIKALQAC 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H +VK D + +VME +L + + E K+ M +L VA+
Sbjct: 57 -QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-FVRPDERL-NDIVGSAYYVAPEV 333
H G++HRDLKP N L + VLK DFGL+ F + RL + V + +Y APE+
Sbjct: 115 MHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171
Query: 334 LH--RSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAV----------LKAD 377
L+ R Y D+W++G I LL GS F + + +FR + L +
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231
Query: 378 P-----SFDEA---PW----PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
P +F E+ P P S EA D +K LL DP KRL+AA+AL HP+
Sbjct: 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 5e-42
Identities = 99/303 (32%), Positives = 142/303 (46%), Gaps = 55/303 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR----REVK 210
NKYE+ VG G +G + K G+ VA+K K + EDV+ REVK
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKA---TGEIVAIK-----KFKESEDDEDVKKTALREVK 52
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQ 268
+LR L H N+V +A+ +Y+V E E ELL+ S GG D ++ + Q
Sbjct: 53 VLRQLR-HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGG-LPPDAVRSYIWQ 108
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV--RPDERLNDIVGSA 326
+L +A+CH ++HRD+KPEN L E+ VLK DFG + + RP L D V +
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATR 165
Query: 327 YYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTES-----GIFRA------- 372
+Y APE+L +Y DVW+IG I LL G P + I +
Sbjct: 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPPS 224
Query: 373 ---VLKADPSFDEAPWPS--------------LSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ ++P F +P +SS A DF+K L DP++RLT + L
Sbjct: 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284
Query: 416 HPW 418
HP+
Sbjct: 285 HPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 86/288 (29%), Positives = 140/288 (48%), Gaps = 39/288 (13%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+EL E +G G +G A+ KK GQ VA+K++ E+++ E ILR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMD----IIEDEEEEIKEEYNILR 57
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGG---ELLDRILSRGGKYTEDDAKA 264
+ H N+ F+ A+ + D +++VMELC GG +L+ + +G + E+
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
++ + L +A+ H V+HRD+K +N L T +N+ +K +DFG+S R N +
Sbjct: 118 ILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 324 GSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
G+ Y++APEV+ SY +DVWS+G+ A L G P + RA+ K
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL---CDMHPMRALFKIP 231
Query: 378 PSFDEAPWPSLSSEAR------DFVKRLLNKDPRKRLTAAQALSHPWI 419
+ P P+L S DF+ L K+ +R + L HP+I
Sbjct: 232 RN----PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 8e-40
Identities = 87/271 (32%), Positives = 136/271 (50%), Gaps = 20/271 (7%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVKI 211
++ GE +G G FG Y G+ AVK + T A++ + +E+ +
Sbjct: 1 RWRKGELLGSGSFGSVYE-GLNLDDGDF----FAVKEVSLADDGQTGQEAVKQLEQEIAL 55
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L L H N+V++ + DN+Y+ +EL GG L ++L + G + E + QIL
Sbjct: 56 LSKLQ-HPNIVQYLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILL 113
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
+ + H + VHRD+K N L D N V+K DFG++ V GS Y++AP
Sbjct: 114 GLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAP 170
Query: 332 EVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SL 388
EV+ + Y AD+WS+G + + +P W++ E AV K S + P P L
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTV-LEMATGKPPWSQLEG--VAAVFKIGRSKELPPIPDHL 227
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
S EA+DF+ + L +DP R TAA+ L HP++
Sbjct: 228 SDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 96/287 (33%), Positives = 139/287 (48%), Gaps = 45/287 (15%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
YE+ E +G+G FG + K G+ + K I MT + V EV ILR L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNMTEKEKQQLVS-EVNILREL 56
Query: 216 TGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRILSR----GGKYTEDDAKAVMIQI 269
H N+V+++D D N +Y+VME CEGG+L +++ + E+ ++ Q+
Sbjct: 57 K-HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 270 LNVVAFCHLQG-----VVHRDLKPEN-FLFTTKDENSVLKAIDFGLSDFVRPDERL-NDI 322
L + CH + V+HRDLKP N FL D N+ +K DFGL+ + D
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFL----DANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 323 VGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWART--------ESGIFRAV 373
VG+ YY++PE L H SY ++D+WS+G + Y L S PF AR + G FR
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR-- 228
Query: 374 LKADPSFDEAPWPSL-SSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
P SSE + +K +LN DP KR + + L P I
Sbjct: 229 ----------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 86/279 (30%), Positives = 139/279 (49%), Gaps = 35/279 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ L E +G+G FG A K+ Q VA+KVI + I ED+++E++ L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEEAEDEI--EDIQQEIQFLSQ 55
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ K++ ++ ++++ME C GG LD L + GK E ++ ++L +
Sbjct: 56 CRS-PYITKYYGSFLKGSKLWIIMEYCGGGSCLD--LLKPGKLDETYIAFILREVLLGLE 112
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
+ H +G +HRD+K N L + E +K DFG+S + N VG+ +++APEV
Sbjct: 113 YLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 334 LHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGI--FRAVL---KADPSFDEAPWPS 387
+ +S Y +AD+WS+G+ A L G P S + R + K +P PS
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPPL-----SDLHPMRVLFLIPKNNP-------PS 217
Query: 388 L-----SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
L S +DFV LNKDP++R +A + L H +IK
Sbjct: 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 8e-39
Identities = 82/277 (29%), Positives = 131/277 (47%), Gaps = 22/277 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ YEL E +G G AA ++VA+K I K T++ +++R+EV+ + +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQTSV--DELRKEVQAM-S 54
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD---RILSRGGKYTEDDAKAVMIQILN 271
H N+VK++ ++ D +++VM GG LLD RGG E V+ ++L
Sbjct: 55 QCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLK 113
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-----RPDERLNDIVGSA 326
+ + H G +HRD+K N L E+ +K DFG+S + R + VG+
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 327 YYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF--DE 382
++APEV+ Y +AD+WS G+ A L G+ P+ + L+ DP
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETG 230
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
A + S R + L KDP KR TA + L H +
Sbjct: 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 92/277 (33%), Positives = 139/277 (50%), Gaps = 21/277 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+++ +VG+G +G AK K G+ VA+K + K + + V E IL
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSLLFKLNEVRHVLTERDIL-T 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
T LVK A++D + +Y+ ME GG+ +L+ G +ED A+ M ++ V
Sbjct: 57 TTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVD 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
H G +HRDLKPENFL D + +K DFGLS V N +VGS Y+APEV
Sbjct: 116 ALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIV---TYANSVVGSPDYMAPEV 169
Query: 334 LH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-----ADPSFDEAPWPS 387
L + Y D WS+G + Y LCG PF T + + + P +D+ P +
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD-PRFN 228
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQAL-SHPWIKNSN 423
LS EA D + +L+N DP +R + + + +HP+ K +
Sbjct: 229 LSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKEVD 264
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 88/305 (28%), Positives = 131/305 (42%), Gaps = 60/305 (19%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKI 211
YE ++G G +G A+ KK G+ VA+K I TAI RE+K+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKK---TGELVALKKIRMENEKEGFPITAI------REIKL 51
Query: 212 LRALTGHNNLVKFFDAY--EDTDNVYVVMELCE----GGELLDRILSRGGKYTEDDAKAV 265
L+ L H N+V+ + + ++Y+V E + G LLD S K+TE K
Sbjct: 52 LQKLR-HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLD---SPEVKFTESQIKCY 105
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV--RPDERLNDIV 323
M Q+L + + H G++HRD+K N L + + VLK DFGL+ R + V
Sbjct: 106 MKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRV 162
Query: 324 GSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
+ +Y PE+L Y E D+WS+G I L G F TE + + S
Sbjct: 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT 222
Query: 382 EAPWPSL---------------------------SSEARDFVKRLLNKDPRKRLTAAQAL 414
+ WP + A D + +LL DP+KR++A QAL
Sbjct: 223 DENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL 282
Query: 415 SHPWI 419
H +
Sbjct: 283 QHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 9e-38
Identities = 87/274 (31%), Positives = 141/274 (51%), Gaps = 33/274 (12%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---------EVKIL 212
++G G G C A K G+QVAVK KM D+R+ EV I+
Sbjct: 26 KIGEGSTGIVCIATDKS---TGRQVAVK-----KM-------DLRKQQRRELLFNEVVIM 70
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
R H N+V+ + +Y D ++VVME EGG L D I++ + E+ V + +L
Sbjct: 71 RDYQ-HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIATVCLAVLKA 127
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAP 331
++F H QGV+HRD+K ++ L T+ + +K DFG V + R +VG+ Y++AP
Sbjct: 128 LSFLHAQGVIHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 184
Query: 332 EVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
EV+ R Y TE D+WS+G++ ++ G P++ + + P + +S
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL-HKVSP 243
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
R F+ R+L +DP +R TAA+ L+HP++ +
Sbjct: 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 82/281 (29%), Positives = 148/281 (52%), Gaps = 27/281 (9%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGH 218
E +GRG +G A K G+ VA+K+I + T + D++REV +L L +
Sbjct: 7 ELIGRGAYG---AVYRGKHVPTGRVVALKII--NLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
N+ K++ +Y ++++ME EGG + R L + G E ++ ++L + + H
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLH-- 335
GV+HRD+K N L T +K DFG++ + + + VG+ Y++APEV+
Sbjct: 120 VGVIHRDIKAANILVTNTGN---VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDEAPWPSLSSE 391
+ Y T+AD+WS+G+ Y + G+ P+ ++ FRA++ P ++ + S
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDNGY---SKL 230
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
R+FV L+++P++RL+A + L WIK + K P+ ++
Sbjct: 231 LREFVAACLDEEPKERLSAEELLKSKWIKAHS--KTPVSIL 269
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 82/276 (29%), Positives = 142/276 (51%), Gaps = 37/276 (13%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+++ E++G G +G A K+ GQ VA+KV+P + + +++ +E+ IL+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKET---GQVVAIKVVP---VEEDL--QEIIKEISILKQ-C 55
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+VK++ +Y ++++VME C G + D + TE++ A++ Q L + +
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND-------IVGSAYYV 329
H +HRD+K N L +E K DFG+S +L D ++G+ +++
Sbjct: 116 HSNKKIHRDIKAGNILL---NEEGQAKLADFGVS------GQLTDTMAKRNTVIGTPFWM 166
Query: 330 APEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSF-DEA 383
APEV+ Y+ +AD+WS+G+ A I + +P ++ RA+ K P+ D
Sbjct: 167 APEVIQEIGYNNKADIWSLGITA-IEMAEGKPPYSDIHP--MRAIFMIPNKPPPTLSDPE 223
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
W S E DFVK+ L KDP +R +A Q L HP+I
Sbjct: 224 KW---SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 4e-37
Identities = 93/304 (30%), Positives = 142/304 (46%), Gaps = 51/304 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +E+ + +GRG FG + K GQ A+KV+ K M I VR E IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDIL-- 55
Query: 215 LTGHNN--LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK---AVMIQI 269
++ +VK + +++D +++Y+VME GG+L+ +L R + E+ A+ A ++
Sbjct: 56 -ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEETARFYIAELVLA 113
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS--------DFVRPDERLND 321
L+ V H G +HRD+KP+N L D + +K DFGL ++ N
Sbjct: 114 LDSV---HKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 322 ----------------------IVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGS 358
VG+ Y+APEVL Y E D WS+GVI Y +L G
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
Query: 359 RPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA-QALSHP 417
PF++ T + ++ S P P +S EA D + RLL DP RL + + SHP
Sbjct: 228 PPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHP 286
Query: 418 WIKN 421
+ K
Sbjct: 287 FFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 6e-37
Identities = 86/275 (31%), Positives = 130/275 (47%), Gaps = 30/275 (10%)
Query: 156 KYELGEEVGRGHFGYTCAAK-FKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
YEL + +G G +G A+ GEL VA+KVI K+ E +++E+ +L+
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGEL----VAIKVI---KLEPGDDFEIIQQEISMLKE 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N+V +F +Y D +++VME C GG L D G +E V + L +A
Sbjct: 57 CR-HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
+ H G +HRD+K N L T E+ +K DFG+S + +G+ Y++APEV
Sbjct: 116 YLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 334 L----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP----- 384
Y + D+W++G+ A L P + + RA+ S P
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMF---DLHPMRALFLISKSNFPPPKLKDK 229
Query: 385 --WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
W S DF+K+ L KDP+KR TA + L HP
Sbjct: 230 EKW---SPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 9e-37
Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 22/285 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ E+G G FG A+ K+ G A K+I ++ + +ED E+ IL +
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKE---TGLFAAAKII---QIESEEELEDFMVEIDIL-SEC 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V ++AY + +++++E C+GG L +L TE + V Q+L + F
Sbjct: 60 KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL- 334
H V+HRDLK N L T + +K DFG+S ++ + +G+ Y++APEV+
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176
Query: 335 -----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP--WPS 387
Y +AD+WS+G+ L P + +LK++P + P W
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW-- 234
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
SS DF+K L KDP R TAA+ L HP++ + +D K D++
Sbjct: 235 -SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLL 278
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 6e-36
Identities = 90/308 (29%), Positives = 139/308 (45%), Gaps = 50/308 (16%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI 211
++Y+ E +G G +G C+A + G++VA+K IP H + RE+KI
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIP-HAFDVPTLAKRTLRELKI 57
Query: 212 LRALTGHNNLVKFFDAY----EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
LR H+N++ D D +VYVVM+L E L I+ TE+ + +
Sbjct: 58 LRHFK-HDNIIAIRDILRPPGADFKDVYVVMDLMESD--LHHIIHSDQPLTEEHIRYFLY 114
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV--RPDER---LNDI 322
Q+L + + H V+HRDLKP N L +E+ L+ DFG++ + P E + +
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 323 VGSAYYVAPE---VLHRSYSTEADVWSIG-----------------------VIAYILLC 356
V + +Y APE L Y+T D+WS+G +I +L
Sbjct: 172 VATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQ 412
S R S R ++ P PW P S EA D + ++L DP +R+T Q
Sbjct: 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290
Query: 413 ALSHPWIK 420
AL HP++
Sbjct: 291 ALQHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 9e-36
Identities = 88/282 (31%), Positives = 143/282 (50%), Gaps = 25/282 (8%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-AIAIEDVRREVKILRAL 215
+EL +G G +G + G G+ A+KV+ K + A E R E ++L A+
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
LV A++ ++++++ GGEL + R +TE + + + +I V+A
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEI--VLAL 118
Query: 276 CHLQ--GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
HL G+++RD+K EN L D + DFGLS +E R G+ Y+AP
Sbjct: 119 DHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 332 EVLHR---SYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADPSFDEAP 384
EV+ + D WS+GV+ + LL G+ PF ++S I R +LK+ P F
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP--- 232
Query: 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQA---LSHPWIKNSN 423
++S+EARDF+++LL KDP+KRL A A +HP+ + +
Sbjct: 233 -KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 80/267 (29%), Positives = 133/267 (49%), Gaps = 20/267 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K + AVKV+ K + +E E ++L H L
Sbjct: 3 LGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ D ++ VME GG+L+ I R G++ E A+ +I+ + F H +G++
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
+RDLK +N L D +K DFG+ + + + G+ Y+APE+L ++ Y
Sbjct: 119 YRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGP 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSSEARDFVKRL 399
D W++GV+ Y +L G PF E +F+++L+ DE +P LS EA+ +K
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-----DEVRYPRWLSKEAKSILKSF 230
Query: 400 LNKDPRKRL----TAAQAL-SHPWIKN 421
L K+P KRL T Q + HP+ +
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 91/309 (29%), Positives = 143/309 (46%), Gaps = 49/309 (15%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
KHF + + +G+G G + K G+ A+KV+ K +M ++ V E +
Sbjct: 1 KHF----KKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQE 53
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQI 269
IL L H L + +++ + +VM+ C GGEL + + GK +E+ A+ ++
Sbjct: 54 ILATLD-HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEV 112
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------------------- 310
L + + HL G+V+RDLKPEN L E+ + DF LS
Sbjct: 113 LLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169
Query: 311 ---------DFVR--PDERLNDIVGSAYYVAPEVLHRSYSTEA-DVWSIGVIAYILLCGS 358
+ P R N VG+ Y+APEV+ A D W++G++ Y +L G+
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
Query: 359 RPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL----TAAQAL 414
PF F +LK + +F P +SS ARD +++LL KDP KRL AA+
Sbjct: 230 TPFKGSNRDETFSNILKKEVTF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287
Query: 415 SHPWIKNSN 423
HP+ + N
Sbjct: 288 QHPFFRGVN 296
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 78/269 (28%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
LG+++G G FG K K KG K +VAVK + + IE+ RE +I+R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKL- 58
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+VK + + +Y+VME EGG+LL + K + D + +QI + +
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +HRDL N L EN V+K DFGLS + D+ YY
Sbjct: 119 ESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDD---------YYRKRGGKLP 166
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEA 383
APE L +++++DVWS GV+ + I G +P+ + + +
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG--YRLPQ 224
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
P P+ E D + + +DP R T ++
Sbjct: 225 P-PNCPPELYDLMLQCWAEDPEDRPTFSE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 95/309 (30%), Positives = 148/309 (47%), Gaps = 45/309 (14%)
Query: 147 FGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR 206
FG N+Y + VG G FG C+A+ +L GQ VA+K I K T +A +
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSAR---DQLTGQNVAIKKIMKPFSTPVLA-KRTY 57
Query: 207 REVKILRALTGHNNLVKFFDAY-EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV 265
RE+K+L+ L H N++ D + +++Y V EL G L R+L+ + +
Sbjct: 58 RELKLLKHLR-HENIISLSDIFISPLEDIYFVTELL--GTDLHRLLT-SRPLEKQFIQYF 113
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDIVG 324
+ QIL + + H GVVHRDLKP N L +EN LK DFGL+ R D ++ V
Sbjct: 114 LYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLA---RIQDPQMTGYVS 167
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL-------- 374
+ YY APE++ + Y E D+WS G I +L G F + F +
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227
Query: 375 ---------------KADPSFDEAP----WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
++ P + P + + A D ++++L DP+KR++AA+AL+
Sbjct: 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287
Query: 416 HPWIKNSND 424
HP++ +D
Sbjct: 288 HPYLAPYHD 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 76/271 (28%), Positives = 120/271 (44%), Gaps = 35/271 (12%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
LG+++G G FG Y K K K +VAVK + + I E+ RE +I+R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDG-KEVEVAVKTLKEDASEQQI--EEFLREARIMRKL 58
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVA 274
H N+VK + + + +VME GG+LLD + K + D + +QI +
Sbjct: 59 -DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + +HRDL N L EN V+K DFGLS + D+ YY
Sbjct: 118 YLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDD---------YYKVKGGK 165
Query: 330 ------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFD 381
APE L +++++DVWS GV+ + I G P+ + + + + K
Sbjct: 166 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGY--RL 223
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
P P+ E + + +DP R T ++
Sbjct: 224 PKP-PNCPPELYKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 74/264 (28%), Positives = 138/264 (52%), Gaps = 14/264 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
Y +G+G FG A +++ E V K + +++ D E+ IL +L
Sbjct: 2 YIPIRVLGKGAFGE--ATLYRRTE-DDSLVVWKEVNLTRLSEKER-RDALNEIVIL-SLL 56
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAF 275
H N++ +++ + D + + + ME GG L D+I+ + G+ + E+ + QI++ V++
Sbjct: 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND-IVGSAYYVAPEVL 334
H G++HRD+K N +F TK ++K DFG+S + + + + +VG+ YY++PE+
Sbjct: 117 IHKAGILHRDIKTLN-IFLTKA--GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC 173
Query: 335 H-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
Y+ ++D+W++G + Y LL R F A + +++ + + + + SSE
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELI 230
Query: 394 DFVKRLLNKDPRKRLTAAQALSHP 417
V LL +DP KR TA + L P
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 83/266 (31%), Positives = 145/266 (54%), Gaps = 27/266 (10%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
++G G G C A+ K G+QVAVK++ K E + EV I+R H N+
Sbjct: 28 KIGEGSTGIVCIAREKH---SGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQ-HQNV 80
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ + +Y + ++V+ME +GG L D I+S+ + E+ V +L + + H QGV
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQT-RLNEEQIATVCESVLQALCYLHSQGV 138
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHRS-YS 339
+HRD+K ++ L T + +K DFG + D + +VG+ Y++APEV+ R+ Y
Sbjct: 139 IHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL------SSEAR 393
TE D+WS+G++ ++ G P+++ + ++A ++P P L S R
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRLRDSPPPKLKNAHKISPVLR 248
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWI 419
DF++R+L ++P++R TA + L HP++
Sbjct: 249 DFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-33
Identities = 81/270 (30%), Positives = 133/270 (49%), Gaps = 21/270 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K+ G+ AVKV+ K + +E E +IL H L
Sbjct: 3 LGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ + ++ D ++ VME GG+L+ I + ++ E A+ +I + + F H +G++
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFLHDKGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLK +N L D K DFG+ + + + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSEARDFVKRL 399
D W++GV+ Y +LCG PF A E +F A+L DE +P+ LS +A D +K
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----DEVVYPTWLSQDAVDILKAF 230
Query: 400 LNKDPRKRLTA------AQALSHPWIKNSN 423
+ K+P RL + L HP+ K +
Sbjct: 231 MTKNPTMRLGSLTLGGEEAILRHPFFKELD 260
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 86/305 (28%), Positives = 146/305 (47%), Gaps = 53/305 (17%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK---HKMTTAIAIEDVRREVKILR 213
YEL +E+G+G +G C+A+ + + + VA+K I K+ A+ RE+K+LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRAL----RELKLLR 56
Query: 214 ALTGHNNLVKFFDA----YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
GH N+ +D + + +Y+ EL E L +I+ G T+ ++ + QI
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQI 114
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-----DFVRPDERLNDIVG 324
L + + H V+HRDLKP N L E LK DFGL+ + + + V
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFW-------------------- 362
+ +Y APE++ +SY+ DVWS+G I LL G +P +
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQVLGTPD 230
Query: 363 ----ARTESGIFRAVLKADPSFDEAPWPSL----SSEARDFVKRLLNKDPRKRLTAAQAL 414
+R S + +++ P+ + P+ S+ + A D +++LL DP KR++ +AL
Sbjct: 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290
Query: 415 SHPWI 419
HP++
Sbjct: 291 EHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 80/253 (31%), Positives = 126/253 (49%), Gaps = 15/253 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+GE +G G FG AK K G+ A+K + K ++ ++ V +E IL L+
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H +V +++D + VY ++E GGEL L + G++ D AK +++ +
Sbjct: 77 -HPFIVNMMCSFQDENRVYFLLEFVVGGELFTH-LRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH- 335
H + +++RDLKPEN L D +K DFG + V +R + G+ Y+APEV+
Sbjct: 135 HSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVIQS 189
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
+ + D W++GV+ Y + G PF+ T I+ +L F W ARD
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDL 245
Query: 396 VKRLLNKDPRKRL 408
VK LL D KRL
Sbjct: 246 VKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-32
Identities = 72/264 (27%), Positives = 127/264 (48%), Gaps = 14/264 (5%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ ++G+G FG K + A+K I KM E + E ++L L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKMNRREREEAID-EARVLAKLD 57
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAF 275
+ ++++++++ D + +VME E G+L + RG ED IQIL +A
Sbjct: 58 -SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIVGSAYYVAPEVL 334
H + ++HRD+K N LF +N +K D G++ + + N IVG+ YY++PE+
Sbjct: 117 LHSKKILHRDIKSLN-LFLDAYDN--VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC 173
Query: 335 H-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
+ Y+ ++DVW++GV+ Y G PF A + + +++ F S +
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG--VFPPVSQM-YSQQLA 230
Query: 394 DFVKRLLNKDPRKRLTAAQALSHP 417
+ + L KD R+R Q L +P
Sbjct: 231 QLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 77/274 (28%), Positives = 138/274 (50%), Gaps = 21/274 (7%)
Query: 160 GEEVGRGHFGYT-CAAKFKKGEL---KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
GE +G+G +G A GE+ K ++ + +H ++ +R E++ L+ L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 216 TGHNNLVKFFDAYEDTDNVY-VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N+V++ +E T+ + +E GG + L G++ E + Q+L +A
Sbjct: 66 D-HLNIVQYL-GFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFTEQVLEGLA 122
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL---SDFVRPDERLNDIVGSAYYVAP 331
+ H +G++HRDLK +N L D + + K DFG+ SD + +++ + GS +++AP
Sbjct: 123 YLHSKGILHRDLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 332 EVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTES--GIFR-AVLKADPSFDEAPW 385
EV+H + YS + D+WS+G + + G RP W+ E+ +F+ ++ P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPPIPPDVS 238
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+LS A DF+ +P R TA + L HP+I
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 77/283 (27%), Positives = 129/283 (45%), Gaps = 45/283 (15%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIP---KHKMTTAIAIEDVRREVKILRALTGH 218
E+G G+ G + G+ +AVK I + I RE+ IL
Sbjct: 8 ELGAGNSGVVSKVLHRP---TGKIMAVKTIRLEINEAIQKQIL-----RELDILHKCN-S 58
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYT-EDDAKAVMIQILNVVAFCH 277
+V F+ A+ + ++ + ME +GG L D+IL E + + +L + + H
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 278 LQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI----VGSAYYVAPE 332
+ ++HRD+KP N L ++ + +K DFG+S + +N + VG++ Y+APE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSG-----QLVNSLAKTFVGTSSYMAPE 169
Query: 333 VLH-RSYSTEADVWSIGVIAYILLCGSRPF--WARTESGIF---RAVLKADPSFDEAPWP 386
+ YS ++D+WS+G+ L G P+ GIF + ++ P P
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-------P 222
Query: 387 SL-----SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
L S + +DFV L KDPR+R + + L HP+IK
Sbjct: 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 87/311 (27%), Positives = 150/311 (48%), Gaps = 60/311 (19%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT----TAIAIEDVRREVK 210
++Y+ VG G +G C+A K G++VA+K K++ +AI + RE++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKT---GRKVAIK-----KLSRPFQSAIHAKRTYRELR 66
Query: 211 ILRALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
+L+ + H N++ D + ED +VY+V L G L+ I+ + K ++D +
Sbjct: 67 LLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIV-KCQKLSDDHIQF 122
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDIV 323
++ QIL + + H G++HRDLKP N +E+ LK +DFGL+ R D+ + V
Sbjct: 123 LVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLA---RHTDDEMTGYV 176
Query: 324 GSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCG-----------------------S 358
+ +Y APE++ Y+ D+WS+G I LL G
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236
Query: 359 RPFWARTESGIFRAVLKADP-----SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ S R +++ P F E + + A D ++++L DP KR+TAA+A
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEA 295
Query: 414 LSHPWIKNSND 424
L+HP++ +D
Sbjct: 296 LAHPYLAEYHD 306
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-32
Identities = 77/270 (28%), Positives = 129/270 (47%), Gaps = 24/270 (8%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR----EV 209
KYE VGRG FG + C + + + V +K IP +MT +D R E
Sbjct: 1 KYEKIRVVGRGAFGIVHLC-----RRKADQKLVIIKQIPVEQMT-----KDERLAAQNEC 50
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQ 268
++L+ L+ H N++++++ + + + +VME GG L + I R ED +Q
Sbjct: 51 QVLKLLS-HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQ 109
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
IL + H + ++HRDLK +N L V+K DFG+S + + +VG+ Y
Sbjct: 110 ILLALHHVHTKLILHRDLKTQNILLDKH--KMVVKIGDFGISKILSSKSKAYTVVGTPCY 167
Query: 329 VAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
++PE+ + Y+ ++D+W++G + Y L R F A + VLK
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIMSGTFAPISDR 224
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
S + R + +LN DP KR +Q ++ P
Sbjct: 225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 9e-32
Identities = 89/297 (29%), Positives = 137/297 (46%), Gaps = 46/297 (15%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
YE E+G G +G A+ G+ VA+K + I + +R E+ +L+ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLE 56
Query: 217 --GHNNLVKFFD--AYEDTDN---VYVVMELCEGGELLDRILSRGGK--YTEDDAKAVMI 267
H N+V+ D TD + +V E + + L LS+ K + K +M
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD--QDLATYLSKCPKPGLPPETIKDLMR 114
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L V F H +VHRDLKP+N L T+ + +K DFGL+ + L +V + +
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMALTSVVVTLW 171
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRP-FWARTESG----IFR---------- 371
Y APEVL +S Y+T D+WS+G I L RP F +E+ IF
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230
Query: 372 ---AVLKADPSFD-------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
L SF ++ P + E D +K++L +P KR++A +AL HP+
Sbjct: 231 PRNVSLPRS-SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 71/263 (26%), Positives = 129/263 (49%), Gaps = 19/263 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH-------KMTTAIAIEDVRREV 209
Y + E +G G FG C K +K +A+K I H K +I D+ EV
Sbjct: 2 YAVLEHLGSGAFG--CVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG---GELLDRILSRGGKYTEDDAKAVM 266
I++ H N+V+++ + + D +Y+VM+L EG GE + + + ++TE+ +
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 267 IQILNVVAFCHLQG-VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
+Q++ + + H + +VHRDL P N + D+ ++ DFGL+ +P+ +L +VG+
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI---TDFGLAKQKQPESKLTSVVGT 176
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
Y PE++ + Y +ADVW+ G I Y + PF++ + +++A ++ P
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA--VYEPLP 234
Query: 385 WPSLSSEARDFVKRLLNKDPRKR 407
S + D + L D R
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 92/317 (29%), Positives = 144/317 (45%), Gaps = 63/317 (19%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVR--REVKILR 213
Y+ +G G +G C+A K G +VA+K I P T R RE+KILR
Sbjct: 7 YQNLSYIGEGAYGMVCSATHK---PTGVKVAIKKISPFEHQTFCQ-----RTLREIKILR 58
Query: 214 ALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
H N++ D ++E ++VY+V EL E L +++ + + D + + Q
Sbjct: 59 RFK-HENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLI-KTQHLSNDHIQYFLYQ 114
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----LNDIVG 324
IL + + H V+HRDLKP N L T N LK DFGL+ P+ L + V
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVI-AYILLCGSRPFW------------------- 362
+ +Y APE++ + Y+ D+WS+G I A +L RP +
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN--RPLFPGKDYLHQLNLILGVLGTP 229
Query: 363 -----ARTESGIFRAVLKADPSFDEAPWPSL----SSEARDFVKRLLNKDPRKRLTAAQA 413
S R +K+ P + PW L +A D + ++L +P KR+T +A
Sbjct: 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289
Query: 414 LSHPWIKNSNDVKVPLD 430
L+HP+++ +D P D
Sbjct: 290 LAHPYLEQYHD---PSD 303
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 69/225 (30%), Positives = 104/225 (46%), Gaps = 40/225 (17%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKG------QQVAVKVIPKHKMTTAIAIEDVRREVKI 211
ELG+++G G FG + KG LKG +VAVK + + + E+ E I
Sbjct: 2 ELGKKLGEGAFG-----EVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASI 54
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
++ L H N+V+ + +Y+V E GG+LLD + G K T D + +QI
Sbjct: 55 MKKL-SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAK 113
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-- 329
+ + + VHRDL N L EN V+K DFGLS + D+ YY
Sbjct: 114 GMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLSRDIYEDD---------YYRKR 161
Query: 330 ----------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFW 362
APE L +++++DVWS GV+ + I G +P+
Sbjct: 162 GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206
|
Length = 258 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 84/291 (28%), Positives = 132/291 (45%), Gaps = 46/291 (15%)
Query: 161 EEVGRGHFGYTCAAKFK-KGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILRALTG 217
E++G G T A +K + G+ VA+K I + T + AI RE+ +++ L
Sbjct: 6 EKLGEG----TYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI----REISLMKELK- 56
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAF 275
H N+V+ D + + +V E + +L + + G G + K+ Q+L +AF
Sbjct: 57 HENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 334
CH V+HRDLKP+N L + E LK DFGL+ F P ++ V + +Y AP+VL
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVL 172
Query: 335 --HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS-- 390
R+YST D+WS+G I ++ G F + + + E+ WP +S
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232
Query: 391 -----------------------EARDFVKRLLNKDPRKRLTAAQALSHPW 418
D + RLL +P R++A AL HPW
Sbjct: 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 74/246 (30%), Positives = 121/246 (49%), Gaps = 35/246 (14%)
Query: 207 REVKILRALTGHNNLVKFFDAY--EDTDNVYVVMELCEGGEL---LDRILSRGGKYTEDD 261
RE++I ++ +VK++ A+ E + ++ + ME CEGG L ++ RGG+ E
Sbjct: 48 RELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV 106
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
+ +L +++ H + ++HRD+KP N L T K + +K DFG+S E +N
Sbjct: 107 LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ---VKLCDFGVSG-----ELVNS 158
Query: 322 I----VGSAYYVAPE-VLHRSYSTEADVWSIGVIAYILLCGSRPFWARTE---------- 366
+ G+++Y+APE + + YS +DVWS+G+ + PF E
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218
Query: 367 --SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
+ LK +P + W S E +DF+K+ L KDP +R T L HPWIK
Sbjct: 219 YIVNMPNPELKDEPG-NGIKW---SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274
Query: 425 VKVPLD 430
KV +
Sbjct: 275 KKVNMA 280
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 85/269 (31%), Positives = 132/269 (49%), Gaps = 17/269 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTAIAIEDVRREVKILRALTGHNNL 221
+G+G +G + G G+ A+KV+ K + + E IL A+ H +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFI 62
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V A++ +Y+++E GGEL L R G + ED A + +I + H QG+
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMH-LEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRSYST 340
++RDLKPEN L D +K DFGL + + + G+ Y+APE+L RS
Sbjct: 122 IYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHG 178
Query: 341 EA-DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
+A D WS+G + Y +L G+ PF A +LK + P L+ EARD +K+L
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLKKL 234
Query: 400 LNKDPRKRL-----TAAQALSHPWIKNSN 423
L ++P RL AA+ SHP+ ++ N
Sbjct: 235 LKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 87/305 (28%), Positives = 136/305 (44%), Gaps = 63/305 (20%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVK---------VIPKHKMTTAIAIED 204
KYE ++G G +G + C + GQ VA+K VI K IA+
Sbjct: 2 KYEKLSKIGEGSYGVVFKC-----RNRETGQIVAIKKFVESEDDPVIKK------IAL-- 48
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
RE+++L+ L H NLV + + +++V E C+ +L+ + E K
Sbjct: 49 --REIRMLKQLK-HPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKK 104
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIV 323
++ Q L V FCH +HRD+KPEN L T + +K DFG + + P + D V
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYV 161
Query: 324 GSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWA------------RT---- 365
+ +Y APE+L Y DVW+IG + LL G +P W +T
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDL 220
Query: 366 ---------ESGIFRAVLKADPSFD---EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ F+ + +P E+ +P++SS A F+K L DP +RL+ +
Sbjct: 221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280
Query: 414 LSHPW 418
L HP+
Sbjct: 281 LEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 82/262 (31%), Positives = 136/262 (51%), Gaps = 17/262 (6%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
++G G G C A K G+QVAVK + K E + EV I+R H N+
Sbjct: 29 KIGEGSTGIVCIATEKH---TGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYH-HENV 81
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V +++Y D ++VVME EGG L D + + E+ V + +L +++ H QGV
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGV 139
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR-SYS 339
+HRD+K ++ L T+ + +K DFG V + + +VG+ Y++APEV+ R Y
Sbjct: 140 IHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA-DPSFDEAPWPSLSSEARDFVKR 398
TE D+WS+G++ ++ G P++ R + P ++ +SS R F+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS--HKVSSVLRGFLDL 254
Query: 399 LLNKDPRKRLTAAQALSHPWIK 420
+L ++P +R TA + L HP++K
Sbjct: 255 MLVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 87/266 (32%), Positives = 135/266 (50%), Gaps = 21/266 (7%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILR 213
+Y + VG G FG A + Q+ A+K I PK ++ A+ED R+E +L
Sbjct: 1 QYNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPK----SSSAVEDSRKEA-VLL 52
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNV 272
A H N+V F +++E ++Y+VME C+GG+L+ +I L RG + ED +Q+
Sbjct: 53 AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAP 331
V H + V+HRD+K +N T +N +K DFG + + P VG+ YYV P
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP 169
Query: 332 EVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LS 389
E+ Y+ ++D+WS+G I Y L PF A + + V + P PS S
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----PLPSHYS 225
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS 415
E R +K++ ++PR R +A LS
Sbjct: 226 YELRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 77/267 (28%), Positives = 140/267 (52%), Gaps = 14/267 (5%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KY +++G G FG K K+ G+Q +K I KM+ E+ R+EV +L +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMSPK-EREESRKEVAVLSNM 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVA 274
H N+V++ +++E+ N+Y+VM+ CEGG+L +I + RG + ED +QI +
Sbjct: 57 K-HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIVGSAYYVAPEV 333
H + ++HRD+K +N +F TKD +K DFG++ + L +G+ YY++PE+
Sbjct: 116 HVHDRKILHRDIKSQN-IFLTKD--GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172
Query: 334 L-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
+R Y+ ++D+W++G + Y + F A + +++ S+ S +
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYPPVS-SHYSYDL 229
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPWI 419
R+ V +L ++PR R + L +I
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-30
Identities = 90/288 (31%), Positives = 143/288 (49%), Gaps = 40/288 (13%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVKIL 212
++ +E+ E +G+G +G KK G + AVK++ P H + E++ E IL
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIHDID-----EEIEAEYNIL 68
Query: 213 RALTGHNNLVKFFDAY-----EDTDNVYVVMELCEGGELLDRI---LSRGGKYTEDDAKA 264
+AL+ H N+VKF+ Y ++ D +++V+ELC GG + D + L RG + E
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
++ + L + H+ +HRD+K N L TT+ +K +DFG+S R N V
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG---VKLVDFGVSAQLTSTRLRRNTSV 185
Query: 324 GSAYYVAPEV------LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
G+ +++APEV L +Y DVWS+G+ A L G P + RA+ K
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFK-- 240
Query: 378 PSFDEAPWPSL------SSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
P P+L S+E DF+++ L KD KR T + L H +I
Sbjct: 241 --IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 81/273 (29%), Positives = 137/273 (50%), Gaps = 22/273 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y L + +G+G FG K KK + + +K IP ++ ++ +E ++L L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ-ANQEAQLLSKL 59
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNV 272
H +VKF ++ + D ++ E CEG +L ++ G +E+ IQ+L
Sbjct: 60 D-HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIVGSAYYVAP 331
V + H + ++HRDLK +N +N++LK DFG+S + L G+ YY++P
Sbjct: 119 VHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL-- 388
E L H+ Y +++D+WS+G I Y + C + F VL+ E P PSL
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG---QNFLSVVLR----IVEGPTPSLPE 227
Query: 389 --SSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
S + ++ +LNKDP R +AA+ L +P+I
Sbjct: 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 8e-30
Identities = 75/277 (27%), Positives = 132/277 (47%), Gaps = 22/277 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
E + VG G FG + + E A+KV+ ++ + V E ++L+ ++
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISE---HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H +++ F D +Y++ME GGEL + + G +++ +I+ + +
Sbjct: 60 -HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYL 117
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR 336
H + +V+RDLKPEN L D+ +K DFG + +R +R + G+ Y+APEV+
Sbjct: 118 HSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQS 172
Query: 337 S-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
++ D W++G++ Y +L G PF+ GI+ +L F L A+D
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDL 228
Query: 396 VKRLLNKDPRKRL-----TAAQALSHPWIK--NSNDV 425
+K+LL D +RL A +H W K + +DV
Sbjct: 229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDV 265
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 82/283 (28%), Positives = 142/283 (50%), Gaps = 25/283 (8%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRAL 215
+EL + +G G +G + G G+ A+KV+ K + A E R E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
LV A++ ++++++ GGEL + R ++ E + + +I+ +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEH 120
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPD-ERLNDIVGSAYYVAPEV 333
H G+++RD+K EN L D N + DFGLS +F + ER G+ Y+AP++
Sbjct: 121 LHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 334 LH---RSYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADPSFDEAPWP 386
+ + D WS+GV+ Y LL G+ PF +++ I R +LK++P P+P
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-----PYP 232
Query: 387 S-LSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
+S+ A+D ++RLL KDP+KRL A + HP+ + N
Sbjct: 233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 23/270 (8%)
Query: 164 GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGHNNL 221
GRGHFG A++KK G+ A+K + K + +E + E +I H L
Sbjct: 8 GRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V F ++ D+V VME GG+L+ I + ++E A ++ + + H +
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKI 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVL-HRSYS 339
V+RDLK +N L T+ +K DFGL + + +R + G+ ++APEVL SY+
Sbjct: 123 VYRDLKLDNLLLDTE---GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSSEARDFVKR 398
D W +GV+ Y +L G PF E +F +++ DE +P LS EA ++R
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRFLSREAISIMRR 234
Query: 399 LLNKDPRKRL-----TAAQALSHPWIKNSN 423
LL ++P +RL A P+ ++ N
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 40/269 (14%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+++G G FG K K + K +VAVK + + + +D +E ++++ L GH N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKL-GHPN 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--------MIQILNV 272
+V+ + + +Y+V+E EGG+LLD + + + + IQI
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV--- 329
+ + + VHRDL N L E+ V+K DFGLS V D+ YY
Sbjct: 118 MEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDD---------YYRKKT 165
Query: 330 ---------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADP 378
APE L +++++DVWS GV+ + I G+ P+ + + + K
Sbjct: 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-- 223
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKR 407
P E + + DP R
Sbjct: 224 YRLPKP-EYCPDELYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 81/277 (29%), Positives = 133/277 (48%), Gaps = 18/277 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ E+G G FG AK K+ G A KVI + + +ED E++IL A
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKE---TGALAAAKVI---ETKSEEELEDYMVEIEIL-ATC 66
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H +VK A+ +++++E C GG + +L TE + + Q+L + +
Sbjct: 67 NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL 126
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL- 334
H ++HRDLK N L T + +K DFG+S V+ +R + +G+ Y++APEV+
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 335 -----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
Y +AD+WS+G+ + P + + K++P P S
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP-SKWS 242
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426
E RDF+K L+K P R +AAQ L HP++ + +
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 84/299 (28%), Positives = 130/299 (43%), Gaps = 49/299 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAIAIEDVRREVKI 211
KYE VG G +G K K+ GQ VA+K KM IA+ RE+++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDKMVKKIAM----REIRM 53
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L+ L H NLV + + +Y+V E + +LD + E + + QIL
Sbjct: 54 LKQLR-HENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILR 111
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVA 330
+ FCH ++HRD+KPEN L + ++ V+K DFG + + P E D V + +Y A
Sbjct: 112 GIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRA 168
Query: 331 PEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI----------------FRA 372
PE+L Y D+W++G + +L G F +S I +
Sbjct: 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF--PGDSDIDQLYHIIKCLGNLIPRHQE 226
Query: 373 VLKADPSFD-------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
+ + +P F E +P LS D K+ L DP R +++Q L H +
Sbjct: 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 88/275 (32%), Positives = 135/275 (49%), Gaps = 19/275 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ E+G G FG A+ K+ G A KVI + +ED E+ IL A
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVI---DTKSEEELEDYMVEIDIL-ASC 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+VK DA+ +N+++++E C GG + +L TE + V Q L + +
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL- 334
H ++HRDLK N LFT + +K DFG+S R +R + +G+ Y++APEV+
Sbjct: 120 HENKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 335 -----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
R Y +ADVWS+G+ + P + + K++P P S
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWS 235
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIK-NSN 423
SE +DF+K+ L K+ R T Q L HP++ NSN
Sbjct: 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 81/266 (30%), Positives = 132/266 (49%), Gaps = 19/266 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
VGRGHFG + + + G A+KV+ K + + E IL +++ +
Sbjct: 9 VGRGHFG---EVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDIL-SISNSPWIP 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+ A++D DN+Y+VME GG+LL +L+R ++ ED A+ + +++ + H G
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI--VGSAYYVAPEVLHR--- 336
VHRD+KPEN L D +K DFG + + ++ +N VG+ Y+APEVL
Sbjct: 124 VHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 337 ----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
+Y E D WS+GVIAY ++ G PF T + + ++ P +SS+
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPW 418
D ++ LL ++RL HP+
Sbjct: 241 LDLIQSLLC-GQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 85/266 (31%), Positives = 134/266 (50%), Gaps = 27/266 (10%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
++G G G C A K G+ VAVK + K E + EV I+R H N+
Sbjct: 27 KIGEGSTGIVCIATVKS---SGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQ-HENV 79
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ +++Y D ++VVME EGG L D + + E+ AV + +L ++ H QGV
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGV 137
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR-SYS 339
+HRD+K ++ L T + +K DFG V + R +VG+ Y++APE++ R Y
Sbjct: 138 IHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL------SSEAR 393
E D+WS+G++ ++ G P++ LKA + P L S +
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNLPPKLKNLHKVSPSLK 247
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWI 419
F+ RLL +DP +R TAA+ L HP++
Sbjct: 248 GFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 81/270 (30%), Positives = 133/270 (49%), Gaps = 23/270 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGHNN 220
+G+G FG + K G+ A+K++ K + IA ++V + R L T H
Sbjct: 3 LGKGTFGKVILVREKAT---GKYYAMKILKKEVI---IAKDEVAHTLTESRVLQNTRHPF 56
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
L +++ D + VME GGEL LSR ++ED A+ +I++ + + H
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-Y 338
VV+RDLK EN + D++ +K DFGL + + + G+ Y+APEVL + Y
Sbjct: 116 VVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398
D W +GV+ Y ++CG PF+ + +F +L + F +LS EA+ +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAG 228
Query: 399 LLNKDPRKRL-----TAAQALSHPWIKNSN 423
LL KDP++RL A + + H + + N
Sbjct: 229 LLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 9e-29
Identities = 95/309 (30%), Positives = 136/309 (44%), Gaps = 74/309 (23%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---------PKHKMTTAIAIEDVRR 207
Y+ E++G G +G A+ K G+ VA+K I P +TAI R
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLT---GEIVALKKIRLETEDEGVP----STAI------R 47
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY---------T 258
E+ +L+ L H N+V+ D + +Y+V E LD L KY
Sbjct: 48 EISLLKELN-HPNIVRLLDVVHSENKLYLVFEF------LDLDLK---KYMDSSPLTGLD 97
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-FVRPDE 317
K+ + Q+L +A+CH V+HRDLKP+N L D LK DFGL+ F P
Sbjct: 98 PPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR 154
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWARTESG----IF 370
V + +Y APE+L R YST D+WSIG I + + RP F +E IF
Sbjct: 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFRIF 213
Query: 371 RAVLKAD--------------PSF-------DEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
R + D P+F P+L + D + ++L DP KR++
Sbjct: 214 RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273
Query: 410 AAQALSHPW 418
A AL HP+
Sbjct: 274 AKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 82/257 (31%), Positives = 130/257 (50%), Gaps = 24/257 (9%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---EVKILRALTGHN 219
+G+G FG + G GQ A+KV+ K + + D R E IL A H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKK----ATLKVRDRVRTKMERDIL-AEVNHP 58
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
+VK A++ +Y++++ GG+L R LS+ +TE+D K + ++ + H
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-S 337
G+++RDLKPEN L DE +K DFGLS + + +++ G+ Y+APEV++R
Sbjct: 118 GIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 174
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---PSFDEAPWPSLSSEARD 394
++ AD WS GV+ + +L GS PF + +LKA P F LS EA+
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF-------LSPEAQS 227
Query: 395 FVKRLLNKDPRKRLTAA 411
++ L ++P RL A
Sbjct: 228 LLRALFKRNPANRLGAG 244
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 73/273 (26%), Positives = 135/273 (49%), Gaps = 26/273 (9%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+++ +++G+G F A L G+ VA+K + +M A A +D +E+ +L+
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICL---LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQ 58
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--------M 266
L H N++K+ ++ + + + +V+EL + G+L SR K+ + + +
Sbjct: 59 LD-HPNVIKYLASFIENNELNIVLELADAGDL-----SRMIKHFKKQKRLIPERTIWKYF 112
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGS 325
+Q+ + + H + ++HRD+KP N T V+K D GL F + +VG+
Sbjct: 113 VQLCSALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 326 AYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
YY++PE +H + Y+ ++D+WS+G + Y + PF+ + ++ K D P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEKCDYPP 227
Query: 385 WPS--LSSEARDFVKRLLNKDPRKRLTAAQALS 415
P+ S E RD V R +N DP KR + L
Sbjct: 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 51/289 (17%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVK 210
+ G+ +G+G FG Y C G+++AVK +P T + + E++
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCY-----DVDTGRELAVKQVPFDPDSPETKKEVNALECEIQ 56
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-------GKYTEDDAK 263
+L+ L H +V+++ D + + + ME GG + D++ + G KYT
Sbjct: 57 LLKNLQ-HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR---- 111
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI- 322
QIL V + H +VHRD+K N L +D +K DFG S +RL I
Sbjct: 112 ----QILEGVEYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGAS------KRLQTIC 158
Query: 323 ---------VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIF 370
G+ Y+++PEV+ Y +ADVWS+G +L +P WA E + IF
Sbjct: 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFEAMAAIF 217
Query: 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+ + P+ + P +S +AR+F++R ++ +KR +A + L H ++
Sbjct: 218 K--IATQPTNPQLP-SHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 81/273 (29%), Positives = 139/273 (50%), Gaps = 25/273 (9%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+YE+ +++G G FG K + + +K I KM E ++EV IL A
Sbjct: 1 RYEIIKKIGEGSFG---KIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEV-ILLAK 55
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNVVA 274
H N+V FF ++++ +++VME C+GG+L+ RI RG ++ED + +QI +
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND-------IVGSAY 327
H + ++HRD+K +N +F +K+ V K DFG++ +LND VG+ Y
Sbjct: 116 HIHDRKILHRDIKSQN-IFLSKN-GMVAKLGDFGIA------RQLNDSMELAYTCVGTPY 167
Query: 328 YVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
Y++PE+ +R Y+ + D+WS+G + Y L PF + + + VLK + P
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF---EGNNLHQLVLKICQGYFAPISP 224
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+ S + R + +L PR R + L P++
Sbjct: 225 NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 93/335 (27%), Positives = 145/335 (43%), Gaps = 73/335 (21%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR---- 206
KH KYE+ +++G+G +G A ++ + VA+K I A +
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFD-------AFRNATDAQR 52
Query: 207 --REVKILRALTGHNNLVKFFD---AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
RE+ L+ L H N+VK + A D D +Y+V E E L ++ R +
Sbjct: 53 TFREIMFLQELGDHPNIVKLLNVIKAENDKD-IYLVFEYMETD--LHAVI-RANILEDVH 108
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER--- 318
+ +M Q+L + + H V+HRDLKP N L + + +K DFGL+ + E
Sbjct: 109 KRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPE 165
Query: 319 ---LNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWART-------- 365
L D V + +Y APE+L Y+ D+WS+G I +L G +P + T
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQLEK 224
Query: 366 ----------------ESGIFRAVLKADPSFDEAP----WPSLSSEARDFVKRLLNKDPR 405
+S +L + PS P P S +A D +K+LL +P
Sbjct: 225 IIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPN 284
Query: 406 KRLTAAQALSHPWIKN----------SNDVKVPLD 430
KRLTA +AL HP++ + +PLD
Sbjct: 285 KRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 82/270 (30%), Positives = 133/270 (49%), Gaps = 23/270 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGHNN 220
+G+G FG + K G+ A+K++ K + IA ++V V R L T H
Sbjct: 3 LGKGTFGKVILVREKA---TGRYYAMKILRKEVI---IAKDEVAHTVTESRVLQNTRHPF 56
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
L A++ D + VME GGEL LSR +TE+ A+ +I++ + + H +
Sbjct: 57 LTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSY 338
VV+RD+K EN + D++ +K DFGL + + + G+ Y+APEVL Y
Sbjct: 116 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398
D W +GV+ Y ++CG PF+ + +F +L + F +LS EA+ +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAG 228
Query: 399 LLNKDPRKRL-----TAAQALSHPWIKNSN 423
LL KDP++RL A + + H + + N
Sbjct: 229 LLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 87/291 (29%), Positives = 134/291 (46%), Gaps = 50/291 (17%)
Query: 166 GHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFF 225
G +G A+ KK G+ VA+K + K I +R E+ IL L H N+V
Sbjct: 16 GTYGVVYRARDKK---TGEIVALKKLKMEKEKEGFPITSLR-EINILLKL-QHPNIVTVK 70
Query: 226 DAY--EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVH 283
+ + D +Y+VME E +L + + + + + K +M+Q+L+ VA H ++H
Sbjct: 71 EVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILH 129
Query: 284 RDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL--HRSYST 340
RDLK N L + +LK DFGL+ ++ P + +V + +Y APE+L + YST
Sbjct: 130 RDLKTSNLLLNNR---GILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 341 EADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPWP---------- 386
D+WS+G I LL F ++E + IF+ + P+ E WP
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL--GTPT--EKIWPGFSELPGAKK 242
Query: 387 ------------------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
SLS D + RLL DP KR++A AL HP+
Sbjct: 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 84/270 (31%), Positives = 136/270 (50%), Gaps = 21/270 (7%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
KY E++G+G G YT E+ +Q+ ++ PK ++ + E+ ++R
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--------IINEILVMR 71
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H N+V + D+Y D ++VVME GG L D + E AV + L +
Sbjct: 72 ENK-HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQAL 128
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPE 332
F H V+HRD+K +N L + SV K DFG + P++ + +VG+ Y++APE
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGM--DGSV-KLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 333 VLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSS 390
V+ R +Y + D+WS+G++A ++ G P+ E+ + L A E P LS+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSA 243
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
RDF+ R L D KR +A + L HP++K
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 89/293 (30%), Positives = 133/293 (45%), Gaps = 50/293 (17%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRAL 215
E++G G +G A+ K G+ VA+K I T TAI RE+ +L+ L
Sbjct: 6 EKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGVPSTAI------REISLLKEL 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRIL--SRGGKYTEDDAKAVMIQILNVV 273
H N+VK D + +Y+V E + L + + S K+ + Q+L +
Sbjct: 57 N-HPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-FVRPDERLNDIVGSAYYVAPE 332
AFCH V+HRDLKP+N L + +K DFGL+ F P V + +Y APE
Sbjct: 114 AFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 170
Query: 333 VL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKAD----PSFDE 382
+L + YST D+WS+G I ++ F +E IFR + D P
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230
Query: 383 AP--------W---------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
P W P L + RD + ++L+ DP KR++A AL+HP+
Sbjct: 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 75/264 (28%), Positives = 129/264 (48%), Gaps = 14/264 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K Q A+K + K + +E E ++L H L
Sbjct: 3 LGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ +N++ VME GG+L+ I S K+ A +I+ + F H +G+V
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
+RDLK +N L D + +K DFG+ + + D + G+ Y+APE+L + Y+T
Sbjct: 119 YRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D WS GV+ Y +L G PF E +F+++ +P + W L+ EA+D + +L
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--W--LTREAKDILVKLF 231
Query: 401 NKDPRKRL-TAAQALSHPWIKNSN 423
++P +RL HP+ + +
Sbjct: 232 VREPERRLGVKGDIRQHPFFREID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 80/278 (28%), Positives = 133/278 (47%), Gaps = 35/278 (12%)
Query: 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAIAIEDVRREVKILRALT 216
GE +G+G +G +G+L +AVK + + + E ++ EV +L++L
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQL----IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V++ D + + + ME GG + IL+R G E QIL+ VA+
Sbjct: 61 -HVNIVQYLGTCLDDNTISIFMEFVPGGSI-SSILNRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFG-------LSDFVRPDERLNDIVGSAYYV 329
H VVHRD+K N + N ++K IDFG + L + G+ Y++
Sbjct: 119 HNNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 330 APEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTE--SGIF-----RAVLKADPSFD 381
APEV++ S Y ++D+WSIG + + G +P A + + +F R ++ P
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATG-KPPLASMDRLAAMFYIGAHRGLM---PRLP 231
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+ S S+ A DFV L +D +R +A Q L H ++
Sbjct: 232 D----SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 81/284 (28%), Positives = 134/284 (47%), Gaps = 55/284 (19%)
Query: 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT----------- 231
++VAVK I +T +++ RE+KI+R L H+N+VK ++ +
Sbjct: 30 DKRVAVKKI---VLTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSL 85
Query: 232 ---DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKP 288
++VY+V E E L +L +G +E+ A+ M Q+L + + H V+HRDLKP
Sbjct: 86 TELNSVYIVQEYMETD--LANVLEQG-PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKP 142
Query: 289 ENFLFTTKDENSVLKAIDFGLSDFVRPDER----LNDIVGSAYYVAPEVL--HRSYSTEA 342
N T E+ VLK DFGL+ V P L++ + + +Y +P +L +Y+
Sbjct: 143 ANVFINT--EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200
Query: 343 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA---------------DPSF-DEAPW- 385
D+W+ G I +L G F E + +L++ PSF
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGE 260
Query: 386 ---------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
P ++ EA DF++++L +P RLTA +AL HP++
Sbjct: 261 PRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 80/270 (29%), Positives = 131/270 (48%), Gaps = 19/270 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR--ALTGHNN 220
+G+G FG + K + A+KV+ K ++ + E IL L
Sbjct: 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPF 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+V +++ ++Y+V + GGEL L + G+++ED AK + +++ + H
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWH-LQKEGRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDF-VRPDERLNDIVGSAYYVAPEVL--HRS 337
+V+RDLKPEN L D + DFGLS + ++ N G+ Y+APEVL +
Sbjct: 117 IVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397
Y+ D WS+GV+ + + CG PF+A ++R + F P LS E R FVK
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVK 230
Query: 398 RLLNKDPRKRL----TAAQALSHPWIKNSN 423
LLN++P+ RL A + HP+ + +
Sbjct: 231 GLLNRNPQHRLGAHRDAVELKEHPFFADID 260
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 82/277 (29%), Positives = 137/277 (49%), Gaps = 31/277 (11%)
Query: 160 GEEVGRGHFGYT-CAAKFKKGELKG-QQVAVKVIP-KHKMTTAIAIEDVRREVKILRALT 216
G +G G FG GEL +QV + + K ++ + RE+ +L+ L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+V++ + D D++ + +E GG + +L+ G + E + + QIL + +
Sbjct: 65 -HENIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQILKGLNYL 122
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV------------RPDERLNDIVG 324
H +G++HRD+K N L D +K DFG+S + RP + G
Sbjct: 123 HNRGIIHRDIKGANILV---DNKGGIKISDFGISKKLEANSLSTKTNGARPS-----LQG 174
Query: 325 SAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDE 382
S +++APEV+ + SY+ +AD+WS+G + +L G PF T+ IF+ A P
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPS 234
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
++SSEA DF+++ D KR TAA+ L HP++
Sbjct: 235 ----NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 81/281 (28%), Positives = 138/281 (49%), Gaps = 22/281 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-AIAIEDVRREVKILRAL 215
+EL + +G G +G + G G+ A+KV+ K + A +E R E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
LV A++ ++++++ GGE+ + R ++ED+ + +I+ +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEH 120
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPD-ERLNDIVGSAYYVAPEV 333
H G+V+RD+K EN L D + DFGLS +F+ + ER G+ Y+APE+
Sbjct: 121 LHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 334 LH--RSYSTEADVWSIGVIAYILLCGSRPFWAR----TESGIFRAVLKADPSFDEAPWPS 387
+ + D WS+G++ + LL G+ PF T+S + R +LK DP F
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----SF 233
Query: 388 LSSEARDFVKRLLNKDPRKRLTAA-----QALSHPWIKNSN 423
+ EA+D + +LL KDP+KRL A + HP+ K +
Sbjct: 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 3e-27
Identities = 86/268 (32%), Positives = 135/268 (50%), Gaps = 17/268 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KY E++G+G G A GQ+VA+K I K E + E+ +++ L
Sbjct: 20 KYTRYEKIGQGASGTVFTAI---DVATGQEVAIKQINLQKQPKK---ELIINEILVMKEL 73
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+ N+V F D++ D ++VVME GG L D + E AV + L + F
Sbjct: 74 K-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEF 130
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVL 334
H V+HRD+K +N L + SV K DFG + P++ + + +VG+ Y++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGM--DGSV-KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 335 HR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSEA 392
R +Y + D+WS+G++A ++ G P+ E+ + L A E P LS
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSPIF 245
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPWIK 420
RDF+ R L D KR +A + L HP++K
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 87/292 (29%), Positives = 133/292 (45%), Gaps = 38/292 (13%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KYE E++G G +G AK ++ + VA+K + + +R E+ +L+ L
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDEGVPSSALR-EICLLKEL 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+V+ +D + +V E C+ +L S G + K+ M Q+L +AF
Sbjct: 57 K-HKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 334
CH V+HRDLKP+N L N LK DFGL+ F P + V + +Y P+VL
Sbjct: 115 CHSHNVLHRDLKPQNLLINK---NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 171
Query: 335 --HRSYSTEADVWSIGVIAYILLCGSRPFWARTE-----SGIFRAV-------------- 373
+ YST D+WS G I L RP + + IFR +
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231
Query: 374 --LKADPSFD-----EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
K P + P L+S RD ++ LL +P +R++A +AL HP+
Sbjct: 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 89/317 (28%), Positives = 131/317 (41%), Gaps = 72/317 (22%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+KYE ++G+G FG A+ KK Q VA+K + I +R E+KIL+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKEGFPITALR-EIKILQL 67
Query: 215 LTGHNNLVKF----------FDAYEDTDNVYVVMELCEGGELLDRILSRGG-KYTEDDAK 263
L H N+V ++ Y+ + Y+V E CE L +LS K+T + K
Sbjct: 68 LK-HENVVNLIEICRTKATPYNRYKGS--FYLVFEFCEHD--LAGLLSNKNVKFTLSEIK 122
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDE----R 318
VM +LN + + H ++HRD+K N L T ++ +LK DFGL+ F R
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKNSKPNR 179
Query: 319 LNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIA---------------------YILL 355
+ V + +Y PE+L R Y D+W G I L
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239
Query: 356 CGS-----------RPFWARTE--SGIFRAVLKADPSFDEAPWPSLSS-EARDFVKRLLN 401
CGS + + E G R V E P + A D + +LL
Sbjct: 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKV-------KERLKPYVKDPHALDLIDKLLV 292
Query: 402 KDPRKRLTAAQALSHPW 418
DP KR+ A AL+H +
Sbjct: 293 LDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 6e-27
Identities = 95/306 (31%), Positives = 142/306 (46%), Gaps = 65/306 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---------PKHKMTTAIAIEDVR 206
Y E++G G +G + KK GQ VA+K I P +TAI
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESEEEGVP----STAI------ 47
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL--CEGGELLDRILSRGGKYTEDD-AK 263
RE+ +L+ L H N+V D +Y++ E + + LD + G+Y + + K
Sbjct: 48 REISLLKELQ-HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVK 104
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDI 322
+ + QIL + FCH + V+HRDLKP+N L D V+K DFGL+ F P
Sbjct: 105 SYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHE 161
Query: 323 VGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRP-FWARTESG----IFRAVLK 375
V + +Y APEVL S YST D+WSIG I + + +P F +E IFR +
Sbjct: 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRIL-- 218
Query: 376 ADPSFDEAP--------------W---------PSLSSEARDFVKRLLNKDPRKRLTAAQ 412
P+ D P W +L + D ++++L DP KR++A +
Sbjct: 219 GTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278
Query: 413 ALSHPW 418
AL+HP+
Sbjct: 279 ALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 88/309 (28%), Positives = 135/309 (43%), Gaps = 61/309 (19%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED------VRRE 208
+ YE E++G G +G A+ K G+ VA+K T + +++ RE
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKN---TGKLVALK-------KTRLEMDEEGIPPTALRE 50
Query: 209 VKILRALTGHNNLVKFFDAYEDTDN------VYVVMELCEGGELLDRILSRGGKYT---- 258
+ +L+ L+ +V+ D E + +Y+V E + +L + S G
Sbjct: 51 ISLLQMLSESIYIVRLLDV-EHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP 108
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDE 317
K+ M Q+L VA CH GV+HRDLKP+N L + +LK D GL F P +
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIPVK 166
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTES----GIFR 371
+ + +Y APEVL YST D+WS+G I + F +E IF+
Sbjct: 167 SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226
Query: 372 AVLKADPSFDEAP-------W---------------PSLSSEARDFVKRLLNKDPRKRLT 409
L P+ P W P LS E D ++++L DP KR++
Sbjct: 227 --LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS 284
Query: 410 AAQALSHPW 418
A AL+HP+
Sbjct: 285 AKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 82/293 (27%), Positives = 131/293 (44%), Gaps = 26/293 (8%)
Query: 149 FSKHFANK-YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
FSK K + E+G G FG A F + + VA+K + + +D+ +
Sbjct: 8 FSKDDPEKLFTDLREIGHGSFG---AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKAV 265
EV+ L+ L H N +++ Y ++VME C G ++L+ + + E + A+
Sbjct: 65 EVRFLQQLR-HPNTIEYKGCYLREHTAWLVMEYCLGSASDILE-VHKKP--LQEVEIAAI 120
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
L +A+ H +HRD+K N L T E +K DFG + V P N VG+
Sbjct: 121 CHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSP---ANSFVGT 174
Query: 326 AYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPS 379
Y++APEV+ Y + DVWS+G I I L +P F S ++ P+
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPT 233
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
W S R+FV L K P+ R ++ + L H ++ V +D+I
Sbjct: 234 LSSNDW---SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLI 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 76/264 (28%), Positives = 131/264 (49%), Gaps = 14/264 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K + A+K + K + +E E ++L H L
Sbjct: 3 LGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
F ++ ++++ VME GG+L+ I S G ++ E A+ +I+ + F H +G++
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDF-VRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK +N L D++ +K DFG+ + + + + G+ Y+APE+L + Y+
Sbjct: 119 YRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D WS GV+ Y +L G PF E +F ++L P F W +S EA+D + +L
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLSKLF 231
Query: 401 NKDPRKRL-TAAQALSHPWIKNSN 423
+DP KRL HP+ + +
Sbjct: 232 ERDPTKRLGVDGDIRQHPFFRGID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 26/279 (9%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G FG A +K + VA+K K K+ ++ V E KIL + H V
Sbjct: 38 LGTGSFGRVILATYKNEDFP--PVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCV 94
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ +++D +Y+V+E GGE L R ++ D QI+ + + +V
Sbjct: 95 NLYGSFKDESYLYLVLEFVIGGEFFT-FLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYSTE 341
+RDLKPEN L D++ +K DFG + V D R + G+ Y+APE+L + +
Sbjct: 154 YRDLKPENLLL---DKDGFIKMTDFGFAKVV--DTRTYTLCGTPEYIAPEILLNVGHGKA 208
Query: 342 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLN 401
AD W++G+ Y +L G PF+A I++ +L+ F + L + + +K+LL+
Sbjct: 209 ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKF----LDNNCKHLMKKLLS 264
Query: 402 KDPRKRL-----TAAQALSHPWIKN-------SNDVKVP 428
D KR A HPW N +V+VP
Sbjct: 265 HDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVP 303
|
Length = 340 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 26/270 (9%)
Query: 163 VGRGHFGYTCAAKFKKGELKG--QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+G+G FG K ELKG + A+KV+ K + ++ E +IL H
Sbjct: 3 LGKGSFG-----KVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
L ++ D ++ VME GG+L+ +I R K+ E ++ ++ + F H G
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQI-QRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHR-SY 338
V++RDLK +N L D K DFG+ + + G+ Y+APE+L Y
Sbjct: 117 VIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSEARDFVK 397
D W++GV+ Y ++ G PF A E +F ++L D+ +P LS EA +K
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-----DDVLYPVWLSKEAVSILK 228
Query: 398 RLLNKDPRKRL--TAAQA-----LSHPWIK 420
+ K+P KRL A+Q HP+ K
Sbjct: 229 AFMTKNPNKRLGCVASQGGEDAIKQHPFFK 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 74/248 (29%), Positives = 122/248 (49%), Gaps = 14/248 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + K G+ A+K++ K + + E ++L+ T H L
Sbjct: 3 LGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLT 58
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ D + VME GGEL LSR ++ED + +I++ + + H +V
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFH-LSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK EN + D++ +K DFGL + + + G+ Y+APEVL Y
Sbjct: 118 YRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +GV+ Y ++CG PF+ + +F +L D F +LS++A+ + LL
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLL 230
Query: 401 NKDPRKRL 408
KDP KRL
Sbjct: 231 IKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 87/307 (28%), Positives = 132/307 (42%), Gaps = 59/307 (19%)
Query: 163 VGRGHFGYTC-AAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
+G G FG C K L A+K + K + V+ E IL A + +
Sbjct: 9 IGIGAFGEVCLVRKVDTNAL----YAMKTLRKADVLMRNQAAHVKAERDIL-AEADNEWV 63
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
VK + +++D DN+Y VM+ GG+++ +L R G + ED A+ + ++ + H G
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL--------------------SDFVRPDERLND 321
+HRD+KP+N L D + +K DFGL D + P E ++
Sbjct: 123 IHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 322 I------------------------VGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLC 356
I VG+ Y+APEVL R+ Y+ D WS+GVI Y +L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQA 413
G PF A T + V+ + + LS EA D + RL RL A +
Sbjct: 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298
Query: 414 LSHPWIK 420
+HP+ K
Sbjct: 299 KAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 80/257 (31%), Positives = 120/257 (46%), Gaps = 41/257 (15%)
Query: 184 QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN--LVKFFDAYEDTDNVYVVMELC 241
Q+ A+K I K + I+ V E IL T N +V F ++E ++ +VME
Sbjct: 27 QRFAMKKINKQNLILRNQIQQVFVERDIL---TFAENPFVVSMFCSFETKRHLCMVMEYV 83
Query: 242 EGGE---LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298
EGG+ LL I G D A+ + + + + H G+VHRDLKP+N L T+
Sbjct: 84 EGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH 139
Query: 299 NSVLKAIDFGLSD-------------FVRPDERL---NDIVGSAYYVAPEV-LHRSYSTE 341
+K DFGLS + D R + G+ Y+APEV L + Y
Sbjct: 140 ---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP 196
Query: 342 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP----SLSSEARDFVK 397
D W++G+I Y L G PF+ T +F V+ D+ WP +L ++A+D +
Sbjct: 197 VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-----DDIEWPEGDEALPADAQDLIS 251
Query: 398 RLLNKDPRKRLTAAQAL 414
RLL ++P +RL A
Sbjct: 252 RLLRQNPLERLGTGGAF 268
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 91/311 (29%), Positives = 142/311 (45%), Gaps = 59/311 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-----TTAIAIEDVRREV 209
++YE E++G G +G A+ + + + +A+K I + +TAI RE+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDR---VTNETIALKKIRLEQEDEGVPSTAI------REI 52
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA------K 263
+L+ + H N+V+ D +Y+V E LD L + + D A K
Sbjct: 53 SLLKEMQ-HGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIK 105
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-FVRPDERLNDI 322
+ QIL +A+CH V+HRDLKP+N L + + LK DFGL+ F P
Sbjct: 106 TYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR--TNALKLADFGLARAFGIPVRTFTHE 163
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWARTE----SGIFRAV-- 373
V + +Y APE+L R YST D+WS+G I + + +P F +E IFR +
Sbjct: 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILGT 222
Query: 374 --------LKADPSFDEA--PW---------PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ + P + A W P+L D + ++L DP KR+TA AL
Sbjct: 223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282
Query: 415 SHPWIKNSNDV 425
H + K+ D
Sbjct: 283 EHEYFKDLGDA 293
|
Length = 294 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 28/281 (9%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A +EL E VG G +G + K GQ A+KV+ T E++++E+ +L+
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTGDEEEEIKQEINMLK 57
Query: 214 ALTGHNNLVKFFDAYEDT------DNVYVVMELCEGGELLDRIL-SRGGKYTEDDAKAVM 266
+ H N+ ++ A+ D +++VME C G + D I ++G E+ +
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGS 325
+IL ++ H V+HRD+K +N L T EN+ +K +DFG+S R R N +G+
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 174
Query: 326 AYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADP 378
Y++APEV+ +Y ++D+WS+G+ A + G+ P +F P
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 234
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
W S + + F++ L K+ +R T Q + HP+I
Sbjct: 235 RLKSKKW---SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-26
Identities = 84/285 (29%), Positives = 129/285 (45%), Gaps = 32/285 (11%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVKIL 212
+ +E+ E +G+G +G KK G AVK++ P + E++ E IL
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPISDVD-----EEIEAEYNIL 72
Query: 213 RALTGHNNLVKFFDAYEDTDN-----VYVVMELCEGG---ELLDRILSRGGKYTEDDAKA 264
++L H N+VKF+ + D +++V+ELC GG EL+ +L G + E
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
++ L + H ++HRD+K N L TT E V K +DFG+S R N V
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTT--EGGV-KLVDFGVSAQLTSTRLRRNTSV 189
Query: 324 GSAYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVLKA 376
G+ +++APEV+ SY DVWS+G+ A L G P F +F+
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249
Query: 377 DPSF-DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
P+ W F+ + L KD R + L HP+IK
Sbjct: 250 PPTLLHPEKW---CRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 81/281 (28%), Positives = 133/281 (47%), Gaps = 28/281 (9%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A +EL E VG G +G + K GQ A+KV+ T E+++ E+ +L+
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTEDEEEEIKLEINMLK 67
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRIL-SRGGKYTEDDAKAVM 266
+ H N+ ++ A+ D +++VME C G + D + ++G ED +
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGS 325
+IL +A H V+HRD+K +N L T EN+ +K +DFG+S R R N +G+
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 184
Query: 326 AYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADP 378
Y++APEV+ +Y +D+WS+G+ A + G+ P +F P
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 244
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
W S + DF++ L K+ R + Q L HP+I
Sbjct: 245 KLKSKKW---SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 79/293 (26%), Positives = 130/293 (44%), Gaps = 44/293 (15%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G +G A+ G+ VA+K + I I +R E+ +L L H N+V
Sbjct: 15 IGEGTYGIVYRARDTT---SGEIVALKKVRMDNERDGIPISSLR-EITLLLNLR-HPNIV 69
Query: 223 KFFD--AYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
+ + + D++++VME CE LLD + + ++E K +M+Q+L + + H
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT---PFSESQVKCLMLQLLRGLQYLHE 126
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL--H 335
++HRDLK N L T K LK DFGL+ + P + + V + +Y APE+L
Sbjct: 127 NFIIHRDLKVSNLLLTDK---GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTE-------------------------SGIF 370
+Y+T D+W++G I LL ++E +
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243
Query: 371 RAVLKADP-SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422
+ L P + + +P LS + LL DP+KR TA +AL + K
Sbjct: 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 75/249 (30%), Positives = 125/249 (50%), Gaps = 15/249 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG K K G+ A+K++ K + + E ++L+ + H L
Sbjct: 3 LGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLT 58
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GV 281
+++ D + VME GGEL LSR ++ED A+ +I++ + + H + V
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYS 339
V+RDLK EN + D++ +K DFGL + ++ + G+ Y+APEVL Y
Sbjct: 118 VYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
D W +GV+ Y ++CG PF+ + +F +L + F +LS EA+ + L
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGL 230
Query: 400 LNKDPRKRL 408
L KDP++RL
Sbjct: 231 LKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 94/330 (28%), Positives = 137/330 (41%), Gaps = 97/330 (29%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-----TTAIAIEDVRREVKI 211
YE+ ++G G FG A+ K G+ VA+K I H TA+ RE+KI
Sbjct: 10 YEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHNEKDGFPITAL------REIKI 60
Query: 212 LRALTGHNNLVKFFD-AYEDTDN-------VYVVM-----ELCEGGELLD--RILSRGGK 256
L+ L H N+V D A E D VY+V +L LL+ + K
Sbjct: 61 LKKLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG---LLENPSV-----K 111
Query: 257 YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP- 315
TE K M+Q+L + + H ++HRD+K N L D +LK DFGL+ RP
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLA---RPY 165
Query: 316 --------------DERLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSR 359
+ ++V + +Y PE+L R Y+T D+W IG + + R
Sbjct: 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-R 224
Query: 360 P-FWARTE----SGIFRAVLKADPSFDEAPWP--------------------------SL 388
P +++ IF+ P+ E WP L
Sbjct: 225 PILQGKSDIDQLHLIFKLC--GTPT--EETWPGWRSLPGCEGVHSFTNYPRTLEERFGKL 280
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
E D + +LL+ DP KRLTA+ AL HP+
Sbjct: 281 GPEGLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 80/270 (29%), Positives = 136/270 (50%), Gaps = 21/270 (7%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
KY E++G+G G YT E+ +Q+ ++ PK ++ + E+ ++R
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--------IINEILVMR 72
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+ N+V + D+Y D ++VVME GG L D + E AV + L +
Sbjct: 73 E-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQAL 129
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPE 332
F H V+HRD+K +N L + +K DFG + P++ + + +VG+ Y++APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 333 VLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSS 390
V+ R +Y + D+WS+G++A ++ G P+ E+ + L A E P LS+
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQNPEKLSA 244
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
RDF+ R L+ D KR +A + L H ++K
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 77/265 (29%), Positives = 133/265 (50%), Gaps = 16/265 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-L 221
+G+G FG A+ K KG+ AVK + K + +E E ++L AL N L
Sbjct: 3 LGKGSFGKVLLAELKG---KGEYFAVKALKKDVVLIDDDVECTMVEKRVL-ALAWENPFL 58
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+ ++ ++++ VME GG+L+ I +G ++ A +I+ + F H +G+
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYS 339
++RDLK +N + D + +K DFG+ + V D R + G+ Y+APE+L Y+
Sbjct: 118 IYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
D WS GV+ Y +L G PF E +F ++ P + W ++ E++D +++L
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEKL 230
Query: 400 LNKDPRKRLTAAQALS-HPWIKNSN 423
+DP +RL + HP+ K N
Sbjct: 231 FERDPTRRLGVVGNIRGHPFFKTIN 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 80/270 (29%), Positives = 136/270 (50%), Gaps = 21/270 (7%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
KY E++G+G G YT E+ +Q+ ++ PK ++ + E+ ++R
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--------IINEILVMR 71
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+ N+V + D+Y D ++VVME GG L D + E AV + L +
Sbjct: 72 E-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQAL 128
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPE 332
F H V+HRD+K +N L + +K DFG + P++ + + +VG+ Y++APE
Sbjct: 129 DFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 333 VLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSS 390
V+ R +Y + D+WS+G++A ++ G P+ E+ + L A E P LS+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPERLSA 243
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
RDF+ R L D +R +A + L HP++K
Sbjct: 244 VFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 88/314 (28%), Positives = 144/314 (45%), Gaps = 35/314 (11%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ + +GRG FG K K GQ A+K++ K +M R E +L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVL--VN 57
Query: 217 GHNNLV-KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
G + A++D +N+Y+VM+ GG+LL + + ED A+ + +++ +
Sbjct: 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDS 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEV 333
H G VHRD+KP+N L D+N ++ DFG + D + N VG+ Y++PE+
Sbjct: 118 VHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 334 LHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW-P 386
L Y E D WS+GV Y +L G PF+A + + ++ F P
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234
Query: 387 SLSSEARDFVKRLLNKDPRKRL---TAAQALSHPW--------IKNSN-----DVKVPLD 430
+S EA+D ++RL+ P RL HP+ I+NS +V P D
Sbjct: 235 DVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTD 293
Query: 431 VIIFKLMKAYMRSS 444
F + +R++
Sbjct: 294 TSNFDVDDDDLRNT 307
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 73/250 (29%), Positives = 120/250 (48%), Gaps = 17/250 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQ--VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+G+G FG K E KG A+K++ K + +E E ++L
Sbjct: 8 LGKGSFG-----KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
L + ++ D +Y VME GG+L+ I + GK+ E A +I + F H +G
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPE-VLHRSY 338
+++RDLK +N + D +K DFG+ + + + G+ Y+APE + ++ Y
Sbjct: 122 IIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398
D W+ GV+ Y +L G PF E +F+++++ + S+ + SLS EA K
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKG 234
Query: 399 LLNKDPRKRL 408
LL K P KRL
Sbjct: 235 LLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 8e-25
Identities = 79/268 (29%), Positives = 125/268 (46%), Gaps = 14/268 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL + +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF-VV 63
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ + GG+L I + G + E+ A +IL + H +
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RDLKPEN L D+ ++ D GL+ + E + VG+ Y+APEVL ++ Y+
Sbjct: 124 VYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y ++ G PF R E V + +E S EA+ K LL
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240
Query: 401 NKDPRKRL-----TAAQALSHPWIKNSN 423
KDP++RL A + HP+ +N N
Sbjct: 241 TKDPKQRLGCQEEGAGEVKRHPFFRNMN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 83/270 (30%), Positives = 141/270 (52%), Gaps = 27/270 (10%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQV-AVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
E +G+G FG FK + + QQV A+K+I + I ED+++E+ +L +
Sbjct: 10 ERIGKGSFGEV----FKGIDNRTQQVVAIKIIDLEEAEDEI--EDIQQEITVL-SQCDSP 62
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
+ K++ +Y ++++ME GG LD L R G + E ++ +IL + + H +
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALD--LLRAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS- 337
+HRD+K N L + E +K DFG++ + + + N VG+ +++APEV+ +S
Sbjct: 121 KKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE----AR 393
Y ++AD+WS+G+ A L G P ++ R VL P P+L+ E +
Sbjct: 178 YDSKADIWSLGITAIELAKGEPP---NSDMHPMR-VLFLIPKN---NPPTLTGEFSKPFK 230
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWI-KNS 422
+F+ LNKDP R TA + L H +I KN+
Sbjct: 231 EFIDACLNKDPSFRPTAKELLKHKFIVKNA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 74/250 (29%), Positives = 120/250 (48%), Gaps = 13/250 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K E + AVKV+ K + + + E +L H LV
Sbjct: 3 IGKGSFGKVLLARHKAEE---KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ D +Y V++ GGEL L R + E A+ +I + + + H +V
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + + + + G+ Y+APEVLH+ Y
Sbjct: 119 YRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF++R + ++ +L P++++ AR ++ LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLL 231
Query: 401 NKDPRKRLTA 410
KD KRL A
Sbjct: 232 QKDRTKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 49/305 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+K+++ ++G G +G A+ K G+ VA+K + I +R E+KILR
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDK---DTGELVALKKVRLDNEKEGFPITAIR-EIKILRQ 62
Query: 215 LTGHNNLVKF----------FDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
L H N+V D +D Y+V E + +L+ + S ++ED K+
Sbjct: 63 LN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKS 120
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER--LNDI 322
M Q+L + +CH + +HRD+K N L K + +K DFGL+ +E +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYTNK 177
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380
V + +Y PE+L Y DVWS G I L F A E + + S
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237
Query: 381 DEAPWPS--------------------------LSSEARDFVKRLLNKDPRKRLTAAQAL 414
A WP + + A D + +L DP KR TA +AL
Sbjct: 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297
Query: 415 SHPWI 419
+ PW+
Sbjct: 298 NSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 94/324 (29%), Positives = 138/324 (42%), Gaps = 70/324 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMT----TAIAIEDVRREV 209
KYE+ +GRG +G AK K G+ G++ A+K K + T +A RE+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGK-DGKEYAIKKFKGDKEQYTGISQSAC------REI 53
Query: 210 KILRALTGHNNLVKFFDAY-EDTD-NVYVVMELCEGGELLDRI----LSRGGKYTEDDAK 263
+LR L H N+V + + E D +VY++ + E +L I ++ K
Sbjct: 54 ALLRELK-HENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFT-TKDENSVLKAIDFGLSDFV----RPDER 318
+++ QILN V + H V+HRDLKP N L E V+K D GL+ +P
Sbjct: 112 SLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 319 LNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTES--------- 367
L+ +V + +Y APE+L R Y+ D+W+IG I LL F R
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231
Query: 368 ----GIFR-------------------AVLKADPSFDEAPWPSL----------SSEARD 394
IF L D P SL S+ D
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291
Query: 395 FVKRLLNKDPRKRLTAAQALSHPW 418
+++LL DP KR+TA +AL HP+
Sbjct: 292 LLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 82/298 (27%), Positives = 142/298 (47%), Gaps = 41/298 (13%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N+YE+ +++G G FG K K+ + + ++ + + + + + + +V RE+K
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK-- 70
Query: 213 RALTGHNNLVKFFDAYEDTDN--VYVVMELCEGGEL---LDRILSRGGKYTEDDAKAVMI 267
H N+V++ D + + N +Y++ME C+ G+L + + GK E +
Sbjct: 71 -----HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125
Query: 268 QILNVVAFCHL-------QGVVHRDLKPENFLFTTK--------------DENSVLKAID 306
Q+L+ +A+CH + V+HRDLKP+N +T + + K D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 307 FGLSDFVRPDERLNDIVGSAYYVAPEVL---HRSYSTEADVWSIGVIAYILLCGSRPFWA 363
FGLS + + + VG+ YY +PE+L +SY ++D+W++G I Y L G PF
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ LK P + P S E +K LLN ++R +A Q L + IKN
Sbjct: 246 ANNFSQLISELKRGP---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 88/304 (28%), Positives = 140/304 (46%), Gaps = 58/304 (19%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG + K G A+K + K +M + VR E IL A + +V
Sbjct: 9 IGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHVRAERDIL-AEADNPWVV 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K + +++D + +Y++ME GG+++ +L + +TE++ + + + + + H G +
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMT-LLMKKDTFTEEETRFYIAETILAIDSIHKLGYI 123
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL---------SDFVR------PDERLNDI----- 322
HRD+KP+N L D +K DFGL ++F R P L+ I
Sbjct: 124 HRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 323 -------------------VGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFW 362
VG+ Y+APEV ++ Y+ E D WS+GVI Y +L G PF
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240
Query: 363 ARTESGIFRAVL--KADPSF-DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA---LSH 416
+ +R ++ K F DE P LS EA+D +KRL + +RL SH
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVP---LSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296
Query: 417 PWIK 420
P+ K
Sbjct: 297 PFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 81/284 (28%), Positives = 131/284 (46%), Gaps = 39/284 (13%)
Query: 156 KYELGEE-----VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
+YE E +G+G +G AA+ ++ ++A+K IP+ ++ + E+
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQV---RIAIKEIPERDSRY---VQPLHEEIA 57
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQ 268
+ L H N+V++ + + + ME GG L + S+ G K E Q
Sbjct: 58 LHSYLK-HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ 116
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI------ 322
IL + + H +VHRD+K +N L T + V+K DFG S +RL I
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLVNTY--SGVVKISDFGTS------KRLAGINPCTET 168
Query: 323 -VGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFW--ARTESGIFR-AVLK 375
G+ Y+APEV+ R Y AD+WS+G + G PF ++ +F+ + K
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK 228
Query: 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
P E SLS+EA++F+ R DP KR +A L P++
Sbjct: 229 IHPEIPE----SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 88/300 (29%), Positives = 136/300 (45%), Gaps = 49/300 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E +G G FG + + G++VA+K +P + ++ + V RE+K+L
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPR---DGKRVALKKMP-NVFQNLVSCKRVFRELKMLCFFK- 57
Query: 218 HNNLVKFFDAYEDTD-----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
H+N++ D + +YVV EL + L +I+ + D K + QIL
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQSD--LHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI--VGSAYYVA 330
+ + H G++HRD+KP N L + N VLK DFGL+ PDE + V + YY A
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172
Query: 331 PEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWART----------------------- 365
PE+L R Y++ D+WS+G I LL F A++
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232
Query: 366 ----ESGIFRAVLKADPSFDEAPWPS--LSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+ I R K PS S + EA + R+L DP KR++AA AL+HP++
Sbjct: 233 CEGARAHILRGPHKP-PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 76/262 (29%), Positives = 136/262 (51%), Gaps = 18/262 (6%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQV-AVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
E++G+G FG FK + + Q+V A+K+I + I ED+++E+ +L +
Sbjct: 10 EKIGKGSFGEV----FKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVL-SQCDSP 62
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
+ K++ +Y ++++ME GG LD L G E ++ +IL + + H +
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSE 120
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS- 337
+HRD+K N L + E+ +K DFG++ + + + N VG+ +++APEV+ +S
Sbjct: 121 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397
Y ++AD+WS+G+ A L G P + + K +P E + S ++FV+
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKPLKEFVE 234
Query: 398 RLLNKDPRKRLTAAQALSHPWI 419
LNK+P R TA + L H +I
Sbjct: 235 ACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 69/220 (31%), Positives = 109/220 (49%), Gaps = 34/220 (15%)
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+V F+ A+ VY+ ME + G L D++ + GG TE + V+ +I V ++G
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYA-GGVATEGIPEDVLRRITYAV----VKG 114
Query: 281 ---------VVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVA 330
++HRD+KP N L + +K DFG+S + V + N +G Y+A
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLVASLAKTN--IGCQSYMA 169
Query: 331 PEVLHR-------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIF---RAVLKADPSF 380
PE + +Y+ ++DVWS+G+ + G P+ T + IF A++ DP
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP- 228
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
P S +A+DFV + LNK P +R T AQ L HPW+
Sbjct: 229 -TLP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 69/255 (27%), Positives = 124/255 (48%), Gaps = 20/255 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK + Q A+KV+ K + I+ V+ E + + + LV
Sbjct: 3 IGRGSYAKVLLVRLKKND---QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ T +++V+E GG+L+ + R K E+ A+ +I + F H +G++
Sbjct: 60 GLHSCFQTTSRLFLVIEYVNGGDLMFH-MQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK +N L D + +K D+G+ + + P + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 341 EADVWSIGVIAYILLCGSRPF-------WARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
D W++GV+ + ++ G PF TE +F+ +L+ LS +A
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKAS 231
Query: 394 DFVKRLLNKDPRKRL 408
+K LNKDP++RL
Sbjct: 232 HVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 1e-23
Identities = 68/239 (28%), Positives = 117/239 (48%), Gaps = 13/239 (5%)
Query: 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242
Q A+K + M+ ED E++IL ++ H N++ + +A+ D + + +VME
Sbjct: 25 NQFYALKEVDLGSMSQK-EREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVMEYAP 82
Query: 243 GGELLDRILSRGGK---YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299
G+L I R K E + + IQ+L + H Q ++HRDLK N L N
Sbjct: 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---AN 139
Query: 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGS 358
++K D G+S V +G+ +Y+APEV R YS ++D+WS+G + Y + +
Sbjct: 140 DLVKIGDLGISK-VLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
Query: 359 RPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
PF AR+ + V + + P P S + ++F++ +L P+ R + L+ P
Sbjct: 199 PPFEARSMQDLRYKVQRG--KYPPIP-PIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-23
Identities = 75/262 (28%), Positives = 134/262 (51%), Gaps = 18/262 (6%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQV-AVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
E +G+G FG +K + + ++V A+K+I + I ED+++E+ +L +
Sbjct: 10 ERIGKGSFGEV----YKGIDNRTKEVVAIKIIDLEEAEDEI--EDIQQEITVL-SQCDSP 62
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
+ +++ +Y ++++ME GG LD L + G E ++ +IL + + H +
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALD--LLKPGPLEETYIATILREILKGLDYLHSE 120
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS- 337
+HRD+K N L + E +K DFG++ + + + N VG+ +++APEV+ +S
Sbjct: 121 RKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397
Y +AD+WS+G+ A L G P + + K P E + S ++FV+
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQY---SKPFKEFVE 234
Query: 398 RLLNKDPRKRLTAAQALSHPWI 419
LNKDPR R TA + L H +I
Sbjct: 235 ACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 2e-23
Identities = 68/270 (25%), Positives = 120/270 (44%), Gaps = 21/270 (7%)
Query: 160 GEEVGRGHFGYTC--AAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRA 214
G+++G G F +C A K G L +AVK + + T++ +E +R+E++++
Sbjct: 5 GQQLGTGAFS-SCYQARDVKTGTL----MAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR 59
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H ++++ A + + + +E GG + +LS+ G + E Q+L ++
Sbjct: 60 LN-HPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLS 117
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL-----SDFVRPDERLNDIVGSAYYV 329
+ H ++HRD+K N L + + L+ DFG + E ++G+ ++
Sbjct: 118 YLHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 330 APEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS- 387
APEVL Y DVWS+G + + P+ A S + K + P
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
LS RD R L P R + + L HP
Sbjct: 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 2e-23
Identities = 84/277 (30%), Positives = 134/277 (48%), Gaps = 35/277 (12%)
Query: 157 YELGEEVGRGHFGYTCAAK-FKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+EL + +G G +G A+ GEL A+KVI K+ V++E+ +++
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGEL----AAIKVI---KLEPGEDFAVVQQEIIMMKDC 63
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H+N+V +F +Y D +++ ME C GG L D I G +E V + L + +
Sbjct: 64 K-HSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEV- 333
H +G +HRD+K N L T +N +K DFG+S + + +G+ Y++APEV
Sbjct: 122 LHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178
Query: 334 -LHRS--YSTEADVWSIGVIAYIL---------LCGSRPFWARTESGIFRAVLKADPSFD 381
+ R Y+ D+W++G+ A L L R + T+S LK D
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK-----D 233
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
+ W S+ FVK L K+P+KR TA + L HP+
Sbjct: 234 KMKW---SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 88/299 (29%), Positives = 131/299 (43%), Gaps = 51/299 (17%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK-ILR 213
N E E+G G G +FKK G +AVK + + + E K IL
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRR---------TGNKEENKRILM 62
Query: 214 AL----TGHN--NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVM 266
L H+ +VK + + +V++ MEL LD++L R G ED +
Sbjct: 63 DLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMT 120
Query: 267 IQILNVVAFCHL---QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+ I+ A +L GV+HRD+KP N L D + +K DFG+S + +
Sbjct: 121 VAIVK--ALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 324 GSAYYVAPEVL-----HRSYSTEADVWSIGVIAYILLCGSRPF-WARTESGIFRAVLKAD 377
G A Y+APE + + Y ADVWS+G+ L G P+ +TE + +L+ +
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE 235
Query: 378 PSFDEAPWPSL------SSEARDFVKRLLNKDPRKRLTAAQALSHPWIK--NSNDVKVP 428
P PSL S + FV L KD RKR + L HP+I+ + +V V
Sbjct: 236 P-------PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDVA 287
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 92/312 (29%), Positives = 138/312 (44%), Gaps = 63/312 (20%)
Query: 163 VGRGHFGYTC-AAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
+G G FG C A K L A+K + K + + V+ E IL A + +
Sbjct: 9 LGIGAFGEVCLARKVDTKAL----YAMKTLRKKDVLLRNQVAHVKAERDIL-AEADNEWV 63
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ + +++D DN+Y VM+ GG+++ +L R G + ED A+ + ++ V H G
Sbjct: 64 VRLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL---------------SDFVRPD---------- 316
+HRD+KP+N L D + +K DFGL D VR D
Sbjct: 123 IHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 317 -------ERL----------------NDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAY 352
+RL + +VG+ Y+APEVL R+ Y+ D WS+GVI Y
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---T 409
+L G PF A+T V+ S P LS EA D + +L + P RL
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG 298
Query: 410 AAQALSHPWIKN 421
A + +HP+ K
Sbjct: 299 ADEIKAHPFFKT 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 85/308 (27%), Positives = 140/308 (45%), Gaps = 56/308 (18%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y+ VG G +G CAA K L+ VAVK + + + I + RE+++L+ +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLR---VAVKKLSR-PFQSIIHAKRTYRELRLLKHM 73
Query: 216 TGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
H N++ D + E+ ++VY+V L G L+ I+ + K T+D + ++ QI
Sbjct: 74 K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV-KCQKLTDDHVQFLIYQI 129
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H ++HRDLKP N +E+ LK +DFGL+ D+ + V + +Y
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHT--DDEMTGYVATRWYR 184
Query: 330 APEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE++ Y+ D+WS+G I LL G F + +L+ P
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR----LVGTPGAE 240
Query: 388 L-----SSEAR--------------------------DFVKRLLNKDPRKRLTAAQALSH 416
L S AR D ++++L D KR+TAAQAL+H
Sbjct: 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300
Query: 417 PWIKNSND 424
+ +D
Sbjct: 301 AYFAQYHD 308
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 87/318 (27%), Positives = 143/318 (44%), Gaps = 71/318 (22%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR------REV 209
KY + +GRG +G C+AK ++VA+K I A ++ RE+
Sbjct: 6 KYVPIKPIGRGAYGIVCSAK---NSETNEKVAIKKIAN-------AFDNRIDAKRTLREI 55
Query: 210 KILRALTGHNNLVKFFD--------AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
K+LR L H N++ D A+ D VY+V EL + L +I+ ++D
Sbjct: 56 KLLRHLD-HENVIAIKDIMPPPHREAFND---VYIVYELMDTD--LHQIIRSSQTLSDDH 109
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP----DE 317
+ + Q+L + + H V+HRDLKP N L + N LK DFGL+ R +
Sbjct: 110 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLA---RTTSEKGD 163
Query: 318 RLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTE--------- 366
+ + V + +Y APE+L Y+T DVWS+G I LL G +P + +
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLIT 222
Query: 367 ---------------SGIFRAVLKADPSFDEAP----WPSLSSEARDFVKRLLNKDPRKR 407
+ R +++ P +P + A D ++++L DP KR
Sbjct: 223 ELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282
Query: 408 LTAAQALSHPWIKNSNDV 425
+T +AL+HP++ + +D
Sbjct: 283 ITVEEALAHPYLASLHDP 300
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 80/277 (28%), Positives = 123/277 (44%), Gaps = 21/277 (7%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G FG A F + VAVK + T +D+ +EVK L+ L H N
Sbjct: 28 EIGHGSFG---AVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNT 83
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+++ Y ++VME C G D + E + A+ L +A+ H +
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----HRS 337
+HRD+K N L T E +K DFG + P N VG+ Y++APEV+
Sbjct: 143 IHRDIKAGNILLT---EPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQ 196
Query: 338 YSTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y + DVWS+G I I L +P F S ++ P+ W + R F
Sbjct: 197 YDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSFRGF 252
Query: 396 VKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
V L K P++R +A+ L H +++ +V +D+I
Sbjct: 253 VDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLI 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-23
Identities = 71/263 (26%), Positives = 131/263 (49%), Gaps = 26/263 (9%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+++ +++GRG F A L + VA+K + +M A A +D +E+ +L+ L
Sbjct: 4 FQIEKKIGRGQFSEVYRATC---LLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--------MIQ 268
H N++K+ D++ + + + +V+EL + G+L I KY + + + +Q
Sbjct: 61 -HPNVIKYLDSFIEDNELNIVLELADAGDLSQMI-----KYFKKQKRLIPERTVWKYFVQ 114
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAY 327
+ + V H + V+HRD+KP N T V+K D GL F + +VG+ Y
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
Y++PE +H + Y+ ++D+WS+G + Y + PF+ + +F K + D P P
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLFSLCQKIEQC-DYPPLP 229
Query: 387 S--LSSEARDFVKRLLNKDPRKR 407
+ S + R+ V + DP +R
Sbjct: 230 TEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 5e-23
Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 28/276 (10%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK E + A+KV+ K + I+ V+ E + + H LV
Sbjct: 3 IGRGSYAKVLLVRLKKTE---RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ ++ V+E GG+L+ + R K E+ A+ +I + + H +G++
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 341 EADVWSIGVIAYILLCGSRPF---------WARTESGIFRAVLKADPSFDEAPWPSLSSE 391
D W++GV+ + ++ G PF TE +F+ +L+ SLS +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 231
Query: 392 ARDFVKRLLNKDPRKRLTA------AQALSHPWIKN 421
A +K LNKDP++RL A HP+ +N
Sbjct: 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 7e-23
Identities = 72/259 (27%), Positives = 126/259 (48%), Gaps = 18/259 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ + +++GRG F A L G VA+K + + A A D +E+ +L+ L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCL---LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYT----EDDAKAVMIQILNV 272
H N++K++ ++ + + + +V+EL + G+L R++ K E +Q+ +
Sbjct: 61 -HPNVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAP 331
+ H + V+HRD+KP N T V+K D GL F + +VG+ YY++P
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 332 EVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS--L 388
E +H + Y+ ++D+WS+G + Y + PF+ + ++ K D P PS
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHY 233
Query: 389 SSEARDFVKRLLNKDPRKR 407
S E R V +N DP KR
Sbjct: 234 SEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 7e-23
Identities = 81/269 (30%), Positives = 127/269 (47%), Gaps = 16/269 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + K G+ A K + K ++ + E KIL +V
Sbjct: 1 LGKGGFGEVCACQVKA---TGKMYACKKLDKKRLKKRKGEQMALNEKKIL-EKVSSRFIV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGV 281
A+E D++ +VM L GG+L I + G + E A QI+ + H + +
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
V+RDLKPEN L D++ ++ D GL+ ++ +++ G+ Y+APEVL Y
Sbjct: 117 VYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSSEARDFVKRL 399
D +++G Y ++ G PF R E + + LK +P S EA+D + L
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL 232
Query: 400 LNKDPRKRL-----TAAQALSHPWIKNSN 423
L KDP KRL +A + HP K+ N
Sbjct: 233 LQKDPEKRLGCRGGSADEVREHPLFKDLN 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 70/261 (26%), Positives = 113/261 (43%), Gaps = 55/261 (21%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
RE+KI+ + H N++ D Y + D + +VM++ L +++ R + TE K ++
Sbjct: 69 RELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCIL 125
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---------------D 311
+QILN + H +HRDL P N +K + K DFGL+ +
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSK---GICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 312 FVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTE--- 366
++ E + V + +Y APE+L + Y D+WS+G I LL G F E
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242
Query: 367 -SGIFRAVLKADPSFDEAPWPSL------------------------SSEARDFVKRLLN 401
IF L P+ E WP S +A D ++ LL
Sbjct: 243 LGRIFE--LLGTPN--EDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLK 298
Query: 402 KDPRKRLTAAQALSHPWIKNS 422
+P +R++A +AL H + K+
Sbjct: 299 LNPLERISAKEALKHEYFKSD 319
|
Length = 335 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 8e-23
Identities = 84/307 (27%), Positives = 143/307 (46%), Gaps = 53/307 (17%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y ++VG G +G C+A K+ G++VA+K + + + I + RE+ +L+ +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHM 71
Query: 216 TGHNNLVKFFD------AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
H N++ D + ++ + Y+VM + L +I G +ED + ++ Q+
Sbjct: 72 Q-HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI--MGHPLSEDKVQYLVYQM 126
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H G++HRDLKP N +E+ LK +DFGL+ D + V + +Y
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNL---AVNEDCELKILDFGLAR--HADAEMTGYVVTRWYR 181
Query: 330 APEV----LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD----PSF- 380
APEV +H Y+ D+WS+G I +L G F + +LK P F
Sbjct: 182 APEVILNWMH--YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239
Query: 381 ----DEAP------------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
D+A +P S +A D ++++L D KRLTA +AL HP+
Sbjct: 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299
Query: 419 IKNSNDV 425
+ D
Sbjct: 300 FDSFRDA 306
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 9e-23
Identities = 74/268 (27%), Positives = 131/268 (48%), Gaps = 29/268 (10%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED--VRREVKILRALTGHNN 220
VG+G +G + + G+Q VI K + A E +E ++L L H N
Sbjct: 8 VGKGSYGEVSLVRHRT---DGKQY---VIKKLNLRNASRRERKAAEQEAQLLSQLK-HPN 60
Query: 221 LVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHL 278
+V + +++E D +Y+VM CEGG+L ++ + GK E+ +QI + + H
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND----IVGSAYYVAPEVL 334
+ ++HRDLK +N T +++K D G++ R E D ++G+ YY++PE+
Sbjct: 121 KHILHRDLKTQNVFLT---RTNIIKVGDLGIA---RVLENQCDMASTLIGTPYYMSPELF 174
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDEAPWPS-LSSE 391
++ Y+ ++DVW++G Y + F A+ S ++R + P P P S E
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-----PMPKDYSPE 229
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+ + +L+K P KR + L P+I
Sbjct: 230 LGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 74/250 (29%), Positives = 116/250 (46%), Gaps = 13/250 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG AK K G AVKV+ K + + E +L H LV
Sbjct: 3 IGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ + +Y V++ GGEL L R + E A+ ++ + + + H ++
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFH-LQRERCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + V P+E + G+ Y+APEVL + Y
Sbjct: 119 YRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF++R S ++ +L + A D + LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLL 231
Query: 401 NKDPRKRLTA 410
+KD R+RL A
Sbjct: 232 HKDQRRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 97/353 (27%), Positives = 157/353 (44%), Gaps = 49/353 (13%)
Query: 85 SSPARSSANSTPNRFFKRP---FPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAA 141
++ ++T +R +RP P P + L S + ++ S P+A
Sbjct: 10 VPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSASGSAPSA 69
Query: 142 GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAI 200
+ S + E +G G G + G+ A+KVI H+ T
Sbjct: 70 AKSLS---------ELERVNRIGSGAGGTVYKVIHRP---TGRLYALKVIYGNHEDTVRR 117
Query: 201 AIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTED 260
I RE++ILR + H N+VK D ++ + V++E +GG L ++ + D
Sbjct: 118 QIC---REIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ-FLAD 172
Query: 261 DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERL 319
A+ QIL+ +A+ H + +VHRD+KP N L + +K DFG+S + + +
Sbjct: 173 VAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMDPC 225
Query: 320 NDIVGSAYYVAPEVL-----HRSYSTEA-DVWSIGVIAYILLCGSRPF-------WARTE 366
N VG+ Y++PE + H +Y A D+WS+GV G PF WA
Sbjct: 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA--- 282
Query: 367 SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
+ A+ + P EAP + S E R F+ L ++P KR +A Q L HP+I
Sbjct: 283 -SLMCAICMSQPP--EAP-ATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-22
Identities = 77/224 (34%), Positives = 115/224 (51%), Gaps = 18/224 (8%)
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK---YTEDDA 262
R E+ L A H +VK FD ++ D + ++ME GG+L +I R + + E +
Sbjct: 113 RSELHCLAACD-HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPEN-FLFTTKDENSVLKAIDFGLS----DFVRPDE 317
+ QI+ + H + ++HRDLK N FL T ++K DFG S D V D
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT----GIIKLGDFGFSKQYSDSVSLDV 227
Query: 318 RLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376
+ G+ YY+APE+ R YS +AD+WS+GVI Y LL RPF ++ I + VL
Sbjct: 228 A-SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286
Query: 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+D P P +SS + + LL+K+P R T Q L ++K
Sbjct: 287 K--YDPFPCP-VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 71/254 (27%), Positives = 122/254 (48%), Gaps = 18/254 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ + +GRG FG K K + + A+K++ K +M R E +L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNAD---KVFAMKILNKWEMLKRAETACFREERDVL--VN 57
Query: 217 GHNNLVKFFD-AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
G N + A++D +N+Y+VM+ GG+LL + + ED A+ + +++ +
Sbjct: 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND--IVGSAYYVAPEV 333
H VHRD+KP+N L D N ++ DFG + D + VG+ Y++PE+
Sbjct: 118 VHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 334 LHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-EAPWP 386
L Y E D WS+GV Y +L G PF+A + + ++ F A
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVT 234
Query: 387 SLSSEARDFVKRLL 400
+S +A+D ++RL+
Sbjct: 235 DVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 20/222 (9%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+E+G G FG G+ +G+ VA+K+I + M+ +D E K++ L+
Sbjct: 8 FLKELGSGQFGVV-----HLGKWRGKIDVAIKMIREGAMSE----DDFIEEAKVMMKLS- 57
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H NLV+ + +++V E G LL+ + R GK + + + + +
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---APEVL 334
G +HRDL N L E++V+K DFGL+ +V D+ + G+ + V PEV
Sbjct: 118 SNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVF 173
Query: 335 HRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVL 374
S +S+++DVWS GV+ + + G P+ + S + +V
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 22/272 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL + +V
Sbjct: 8 LGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF-VV 63
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ L GG+L I + G + E+ A +I + H + +
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RDLKPEN L D+ ++ D GL+ + E + VG+ Y+APEV+ + Y+
Sbjct: 124 VYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180
Query: 341 EADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPWPSLSSEARDFV 396
D W +G + Y ++ G PF R E + R V + + E S AR
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE----KFSEAARSIC 236
Query: 397 KRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
++LL KDP RL A + +HP+ + +N
Sbjct: 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-22
Identities = 68/242 (28%), Positives = 107/242 (44%), Gaps = 14/242 (5%)
Query: 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN-VYVVMELC 241
G +VA+K++ RRE + L H N+V D+ E ++ V E
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 242 EGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301
G L + L+ G + +M+Q+L+ +A H QG+VHRDLKP+N + +
Sbjct: 62 PGRTLREV-LAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 302 LKAIDFG----LSDFVRPDE----RLNDIVGSAYYVAPEVLHRSYST-EADVWSIGVIAY 352
K +DFG L D R +++G+ Y APE L T +D+++ G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
L G R + + I L PW + +++ LNKDPR+R +A
Sbjct: 181 ECLTGQRVVQGASVAEILYQQLSPVD-VSLPPWIA-GHPLGQVLRKALNKDPRQRAASAP 238
Query: 413 AL 414
AL
Sbjct: 239 AL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 87/308 (28%), Positives = 138/308 (44%), Gaps = 70/308 (22%)
Query: 157 YELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVI--------PKHKMTTAIAIEDVRR 207
Y+ +++G G + A +K + +L GQ VA+K I P TAI R
Sbjct: 7 YKKLDKLGEG----SYATVYKGRSKLTGQLVALKEIRLEHEEGAP----FTAI------R 52
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
E +L+ L H N+V D + +V E + +L + GG + + + +
Sbjct: 53 EASLLKDLK-HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLF 110
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR----PDERLNDIV 323
Q+L +A+CH + V+HRDLKP+N L + + E LK DFGL+ R P + ++ V
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLA---RAKSVPSKTYSNEV 164
Query: 324 GSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESG-----IFRAVLKA 376
+ +Y P+VL S YST D+W +G I Y + G F T+ IFR VL
Sbjct: 165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR-VL-G 222
Query: 377 DPSFDEAP------------------------WPSLS--SEARDFVKRLLNKDPRKRLTA 410
P+ + P P L + + L +P+KR++A
Sbjct: 223 TPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA 282
Query: 411 AQALSHPW 418
A+A+ HP+
Sbjct: 283 AEAMKHPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 71/266 (26%), Positives = 127/266 (47%), Gaps = 17/266 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + K+ + A+K I K + + + E +L A +V
Sbjct: 1 IGKGSFGKVMQVR-KRDTQR--IYALKTIRKAHIVSRSEVTHTLAERTVL-AQVNCPFIV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ + +Y+V+ GGEL L R G++ A+ ++L + H V+
Sbjct: 57 PLKFSFQSPEKLYLVLAFINGGELFHH-LQREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDF-VRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLKPEN L D + DFGL ++ D++ N G+ Y+APE+L Y+
Sbjct: 116 YRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W++GV+ Y +L G PF+ + ++R +L+ F + +A+D + LL
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLL 228
Query: 401 NKDPRKRL---TAAQALSHPWIKNSN 423
++DP +RL A + +HP+ +
Sbjct: 229 SRDPTRRLGYNGAQEIKNHPFFSQLS 254
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 4e-22
Identities = 82/275 (29%), Positives = 132/275 (48%), Gaps = 35/275 (12%)
Query: 157 YELGEEVGRGHFGYTCAA-KFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
YEL + VG G +G A GEL AVK+I K+ +++E+ +++
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGEL----AAVKII---KLEPGDDFSLIQQEIFMVKEC 63
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+V +F +Y + +++ ME C GG L D I G +E V + L +A+
Sbjct: 64 K-HCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAY 121
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVL 334
H +G +HRD+K N L T +N +K DFG++ + + +G+ Y++APEV
Sbjct: 122 LHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA 178
Query: 335 ----HRSYSTEADVWSIGVIAYIL---------LCGSRPFWARTESGIFRAVLKADPSFD 381
+ Y+ D+W++G+ A L L R + ++S LK D
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK-----D 233
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
+ W SS +FVK L K+P+KR TA + L+H
Sbjct: 234 KTKW---SSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-22
Identities = 73/257 (28%), Positives = 122/257 (47%), Gaps = 23/257 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K + A+K++ K + +E E ++L L
Sbjct: 8 LGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ D +Y VME GG+L+ I + GK+ E A +I + F H +G++
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRRGII 123
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV------GSAYYVAPEVL-H 335
+RDLK +N + D +K DFG+ E + D V G+ Y+APE++ +
Sbjct: 124 YRDLKLDNVML---DSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIAPEIIAY 175
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
+ Y D W+ GV+ Y +L G PF E +F+++++ + S+ + SLS EA
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSI 231
Query: 396 VKRLLNKDPRKRLTAAQ 412
K L+ K P KRL
Sbjct: 232 CKGLMTKHPSKRLGCGP 248
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-22
Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 24/263 (9%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ + +GRG FG K K E + A+K++ K +M R E +L +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTE---RIYAMKILNKWEMLKRAETACFREERNVL--VN 57
Query: 217 GHNNLVKFFD-AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
G + A++D + +Y+VM+ GG+LL + + ED A+ + +++ +
Sbjct: 58 GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND--IVGSAYYVAPEV 333
H VHRD+KP+N L D N ++ DFG + D + VG+ Y++PE+
Sbjct: 118 IHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 334 LHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
L Y E D WS+GV Y +L G PF+A + + ++ + F +PS
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPS 231
Query: 388 ----LSSEARDFVKRLLNKDPRK 406
+S EA+D ++RL+ R+
Sbjct: 232 HITDVSEEAKDLIQRLICSRERR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 7e-22
Identities = 84/310 (27%), Positives = 136/310 (43%), Gaps = 51/310 (16%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y++ E +G+G +G C+A G++VA+K I + A + RE+K+LR L
Sbjct: 1 RYKIQEVIGKGSYGVVCSAI---DTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLL 56
Query: 216 TGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
H ++V+ + + ++YVV EL E L +++ T + + + Q+L
Sbjct: 57 R-HPDIVEIKHIMLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHHQFFLYQLL 113
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----LNDIVGSA 326
+ + H V HRDLKP+N L + + LK DFGL+ D D V +
Sbjct: 114 RALKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 327 YYVAPEV---LHRSYSTEADVWSIGVIAYILLCGSRPFW--------------------- 362
+Y APE+ Y+ D+WSIG I +L G +P +
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLITDLLGTPSP 229
Query: 363 ---ARTESGIFRAVL----KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+R + R L K P +P+ A ++RLL DP+ R TA +AL+
Sbjct: 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289
Query: 416 HPWIKNSNDV 425
P+ K V
Sbjct: 290 DPYFKGLAKV 299
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 9e-22
Identities = 80/306 (26%), Positives = 145/306 (47%), Gaps = 48/306 (15%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y ++VG G +G C+A ++ G +VA+K + + + A + RE+++L+ +
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRPFQSELFA-KRAYRELRLLKHM 71
Query: 216 TGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
H N++ D + + + Y+VM G L +++ + K +ED + ++ Q+
Sbjct: 72 K-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLM-KHEKLSEDRIQFLVYQM 127
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H G++HRDLKP N +E+ LK +DFGL+ + D + V + +Y
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR--QTDSEMTGYVVTRWYR 182
Query: 330 APEVLHR--SYSTEADVWSIGVIAYILLCG-----------------------SRPFWAR 364
APEV+ Y+ D+WS+G I +L G S+ F +
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK----DPRKRLTAAQALSHPWIK 420
+S + +K P F + + SL A +L K D R+TAA+AL+HP+ +
Sbjct: 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
Query: 421 NSNDVK 426
+D +
Sbjct: 303 EFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 34/276 (12%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL---RALTGHN 219
+GRG FG + + + Q A+K++ K +M R + R + H
Sbjct: 51 IGRGAFG---EVQLVRHKSSKQVYAMKLLSKFEMIK-------RSDSAFFWEERDIMAHA 100
Query: 220 N---LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
N +V+ A++D +Y+VME GG+L++ L E A+ +++ +
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN--LMSNYDIPEKWARFYTAEVVLALDAI 158
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----RLNDIVGSAYYVAPE 332
H G +HRD+KP+N L D++ LK DFG ++ D R + VG+ Y++PE
Sbjct: 159 HSMGFIHRDVKPDNMLL---DKSGHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISPE 213
Query: 333 VL-----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
VL Y E D WS+GV Y +L G PF+A + G + ++ S
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273
Query: 388 LSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKN 421
+S +A+D + L + R + SHP+ KN
Sbjct: 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 75/276 (27%), Positives = 128/276 (46%), Gaps = 28/276 (10%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK + A+KVI K + I+ V+ E + + H LV
Sbjct: 3 IGRGSYAKVLLVELKKTR---RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ ++ V+E GG+L+ + R K E+ A+ +I + F H +G++
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDLMFH-MQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLH-RSYST 340
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L Y
Sbjct: 119 YRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 341 EADVWSIGVIAYILLCGSRPF---------WARTESGIFRAVLKADPSFDEAPWPSLSSE 391
D W++GV+ + ++ G PF TE +F+ +L+ SLS +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 231
Query: 392 ARDFVKRLLNKDPRKRLTA------AQALSHPWIKN 421
A +K LNKDP++RL SHP+ +N
Sbjct: 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 75/267 (28%), Positives = 123/267 (46%), Gaps = 17/267 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG AK K L G+ AVKV+ K + + + E +L H LV
Sbjct: 3 IGKGSFGKVLLAKRK---LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ T+ +Y V++ GGEL L R + E A+ +I + + + H +V
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + + + G+ Y+APEV+ + Y
Sbjct: 119 YRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF+ R + ++ +L P S A ++ LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELL 231
Query: 401 NKDPRKRLTAAQAL----SHPWIKNSN 423
KD ++RL A + HP+ ++ +
Sbjct: 232 EKDRQRRLGAKEDFLEIQEHPFFESLS 258
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 78/274 (28%), Positives = 135/274 (49%), Gaps = 24/274 (8%)
Query: 157 YELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ LG+ +G+G FG Y C EL +QV P+ T+ + + E+++L+
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFD--PESPETSK-EVNALECEIQLLKN 60
Query: 215 LTGHNNLVKFFDAYEDT--DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L H +V+++ D + + ME GG + D++ S G TE+ + QIL
Sbjct: 61 LL-HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEG 118
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR----PDERLNDIVGSAYY 328
V++ H +VHRD+K N L +D +K DFG S ++ + + G+ Y+
Sbjct: 119 VSYLHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 329 VAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDEAPW 385
++PEV+ Y +AD+WS+G +L +P WA E + IF+ + P+ P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFEAMAAIFK--IATQPTNPVLP- 231
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
P +S RDF+KR+ + + R +A + L H ++
Sbjct: 232 PHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 73/254 (28%), Positives = 128/254 (50%), Gaps = 25/254 (9%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-L 221
+G+G FG A+ K + + A+K++ K + +E E ++L AL+G L
Sbjct: 8 LGKGSFGKVMLAERKGTD---ELYAIKILKKDVVIQDDDVECTMVEKRVL-ALSGKPPFL 63
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+ ++ D +Y VME GG+L+ +I + G++ E A +I + F H +G+
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQI-QQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV------GSAYYVAPEVL- 334
++RDLK +N + D +K DFG+ E + D V G+ Y+APE++
Sbjct: 123 IYRDLKLDNVML---DSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 335 HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394
++ Y D W+ GV+ Y +L G PF E +F+++++ + ++ + S+S EA
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVA 230
Query: 395 FVKRLLNKDPRKRL 408
K L+ K P KRL
Sbjct: 231 ICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 77/268 (28%), Positives = 121/268 (45%), Gaps = 14/268 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL + +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF-VV 63
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ L GG+L I G + E A +I + H + +
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RDLKPEN L D++ ++ D GL+ V + + VG+ Y+APEV+ + Y+
Sbjct: 124 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W++G + Y ++ G PF R + V + E S +AR K LL
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240
Query: 401 NKDPRKRL-----TAAQALSHPWIKNSN 423
KDP++RL A + HP K N
Sbjct: 241 CKDPKERLGCQGGGAREVKEHPLFKQIN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 77/277 (27%), Positives = 123/277 (44%), Gaps = 21/277 (7%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G FG A F + + VA+K + + +D+ +EV+ L+ L H N
Sbjct: 22 EIGHGSFG---AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNT 77
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+++ Y ++VME C G D + E + AV L +A+ H +
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----HRS 337
+HRD+K N L + E ++K DFG + + P N VG+ Y++APEV+
Sbjct: 137 IHRDVKAGNILLS---EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQ 190
Query: 338 YSTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y + DVWS+G+ I L +P F S ++ P+ W S R+F
Sbjct: 191 YDGKVDVWSLGITC-IELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNF 246
Query: 396 VKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
V L K P+ R T+ L H ++ V +D+I
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 5e-21
Identities = 74/268 (27%), Positives = 120/268 (44%), Gaps = 14/268 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL + +V
Sbjct: 8 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-RFVV 63
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ + GG+L I + G + E A ++ + + +
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RDLKPEN L D+ ++ D GL+ + E + VG+ Y+APEV+ + Y+
Sbjct: 124 VYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTF 180
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y ++ G PF R E V + E S +A+ + LL
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240
Query: 401 NKDPRKRL-----TAAQALSHPWIKNSN 423
K+P++RL AA HP KN N
Sbjct: 241 TKNPKERLGCRGNGAAGVKQHPIFKNIN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 74/250 (29%), Positives = 118/250 (47%), Gaps = 13/250 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG AK K G+ AVKV+ K + + + E +L H LV
Sbjct: 3 IGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ D +Y V++ GGEL L R + E A+ +I + + + H ++
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFH-LQRERSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL-SDFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + + + + G+ Y+APEVL + Y
Sbjct: 119 YRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF++R + ++ +L P++S AR ++ LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLL 231
Query: 401 NKDPRKRLTA 410
KD KRL A
Sbjct: 232 QKDRTKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-21
Identities = 90/314 (28%), Positives = 138/314 (43%), Gaps = 35/314 (11%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ 185
+A I P K +K A KY + +G G G AK G+
Sbjct: 4 SGDAMIGRVCRTFPDT-FAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVS---DGEP 59
Query: 186 VAVKVIPKHKMTTAIAIEDVRREVKIL------RALTGHNNLVKFFDAYEDTDN------ 233
AVKV+ M+ A + EV L + H + A +D N
Sbjct: 60 FAVKVVDMEGMSEA-DKNRAQAEVCCLLNCDFFSIVKCHEDF-----AKKDPRNPENVLM 113
Query: 234 VYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
+ +V++ G+L I SR + E +A + IQ+L V H + ++HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 291 FLFTTKDENSVLKAIDFGLSDFVR---PDERLNDIVGSAYYVAPEVLHRS-YSTEADVWS 346
L + N ++K DFG S D+ G+ YYVAPE+ R YS +AD++S
Sbjct: 174 ILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFS 230
Query: 347 IGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRK 406
+GV+ Y LL RPF + L +D P PS+S E ++ V LL+ DP++
Sbjct: 231 LGVLLYELLTLKRPFDGENMEEVMHKTLAG--RYDPLP-PSISPEMQEIVTALLSSDPKR 287
Query: 407 RLTAAQALSHPWIK 420
R ++++ L+ P K
Sbjct: 288 RPSSSKLLNMPICK 301
|
Length = 496 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 8e-21
Identities = 59/197 (29%), Positives = 89/197 (45%), Gaps = 21/197 (10%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+LG +G+G FG G+ +GQ+VAVK + K T A A E ++ L
Sbjct: 9 KLGATIGKGEFG-----DVMLGDYRGQKVAVKCL-KDDSTAAQAFLA---EASVMTTLR- 58
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAFC 276
H NLV+ + +Y+V E G L+D + SRG T + + + +
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS--AYYVAPEVL 334
+ VHRDL N L E+ V K DFGL+ + G + APE L
Sbjct: 119 EEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEAL 171
Query: 335 -HRSYSTEADVWSIGVI 350
+ +ST++DVWS G++
Sbjct: 172 REKKFSTKSDVWSFGIL 188
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 24/280 (8%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A Y++ + +GRG FG + K + + A+K++ K +M E I+
Sbjct: 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQ---KVYAMKLLSKFEMIKRSDSAFFWEERDIM- 97
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
A +V+ F A++D +Y+VME GG+L++ L E AK +++ +
Sbjct: 98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN--LMSNYDVPEKWAKFYTAEVVLAL 155
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----RLNDIVGSAYYV 329
H G++HRD+KP+N L D++ LK DFG ++ DE R + VG+ Y+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYI 210
Query: 330 APEVLHRS-----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
+PEVL Y E D WS+GV + +L G PF+A + G + ++ S +
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE 270
Query: 385 WPSLSSEARDFVKRLLNKDPRKRL---TAAQALSHPWIKN 421
+S A++ + L D RL + HP+ KN
Sbjct: 271 DVEISKHAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 1e-20
Identities = 78/277 (28%), Positives = 122/277 (44%), Gaps = 21/277 (7%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G FG A F + + VA+K + + +D+ +EVK L+ + H N
Sbjct: 32 EIGHGSFG---AVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNS 87
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+++ Y ++VME C G D + E + A+ L +A+ H +
Sbjct: 88 IEYKGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----HRS 337
+HRD+K N L T E +K DFG + P N VG+ Y++APEV+
Sbjct: 147 IHRDIKAGNILLT---EPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQ 200
Query: 338 YSTEADVWSIGVIAYILLCGSRP--FWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y + DVWS+G I I L +P F S ++ P+ W S R+F
Sbjct: 201 YDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFRNF 256
Query: 396 VKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
V L K P+ R T+ + L H ++ V +D+I
Sbjct: 257 VDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLI 293
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-20
Identities = 77/269 (28%), Positives = 128/269 (47%), Gaps = 22/269 (8%)
Query: 160 GEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
G+ +G+G FG Y C EL +QV P+ T+ + + E+++L+ L
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFD--PESPETSK-EVSALECEIQLLKNLQ- 62
Query: 218 HNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H +V+++ D + + ME GG + D++ + G TE + QIL +++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSY 121
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR----PDERLNDIVGSAYYVAP 331
H +VHRD+K N L +D +K DFG S ++ + + G+ Y+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 332 EVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
EV+ Y +ADVWS+G +L +P WA E+ A+ K PS S
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLT-EKPPWAEYEA--MAAIFKIATQPTNPQLPSHIS 235
Query: 391 E-ARDFVKRLLNKDPRKRLTAAQALSHPW 418
E ARDF+ + + R R +A + L HP+
Sbjct: 236 EHARDFLGCIF-VEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 87/301 (28%), Positives = 129/301 (42%), Gaps = 50/301 (16%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+YE E+G G +G A+ G VA+K + + + VR EV +L+ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRL 56
Query: 216 TG--HNNLVKFFD--AYEDTD---NVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVM 266
H N+V+ D A TD V +V E + LD++ G + K +M
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLM 114
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
Q L + F H +VHRDLKPEN L T+ + +K DFGL+ L +V +
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTL 171
Query: 327 YYVAPEVLHRS-YSTEADVWSIGVI------AYILLCGSRPFWARTESGIFRAVLKADPS 379
+Y APEVL +S Y+T D+WS+G I L CG+ A IF + P
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLI--GLPP 227
Query: 380 FDEAPW---------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
D+ P P + + +L +P KR++A +AL HP+
Sbjct: 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287
Query: 419 I 419
Sbjct: 288 F 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 78/307 (25%), Positives = 142/307 (46%), Gaps = 54/307 (17%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y+ VG G +G C+A + Q+VAVK + + + I RE+++L+ +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLR---QKVAVKKLSR-PFQSLIHARRTYRELRLLKHM 71
Query: 216 TGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
H N++ D + E+ + VY+V L G L+ I+ + K +++ + ++ Q+
Sbjct: 72 K-HENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIV-KCQKLSDEHVQFLIYQL 127
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H G++HRDLKP N +E+ L+ +DFGL+ + D+ + V + +Y
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRILDFGLAR--QADDEMTGYVATRWYR 182
Query: 330 APEVLHR--SYSTEADVWSIGVIAYILLCG-----------------------SRPFWAR 364
APE++ Y+ D+WS+G I LL G S +
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEAR-------DFVKRLLNKDPRKRLTAAQALSHP 417
S R +++ P P L R D ++++L D KR++A++AL+HP
Sbjct: 243 ISSEHARKYIQSLPHM---PQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299
Query: 418 WIKNSND 424
+ +D
Sbjct: 300 YFSQYHD 306
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-20
Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
L +E+G G FG + L+ ++VA+K I + M+ ED E +++ L+ H
Sbjct: 8 LVQEIGSGQFGLV----WLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLS-H 58
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
LV+ + + + +V E E G L D + ++ GK++++ + + + +A+
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---APEVLH 335
V+HRDL N L EN V+K DFG++ FV D++ G+ + V +PEV
Sbjct: 119 SNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFS 174
Query: 336 RS-YSTEADVWSIGVIAYILLC-GSRPFWARTES 367
S YS+++DVWS GV+ + + G P+ R+ S
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 40/294 (13%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
NK+E+ VG G +G + K+ + + VA+K + + E RE+K+LR
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETK---EIVAIKKFKDSEENEEVK-ETTLRELKMLRT 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L N+V+ +A+ +Y+V E E +L+ + + ++ + Q++ +
Sbjct: 57 LK-QENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIH 114
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP--DERLNDIVGSAYYVAPE 332
+CH +VHRD+KPEN L + D VLK DFG + + + + V + +Y +PE
Sbjct: 115 WCHKNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 333 VLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK--------------AD 377
+L + Y D+WS+G I L G F +E + K ++
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 378 PSFDEAPWPS--------------LSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
P F +P+ LS D +K LL +P R Q L+HP
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 20/278 (7%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A YE+ + +GRG FG + + + + A+K++ K +M E I+
Sbjct: 42 AEDYEVVKVIGRGAFG---EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM- 97
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
A +V+ F A++D +Y+VME GG+L++ L E A+ +++ +
Sbjct: 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN--LMSNYDVPEKWARFYTAEVVLAL 155
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
H G +HRD+KP+N L D++ LK DFG + + R + VG+ Y++P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 212
Query: 332 EVLHRS-----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
EVL Y E D WS+GV Y +L G PF+A + G + ++ S
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272
Query: 387 SLSSEARDFVKRLLNKDPRKRL---TAAQALSHPWIKN 421
+S EA++ + L D RL + H + KN
Sbjct: 273 DISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 4e-20
Identities = 79/276 (28%), Positives = 137/276 (49%), Gaps = 28/276 (10%)
Query: 157 YELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVKIL 212
+ LG+ +GRG FG Y C G+++AVK +P T+ + + E+++L
Sbjct: 4 WRLGKLLGRGAFGEVYLCY-----DADTGRELAVKQVPFDPDSQETSKEVNALECEIQLL 58
Query: 213 RALTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
+ L H+ +V+++ D + + + +E GG + D+ L G TE+ + QIL
Sbjct: 59 KNLR-HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQ-LKAYGALTENVTRRYTRQIL 116
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR----PDERLNDIVGSA 326
V++ H +VHRD+K N L +D +K DFG S ++ + + G+
Sbjct: 117 QGVSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 327 YYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDEA 383
Y+++PEV+ Y +ADVWS+ +L +P WA E + IF+ + P+
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT-EKPPWAEYEAMAAIFK--IATQPTKPML 230
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
P +S RDF+K++ ++ R R TA L HP++
Sbjct: 231 P-DGVSDACRDFLKQIFVEEKR-RPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 5e-20
Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 44/233 (18%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L E+G G FG + E + VAVK + + + A +D RE ++L
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL--KETASNDARKDFEREAELLTNF- 65
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-------------GKYTEDDAK 263
H N+VKF+ + D +V E E G+L + S G G+ T
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+ +QI + + + Q VHRDL N L + V+K DFG+S D+
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGY---DLVVKIGDFGMS---------RDVY 173
Query: 324 GSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFW 362
+ YY + PE +++R ++TE+DVWS GV+ + I G +P++
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-20
Identities = 80/306 (26%), Positives = 135/306 (44%), Gaps = 49/306 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +E + +GRG FG + + + G A+K++ K M + +R E IL
Sbjct: 1 DDFESLKVIGRGAFG---EVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
G +VK F +++D N+Y++ME GG+++ +L + +E+ + + + + +
Sbjct: 58 ADG-AWVVKMFYSFQDKRNLYLIMEFLPGGDMMT-LLMKKDTLSEEATQFYIAETVLAID 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL---------------------SDFV 313
H G +HRD+KP+N L K +K DFGL SDF
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 314 -------RPDERLN--------DIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCG 357
R E VG+ Y+APEV ++ Y+ D WS+GVI Y +L G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 358 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA---QAL 414
PF + T +R V+ + P +S +A+D + R D R+ + +
Sbjct: 233 YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291
Query: 415 SHPWIK 420
SHP+ +
Sbjct: 292 SHPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 87/316 (27%), Positives = 141/316 (44%), Gaps = 66/316 (20%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKIL 212
+Y+ + +G G G CAA + GQ VA+K + P +T A + RE+ ++
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAY---DTVTGQNVAIKKLSRPFQNVTHA---KRAYRELVLM 69
Query: 213 RALTGHNNLVKFFDAY------EDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKA 264
+ L H N++ + + E+ +VY+VMEL + +++ L +
Sbjct: 70 K-LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD------HERMSY 122
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
++ Q+L + H G++HRDLKP N + + + LK +DFGL+ + V
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVV 179
Query: 325 SAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPF--------WAR------TESGI 369
+ YY APEV L Y D+WS+G I ++ G+ F W + T S
Sbjct: 180 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239
Query: 370 FRAVLK-------------ADPSFDEA------PWPSLS------SEARDFVKRLLNKDP 404
F + L+ A SF+E P S S S+ARD + ++L DP
Sbjct: 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDP 299
Query: 405 RKRLTAAQALSHPWIK 420
KR++ AL HP+I
Sbjct: 300 EKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 75/261 (28%), Positives = 117/261 (44%), Gaps = 54/261 (20%)
Query: 201 AIEDVRREVKILRAL-TGHN----NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGG 255
A VR++ ILR L H +V F+ A+ + +N+ + ME + G L DRI +GG
Sbjct: 42 AKSSVRKQ--ILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGG 98
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQG---------VVHRDLKPENFLFTTKDENSVLKAID 306
+ IL +A ++G ++HRD+KP N L ++ + +K D
Sbjct: 99 PIPVE--------ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCD 147
Query: 307 FGLSDFVRPDERLNDI----VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPF 361
FG+S E +N I VG++ Y++PE + Y+ ++DVWS+G+ L G PF
Sbjct: 148 FGVSG-----ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
Query: 362 WARTES--------GIF----RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
GI + V + P + +P + RDFV L KDP +R T
Sbjct: 203 AFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE---DLRDFVDACLLKDPTERPT 259
Query: 410 AAQAL-SHPWIKNSNDVKVPL 429
Q P+I+ V L
Sbjct: 260 PQQLCAMPPFIQALRASNVDL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 86/311 (27%), Positives = 140/311 (45%), Gaps = 61/311 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILR 213
+Y+ + +G G G CAA + G VAVK + P T A + RE+ +L+
Sbjct: 22 RYQQLKPIGSGAQGIVCAAF---DTVLGINVAVKKLSRPFQNQTHA---KRAYRELVLLK 75
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
+ H N++ + + E+ +VY+VMEL + L +++ + + ++
Sbjct: 76 CVN-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHM--ELDHERMSYLLY 130
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L + H G++HRDLKP N + + + LK +DFGL+ + + V + Y
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRY 187
Query: 328 YVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPF--------WAR------TESGIFRA 372
Y APEV L Y D+WS+G I L+ GS F W + T S F
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247
Query: 373 VLKA-----------------DPSFDEAPWPSLS-------SEARDFVKRLLNKDPRKRL 408
L+ + F + +PS S S+ARD + ++L DP KR+
Sbjct: 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI 307
Query: 409 TAAQALSHPWI 419
+ +AL HP+I
Sbjct: 308 SVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 45/274 (16%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG + + + G A+K++ K M + +R E IL +V
Sbjct: 9 IGRGAFG---EVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDIL-VEADSLWVV 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
K F +++D N+Y++ME GG+++ +L + TE++ + + + + + H G +
Sbjct: 65 KMFYSFQDKLNLYLIMEFLPGGDMMT-LLMKKDTLTEEETQFYIAETVLAIDSIHQLGFI 123
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGL---------------------SDFV-------- 313
HRD+KP+N L +K +K DFGL SDF
Sbjct: 124 HRDIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 314 ------RPDERLN-DIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWART 365
R +L VG+ Y+APEV + Y+ D WS+GVI Y +L G PF + T
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 366 ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
++ V+ + P +S +A+D + R
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRF 274
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 78/287 (27%), Positives = 123/287 (42%), Gaps = 59/287 (20%)
Query: 163 VGRGHFGYTC-AAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
+G G FG C A K L A+K + K + + V+ E IL A + +
Sbjct: 9 LGIGAFGEVCLACKVDTHAL----YAMKTLRKKDVLNRNQVAHVKAERDIL-AEADNEWV 63
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
VK + +++D DN+Y VM+ GG+++ +L R + E A+ + ++ + H G
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGL--------------------SDFVRPDERLND 321
+HRD+KP+N L D + +K DFGL D + P + +D
Sbjct: 123 IHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 322 I----------------------------VGSAYYVAPEVLHRS-YSTEADVWSIGVIAY 352
+ VG+ Y+APEVL R Y+ D WS+GVI +
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
+L G PF A T + V+ + + P LS EA D + +L
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 17/222 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ L ++G G+FG +K +VA+K++ K + +D ++EV+ L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR----VRVAIKIL---KSDDLLKQQDFQKEVQALKRLR 60
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI--QILNVVA 274
H +L+ F + VY++ EL E G LL + S G+ A + + Q+ +A
Sbjct: 61 -HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMA 118
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY-YVAPEV 333
+ Q +HRDL N L E+ V K DFGL+ ++ D L+ Y + APE
Sbjct: 119 YLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEA 175
Query: 334 L-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
H ++ST++DVWS G++ Y + G P+ ++ +
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 82/284 (28%), Positives = 126/284 (44%), Gaps = 49/284 (17%)
Query: 171 TCAAKFK-KGELKGQQVAVKVIP-KHKM---TTAIAIEDVRREVKILRALTGHNNLVKFF 225
T A FK + +L VA+K I +H+ TAI REV +L+ L H N+V
Sbjct: 17 TYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI------REVSLLKNLK-HANIVTLH 69
Query: 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRD 285
D + +V E + +L + + G + + K M Q+L +++CH + ++HRD
Sbjct: 70 DIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEVLHRS--YSTEA 342
LKP+N L K E LK DFGL+ P + ++ V + +Y P+VL S YST
Sbjct: 129 LKPQNLLINEKGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 343 DVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSFDEAPW------------- 385
D+W +G I Y + G F T IFR L P+ + P
Sbjct: 186 DMWGVGCILYEMATGRPMFPGSTVKEELHLIFR--LLGTPTEETWPGITSNEEFRSYLFP 243
Query: 386 -----------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
P L ++ D + LL + + R++A AL H +
Sbjct: 244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 44/246 (17%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR-----GGKYTEDD 261
REV +L+ L H N+V D ++ +V E LD+ L + G +
Sbjct: 53 REVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEY------LDKDLKQYLDDCGNSINMHN 105
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLN 320
K + Q+L + +CH + V+HRDLKP+N L + E LK DFGL+ P + +
Sbjct: 106 VKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYS 162
Query: 321 DIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378
+ V + +Y P++L S YST+ D+W +G I Y + G F T + +
Sbjct: 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG 222
Query: 379 SFDEAPWPS--------------------------LSSEARDFVKRLLNKDPRKRLTAAQ 412
+ E WP L S+ + + +LL + RKR++A +
Sbjct: 223 TPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE 282
Query: 413 ALSHPW 418
A+ HP+
Sbjct: 283 AMKHPY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 162 EVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
++G GHFG C G+QVAVK H D RE++ILR L H
Sbjct: 11 QLGEGHFGKVELCRYDPLGDN-TGEQVAVKS-LNHSGEEQ-HRSDFEREIEILRTLD-HE 66
Query: 220 NLVKFFDAYEDT--DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM--IQILNVVAF 275
N+VK+ E ++ ++ME G L R + + + + ++ QI + +
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGS-AYYVAP 331
Q +HRDL N L + ++K DFGL+ + D+ + + S ++ AP
Sbjct: 125 LGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 332 EVLH-RSYSTEADVWSIGVIAYILLCGSRPF 361
E L +S+ +DVWS GV Y L P
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 77/310 (24%), Positives = 132/310 (42%), Gaps = 61/310 (19%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + + + G+ A+K + K +M + V+ E +L A + +V
Sbjct: 9 IGKGAFG---EVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVL-AESDSPWVV 64
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ +++D +Y++ME GG+L+ +L + ++ED + M + + + H G +
Sbjct: 65 SLYYSFQDAQYLYLIMEFLPGGDLMT-MLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFI 123
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSD----------FVRP----------DERLNDI 322
HRD+KP+N L D +K DFGLS + + D R +
Sbjct: 124 HRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 323 VGS---------------------AY-------YVAPEV-LHRSYSTEADVWSIGVIAYI 353
V S AY Y+APE+ L + Y E D WS+G I +
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
Query: 354 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TA 410
L G PF + +R ++ + LS EA D ++RL+ + RL A
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299
Query: 411 AQALSHPWIK 420
+ SHP+ +
Sbjct: 300 HEIKSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
+E+G G FG K G+ +GQ VA+K+I + M+ IE E K++ L+ H
Sbjct: 10 KELGTGQFGVV-----KYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLS-HE 59
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
LV+ + +Y+V E G LL+ + G ++ + + +A+ +
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---APEVLHR 336
+HRDL N L D+ +K DFGLS +V DE + VGS + V PEVL
Sbjct: 120 QFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLY 175
Query: 337 S-YSTEADVWSIGVIAY-ILLCGSRPF 361
S +S+++DVW+ GV+ + + G P+
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 82/285 (28%), Positives = 127/285 (44%), Gaps = 52/285 (18%)
Query: 177 KKGE------LK------GQQVAVKVIPKHKMTTAIAIEDVR--REVKILRALTGHNNLV 222
K GE LK G+ A+K + KH ++E V RE++ LR L+ H N++
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKH----FKSLEQVNNLREIQALRRLSPHPNIL 61
Query: 223 KFFDAYED--TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+ + D T + +V EL + L + I R E K+ M Q+L + H G
Sbjct: 62 RLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--Y 338
+ HRD+KPEN L KD+ +LK DFG + + + + +Y APE L Y
Sbjct: 121 IFHRDIKPENILI--KDD--ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTE----SGI--------------FRAVLKADPSF 380
+ D+W++G + + +L F E + I FR + +F
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236
Query: 381 -----DEAPW--PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
P+ S+E D +K+LL DP +R+TA QAL HP+
Sbjct: 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 4e-18
Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
+E+G G FG G+ + Q +VA+K I + M+ ED E K++ L+ H
Sbjct: 10 KELGSGQFGVV-----HLGKWRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLS-HP 59
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
LV+ + +Y+V E E G LL+ + R GK ++D ++ + + +
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---APEVLHR 336
+HRDL N L + V+K DFG++ +V DE + G+ + V PEV +
Sbjct: 120 SFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNF 175
Query: 337 S-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKAD 377
S YS+++DVWS GV+ + + G PF ++ + + +
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 5e-18
Identities = 77/275 (28%), Positives = 135/275 (49%), Gaps = 32/275 (11%)
Query: 163 VGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+GRG FG Y C +K + G+ A+K + K ++ E + +I+ +L +
Sbjct: 2 IGRGGFGEVYGC----RKAD-TGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGD 55
Query: 221 ---LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
+V A+ D + +++L GG+L LS+ G ++E + + +I+ + H
Sbjct: 56 CPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR 336
+ VV+RDLKP N L DE+ ++ D GL+ DF + ++ + VG+ Y+APEVL +
Sbjct: 115 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQK 169
Query: 337 --SYSTEADVWSIGVIAYILLCGSRPF---WARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+Y + AD +S+G + + LL G PF + + I R L + S S E
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPE 225
Query: 392 ARDFVKRLLNKDPRKRL-----TAAQALSHPWIKN 421
R ++ LL +D +RL A + HP+ ++
Sbjct: 226 LRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 50/268 (18%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR-----GGKYTEDD 261
REV +L+ L H N+V D ++ +V E LD+ L + G + +
Sbjct: 53 REVSLLKDLK-HANIVTLHDIVHTDKSLTLVFEY------LDKDLKQYMDDCGNIMSMHN 105
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLN 320
K + QIL +A+CH + V+HRDLKP+N L + E LK DFGL+ P + +
Sbjct: 106 VKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYS 162
Query: 321 DIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVL 374
+ V + +Y P+VL S YST+ D+W +G I + + G F T IFR L
Sbjct: 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR--L 220
Query: 375 KADPSFDEAPW------------------------PSLSSEARDFVKRLLNKDPRKRLTA 410
P+ + P P L +E + + + L + +KR++A
Sbjct: 221 LGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA 280
Query: 411 AQALSHPWIKN--SNDVKVPLDVIIFKL 436
+A+ H + ++ + +P + IF L
Sbjct: 281 EEAMKHAYFRSLGTRIHSLPESISIFSL 308
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 84/304 (27%), Positives = 133/304 (43%), Gaps = 50/304 (16%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKI 211
A+ YE E++G G + K K + G+ VA+KVI + + T AI RE +
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSK---VNGKLVALKVIRLQEEEGTPFTAI----REASL 56
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L+ L H N+V D + + +V E +L + G ++ K + Q+L
Sbjct: 57 LKGLK-HANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVA 330
+++ H + ++HRDLKP+N L + E LK DFGL+ P ++ V + +Y
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSNEVVTLWYRP 171
Query: 331 PEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTE-----SGIFRAVLKADPSFDEA 383
P+VL S YST D+W +G I ++ G F + IF ++ P+ D
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF--LVLGTPNEDTW 229
Query: 384 P------------------------WPSLS--SEARDFVKRLLNKDPRKRLTAAQALSHP 417
P W LS + A D +LL P+ RL+A ALSH
Sbjct: 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289
Query: 418 WIKN 421
+ +
Sbjct: 290 YFSD 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
L ++G G FG + +VAVK + M+ E +E +I++ L H
Sbjct: 10 LERKLGAGQFGEVWMGTW----NGTTKVAVKTLKPGTMSP----EAFLQEAQIMKKLR-H 60
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAFCH 277
+ LV+ + + + +Y+V E G LLD + S GK M QI +A+
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE-V 333
+ +HRDL N L EN V K DFGL+ + DE G+ + + APE
Sbjct: 121 SRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAA 176
Query: 334 LHRSYSTEADVWSIGVIAY 352
+ ++ ++DVWS G++
Sbjct: 177 NYGRFTIKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 82/310 (26%), Positives = 131/310 (42%), Gaps = 58/310 (18%)
Query: 147 FGFSKHFANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIE-D 204
FG + + N +LGE + A +K + GQ VA+KVI M T +
Sbjct: 1 FGAATSYLNLEKLGEG--------SYATVYKGISRINGQLVALKVI---SMKTEEGVPFT 49
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
RE +L+ L H N+V D + + V E +L ++ G + +
Sbjct: 50 AIREASLLKGLK-HANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL 107
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIV 323
M Q+L +A+ H Q ++HRDLKP+N L + E LK DFGL+ P + + V
Sbjct: 108 FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEV 164
Query: 324 GSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-----A 376
+ +Y P+VL + YS+ D+W G I +I + +P + S +F + K
Sbjct: 165 VTLWYRPPDVLLGATDYSSALDIWGAGCI-FIEMLQGQPAFPGV-SDVFEQLEKIWTVLG 222
Query: 377 DPSFDEAPWPSLSS----------------------------EARDFVKRLLNKDPRKRL 408
P+ E WP +S +A D ++L P+ R+
Sbjct: 223 VPT--EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI 280
Query: 409 TAAQALSHPW 418
+A AL HP+
Sbjct: 281 SAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 86/300 (28%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+YE E+G G +G FK +LK G+ VA+K + + + +R EV +LR
Sbjct: 2 QYECVAEIGEGAYGKV----FKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLR 56
Query: 214 ALTG--HNNLVKFFD--AYEDTD---NVYVVMELCEGG--ELLDRILSRGGKYTEDDAKA 264
L H N+V+ FD TD + +V E + LD++ G + K
Sbjct: 57 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKD 114
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
+M Q+L + F H VVHRDLKP+N L T+ + +K DFGL+ L +V
Sbjct: 115 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVV 171
Query: 325 SAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPF---------------------- 361
+ +Y APEV L SY+T D+WS+G I + + +P
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230
Query: 362 --WARTESGIFRAVLKADPSFD-EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
W R + + R + + E + +D + + L +P KR++A ALSHP+
Sbjct: 231 EDWPR-DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 79/273 (28%), Positives = 121/273 (44%), Gaps = 29/273 (10%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED--VRREVKIL 212
N G+ +G G FG A L +KV K TA + E + E+KI+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYG--LSKSDAVMKVAVKMLKPTAHSSEREALMSELKIM 92
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILN 271
L H N+V A + V+ E C G+LL+ + + + T +D + Q+
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV-GSAY--- 327
+AF + +HRDL N L T ++K DFGL+ + D N +V G+A
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLT---HGKIVKICDFGLARDIMNDS--NYVVKGNARLPV 207
Query: 328 -YVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK-----ADPS 379
++APE + + Y+ E+DVWS G++ + I GS P+ F ++K A P
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
AP +E D +K + DP KR T Q
Sbjct: 268 H--AP-----AEIYDIMKTCWDADPLKRPTFKQ 293
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 67/261 (25%), Positives = 116/261 (44%), Gaps = 16/261 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + K G+ A K + K ++ + E +IL + +V
Sbjct: 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF-IV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTE-DDAKAVMIQILNVVAFCHLQGV 281
A+E ++ +VM L GG+L I + G + E + QI + H +
Sbjct: 57 NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYST 340
V+RD+KPEN L D+ + D GL+ ++ + + G+ Y+APE+L YS
Sbjct: 117 VYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 341 EADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPWPSLSSEARDFV 396
D +++G Y ++ G PF E + R L+ + F+ + + E++D
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEESKDIC 230
Query: 397 KRLLNKDPRKRLTAAQALSHP 417
+ L K P RL + + P
Sbjct: 231 RLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 30/231 (12%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+++G G FG ++ K VAVK + K++ + +D +E I+ +L H N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM--DDFLKEAAIMHSLD-HEN 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
L++ + T + +V EL G LLDR+ G + +QI N + + +
Sbjct: 58 LIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---------- 329
+HRDL N L + D+ +K DFGL L +YV
Sbjct: 117 RFIHRDLAARNILLASDDK---VKIGDFGLM------RALPQ--NEDHYVMEEHLKVPFA 165
Query: 330 --APEVL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 376
APE L R++S +DVW GV + + G P+ + S I + + K
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE 216
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 9e-17
Identities = 78/311 (25%), Positives = 135/311 (43%), Gaps = 61/311 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILR 213
+Y+ + +G G G CAA + + VA+K + P T A + RE+ +++
Sbjct: 18 RYQNLKPIGSGAQGIVCAAY---DAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMK 71
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
+ H N++ + + E+ +VY+VMEL + L +++ + + ++
Sbjct: 72 CVN-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYLLY 126
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L + H G++HRDLKP N + + + LK +DFGL+ + V + Y
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 328 YVAPEV-LHRSYSTEADVWSIGVIA------YILLCGSR----------------PFWAR 364
Y APEV L Y D+WS+G I IL G P + +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 365 TESGIFRAVLKADPSFDEAPWPSL----------------SSEARDFVKRLLNKDPRKRL 408
R ++ P + +P L +S+ARD + ++L DP KR+
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 409 TAAQALSHPWI 419
+ +AL HP+I
Sbjct: 304 SVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 77/324 (23%), Positives = 132/324 (40%), Gaps = 71/324 (21%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-- 219
E+G G+ G + G +A K+I H + RE+K+L H
Sbjct: 8 ELGAGNGGVVTKVLHRP---SGLIMARKLI--HLEIKPAIRNQIIRELKVL-----HECN 57
Query: 220 --NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
+V F+ A+ + + ME +GG L D++L + G+ E+ IL ++
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEN--------ILGKISIAV 108
Query: 278 LQG---------VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
L+G ++HRD+KP N L ++ E +K DFG+S + D N VG+ Y
Sbjct: 109 LRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 164
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFD--- 381
++PE L + Y+ ++D+WS+G+ + G P +F + + +
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224
Query: 382 -----------------------EAPWPSL-----SSEARDFVKRLLNKDPRKRLTAAQA 413
P P L S E +DFV + L K+P++R +
Sbjct: 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL 284
Query: 414 LSHPWIKNSNDVKVPLDVIIFKLM 437
HP+IK + +V + M
Sbjct: 285 TKHPFIKRAELEEVDFAGWVCSTM 308
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 71/272 (26%), Positives = 120/272 (44%), Gaps = 19/272 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A + + G+ A K + K ++ E E +IL A +V
Sbjct: 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRIL-AKVHSRFIV 56
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQ 279
A++ ++ +VM + GG+L I + + E A QI++ + H +
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLH-RS 337
+++RDLKPEN L D + ++ D GL+ + + G+ ++APE+L
Sbjct: 117 RIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSSEARDFV 396
Y D +++GV Y ++ PF AR E + LK D +P S ++ F
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRILNDSVTYPDKFSPASKSFC 232
Query: 397 KRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
+ LL KDP KRL +HP ++ N
Sbjct: 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 17/215 (7%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
F K F + ++G GHFG ++ +G+ G+QVAVK + IA D+++
Sbjct: 1 FEKRFLKRIR---DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--DLKK 55
Query: 208 EVKILRALTGHNNLVKFFD-AYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAV 265
E++ILR L H N+VK+ ED N + ++ME G L + + K
Sbjct: 56 EIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY 114
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL----ND 321
+QI + + + VHRDL N L + E+ V K DFGL+ + D+ +D
Sbjct: 115 AVQICKGMDYLGSRQYVHRDLAARNVL--VESEHQV-KIGDFGLTKAIETDKEYYTVKDD 171
Query: 322 IVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILL 355
+ ++ APE L + +DVWS GV Y LL
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 69/251 (27%), Positives = 109/251 (43%), Gaps = 54/251 (21%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRR----EVKILRAL 215
E++G+G+FG KG LKG +VAVK + T D++R E +IL+
Sbjct: 1 EKIGKGNFG-----DVYKGVLKGNTEVAVKTC---RSTL---PPDLKRKFLQEAEILKQY 49
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VK +Y+VMEL GG LL + + + T + + + +
Sbjct: 50 D-HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY 108
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY------YV 329
+ +HRDL N L EN+VLK DFG+S R +E V +
Sbjct: 109 LESKNCIHRDLAARNCLV---GENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWT 162
Query: 330 APEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
APE L+ Y++E+DVWS G++ + F S + P+P +
Sbjct: 163 APEALNYGRYTSESDVWSYGILLW---------------ETF--------SLGDTPYPGM 199
Query: 389 S-SEARDFVKR 398
S + R+ ++
Sbjct: 200 SNQQTRERIES 210
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 78/311 (25%), Positives = 135/311 (43%), Gaps = 61/311 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI--PKHKMTTAIAIEDVRREVKILR 213
+Y+ + +G G G CAA E + VA+K + P T A + RE+ +++
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILE---RNVAIKKLSRPFQNQTHA---KRAYRELVLMK 78
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
+ H N++ + + E+ +VY+VMEL + L +++ + + ++
Sbjct: 79 CVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSYLLY 133
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L + H G++HRDLKP N + + + LK +DFGL+ + V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 328 YVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL------------ 374
Y APEV L Y D+WS+G I ++ G F + V+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250
Query: 375 KADPS-------------------FDEAPWPSLS-------SEARDFVKRLLNKDPRKRL 408
K P+ F + +P+ S S+ARD + ++L D KR+
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 409 TAAQALSHPWI 419
+ +AL HP+I
Sbjct: 311 SVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 74/257 (28%), Positives = 129/257 (50%), Gaps = 27/257 (10%)
Query: 163 VGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+GRG FG Y C +K + G+ A+K + K ++ E + +I+ +L +
Sbjct: 2 IGRGGFGEVYGC----RKAD-TGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGD 55
Query: 221 ---LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
+V A+ D + +++L GG+L LS+ G ++E + + +I+ + H
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDL-HYHLSQHGVFSEKEMRFYATEIILGLEHMH 114
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR 336
+ VV+RDLKP N L DE+ ++ D GL+ DF + ++ + VG+ Y+APEVL +
Sbjct: 115 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQK 169
Query: 337 --SYSTEADVWSIGVIAYILLCGSRPFW---ARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+Y + AD +S+G + + LL G PF + + I R L + + S S E
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD----SFSPE 225
Query: 392 ARDFVKRLLNKDPRKRL 408
+ ++ LL +D KRL
Sbjct: 226 LKSLLEGLLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 6e-16
Identities = 62/247 (25%), Positives = 110/247 (44%), Gaps = 29/247 (11%)
Query: 184 QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG 243
Q++ V+ I K K AI E + + + + N +K + + ++M+ +
Sbjct: 41 QKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKD 93
Query: 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303
G+L D +L + GK +E + K ++ Q++ + H ++H D+K EN L+ + L
Sbjct: 94 GDLFD-LLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYL- 151
Query: 304 AIDFGLSDFVRPDERLNDIVG--SAY-----YVAPE-VLHRSYSTEADVWSIGVIAYILL 355
D+GL I+G S Y Y +PE + +Y D W++GV+ Y LL
Sbjct: 152 -CDYGLC----------KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELL 200
Query: 356 CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA-AQAL 414
G PF + + L ++S A DFV+ +L + RLT + +
Sbjct: 201 TGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260
Query: 415 SHPWIKN 421
HP++K
Sbjct: 261 KHPFLKI 267
|
Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 76/277 (27%), Positives = 118/277 (42%), Gaps = 50/277 (18%)
Query: 163 VGRGHFG--YTCAAKFKKGELKG-QQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG-- 217
+G G FG Y A G G +VAVK + K A + ++E L
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG------ATDQEKKEFLKEAHLMSNF 56
Query: 218 -HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV----MIQI-LN 271
H N+VK + Y++MEL EGG+LL + R + + ++ I L+
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLD 114
Query: 272 VVAFCH-LQGV--VHRDLKPENFLFTTKDENS--VLKAIDFGLSDFVRPDERLNDIVGSA 326
V C L+ + +HRDL N L + K ++ V+K DFGL+ DI S
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKSD 165
Query: 327 YY------------VAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRA 372
YY +APE L ++T++DVWS GV+ + IL G +P+ A + +
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH 225
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
V A + P + + + +DP +R T
Sbjct: 226 V-TAGGRL-QKP-ENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 68/261 (26%), Positives = 115/261 (44%), Gaps = 50/261 (19%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
RE+++L +V F+ A+ + + ME +GG L D++L + G+ E V
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 109
Query: 267 IQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
I ++ + + + ++HRD+KP N L ++ E +K DFG+S + D N VG+
Sbjct: 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGT 165
Query: 326 AYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFW---ARTESGIFRAVLKADPSFD 381
Y++PE L + YS ++D+WS+G+ + G P A+ +F ++ DP+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225
Query: 382 EA----------------------------------PWPSLSS-----EARDFVKRLLNK 402
E P P L S E +DFV + L K
Sbjct: 226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIK 285
Query: 403 DPRKRLTAAQALSHPWIKNSN 423
+P +R Q + H +IK S
Sbjct: 286 NPAERADLKQLMVHAFIKRSE 306
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 68/273 (24%), Positives = 125/273 (45%), Gaps = 27/273 (9%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---EVKILRALTG 217
EE+GRG +G + G +AVK ++ + ++ +R ++ I
Sbjct: 7 EELGRGAYGVVDKMRHVP---TGTIMAVK-----RIRATVNSQEQKRLLMDLDISMRSVD 58
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
V F+ A +V++ ME+ + + ++ +G ED + + I+ + +
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 276 CHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
H + V+HRD+KP N L + N +K DFG+S ++ G Y+APE +
Sbjct: 119 LHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERI 175
Query: 335 -----HRSYSTEADVWSIGVIAYILLCGSRPF--WARTESGIFRAVLKADPSFDEAPWPS 387
+ Y ++DVWS+G+ L G P+ W +T + V++ +PS + P
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW-KTPFQQLKQVVE-EPS-PQLPAEK 232
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
S E +DFV + L K+ ++R + L HP+ +
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 29/202 (14%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+E+G G+FG + K +VAVK + + + ++ RE ++ L H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLD-HPC 57
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+V+ + + + +VMEL G LL + R + D K + Q+ +A+ +
Sbjct: 58 IVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH 115
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY------------ 328
VHRDL N L + + K DFG+S + GS YY
Sbjct: 116 FVHRDLAARNVLLVNRHQ---AKISDFGMSRALGA--------GSDYYRATTAGRWPLKW 164
Query: 329 VAPEVLH-RSYSTEADVWSIGV 349
APE ++ +S+++DVWS GV
Sbjct: 165 YAPECINYGKFSSKSDVWSYGV 186
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+ +G G FG C + K K VA+K + ++ D E I+ H N
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFD-HPN 66
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+++ + V ++ E E G L D+ L E+D K + Q++ + L+G
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSL-DKFLR------ENDGKFTVGQLVGM-----LRG 114
Query: 281 V------------VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG---S 325
+ VHRDL N L + N V K DFGLS + E G
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+ APE + +R +++ +DVWS G++ + ++ G RP+W + + +AV
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 74/258 (28%), Positives = 116/258 (44%), Gaps = 55/258 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
K LGE +G G FG GE GQ+VAVK I K +T +E+ K+
Sbjct: 7 KLTLGEIIGEGEFGAVLQ-----GEYTGQKVAVKNI-KCDVTAQAFLEETAVMTKL---- 56
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV--- 272
H NLV+ + +Y+VMEL G L++ + +RG A +IQ+L
Sbjct: 57 -HHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRG------RALVSVIQLLQFSLD 108
Query: 273 ----VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+ + + +VHRDL N L + E+ V K DFGL+ +++ +
Sbjct: 109 VAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGS--MGVDNSKLPVKW 163
Query: 329 VAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE L H+ +S+++DVWS GV+ W +F S+ AP+P
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVL----------LWE-----VF--------SYGRAPYPK 200
Query: 388 LS-SEARDFVKRLLNKDP 404
+S E ++ V++ +P
Sbjct: 201 MSLKEVKECVEKGYRMEP 218
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 67/265 (25%), Positives = 115/265 (43%), Gaps = 48/265 (18%)
Query: 181 LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN--LVKFFDAYEDTDNVYVVM 238
L + +AVKVIP I +E ++ + L L ++ ++ F+ A+ + + +
Sbjct: 24 LTRRILAVKVIP-----LDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78
Query: 239 ELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--------VVHRDLKPEN 290
E +GG L D + + +L +A ++G ++HRD+KP N
Sbjct: 79 EFMDGGSL-------------DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDI----VGSAYYVAPE-VLHRSYSTEADVW 345
L T+ + +K DFG+S + +N I VG+ Y+APE + Y +DVW
Sbjct: 126 MLVNTRGQ---VKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVW 177
Query: 346 SIGVIAYILLCGSRPF-WARTESGIFRAVLKADPSFDEAPWPSL-----SSEARDFVKRL 399
S+G+ L G P+ + G + DE P P L S + F+ +
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-PVLPVGQFSEKFVHFITQC 236
Query: 400 LNKDPRKRLTAAQALSHPWIKNSND 424
+ K P++R + HP+I ND
Sbjct: 237 MRKQPKERPAPENLMDHPFIVQYND 261
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 85/322 (26%), Positives = 138/322 (42%), Gaps = 67/322 (20%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+YE G +VGRG +G+ AK K G+ + A+K I ++ + RE+ +LR L
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEGTGISMSAC-----REIALLREL 55
Query: 216 TGHN--NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA-------KAVM 266
N +L K F ++ D V+++ + E R K + K+++
Sbjct: 56 KHPNVISLQKVFLSHADR-KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDF----VRPDERLND 321
QIL+ + + H V+HRDLKP N L + E +K D G + ++P L+
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 322 IVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE------------- 366
+V + +Y APE+L R Y+ D+W+IG I LL F R E
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234
Query: 367 SGIFRAV-LKADPSFDE-APWPSLSSEARDF----------------------------V 396
IF + AD +++ P S+ +DF +
Sbjct: 235 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 294
Query: 397 KRLLNKDPRKRLTAAQALSHPW 418
++LL DP KR+T+ QA+ P+
Sbjct: 295 QKLLTMDPIKRITSEQAMQDPY 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 85/323 (26%), Positives = 140/323 (43%), Gaps = 69/323 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+YE G +VGRG +G+ AK K G+ ++ A+K I ++ + RE+ +LR L
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGTGISMSAC-----REIALLREL 55
Query: 216 TGHNNLV---KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD-------AKAV 265
H N++ K F ++ D V+++ + E R K + K++
Sbjct: 56 K-HPNVIALQKVFLSHSDR-KVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDF----VRPDERLN 320
+ QIL+ + + H V+HRDLKP N L + E +K D G + ++P L+
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 321 DIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE------------ 366
+V + +Y APE+L R Y+ D+W+IG I LL F R E
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233
Query: 367 -SGIFRAV-LKADPSFDE----APWPSLSSEARD-------------------------F 395
IF + AD +++ +P+L + R
Sbjct: 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLL 293
Query: 396 VKRLLNKDPRKRLTAAQALSHPW 418
+++LL DP KR+T+ QAL P+
Sbjct: 294 LQKLLTMDPTKRITSEQALQDPY 316
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 22/258 (8%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
LG +G G FG + E + VAVK K+ + ++ E +E I+R
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVR-EKFLQEAYIMRQFD- 65
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM--IQILNVVAF 275
H ++VK + + V++VMEL GEL R + KY+ D A ++ Q+ +A+
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGEL--RSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS--AYYVAPEV 333
+ VHRD+ N L ++ D +K DFGLS ++ + G ++APE
Sbjct: 123 LESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179
Query: 334 LH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKAD--PSFDEAPWPSLS 389
++ R +++ +DVW GV + IL+ G +PF + + + + P P P+L
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCP-PTLY 238
Query: 390 SEARDFVKRLLNKDPRKR 407
S + + DP KR
Sbjct: 239 S----LMTKCWAYDPSKR 252
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L + +G+G FG G+ +G +VAVK I K+ T + E ++ L
Sbjct: 9 KLLQTIGKGEFG-----DVMLGDYRGNKVAVKCI-KNDATAQAFLA----EASVMTQLR- 57
Query: 218 HNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK-AVMIQILNVVAF 275
H+NLV+ E+ +Y+V E G L+D + SRG D + + + +
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL- 334
VHRDL N L + E++V K DFGL+ + + + APE L
Sbjct: 118 LEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALR 172
Query: 335 HRSYSTEADVWSIGVIAY 352
+ +ST++DVWS G++ +
Sbjct: 173 EKKFSTKSDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 76/326 (23%), Positives = 141/326 (43%), Gaps = 68/326 (20%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAIAIEDVRREVKILR 213
Y+LG +G G FG A ++VA+K + P++K RE+ I++
Sbjct: 68 YKLGNIIGNGSFGVVYEAICID---TSEKVAIKKVLQDPQYK----------NRELLIMK 114
Query: 214 ALTGHNNLVKFFDAY------EDTDNVY--VVMELCEGGELLDRILSRGGKYTEDDAKAV 265
L H N++ D Y ++ N++ VVME + + + + K+ + A+
Sbjct: 115 NLN-HINIIFLKDYYYTECFKKNEKNIFLNVVMEF------IPQTVHKYMKHYARNNHAL 167
Query: 266 MI--------QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
+ Q+ +A+ H + + HRDLKP+N L LK DFG + + +
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPN--THTLKLCDFGSAKNLLAGQ 225
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375
R + S +Y APE++ +Y+T D+WS+G I ++ G F ++ +++
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285
Query: 376 A------------DPSFDEAPWPSLSS-------------EARDFVKRLLNKDPRKRLTA 410
+P++ + +P + +A +F+ + L +P KRL
Sbjct: 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP 345
Query: 411 AQALSHPWIKNSNDVKVPLDVIIFKL 436
+AL+ P+ + D + L I KL
Sbjct: 346 IEALADPFFDDLRDPCIKLPKYIDKL 371
|
Length = 440 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 69/262 (26%), Positives = 115/262 (43%), Gaps = 37/262 (14%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
E +GRG+FG + G L+ V V + +E +IL+ + H N
Sbjct: 1 ERIGRGNFGEVFS-----GRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPN 54
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+V+ +Y+VMEL +GG+ L + + G + + ++ + + +
Sbjct: 55 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---------YVAP 331
+HRDL N L T E +VLK DFG+S R +E D V ++ + AP
Sbjct: 115 CIHRDLAARNCLVT---EKNVLKISDFGMS---REEE---DGVYASTGGMKQIPVKWTAP 165
Query: 332 EVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
E L + YS+E+DVWS G++ + G+ P+ + A+ + P P L
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG----VRLPCPELC 221
Query: 390 SEARDFVKRLLNK----DPRKR 407
+A V RL+ + DP +R
Sbjct: 222 PDA---VYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 66/292 (22%), Positives = 112/292 (38%), Gaps = 55/292 (18%)
Query: 155 NKYELGEEVGRGHFGYT---CAAKFKKGELKGQQVAVK-VIPKHKMTTAIAIEDVRREVK 210
K L E+G+G FG A KGE + + VA+K V M I E
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETR-VAIKTVNENASMRERIEF---LNEAS 61
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---------GGKYTEDD 261
+++ H+ +V+ VVMEL G+L + SR G T
Sbjct: 62 VMKEFNCHH-VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
+ +I + +A+ + VHRDL N + E+ +K DFG++ D
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMT---------RD 168
Query: 322 IVGSAYY------------VAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTES 367
I + YY +APE L ++T++DVWS GV+ + + +P+ +
Sbjct: 169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE 228
Query: 368 GIFRAVLKAD----PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ + V+ P + ++ +P+ R T + +S
Sbjct: 229 EVLKFVIDGGHLDLPENCPDKL-------LELMRMCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQ-VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
E +G+G+FG + KG LK + VAVK K + + I+ + E +IL+ H
Sbjct: 1 ELLGKGNFG-----EVFKGTLKDKTPVAVKTC-KEDLPQELKIKFLS-EARILKQYD-HP 52
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
N+VK +Y+VMEL GG+ L + + + + +A+ +
Sbjct: 53 NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLS----DFVRPDERLNDIVGSAYYVAPEVL- 334
+HRDL N L EN+VLK DFG+S D + L I + APE L
Sbjct: 113 NCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALN 167
Query: 335 HRSYSTEADVWSIGVIAY 352
+ YS+E+DVWS G++ +
Sbjct: 168 YGRYSSESDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
+K LG+ +G G FG A+ K + VAVK++ T + D+ E++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 72
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTED------- 260
+++ + H N++ A +YV++E G L + + +R G +Y+ D
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE 132
Query: 261 -----DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
D + Q+ + + Q +HRDL N L T EN+V+K DFGL+ V
Sbjct: 133 QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNN 189
Query: 316 DERLNDIVGS---AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+ ++APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 65/260 (25%), Positives = 117/260 (45%), Gaps = 26/260 (10%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L +++G G FG + +VAVK + M+ +E E +++ L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNS----TKVAVKTLKPGTMSVQAFLE----EANLMKTLQ- 59
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFC 276
H+ LV+ + + +Y++ E G LLD + S GGK QI +A+
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEV 333
+ +HRDL+ N L + E+ + K DFGL+ + +E G+ + + APE
Sbjct: 120 ERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEA 175
Query: 334 LHR-SYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKA--DPSFDEAPWPSLS 389
++ S++ ++DVWS G++ Y I+ G P+ + S + A+ + P + P
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCP----- 230
Query: 390 SEARDFVKRLLNKDPRKRLT 409
E D +K + +R T
Sbjct: 231 DELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 50/182 (27%), Positives = 88/182 (48%), Gaps = 15/182 (8%)
Query: 186 VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGE 245
VAVK + M +D E +I++ L H L++ + + +Y+V EL + G
Sbjct: 33 VAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYIVTELMKYGS 87
Query: 246 LLDRILSRGGKYTE-DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304
LL+ + G+ + + Q+ + +A+ Q +HRDL N L EN++ K
Sbjct: 88 LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKV 144
Query: 305 IDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSR 359
DFGL+ ++ D G+ + + APE L+ +S ++DVWS G++ I+ G
Sbjct: 145 ADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRM 203
Query: 360 PF 361
P+
Sbjct: 204 PY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 8e-13
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 30/226 (13%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG---HN 219
+G G FG C+ + K + VA+K + A E RR+ ++ G H
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTL------KAGYTEKQRRDFLSEASIMGQFDHP 65
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
N++ + V +V E E G L + G++T ++ I + + +
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY----------YV 329
G VHRDL N L + N V K DFGLS + D +AY +
Sbjct: 126 GYVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPE------AAYTTRGGKIPIRWT 176
Query: 330 APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + +R +++ +DVWS G++ + ++ G RP+W + + +A+
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 60/242 (24%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
K+ELGE G FG A+ E VAVK + K + A +D +RE ++L
Sbjct: 10 KWELGE----GAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLT 62
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV-------- 265
L H ++V+F+ + + +V E G+L +R L G DAK +
Sbjct: 63 VLQ-HQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGP----DAKILAGGEDVAP 116
Query: 266 -------MIQILNVVA--FCHLQGV--VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314
M+ I + +A +L + VHRDL N L + V+K DFG+S
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQGLVVKIGDFGMS---- 169
Query: 315 PDERLNDIVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRP 360
DI + YY + PE +L+R ++TE+D+WS GV+ + I G +P
Sbjct: 170 -----RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
Query: 361 FW 362
++
Sbjct: 225 WY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-13
Identities = 79/298 (26%), Positives = 123/298 (41%), Gaps = 56/298 (18%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y++ +G+G G A ++VA+K I + + + RE KI L
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVC---SRRVALKKIREDLSENPLLKKRFLREAKIAADL 59
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRIL-------SRGGKYTEDDAKAVMIQ 268
H +V + D D VY M EG L +L S + E + +
Sbjct: 60 I-HPGIVPVYSICSDGDPVYYTMPYIEG-YTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 269 ILN----VVAFCHLQGVVHRDLKPENFLF---------------TTKDENSVLKAIDFGL 309
I + + + H +GV+HRDLKP+N L K E L ID
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 310 -----SDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEA-DVWSIGVIAYILLCGSRPFWA 363
S P + IVG+ Y+APE L ++E+ D++++GVI Y +L S P+
Sbjct: 178 RNICYSSMTIPGK----IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY-- 231
Query: 364 RTESG---IFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
R + G +R V+ P + AP+ P LS + L DP +R ++ Q L
Sbjct: 232 RRKKGRKISYRDVI-LSPI-EVAPYREIPPFLSQ----IAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 48/156 (30%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
RE+++L +V F+ A+ + + ME +GG L D++L + E+ V
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVS 109
Query: 267 IQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
I +L +A+ + ++HRD+KP N L ++ E +K DFG+S + D N VG+
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGT 165
Query: 326 AYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRP 360
Y++PE L + YS ++D+WS+G+ L G P
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 73/281 (25%), Positives = 126/281 (44%), Gaps = 50/281 (17%)
Query: 159 LGEEVGRGHFGYTCAAK-FKKGELKGQQ-VAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L E+G G FG A+ + K + VAVK + K T A +D +RE ++L L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQ 65
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG--------GKYTEDDAKAVMIQ 268
H ++VKF+ D D + +V E + G+L + + G G+ + + + Q
Sbjct: 66 -HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 269 ILNV-------VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
+L++ + + Q VHRDL N L N ++K DFG+S D
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMS---------RD 172
Query: 322 IVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWARTES 367
+ + YY + PE +++R ++TE+DVWS GVI + I G +P++ + +
Sbjct: 173 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
Query: 368 GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL 408
+ + + E P E D + ++P++RL
Sbjct: 233 EVIECITQG--RVLERP-RVCPKEVYDIMLGCWQREPQQRL 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 66/246 (26%), Positives = 111/246 (45%), Gaps = 44/246 (17%)
Query: 159 LGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L E+G G FG A+ E VAVK + K + A +D RE ++L L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLTNLQ 65
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGEL--------LDRILSRGGKYTEDDAKAVMIQ 268
H ++VKF+ + D + +V E + G+L D +L G + ++ M+
Sbjct: 66 -HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 269 ILNVVA----FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
I +A + Q VHRDL N L EN ++K DFG+S D+
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMS---------RDVYS 172
Query: 325 SAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIF 370
+ YY + PE +++R ++TE+DVWS+GV+ + I G +P++ + + +
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
Query: 371 RAVLKA 376
+ +
Sbjct: 233 ECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 22/225 (9%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG--- 217
E +G G FG C + K + VA+K + K T E RR+ ++ G
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYT-----EKQRRDFLSEASIMGQFD 63
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N++ + V ++ E E G L + G++T ++ I + +
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY-------YVA 330
VHRDL N L + N V K DFGLS F+ D+ + S+ + A
Sbjct: 124 EMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLE-DDTSDPTYTSSLGGKIPIRWTA 179
Query: 331 PE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
PE + +R +++ +DVWS G++ + ++ G RP+W + + A+
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 41/235 (17%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIE----DVRREVKI 211
+ LG+ +G G FG A+ + + V V KM A E D+ E+++
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAV----KMLKDDATEKDLSDLVSEMEM 68
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---------------GGK 256
++ + H N++ +YVV+E G L D + +R
Sbjct: 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128
Query: 257 YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------ 310
T+ D + Q+ + F + +HRDL N L T E+ V+K DFGL+
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLARDIHHI 185
Query: 311 DFVRP--DERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
D+ R + RL ++APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 186 DYYRKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L +++G G FG A + K +VAVK + M+ + E +++ L
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKH----TKVAVKTMKPGSMSVEAFLA----EANVMKTLQ- 59
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFC 276
H+ LVK A + +Y++ E G LLD + S G K QI +AF
Sbjct: 60 HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEV 333
+ +HRDL+ N L + V K DFGL+ + +E G+ + + APE
Sbjct: 119 EQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEA 174
Query: 334 L-HRSYSTEADVWSIGV-IAYILLCGSRPFWARTESGIFRAV 373
+ S++ ++DVWS G+ + I+ G P+ + + RA+
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 9e-12
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
++G G +G +KK VAVK + + M +E+ +E +++ + H NL
Sbjct: 13 KLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNL 64
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM---IQILNVVAFCHL 278
V+ Y++ E G LLD + R E +A ++ QI + + +
Sbjct: 65 VQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEVL- 334
+ +HRDL N L EN ++K DFGLS + + G+ + + APE L
Sbjct: 123 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 178
Query: 335 HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+ +S ++DVW+ GV+ + I G P+
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 79/285 (27%), Positives = 124/285 (43%), Gaps = 48/285 (16%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKILRALTGH 218
E+GRG FG K G +AVK I +T E R ++ ++ +
Sbjct: 10 GEIGRGAFGTVNKMLHKP---SGTIMAVKRI----RSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAFC- 276
+VKF+ A + ++ MEL +D L + KY + K+V+ +IL +A
Sbjct: 63 PYIVKFYGALFREGDCWICMEL------MDISLDKFYKYVYEVLKSVIPEEILGKIAVAT 116
Query: 277 -----HLQ---GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI-----V 323
+L+ ++HRD+KP N L D N +K DFG+S + ++ I
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQL-----VDSIAKTRDA 168
Query: 324 GSAYYVAPEVLHRS----YSTEADVWSIGVIAYILLCGSRPFWARTESGIF---RAVLKA 376
G Y+APE + S Y +DVWS+G+ Y + G P+ + +F V+K
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFDQLTQVVKG 226
Query: 377 D-PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
D P + S +F+ L KD KR + L HP+IK
Sbjct: 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 60/231 (25%), Positives = 92/231 (39%), Gaps = 36/231 (15%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
L +G G FG Y + + G+ QVAVK +P+ + D E I+
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE--SCSEQDESDFLMEALIMSKF 66
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN---- 271
H N+V+ + ++++EL GG+L L E + M +L
Sbjct: 67 N-HQNIVRLIGVSFERLPRFILLELMAGGDLKS-FLRENRPRPERPSSLTMKDLLFCARD 124
Query: 272 VVAFCHL---QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
V C +HRD+ N L T K V K DFG++ DI ++YY
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYY 175
Query: 329 ------------VAPEV-LHRSYSTEADVWSIGVIAY-ILLCGSRPFWART 365
+ PE L ++++ DVWS GV+ + I G P+ RT
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 22/250 (8%)
Query: 168 FGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD 226
G C + G G +VA+K + M ++ E +I++ L H+ LV +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ----EAQIMKKLR-HDKLVPLY- 67
Query: 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAFCHLQGVVHRD 285
A + +Y+V E G LLD + GKY + M QI + +A+ +HRD
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYSTE 341
L+ N L +N V K DFGL+ + D G+ + + APE L+ ++ +
Sbjct: 128 LRAANILVG---DNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 342 ADVWSIGVIAYILLCGSR-PFWARTESGIFRAVLKADPSFDEAPWPSLSSEA-RDFVKRL 399
+DVWS G++ L+ R P+ + R VL+ P P E+ + +K
Sbjct: 184 SDVWSFGILLTELVTKGRVPY----PGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC 239
Query: 400 LNKDPRKRLT 409
KDP +R T
Sbjct: 240 WKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 33/222 (14%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVI-----PKHKMTTAIAI 202
F K + K +G GHFG + + G+ VAVK + ++
Sbjct: 1 FHKRYLKKIR---VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT------- 50
Query: 203 EDVRREVKILRALTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRILSRGGKYTED 260
++E+ IL+ L H N+VK+ + + ++ME G L D + K+ +
Sbjct: 51 SGWKKEINILKTLY-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLN 105
Query: 261 DAKAVMI--QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318
A+ ++ QI +A+ H Q +HRDL N L D + ++K DFGL+ V
Sbjct: 106 LAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHE 162
Query: 319 L----NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILL 355
D ++ A E L +S +DVWS GV Y LL
Sbjct: 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 30/210 (14%)
Query: 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
N+V D+V++V++ EGG+L I E+ K +++ + H +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHRE 104
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYS 339
G+V RDL P N L D+ ++ F V + V Y APEV S
Sbjct: 105 GIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEE 159
Query: 340 TEA-DVWSIGVIAYILLCG-----SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
TEA D WS+G I + LL G P SGI P + +S EAR
Sbjct: 160 TEACDWWSLGAILFELLTGKTLVECHP------SGINTHTTLNIPEW-------VSEEAR 206
Query: 394 DFVKRLLNKDPRKRLTAAQA-----LSHPW 418
+++LL +P +RL A A SHP+
Sbjct: 207 SLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 41/215 (19%)
Query: 161 EEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN 219
+++G+G+FG ++ + G+ VAVK K + +TA + D RE++IL++L H+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKSLQ-HD 65
Query: 220 NLVKF----FDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI---QILNV 272
N+VK+ + A N+ +VME G L D + + D + +++ QI
Sbjct: 66 NIVKYKGVCYSA--GRRNLRLVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQICKG 120
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV--- 329
+ + + VHRDL N L + EN V K DFGL+ + D+ YY
Sbjct: 121 MEYLGSKRYVHRDLATRNIL--VESENRV-KIGDFGLTKVLPQDKE--------YYKVRE 169
Query: 330 ---------APEVLHRS-YSTEADVWSIGVIAYIL 354
APE L S +S +DVWS GV+ Y L
Sbjct: 170 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 29/231 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
+ LG+ +G G FG A+ K K VAVK++ T + D+ E++
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEME 69
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTEDDAK---- 263
+++ + H N++ A +YV++E G L + + +R G Y+ D K
Sbjct: 70 MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEE 129
Query: 264 --------AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ Q+ + + Q +HRDL N L T E++V+K DFGL+ V
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHN 186
Query: 316 DERLNDIVGS---AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+ ++APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
E + +G G FG + +GE VA+KV+ + T+ A +++ E ++ A
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAYVM-ASV 66
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H ++V+ + V ++ +L G LLD + + +QI +++
Sbjct: 67 DHPHVVRLL-GICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE- 332
+ +VHRDL N L T +K DFGL+ + DE+ G ++A E
Sbjct: 126 EEKRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 333 VLHRSYSTEADVWSIGVIAYILLC-GSRPF 361
+LHR Y+ ++DVWS GV + L+ G++P+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 29/223 (13%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G+FG A+ KK L+ A+K + ++ + D E+++L L H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLR-MDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVMI---QIL---- 270
A E +Y+ +E G LLD R+L + ++ A + Q+L
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 271 ---NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGS- 325
+ + + +HRDL N L EN V K DFGLS R E + +G
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS---RGQEVYVKKTMGRL 173
Query: 326 -AYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWART 365
++A E L+ S Y+T +DVWS GV+ + I+ G P+ T
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQ--VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220
+GRG FG AK K E +G + V VK + K K + + RRE+ + R L+ H N
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLS-HKN 69
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH--L 278
+V+ + + Y+++E + G+L + + K ++ K + VA C
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSK--DEKLKPPPLSTKQKVALCTQIA 127
Query: 279 QGV--------VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYY 328
G+ VHRDL N L ++ + V K LS V E +L + + +
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSS--QREV-KVSLLSLSKDVYNSEYYKLRNALIPLRW 184
Query: 329 VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+APE V +ST++DVWS GV+ + + G PF
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 69/250 (27%), Positives = 108/250 (43%), Gaps = 22/250 (8%)
Query: 168 FGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD 226
G C + G G +VA+K + M+ E +E ++++ L H LV+ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLR-HEKLVQLY- 67
Query: 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAFCHLQGVVHRD 285
A + +Y+V E G LLD + GKY M QI + +A+ VHRD
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYSTE 341
L+ N L EN V K DFGL+ + D G+ + + APE L+ ++ +
Sbjct: 128 LRAANILV---GENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 342 ADVWSIGVIAYILLCGSR-PFWARTESGIFRAVLKADPSFDEAPWPSLSSEA-RDFVKRL 399
+DVWS G++ L R P+ + R VL P P E+ D + +
Sbjct: 184 SDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 239
Query: 400 LNKDPRKRLT 409
K+P +R T
Sbjct: 240 WRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 20/220 (9%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L +++G G FG + +VA+K + + M+ + E +++ L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGH----TKVAIKSLKQGSMSPEAFLA----EANLMKQLQ- 59
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNVVAFC 276
H LV+ + A + +Y++ E E G L+D + G K T + + QI +AF
Sbjct: 60 HPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPEV 333
+ +HRDL+ N L + E K DFGL+ + +E G+ + + APE
Sbjct: 119 ERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEA 174
Query: 334 L-HRSYSTEADVWSIGV-IAYILLCGSRPFWARTESGIFR 371
+ + +++ ++DVWS G+ + I+ G P+ T + +
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ 214
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 29/223 (13%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G+FG A KK LK A+K++ + + D E+++L L H N++
Sbjct: 10 IGEGNFGQVIRAMIKKDGLK-MNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNII 66
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVMI---QIL---- 270
A E+ +Y+ +E G LLD R+L + ++ A + Q+L
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 271 ---NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGS- 325
+ + + +HRDL N L EN K DFGLS R +E + +G
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLS---RGEEVYVKKTMGRL 180
Query: 326 -AYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWART 365
++A E L+ S Y+T++DVWS GV+ + I+ G P+ T
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 8/148 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+ RG FG + K + AVKV+ K M + V+ E L AL+ +V
Sbjct: 12 ISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDAL-ALSKSPFIV 67
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ + + +NVY+VME GG++ +L G + E+ A + ++ + + H G++
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLHRHGII 126
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS 310
HRDLKP+N L + + +K DFGLS
Sbjct: 127 HRDLKPDNMLISNEGH---IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 38/283 (13%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---EVKI 211
N + + +G G+FG A+ KK L+ A+K +M + +D R E+++
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLR-MDAAIK-----RMKEYASKDDHRDFAGELEV 60
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVM 266
L L H N++ A E +Y+ +E G LLD R+L + ++ A
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 267 IQILNVVAFC----------HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316
+ ++ F + +HRDL N L EN V K DFGLS R
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS---RGQ 174
Query: 317 E-RLNDIVGS--AYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFR 371
E + +G ++A E L+ S Y+T +DVWS GV+ + I+ G P+ T + ++
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234
Query: 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
K + + E D +++ + P +R + AQ L
Sbjct: 235 ---KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 159 LGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
LG+ +G G FG A+ K+ + +VAVK++ T + D+ E+++++
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKM 79
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTED----------- 260
+ H N++ A +YV++E G L + + +R G +Y +
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 261 -DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDER 318
D + Q+ + + + +HRDL N L T E++V+K DFGL+ D D
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 196
Query: 319 LNDIVGS--AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
G ++APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 25/202 (12%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQ----VAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E+G G+FG KKG K ++ VAVK++ A+ +++ RE +++ L
Sbjct: 2 ELGSGNFG-----TVKKGMYKMKKSEKTVAVKILKNDNNDPALK-DELLREANVMQQL-- 53
Query: 218 HNN--LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+N +V+ E ++ +VMEL E G L ++ L + TE + ++ Q+ + +
Sbjct: 54 -DNPYIVRMIGICE-AESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKY 110
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY----VAP 331
VHRDL N L T+ K DFGLS + DE + AP
Sbjct: 111 LEETNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167
Query: 332 EVL-HRSYSTEADVWSIGVIAY 352
E + + +S+++DVWS GV+ +
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 170 YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229
+ C K G+ + ++V VK + K RE+ IL+ ++ H ++ AY
Sbjct: 109 FVCT---KHGDEQRKKVIVKAVTGGK--------TPGREIDILKTIS-HRAIINLIHAYR 156
Query: 230 DTDNVYVVMEL--CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287
V +VM C+ +DR G + A + ++L +A+ H +G++HRD+K
Sbjct: 157 WKSTVCMVMPKYKCDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVK 212
Query: 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDERLND-----IVGSAYYVAPEVLH-RSYSTE 341
EN +F + EN+VL DFG + + D + G+ +PE+L Y +
Sbjct: 213 TEN-IFLDEPENAVLG--DFGAA--CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK 267
Query: 342 ADVWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKA 376
D+WS G++ + + + + + + S R++++
Sbjct: 268 TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305
|
Length = 392 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 253 RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312
R D A + QIL + + H Q ++HRD+K EN D + V D G + F
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI--NDVDQVCIG-DLGAAQF 206
Query: 313 VRPDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILL 355
+ G+ APEVL R Y+++AD+WS G++ + +L
Sbjct: 207 PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 159 LGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
LG+ +G G FG A+ K + VAVK++ + +A D+ E+++++
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA--DLISEMELMKL 73
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTED----------- 260
+ H N++ +YV++E G L + + +R G YT D
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 261 -DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319
D + Q+ + + + +HRDL N L T E++V+K DFGL+ V +
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDYY 190
Query: 320 NDIVGS---AYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
++APE L R Y+ ++DVWS G++ + I G P+
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-09
Identities = 34/135 (25%), Positives = 56/135 (41%), Gaps = 20/135 (14%)
Query: 180 ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV-KFFDAYEDTDNVYVVM 238
K + +K+ P + D REV IL+ L V K + E Y++M
Sbjct: 18 GTKDEDYVLKINP-----SREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72
Query: 239 ELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH---LQGVVHRDLKPENFLFTT 295
E EG L + +E++ + + Q+ ++A H L + H DL P N L
Sbjct: 73 EWIEGETL--------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV-- 122
Query: 296 KDENSVLKAIDFGLS 310
D+ +L ID+ +
Sbjct: 123 -DDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+L +++G G FG + G G +VAVK + M+ +E E +I++ L
Sbjct: 9 QLIKKLGNGQFG-----EVWMGTWNGNTKVAVKTLKPGTMSPESFLE----EAQIMKKLR 59
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI-QILNVVAF 275
H+ LV+ + A + +Y+V E G LLD + G+ + M Q+ +A+
Sbjct: 60 -HDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE 332
+HRDL+ N L + V K DFGL+ + D G+ + + APE
Sbjct: 118 IERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 333 V-LHRSYSTEADVWSIGVIAYILLCGSR 359
L+ ++ ++DVWS G++ L+ R
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 60/246 (24%), Positives = 95/246 (38%), Gaps = 66/246 (26%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI------------EDV 205
EE+G G FG K KGEL G + T++AI ++
Sbjct: 8 RFLEELGEGAFG-----KVYKGELTGPN-------ERLSATSVAIKTLKENAEPKVQQEF 55
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-----GKYTED 260
R+E + L + H N+V ++ E G+L + ++ G + D
Sbjct: 56 RQEAE-LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 261 DAKA----------VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310
+ + IQI + + VHRDL N L E +K DFGLS
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLS 171
Query: 311 DFVRPDERLNDIVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLC 356
DI + YY + PE +L+ ++TE+D+WS GV+ + I
Sbjct: 172 ---------RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSY 222
Query: 357 GSRPFW 362
G +P++
Sbjct: 223 GLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 12/217 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G G FG K K VA+K + T +D E I+ + H+N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFS-HHNII 69
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ E E G L + G+++ ++ I + + V
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAY---YVAPEVL-HRS 337
HRDL N L + N K DFGLS + D E G + APE + +R
Sbjct: 130 HRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 338 YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+++ +DVWS G++ + ++ G RP+W + + +A+
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 9e-09
Identities = 61/239 (25%), Positives = 105/239 (43%), Gaps = 42/239 (17%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQ----QVAVKVIPKHKMTTAIAIEDVRREVKI 211
LG+ +G G FG K LKG+ VAVK++ ++ ++ + D+ E +
Sbjct: 1 NLVLGKTLGEGEFGKV--VKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNL 56
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL--------------LDRILSRGGKY 257
L+ + H +++K + A + +++E + G L L +R Y
Sbjct: 57 LKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 258 TE-DDAKAVMIQILNVVAFCHLQG--------VVHRDLKPENFLFTTKDENSVLKAIDFG 308
+ D +A+ + L A+ +G +VHRDL N L E +K DFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKISDFG 172
Query: 309 LSDFVRPDE----RLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
LS V ++ R + ++A E L Y+T++DVWS GV+ + I+ G P+
Sbjct: 173 LSRDVYEEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 67/292 (22%), Positives = 111/292 (38%), Gaps = 51/292 (17%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQ---VAVKVIPKHKMTTAIAIEDVRREVKI 211
N E ++G+G FG A+ G L + VAVK++ + A D +RE +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAAL 61
Query: 212 LRALTGHNNLVKF---------------FDAYEDTDNV------YVVMELCEGGELLDRI 250
+ H N+VK + AY D + L +
Sbjct: 62 MAEFD-HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 251 LSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310
+ + + Q+ +A+ + VHRDL N L EN V+K DFGLS
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS 177
Query: 311 ------DFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAY-ILLCGSRPFWA 363
D+ + E ND + + + + Y+TE+DVW+ GV+ + I G +P++
Sbjct: 178 RNIYSADYYKASE--NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235
Query: 364 RTESGIFRAVLKAD----PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA 411
+ V + P D P E + ++ +K P R + A
Sbjct: 236 MAHEEVIYYVRDGNVLSCP--DNCP-----LELYNLMRLCWSKLPSDRPSFA 280
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 40/219 (18%)
Query: 162 EVGRGHFGYTCAAKFKKG--ELKGQQ--VAVKVIPKHKMTTAIAIED-VRREVKILRALT 216
E+G G+FG C KKG +++ +Q VA+KV+ K ++ D + RE +I+ L
Sbjct: 2 ELGSGNFG--CV---KKGVYKMRKKQIDVAIKVL---KNENEKSVRDEMMREAEIMHQLD 53
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+ +V+ E + + +VME+ GG L + + + T + +M Q+ + +
Sbjct: 54 -NPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL 111
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY-------- 328
+ VHRDL N L + K DFGLS + D+ +YY
Sbjct: 112 EGKNFVHRDLAARNVLLVNQ---HYAKISDFGLSKALGADD--------SYYKARSAGKW 160
Query: 329 ----VAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPF 361
APE ++ R +S+ +DVWS G+ + G +P+
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 41/136 (30%), Positives = 63/136 (46%), Gaps = 8/136 (5%)
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
T V +V +L G LLD + + D +QI +++ +VHRDL N
Sbjct: 80 TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARN 139
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA----YYVAPEVLHRSYSTEADVWS 346
L K N V K DFGL+ + DE G + +LHR ++ ++DVWS
Sbjct: 140 VL--VKSPNHV-KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWS 196
Query: 347 IGVIAYILLC-GSRPF 361
GV + L+ G++P+
Sbjct: 197 YGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 71/327 (21%), Positives = 126/327 (38%), Gaps = 71/327 (21%)
Query: 158 ELGEEVGRGHFGYTCA--AKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR---EVKIL 212
EL +G+ AK K VAVK I + ED++ E+
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP---TNTLVAVKKINLDSCSK----EDLKLLQQEIITS 53
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGG---ELLDRILSRGGKYTEDDAKAVMIQ- 268
R L H N++ + ++ +YVV L G +LL G A A +++
Sbjct: 54 RQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL---AIAFILKD 109
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA-- 326
+LN + + H +G +HR +K + L + D VL + + +S ++ +R +
Sbjct: 110 VLNALDYIHSKGFIHRSVKASHILLSG-DGKVVLSGLRYSVS-MIKHGKRQRVVHDFPKS 167
Query: 327 -----YYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPFW---------------- 362
+++PEVL ++ Y+ ++D++S+G+ A L G PF
Sbjct: 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTV 227
Query: 363 ----------------ARTESGIFRAVLKADPSFDEAPWPSLSSEA-RDFVKRLLNKDPR 405
+++ S + P+ SE FV+ L +DP
Sbjct: 228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVD---HPYTRTFSEHFHQFVELCLQRDPE 284
Query: 406 KRLTAAQALSHPW---IKNSNDVKVPL 429
R +A+Q L+H + K N + L
Sbjct: 285 SRPSASQLLNHSFFKQCKRRNTSLLDL 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 32/131 (24%), Positives = 63/131 (48%), Gaps = 8/131 (6%)
Query: 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295
+V +L G LLD + +QI + + +VHR+L N L +
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS 144
Query: 296 KDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIA 351
+S+++ DFG++D + PD++ ++ ++A E + Y+ ++DVWS GV
Sbjct: 145 ---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201
Query: 352 YILLC-GSRPF 361
+ ++ G+ P+
Sbjct: 202 WEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 54/193 (27%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 249 RILSRGGKYTEDDAKAVMI-----------------QILNVVAFCHLQGVVHRDLKPENF 291
R R G Y + D + ++ Q+ ++F + +HRDL N
Sbjct: 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNI 245
Query: 292 LFTTKDENSVLKAIDFGLSDFVRPDERLNDIV-GSAY----YVAPE-VLHRSYSTEADVW 345
L T + K DFGL+ +R D N +V G+A ++APE + + Y+ E+DVW
Sbjct: 246 LLT---HGRITKICDFGLARDIRNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVW 300
Query: 346 SIGVIAY-ILLCGSRPFWARTESGIFRAVLKA-----DPSFDEAPWPSLSSEARDFVKRL 399
S G++ + I GS P+ F ++K P AP SE D +K
Sbjct: 301 SYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC--AP-----SEMYDIMKSC 353
Query: 400 LNKDPRKRLTAAQ 412
+ DP KR T Q
Sbjct: 354 WDADPLKRPTFKQ 366
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 9e-08
Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+GHFG + + AVK + +++T +E +E I++ + H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFS-HPNVL 59
Query: 223 KFFDAYEDTDNV-YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
++ VV+ + G+L + I S T D +Q+ + + +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY------------- 328
VHRDL N + DE+ +K DFGL+ DI YY
Sbjct: 120 VHRDLAARNCML---DESFTVKVADFGLA---------RDIYDKEYYSVHNHTGAKLPVK 167
Query: 329 -VAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPF 361
+A E L + ++T++DVWS GV+ + L+ G+ P+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 322 IVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380
I+G+ Y+APE+L + + D W++GV + L G PF T +F+ +L D
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRD--- 596
Query: 381 DEAPWP----SLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
PWP LS A++ ++ LL DP KR + HP
Sbjct: 597 --IPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 41/136 (30%), Positives = 64/136 (47%), Gaps = 8/136 (5%)
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
T V ++ +L G LLD + +QI + + + +VHRDL N
Sbjct: 80 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARN 139
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY---YVAPE-VLHRSYSTEADVWS 346
L T +K DFGL+ + DE+ G ++A E +LHR Y+ ++DVWS
Sbjct: 140 VLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 196
Query: 347 IGVIAYILLC-GSRPF 361
GV + L+ GS+P+
Sbjct: 197 YGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 38/114 (33%), Positives = 58/114 (50%), Gaps = 18/114 (15%)
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------- 310
T +D Q+ + F + +HRDL N L + EN+V+K DFGL+
Sbjct: 177 TLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDP 233
Query: 311 DFVRP-DERLNDIVGSAYYVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
D+VR D RL ++APE + R Y+ ++DVWS GV+ + I G+ P+
Sbjct: 234 DYVRKGDARL-----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 18/90 (20%)
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLS-------DFVRP-DERLNDIVGSAYYVAPE- 332
+HRDL N L + EN+V+K DFGL+ D+VR D RL ++APE
Sbjct: 195 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL-----PLKWMAPES 246
Query: 333 VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
+ + Y+T++DVWS GV+ + I G+ P+
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 155 NKYELGEEVGRGHFG--YTCAAK-------FKKGELKGQQVAVKVIPKHKMTTAIAIEDV 205
+ L E++G G FG + C A+ E GQ V V V T A D
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTE------ 259
+E+KI+ L + N+++ D + ++ E E G+L ++ LS+ +
Sbjct: 65 LKEIKIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDL-NQFLSQREIESTFTHANN 122
Query: 260 ------DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS--- 310
+ + +QI + + + VHRDL N L + +K DFG+S
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNL 179
Query: 311 ---DFVRPDERLNDIVGSAYYVAPE-VLHRSYSTEADVWSIGVIAY--ILLCGSRPF 361
D+ R R V ++A E +L ++T +DVW+ GV + LC +P+
Sbjct: 180 YSGDYYRIQGR---AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 59/247 (23%), Positives = 99/247 (40%), Gaps = 24/247 (9%)
Query: 122 GSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFG--YTCAAKFKKG 179
S + A P+ + P P A F + + +++ G FG + CA +
Sbjct: 117 ASHLDFDEAPPDAAGPVPLA--QAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTE 174
Query: 180 EL---KGQQVAVKVIPKHKMTTAIAIEDVRR-------EVKILRALTGHNNLVKFFDAYE 229
E +G + PK + A ++ R E+ L L H N++K +
Sbjct: 175 EAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-HENILKIEEILR 233
Query: 230 DTDNVYVVMELCE---GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDL 286
N Y++ + + + D + +A+M Q+L V + H + ++HRD+
Sbjct: 234 SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDI 293
Query: 287 KPENFLFTTKDENSVLKAIDFG-LSDFVRPDE-RLNDIVGSAYYVAPEVLHR-SYSTEAD 343
K EN +F D VL DFG F + E VG+ +PE+L Y D
Sbjct: 294 KLEN-IFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITD 350
Query: 344 VWSIGVI 350
+WS G+I
Sbjct: 351 IWSCGLI 357
|
Length = 501 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 40/275 (14%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ LG +G+G FG A+ K + Q+VAVK++ K + ++ IE+ RE ++
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 217 GHNNLVKFFD------AYEDTDNVYVVMELCEGGELLDRIL-SRGGK----YTEDDAKAV 265
H N++K A V++ + G+L +L SR G+
Sbjct: 60 -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------DFVRPDERL 319
MI I + + + + +HRDL N + +EN + DFGLS D+ R
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQ---- 171
Query: 320 NDIVGSAY-----YVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRA 372
G A ++A E L + Y+T +DVW+ GV + I+ G P+ S I+
Sbjct: 172 ----GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY 227
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKR 407
++K + + P P + + + + + +P+ R
Sbjct: 228 LIKGNRL--KQP-PDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 38/117 (32%), Positives = 59/117 (50%), Gaps = 24/117 (20%)
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------- 310
T +D Q+ + F + +HRDL N L + EN+V+K DFGL+
Sbjct: 172 TMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDP 228
Query: 311 DFVRPDERLNDIVGSAY----YVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
D+VR GSA ++APE + + Y+T++DVWS GV+ + I G+ P+
Sbjct: 229 DYVRK--------GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 35/223 (15%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKILRALTGH 218
+E+G G FG K GE+ +V+ K +A E ++ E + R+L H
Sbjct: 1 KEIGNGWFG-----KVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-H 54
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVM---IQILNVVA 274
+NL++ + +VME C G+L + S R + D + +I +
Sbjct: 55 SNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL 114
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD-------FVRPDERLNDIVGSAY 327
H +H DL N L T + +K D+GLS +V PD+ +
Sbjct: 115 HLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL----R 167
Query: 328 YVAPEVLHRSY--------STEADVWSIGVIAYILL-CGSRPF 361
++APE++ + + E++VWS+GV + L GS+P+
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN--- 320
AV Q+L+ + + H +G++HRD+K EN L E+ L DFG + F R
Sbjct: 264 AVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLG--DFGAACFARGSWSTPFHY 320
Query: 321 DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAY 352
I G+ APEVL Y+ D+WS G++ +
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 242 EGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301
D +++ + D Q+ N + F + VHRDL N L E +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC---EGKL 277
Query: 302 LKAIDFGLS-DFVRPDERLNDIVGSAY----YVAPE-VLHRSYSTEADVWSIGVIAY-IL 354
+K DFGL+ D +R ++ GS + ++APE + + Y+T +DVWS G++ + I
Sbjct: 278 VKICDFGLARDIMRDSNYISK--GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF 335
Query: 355 LCGSRPF 361
G P+
Sbjct: 336 TLGGTPY 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 61/213 (28%)
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR------PDER 318
+M QIL + H G+VHRD+KP+N +F+ + + K ID G + +R P E
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEF 317
Query: 319 LNDIVGSAYYVAPEVLHRSYST-EA----------------------DVWSIGVIAYILL 355
L D Y APE S T A D++S G+I ++ +
Sbjct: 318 LLD----PRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI-FLQM 372
Query: 356 CGSRPFWARTESGI--FRAVLKADPSFDEAPW-----PSLSSEAR--------------D 394
R++S + F LK +D W P S + R +
Sbjct: 373 AFPN---LRSDSNLIQFNRQLK-RNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE 428
Query: 395 FVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427
+K ++ R+R++A AL+HP+ + +
Sbjct: 429 LLKSMMRFKGRQRISAKAALAHPYFDREGLLGL 461
|
Length = 566 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 41/152 (26%), Positives = 65/152 (42%), Gaps = 21/152 (13%)
Query: 174 AKFKKGELKGQQVAVKV-IPK----HKMTTAIAIEDVRREVKIL-RALTGHNN--LVKFF 225
A+ G+ G + +K IPK ++ I E RRE +I+ RA N V F
Sbjct: 10 AEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV 69
Query: 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRD 285
D +VME EG L D +++ G + ++ + V H G++H D
Sbjct: 70 DPENFI----IVMEYIEGEPLKD-LINSNGMEELELSREIGRL----VGKLHSAGIIHGD 120
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
L N + + + IDFGL++F + E
Sbjct: 121 LTTSNMILSGGK----IYLIDFGLAEFSKDLE 148
|
Length = 211 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 58/239 (24%), Positives = 102/239 (42%), Gaps = 26/239 (10%)
Query: 156 KYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVKI 211
K + E+G+G FG Y AK + +VA+K + + A E + E +
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASV 62
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV-----M 266
++ H+ +V+ V+MEL G+L + S + + +A M
Sbjct: 63 MKEFNCHH-VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 267 IQ----ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLND 321
IQ I + +A+ + VHRDL N + E+ +K DFG++ D D
Sbjct: 122 IQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 322 IVG--SAYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKA 376
G +++PE L ++T +DVWS GV+ + I +P+ + + R V++
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 62/239 (25%), Positives = 95/239 (39%), Gaps = 45/239 (18%)
Query: 161 EEVGRGHFG--YTCAA---------KFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
E++G G FG + C +F KG+ + V V A D +EV
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL--------LDRILSRGGKYTEDD 261
KIL L N+++ D D + ++ E E G+L LD G
Sbjct: 71 KILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 262 AK----------AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS- 310
V +QI + + + VHRDL N L EN +K DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGMSR 186
Query: 311 -----DFVRPDERLNDIVGSAYYVAPE-VLHRSYSTEADVWSIGVIAY--ILLCGSRPF 361
D+ R R V ++A E +L ++T +DVW+ GV + ++LC +P+
Sbjct: 187 NLYAGDYYRIQGR---AVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 8e-06
Identities = 42/150 (28%), Positives = 59/150 (39%), Gaps = 20/150 (13%)
Query: 174 AKFKKGELKGQQVAVKV-IPK---HK-MTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228
A + G VK IPK H + + E RRE +IL V Y
Sbjct: 10 AIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA--REAGVPVPIVY 67
Query: 229 E-DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287
+ D DN +VME EG L D E+ ++ ++ +V H G+VH DL
Sbjct: 68 DVDPDNGLIVMEYIEGELLKD--------ALEEARPDLLREVGRLVGKLHKAGIVHGDLT 119
Query: 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
N + + + IDFGL +F E
Sbjct: 120 TSNIILS----GGRIYFIDFGLGEFSDEVE 145
|
Length = 204 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 63/247 (25%), Positives = 97/247 (39%), Gaps = 57/247 (23%)
Query: 155 NKYELGEEVGRGHFG------------YTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAI 200
E++G G FG ++ A F + + VAVKV+ A
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKA-FAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 201 AIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTED 260
ED +EVKIL L+ N+ + + ++ME E G+L ++ L + T
Sbjct: 64 --EDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSG 119
Query: 261 DAKAV----------MI-QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
A M QI + + + VHRDL N L +N +K DFG+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV---GKNYTIKIADFGM 176
Query: 310 SDFVRPDERLNDIVGSAYY------VAP-------EVLHRSYSTEADVWSIGVIAY-IL- 354
S ++ S YY P VL ++T++DVW+ GV + IL
Sbjct: 177 S---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
Query: 355 LCGSRPF 361
LC +P+
Sbjct: 228 LCREQPY 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 58/242 (23%), Positives = 95/242 (39%), Gaps = 59/242 (24%)
Query: 161 EEVGRGHFG--YTCAA----KFKKGELKGQQVAVKVIPKHKMTTAI----------AIED 204
E++G G FG + C A KF + ++ V + A+ A D
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDF-----SLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL---LDRILSRGGKYTED- 260
+E+KI+ L N+++ +D + ++ E E G+L L R + D
Sbjct: 66 FLKEIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 261 ------DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---- 310
+ QI + + + VHRDL N L +N +K DFG+S
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLY 181
Query: 311 --DFVRPDERLNDIVGSAYYVAP-------EVLHRSYSTEADVWSIGVIAY--ILLCGSR 359
D+ R I G A V P +L ++T +DVW+ GV + + LC +
Sbjct: 182 SGDYYR-------IQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232
Query: 360 PF 361
P+
Sbjct: 233 PY 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
+QI + + + +VHRDL N L K N V K DFGL+ + DE+ + G
Sbjct: 116 VQIAKGMMYLEERRLVHRDLAARNVL--VKSPNHV-KITDFGLARLLEGDEKEYNADGGK 172
Query: 327 Y---YVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPF 361
++A E +H R ++ ++DVWS GV + L+ G +P+
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 44/185 (23%), Positives = 70/185 (37%), Gaps = 22/185 (11%)
Query: 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303
L D + RG E++ AV +Q L + H + T D +LK
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELH-------RQAKSGNILLTWD--GLLK 51
Query: 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRP-F 361
G F Y++APEV+ SY+ +AD++S+G+ Y L P
Sbjct: 52 L--DGSVAFK---TPEQSRPDP-YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN 105
Query: 362 WARTESGIFRAVLKADPSFDEAPWPSLSS-----EARDFVKRLLNKDPRKRLTAAQALSH 416
R S I +L P+ D +L DF++ ++ P++R A L+H
Sbjct: 106 EERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAH 165
Query: 417 PWIKN 421
Sbjct: 166 CRALF 170
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 178 KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVK----FFDAYEDTDN 233
KG ++V ++ K + I+ E+K LR + NN++K D +D
Sbjct: 38 KGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPR 96
Query: 234 VYVVMELCEGGELLDRILSRGGKYTEDD---AKAVMIQI---LNVVAFCHLQGVVHRDLK 287
+ +++E C G L R E D + + I + +++L
Sbjct: 97 LSLILEYCTRGYL------REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150
Query: 288 PENFLFTTKDENSVLKAIDFGLSDF--VRPDERLNDIVGSAYYVAPEVLH---RSYSTEA 342
+FL T EN LK I GL P + +N +V Y + ++L+ Y+ +
Sbjct: 151 SVSFLVT---ENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKD 203
Query: 343 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380
D++S+GV+ + + G PF T I+ ++ + S
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL 241
|
Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 58/251 (23%), Positives = 97/251 (38%), Gaps = 56/251 (22%)
Query: 161 EEVGRGHFGYTCAAKFKKGEL------KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
EE+G FG K KG L Q VA+K + + + ++E ++
Sbjct: 11 EELGECAFG-----KIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAE 63
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR------GGKYTED-------- 260
L H N+V V ++ E G+L + ++ R G ED
Sbjct: 64 LH-HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122
Query: 261 --DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318
D + IQI + + VH+DL N L E +K D GLS
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLS-------- 171
Query: 319 LNDIVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWAR 364
+I + YY + PE +++ +S+++D+WS GV+ + I G +P++
Sbjct: 172 -REIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230
Query: 365 TESGIFRAVLK 375
+ + V K
Sbjct: 231 SNQEVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
LG+ +G G FG + + + LK VAVK + K + T +ED E ++
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILK---VAVKTM-KIAICTRSEMEDFLSEAVCMKEFD 58
Query: 217 GHNNLVKFFDA-YEDTDN-----VYVVMELCEGGELLDRIL-SRGGKYTEDDAKAVMIQI 269
H N+++ + ++ V++ + G+L +L SR G + ++++
Sbjct: 59 -HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 270 LNVVA----FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------DFVRPDERL 319
+ +A + + +HRDL N + +EN + DFGLS D+ R R+
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYR-QGRI 173
Query: 320 NDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIF 370
+ ++A E L R Y+T++DVWS GV + I G P+ S I+
Sbjct: 174 AKM--PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 49/225 (21%), Positives = 89/225 (39%), Gaps = 30/225 (13%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT----GH 218
+G G FG C K + VA+ T D +R + ALT H
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIH-------TLRAGCSDKQRRGFLAEALTLGQFDH 65
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCH 277
+N+V+ + + +V E G LD L + G+ ++ + + + +
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNG-ALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS 124
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS------AYYVAP 331
G VH+ L L + + V K F +++ I + + AP
Sbjct: 125 EMGYVHKGLAAHKVLVNS---DLVCKISGFRRL----QEDKSEAIYTTMSGKSPVLWAAP 177
Query: 332 EVL--HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
E + H +S+ +DVWS G++ + ++ G RP+W + + +AV
Sbjct: 178 EAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 62/247 (25%), Positives = 106/247 (42%), Gaps = 46/247 (18%)
Query: 156 KYELGEEVGRGHFG--YTCAAK-FKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REVK 210
K L E+G+G FG Y A+ KGE + +VAVK + + +A E + E
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAE-TRVAVKTVNE----SASLRERIEFLNEAS 61
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV----- 265
+++ T H+ +V+ VVMEL G+L + S + + +
Sbjct: 62 VMKGFTCHH-VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 266 MIQ----ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
MIQ I + +A+ + + VHRDL N + + +K DFG++ D
Sbjct: 121 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMT---------RD 168
Query: 322 IVGSAYY------------VAPEVLHR-SYSTEADVWSIGVIAY-ILLCGSRPFWARTES 367
I + YY +APE L ++T +D+WS GV+ + I +P+ +
Sbjct: 169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228
Query: 368 GIFRAVL 374
+ + V+
Sbjct: 229 QVLKFVM 235
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 52/233 (22%), Positives = 90/233 (38%), Gaps = 49/233 (21%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
LG+ +G G FG + + + +VAVK + K + T IE+ E ++ H
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD-H 60
Query: 219 NNLVKFF------DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
N++K + + V++ + G+L +L + + +Q L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY---SRLGGLPEKLPLQTL-- 115
Query: 273 VAF-----CHLQ-----GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
+ F ++ +HRDL N + E+ + DFGLS I
Sbjct: 116 LKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLS---------KKI 163
Query: 323 VGSAYY------------VAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
YY +A E L R Y++++DVW+ GV + I G P+
Sbjct: 164 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 18/171 (10%)
Query: 247 LDRILSRGGK--YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304
+ +LS G T D + Q+ + F + VHRDL N L + ++K
Sbjct: 222 VKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA---QGKIVKI 278
Query: 305 IDFGLSDFVRPDERLNDIV--GSAY----YVAPE-VLHRSYSTEADVWSIGVIAY-ILLC 356
DFGL+ + D ++ V GS + ++APE + Y+T +DVWS G++ + I
Sbjct: 279 CDFGLARDIMHD---SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSL 335
Query: 357 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKR 407
G P+ F +K+ + A + E D + + N +P KR
Sbjct: 336 GGTPYPGMIVDSTFYNKIKS--GYRMAKPDHATQEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 102/471 (21%), Positives = 168/471 (35%), Gaps = 123/471 (26%)
Query: 24 NTPVPANGTPIPAPSPLNAESQSNNNRTNVKGNDDAVIEGKKSPFFPFYSPSPAHYFFSK 83
+ P N +P N+ S +T + + A G K + +
Sbjct: 19 TSGAPVNALSGNSPKANNSAS---TGQTTSRSTNSARRSGSKRDR----ETATSTDSGRT 71
Query: 84 KSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGL 143
KS ++ P P K K A + S + + G + + +
Sbjct: 72 KSHEGAATTKQATTTPTTNVEVAPPPKKK-KVTYALPNQSREEGHFYVVLGEDIDVSTQ- 129
Query: 144 NKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAI 200
++++ +G G FG A +K + + AVK++ PK+ I
Sbjct: 130 ------------RFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNVPKYTRDAKI 174
Query: 201 AI---EDVRRE--------VKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDR 249
I E VR+ +KI R +F +T ++ +VM G LLD
Sbjct: 175 EIQFMEKVRQADPADRFPLMKIQR----------YFQ--NETGHMCIVMPK-YGPCLLDW 221
Query: 250 ILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFG 308
I+ + G ++ ++ Q + + H + ++H DLKPEN L T D +D
Sbjct: 222 IM-KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSD-----TVVDPV 275
Query: 309 LSDFVRPDE---RLND-------------IVGSAYYVAPEV---LHRSYSTEADVWSIGV 349
+ + PD R+ D IV + +Y +PEV L YST D+WS+G
Sbjct: 276 TNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGC 333
Query: 350 IAYILLCGSRPF----------------------WAR---TESG--IFRAVLKADPSFDE 382
I Y L G + WA TE ++ + + P D
Sbjct: 334 IIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDP 393
Query: 383 APWPSLSSEAR--------------DFVKRLLNKDPRKRLTAAQALSHPWI 419
L+ AR D + LL+ D +KRL A Q +HP++
Sbjct: 394 K---HLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441
|
Length = 467 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
IQI +++ H +GV+H+D+ N + DE +K D LS + P + +G
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDY--HCLGDN 178
Query: 327 YY-----VAPEVL-HRSYSTEADVWSIGV 349
+A E L ++ YS+ +DVWS GV
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGV 207
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 56/237 (23%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKG-------QQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
EE+G FG K KG L G Q VA+K + K K + E+ + E ++R
Sbjct: 11 EELGEDRFG-----KVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLR-EEFKHEA-MMR 62
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY----TEDDAKA----- 264
+ H N+V + ++ C +L + ++ R T+DD
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 265 ------VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318
++ QI + F VVH+DL N L K +K D GL
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGL--------- 170
Query: 319 LNDIVGSAYY------------VAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
++ + YY ++PE +++ +S ++D+WS GV+ + + G +P+
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 41/152 (26%), Positives = 58/152 (38%), Gaps = 24/152 (15%)
Query: 174 AKFKKGELKGQQVAVKV-IPK---H-KMTTAIAIEDVRREVKILRAL--TGHNN-LVKFF 225
A G+ G + +K +PK H ++ I E R E ++L G N +V
Sbjct: 8 AIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV 67
Query: 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRD 285
D T +VME EG L D I + + + V H G+VH D
Sbjct: 68 DPDNKT----IVMEYIEGKPLKDVIEEGNDELLREIGRLV--------GKLHKAGIVHGD 115
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
L N + D+ L IDFGL + E
Sbjct: 116 LTTSNIIVR--DDKLYL--IDFGLGKYSDEIE 143
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 22/46 (47%), Positives = 28/46 (60%), Gaps = 3/46 (6%)
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
K VM Q+L + H G+VHRD+KPEN L T + +K IDFG
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFG 354
|
Length = 507 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 28/217 (12%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+ RG G + K K + Q VK I + I D+ + L+ H N+V
Sbjct: 698 ISRGKKGASYKGKSIKNGM---QFVVKEINDVNSIPSSEIADMGK----LQ----HPNIV 746
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ--- 279
K Y++ E EG L + + + + + + + I I + F H +
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYS 339
VV +L PE + KDE + L + D S+ YVAPE
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR----LSLPGLLCTD---TKCFISSAYVAPETRETKDI 855
Query: 340 TE-ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375
TE +D++ G+I LL G P A E G+ ++++
Sbjct: 856 TEKSDIYGFGLILIELLTGKSP--ADAEFGVHGSIVE 890
|
Length = 968 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV-GSA 326
Q+ + F + +HRD+ N L T V K DFGL+ + D N +V G+A
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDG---RVAKICDFGLARDIMNDS--NYVVKGNA 274
Query: 327 Y----YVAPE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPF 361
++APE + Y+ ++DVWS G++ + I G P+
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 52/263 (19%), Positives = 98/263 (37%), Gaps = 63/263 (23%)
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ-ILNVV 273
L H N+V + + + ++VV G D I + + A A ++Q +L +
Sbjct: 55 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKAL 114
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDE------NSVLKAIDFG-----LSDFVRPDERLNDI 322
+ H G VHR +K + L + + S L I+ G + DF + ++
Sbjct: 115 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKV--- 171
Query: 323 VGSAYYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPF------------------ 361
+++PEVL ++ Y ++D++S+G+ A L G PF
Sbjct: 172 ---LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 228
Query: 362 ------------------WARTESGIFRAVLKADPSFDEAPWP------SLSSEARDFVK 397
+ SG+ + + P + S FV+
Sbjct: 229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVE 288
Query: 398 RLLNKDPRKRLTAAQALSHPWIK 420
+ L ++P R +A+ L+H + K
Sbjct: 289 QCLQRNPDARPSASTLLNHSFFK 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 26/106 (24%), Positives = 40/106 (37%), Gaps = 21/106 (19%)
Query: 248 DRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307
I R + K +M +L + + H G+ H D+KPEN + + + ID+
Sbjct: 114 KEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI---IDY 170
Query: 308 GL-SDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAY 352
G+ S F+ I G H YS E G + Y
Sbjct: 171 GIASHFI--------IHGK---------HIEYSKEQKDLHRGTLYY 199
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 455 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.4 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.39 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.34 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.33 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.13 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.1 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.09 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.06 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.01 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.93 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.7 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.67 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.65 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.57 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.55 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.5 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.49 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.38 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.35 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.34 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.31 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.27 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.02 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.0 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.85 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.77 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.76 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.71 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.63 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.61 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.58 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.5 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.44 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.37 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.3 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.2 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.15 | |
| PLN02236 | 344 | choline kinase | 97.13 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.91 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.83 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.81 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.67 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.32 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.3 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.17 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.86 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.79 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.67 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.61 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.55 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.46 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.45 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.0 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.93 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-59 Score=443.04 Aligned_cols=268 Identities=37% Similarity=0.678 Sum_probs=241.5
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCH----HHHHHHHHHHHHHHHhcCCCCeeEEe
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA----IAIEDVRREVKILRALTGHNNLVKFF 225 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~----~~~~~~~~Ei~~l~~l~~hp~Iv~l~ 225 (455)
.+.+.+.|.+.+.||.|+||.|-+|..++ +|+.||||++.+...... .....+.+|+++|++|+ |||||+++
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~---tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~ 242 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKK---TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIK 242 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcc---cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEe
Confidence 34567889999999999999999999777 799999999987654442 12345789999999999 99999999
Q ss_pred EEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 226 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
++|+..+..||||||++||+|.+.+. .++.+.+..-+.+++||+.||.|||++||+||||||+|||+..++++-.+||+
T Consensus 243 d~f~~~ds~YmVlE~v~GGeLfd~vv-~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 243 DFFEVPDSSYMVLEYVEGGELFDKVV-ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred eeeecCCceEEEEEEecCccHHHHHH-hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEec
Confidence 99999999999999999999999885 45678999999999999999999999999999999999999887788999999
Q ss_pred ecccccccCCCCcccccccCCCcccccccCC-C---CCCcchHHHHHHHHHHHHcCCCCCCCCChhH-HHHHHHhcCCCC
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-S---YSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSF 380 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~---~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~-~~~~i~~~~~~~ 380 (455)
|||+|+.......+.+.|||+.|.|||++.+ . +..+.|||||||+||-+++|..||....... ..+++.++...+
T Consensus 322 DFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 322 DFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred ccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence 9999999998888899999999999999863 2 4558899999999999999999997766655 778888888888
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
....|..++++..+||.+||..||++|||+.|+|+||||+..
T Consensus 402 ~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 402 GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 888899999999999999999999999999999999999964
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-56 Score=443.19 Aligned_cols=261 Identities=35% Similarity=0.641 Sum_probs=241.5
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
.+|+..+.||+|||+.||.+++.. +|..||+|++.+.........+.+.+||++++.|+ |||||+++++|++.+++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCce
Confidence 689999999999999999999765 69999999999887778888889999999999999 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|||+|+|+.++|..++ ++.+.++|.+++.++.||+.||.|||+++|+|||||..|+|+ +++.+|||+|||+|..+.
T Consensus 94 YivLELC~~~sL~el~-Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELL-KRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEEEEecCCccHHHHH-HhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeec
Confidence 9999999999998866 477899999999999999999999999999999999999999 899999999999999987
Q ss_pred CC-CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 315 PD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
.+ ++..+.|||+.|.|||++. ..++..+||||+||+||-||.|+.||+..+-.+.+..+...+..++. .++.++
T Consensus 170 ~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A 245 (592)
T KOG0575|consen 170 YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEA 245 (592)
T ss_pred CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHH
Confidence 55 7888999999999999987 57999999999999999999999999999999999999988877766 689999
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCccc-CCCCCCCC
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWI-KNSNDVKV 427 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~-~~~~~~~~ 427 (455)
++||.+||+.||.+|||+.+||.|+|| ++..-..+
T Consensus 246 ~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~l 281 (592)
T KOG0575|consen 246 KDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARL 281 (592)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCC
Confidence 999999999999999999999999999 44433333
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-56 Score=421.66 Aligned_cols=271 Identities=29% Similarity=0.466 Sum_probs=235.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++.+.++.||+|..|+||+++++. +++.+|+|++... .+....+++.+|+++++..+ |||||.+||.|..++.
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~---t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKP---TGKIYALKVILLN--IDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGE 151 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcC---CCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCc
Confidence 4678889999999999999999887 6899999999433 56777889999999999996 9999999999999984
Q ss_pred -eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 234 -VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 234 -~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
++|+||||+||+|.+.+. ..++++|..+.+|+.++++||.|||+ ++||||||||+|||+ +..|.|||||||.++
T Consensus 152 ~isI~mEYMDgGSLd~~~k-~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILK-RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSG 227 (364)
T ss_pred eEEeehhhcCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccH
Confidence 999999999999998764 44789999999999999999999996 899999999999999 678889999999998
Q ss_pred ccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCC-----ChhHHHHHHHhcCCCCCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWAR-----TESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~ 385 (455)
.+... ..++++||..|||||.+.+ .|+.++||||||++++|+++|+.||... ...+.+..|....+.....
T Consensus 228 ~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~-- 304 (364)
T KOG0581|consen 228 ILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE-- 304 (364)
T ss_pred Hhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--
Confidence 88654 6688999999999999985 6999999999999999999999999764 4455666666644333222
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHHHHHH
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLM 437 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~~~~~ 437 (455)
..+|++|.+||..||++||.+||++.|+++|||+++..+..+-+...+.+.+
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~~~~~~~~~ 356 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDMASFVRKAL 356 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccccHHHHHHHhc
Confidence 1589999999999999999999999999999999998887776655555444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-55 Score=411.18 Aligned_cols=260 Identities=33% Similarity=0.632 Sum_probs=237.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++++.||+|+||.||.++.++ +++.||+|++++.........+...+|..+|.+++ ||.||.++-.|++.+.
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~d---t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKD---TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEK 99 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcc---cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCe
Confidence 5789999999999999999999775 79999999999888777777889999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|||+||+.||.|..++ ++.+.+++..++.++.+|+.||.|||++|||||||||+|||| |++|+++|+|||+++..
T Consensus 100 LylVld~~~GGeLf~hL-~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHL-QREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEEEeccCCccHHHHH-HhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhc
Confidence 99999999999999877 566789999999999999999999999999999999999999 89999999999999865
Q ss_pred C-CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 R-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
. .+....++|||+.|||||++. ..|+..+|+||||+++|||++|..||.+.+...+.+++++....... ..++.+
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ 252 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEE 252 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHH
Confidence 4 345667789999999999876 57999999999999999999999999999999999999988733332 248999
Q ss_pred HHHHHHHhccCCccCCC----CHHHHHcCcccCCCCC
Q 012825 392 ARDFVKRLLNKDPRKRL----TAAQALSHPWIKNSND 424 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rp----s~~elL~hp~~~~~~~ 424 (455)
.++||+++|..||++|. ++.+|-+||||+..++
T Consensus 253 ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 253 ARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred HHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 99999999999999996 7999999999998653
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-52 Score=414.74 Aligned_cols=300 Identities=55% Similarity=0.939 Sum_probs=277.3
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
...+...|++.+.||+|.||.||+++.+. +|+.+|+|++.+...........+.+|+.+|+++.+|||||.++++|+
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~---tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e 106 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKS---TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE 106 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecC---CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44567899999999999999999999887 599999999988777666677889999999999999999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCC-CceEEEeecc
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDFG 308 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~-~~~vkL~DfG 308 (455)
+.+.+++|||+|.||.|.+.+... .+++.++..++.||+.++.|||+.||+||||||+|+|+...++ ++.+|++|||
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999999999877 3999999999999999999999999999999999999986654 4689999999
Q ss_pred cccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
++............+||+.|+|||++. ..|+...||||+|+++|.|++|..||++.+..+.+..+...+..+....|+.
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence 999998877888999999999999998 6899999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC-CCCCCchhHHHHHHHHHHHhccHHHHHHHhhh
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS-NDVKVPLDVIIFKLMKAYMRSSSLRKAALRVS 454 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~-~~~~~p~~~~~~~~~~~~~~~~~l~~~~~~~~ 454 (455)
++..+++||+.||..||.+|+++.++|+|||++.. ....++.+..+...++.......+++.+++++
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVL 332 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999986 56677888888888888888888888777653
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=387.63 Aligned_cols=297 Identities=35% Similarity=0.677 Sum_probs=268.0
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|.|+.|+++.... +|+.+|+|++....+... ..+++.+|+.|.+.|+ |||||+|++.+.+.
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~---tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ-HPNIVRLHDSIQEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhcc---chHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcC-CCcEeehhhhhccc
Confidence 457889999999999999999887665 799999999976554443 6678999999999999 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..|||+|+|.|++|..-+..+ ..++|..+-..++||+++|.|+|.+||||||+||+|+|+.+++...-+||+|||+|.
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999999999997766655 568999999999999999999999999999999999999988888899999999999
Q ss_pred ccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
.+..+......+||++|||||++. ..|+..+|||+-||+||-|+.|..||++.+....++.++.....++...|+.+++
T Consensus 162 ~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 162 EVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred EeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence 988777778889999999999988 5799999999999999999999999999999999999999999999989999999
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCc-hhHHHHHHHHHHHhccHHHHHHHhhh
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP-LDVIIFKLMKAYMRSSSLRKAALRVS 454 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p-~~~~~~~~~~~~~~~~~l~~~~~~~~ 454 (455)
+.++||++||..||.+|+|+.|+|+|||+++......- ......++++.+-.+-.|+.++|.+.
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav 306 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTV 306 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHH
Confidence 99999999999999999999999999999985322221 25567889999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=415.20 Aligned_cols=262 Identities=34% Similarity=0.644 Sum_probs=239.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
-++|.+++.||+|+|++|++|+.++ +++.||||++.+.......-.+.+..|-.+|.+|.+||.|++|+-.|+++..
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~---t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKA---TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred hhhcchhheeccccceeEEEeeecC---CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 5789999999999999999999887 7899999999876665666667788999999999889999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+|+||+++|+|+++|.+ -+.|++..++.++.+|+.||+|||++|||||||||+|||| |+++++||+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccC
Confidence 9999999999999998854 5789999999999999999999999999999999999999 99999999999999887
Q ss_pred CCCCcc--------------cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC
Q 012825 314 RPDERL--------------NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (455)
Q Consensus 314 ~~~~~~--------------~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (455)
...... ..++||..|.+||++. +..+..+|||+|||+||.|+.|..||.+.++.-++++|+..+.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y 304 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY 304 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence 543211 4489999999999998 5678899999999999999999999999999999999999988
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCC
Q 012825 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426 (455)
Q Consensus 379 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~ 426 (455)
.++. .+++.+.+||+++|..||++|+++.||.+||||.++.+..
T Consensus 305 ~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 305 EFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred cCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 8776 6789999999999999999999999999999999986544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=399.04 Aligned_cols=263 Identities=37% Similarity=0.672 Sum_probs=233.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
..+|.+.++||+|+||+||+|+.++ ++..||||.+.+... .....+.+..|+++|+.++ |+|||+|++++..++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~---~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKK---SGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEecc---CCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCe
Confidence 5689999999999999999999988 579999999976543 6667788999999999999 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCC---ceEEEeecccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN---SVLKAIDFGLS 310 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~---~~vkL~DfG~a 310 (455)
+|||||||.||+|.++++.+ +.+++..++.++.||+.||++||+++||||||||.||||+....+ -.+||+|||+|
T Consensus 84 i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999999998655 579999999999999999999999999999999999999765333 68999999999
Q ss_pred cccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
+.+.+.....+.+|++.|||||++. +.|+.|+|+||+|++||+|++|+.||...+..+.+..+.+.....+ .....++
T Consensus 163 R~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~-~~~~~~s 241 (429)
T KOG0595|consen 163 RFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP-VLPAELS 241 (429)
T ss_pred hhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC-chhhhcc
Confidence 9999888889999999999999985 7899999999999999999999999999999888776655443222 2223466
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
....+|+..+|+.++.+|.+..+-+.|+++....
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 7778999999999999999999999999998754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=383.03 Aligned_cols=258 Identities=32% Similarity=0.618 Sum_probs=239.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++++.||.|+||.|.+++.+. +|..||+|++.+...-.-.+.+...+|..+|+.+. ||+++++++.|.+.+.
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~---~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKH---SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSN 118 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEcc---CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCe
Confidence 4689999999999999999999887 68999999998887777777888999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+||||++||.|..++ .+.+++++..++.++.||+.||+|||..+|++|||||+|||| |.+|.+||+|||+|+..
T Consensus 119 lymvmeyv~GGElFS~L-rk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYL-RKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEEEEeccCCccHHHHH-HhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEe
Confidence 99999999999999977 466789999999999999999999999999999999999999 89999999999999988
Q ss_pred CCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
.. .+.+.|||+.|+|||++. +.|+..+|+|+|||++|||+.|..||...+...++.+|++.+..++. .++.++
T Consensus 195 ~~--rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~ 268 (355)
T KOG0616|consen 195 SG--RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDA 268 (355)
T ss_pred cC--cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHH
Confidence 53 377899999999999887 67999999999999999999999999999999999999999988876 689999
Q ss_pred HHHHHHhccCCccCC-----CCHHHHHcCcccCCCCCC
Q 012825 393 RDFVKRLLNKDPRKR-----LTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 393 ~~li~~~L~~dP~~R-----ps~~elL~hp~~~~~~~~ 425 (455)
++||+.+|+.|-.+| ...++|..||||++..+.
T Consensus 269 kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 269 KDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred HHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence 999999999999999 367899999999986543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-53 Score=407.33 Aligned_cols=263 Identities=36% Similarity=0.545 Sum_probs=233.5
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+-++|.++++||.|.||.||+|+.+. +|..||||.+++.-. .- ..-.-.||++.|++|..||||++|.+++.+.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~---~~~~VAIK~MK~Kf~-s~-ee~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKE---TGELVAIKKMKKKFY-SW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecC---CCceeeHHHHHhhhc-cH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 346899999999999999999999777 688999999976432 22 2223468999999999999999999999988
Q ss_pred C-ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 232 D-NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 232 ~-~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
+ .+|+|||||+. +|++++..++..|++..++.|+.||++||+|+|.+|++|||+||+|||+ .....+||+|||+|
T Consensus 82 ~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi---~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 82 DRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI---SGNDVIKIADFGLA 157 (538)
T ss_pred CceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe---cccceeEecccccc
Confidence 8 89999999965 9999999999999999999999999999999999999999999999999 55778999999999
Q ss_pred cccCCCCcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC---
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW--- 385 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--- 385 (455)
+........+.++.|.+|+|||++. +.|+.+.|||++||+++|+.+-+..|.+.++.+.+.+++.-........|
T Consensus 158 Rev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 158 REVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 9999888999999999999999875 56999999999999999999999999999999988888765544433332
Q ss_pred -----------------------CCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 386 -----------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 386 -----------------------~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+.++.++.++|.+||.|||.+||||.|+|+||||+...
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 34688999999999999999999999999999999753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=383.42 Aligned_cols=259 Identities=31% Similarity=0.577 Sum_probs=226.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|+.+.++|+|+||.||+++.++ +|+.||||.+.... ++....+-..+|+++|++|+ |+|+|.|+.+|.....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~---TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD---TGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC---cccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhccee
Confidence 578999999999999999999887 79999999986542 33444455789999999999 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+||+|||+. ++++.+......++.+.+++++.|++.|+.|+|++++|||||||+|||| ..++.+||||||+|+.+.
T Consensus 77 hLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLS 152 (396)
T ss_pred EEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhc
Confidence 999999977 6677777777789999999999999999999999999999999999999 788999999999999987
Q ss_pred -CCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhc--------------C
Q 012825 315 -PDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA--------------D 377 (455)
Q Consensus 315 -~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~--------------~ 377 (455)
++...+.++.|.+|+|||.+.| +|....|||++||++.||++|...|.+..+.+.+..|... .
T Consensus 153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 7778889999999999998875 6999999999999999999999999998888766555432 2
Q ss_pred CCCC-------------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 378 PSFD-------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 378 ~~~~-------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+.|. +..++.++..+.||++.||+.||.+|++.+|+|.|+||.+.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 2221 12234577889999999999999999999999999999654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-51 Score=404.14 Aligned_cols=258 Identities=41% Similarity=0.775 Sum_probs=232.8
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-C-HHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-T-AIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~-~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
..++|++++.||+|+||.|++|+... +|..||+|++.+.... . ....+.+.+|+.+++.+..||||+++++++..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~---t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRL---TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeecc---CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 46789999999999999999998776 5799999988664222 1 13456778999999999889999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCC-ceEEEeeccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKAIDFGL 309 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~-~~vkL~DfG~ 309 (455)
...+|+|||||.||+|++++.+ .+++.|..++++++||+.|++|||++||+||||||+|||+ +.+ +++||+|||+
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGL 167 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEecccc
Confidence 9999999999999999999987 7889999999999999999999999999999999999999 666 9999999999
Q ss_pred cccc-CCCCcccccccCCCcccccccCC-C-C-CCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 310 SDFV-RPDERLNDIVGSAYYVAPEVLHR-S-Y-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 310 a~~~-~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
+... ..+....+.+||+.|+|||++.+ . | ..++||||+||+||.|++|+.||...+....+..+.+....++..
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~-- 245 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY-- 245 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC--
Confidence 9988 56778889999999999999985 3 5 467999999999999999999999988888888888877766653
Q ss_pred CCC-CHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 386 PSL-SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 386 ~~~-s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
+ +.++.+||++||..||.+|+++.+++.||||+.
T Consensus 246 --~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 246 --LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 4 999999999999999999999999999999997
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=400.81 Aligned_cols=267 Identities=32% Similarity=0.547 Sum_probs=236.6
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.-.++|++++.||+|+||.||+|+.+. +|..||+|++++..+......+.++.|-++|.... +++||+|+-.|++.
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~---Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d-s~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKD---TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD-SPWVVKLYYSFQDK 213 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEcc---CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC-CCcEEEEEEEecCC
Confidence 346899999999999999999999777 79999999999998888888999999999999965 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+.+||||||++||++..+|. +.+.|++..++.++.+++.|++.||+.|+|||||||+|+|| |..|++||+|||++.
T Consensus 214 ~~LYLiMEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLST 289 (550)
T ss_pred CeeEEEEEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccc
Confidence 99999999999999998774 55789999999999999999999999999999999999999 999999999999974
Q ss_pred ccCC----------------------CC-c-------------------------ccccccCCCcccccccCC-CCCCcc
Q 012825 312 FVRP----------------------DE-R-------------------------LNDIVGSAYYVAPEVLHR-SYSTEA 342 (455)
Q Consensus 312 ~~~~----------------------~~-~-------------------------~~~~~gt~~y~aPE~~~~-~~~~~s 342 (455)
-+.. .. . ....+||+.|||||++.+ .|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 3210 00 0 012479999999999874 699999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCC---CHHHHHcCccc
Q 012825 343 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQALSHPWI 419 (455)
Q Consensus 343 DiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~elL~hp~~ 419 (455)
|+|||||||||||.|..||.+.+..+.++++++.........-..++.+++|||.+||+ ||++|. .+.||.+||||
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF 448 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFF 448 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcc
Confidence 99999999999999999999999999999999877544443334688999999999999 999998 49999999999
Q ss_pred CCCCCCCC
Q 012825 420 KNSNDVKV 427 (455)
Q Consensus 420 ~~~~~~~~ 427 (455)
+++++..+
T Consensus 449 ~~v~W~~l 456 (550)
T KOG0605|consen 449 KGVDWDHL 456 (550)
T ss_pred ccCCcchh
Confidence 99875544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=408.49 Aligned_cols=259 Identities=30% Similarity=0.545 Sum_probs=240.5
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
-.++|.++++||+|+||+|+++..+. +++.||||++++.........+....|..|+.....||.+++|+..|+..+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~---~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKG---TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcC---CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 36789999999999999999999887 688999999999998888889999999999999989999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
++|+||||+.||++.. ..+.+.|++..++.++..|+.||.|||++||||||||.+|||| |.+|++||+||||++.
T Consensus 443 ~l~fvmey~~Ggdm~~--~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMH--HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKE 517 (694)
T ss_pred eEEEEEEecCCCcEEE--EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccc
Confidence 9999999999998433 2455789999999999999999999999999999999999999 8999999999999987
Q ss_pred cC-CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 313 VR-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 313 ~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
.- .+..+.+++||+.|||||++. ..|+...|+|+|||+|||||.|..||.+.++++.+..|+..++.++. .++.
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ 593 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSK 593 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccH
Confidence 54 566788999999999999998 57999999999999999999999999999999999999999988887 5899
Q ss_pred HHHHHHHHhccCCccCCCC-----HHHHHcCcccCCCC
Q 012825 391 EARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps-----~~elL~hp~~~~~~ 423 (455)
+..++++++|.+||++|.. +.+|..||||+.++
T Consensus 594 ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 594 EAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred HHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 9999999999999999985 58899999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-50 Score=394.13 Aligned_cols=258 Identities=30% Similarity=0.522 Sum_probs=223.4
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
..-...|....+||+|+.|.||.|+... +++.||||.+.... ....+.+.+|+.+|+.++ |+|||++++.|..
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~---~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv 341 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKIS---TKQEVAIKRMDLRK---QPKKELLLNEILVMRDLH-HPNIVNFLDSYLV 341 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeecc---CCceEEEEEEEecc---CCchhhhHHHHHHHHhcc-chHHHHHHHHhcc
Confidence 3345779999999999999999999777 68899999996543 222356889999999998 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
++.+|+||||++||+|.|.+.. ..++|.++..|+++++.||+|||.+||+|||||.+|||+ +.++.+||+|||++
T Consensus 342 ~deLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFc 416 (550)
T KOG0578|consen 342 GDELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFC 416 (550)
T ss_pred cceeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeee
Confidence 9999999999999999997743 459999999999999999999999999999999999999 78888999999999
Q ss_pred cccCCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 311 DFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 311 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
..+.... .-.+.+||++|||||+.. ..|+.+.||||||++++||+-|+.||...+....+..+.... .........+
T Consensus 417 aqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng-~P~lk~~~kl 495 (550)
T KOG0578|consen 417 AQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPKLKNPEKL 495 (550)
T ss_pred eccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC-CCCcCCcccc
Confidence 8877665 557789999999999887 579999999999999999999999998766655554444332 3333344579
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
|..|++||.+||+.|+++|+++.+||+||||+.
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 999999999999999999999999999999964
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=394.76 Aligned_cols=262 Identities=34% Similarity=0.536 Sum_probs=231.6
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...+.|+.+++||+|.||.||+|++.. +|+.||+|.+..+.. .........+||.||++|. ||||++|.+...+.
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~---tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLE---TGKIVALKKVRFDNE-KEGFPITAIREIKILRRLD-HPNIIKLEEIVTSK 188 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecc---cCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcC-CCcccceeeEEEec
Confidence 346789999999999999999999777 799999999976543 3334456679999999998 99999999998876
Q ss_pred --CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 232 --DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 232 --~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
+.+|||+|||+. +|..++....-.|++.+++.++.||+.||+|||.+||+|||||.+|||| |.+|++||+||||
T Consensus 189 ~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGL 264 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGL 264 (560)
T ss_pred CCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccc
Confidence 689999999987 8888887767799999999999999999999999999999999999999 8999999999999
Q ss_pred ccccCCCC--cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 310 SDFVRPDE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 310 a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
|+++.... ..+..+-|.+|+|||.+.| .|+...|+||.||||.||++|+..|.+.++.+.+..|.+.-....+..|
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 99776554 4677788999999999875 5999999999999999999999999999999999999887666655555
Q ss_pred C-------------------------CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 386 P-------------------------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 386 ~-------------------------~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+ .++....+|+..||+.||.+|.||.++|.|+||...
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 4 246788999999999999999999999999999543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=402.14 Aligned_cols=258 Identities=34% Similarity=0.651 Sum_probs=235.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
-.-|++++.||.|+-|.|-+|+... +|+.+|||++.+...........+.+|+-+|+-+. |||++++|++|++..+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~---TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAE---TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQH 86 (786)
T ss_pred ccceeccccccCCCCceehhhhccc---ccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCce
Confidence 4569999999999999999998776 79999999998775555555677999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+|+||++||.|++++..+ +.+++.++.++++||+.|+.|||..+|+||||||+|+|| |..+++||+|||||..-
T Consensus 87 lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLE 162 (786)
T ss_pred EEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecc
Confidence 99999999999999998655 678999999999999999999999999999999999999 77778999999999988
Q ss_pred CCCCcccccccCCCcccccccCC-CC-CCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPDERLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
.++....+.||++.|.+||++.| .| +.++||||.|||||.||+|+.||++.+....+.++.++....+. .++.+
T Consensus 163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs----~Is~e 238 (786)
T KOG0588|consen 163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS----NISSE 238 (786)
T ss_pred cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----cCCHH
Confidence 88888899999999999999885 44 67899999999999999999999999988888888887766553 78999
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+++||++||..||++|+|.+||++|||+++..
T Consensus 239 aQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 239 AQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 99999999999999999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=359.52 Aligned_cols=260 Identities=32% Similarity=0.558 Sum_probs=230.6
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
.+|...++||+|.||.||+|++.+ +|+.||||.++.....+... ....+|++.|+.++ |+||+.++++|-..+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~-h~nIi~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---TGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELK-HPNIIELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---CCcEEEEEEeeccccccCcc-HHHHHHHHHHHHcc-CcchhhhhhhccCCCce
Confidence 578899999999999999999777 79999999998765443332 34678999999999 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
.||+||++. +|+..+..+...++..+++.++.++++||+|||++.|+||||||+|+|+ +.++.+||+|||+|+.+.
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFG 152 (318)
T ss_pred EEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccC
Confidence 999999965 9999888888899999999999999999999999999999999999999 789999999999999886
Q ss_pred CCCcc-cccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC----
Q 012825 315 PDERL-NDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS---- 387 (455)
Q Consensus 315 ~~~~~-~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~---- 387 (455)
..... ...+-|.+|+|||.+.| .|+...||||.||++.||+.|...|.+.++.+.+..+++.........|++
T Consensus 153 ~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 153 SPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred CCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 54433 33478999999998875 699999999999999999999999999999999999988776666555553
Q ss_pred --------------------CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 388 --------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 388 --------------------~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.+.++.||+.+||..||.+|+++.|+|+|+||+...
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 467789999999999999999999999999999753
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-50 Score=363.48 Aligned_cols=263 Identities=37% Similarity=0.670 Sum_probs=238.5
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc-----CCHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-----TTAIAIEDVRREVKILRALTGHNNLVKFF 225 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~ 225 (455)
+.+-++|+-.+.||.|..+.|-++..+. +|+++|+|++..... ...+..+.-.+|+.+|+++.|||+|+++.
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~---t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKE---TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcc---cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 3445678889999999999998887776 688999999853211 12334455678999999999999999999
Q ss_pred EEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 226 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
++|+.+..+++|+|.|+.|.|.|++.+ .-.++++..++|++|+++|++|||.++||||||||+|||+ +++.++||+
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~is 165 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKIS 165 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEe
Confidence 999999999999999999999999854 4568999999999999999999999999999999999999 899999999
Q ss_pred ecccccccCCCCcccccccCCCcccccccC-------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (455)
|||+++.+..+......|||++|+|||.+. ..|+...|+|++||+||-|+.|..|||....--+++.++.+..
T Consensus 166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky 245 (411)
T KOG0599|consen 166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY 245 (411)
T ss_pred ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence 999999999999999999999999999873 3488899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccC
Q 012825 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (455)
Q Consensus 379 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~ 420 (455)
.|....|.+++...++||.+||+.||.+|.|++|+|.||||+
T Consensus 246 qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 246 QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 999999999999999999999999999999999999999994
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=380.20 Aligned_cols=258 Identities=34% Similarity=0.572 Sum_probs=215.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC-
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~- 232 (455)
..+|...+.||+|+||.||++...+ +|..+|||.+... +....+.+.+|+.+|.+|+ |||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~---~g~~~AvK~v~~~---~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKK---TGELMAVKSVELE---DSPTSESLEREIRILSRLN-HPNIVQYYGSSSSREN 88 (313)
T ss_pred cchhhhhccccCccceEEEEEEecC---CCcceeeeeeecc---cchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccC
Confidence 3568889999999999999999877 4889999998654 2222677999999999999 999999999855444
Q ss_pred -ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCC-CceEEEeecccc
Q 012825 233 -NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDFGLS 310 (455)
Q Consensus 233 -~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~-~~~vkL~DfG~a 310 (455)
.++|.|||+++|+|.+++...++.+++..++.+.+||++||.|||++|||||||||+|||+ +. ++.+||+|||++
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLA 165 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCccc
Confidence 6999999999999999997776689999999999999999999999999999999999999 66 689999999999
Q ss_pred cccCC----CCcccccccCCCcccccccCCC-C-CCcchHHHHHHHHHHHHcCCCCCCCC-ChhHHHHHHHhcCCCCCCC
Q 012825 311 DFVRP----DERLNDIVGSAYYVAPEVLHRS-Y-STEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDEA 383 (455)
Q Consensus 311 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~-~~~sDiwSlG~~l~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~ 383 (455)
..... ........||+.|||||++... . ..++|||||||+++||+||..||... .....+..+.... ..+ .
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P-~ 243 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP-E 243 (313)
T ss_pred cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC-C
Confidence 87763 1223457899999999998843 2 34899999999999999999999873 3333334444333 111 2
Q ss_pred CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 384 ~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
....++.++++||.+||..||++|||+.++|+|||++...
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 3346899999999999999999999999999999998753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=390.47 Aligned_cols=254 Identities=33% Similarity=0.631 Sum_probs=231.1
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|-+.+.||+|.||.||+|+.+. +.+.||+|.+.+.. .....++.+.+|+++++.|+ |||||.++++|+...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~---t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY---TIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc---ceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceE
Confidence 578999999999999999999777 68999999998765 55667889999999999999 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|+|.|||.| +|..++ +.++.++|+.++.|+.+++.||.|||+++|+|||+||.|||+ +..+.+|+||||+|+.+.
T Consensus 77 ~vVte~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMS 151 (808)
T ss_pred EEEehhhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcc
Confidence 999999976 988866 677889999999999999999999999999999999999999 899999999999999887
Q ss_pred CCCc-ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 315 PDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 315 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
.+.. .+.+.||+.|||||+.. +.|+..+|+|||||++||++.|+.||.........+.|+..+...+. ..+..+
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f 227 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSF 227 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHH
Confidence 5543 46678999999999887 57999999999999999999999999988888888888877665544 789999
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
..|++.+|.+||.+|.+-.+++.|||.++.
T Consensus 228 ~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 228 VNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 999999999999999999999999999874
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=373.91 Aligned_cols=263 Identities=30% Similarity=0.536 Sum_probs=238.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
-+.|++++.||+|.-|+||+++... ++..+|+|++.+..........+++.|-+||..+. ||.++.||..|+.++.
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~---t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRG---TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKY 151 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecC---CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccce
Confidence 4679999999999999999999887 56899999999888888888889999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.|+|||||+||+|....+++ ++.|++..++.++.+++.||+|||-.|||+|||||+|||| .++|++-|+||.++..
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLR 228 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeecccccc
Confidence 99999999999998877654 4579999999999999999999999999999999999999 8999999999998633
Q ss_pred cCC-----------------------------------C----------------------CcccccccCCCcccccccC
Q 012825 313 VRP-----------------------------------D----------------------ERLNDIVGSAYYVAPEVLH 335 (455)
Q Consensus 313 ~~~-----------------------------------~----------------------~~~~~~~gt~~y~aPE~~~ 335 (455)
... . .....++||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 110 0 0112357999999999998
Q ss_pred C-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCC----H
Q 012825 336 R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT----A 410 (455)
Q Consensus 336 ~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps----~ 410 (455)
| ..+.+.|+|.|||+||||+.|..||.+.+..+.+.+++.....+++.. .++..++|||+++|.+||.+|.. +
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccch
Confidence 6 689999999999999999999999999999999999999999998875 78899999999999999999998 9
Q ss_pred HHHHcCcccCCCCCC
Q 012825 411 AQALSHPWIKNSNDV 425 (455)
Q Consensus 411 ~elL~hp~~~~~~~~ 425 (455)
.||.+||||+++++.
T Consensus 387 ~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 387 AEIKRHPFFEGVNWA 401 (459)
T ss_pred HHhhcCccccCCChh
Confidence 999999999998754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=373.95 Aligned_cols=262 Identities=31% Similarity=0.508 Sum_probs=228.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.+.|++...||.|.-++||+|+... .+..||||++..+..... .+.+.+|+..+..+. ||||++++..|..++.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p---~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIP---TNEVVAIKIINLEKCNND--LDALRKEVQTMSLID-HPNIVTYHCSFVVDSE 98 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecc---cCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcC-CCCcceEEEEEEecce
Confidence 5789999999999999999999887 579999999977655443 788999999999988 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+|+||.||.+|++.+.+... ...++|..+..|++++++||.|||++|.||||||+.|||| +.+|.|||+|||.+-.
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSAS 175 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeee
Confidence 99999999999999988653 3459999999999999999999999999999999999999 8999999999998755
Q ss_pred cCCCC-----cccccccCCCcccccccC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC--
Q 012825 313 VRPDE-----RLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-- 382 (455)
Q Consensus 313 ~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-- 382 (455)
+.... .++.++||++|||||++. ..|+.|+||||||++.+||.+|..||.....-.++..-++..+....
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS 255 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence 43322 225679999999999954 46999999999999999999999999988888777777777664322
Q ss_pred ----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 383 ----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 383 ----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
.....++..|+.+|..||.+||.+|||+.++|+|+||+....
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 223357889999999999999999999999999999998653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=366.31 Aligned_cols=248 Identities=28% Similarity=0.550 Sum_probs=215.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeE-EEeeC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD-AYEDT 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~-~~~~~ 231 (455)
...+|++.++||+|.||.||+++... +|..||.|.+.... -+....+.+..|+.+|++|+ |||||++++ .|.++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~---~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLL---DGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIED 91 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeecc---Ccchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhcc
Confidence 35679999999999999999999776 68999999998544 45666778899999999999 999999998 45555
Q ss_pred Cc-eEEEEeecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH--cC--CEEeeccCCceEEeecCCCceEE
Q 012825 232 DN-VYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCHL--QG--VVHRDLKPENFLFTTKDENSVLK 303 (455)
Q Consensus 232 ~~-~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qi~~gL~~LH~--~~--ivHrDikp~NILl~~~~~~~~vk 303 (455)
.. ++||||||.+|+|...+. +....++|..+|+++.|++.||..+|. .. |+||||||.||+| +.+|.||
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvK 168 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVK 168 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCcee
Confidence 54 999999999999988775 345689999999999999999999999 44 9999999999999 8899999
Q ss_pred EeecccccccCCCCc-ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC
Q 012825 304 AIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (455)
Q Consensus 304 L~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (455)
|+|||+++.+..... ....+||++||+||+++ ..|+.++||||+||++|||+.-+.||.+.+-.+...+|.+.+...
T Consensus 169 LGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~- 247 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP- 247 (375)
T ss_pred eccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC-
Confidence 999999999876654 36789999999999987 579999999999999999999999999998888888887775331
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccCCCCH
Q 012825 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTA 410 (455)
Q Consensus 382 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~ 410 (455)
.+-..+|.++..||..|+..|++.||+.
T Consensus 248 -~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 248 -LPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred -CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 1113689999999999999999999984
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-49 Score=363.90 Aligned_cols=261 Identities=31% Similarity=0.484 Sum_probs=227.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee--C
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--~ 231 (455)
.+.|+.++.|++|+||.||+|+++. ++..||+|+++-+.-...--+ .-.+||.+|.+++ |||||.+-.+... -
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~---t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~-H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKK---TDEIVALKRLKMEKEKEGFPI-TSLREINILLKAR-HPNIVEVKEVVVGSNM 149 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCC---cceeEEeeecccccccCCCcc-hhHHHHHHHHhcC-CCCeeeeEEEEecccc
Confidence 4679999999999999999999887 689999999975542222222 2358999999998 9999999988763 4
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+.+|||||||+. +|...+.....+|...+++.++.|+++||+|||.+.|+|||||++|+|+ ...|.+||+|||+|+
T Consensus 150 d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 150 DKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAR 225 (419)
T ss_pred ceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhh
Confidence 569999999976 8888888888899999999999999999999999999999999999999 788899999999999
Q ss_pred ccCCC-CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC-
Q 012825 312 FVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS- 387 (455)
Q Consensus 312 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~- 387 (455)
.+... ...+..+-|.+|+|||.+.+ .|+...|+||+|||+.||++++..|.+..+.+.+..|++......+..|+.
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 88644 35677889999999999875 599999999999999999999999999999999999887765555555542
Q ss_pred ---------------------------CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 388 ---------------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 388 ---------------------------~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+++...+|+..+|..||.+|.|+.|.|+|.||.+..
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 357788999999999999999999999999999854
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=375.30 Aligned_cols=262 Identities=28% Similarity=0.437 Sum_probs=219.3
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
.|++.+.||+|+||.||+|.... +|+.||+|.+.+...........+.+|+.+++++. |+||+++++++.+++..+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~ 76 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec---CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEE
Confidence 37889999999999999999876 58899999986554444444556789999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 236 VVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+||||+++|+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIP 153 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcC
Confidence 999999999998877543 3468999999999999999999999999999999999999 778889999999998765
Q ss_pred CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
.........||..|+|||++. ..++.++|||||||++|+|++|+.||...........+..............++.++.
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 233 (285)
T cd05631 154 EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAK 233 (285)
T ss_pred CCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHH
Confidence 444455668999999999886 5689999999999999999999999987654332222222221222223346889999
Q ss_pred HHHHHhccCCccCCCC-----HHHHHcCcccCCCCC
Q 012825 394 DFVKRLLNKDPRKRLT-----AAQALSHPWIKNSND 424 (455)
Q Consensus 394 ~li~~~L~~dP~~Rps-----~~elL~hp~~~~~~~ 424 (455)
+||++||+.||.+|++ +.++++||||+..+.
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 9999999999999997 899999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=377.54 Aligned_cols=265 Identities=33% Similarity=0.659 Sum_probs=225.8
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC-----------HHHHHHHHHHHHHHHHhcCCC
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----------AIAIEDVRREVKILRALTGHN 219 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~-----------~~~~~~~~~Ei~~l~~l~~hp 219 (455)
....++|++.+.||+|.||.|-+|+... +++.||||++.+..... ...++.+.+||.+|++|. |+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~---~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~ 168 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEV---DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HP 168 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecC---CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-Cc
Confidence 3446889999999999999999999665 68999999997643221 112467899999999999 99
Q ss_pred CeeEEeEEEee--CCceEEEEeecCCCcHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec
Q 012825 220 NLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (455)
Q Consensus 220 ~Iv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~-l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~ 296 (455)
|||+|+.+..+ .+.+|||+|||..|.+.. . ..... +++.++++++++++.||+|||.+|||||||||+|+||
T Consensus 169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w-~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl--- 243 (576)
T KOG0585|consen 169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKW-C-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL--- 243 (576)
T ss_pred CeeEEEEeecCcccCceEEEEEeccCCcccc-C-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---
Confidence 99999999875 457999999999987643 2 22334 8999999999999999999999999999999999999
Q ss_pred CCCceEEEeecccccccC------CCCcccccccCCCcccccccCC-C----CCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 012825 297 DENSVLKAIDFGLSDFVR------PDERLNDIVGSAYYVAPEVLHR-S----YSTEADVWSIGVIAYILLCGSRPFWART 365 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~~------~~~~~~~~~gt~~y~aPE~~~~-~----~~~~sDiwSlG~~l~elltg~~Pf~~~~ 365 (455)
+++++|||+|||.+..+. .+......+||+.|+|||...+ . .+.+.||||+||+||+|+.|+.||.+..
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 788999999999988662 2233455789999999998764 2 3567899999999999999999999999
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCC
Q 012825 366 ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426 (455)
Q Consensus 366 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~ 426 (455)
..+.+.+|.+....++... .+.++++|||++||++||++|+++.+|..|||....-+..
T Consensus 324 ~~~l~~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 324 ELELFDKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred HHHHHHHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 9999999999888777753 7889999999999999999999999999999998764433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=376.79 Aligned_cols=255 Identities=28% Similarity=0.537 Sum_probs=222.8
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|.... +|+.||+|++...........+.+.+|+.+++++. ||||+++++++.+++.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 76 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFL 76 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeE
Confidence 479999999999999999999776 58899999986543334445567889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|+||||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 77 YMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred EEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhcc
Confidence 999999999999998754 4578999999999999999999999999999999999999 778899999999998764
Q ss_pred CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
. ......|++.|+|||++. ..++.++|||||||++|+|++|+.||......+.+..+......++. .++..+.
T Consensus 153 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~ 226 (291)
T cd05612 153 D--RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAK 226 (291)
T ss_pred C--CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHH
Confidence 3 223457999999999887 45889999999999999999999999988888878777776554433 5688999
Q ss_pred HHHHHhccCCccCCCC-----HHHHHcCcccCCCC
Q 012825 394 DFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (455)
Q Consensus 394 ~li~~~L~~dP~~Rps-----~~elL~hp~~~~~~ 423 (455)
+||++||+.||.+|++ +.++++|+||+...
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 9999999999999995 99999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=378.06 Aligned_cols=249 Identities=28% Similarity=0.458 Sum_probs=214.9
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeE-EEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC-
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQ-VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~-vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~- 232 (455)
.+..+.+.||.|+||+||++.+. |+. ||||++......... .+.|.+|+.+|.+|+ |||||+++|++.+..
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~-----g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR-----GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPG 113 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC-----CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCC
Confidence 44556667999999999998865 455 999999776544444 789999999999999 999999999999887
Q ss_pred ceEEEEeecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC-CEEeeccCCceEEeecCCCc-eEEEeeccc
Q 012825 233 NVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQG-VVHRDLKPENFLFTTKDENS-VLKAIDFGL 309 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~-ivHrDikp~NILl~~~~~~~-~vkL~DfG~ 309 (455)
.++|||||+++|+|.+++.. ....+++..+..|+.+|++||.|||+++ |||||||++|||| +.++ ++||+|||+
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGL 190 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCcc
Confidence 79999999999999999987 4789999999999999999999999999 9999999999999 7776 999999999
Q ss_pred ccccCCC-CcccccccCCCcccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 310 SDFVRPD-ERLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 310 a~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
++..... .......||+.|||||++.+ .|+.++||||||++||||+||+.||...........+...........
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~- 269 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK- 269 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc-
Confidence 9887654 34455789999999999984 499999999999999999999999999888666666654443333221
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.+++.+..|+.+||+.||++||+..+++.
T Consensus 270 -~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 270 -ECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -cCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 38899999999999999999999999863
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=381.74 Aligned_cols=255 Identities=31% Similarity=0.591 Sum_probs=222.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+... +++.||||++.+.........+.+.+|+.+++++. ||||+++++++.+++.
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENR 92 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCE
Confidence 4789999999999999999999776 58899999986544334445577899999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 93 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEc
Confidence 9999999999999998854 4678999999999999999999999999999999999999 78889999999999876
Q ss_pred CCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
... .....||+.|+|||++. ..++.++|||||||++|+|++|..||...........+......++. .++..+
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~ 242 (329)
T PTZ00263 169 PDR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRA 242 (329)
T ss_pred CCC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHH
Confidence 432 23457999999999987 45889999999999999999999999888877777777665544332 478999
Q ss_pred HHHHHHhccCCccCCCC-----HHHHHcCcccCCC
Q 012825 393 RDFVKRLLNKDPRKRLT-----AAQALSHPWIKNS 422 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps-----~~elL~hp~~~~~ 422 (455)
.+||++||+.||.+|++ +.+++.||||++.
T Consensus 243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999999999997 7999999999975
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=351.78 Aligned_cols=258 Identities=32% Similarity=0.621 Sum_probs=237.7
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.-++|++++.||+|.||.||+|+.++ ++..||+|++.+......+..+++.+|+++...|+ ||||+++|++|.+..
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekk---s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKK---SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSK 95 (281)
T ss_pred chhhccccccccCCccccEeEeeecc---CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccc
Confidence 35789999999999999999999887 68899999998877777777788999999999999 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
.+||++||...|+++..+.+ ...++++...+.++.|++.||.|+|..+||||||||+|+|+ +..+.+||+|||.+.
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSV 172 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCcee
Confidence 99999999999999998864 44579999999999999999999999999999999999999 777889999999997
Q ss_pred ccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
... ...-.+.|||..|.+||...+ .++...|+|++|++.||++.|..||......+.++.+.+.+..++. .++.
T Consensus 173 ~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~----~is~ 247 (281)
T KOG0580|consen 173 HAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS----TISG 247 (281)
T ss_pred ecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc----ccCh
Confidence 765 555678899999999998874 6999999999999999999999999999999999999998877773 7899
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
++.|||.+||.++|.+|....|+++|||+...
T Consensus 248 ~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 248 GAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred hHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 99999999999999999999999999999764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=378.16 Aligned_cols=250 Identities=30% Similarity=0.550 Sum_probs=217.1
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|+... +|+.||||++.+...........+.+|+.+++++. |+||+++++++..++.+||||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeC
Confidence 469999999999998766 58999999997544334445567889999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCcc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~~ 319 (455)
+++++|.+++. ..+.+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++.... ....
T Consensus 77 ~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 77 ANGGELFFHLS-RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCcc
Confidence 99999988775 45678999999999999999999999999999999999999 7788999999999875422 2334
Q ss_pred cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012825 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~ 398 (455)
...+||+.|+|||++. ..++.++|||||||++|||++|+.||...........+......++ ..++.++.+||++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAG 228 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 4567999999999987 4689999999999999999999999988887777776666554443 3688999999999
Q ss_pred hccCCccCCC-----CHHHHHcCcccCCC
Q 012825 399 LLNKDPRKRL-----TAAQALSHPWIKNS 422 (455)
Q Consensus 399 ~L~~dP~~Rp-----s~~elL~hp~~~~~ 422 (455)
||+.||++|| ++.++++||||+..
T Consensus 229 ~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 229 LLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999 89999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=382.43 Aligned_cols=260 Identities=27% Similarity=0.480 Sum_probs=219.0
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|+... +++.||||++.+...........+.+|+.++.++. |+||+++++.+.+++.+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~ 76 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---TGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNL 76 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeE
Confidence 479999999999999999998765 58899999997544334455567889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
||||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 77 ~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCccccc
Confidence 999999999999998854 4679999999999999999999999999999999999999 778899999999987543
Q ss_pred CCC------------------------------------cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcC
Q 012825 315 PDE------------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG 357 (455)
Q Consensus 315 ~~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg 357 (455)
... .....+||+.|+|||++. ..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 211 012357999999999986 5689999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCcc---CCCCHHHHHcCcccCCCC
Q 012825 358 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPR---KRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 358 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~---~Rps~~elL~hp~~~~~~ 423 (455)
+.||......+.+..+..............++.++.+||.+|+. +|. .||++.||++||||++..
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 233 YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred CCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 99999888888777777643332222223578999999999876 444 458999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=375.48 Aligned_cols=258 Identities=33% Similarity=0.539 Sum_probs=222.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|+... +++.||||++.+.........+.+.+|++++..+. |+||+++++++.+++..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~ 76 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYL 76 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEE
Confidence 479999999999999999999776 57899999997543333445667889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
||||||++|++|.+++. ..+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 77 YLAMEYVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIV 152 (333)
T ss_pred EEEEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCcccc
Confidence 99999999999999874 44578999999999999999999999999999999999999 778899999999997654
Q ss_pred CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC----CCCC
Q 012825 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW----PSLS 389 (455)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s 389 (455)
. ......||..|+|||++. ..++.++|||||||++|||++|..||......+.+..+............ ..++
T Consensus 153 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 153 T--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred c--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence 3 344567999999999887 46899999999999999999999999988877766666543322222111 2568
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.++.+||.+||..+|.+||++.++++||||+..
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=380.06 Aligned_cols=260 Identities=30% Similarity=0.545 Sum_probs=221.4
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|+... +|+.||||++.+...........+.+|+.++..+. |+||+++++++.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~ 76 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYL 76 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeE
Confidence 479999999999999999999776 58899999996543334455667889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
||||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred EEEECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceecc
Confidence 999999999999998754 4579999999999999999999999999999999999999 788899999999986543
Q ss_pred CCC---------------------------------------cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHH
Q 012825 315 PDE---------------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYIL 354 (455)
Q Consensus 315 ~~~---------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~el 354 (455)
... .....+||+.|+|||++. ..++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 211 011246999999999876 5689999999999999999
Q ss_pred HcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCC---HHHHHcCcccCCCC
Q 012825 355 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT---AAQALSHPWIKNSN 423 (455)
Q Consensus 355 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps---~~elL~hp~~~~~~ 423 (455)
++|..||........+..++.............+++++.+||++||. +|.+|++ +.+++.||||++..
T Consensus 233 ~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 99999999888777777776544333322223578999999999997 9999998 99999999999763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=365.37 Aligned_cols=258 Identities=34% Similarity=0.644 Sum_probs=237.2
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
.....+|++.+.||+|.||.|-+|+... .|+.||||.|.+....+.+..-.+++|++|+..|+ ||||+++|.+|+.
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~---sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFEN 124 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHK---SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFEN 124 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhcc---CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcC
Confidence 3457899999999999999999998655 69999999999999999999999999999999998 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
.+.+.|||||..+|.|+|++. ..+.+++.+++.+++||..|+.|||.++++|||||.+|||+ |.++++||+|||++
T Consensus 125 kdKIvivMEYaS~GeLYDYiS-er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLS 200 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYIS-ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLS 200 (668)
T ss_pred CceEEEEEEecCCccHHHHHH-HhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchh
Confidence 999999999999999999985 45679999999999999999999999999999999999999 89999999999999
Q ss_pred cccCCCCcccccccCCCcccccccCCC-C-CCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLHRS-Y-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
..+..+...+++||++.|.+||+++|. | .+..|-|||||+||.|+.|..||++......++++-++....+ .-
T Consensus 201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-----~~ 275 (668)
T KOG0611|consen 201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP-----ET 275 (668)
T ss_pred hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC-----CC
Confidence 998888888999999999999999864 4 6789999999999999999999999998888888876654433 34
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
+.+..-||++||..||++|.|+.+|-.|-|+.-
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 577889999999999999999999999999974
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=365.49 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=213.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+... +++.||+|++..... ......+.+|+.++++++ |+||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 77 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKL---TENLVALKEIRLEHE--EGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERC 77 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECC---CCCEEEEEEeccccc--CCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCe
Confidence 3679999999999999999998765 588999999865422 222345778999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++ +|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 78 LTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAK 153 (288)
T ss_pred EEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeec
Confidence 9999999975 8998887666678999999999999999999999999999999999999 77888999999998765
Q ss_pred CCCC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC--------
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-------- 382 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 382 (455)
.... ......++..|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.+.......
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 4222 2344578999999998753 5899999999999999999999999887766655554432211100
Q ss_pred ------------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 383 ------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 383 ------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
...+.++.++.+||++||++||.+|||+.|+|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=375.17 Aligned_cols=257 Identities=29% Similarity=0.539 Sum_probs=222.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|.+... .+..||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+++.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESY 105 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECC--CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCE
Confidence 56899999999999999999986652 24689999986543334445567889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeec
Confidence 9999999999999988754 4579999999999999999999999999999999999999 77889999999999876
Q ss_pred CCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 314 RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++ ..++..+
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~ 255 (340)
T PTZ00426 182 DT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNC 255 (340)
T ss_pred CC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHH
Confidence 42 2345679999999999864 588999999999999999999999998887777777776654433 3578999
Q ss_pred HHHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 393 RDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
.++|++||+.||++|+ ++.++++||||+...
T Consensus 256 ~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 256 KHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred HHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 9999999999999995 899999999999754
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=378.96 Aligned_cols=260 Identities=28% Similarity=0.476 Sum_probs=217.6
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
.|++++.||+|+||.||+|+... +++.||||++.+...........+.+|+++++++. |+||+++++++.+.+.+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~ 77 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD---THALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLY 77 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEE
Confidence 68999999999999999998766 68999999997654445556678999999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
+||||++||+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.....
T Consensus 78 lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 78 FVMDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccc
Confidence 99999999999998754 4578999999999999999999999999999999999999 7788999999999753310
Q ss_pred CC------------------------------------------------cccccccCCCcccccccC-CCCCCcchHHH
Q 012825 316 DE------------------------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWS 346 (455)
Q Consensus 316 ~~------------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwS 346 (455)
.. .....+||..|+|||++. ..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 00 012357999999999886 56899999999
Q ss_pred HHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccC--CccCCCCHHHHHcCcccCCCC
Q 012825 347 IGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK--DPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 347 lG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~--dP~~Rps~~elL~hp~~~~~~ 423 (455)
|||++|||++|..||...........+..............++.++.+||.+|+.. ++..|+++.+++.||||+...
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 99999999999999988777666666654333333333346899999999996654 555599999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=349.34 Aligned_cols=259 Identities=37% Similarity=0.690 Sum_probs=233.1
Q ss_pred cCCCeEEe-ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-
Q 012825 153 FANKYELG-EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (455)
Q Consensus 153 ~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~- 230 (455)
++++|.+. ++||-|--|.|..+..+. +|+.+|+|++... ...++|+++.-...+|+|||.++++|+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~---T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKR---TQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred chhhheehhhhhccccCCceEEEEecc---chhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 57888885 478999999998888776 7899999998432 3467899999888899999999999863
Q ss_pred ---CCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 231 ---TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 231 ---~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
...+.+|||.|+||.|+..+.+++ ..|+|.++..|++||+.|+.|||+.+|.||||||+|+|.+....+..+||+|
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence 346889999999999999998765 4799999999999999999999999999999999999999888899999999
Q ss_pred cccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC----hhHHHHHHHhcCCCCC
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFD 381 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~ 381 (455)
||+|+.........+.+.|++|.|||++. ..|+...|+||+||++|.|+||..||.... ..++...|..+...|+
T Consensus 208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred cccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 99999987777788889999999999997 579999999999999999999999997654 3467888888999999
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 382 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
...|..+|++.+|+|+.+|..+|.+|.|+.++++|||+...
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 99999999999999999999999999999999999999974
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=377.52 Aligned_cols=259 Identities=34% Similarity=0.605 Sum_probs=223.5
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|+... +|+.||||++.+...........+.+|++++..+. |+||+++++++.+++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHL 76 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeE
Confidence 479999999999999999999776 58999999997544334345667889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|+||||+++++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMN 152 (350)
T ss_pred EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCc
Confidence 9999999999999988655 679999999999999999999999999999999999999 788899999999997765
Q ss_pred CCC------------------------------cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 012825 315 PDE------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWA 363 (455)
Q Consensus 315 ~~~------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~ 363 (455)
... ......||..|+|||++. ..++.++|||||||++|+|++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 433 223457999999999987 4689999999999999999999999998
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCC-HHHHHcCcccCCC
Q 012825 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT-AAQALSHPWIKNS 422 (455)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-~~elL~hp~~~~~ 422 (455)
.........+..............+++++.+||.+||. ||.+|++ +.++|+||||+..
T Consensus 233 ~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 233 DTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred CCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 88777777776633333222233579999999999998 9999999 9999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=371.72 Aligned_cols=250 Identities=29% Similarity=0.547 Sum_probs=216.5
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+++... +|+.||+|++.+...........+.+|+.+++.+. |+||+++++++..++.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeC
Confidence 469999999999999765 58999999997654444555677889999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCcc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~~ 319 (455)
+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.... ....
T Consensus 77 ~~~g~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 77 VNGGELFFHLS-RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred CCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccc
Confidence 99999988774 45679999999999999999999999999999999999999 7788999999999876432 2233
Q ss_pred cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012825 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~ 398 (455)
...+||..|+|||++. ..++.++|||||||++|+|++|+.||...........+......++ ..++.++.+||++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSG 228 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHH
Confidence 4567999999999986 5689999999999999999999999988877776666665544433 3688999999999
Q ss_pred hccCCccCCC-----CHHHHHcCcccCCC
Q 012825 399 LLNKDPRKRL-----TAAQALSHPWIKNS 422 (455)
Q Consensus 399 ~L~~dP~~Rp-----s~~elL~hp~~~~~ 422 (455)
||+.||++|+ ++.++++|+||...
T Consensus 229 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 229 LLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999997 89999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=365.39 Aligned_cols=260 Identities=28% Similarity=0.424 Sum_probs=210.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+... +++.||||++..... ......+.+|+.+++.+. |+||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV---NGKLVALKVIRLQEE--EGTPFTAIREASLLKGLK-HANIVLLHDIIHTKET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC---CCCEEEEEEeccccc--cccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCe
Confidence 5789999999999999999999765 588999999865432 122345678999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+. ++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAK 153 (303)
T ss_pred EEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceec
Confidence 999999995 58888887777789999999999999999999999999999999999999 77889999999998754
Q ss_pred CCC-CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChh-HHHHHHHhcCCCCCC-------
Q 012825 314 RPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDE------- 382 (455)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~------- 382 (455)
... .......++..|+|||++.+ .++.++|||||||++|+|++|..||.+.... ..+..+.........
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 322 23344678999999998753 4788999999999999999999999765432 222222211000000
Q ss_pred -------C--------------CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 383 -------A--------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 383 -------~--------------~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
. ....++.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 0 0012457889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=379.66 Aligned_cols=260 Identities=27% Similarity=0.493 Sum_probs=217.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++++.||+|+||.||+++... +|+.||||++.+.........+.+.+|+++++++. |+||+++++++.+.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~ 76 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYL 76 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCee
Confidence 479999999999999999998776 58899999986543334455677899999999997 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
||||||++||+|.+++. ..+.+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++...
T Consensus 77 ~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 77 YLIMEFLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred EEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeecccccccc
Confidence 99999999999999875 45678999999999999999999999999999999999999 778899999999986321
Q ss_pred CCC------------------------------------------------cccccccCCCcccccccC-CCCCCcchHH
Q 012825 315 PDE------------------------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVW 345 (455)
Q Consensus 315 ~~~------------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiw 345 (455)
... .....+||+.|+|||++. ..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 100 001246999999999876 5689999999
Q ss_pred HHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCC---CCHHHHHcCcccCCC
Q 012825 346 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKR---LTAAQALSHPWIKNS 422 (455)
Q Consensus 346 SlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R---ps~~elL~hp~~~~~ 422 (455)
||||++|||++|..||......+.+..+..............++.++.+||.+||. +|.+| +++.+++.||||++.
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999999999998887777777666533222222223578999999999998 77765 599999999999975
Q ss_pred C
Q 012825 423 N 423 (455)
Q Consensus 423 ~ 423 (455)
.
T Consensus 312 ~ 312 (377)
T cd05629 312 D 312 (377)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=374.26 Aligned_cols=261 Identities=30% Similarity=0.506 Sum_probs=224.4
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|+... +|+.||+|++...........+.+.+|+.+++.+. |+||+++++++.+++..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~ 76 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNL 76 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeE
Confidence 479999999999999999998776 58899999997654434455677889999999887 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|+||||+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLT 153 (330)
T ss_pred EEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECC
Confidence 99999999999999887766789999999999999999999999999999999999999 788899999999998765
Q ss_pred CCCcc--cccccCCCcccccccC-------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 315 PDERL--NDIVGSAYYVAPEVLH-------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 315 ~~~~~--~~~~gt~~y~aPE~~~-------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
..... ....||..|+|||++. ..++.++|||||||++|+|++|+.||........+..++...........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED 233 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCC
Confidence 43322 2347899999999874 34788999999999999999999999888877777777665433222223
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+.++.++.+||+.||+ ||.+||++.+++.||||+...
T Consensus 234 ~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 234 PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 4688999999999998 999999999999999999753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=370.29 Aligned_cols=251 Identities=30% Similarity=0.555 Sum_probs=216.4
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+++... +|+.||+|++.............+.+|+.+++.+. ||||+++++++..++.+||||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeC
Confidence 479999999999998765 58999999997543334445567788999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCcc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~~ 319 (455)
+++++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 77 ~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 77 ANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcc
Confidence 99999988764 45579999999999999999999999999999999999999 7788999999999876432 2233
Q ss_pred cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012825 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~ 398 (455)
....||..|+|||++. +.++.++|||||||++|||++|+.||...........+......++ ..+++++.+||.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~ 228 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAG 228 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHH
Confidence 4567999999999986 5689999999999999999999999988887777776665554433 3688999999999
Q ss_pred hccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 399 LLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 399 ~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
||+.||++|+ ++.++++|+||....
T Consensus 229 ~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 229 LLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred HccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 9999999998 999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=370.13 Aligned_cols=257 Identities=28% Similarity=0.487 Sum_probs=221.1
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||+|+||.||+|+... +++.||||++.+.........+.+..|+.++..+.+|++|+++++++.+.+.+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence 58999999999999999998766 578999999976443344455678889999999985677999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC-
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR- 314 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~- 314 (455)
+||||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 78 lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCC
Confidence 99999999999987754 4578999999999999999999999999999999999999 778899999999986532
Q ss_pred CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
.........||..|+|||++. ..++.++|||||||++|+|++|+.||........+..+......++ ..++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~ 229 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAV 229 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 223334567999999999887 4689999999999999999999999998888887777776554443 35889999
Q ss_pred HHHHHhccCCccCCCCH-----HHHHcCcccCCCC
Q 012825 394 DFVKRLLNKDPRKRLTA-----AQALSHPWIKNSN 423 (455)
Q Consensus 394 ~li~~~L~~dP~~Rps~-----~elL~hp~~~~~~ 423 (455)
+||++||+.||.+|++. .++++||||+...
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 230 SICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999999999999986 8999999999754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=373.58 Aligned_cols=272 Identities=28% Similarity=0.494 Sum_probs=229.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
...|...+.||+|.||.||+|.+.. +++.||+|++... .....++++++|+.+|.++. ++||.++|+.|..+..
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~---t~k~vAiKii~Le--~~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNK---TKKVVAIKIIDLE--EAEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTK 85 (467)
T ss_pred ccccccchhccccccceeeeeeecc---ccceEEEEEechh--hcchhhHHHHHHHHHHHhcC-cchHHhhhhheeeccc
Confidence 4567778999999999999999777 7899999999765 34455688999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
++++||||.||++.+.+ +.+..+.+..+..|+++++.||.|||.++.+|||||+.|||+ .+++.|||+|||.+...
T Consensus 86 LwiiMey~~gGsv~~lL-~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~---s~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLL-KSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL---SESGDVKLADFGVAGQL 161 (467)
T ss_pred HHHHHHHhcCcchhhhh-ccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeE---eccCcEEEEecceeeee
Confidence 99999999999999976 455566999999999999999999999999999999999999 56689999999999877
Q ss_pred CCCCc-ccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPDER-LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
..... ..+++||+.|||||++.+ .|+.++||||||++.+||++|..||........+..|-+..++.... .+++.
T Consensus 162 ~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~---~~S~~ 238 (467)
T KOG0201|consen 162 TNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG---DFSPP 238 (467)
T ss_pred echhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc---ccCHH
Confidence 65443 378899999999999985 79999999999999999999999998777644444443433333332 68999
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHHHHHHHHH
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAY 440 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~~~~~~~~ 440 (455)
+++||..||++||+.||+|.++|+|+|++.. .+...-+.+.+..+.+
T Consensus 239 ~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a--~k~s~L~~~i~r~~~~ 285 (467)
T KOG0201|consen 239 FKEFVEACLDKNPEFRPSAKELLKHKFIKRA--KKTSELKELIDRYKRW 285 (467)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhhHHHHhc--CCchHHHHHHHHHHHH
Confidence 9999999999999999999999999999983 3344444444444333
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=368.48 Aligned_cols=248 Identities=27% Similarity=0.540 Sum_probs=215.8
Q ss_pred EeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecC
Q 012825 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (455)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 242 (455)
||+|+||.||+|+... +++.||+|++.+...........+.+|+.+++++. |+||+++++++.+.+..|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCC
Confidence 6999999999999765 57899999986544344555677889999999997 9999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCcccc
Q 012825 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLND 321 (455)
Q Consensus 243 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~~~~ 321 (455)
+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.... ......
T Consensus 77 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~ 152 (312)
T cd05585 77 GGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNT 152 (312)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCcccc
Confidence 9999998754 5679999999999999999999999999999999999999 7888999999999876432 223345
Q ss_pred cccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhc
Q 012825 322 IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400 (455)
Q Consensus 322 ~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L 400 (455)
..||..|+|||++. ..++.++|||||||++|+|++|+.||........+..++.....+. ..++.++.+||.+||
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L 228 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLL 228 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHc
Confidence 67999999999887 4689999999999999999999999998888777777776554443 368899999999999
Q ss_pred cCCccCCC---CHHHHHcCcccCCC
Q 012825 401 NKDPRKRL---TAAQALSHPWIKNS 422 (455)
Q Consensus 401 ~~dP~~Rp---s~~elL~hp~~~~~ 422 (455)
+.||++|| ++.++|.||||+..
T Consensus 229 ~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 229 SRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99999997 58999999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=378.24 Aligned_cols=259 Identities=31% Similarity=0.533 Sum_probs=219.4
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
.+|+++++||+|+||.||+|+... +++.||+|++.+...........+.+|+.+++++. |+||+++++++.+++.+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~ 76 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVD---TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNL 76 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEE
Confidence 369999999999999999999766 58899999986544334455678899999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|+|||||++|+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCcccc
Confidence 999999999999998754 4578999999999999999999999999999999999999 788899999999975321
Q ss_pred CC------------------------------------------------CcccccccCCCcccccccC-CCCCCcchHH
Q 012825 315 PD------------------------------------------------ERLNDIVGSAYYVAPEVLH-RSYSTEADVW 345 (455)
Q Consensus 315 ~~------------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~sDiw 345 (455)
.. ......+||+.|+|||++. ..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 00 0012347999999999886 5689999999
Q ss_pred HHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCC---HHHHHcCcccCCC
Q 012825 346 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT---AAQALSHPWIKNS 422 (455)
Q Consensus 346 SlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps---~~elL~hp~~~~~ 422 (455)
||||++|||++|+.||......+....+..............+++++.++|.+|+ .||.+|++ +.+++.||||+..
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred echHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 9999999999999999988877776666654444433334568999999999986 59999997 9999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=376.61 Aligned_cols=260 Identities=28% Similarity=0.486 Sum_probs=222.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+++... +++.||+|++.+.........+.+.+|+.+++.+. |+||+++++++.+++.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKY 117 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCE
Confidence 5789999999999999999998776 58899999986543333344456788999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeec
Confidence 9999999999999987743 458999999999999999999999999999999999999 78889999999999876
Q ss_pred CCCC--cccccccCCCcccccccCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 314 RPDE--RLNDIVGSAYYVAPEVLHR-----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
.... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||........+..+.............
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence 4332 2245679999999998753 37889999999999999999999999888877777777654333333334
Q ss_pred CCCHHHHHHHHHhccCCccC--CCCHHHHHcCcccCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNS 422 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~--Rps~~elL~hp~~~~~ 422 (455)
.++.++.+||++||+.+|.+ |+++.++++||||+..
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 68999999999999999988 9999999999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=356.74 Aligned_cols=262 Identities=33% Similarity=0.579 Sum_probs=221.4
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~- 230 (455)
....+|...+.||+|+||.||.+.++. +|..||||.+.. .+......++..+|+++|+.++ |+||+.+++.+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~---t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKR---TGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPP 93 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcC---CCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccc
Confidence 446677778999999999999999887 689999999853 3456677788999999999999 9999999999864
Q ss_pred ----CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 231 ----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
-+.+|+|+|+| +.+|...+ +.+..+++..+..++.||++||+|+|+.+|+||||||.|+|+ +.+-.+||||
T Consensus 94 ~~~~f~DvYiV~elM-etDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~D 168 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELM-ETDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICD 168 (359)
T ss_pred cccccceeEEehhHH-hhHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEecc
Confidence 45699999999 44776655 555669999999999999999999999999999999999999 6677799999
Q ss_pred cccccccCC---CCcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC-
Q 012825 307 FGLSDFVRP---DERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF- 380 (455)
Q Consensus 307 fG~a~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~- 380 (455)
||+|+.... +...+.++.|.+|+|||++. ..|+...||||+||+|.||++|+..|.+......+..++...+..
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 999998864 45557788999999999875 469999999999999999999999998877666555554332222
Q ss_pred ----------------------CCC----CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 381 ----------------------DEA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 381 ----------------------~~~----~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+.. .++..++.+.+|+.+||..||.+|+|++|+|+||||....
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 111 2357889999999999999999999999999999999753
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=365.71 Aligned_cols=290 Identities=33% Similarity=0.648 Sum_probs=250.1
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+..-|.+.+.||+|.|..|-+|++.- +|..||||++.+...+. .....+.+|+..++.++ |||||+||.+.....
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVF---TGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhc---ccceeEEEEecccccch-hhhhHHHHHHHHHHHhc-CcCeeeeeehhcccc
Confidence 45679999999999999998888554 79999999998876544 33456788999999888 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+|||+|+-++|+|.|+|.+....++|..+++++.||+.|+.|+|+..+|||||||+||.+. ..-|.|||+|||++..
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNK 168 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeecccccc
Confidence 99999999999999999999999999999999999999999999999999999999999886 5678999999999999
Q ss_pred cCCCCcccccccCCCcccccccCC-CCC-CcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLHR-SYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~-~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
+.+++...+.||+..|.|||++.| .|+ ++.||||||||||-|+||+.||+..++.+.+..|+......+. .++.
T Consensus 169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~ 244 (864)
T KOG4717|consen 169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSK 244 (864)
T ss_pred CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhH
Confidence 999999999999999999999876 464 5689999999999999999999999999999998877665554 6899
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC---CCCch--------hHHHHHHHHHH-HhccHHHHHHHhhh
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND---VKVPL--------DVIIFKLMKAY-MRSSSLRKAALRVS 454 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~---~~~p~--------~~~~~~~~~~~-~~~~~l~~~~~~~~ 454 (455)
+.++||..||..||++|.+.++|..|+|++.... ..+|+ +.-. -+++.| .....-+.++|++|
T Consensus 245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPLvsr~~L~ee~Ha-~IIq~Mv~G~IAs~e~Il~aL 319 (864)
T KOG4717|consen 245 ECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPLVSRHHLPEEAHA-TIIQQMVAGAIASEEDILRAL 319 (864)
T ss_pred HHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCceeehhhCChHHHH-HHHHHHhcccccCHHHHHHHH
Confidence 9999999999999999999999999999998642 23443 1111 122222 33466677777765
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=370.75 Aligned_cols=259 Identities=30% Similarity=0.544 Sum_probs=216.3
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc-CCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
+|++.+.||+|+||.||+++...+..+++.||+|++.+... ......+.+.+|+.+++.+.+|+||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 58999999999999999998766555789999999865322 22334566889999999997799999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCcccc
Confidence 999999999999998754 4568999999999999999999999999999999999999 778899999999997653
Q ss_pred CCC--cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCC----hhHHHHHHHhcCCCCCCCCCC
Q 012825 315 PDE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 386 (455)
... ......||..|+|||++.+ .++.++|||||||++|||++|..||.... .......+....+.+. .
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~ 232 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----S 232 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC----C
Confidence 322 2334679999999999864 47889999999999999999999996432 2233334444333332 3
Q ss_pred CCCHHHHHHHHHhccCCccCCC-----CHHHHHcCcccCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~ 422 (455)
.++..+.+||.+||+.||++|| ++.++++||||+..
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 5889999999999999999999 88999999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=378.32 Aligned_cols=259 Identities=30% Similarity=0.505 Sum_probs=218.0
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++++.||+|+||.||+|+... +++.||||++.+...........+.+|+.+++++. |+||+++++.+.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~ 76 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD---TNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNL 76 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEE
Confidence 479999999999999999999776 58999999986543333344567889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
||||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCcccc
Confidence 999999999999998854 4578999999999999999999999999999999999999 788899999999975321
Q ss_pred CC--------------------------------------------CcccccccCCCcccccccC-CCCCCcchHHHHHH
Q 012825 315 PD--------------------------------------------ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGV 349 (455)
Q Consensus 315 ~~--------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~ 349 (455)
.. ......+||+.|+|||++. ..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 00 0012357999999999987 46899999999999
Q ss_pred HHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCC---CHHHHHcCcccCCC
Q 012825 350 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQALSHPWIKNS 422 (455)
Q Consensus 350 ~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~elL~hp~~~~~ 422 (455)
++|||++|+.||......+....+..............++.++.+||.+|+ .+|.+|+ ++.+++.||||+..
T Consensus 233 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred eeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 999999999999888777666666554433333334468999999999977 5999999 99999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=369.86 Aligned_cols=251 Identities=31% Similarity=0.565 Sum_probs=216.5
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|+.+. +++.||||++.+.........+.+..|+.++..+..|+||+++++++.+.+.+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 479999999999998776 58899999986543333445566778999998876799999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCcc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~~ 319 (455)
+++++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~i~-~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 78 VNGGDLMFHIQ-KSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CCCchHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcc
Confidence 99999998775 44679999999999999999999999999999999999999 7788999999999875432 2334
Q ss_pred cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012825 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~ 398 (455)
....||+.|+|||++. ..++.++|||||||++|+|++|+.||...+....+..+......... .++.++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~ 229 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILKA 229 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHH
Confidence 4567999999999987 46899999999999999999999999998888888777765544332 578999999999
Q ss_pred hccCCccCCCCH------HHHHcCcccCCC
Q 012825 399 LLNKDPRKRLTA------AQALSHPWIKNS 422 (455)
Q Consensus 399 ~L~~dP~~Rps~------~elL~hp~~~~~ 422 (455)
||+.||++|+++ .+++.||||+..
T Consensus 230 ~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 999999999998 999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=368.27 Aligned_cols=257 Identities=26% Similarity=0.473 Sum_probs=222.0
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||+|+||.||+|+... +++.||||++.+.........+.+..|..++..+..|++|+++++++.+.+.+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence 58999999999999999998765 578999999976543344455667788888888877999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 78 lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCC
Confidence 99999999999987754 4569999999999999999999999999999999999999 7888999999999875432
Q ss_pred -CCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 316 -DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 316 -~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
........||+.|+|||++. +.++.++|||||||++|||++|+.||........+..+......++ ..++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 229 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAV 229 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHH
Confidence 22344567999999999887 5689999999999999999999999998888888777776654443 35889999
Q ss_pred HHHHHhccCCccCCCC-----HHHHHcCcccCCCC
Q 012825 394 DFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (455)
Q Consensus 394 ~li~~~L~~dP~~Rps-----~~elL~hp~~~~~~ 423 (455)
+||.+||+.||.+|++ ..++++|+||+...
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred HHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999999999999998 48999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=359.96 Aligned_cols=261 Identities=29% Similarity=0.455 Sum_probs=218.2
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
.|++.+.||+|+||.||++.... +++.||||++.............+.+|+.+++.++ |+||+++++++.+++.++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 76 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEE
Confidence 48899999999999999998665 58899999986544334444556788999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 236 VVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+||++ ++++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIP 153 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecC
Confidence 999999999999877654 3469999999999999999999999999999999999999 778899999999998765
Q ss_pred CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
.........|+..|+|||++. ..++.++||||||+++|+|++|+.||.+.........+..............++..+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05605 154 EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233 (285)
T ss_pred CCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence 444445567899999999886 5688999999999999999999999987665433333322211112222345889999
Q ss_pred HHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 394 DFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 394 ~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
+||.+||+.||++|| ++.++++|+||....
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 999999999999999 999999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=366.11 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=208.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.++||+|+||.||+|++.. +|+.||||++... ........+.+|+++++.++ |+||+++++++.+++.
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRP---TGRLYALKVIYGN--HEDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECC---CCCEEEEEEEecC--CcHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCe
Confidence 3568889999999999999998765 5889999998643 33445677899999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+++||||+++++|.+. ....+..+..++.||+.||.|||++||+||||||+|||+ ++++.+||+|||++...
T Consensus 147 ~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRIL 218 (353)
T ss_pred EEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceec
Confidence 9999999999987542 345788899999999999999999999999999999999 77889999999999876
Q ss_pred CCCC-cccccccCCCcccccccCC------CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
.... ......||..|+|||++.. ..+.++|||||||++|||++|+.||......+....+.............
T Consensus 219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (353)
T PLN00034 219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPA 298 (353)
T ss_pred ccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCC
Confidence 4332 2345679999999998742 23568999999999999999999997433322222111111111122224
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.++.++.+||.+||+.||++||++.|+|+||||....
T Consensus 299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 299 TASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 6889999999999999999999999999999999863
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=366.77 Aligned_cols=251 Identities=29% Similarity=0.510 Sum_probs=217.3
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|+... +++.||||++.+.........+.+..|.+++..+.+|+||+++++++.+++..|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 469999999999998765 57899999997644334455566778999998876799999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCcc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~~ 319 (455)
+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 78 VNGGDLMFQIQ-RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccc
Confidence 99999988775 44678999999999999999999999999999999999999 7888999999999875432 2233
Q ss_pred cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012825 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~ 398 (455)
....||..|+|||++. ..++.++|||||||++|+|++|+.||........+..+......++. .++.++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~ 229 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKA 229 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence 4567999999999887 46899999999999999999999999998888888888776544332 478999999999
Q ss_pred hccCCccCCC-------CHHHHHcCcccCCC
Q 012825 399 LLNKDPRKRL-------TAAQALSHPWIKNS 422 (455)
Q Consensus 399 ~L~~dP~~Rp-------s~~elL~hp~~~~~ 422 (455)
||+.||++|+ ++.++++||||...
T Consensus 230 ~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred HhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 9999999999 99999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=376.83 Aligned_cols=265 Identities=31% Similarity=0.487 Sum_probs=221.9
Q ss_pred CcccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCC-----CCee
Q 012825 148 GFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-----NNLV 222 (455)
Q Consensus 148 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-----p~Iv 222 (455)
-..+.+..+|++.+.||+|+||+|.+|++.+ +++.||||+++.. .....+...|+.+|..|+.| -|+|
T Consensus 179 v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~---T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~V 251 (586)
T KOG0667|consen 179 VVNDHIAYRYEVLEVLGKGSFGQVVKAYDHK---TGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIV 251 (586)
T ss_pred EecceeEEEEEEEEEecccccceeEEEEecC---CCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEE
Confidence 3445667799999999999999999999887 7999999999644 44556777899999999844 3899
Q ss_pred EEeEEEeeCCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCce
Q 012825 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (455)
Q Consensus 223 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~ 301 (455)
+++++|...+++|||+|.+ ..+|.+++..++ ..++...++.|+.||+.||.+||+.||||+||||+||||...+.. .
T Consensus 252 rm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~-~ 329 (586)
T KOG0667|consen 252 RMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS-R 329 (586)
T ss_pred Eeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC-c
Confidence 9999999999999999999 559999987654 469999999999999999999999999999999999999765444 8
Q ss_pred EEEeecccccccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC
Q 012825 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380 (455)
Q Consensus 302 vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 380 (455)
|||+|||.++... +....++.+..|+|||++.| .|+.+.||||||||++||++|...|.+.++.+.+..|++.....
T Consensus 330 vKVIDFGSSc~~~--q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 330 IKVIDFGSSCFES--QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred eeEEecccccccC--CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence 9999999998874 33337889999999999875 79999999999999999999999998888888777765322111
Q ss_pred C---------------C--------------------------------CCCC------------CCCHHHHHHHHHhcc
Q 012825 381 D---------------E--------------------------------APWP------------SLSSEARDFVKRLLN 401 (455)
Q Consensus 381 ~---------------~--------------------------------~~~~------------~~s~~l~~li~~~L~ 401 (455)
+ . ...+ .-...|.|||++||.
T Consensus 408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~ 487 (586)
T KOG0667|consen 408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE 487 (586)
T ss_pred CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence 1 0 0001 113468999999999
Q ss_pred CCccCCCCHHHHHcCcccCCCC
Q 012825 402 KDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 402 ~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+||.+|+|+.++|+||||....
T Consensus 488 ~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 488 WDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred cCchhcCCHHHHhcCccccccc
Confidence 9999999999999999999653
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=358.30 Aligned_cols=256 Identities=29% Similarity=0.487 Sum_probs=210.9
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|+... +++.||+|++.... ......+.+.+|+.+++.++ |+||+++++++..++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSE-ENEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC---CCcEEEEEEEeccc-ccccchhhHHHHHHHHHhCC-CccccchhhhEecCCEE
Confidence 479999999999999999999776 58899999986543 22334567889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||++++.+ +.+......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~lv~e~~~~~~l-~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 76 YLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLS 151 (287)
T ss_pred EEEEecCCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccc
Confidence 999999988655 4455556679999999999999999999999999999999999999 778899999999998764
Q ss_pred CCC--cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC------------
Q 012825 315 PDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------------ 379 (455)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~------------ 379 (455)
... ......|+..|+|||++. ..++.++|||||||++|||++|+.||......+....+......
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred ccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 322 233457899999999876 46899999999999999999999999876655444333221110
Q ss_pred --CCC--------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 380 --FDE--------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 380 --~~~--------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
+.. .....++.++.+||++||++||++|||+.++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0112368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=364.99 Aligned_cols=254 Identities=31% Similarity=0.548 Sum_probs=216.8
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHH---HhcCCCCeeEEeEEEeeCCc
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR---ALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~---~l~~hp~Iv~l~~~~~~~~~ 233 (455)
|++.+.||+|+||.||+|.... +|+.||||++.+.........+.+.+|+.++. .+. |+||+++++++.+.+.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~-hp~i~~~~~~~~~~~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-HPFLVNLFACFQTEDH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC-CCChhceeeEEEcCCE
Confidence 7889999999999999998765 58899999997543333344566777777664 444 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.|+||||+++++|...+. .+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 77 ~~lv~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEG 151 (324)
T ss_pred EEEEEcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccC
Confidence 999999999999987763 3579999999999999999999999999999999999999 77889999999998754
Q ss_pred CC-CCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RP-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
.. .......+|+..|+|||++. ..++.++|||||||++|+|++|+.||........+..+......++ ..++..
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~ 227 (324)
T cd05589 152 MGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSRE 227 (324)
T ss_pred CCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHH
Confidence 32 23344567999999999886 4689999999999999999999999998888877777776655443 357899
Q ss_pred HHHHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
+.+||++||+.||.+|| ++.++++||||++..
T Consensus 228 ~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 228 AISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 99999999999999999 799999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=373.07 Aligned_cols=261 Identities=28% Similarity=0.479 Sum_probs=221.2
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+++... +++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~ 116 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDK 116 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCC
Confidence 35789999999999999999999776 58899999986543333444566889999999988 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEeccccee
Confidence 99999999999999998743 358999999999999999999999999999999999999 7888999999999987
Q ss_pred cCCCC--cccccccCCCcccccccCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 313 VRPDE--RLNDIVGSAYYVAPEVLHR-----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+..+............
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 271 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED 271 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc
Confidence 64332 2245679999999998753 2788999999999999999999999988887777777765433332222
Q ss_pred CCCCHHHHHHHHHhccCCccC--CCCHHHHHcCcccCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNS 422 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~--Rps~~elL~hp~~~~~ 422 (455)
..++..+.++|..||..++.+ |+++.++++||||+..
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 367999999999999866544 8999999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=368.71 Aligned_cols=250 Identities=30% Similarity=0.552 Sum_probs=215.4
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+++... +|+.||+|++.+...........+.+|++++..+. |+||+++++++...+.+||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeC
Confidence 469999999999998765 58999999997654444455567788999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DER 318 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~ 318 (455)
+++++|.+++. ....+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++..... ...
T Consensus 77 ~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 77 ANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred CCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcc
Confidence 99999988764 44579999999999999999999997 799999999999999 7888999999999875432 233
Q ss_pred ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012825 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (455)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~ 397 (455)
.....||..|+|||++. +.++.++|||||||++|+|++|+.||...........+......++ ..+++++.+||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 228 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLS 228 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHH
Confidence 34567999999999986 5689999999999999999999999988887777766665554443 357899999999
Q ss_pred HhccCCccCCC-----CHHHHHcCcccCCC
Q 012825 398 RLLNKDPRKRL-----TAAQALSHPWIKNS 422 (455)
Q Consensus 398 ~~L~~dP~~Rp-----s~~elL~hp~~~~~ 422 (455)
+||+.||++|+ ++.++++|+||+..
T Consensus 229 ~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 229 GLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 99999999997 99999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=351.42 Aligned_cols=261 Identities=32% Similarity=0.511 Sum_probs=224.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCC-eeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-LVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~-Iv~l~~~~~~~~ 232 (455)
...|+.+++||+|+||+||+|+.+. +|+.||+|.+....... -.-....+|+.+++.|+ |+| ||+|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~---~g~~VALKkirl~~~~E-G~P~taiREisllk~L~-~~~~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKR---TGKFVALKKIRLEFEEE-GVPSTAIREISLLKRLS-HANHIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEec---CCCEEEEEEEecccccc-CCCchhhHHHHHHHHhC-CCcceEEEEeeeeecc
Confidence 4568888999999999999999887 68999999996543211 11234579999999999 999 999999998877
Q ss_pred ------ceEEEEeecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEE
Q 012825 233 ------NVYVVMELCEGGELLDRILSRG---GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (455)
Q Consensus 233 ------~~~lV~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vk 303 (455)
.+++|+||++. +|.+++.... ..++...++.++.||+.||+|||+++|+||||||.|||| ++.|.+|
T Consensus 85 ~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lK 160 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLK 160 (323)
T ss_pred cccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEe
Confidence 79999999965 8888887655 468889999999999999999999999999999999999 7799999
Q ss_pred EeecccccccC-CCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC
Q 012825 304 AIDFGLSDFVR-PDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380 (455)
Q Consensus 304 L~DfG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 380 (455)
|+|||+|+... +.......++|.+|+|||++.+ .|+...||||+||+++||++++..|.+..+.+.+..+.+.....
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 99999999776 4455778899999999999875 49999999999999999999999999999999888888766555
Q ss_pred CCCCCCC--------------------------CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 381 DEAPWPS--------------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 381 ~~~~~~~--------------------------~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.+..|+. .+.+..+++.+||+.+|.+|.|+..+|.||||....
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 5554443 234789999999999999999999999999999874
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=366.10 Aligned_cols=251 Identities=29% Similarity=0.533 Sum_probs=210.9
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|+... +++.||||++.+.........+.+.+|+.++.++.+||||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 479999999999999776 58899999997654445556677889999999997799999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc-CCCCcc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERL 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~-~~~~~~ 319 (455)
+++++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.. ......
T Consensus 78 ~~~g~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 78 VSGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcc
Confidence 99999988774 44679999999999999999999999999999999999999 77889999999998753 223344
Q ss_pred cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC---------hhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART---------ESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
...+||..|+|||++. ..++.++|||||||++|+|++|+.||.... .......+.......+ ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~ 229 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCC
Confidence 5678999999999987 468999999999999999999999996321 1122333443333322 3578
Q ss_pred HHHHHHHHHhccCCccCCCC------HHHHHcCcccCCC
Q 012825 390 SEARDFVKRLLNKDPRKRLT------AAQALSHPWIKNS 422 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps------~~elL~hp~~~~~ 422 (455)
.++.+||++||+.||.+|++ +.++++||||+..
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999999999999997 7899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=365.15 Aligned_cols=254 Identities=31% Similarity=0.545 Sum_probs=216.8
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc-CCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEE
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVM 238 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~ 238 (455)
++.||+|+||.||+++...+...++.||||++.+... ........+.+|+.+++.+. ||||+++++++..++..|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEE
Confidence 3689999999999998766555789999999865322 12233456789999999998 999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCC-C
Q 012825 239 ELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-E 317 (455)
Q Consensus 239 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~-~ 317 (455)
||+++++|.+++. ..+.+.+..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..... .
T Consensus 80 e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 80 EYLSGGELFMHLE-REGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred eCCCCchHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC
Confidence 9999999998775 45678999999999999999999999999999999999999 77889999999998754322 2
Q ss_pred cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 012825 318 RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFV 396 (455)
Q Consensus 318 ~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li 396 (455)
......||..|+|||++. ..++.++|||||||++|||++|+.||........+..+.......+ +.++.++.+||
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li 231 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 334567999999999986 4588999999999999999999999998887777777766554332 35789999999
Q ss_pred HHhccCCccCCC-----CHHHHHcCcccCCC
Q 012825 397 KRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (455)
Q Consensus 397 ~~~L~~dP~~Rp-----s~~elL~hp~~~~~ 422 (455)
++||+.||++|| ++.++++||||+..
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999 89999999999875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=373.39 Aligned_cols=260 Identities=28% Similarity=0.525 Sum_probs=219.4
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|+... +++.||||++.............+.+|+.++..+. |+||+++++.+.+++.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~ 76 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD---TGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNL 76 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEE
Confidence 479999999999999999999776 58899999996543334455677889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
||||||++||+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred EEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCcccc
Confidence 999999999999998754 4579999999999999999999999999999999999999 778899999999986542
Q ss_pred CCC------------------------------------cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcC
Q 012825 315 PDE------------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG 357 (455)
Q Consensus 315 ~~~------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg 357 (455)
... .....+||..|+|||++. ..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 211 012357999999999986 5689999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCC---CHHHHHcCcccCCCC
Q 012825 358 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQALSHPWIKNSN 423 (455)
Q Consensus 358 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~elL~hp~~~~~~ 423 (455)
+.||........+..+..............++.++.+||.+|+ .||.+|+ ++.++++||||++.+
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 233 YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVD 300 (360)
T ss_pred CCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCC
Confidence 9999988887777777654332222222347899999999987 4999998 589999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=364.39 Aligned_cols=287 Identities=29% Similarity=0.488 Sum_probs=220.3
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC----
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT---- 231 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~---- 231 (455)
+|++.+.||+|+||.||+|+... +|+.||||++.... ........+.+|++++++++ ||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKINDVF-EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---CCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCC
Confidence 69999999999999999999766 58899999986432 22333457889999999998 99999999988643
Q ss_pred -CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 232 -DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 232 -~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
..+|+|||||. ++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 76 ~~~~~lv~e~~~-~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~ 150 (338)
T cd07859 76 FKDIYVVFELME-SDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLA 150 (338)
T ss_pred CceEEEEEecCC-CCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccc
Confidence 24899999995 68888764 45579999999999999999999999999999999999999 78889999999999
Q ss_pred cccCCCC----cccccccCCCcccccccC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHh--------
Q 012825 311 DFVRPDE----RLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-------- 375 (455)
Q Consensus 311 ~~~~~~~----~~~~~~gt~~y~aPE~~~---~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~-------- 375 (455)
+...... ......||..|+|||++. ..++.++|||||||++|+|++|+.||........+..+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 7643222 123457999999999875 4688999999999999999999999976654332221111
Q ss_pred -------------------cCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC-----CCCchhH
Q 012825 376 -------------------ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND-----VKVPLDV 431 (455)
Q Consensus 376 -------------------~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~-----~~~p~~~ 431 (455)
..+......++.++..+.+||.+||+.||++||++.++|+||||+.... ..-|...
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~ 310 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITK 310 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCcccc
Confidence 0111111123457888999999999999999999999999999987643 2234434
Q ss_pred HHHHHHHHHHhccHHHHHHHh
Q 012825 432 IIFKLMKAYMRSSSLRKAALR 452 (455)
Q Consensus 432 ~~~~~~~~~~~~~~l~~~~~~ 452 (455)
..+......+.....+....+
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~ 331 (338)
T cd07859 311 LEFEFERRRLTKEDVRELIYR 331 (338)
T ss_pred ccccHHHHhcCHHHHHHHHHH
Confidence 444444444555555544433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=373.81 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=202.4
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc-----CCCCeeEEeEE
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-----GHNNLVKFFDA 227 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----~hp~Iv~l~~~ 227 (455)
..++|++.++||+|+||.||+|.+.. .++.||||++... ....+.+..|+.++..+. +|.++++++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~---~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcC---CCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 46889999999999999999998766 5789999998532 223345667888877775 24468999999
Q ss_pred EeeC-CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEeecC--------
Q 012825 228 YEDT-DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKD-------- 297 (455)
Q Consensus 228 ~~~~-~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~~~-------- 297 (455)
|..+ +++|||||++ |++|.+++.. .+.+++..++.|+.||+.||.|||+ .|||||||||+|||+...+
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccc
Confidence 8764 5789999998 7788888754 4679999999999999999999998 5999999999999995322
Q ss_pred -----CCceEEEeecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 012825 298 -----ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 371 (455)
Q Consensus 298 -----~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~ 371 (455)
+...+||+|||.+.... ......+||..|+|||++. ..++.++|||||||++|||++|+.||......+.+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred cccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 12359999999876432 2334568999999999987 469999999999999999999999998776655444
Q ss_pred HHHhcCCCCCCC------------------------------------CC--CCCCHHHHHHHHHhccCCccCCCCHHHH
Q 012825 372 AVLKADPSFDEA------------------------------------PW--PSLSSEARDFVKRLLNKDPRKRLTAAQA 413 (455)
Q Consensus 372 ~i~~~~~~~~~~------------------------------------~~--~~~s~~l~~li~~~L~~dP~~Rps~~el 413 (455)
.+......++.. .. ...+..+.+||.+||++||++|||+.|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 332221111000 00 0114567899999999999999999999
Q ss_pred HcCcccCCC
Q 012825 414 LSHPWIKNS 422 (455)
Q Consensus 414 L~hp~~~~~ 422 (455)
|+||||+..
T Consensus 436 L~Hp~~~~~ 444 (467)
T PTZ00284 436 TTHPYVLKY 444 (467)
T ss_pred hcCcccccc
Confidence 999999974
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=356.67 Aligned_cols=258 Identities=30% Similarity=0.440 Sum_probs=210.5
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEeEEEe---
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYE--- 229 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hp~Iv~l~~~~~--- 229 (455)
++|++.+.||+|+||.||+|+.... .++.||+|++....... .....+.+|+.+++.+. .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC--CCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 4799999999999999999987542 36889999986543222 12234567888777764 3999999999885
Q ss_pred --eCCceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 230 --DTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 230 --~~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
....+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~D 153 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD 153 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEcc
Confidence 3456899999996 5888887654 3458999999999999999999999999999999999999 7788999999
Q ss_pred cccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC---
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE--- 382 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--- 382 (455)
||++.............|+..|+|||++. ..++.++|||||||++|||++|+.||.+....+.+..+.........
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99998766554555667999999999876 56899999999999999999999999988877777666543211100
Q ss_pred --------------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 383 --------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 383 --------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
...+.++..+.+||.+||+.||++|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0123578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=362.74 Aligned_cols=252 Identities=30% Similarity=0.568 Sum_probs=213.2
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|+... +++.||||++...........+.+..|..++..+.+|+||+++++++..++.+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 479999999999999766 58899999997543333344455667788887665699999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCcc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~~ 319 (455)
++|++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 78 LNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcc
Confidence 999999887754 4579999999999999999999999999999999999999 7788999999999976432 2334
Q ss_pred cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012825 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~ 398 (455)
...+||..|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+....+.++ ..++.++.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~ 229 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSK 229 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 5567999999999987 4689999999999999999999999998888777777665544333 2578999999999
Q ss_pred hccCCccCCCCH-HHHHcCcccCCCC
Q 012825 399 LLNKDPRKRLTA-AQALSHPWIKNSN 423 (455)
Q Consensus 399 ~L~~dP~~Rps~-~elL~hp~~~~~~ 423 (455)
||+.||.+|+++ .++++|+||+...
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 230 LFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred HccCCHHHcCCChHHHHcCcccCCCC
Confidence 999999999986 4888999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=356.52 Aligned_cols=254 Identities=26% Similarity=0.434 Sum_probs=208.9
Q ss_pred EeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecC
Q 012825 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (455)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 242 (455)
||+|+||.||++.... +|+.||+|.+.+.........+.+..|+++++.++ |+||+++++++..++..++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEcc---CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCC
Confidence 6999999999998776 58899999987654444445567788999999997 9999999999999999999999999
Q ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCC-c
Q 012825 243 GGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-R 318 (455)
Q Consensus 243 ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~-~ 318 (455)
+|+|.+++.. .+..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....... .
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCcc
Confidence 9999887643 34569999999999999999999999999999999999999 778889999999997654332 2
Q ss_pred ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012825 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (455)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~ 397 (455)
.....||..|+|||++. +.++.++||||||+++|+|++|+.||...........+..............++.++.+|+.
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHH
Confidence 34457899999999887 56889999999999999999999999765432222222211111111222368899999999
Q ss_pred HhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 398 RLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 398 ~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
+||+.||++|+ ++.++++||||+...
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 234 ALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred HHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 99999999999 889999999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=363.10 Aligned_cols=252 Identities=30% Similarity=0.546 Sum_probs=216.5
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|+... +++.||||++.+...........+.+|+.++..+.+|+||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 479999999999999766 57899999997644334445567788999998886799999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCcc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~~ 319 (455)
+++++|.+++. ..+.+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 78 VNGGDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCcc
Confidence 99999988775 44579999999999999999999999999999999999999 7788999999999875322 2233
Q ss_pred cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012825 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~ 398 (455)
...+|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+......++ ..++..+.+||++
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~ 229 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKS 229 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHH
Confidence 4567999999999987 4689999999999999999999999988887777777666554433 2578999999999
Q ss_pred hccCCccCCCCH-----HHHHcCcccCCCC
Q 012825 399 LLNKDPRKRLTA-----AQALSHPWIKNSN 423 (455)
Q Consensus 399 ~L~~dP~~Rps~-----~elL~hp~~~~~~ 423 (455)
||+.||++||++ .+++.||||+...
T Consensus 230 ~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 230 FLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred HccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999999999999 9999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=362.32 Aligned_cols=252 Identities=29% Similarity=0.540 Sum_probs=213.2
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|+.+. +|+.||+|++.+.........+.+..|..++..+.+|+||+++++++.+++.+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 479999999999999776 58899999986543222334456777888888775699999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCcc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~~ 319 (455)
+.+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.... ....
T Consensus 78 ~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 78 LNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCce
Confidence 999999988754 4678999999999999999999999999999999999999 7788999999999875322 2334
Q ss_pred cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012825 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~ 398 (455)
....||..|+|||++. ..++.++|||||||++|+|++|+.||...........+....+.+.. .++.++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~ 229 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEK 229 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHH
Confidence 5567999999999987 46899999999999999999999999988877777666555443332 478999999999
Q ss_pred hccCCccCCCCH-HHHHcCcccCCCC
Q 012825 399 LLNKDPRKRLTA-AQALSHPWIKNSN 423 (455)
Q Consensus 399 ~L~~dP~~Rps~-~elL~hp~~~~~~ 423 (455)
||+.||++|+++ .++++||||+...
T Consensus 230 ~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 230 LFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred HccCCHHHcCCChHHHHcCCCcCCCC
Confidence 999999999998 5888999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=363.00 Aligned_cols=261 Identities=29% Similarity=0.518 Sum_probs=218.8
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+++... +++.||+|++.+.........+.+.+|+.++..+. |+||+++++++.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNL 76 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeE
Confidence 479999999999999999998776 58899999986533333444566889999999987 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|+||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLL 153 (331)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecC
Confidence 99999999999999887667789999999999999999999999999999999999999 778899999999987654
Q ss_pred CCCc--ccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC-CCC
Q 012825 315 PDER--LNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-APW 385 (455)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 385 (455)
.... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||......+.+..+......... ...
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCcc
Confidence 3332 22356999999999875 34788999999999999999999999887776666666554332221 122
Q ss_pred CCCCHHHHHHHHHhccCCccC--CCCHHHHHcCcccCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNS 422 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~--Rps~~elL~hp~~~~~ 422 (455)
..++.++.+||++||+.++++ |+++.++++||||...
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 358999999999999765544 7899999999999875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=359.21 Aligned_cols=262 Identities=25% Similarity=0.417 Sum_probs=216.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+++... +|..||+|++... ......+.+.+|++++++++ |+||+++++++..++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP---SGLIMARKLIHLE--IKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC---CCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCE
Confidence 5789999999999999999999776 5889999998653 23445677999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccc
Confidence 9999999999999988754 45689999999999999999999986 69999999999999 6788899999999876
Q ss_pred cCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcC--------------
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-------------- 377 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~-------------- 377 (455)
... .......|+..|+|||++. ..++.++|||||||++|||++|+.||......+... ++...
T Consensus 154 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 154 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA-IFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred ccc-cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HhcccccccccCCccccCc
Confidence 642 2334567999999999987 468999999999999999999999997655433221 11100
Q ss_pred -------------------------------CCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCC
Q 012825 378 -------------------------------PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426 (455)
Q Consensus 378 -------------------------------~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~ 426 (455)
..........++.++.+||.+||++||++|||+.++|+||||+......
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~ 311 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEE 311 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccccc
Confidence 0001111124688999999999999999999999999999999765444
Q ss_pred C
Q 012825 427 V 427 (455)
Q Consensus 427 ~ 427 (455)
+
T Consensus 312 ~ 312 (331)
T cd06649 312 V 312 (331)
T ss_pred c
Confidence 4
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=360.98 Aligned_cols=257 Identities=28% Similarity=0.492 Sum_probs=220.9
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||+|+||.||+|+... +|+.||+|++.+.........+.+..|+.++..+.+|++|+++++++.+.+.+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLY 77 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEE
Confidence 47889999999999999998766 588999999875433334455677889999988886788999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
+||||++||+|.+++. ..+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 78 lv~Ey~~~g~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 78 FVMEYVNGGDLMYHIQ-QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EEEcCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCC
Confidence 9999999999988774 44679999999999999999999999999999999999999 7788999999999876432
Q ss_pred CC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 316 DE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
.. ......||..|+|||++. +.++.++|||||||++|+|++|+.||...........+......++ ..++.++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 229 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAV 229 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Confidence 22 234567999999999886 5689999999999999999999999998888877777776654433 35789999
Q ss_pred HHHHHhccCCccCCCC-----HHHHHcCcccCCCC
Q 012825 394 DFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (455)
Q Consensus 394 ~li~~~L~~dP~~Rps-----~~elL~hp~~~~~~ 423 (455)
+++.+||+.||.+|++ ..++++|+||+...
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred HHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 9999999999999997 57999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=362.43 Aligned_cols=251 Identities=29% Similarity=0.529 Sum_probs=210.2
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|+... +++.||+|++.+.........+.+.+|+.++.++.+|+||+++++++.+++..|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 479999999999999776 58899999997655455556677889999998886699999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC-CCCcc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERL 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~-~~~~~ 319 (455)
+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... .....
T Consensus 78 ~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 78 VNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcc
Confidence 99999988764 44679999999999999999999999999999999999999 788899999999987542 22334
Q ss_pred cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCC---------ChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR---------TESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
....||..|+|||++. ..++.++|||||||++|+|++|+.||... ........+......++ ..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~ 229 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCC
Confidence 4567999999999887 46899999999999999999999999521 11122333343333322 3678
Q ss_pred HHHHHHHHHhccCCccCCCC------HHHHHcCcccCCC
Q 012825 390 SEARDFVKRLLNKDPRKRLT------AAQALSHPWIKNS 422 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps------~~elL~hp~~~~~ 422 (455)
..+.+||++||+.||++|++ +.++++||||+..
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999999999999998 5799999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=364.13 Aligned_cols=245 Identities=29% Similarity=0.461 Sum_probs=212.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
+.+.+++.||+|.||.||.|.+.. ...||+|.+....+.. +.|.+|+++|++|+ |++||+|+++|..++.+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~----~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG----STKVAVKTIKEGSMSP----EAFLREAQIMKKLR-HEKLVKLYGVCTKQEPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC----CCcccceEEeccccCh----hHHHHHHHHHHhCc-ccCeEEEEEEEecCCce
Confidence 446678999999999999999776 4589999987654333 45779999999999 99999999999998899
Q ss_pred EEEEeecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 235 YVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
|||||||+.|+|++++.. .+..+...+...++.|||+|++||+++++|||||-..|||| +++..+||+|||||+..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEccccccccc
Confidence 999999999999999987 56689999999999999999999999999999999999999 88999999999999965
Q ss_pred CCCCcccc--cccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 314 RPDERLND--IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 314 ~~~~~~~~--~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
.++..... ..-..-|.|||.+. +.|+.+||||||||+||||+| |+.||.+.+..+.++.+.++...... ..++
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P---~~CP 430 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP---EGCP 430 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC---CCCC
Confidence 54443222 12235699999987 789999999999999999998 99999999999998888776543332 3689
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHH
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQAL 414 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL 414 (455)
.++.+++..|++.+|++|||.+.+.
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999999999999998664
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=367.46 Aligned_cols=261 Identities=28% Similarity=0.474 Sum_probs=220.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|+... +++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~ 116 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDR 116 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECC---CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCC
Confidence 35899999999999999999999776 58899999986543333444556788999999987 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeE
Confidence 99999999999999988744 358999999999999999999999999999999999999 7788999999999987
Q ss_pred cCCCC--cccccccCCCcccccccCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 313 VRPDE--RLNDIVGSAYYVAPEVLHR-----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
..... .....+||+.|+|||++.+ .++.++|||||||++|||++|..||........+..++...........
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 271 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCc
Confidence 64332 2235679999999998753 2788999999999999999999999988888788887765443333333
Q ss_pred CCCCHHHHHHHHHhccCCccC--CCCHHHHHcCcccCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNS 422 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~--Rps~~elL~hp~~~~~ 422 (455)
..++..+.+||..||..++.+ |+++.++++|+||++.
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 468999999999999854443 7899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=351.66 Aligned_cols=258 Identities=30% Similarity=0.491 Sum_probs=216.1
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
.|++.+.||+|+||.||++.... +++.||||.+.............+.+|+.+++.++ |++|+.+++.+.+++..+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALC 76 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC---CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEE
Confidence 47888999999999999999776 58899999987654444455566788999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||++....
T Consensus 77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVP 153 (285)
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecC
Confidence 9999999999998875433 469999999999999999999999999999999999999 778889999999997765
Q ss_pred CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh---HHHHHHHhcCCCCCCCCCCCCCH
Q 012825 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES---GIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
.........|+..|+|||++. +.++.++||||||+++|+|++|+.||...... .......... .......++.
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (285)
T cd05630 154 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---QEEYSEKFSP 230 (285)
T ss_pred CCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---hhhcCccCCH
Confidence 444445567999999999986 56899999999999999999999999765432 1222222111 1122346789
Q ss_pred HHHHHHHHhccCCccCCCC-----HHHHHcCcccCCCC
Q 012825 391 EARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps-----~~elL~hp~~~~~~ 423 (455)
++.+||++||+.||++|+| +.++++||||+..+
T Consensus 231 ~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 231 DARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred HHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 9999999999999999999 99999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=350.34 Aligned_cols=257 Identities=30% Similarity=0.488 Sum_probs=217.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC--
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~-- 231 (455)
.-.|...+++|.|+||.||.|.... ++..||||..-.+.. .-.+|+++|+.+. |||||+|+-+|...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e---~~~~vAIKKv~~d~r-------~knrEl~im~~l~-HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRE---TEEEVAIKKVLQDKR-------YKNRELQIMRKLD-HPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcC---CCceeEEEEecCCCC-------cCcHHHHHHHhcC-CcCeeeEEEEEEecCC
Confidence 4468889999999999999999888 478999998743321 2237999999887 99999999888632
Q ss_pred -C--ceEEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 232 -D--NVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 232 -~--~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
+ ...+||||++. +|.+.+.. .+..++.-.++-+..||++||.|||+.||+||||||.|||++ .+.+.+|||
T Consensus 92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKic 168 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKIC 168 (364)
T ss_pred CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEec
Confidence 2 35689999975 88887754 367899999999999999999999999999999999999995 456999999
Q ss_pred ecccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC--
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-- 381 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-- 381 (455)
|||.|+.+..++....+..|..|+|||.+.| .|+.+.||||.||++.||+.|+..|.+....+.+..+.+......
T Consensus 169 DFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred cCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999999988888888999999999998875 699999999999999999999999999888887777654322111
Q ss_pred ----------C--------C-----CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 382 ----------E--------A-----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 382 ----------~--------~-----~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
+ . .....++++.+|+.++|..+|.+|.++.|+|.||||....+
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 1 1 12346889999999999999999999999999999998654
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=357.05 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=215.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|.+.++||+|+||.||+|+... +++.||+|++...... .....+.+|+.++++++ |+||+++++++..++.
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 78 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEE--GAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKS 78 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecC---CCCeEEEEEeeccccC--CcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCe
Confidence 4679999999999999999998765 5789999998654322 22345678999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++ +|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 79 LTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAK 154 (309)
T ss_pred EEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceec
Confidence 9999999975 8888887767778999999999999999999999999999999999999 77888999999998765
Q ss_pred CCCC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC---------
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--------- 381 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--------- 381 (455)
.... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||...+..+.+..+.+......
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 3322 2334568899999998753 588999999999999999999999987776655544433211100
Q ss_pred -----------------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 382 -----------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 382 -----------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
....+.++.++.+||.+||+.||.+|||+.|+|.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 011235788999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=360.82 Aligned_cols=262 Identities=27% Similarity=0.491 Sum_probs=219.8
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.++||+|+||.||+++... +++.||+|++.+...........+.+|+.++..+. |++|+++++++.+.+.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNL 76 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEE
Confidence 479999999999999999998776 57899999986433233334456888999999887 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|+||||+++|+|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 153 (332)
T ss_pred EEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecc
Confidence 99999999999999987766789999999999999999999999999999999999999 778899999999987654
Q ss_pred CCCc--ccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC-CCC
Q 012825 315 PDER--LNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-APW 385 (455)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 385 (455)
.... ....+||+.|+|||++. +.++.++|||||||++|||++|+.||........+..+......... ...
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcc
Confidence 3322 23457999999999874 35788999999999999999999999988877777777665432221 122
Q ss_pred CCCCHHHHHHHHHhccCCccC--CCCHHHHHcCcccCCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNSN 423 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~--Rps~~elL~hp~~~~~~ 423 (455)
..++.++.+||++||+.++++ |+++.++++||||++..
T Consensus 234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 467999999999999765554 68999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=362.14 Aligned_cols=251 Identities=30% Similarity=0.538 Sum_probs=211.5
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHH-HHHhcCCCCeeEEeEEEeeCCceEEEEe
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI-LRALTGHNNLVKFFDAYEDTDNVYVVME 239 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~~hp~Iv~l~~~~~~~~~~~lV~E 239 (455)
+.||+|+||.||+|+... +|+.||+|++.+..........++..|... ++.+. |+||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEc
Confidence 479999999999999776 589999999865433333344555566554 46676 9999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCc
Q 012825 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DER 318 (455)
Q Consensus 240 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~ 318 (455)
|+++++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ...
T Consensus 77 ~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 77 YVNGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred CCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCc
Confidence 999999988775 45679999999999999999999999999999999999999 7788999999999875432 233
Q ss_pred ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012825 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (455)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~ 397 (455)
.....||..|+|||++. ..++.++|||||||++|+|++|..||......+.+..++...... .+.++..+.+||+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~ 228 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL----KPNISVSARHLLE 228 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHH
Confidence 44567999999999887 468999999999999999999999999888777777776654333 2367899999999
Q ss_pred HhccCCccCCCCH----HHHHcCcccCCCC
Q 012825 398 RLLNKDPRKRLTA----AQALSHPWIKNSN 423 (455)
Q Consensus 398 ~~L~~dP~~Rps~----~elL~hp~~~~~~ 423 (455)
+||+.||.+||++ .++++||||....
T Consensus 229 ~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 229 GLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred HHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 9999999999988 6999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=358.42 Aligned_cols=252 Identities=29% Similarity=0.529 Sum_probs=212.5
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|+... +++.||||++...........+.+..|..++..+.+||||+++++++.+.+.+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 479999999999999776 57899999986543222233455677888888765699999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCcc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~~ 319 (455)
+++|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 78 LNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCce
Confidence 999999988754 4578999999999999999999999999999999999999 7788999999999875422 2233
Q ss_pred cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012825 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~ 398 (455)
....||..|+|||++. ..++.++|||||||++|+|++|..||........+..+....+.++ ..++.++.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~ 229 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVK 229 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHH
Confidence 4567999999999986 4689999999999999999999999988887777666655443333 2478999999999
Q ss_pred hccCCccCCCCHH-HHHcCcccCCCC
Q 012825 399 LLNKDPRKRLTAA-QALSHPWIKNSN 423 (455)
Q Consensus 399 ~L~~dP~~Rps~~-elL~hp~~~~~~ 423 (455)
||+.||++|+++. +++.||||+...
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 230 LFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred HhccCHhhcCCChHHHHcCcccCCCC
Confidence 9999999999997 899999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=362.36 Aligned_cols=253 Identities=30% Similarity=0.523 Sum_probs=216.5
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEe
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E 239 (455)
++.||+|+||.||+++...+..+|+.||+|++.+... .......+.+|+++++++. |+||+++++++.+++..|+|||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEc
Confidence 3679999999999998765555789999999865322 2223455778999999998 9999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCC-Cc
Q 012825 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ER 318 (455)
Q Consensus 240 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~-~~ 318 (455)
|+++++|.+++. +...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...... ..
T Consensus 79 ~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 79 FLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCc
Confidence 999999998874 44579999999999999999999999999999999999999 77889999999998765433 23
Q ss_pred ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012825 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (455)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~ 397 (455)
.....|+..|+|||++. ..++.++|||||||++|+|++|+.||...........+.+.....+ ..++.++.+||+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 230 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLR 230 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 34567999999999986 4688999999999999999999999998887777777766554333 357899999999
Q ss_pred HhccCCccCCCC-----HHHHHcCcccCCC
Q 012825 398 RLLNKDPRKRLT-----AAQALSHPWIKNS 422 (455)
Q Consensus 398 ~~L~~dP~~Rps-----~~elL~hp~~~~~ 422 (455)
+||+.||++||+ +.+++.|+||+..
T Consensus 231 ~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 231 ALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 999999999999 7889999999875
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=373.28 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=208.5
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
..++|++++.||+|+||.||+|.... +++.||||++.... ....+|+.+++.+. |+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~ 132 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICID---TSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTEC 132 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeecc
Confidence 35789999999999999999998765 58899999885321 22357999999998 99999999987432
Q ss_pred -------CceEEEEeecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCce
Q 012825 232 -------DNVYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (455)
Q Consensus 232 -------~~~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~ 301 (455)
..+++||||+++ +|.+++. ..+..+++..++.++.||+.||.|||+.||+||||||+|||++ ..++.
T Consensus 133 ~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~ 209 (440)
T PTZ00036 133 FKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHT 209 (440)
T ss_pred cccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCc
Confidence 246799999975 6766654 2456799999999999999999999999999999999999993 23347
Q ss_pred EEEeecccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC
Q 012825 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (455)
Q Consensus 302 vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 379 (455)
+||+|||+++............||..|+|||++.+ .++.++|||||||++|||++|..||.+....+.+..++.....
T Consensus 210 vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred eeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999999987765555556788999999998754 5899999999999999999999999887766655555432111
Q ss_pred ------------CCCC-------------CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 380 ------------FDEA-------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 380 ------------~~~~-------------~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
+... .....+.++.+||.+||++||.+|+|+.|+|.||||+...+
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 0000 01135789999999999999999999999999999987643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=360.09 Aligned_cols=251 Identities=25% Similarity=0.416 Sum_probs=215.1
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..+++.+...||+|.||+||+|++.. .||||++.... ...+..+.|++|+.++++-+ |-||+-+.|+|....
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG------dVAVK~Lnv~~-pt~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG------DVAVKLLNVDD-PTPEQLQAFKNEVAVLKKTR-HENILLFMGACMNPP 461 (678)
T ss_pred CHHHhhccceeccccccceeeccccc------ceEEEEEecCC-CCHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCc
Confidence 35677889999999999999999776 59999997654 45568899999999999999 999999999998887
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
. .||+.+|+|.+|+.+++-...+|.....+.|++||++|+.|||.++|||||||..|||+ ++++.|||+|||++..
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATV 537 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceee
Confidence 7 99999999999999998888899999999999999999999999999999999999999 7779999999999865
Q ss_pred c---CCCCcccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC-CCCC
Q 012825 313 V---RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF-DEAP 384 (455)
Q Consensus 313 ~---~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~ 384 (455)
. ..........|...|||||+++ ..|+..+|||+||+++|||++|..||.....+.++..+-++.... .-..
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence 3 3334455567888999999875 359999999999999999999999999666666555554442222 1222
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
...+++++++|+..||..++++||...+||.
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 3457789999999999999999999999987
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=359.70 Aligned_cols=262 Identities=27% Similarity=0.486 Sum_probs=219.7
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+++... +++.||+|++.+...........+.+|+.++..+. |+||+++++++.+++..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~ 76 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH---TERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYL 76 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEE
Confidence 479999999999999999998766 57899999986533233344556788999999887 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
||||||++||+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMN 153 (331)
T ss_pred EEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeecc
Confidence 99999999999999987766789999999999999999999999999999999999999 778889999999997665
Q ss_pred CCCcc--cccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC-CCCC
Q 012825 315 PDERL--NDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-EAPW 385 (455)
Q Consensus 315 ~~~~~--~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~ 385 (455)
..... ....||..|+|||++. +.++.++|||||||++|+|++|+.||......+.+..+........ ....
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcc
Confidence 43322 3357999999999875 3578899999999999999999999988877777776665433222 1122
Q ss_pred CCCCHHHHHHHHHhccCCccC--CCCHHHHHcCcccCCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNSN 423 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~--Rps~~elL~hp~~~~~~ 423 (455)
..++.++.+||.+||+.++++ |++++++++|+||+...
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 457899999999999976654 57999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=358.01 Aligned_cols=252 Identities=28% Similarity=0.512 Sum_probs=211.1
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|+... +++.||+|++.+.........+.+.+|+.++.++.+|+||+++++++.+.+.+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 479999999999998776 57899999997654445556677889999999997799999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC-CCCcc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERL 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~-~~~~~ 319 (455)
+++++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 78 VNGGDLMFHMQ-RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCce
Confidence 99999988774 44579999999999999999999999999999999999999 778889999999987532 23344
Q ss_pred cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC-------hhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART-------ESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
...+||..|+|||++. ..++.++|||||||++|+|++|+.||.... .......+.......+ ..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~ 229 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVK 229 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHH
Confidence 5578999999999886 568999999999999999999999995322 1223333333322222 357899
Q ss_pred HHHHHHHhccCCccCCCC------HHHHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLT------AAQALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps------~~elL~hp~~~~~~ 423 (455)
+.++|++||+.||++|++ +.+++.||||+...
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 999999999999999998 57999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=349.31 Aligned_cols=261 Identities=30% Similarity=0.481 Sum_probs=220.0
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
.|+..+.||+|+||.||++.... +++.||+|.+.............+.+|+++++.++ |+||+.+++++..++..+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC---CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEE
Confidence 37888999999999999998776 58899999986654444444566788999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 236 VVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecC
Confidence 999999999998877654 3469999999999999999999999999999999999999 677889999999987665
Q ss_pred CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
.........|+..|+|||++. ..++.++||||||+++|+|++|..||...........+..............++.++.
T Consensus 154 ~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05632 154 EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAK 233 (285)
T ss_pred CCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHH
Confidence 444445567899999999876 5689999999999999999999999987665544444433322222333456889999
Q ss_pred HHHHHhccCCccCCCC-----HHHHHcCcccCCCC
Q 012825 394 DFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (455)
Q Consensus 394 ~li~~~L~~dP~~Rps-----~~elL~hp~~~~~~ 423 (455)
+|+.+||+.||++||+ +.+++.|+||+...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 9999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=362.20 Aligned_cols=257 Identities=31% Similarity=0.522 Sum_probs=230.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|+.++++|+|+||.+++++.+. .+..|++|.+......... .+...+|+.++++++ |||||.+.+.|.+++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~---~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS---DDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc---CCceEEEEEEeccccCchh-hHHHHHHHHHHHhcc-CCCeeeeccchhcCCc
Confidence 4689999999999999999998776 4679999999766544443 347789999999998 9999999999999998
Q ss_pred -eEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 234 -VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 234 -~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
++|||+||+||++.+.+.+.+ ..++++.+..|+.||+.|+.|||++.|+|||||+.|||+ ..+..|||+|||+|+
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAK 154 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhh
Confidence 999999999999999987765 679999999999999999999999999999999999999 566778999999999
Q ss_pred ccCCCC-cccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FVRPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
...... .....+||+.||.||.+.+ .|+.|+|||||||++|||++-+.+|.+.+......++.+....... ..++
T Consensus 155 ~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys 231 (426)
T KOG0589|consen 155 ILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYS 231 (426)
T ss_pred hcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---cccc
Confidence 998776 6788899999999999985 7999999999999999999999999999999988888887632222 3689
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.+++.+|+.||+.+|..||++.++|.+|.++.
T Consensus 232 ~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 232 SELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 99999999999999999999999999988873
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=342.66 Aligned_cols=260 Identities=29% Similarity=0.558 Sum_probs=238.5
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
..-++|+.+++||+|.||.|-+++.+. +|+.||+|++++...........-..|-.+|+... ||.+..|--.|+..
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKa---t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKA---TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQ 240 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecc---cCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccC
Confidence 345789999999999999999998776 79999999999988777777778889999999988 99999998899999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+++|+||||..||.|.-++ .+...+++...+.+...|+.||.|||+++||+||||.+|.|+ |.+|++||+|||+++
T Consensus 241 drlCFVMeyanGGeLf~HL-srer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHL-SRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCK 316 (516)
T ss_pred ceEEEEEEEccCceEeeeh-hhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccch
Confidence 9999999999999998776 456779999999999999999999999999999999999999 899999999999997
Q ss_pred cc-CCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FV-RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
.- ..+....++|||+.|+|||++. ..|....|+|.+||++|||+||+.||.+..+...+..|+-.+..++. .++
T Consensus 317 E~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls 392 (516)
T KOG0690|consen 317 EEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLS 392 (516)
T ss_pred hcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCC
Confidence 64 3455678899999999999997 67999999999999999999999999999999999999999888877 689
Q ss_pred HHHHHHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 390 SEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
++.+.|+..+|.+||.+|. .+.+|.+|+||..++
T Consensus 393 ~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 393 PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred HHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 9999999999999999997 689999999999865
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=348.57 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=207.6
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEeEEEee---
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYED--- 230 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hp~Iv~l~~~~~~--- 230 (455)
+|++.+.||+|+||.||+|+... +|+.||+|.+....... .....+.+|+.+++.+. +|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 58999999999999999999776 58999999986532221 11234556777777664 49999999998864
Q ss_pred --CCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeec
Q 012825 231 --TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 231 --~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
....++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+||
T Consensus 77 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~df 152 (288)
T cd07863 77 DRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADF 152 (288)
T ss_pred CCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcc
Confidence 3458999999975 8888776543 458999999999999999999999999999999999999 77888999999
Q ss_pred ccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC------
Q 012825 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF------ 380 (455)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~------ 380 (455)
|++.............|+..|+|||++. ..++.++|||||||++|+|++|+.||......+.+..+.......
T Consensus 153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 153 GLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred CccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 9998776544445567899999999876 568999999999999999999999998777666555554321100
Q ss_pred -----------------CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 381 -----------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 381 -----------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.....+.++..+.+||.+||+.||++|||+.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 001123578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=368.87 Aligned_cols=261 Identities=30% Similarity=0.507 Sum_probs=228.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.+-|+|+..||.|+||.||+|..+. ++-..|.|+| ...+.+.++++.-||+||..+. ||+||+|++.|..++.
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nke---t~~lAAaKvI---etkseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKE---TKLLAAAKVI---ETKSEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENK 103 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhccc---chhhhhhhhh---cccchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCc
Confidence 4568999999999999999999775 4667788988 4467788899999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+||+.|||.||-+...+.+-+..+++.++..+++|++.||.|||+++|||||||..|||+ ..+|.++|+|||.+...
T Consensus 104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKN 180 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccc
Confidence 999999999999998888999999999999999999999999999999999999999999 67788999999987543
Q ss_pred -CCCCcccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 314 -RPDERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 314 -~~~~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
...+....++||++|||||++. .+|+.++||||||++|+||..+..|-...+.-.++.++.+..+..... ..
T Consensus 181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq-PS 259 (1187)
T KOG0579|consen 181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ-PS 259 (1187)
T ss_pred hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC-cc
Confidence 2334556789999999999863 469999999999999999999999987777766666776666544332 24
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~ 425 (455)
.|+..|.||+++||.+||+.||++.++|+||||+.....
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 689999999999999999999999999999999976444
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=358.63 Aligned_cols=250 Identities=29% Similarity=0.528 Sum_probs=211.1
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHH-HHHhcCCCCeeEEeEEEeeCCceEEEEe
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI-LRALTGHNNLVKFFDAYEDTDNVYVVME 239 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~~hp~Iv~l~~~~~~~~~~~lV~E 239 (455)
+.||+|+||.||+|+... +|+.||+|++.+...........+..|..+ ++.+. |+||+++++++..++..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEc
Confidence 469999999999998765 589999999865433334444566667665 55566 9999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCc
Q 012825 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DER 318 (455)
Q Consensus 240 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~ 318 (455)
|+++++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..... ...
T Consensus 77 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 77 FVNGGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCC
Confidence 999999988774 45679999999999999999999999999999999999999 7788999999999875422 233
Q ss_pred ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012825 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (455)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~ 397 (455)
.....||..|+|||++. +.++.++|||||||++|+|++|..||........+..++...... .+.++..+.++|+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ll~ 228 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL----RPGASLTAWSILE 228 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC----CCCCCHHHHHHHH
Confidence 44567999999999987 468999999999999999999999999888777777776654332 2368899999999
Q ss_pred HhccCCccCCCCH----HHHHcCcccCCC
Q 012825 398 RLLNKDPRKRLTA----AQALSHPWIKNS 422 (455)
Q Consensus 398 ~~L~~dP~~Rps~----~elL~hp~~~~~ 422 (455)
+||+.||.+||++ .++++||||+..
T Consensus 229 ~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 229 ELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred HHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 9999999999977 589999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=361.35 Aligned_cols=250 Identities=31% Similarity=0.564 Sum_probs=210.9
Q ss_pred EeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEeEEEeeCCceEEEEee
Q 012825 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
||+|+||.||+|+... +|+.||||++.+..............|..++..+. +||||+++++++.+.+..|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 6999999999998766 58899999986543333334445566777776654 699999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCcc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERL 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~~ 319 (455)
+++++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~-~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 78 MSGGELFWHLQ-KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred CCCChHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCc
Confidence 99999988775 45679999999999999999999999999999999999999 7788999999999876432 2334
Q ss_pred cccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012825 320 NDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~ 397 (455)
...+||..|+|||++.+ .++.++|||||||++|+|++|..||........+..+......+.. ..++.++.+||+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~ 230 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVK 230 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHH
Confidence 55689999999998863 4789999999999999999999999988877777776655544432 247899999999
Q ss_pred HhccCCccCCC----CHHHHHcCcccCCC
Q 012825 398 RLLNKDPRKRL----TAAQALSHPWIKNS 422 (455)
Q Consensus 398 ~~L~~dP~~Rp----s~~elL~hp~~~~~ 422 (455)
+||+.||.+|| ++.++++||||+..
T Consensus 231 ~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 231 GLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 99999999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=359.67 Aligned_cols=258 Identities=29% Similarity=0.501 Sum_probs=209.2
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||++.... +|+.||||++.... ........+.+|+.+++.+. |+||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 92 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTV---LGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQ 92 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcC---CCceeEEEEecccc-cchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccC
Confidence 346899999999999999999998765 58899999986543 33444567889999999998 99999999998644
Q ss_pred C------ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 232 D------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 232 ~------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
+ .+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~ 165 (359)
T cd07876 93 KSLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKIL 165 (359)
T ss_pred CCccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEe
Confidence 3 47999999965 6666553 348899999999999999999999999999999999999 778899999
Q ss_pred ecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhc--------
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA-------- 376 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~-------- 376 (455)
|||++.............||..|+|||++. ..++.++|||||||++|+|++|+.||...........+++.
T Consensus 166 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 166 DFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred cCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 999998765444455668899999999987 46899999999999999999999999876654433222211
Q ss_pred --------------CCCCCCC----------------CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 377 --------------DPSFDEA----------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 377 --------------~~~~~~~----------------~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.+..... .....+.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 1111000 00124678999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=327.35 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=227.4
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++.+++..||.|.-|+|++++++. +|...|||.+.+. .+.+..+++...++++.+..++|+||+.+|+|..+..+
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs---~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRS---TGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcc---cceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 455678889999999999999888 6899999999765 56777889999999998888899999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|.||.|. .-+..++..-.+.++|..+-++...++.||.||.++ ||+|||+||+|||+ |+.|++||||||.+..+
T Consensus 167 ~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 167 FICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeeccccccee
Confidence 99999994 344555555567899999999999999999999876 89999999999999 99999999999999988
Q ss_pred CCCCcccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCC-CChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
.+....+...|-+.|||||.+. ..|+..+||||||++++||.||+.||.+ .++.+.+..+++..+..... -..+
T Consensus 243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~-~~gF 321 (391)
T KOG0983|consen 243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG-HMGF 321 (391)
T ss_pred ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc-ccCc
Confidence 8777778889999999999986 3599999999999999999999999987 56778888888876643222 1248
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+++|.+|+..||++|+.+||...++|+|||++...
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 99999999999999999999999999999999764
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=345.70 Aligned_cols=251 Identities=27% Similarity=0.459 Sum_probs=207.4
Q ss_pred EeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecC
Q 012825 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (455)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 242 (455)
||+|+||.||+++.+. +|+.||+|++.............+..|+++++++. |+||+++++++.++...++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEcc---CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCC
Confidence 6999999999999776 58999999986543333333445667999999997 9999999999999999999999999
Q ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcccc
Q 012825 243 GGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321 (455)
Q Consensus 243 ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~ 321 (455)
|++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++...........
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeec
Confidence 999988776543 368999999999999999999999999999999999999 7788899999999987655444445
Q ss_pred cccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh----HHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 012825 322 IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES----GIFRAVLKADPSFDEAPWPSLSSEARDFV 396 (455)
Q Consensus 322 ~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~l~~li 396 (455)
..|+..|+|||++. +.++.++|||||||++|+|++|+.||...... ............. ....++.++.+||
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li 230 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF---EHQNFTEESKDIC 230 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc---ccccCCHHHHHHH
Confidence 67899999999876 46899999999999999999999999754332 2222222222221 1235889999999
Q ss_pred HHhccCCccCCCCH----HHHHcCcccCCCC
Q 012825 397 KRLLNKDPRKRLTA----AQALSHPWIKNSN 423 (455)
Q Consensus 397 ~~~L~~dP~~Rps~----~elL~hp~~~~~~ 423 (455)
.+||+.||++||++ .+++.|+||+..+
T Consensus 231 ~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 231 RLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred HHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 99999999999999 6788999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=353.34 Aligned_cols=278 Identities=27% Similarity=0.430 Sum_probs=223.8
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
...-+..|+++++||+||-+.||++...+ .+.||+|.+.... .+.+.+.-+.+|+.+|.+|++|.+||+||||-.
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~----~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSD----KQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCC----CcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 34457889999999999999999998554 4667777664432 567778889999999999999999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
.++.+|+||||-+ .+|..+|.++...++.-.++.+..||+.++.++|++||||.||||.|+|+. .|.+||+|||.
T Consensus 431 ~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGI 505 (677)
T KOG0596|consen 431 TDGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGI 505 (677)
T ss_pred cCceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeech
Confidence 9999999999874 488888877777666669999999999999999999999999999999994 67899999999
Q ss_pred ccccCCCCcc---cccccCCCcccccccCC------------CCCCcchHHHHHHHHHHHHcCCCCCCCCC-hhHHHHHH
Q 012825 310 SDFVRPDERL---NDIVGSAYYVAPEVLHR------------SYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAV 373 (455)
Q Consensus 310 a~~~~~~~~~---~~~~gt~~y~aPE~~~~------------~~~~~sDiwSlG~~l~elltg~~Pf~~~~-~~~~~~~i 373 (455)
|..+..+... ...+||..||+||.+.. ..+.++||||||||||+|+.|+.||.... ....+..+
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI 585 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI 585 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh
Confidence 9888765432 45689999999998731 15778999999999999999999996543 22233333
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHHHHHHH
Q 012825 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMK 438 (455)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~~~~~~ 438 (455)
...+...+....+. ..++.++++.||.+||++||++.++|+|||++-+.-..-++.+.+...++
T Consensus 586 ~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~~~m~~~~~~~~k 649 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPVEQMAKLTTNEMK 649 (677)
T ss_pred cCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccchHHHHHHHHHHH
Confidence 33333222221112 23499999999999999999999999999999876666666666666664
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=352.85 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=212.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.++||+|+||.||++.... ++..+|+|++... ........+.+|++++++++ |+||++++++|.+++.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP---SGLIMARKLIHLE--IKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC---CCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCE
Confidence 5789999999999999999998765 5789999998653 23445567899999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+++||||+++++|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchh
Confidence 9999999999999998754 45689999999999999999999985 79999999999999 6778899999999876
Q ss_pred cCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHh---c------------
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK---A------------ 376 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~---~------------ 376 (455)
... .......|+..|+|||++.+ .++.++|||||||++|+|++|+.||...........+.. .
T Consensus 154 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 154 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred hhh-hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 532 22344578999999999874 588999999999999999999999975543322111100 0
Q ss_pred ---------------------------CCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 377 ---------------------------DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 377 ---------------------------~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
...........++.++.+||.+||++||++|||+.|++.|+||+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 307 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA 307 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence 000000011135788999999999999999999999999999997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=354.57 Aligned_cols=250 Identities=30% Similarity=0.521 Sum_probs=209.2
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHH-HHHHhcCCCCeeEEeEEEeeCCceEEEEe
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK-ILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E 239 (455)
+.||+|+||.||+|+... +|+.||+|++.+...........+.+|.. +++.+. |+||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEc
Confidence 479999999999999766 58899999986543333334455666665 566776 9999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC-CCCc
Q 012825 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDER 318 (455)
Q Consensus 240 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~-~~~~ 318 (455)
|+++++|.+.+. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 77 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 77 YVNGGELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCc
Confidence 999999988774 45678999999999999999999999999999999999999 778899999999987532 2233
Q ss_pred ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012825 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (455)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~ 397 (455)
....+||..|+|||++. ..++.++|||||||++|||++|..||...+.......+........ +..+..+.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 228 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLV 228 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHH
Confidence 44567999999999987 4689999999999999999999999998877777776665543332 357889999999
Q ss_pred HhccCCccCCCCH----HHHHcCcccCCC
Q 012825 398 RLLNKDPRKRLTA----AQALSHPWIKNS 422 (455)
Q Consensus 398 ~~L~~dP~~Rps~----~elL~hp~~~~~ 422 (455)
+||+.||.+|+++ .++++|+||...
T Consensus 229 ~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 229 GLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred HHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 9999999999976 499999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=361.21 Aligned_cols=252 Identities=17% Similarity=0.295 Sum_probs=203.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
..+|++.+.||+|+||.||+|.+.. +++.||+|.... ..+.+|++++++|+ ||||+++++++..++.
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~---~~~~vaiK~~~~---------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNK---TCEHVVIKAGQR---------GGTATEAHILRAIN-HPSIIQLKGTFTYNKF 157 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECC---CCCEEEEechhh---------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCe
Confidence 4689999999999999999999776 688999997531 34678999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++|||++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 158 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFP 232 (391)
T ss_pred eEEEEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccc
Confidence 999999995 688887754 4568999999999999999999999999999999999999 77788999999999754
Q ss_pred CCC--CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC-------hhHHHHHHHhcCC-----
Q 012825 314 RPD--ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART-------ESGIFRAVLKADP----- 378 (455)
Q Consensus 314 ~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~-------~~~~~~~i~~~~~----- 378 (455)
... .......||+.|+|||++. ..++.++|||||||++|||++|..||.... ....+..++....
T Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred ccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 322 2334568999999999986 468999999999999999999998875322 1111111111100
Q ss_pred ---------------------CCC--CCC---CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 379 ---------------------SFD--EAP---WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 379 ---------------------~~~--~~~---~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
... ... ...++.++.+||.+||++||++|||+.|+|+||||+...
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 000 000 013467899999999999999999999999999999864
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=348.07 Aligned_cols=261 Identities=27% Similarity=0.444 Sum_probs=215.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||.|+||.||+|+... +++.||+|.+...... .....+.+|+.+++.++ |+||+++++++..++.
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~ 78 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKL---TDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKS 78 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcC---CCcEEEEEEEeccccc--CchhHHHHHHHHHHhcC-CCCcceEEEEEecCCe
Confidence 4679999999999999999998765 5789999998644322 22345678999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||++ ++|.+++......+++..++.++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||++...
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 79 LTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAK 154 (301)
T ss_pred EEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhcc
Confidence 999999996 58988887777789999999999999999999999999999999999999 77888999999998765
Q ss_pred CCCC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC---------
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--------- 381 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--------- 381 (455)
.... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||...+..+....+........
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 3222 2234567889999998753 478899999999999999999999987776555444433211100
Q ss_pred -----------------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 382 -----------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 382 -----------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
....+.+++++.+||.+||+.||.+|||+.++|+||||+...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 0012357889999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=355.10 Aligned_cols=250 Identities=29% Similarity=0.522 Sum_probs=209.2
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHH-HHHhcCCCCeeEEeEEEeeCCceEEEEe
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI-LRALTGHNNLVKFFDAYEDTDNVYVVME 239 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~~hp~Iv~l~~~~~~~~~~~lV~E 239 (455)
+.||+|+||.||+|+... +++.||+|++.+...........+..|... ++.+. |+||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEe
Confidence 479999999999998776 578999999865432233333455555554 56666 9999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCc
Q 012825 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DER 318 (455)
Q Consensus 240 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~ 318 (455)
|+++++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.... ...
T Consensus 77 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 77 YINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCC
Confidence 9999999987754 4568999999999999999999999999999999999999 7788999999999875432 233
Q ss_pred ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012825 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (455)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~ 397 (455)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||......+.+..+....... .+.++..+.++|+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~ 228 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLE 228 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHH
Confidence 45567999999999887 468999999999999999999999999888877777776654332 2468999999999
Q ss_pred HhccCCccCCCCHH----HHHcCcccCCC
Q 012825 398 RLLNKDPRKRLTAA----QALSHPWIKNS 422 (455)
Q Consensus 398 ~~L~~dP~~Rps~~----elL~hp~~~~~ 422 (455)
+||+.||.+|+++. ++++|+||...
T Consensus 229 ~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 229 GLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred HHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 99999999999876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=361.05 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=228.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.+.|.-++.||.|+||.||.|++.. +...||||.+........+.-.++..||.+|++|. |||++.+-|+|..+..
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~---n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHT 100 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccC---ccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccch
Confidence 3558889999999999999999777 67899999997766666677788999999999999 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.||||||| -|+-.|.+.-...++-+..+..|+.+.+.||.|||+.+.||||||..|||+ .+.|.|||+|||.|...
T Consensus 101 aWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 101 AWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhc
Confidence 99999999 558888887677889999999999999999999999999999999999999 78999999999999876
Q ss_pred CCCCcccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
.+ .+.++||++|||||++. |.|+-++||||||++.+||.-.+.|+.+.+.-..+..|...+.+... ...++
T Consensus 177 ~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--s~eWS 251 (948)
T KOG0577|consen 177 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWS 251 (948)
T ss_pred Cc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--CchhH
Confidence 54 46679999999999863 78999999999999999999999999888877777766665544332 34789
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
..|..||..||++-|.+|||.+++|.|+|.....
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 9999999999999999999999999999998753
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=341.94 Aligned_cols=254 Identities=41% Similarity=0.720 Sum_probs=210.2
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
|++++.||+|+||+||++.... +++.||+|++....... .......+|+.+++++. |+||+++++++.+.+..++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---NGQKVAVKIIDKSEIEE-EEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---TTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECC---CCeEEEEEEeccccccc-cccchhhhhhhcccccc-ccccccccccccccccccc
Confidence 8899999999999999999777 57899999997653222 22233456999999996 9999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc-CC
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RP 315 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~-~~ 315 (455)
||||+.+++|.+++. ....+++..++.++.||++||.+||+.||+|+||||+|||+ ++++.++|+|||.+... ..
T Consensus 76 v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTST
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccc
Confidence 999999999999886 55678999999999999999999999999999999999999 78899999999999763 33
Q ss_pred CCcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCh---hHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 316 DERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
........++..|+|||++. ..++.++||||||+++|+|++|..||..... ...+....................
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE 231 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence 34556678899999999987 5689999999999999999999999987732 223333332211111111112248
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.+.++|++||+.||++||++.++++||||
T Consensus 232 ~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 232 ELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=366.95 Aligned_cols=256 Identities=29% Similarity=0.422 Sum_probs=218.8
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
..|.+.+.||+|+||.||+|..... .++.||+|.+.. ........+.+|+.+++.+. ||||+++++++..++.+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~--~~~~vv~K~~~~---~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSD--PKEKVVAKFVML---NDERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKL 140 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCC--CCeEEEEEEccc---CCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEE
Confidence 4599999999999999999986652 267889997743 33445567889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 235 YVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
||||||++||+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCce
Confidence 999999999999987754 24568999999999999999999999999999999999999 778899999999998
Q ss_pred ccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 312 FVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 312 ~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
...... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||......+.+..++...... ....
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~ 294 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---FPCP 294 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CCcc
Confidence 764332 234567999999999986 468999999999999999999999998888777777776654321 1235
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
++.++.+||.+||+.||++||++.+++.|+|++..
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 78999999999999999999999999999999753
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=337.50 Aligned_cols=273 Identities=34% Similarity=0.634 Sum_probs=231.2
Q ss_pred CCeEE-eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 155 NKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 155 ~~y~~-~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
+-|++ .+.||+|+|+.|--+.... +|.+||||++.+. ......++.+|++++.+.++|+||++|+++|+++..
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~---t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQ---TGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeec---cchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 34554 4579999999998877655 6899999999764 445567899999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|||||.|.||.|+.+|+++ ..|++.++.++.++|+.||.|||.+||.||||||+|||....+.---||||||.+..-.
T Consensus 151 FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 99999999999999999654 56999999999999999999999999999999999999976666667999999987543
Q ss_pred CCCC--------cccccccCCCcccccccC---C---CCCCcchHHHHHHHHHHHHcCCCCCCCCC--------------
Q 012825 314 RPDE--------RLNDIVGSAYYVAPEVLH---R---SYSTEADVWSIGVIAYILLCGSRPFWART-------------- 365 (455)
Q Consensus 314 ~~~~--------~~~~~~gt~~y~aPE~~~---~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~-------------- 365 (455)
.... ...+.+|+..|||||+.. + .|+.+.|.||||||||.|++|..||.+.-
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~ 309 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV 309 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH
Confidence 2221 223457888999999753 2 48999999999999999999999995432
Q ss_pred -hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC-CCCCchhHHHH
Q 012825 366 -ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN-DVKVPLDVIIF 434 (455)
Q Consensus 366 -~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~-~~~~p~~~~~~ 434 (455)
....+..|..+...|++..|..+|.+.+|+|..+|..|+.+|.++.+++.|||++... +..+|....+.
T Consensus 310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v~~ 380 (463)
T KOG0607|consen 310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQVLQ 380 (463)
T ss_pred HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCcccc
Confidence 2357788888999999999999999999999999999999999999999999999864 34455444333
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=353.00 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=202.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
..+|++.+.||+|+||.||+|+... +++.||+|+.... ....|+.++++++ |+||+++++++.+.+.
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPG---QPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECC---CCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCe
Confidence 4579999999999999999999765 5789999986432 1246999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++|||++. ++|.+++......+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 132 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFP 207 (357)
T ss_pred eEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCcccccc
Confidence 999999995 58898887777889999999999999999999999999999999999999 77888999999999765
Q ss_pred CCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCh----------hHHHHHHHhcCC----
Q 012825 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE----------SGIFRAVLKADP---- 378 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~----------~~~~~~i~~~~~---- 378 (455)
..........||..|+|||++. ..++.++|||||||++|||+++..++..... ...+..++....
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 4444445567999999999986 4689999999999999999986555422211 111111111100
Q ss_pred CCCC--------------------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 379 SFDE--------------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 379 ~~~~--------------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.+.. .....++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0000 001135677888999999999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=351.38 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=204.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.+.||+|+||.||+|.... ....+..||||++... ......+.+.+|+.++.++.+|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG--ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc--cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 5789999999999999999998642 1224678999998643 23344567899999999995599999999988764
Q ss_pred -CceEEEEeecCCCcHHHHHHhcC--------------------------------------------------------
Q 012825 232 -DNVYVVMELCEGGELLDRILSRG-------------------------------------------------------- 254 (455)
Q Consensus 232 -~~~~lV~E~~~ggsL~~~l~~~~-------------------------------------------------------- 254 (455)
+.+++||||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 46899999999999999886431
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCc---ccccccCC
Q 012825 255 -----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSA 326 (455)
Q Consensus 255 -----~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~ 326 (455)
..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++....... .....++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 247888999999999999999999999999999999999 6788999999999976543221 12334567
Q ss_pred CcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCc
Q 012825 327 YYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDP 404 (455)
Q Consensus 327 ~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 404 (455)
.|+|||++. ..++.++|||||||+||||++ |..||........+...+....... ....++.++.+||.+||+.||
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR--APENATPEIYRIMLACWQGDP 318 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHccCCh
Confidence 899999876 568999999999999999997 9999987654444434333322211 123678999999999999999
Q ss_pred cCCCCHHHHHc
Q 012825 405 RKRLTAAQALS 415 (455)
Q Consensus 405 ~~Rps~~elL~ 415 (455)
++|||+.++++
T Consensus 319 ~~RPs~~el~~ 329 (338)
T cd05102 319 KERPTFSALVE 329 (338)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=353.81 Aligned_cols=258 Identities=27% Similarity=0.477 Sum_probs=209.1
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
..++|++.+.||+|+||.||++.... .++.||||++.... ........+.+|+.+++.+. |+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC---CCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccc
Confidence 46899999999999999999998665 58899999986543 33444567789999999998 99999999988643
Q ss_pred -----CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 232 -----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
...|+||||+++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~D 162 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 162 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEee
Confidence 357999999965 6666553 348999999999999999999999999999999999999 7788999999
Q ss_pred cccccccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcC--------
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD-------- 377 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~-------- 377 (455)
||+++............||..|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..++...
T Consensus 163 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred CcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999987655544556789999999998874 68999999999999999999999998766544333322210
Q ss_pred --------------CCCC----------------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 378 --------------PSFD----------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 378 --------------~~~~----------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+... .......+.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0000 00111245678999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=353.93 Aligned_cols=257 Identities=26% Similarity=0.470 Sum_probs=210.5
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
..++|++.+.||+|+||.||++.... .++.||||++.... ........+.+|+.+++.+. |+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~ 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC---CCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcC-CCCccccceeecccc
Confidence 46889999999999999999998765 57899999986533 23344567789999999998 99999999987543
Q ss_pred -----CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 232 -----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
..+|+||||+++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 97 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~D 169 (364)
T cd07875 97 SLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 169 (364)
T ss_pred cccccCeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEe
Confidence 357999999965 6777663 247899999999999999999999999999999999999 7788999999
Q ss_pred cccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC------
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------ 379 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~------ 379 (455)
||+++............+|..|+|||++. ..++.++|||||||++|+|++|+.||......+.+..++.....
T Consensus 170 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99998765544455668999999999886 46899999999999999999999999887766655555432110
Q ss_pred ----------------CCC----------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 380 ----------------FDE----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 380 ----------------~~~----------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
+.. ......+.++.+||.+||+.||++|||+.++|+||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 000 000113567899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=356.66 Aligned_cols=256 Identities=32% Similarity=0.520 Sum_probs=210.5
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC---
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD--- 232 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~--- 232 (455)
+|++.+.||+|+||.||++.... +|+.||||.+... .......+.+.+|+.+++.++ |+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---DGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---CCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccc
Confidence 47889999999999999998765 5889999998643 233445567889999999998 999999999998776
Q ss_pred --ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 233 --NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 233 --~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
..|+||||+. ++|.+.+. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a 150 (372)
T cd07853 76 FEEIYVVTELMQ-SDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLA 150 (372)
T ss_pred cceEEEEeeccc-cCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccce
Confidence 7899999996 57777664 45679999999999999999999999999999999999999 77889999999999
Q ss_pred cccCCCC--cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC--------
Q 012825 311 DFVRPDE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP-------- 378 (455)
Q Consensus 311 ~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~-------- 378 (455)
....... ......++..|+|||++.+ .++.++|||||||++|||++|+.||.+......+..+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 7654322 2334568899999998864 478999999999999999999999987766554444332110
Q ss_pred ---------------CCCC-----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 379 ---------------SFDE-----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 379 ---------------~~~~-----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.... ......+.++.+||.+||+.||++|||+.++|.||||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 0000 112346889999999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=365.53 Aligned_cols=260 Identities=30% Similarity=0.471 Sum_probs=220.1
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.+.||+|+||.||+|+... +|+.||||++..... .......+.+|+.++..+. |+||+++++.+...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVS---DGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKK 103 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcC---CCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceecc
Confidence 346799999999999999999998766 589999999876543 4455667889999999998 99999998877543
Q ss_pred C--------ceEEEEeecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCc
Q 012825 232 D--------NVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (455)
Q Consensus 232 ~--------~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~ 300 (455)
+ .+++||||+++|+|.+++..+ ...+++..+..++.||+.||.|||+.+|+||||||+|||+ +.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCC
Confidence 2 378999999999999988653 3568999999999999999999999999999999999999 6788
Q ss_pred eEEEeecccccccCCC---CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhc
Q 012825 301 VLKAIDFGLSDFVRPD---ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (455)
Q Consensus 301 ~vkL~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~ 376 (455)
.+||+|||+++..... ......+||+.|+|||++. ..++.++|||||||++|||++|+.||........+..++..
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~ 260 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 9999999998765422 2234567999999999987 46899999999999999999999999988877777766654
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 377 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.... ..+.+++++.+||.+||+.||.+||++.+++.|||++..
T Consensus 261 ~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 261 RYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 3321 224688999999999999999999999999999998753
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=378.63 Aligned_cols=268 Identities=31% Similarity=0.541 Sum_probs=221.4
Q ss_pred cCcccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeE
Q 012825 147 FGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD 226 (455)
Q Consensus 147 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~ 226 (455)
+..++.+.++|++++.||+|+||.||+|+... .+..||+|++..... .......+..|+.++++|. |+|||++++
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d 79 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKR---TQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYID 79 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECC---CCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEE
Confidence 33455667899999999999999999999776 578999999865432 3344567889999999998 999999999
Q ss_pred EEee--CCceEEEEeecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc-------CCEEeeccCCceEEe
Q 012825 227 AYED--TDNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQ-------GVVHRDLKPENFLFT 294 (455)
Q Consensus 227 ~~~~--~~~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~-------~ivHrDikp~NILl~ 294 (455)
+|.+ .+.+||||||+++++|.++|... .+.+++..++.|+.||+.||.|||+. +||||||||+||||.
T Consensus 80 ~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 8864 35689999999999999988642 35799999999999999999999995 499999999999995
Q ss_pred ec--------------CCCceEEEeecccccccCCCCcccccccCCCcccccccC---CCCCCcchHHHHHHHHHHHHcC
Q 012825 295 TK--------------DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCG 357 (455)
Q Consensus 295 ~~--------------~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~sDiwSlG~~l~elltg 357 (455)
.. +....+||+|||++.............||+.|+|||++. ..++.++|||||||+||+|++|
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 32 224469999999998775554455668999999999874 3488999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 358 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 358 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
..||........+...+...+... ...++.++.+||..||+.+|.+||++.|+|.|+||+..
T Consensus 240 k~PF~~~~~~~qli~~lk~~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 240 KTPFHKANNFSQLISELKRGPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCCCcCCcHHHHHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 999987665554444444433322 23578999999999999999999999999999999854
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=356.01 Aligned_cols=259 Identities=36% Similarity=0.645 Sum_probs=232.8
Q ss_pred CeEE--eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 156 KYEL--GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 156 ~y~~--~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
-|++ .+.||.|-||+||-|..++ +|+.||||+|.+..+...+ ..++++|+.||.++. ||.||.|...|+..+.
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRk---tGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~-HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRK---TGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLH-HPGIVNLECMFETPER 637 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecc---cCceeeeeeeecccCCCch-HHHHHHHHHHHHhcC-CCCeeEEEEeecCCce
Confidence 3554 5789999999999999887 7999999999887765544 478999999999999 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRIL-SRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
++.|||.+.| +.++.|. ...+++++...+.++.||+.||.|||.++|+|+||||+|||+.+.+.--.+||||||+|++
T Consensus 638 vFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 638 VFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 9999999955 6666665 4568999999999999999999999999999999999999998777777899999999999
Q ss_pred cCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
..........+||+.|+|||+++ +.|+...|+||+||++|--+.|.+||... +++-.+|.+....++..+|.+++.+
T Consensus 717 IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 717 IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPE 794 (888)
T ss_pred cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHH
Confidence 98777778889999999999987 67999999999999999999999999644 4556777888888999999999999
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
..|||..+|+..-++|.++.+.|.|||+|+-
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999999999973
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=349.42 Aligned_cols=267 Identities=29% Similarity=0.466 Sum_probs=233.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.+.|..-+.||+||||.||-++.+. +|+.||.|.+.+.............+|-.+|.+++ .+.||.+--.|+..+.
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvra---TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRA---TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDA 259 (591)
T ss_pred ccceeeeEEEecccccceeEEEEec---chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCc
Confidence 4668889999999999999999887 79999999998777667777788899999999998 8999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+||||..|.||+|.-+|.+.+ ..|++..+..++.+|+.||++||+.+||+|||||+|||+ |+.|+++|+|+|+|..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEe
Confidence 999999999999988886654 469999999999999999999999999999999999999 8999999999999999
Q ss_pred cCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
+..++.....+||.+|||||++. +.|+...|+|+|||+||||+.|+.||....+......+-+............+|++
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~e 416 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEE 416 (591)
T ss_pred cCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHH
Confidence 98888888889999999999987 56999999999999999999999999776554433333333333333344578999
Q ss_pred HHHHHHHhccCCccCCC-----CHHHHHcCcccCCCCCCCC
Q 012825 392 ARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSNDVKV 427 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~~~~~ 427 (455)
+++|.+.+|++||++|. .+.++.+||||++.+.+.+
T Consensus 417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl 457 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL 457 (591)
T ss_pred HHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence 99999999999999998 5679999999999876544
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.83 Aligned_cols=262 Identities=29% Similarity=0.496 Sum_probs=219.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.+.|+++++||.|+||.||+|+... +++.|++|++.. ......+.+.+|+.+++.+. |+||+++++++..++.
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 83 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKE---TGALAAAKVIET---KSEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGK 83 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECC---CCceEEEEEecc---CCHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCe
Confidence 4679999999999999999998766 578999999854 34556677889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|..++.+....+++..++.++.||+.+|.|||+.||+||||||+||++ +.++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKN 160 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceec
Confidence 999999999999988877767789999999999999999999999999999999999999 67888999999988654
Q ss_pred CCC-CcccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 314 RPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
... .......++..|+|||++. ..++.++|||||||++|+|++|..||........+..+...... ......
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 239 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPS 239 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCc
Confidence 322 2234456888999999874 23688999999999999999999999876655544444433221 111223
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~ 426 (455)
.++.++.+||++||+.||++||++.++++||||......+
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 5788999999999999999999999999999999876555
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=339.51 Aligned_cols=254 Identities=31% Similarity=0.622 Sum_probs=220.7
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||++.... +++.||+|++...........+.+.+|+++++++. |+||+++++++.+++..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNL 76 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeE
Confidence 479999999999999999999776 58899999987654444455677899999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++++|.+++... +.+++..+..++.||+.||.|||+.||+|+||+|+|||+ +.++.+||+|||++....
T Consensus 77 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVK 152 (290)
T ss_pred EEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccC
Confidence 9999999999999987544 679999999999999999999999999999999999999 778889999999998765
Q ss_pred CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
.. .....++..|+|||.+. +.++.++||||||+++|+|++|..||...........+......+. ..++..+.
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~ 226 (290)
T cd05580 153 GR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAK 226 (290)
T ss_pred CC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHH
Confidence 43 34457899999999876 4678899999999999999999999987776666666654443333 25689999
Q ss_pred HHHHHhccCCccCCC-----CHHHHHcCcccCCC
Q 012825 394 DFVKRLLNKDPRKRL-----TAAQALSHPWIKNS 422 (455)
Q Consensus 394 ~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~ 422 (455)
++|.+||..||.+|+ ++++++.||||+..
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 227 DLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 999999999999999 99999999999874
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=343.62 Aligned_cols=261 Identities=33% Similarity=0.584 Sum_probs=223.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|.... +++.||+|.+...........+.+.+|+++++.+. |+||+++++.+.+++..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 76 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYL 76 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEE
Confidence 479999999999999999998766 58899999997665444456678999999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 235 YVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
|+||||+.+++|.+++... +..+++..++.++.||+.||.|||+.|++|+||||+|||+ +.++.++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhcc
Confidence 9999999999999987653 3579999999999999999999999999999999999999 67888999999998654
Q ss_pred CCCC------------------------------cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCC
Q 012825 314 RPDE------------------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFW 362 (455)
Q Consensus 314 ~~~~------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~ 362 (455)
.... ......|+..|+|||++. ..++.++||||||+++|+|++|..||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 3221 112346888999999886 458889999999999999999999998
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCC----HHHHHcCcccCCCCC
Q 012825 363 ARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT----AAQALSHPWIKNSND 424 (455)
Q Consensus 363 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps----~~elL~hp~~~~~~~ 424 (455)
.......+..+......+... ..++..+.++|.+||+.||++||+ ++++|.||||+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 234 GSNRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW 297 (316)
T ss_pred CCchHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence 888777777666554443332 237899999999999999999999 999999999998653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=353.74 Aligned_cols=257 Identities=21% Similarity=0.369 Sum_probs=207.9
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
....+|++++.||+|+||.||++..... ..+..||+|.+... +...+|++++++++ |+||+++++++...
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~-~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~ 158 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWK 158 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCC-ccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeC
Confidence 3467899999999999999999975432 35788999988543 23458999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..|+|||++. ++|.+++ .....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 159 ~~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAAC 233 (392)
T ss_pred CEEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCcccc
Confidence 99999999995 5888877 556789999999999999999999999999999999999999 778899999999997
Q ss_pred ccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCh---hHHHHHHHhcCCC----C
Q 012825 312 FVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADPS----F 380 (455)
Q Consensus 312 ~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~---~~~~~~i~~~~~~----~ 380 (455)
....... .....||..|+|||++. ..++.++|||||||++|||++|+.||.+... ...+..+.+.... +
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 6543322 23467999999999987 4689999999999999999999999966432 2222222221100 0
Q ss_pred CC--------------------CC------CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 381 DE--------------------AP------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 381 ~~--------------------~~------~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.. .. ...++.++.+||++||..||++||++.++|.||||+...
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 00 00 013567889999999999999999999999999998753
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=335.04 Aligned_cols=268 Identities=29% Similarity=0.527 Sum_probs=222.1
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||.|++|.||+|.... +++.||+|++.... .......+.+|+++++.++ |+||+++++++.++...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC---CCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeE
Confidence 478999999999999999998765 58899999986542 2334567889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++|+||+++++|.+++... .+++..++.++.|++.||.|||+.+++|+||+|+||++ ++++.++|+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLT 149 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeec
Confidence 9999999999999987543 78999999999999999999999999999999999999 778899999999998765
Q ss_pred CC-CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 315 PD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
.. .......++..|+|||++. ..++.++||||||+++|+|++|..||...........+.......... ..++.++
T Consensus 150 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 227 (274)
T cd06609 150 STMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG--NKFSKPF 227 (274)
T ss_pred ccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcc--cccCHHH
Confidence 43 2334457888999999876 458999999999999999999999998766555444444432221111 1278899
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHHHHHH
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLM 437 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~~~~~ 437 (455)
.++|.+||..||++||+++++++|+||++..+. ...+.+...+
T Consensus 228 ~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~--~~~~~~~~~~ 270 (274)
T cd06609 228 KDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT--SYLTLLIERI 270 (274)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc--cHHHHHHHHH
Confidence 999999999999999999999999999986544 3344443333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=351.64 Aligned_cols=258 Identities=27% Similarity=0.522 Sum_probs=209.5
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
+.++|++.+.||.|+||.||+|.... +++.||||++.... ......+.+.+|+.+++++. |+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 87 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTR---LRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECC---CCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccc
Confidence 46789999999999999999998766 57899999986532 22334456779999999998 99999999988643
Q ss_pred -----CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 232 -----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
...|+++|++ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~D 161 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILD 161 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcC
Confidence 3579999998 778887653 4569999999999999999999999999999999999999 7788999999
Q ss_pred cccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC-----
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----- 379 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~----- 379 (455)
||++..... ......||..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+......
T Consensus 162 fg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 162 FGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred CccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999987643 3345678999999998864 5889999999999999999999999776554444433321110
Q ss_pred ------------------CCC----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 380 ------------------FDE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 380 ------------------~~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
... ..+..+++.+.+||.+||+.||.+|||+.|+|.||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 000 01124567789999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=333.92 Aligned_cols=256 Identities=24% Similarity=0.406 Sum_probs=211.3
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|.+.. +++.||+|++... ......+.+.+|+++++++. |+||+++++++...+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL---TRRILAVKVIPLD--ITVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC---CCcEEEEEEEecC--CChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEE
Confidence 468899999999999999998765 5889999998654 23445567889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||+ +.++.++|+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 75 SICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred EEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecc
Confidence 999999999987543 347899999999999999999999999999999999999 778899999999987654
Q ss_pred CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh-------HHHHHHHhcCCCCCCCCCC
Q 012825 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES-------GIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~ 386 (455)
. .......|+..|+|||++. ..++.++||||||+++|+|++|..||...... .....+.... .......
T Consensus 147 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 223 (279)
T cd06619 147 N-SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVG 223 (279)
T ss_pred c-ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCC
Confidence 2 2334567899999999886 46899999999999999999999999643211 1222222221 1112223
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~ 427 (455)
.++.++.+||.+||+.||++||++.++++||||+..+...+
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~ 264 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCccH
Confidence 57889999999999999999999999999999998755544
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=331.37 Aligned_cols=255 Identities=26% Similarity=0.461 Sum_probs=212.7
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC--CHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+.|++.+.||+|++|.||.+.... +++.||+|.+...... .....+.+.+|+++++++. |+||+++++++.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCC
Confidence 569999999999999999998665 5889999998654322 2233467889999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||+|+||++ +.++.++|+|||++..
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKR 153 (263)
T ss_pred eEEEEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeccccee
Confidence 99999999999999987754 4568999999999999999999999999999999999999 6778899999999876
Q ss_pred cCCCCcc----cccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 313 VRPDERL----NDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 313 ~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
....... ....++..|+|||++.+ .++.++||||||+++|+|++|+.||...........+...... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~ 231 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PQLPSH 231 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--CCCCcc
Confidence 5432211 33567889999999874 5889999999999999999999999776555544444333222 112236
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
++..+.+||++||..||.+||++.++|.|+||
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 232 VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 88999999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=351.18 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=207.6
Q ss_pred CcCcccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 012825 146 SFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFF 225 (455)
Q Consensus 146 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~ 225 (455)
.+...+.++++|...+.||+|+||.||+|...+ |..||||++....... .++|.+|+.++.+++ |+|+|+|+
T Consensus 66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~Nlv~Ll 137 (361)
T KOG1187|consen 66 SYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----GTVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HPNLVKLL 137 (361)
T ss_pred eHHHHHHHHhCCchhcceecCCCeEEEEEEECC----CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-CcCcccEE
Confidence 333445678999999999999999999999876 5899999886543221 456999999999999 99999999
Q ss_pred EEEeeCC-ceEEEEeecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC---CEEeeccCCceEEeecCCCc
Q 012825 226 DAYEDTD-NVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQG---VVHRDLKPENFLFTTKDENS 300 (455)
Q Consensus 226 ~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~---ivHrDikp~NILl~~~~~~~ 300 (455)
|||.+.+ +.+|||||+++|+|.++++.... .++|..+.+|+.++++||+|||+.. |||||||++|||| |+++
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~ 214 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDF 214 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCC
Confidence 9999999 59999999999999999987776 8999999999999999999999964 9999999999999 8999
Q ss_pred eEEEeecccccccCC-CCccccc-ccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC---h---hHHHH
Q 012825 301 VLKAIDFGLSDFVRP-DERLNDI-VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART---E---SGIFR 371 (455)
Q Consensus 301 ~vkL~DfG~a~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~---~---~~~~~ 371 (455)
++||+|||+|+.... ....... .||.+|+|||++. +..+.++|||||||+|+||++|+.+..... . .+...
T Consensus 215 ~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 215 NAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred CEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 999999999976654 3333333 8999999999886 789999999999999999999998876432 1 11112
Q ss_pred HHHhcC--CCCCCCC-C-CCCC-----HHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 372 AVLKAD--PSFDEAP-W-PSLS-----SEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 372 ~i~~~~--~~~~~~~-~-~~~s-----~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
..+... ....+.. . ..+. ..+..+..+|++.+|++||++.|+++
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 222221 0011110 0 1222 23667888999999999999999754
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=337.95 Aligned_cols=259 Identities=31% Similarity=0.530 Sum_probs=219.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||.|+||.||++.... ++..||+|++.. ......+.+.+|+++++++. |+||+++++++..++.
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~---~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE---TGLFAAAKIIQI---ESEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC---CCcEEEEEEEee---CCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCe
Confidence 4679999999999999999998765 578999999853 34455677889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.|+||||+++++|.+++......+++..++.++.|++.||.|||+.||+|+||||+||++ +.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKN 153 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhh
Confidence 999999999999999887767789999999999999999999999999999999999999 77889999999988765
Q ss_pred CCC-CcccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 314 RPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
... .......++..|++||++. ..++.++||||||+++|+|++|+.||........+..+........ ....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 232 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPS 232 (280)
T ss_pred cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcc
Confidence 332 2234456899999999863 2467899999999999999999999987766655555544332211 1123
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.++.++.+||.+||+.||.+||++.++|+|+||....
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 233 KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 5789999999999999999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=337.60 Aligned_cols=269 Identities=26% Similarity=0.440 Sum_probs=217.9
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++++.||+|+||.||++.... +|..||+|.+... ........+.+|+.+++++. |+||+++++++..++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP---TGVTMAMKEIRLE--LDESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC---CCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeE
Confidence 478999999999999999998765 5889999988643 23444567889999999997 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 235 YVVMELCEGGELLDRILSR--GGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
++||||+++++|..++... ...+++..+..++.||+.||.|||+ .||+|+||||+||++ +.++.+||+|||++.
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 151 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSG 151 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcc
Confidence 9999999999998877543 3478999999999999999999997 599999999999999 668889999999987
Q ss_pred ccCCCCcccccccCCCcccccccCC-------CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHR-------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (455)
.... .......++..|+|||++.+ .++.++|||||||++|+|++|..||...........+...........
T Consensus 152 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd06622 152 NLVA-SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230 (286)
T ss_pred cccC-CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCC
Confidence 6532 22334568889999998753 257899999999999999999999976554443333222111112222
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHH
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVII 433 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~ 433 (455)
.+.++.++.+||.+||+.+|++||++.+++.||||........++-..+
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~~~~~~~~ 279 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWV 279 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCCccchHHHH
Confidence 3458899999999999999999999999999999998766655444333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=336.59 Aligned_cols=255 Identities=31% Similarity=0.466 Sum_probs=208.1
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||+|++|.||+|+... +++.||||.+.... ......+.+.+|+.+++.+. |+||+++++++.+++..|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---CCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEE
Confidence 58999999999999999998765 57899999986532 22223456788999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 236 VVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+||||++ ++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||++...
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAF 151 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeec
Confidence 9999997 58888775432 579999999999999999999999999999999999999 77889999999998765
Q ss_pred CCCC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC----------
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF---------- 380 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~---------- 380 (455)
.... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||...........+.+.....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 152 GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred CCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 4322 2233467889999998763 47889999999999999999999998766544433332211100
Q ss_pred ---------------CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 381 ---------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 381 ---------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.......++.++.+||++||+.||.+|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 011123578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=340.02 Aligned_cols=268 Identities=26% Similarity=0.522 Sum_probs=226.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.+-|.++.+||+|+||.||+|.+++ .|+.+|||.+.. ...++++..|+.++.++. .+++|++||.|.....
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~E---sG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRE---SGHVLAIKKVPV-----DTDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhc---cCcEEEEEecCc-----cchHHHHHHHHHHHHHcC-CchhhhhhhhhccCCc
Confidence 4558899999999999999999887 699999998743 335678999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|||||||..|++.|.+..++..+++.++..+++..+.||+|||...-||||||..|||+ +.+|+.||+|||.|..+
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQL 179 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchh
Confidence 999999999999999999999999999999999999999999999999999999999999 78899999999999876
Q ss_pred CCCC-cccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH--hcCCCCCCCCCCCCC
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL--KADPSFDEAPWPSLS 389 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~s 389 (455)
.+.. ..++.+||+.|||||++.. .|+.++||||||++..||..|+.||.....- +.++ -..+.........++
T Consensus 180 TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 180 TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPTFKKPEEWS 256 (502)
T ss_pred hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCCCCChHhhh
Confidence 5433 3467899999999999985 7999999999999999999999999654432 2221 112222222234689
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHHHHHH
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLM 437 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~~~~~ 437 (455)
.+|.|||+.||-++|++|-|+.++++|+|++.-....+ +...|++-+
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I-~~~~I~~A~ 303 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDI-MQLMIQDAQ 303 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccH-HHHHHHHHH
Confidence 99999999999999999999999999999998655544 333444444
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=334.26 Aligned_cols=255 Identities=29% Similarity=0.512 Sum_probs=210.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
..+.|++.+.||+|+||.||+|.... +++.||+|++.... .....+.+|+.++.++.+|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC---CCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 45789999999999999999998776 57899999986432 22356789999999996699999999998753
Q ss_pred -----CceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 232 -----DNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 232 -----~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
..+|+||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+|+|+||||+||++ ++++.++|+
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~ 153 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLV 153 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEc
Confidence 4589999999999999988664 3568999999999999999999999999999999999999 778889999
Q ss_pred ecccccccCCC-CcccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC
Q 012825 306 DFGLSDFVRPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (455)
Q Consensus 306 DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (455)
|||++...... .......|+..|+|||++. ..++.++|||||||++|+|++|..||................
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~- 232 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP- 232 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC-
Confidence 99998765432 2334567899999999874 247889999999999999999999997655444333332221
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 379 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
........++.++.+||.+||..||.+||++.+++.||||
T Consensus 233 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 -APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 1222223578999999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=344.90 Aligned_cols=252 Identities=29% Similarity=0.462 Sum_probs=194.4
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee--CCceEEE
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--TDNVYVV 237 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--~~~~~lV 237 (455)
.++||+|+||.||+|+.+... +++.||+|.+..... ...+.+|+.+++++. |+||+++++++.. +..+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~-~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCC-CCceEEEEEECCCCC-----cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEE
Confidence 468999999999999876432 478999999864321 234678999999998 9999999999864 4568999
Q ss_pred EeecCCCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec-CCCceEEEeecc
Q 012825 238 MELCEGGELLDRILSR--------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENSVLKAIDFG 308 (455)
Q Consensus 238 ~E~~~ggsL~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~-~~~~~vkL~DfG 308 (455)
|||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 99995 4887776432 2358999999999999999999999999999999999999533 356789999999
Q ss_pred cccccCCCC----cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChh---------HHHHHH
Q 012825 309 LSDFVRPDE----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTES---------GIFRAV 373 (455)
Q Consensus 309 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~---------~~~~~i 373 (455)
+++...... ......||..|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 998764322 2345678999999998864 4889999999999999999999999643321 122222
Q ss_pred HhcCCCCC----------------------------------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 374 LKADPSFD----------------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 374 ~~~~~~~~----------------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.+...... .......+..+.+||++||++||++|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11100000 00001235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=339.33 Aligned_cols=255 Identities=31% Similarity=0.530 Sum_probs=207.3
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||+|+||.||+|+... +|+.||+|++..... .......+.+|+.+++++. |+||+++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---CCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceE
Confidence 58999999999999999999776 588999999865422 2223356778999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
+|+||++ ++|.+++....+.+++..++.++.||++||.|||+.||+||||||+||++ +.++.+||+|||++.....
T Consensus 76 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGI 151 (284)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCC
Confidence 9999996 58888887667789999999999999999999999999999999999999 6788899999999876543
Q ss_pred CC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCC-CChhHHHHHHHhcCCC------------
Q 012825 316 DE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPS------------ 379 (455)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~-~~~~~~~~~i~~~~~~------------ 379 (455)
.. ......++..|+|||++.+ .++.++|||||||++|+|++|..||.. ....+.+..+.+....
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 32 2334567889999998764 378899999999999999999988643 3333333333221100
Q ss_pred --C------C-----CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 380 --F------D-----EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 380 --~------~-----~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
. . ....+.++.++.+||++||+.||.+|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0 01123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=327.83 Aligned_cols=253 Identities=27% Similarity=0.487 Sum_probs=216.9
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|.+.+.||+|++|.||+|.... +++.|++|.+..... .......+.+|+++++.++ |+||+++++++.+.+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---CCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEE
Confidence 48899999999999999998776 588999999865432 3455677899999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 236 VVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceecc
Confidence 999999999999988764 4679999999999999999999999999999999999999 677889999999988765
Q ss_pred CCCc-ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 315 PDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 315 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
.... .....|+..|+|||++. +.++.++||||||+++|+|++|+.||...........+......... ..++.++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (256)
T cd08529 153 DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQL 229 (256)
T ss_pred CccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHH
Confidence 4332 23456889999999876 56889999999999999999999999888766666665554322211 2578999
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.++|.+||+.+|++||++.++++|||+
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 230 AQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=330.51 Aligned_cols=256 Identities=31% Similarity=0.523 Sum_probs=216.8
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||.|+||.||+|.... ++..+|+|++..... ....+.+.+|+++++.+. |+||+++++.+..++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---CCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEE
Confidence 479999999999999999998765 578999999865432 225678999999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 235 YVVMELCEGGELLDRILSR--GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
++|||++++++|.+++... ...+++..++.++.||+.||.|||+.||+|+||+|+||++ ++++.++|+|||++..
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~ 151 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSAS 151 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHH
Confidence 9999999999999988654 2468999999999999999999999999999999999999 6778899999999876
Q ss_pred cCCCCcc-----cccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCC-
Q 012825 313 VRPDERL-----NDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP- 384 (455)
Q Consensus 313 ~~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~- 384 (455)
....... ....|+..|++||++.. .++.++|+||||+++|+|++|+.||........+..............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGA 231 (267)
T ss_pred hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcc
Confidence 6543222 34468899999998763 588999999999999999999999987766665555555433222211
Q ss_pred -CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 385 -WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 385 -~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
+..++..+.+||.+||+.||++||++.+++.||||
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 23678999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=333.05 Aligned_cols=259 Identities=32% Similarity=0.519 Sum_probs=217.3
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
.|++.+.||.|+||.||++.... ++..+++|.+.. ......+.+.+|+++++.+. |+||+++++++..++..+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~ 78 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVIDT---KSEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLW 78 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECC---CCeEEEEEEeCC---CCHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEE
Confidence 47889999999999999998765 578899999854 33455677889999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
+||||+++++|..++......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.....
T Consensus 79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccc
Confidence 9999999999988876666789999999999999999999999999999999999999 6778899999999876532
Q ss_pred C-CcccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 316 D-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 316 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
. .......++..|+|||++. ..++.++|||||||++|+|++|..||...........+........ .....+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 234 (282)
T cd06643 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRW 234 (282)
T ss_pred cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-CCcccc
Confidence 2 2234457899999999873 2477899999999999999999999987766665555544332211 112357
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~ 425 (455)
+.++.+||.+||+.||.+||++.+++.||||+.....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 271 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCCC
Confidence 8999999999999999999999999999999976443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=359.98 Aligned_cols=253 Identities=28% Similarity=0.492 Sum_probs=215.8
Q ss_pred eEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeec
Q 012825 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241 (455)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~ 241 (455)
.||+|.||+||.|++.. +...+|||.+.. .+.+..+-+..|+.+.++|+ |.|||+++|.+.+++.+-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~---tqvrIaIKEIpe---kdsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---TQVRIAIKEIPE---KDSREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeecccc---ceeEEEeeeccc---ccchhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecC
Confidence 68999999999999877 678899999954 33445566889999999999 999999999999999999999999
Q ss_pred CCCcHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC-CCc
Q 012825 242 EGGELLDRILSRGGKY--TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DER 318 (455)
Q Consensus 242 ~ggsL~~~l~~~~~~l--~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-~~~ 318 (455)
+||+|.+.+..+.+++ ++..+..+.+||++||.|||++.|||||||-+||||+ .-.|.+||+|||-++.+.. +.-
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCcc
Confidence 9999999999988888 8999999999999999999999999999999999997 5678999999999877643 334
Q ss_pred ccccccCCCcccccccC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhH-HHHH--HHhcCCCCCCCCCCCCCHHH
Q 012825 319 LNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRA--VLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 319 ~~~~~gt~~y~aPE~~~---~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~-~~~~--i~~~~~~~~~~~~~~~s~~l 392 (455)
+.++-||..|||||++. ..|..++|||||||++.||.||+.||....... .+.+ +.+..+..++ .++.+.
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPe----elsaea 808 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPE----ELSAEA 808 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcH----HHHHHH
Confidence 56788999999999986 359999999999999999999999996543322 1111 1222333333 688899
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCC
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~ 427 (455)
+.||.+|+.+||.+||++.++|..||++..+++..
T Consensus 809 k~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r 843 (1226)
T KOG4279|consen 809 KNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPR 843 (1226)
T ss_pred HHHHHHHcCCCcccCccHHHhccCcccccCCCCCC
Confidence 99999999999999999999999999998755433
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=330.32 Aligned_cols=253 Identities=18% Similarity=0.309 Sum_probs=211.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|.++.....+..||+|.+... ........+.+|+.+++++. |+||+++++++..++.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG--CSDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC--CCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCC
Confidence 46799999999999999999987754446789999998654 33444567889999999997 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++......+++..++.++.||+.||+|||++|++||||||+|||+ +.++.+||+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence 999999999999999887666789999999999999999999999999999999999999 77889999999987654
Q ss_pred CCCCccc--ccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 314 RPDERLN--DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 314 ~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
....... ...++..|+|||++. +.++.++|||||||++||+++ |..||+.....+....+..... . .....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~ 234 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-L--PAPRNCP 234 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-C--CCCCCCC
Confidence 3222111 223457899999876 578999999999999999775 9999998887776665543322 1 1234688
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
..+.+++.+||+.+|.+||++.+|++
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.66 Aligned_cols=257 Identities=21% Similarity=0.318 Sum_probs=205.0
Q ss_pred EeceEeec--CCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 159 LGEEVGRG--HFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 159 ~~~~LG~G--~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
++++||+| +||+||++..+. +|+.||+|++..... .....+.+.+|+.+++.++ ||||++++++|..++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---TGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecc---cCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEE
Confidence 56789999 678999998776 689999999865432 3445567888999999997 9999999999999999999
Q ss_pred EEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 237 VMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++++||+.......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhcccc
Confidence 99999999999988654 3468999999999999999999999999999999999999 6778899999986543321
Q ss_pred CC--------cccccccCCCcccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC---
Q 012825 316 DE--------RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--- 381 (455)
Q Consensus 316 ~~--------~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--- 381 (455)
.. ......++..|+|||++.+ .++.++|||||||++|||++|+.||....................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence 11 1122356778999999863 488999999999999999999999976554443333222111000
Q ss_pred ---------------------------------------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 382 ---------------------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 382 ---------------------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
......+++++.+||++||+.||++|||+.++++||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00112356789999999999999999999999999999875
Q ss_pred C
Q 012825 423 N 423 (455)
Q Consensus 423 ~ 423 (455)
.
T Consensus 314 ~ 314 (327)
T cd08227 314 K 314 (327)
T ss_pred c
Confidence 3
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=335.16 Aligned_cols=258 Identities=29% Similarity=0.497 Sum_probs=214.6
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
..+|++.+.||+|+||.||+|.... +++.||+|.+..... ...+.+.+|+.+++.+. |+||+++++.+..++.
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~ 91 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDE 91 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECC---CCcEEEEEEEecCCc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCE
Confidence 4789999999999999999998655 578999999865432 23466889999999987 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 92 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI 166 (296)
T ss_pred EEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhc
Confidence 9999999999999998743 458999999999999999999999999999999999999 67888999999998765
Q ss_pred CCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
.... ......++..|+|||.+. ..++.++|||||||++|+|++|+.||...........+.... .........++..
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 245 (296)
T cd06654 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAI 245 (296)
T ss_pred cccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCCCCccccCHH
Confidence 4332 223457889999999876 458899999999999999999999998766544433333222 1111122357889
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
+.+||.+||..||++||++.+++.|+||.....
T Consensus 246 l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred HHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.34 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=202.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
...|.+.+.||+|+||.||++.... .++.||||.... ..+.+|++++++|+ |+|||++++++..++.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---~~~~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD---YPQRVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVVGGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC---CCCEEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCE
Confidence 5679999999999999999998776 578999996421 23568999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++|||++. ++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 235 ~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 235 TCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFA 310 (461)
T ss_pred EEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceec
Confidence 999999995 68888887766789999999999999999999999999999999999999 67788999999999765
Q ss_pred CCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC--------hhHHHHHHHhcCCC--
Q 012825 314 RPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART--------ESGIFRAVLKADPS-- 379 (455)
Q Consensus 314 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~--------~~~~~~~i~~~~~~-- 379 (455)
..... .....||..|+|||++. ..++.++|||||||+||||++|..++.... .....+.+......
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 43221 22457999999999987 468999999999999999999876653221 11222222211110
Q ss_pred -C------------------------CCCCC---CCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 380 -F------------------------DEAPW---PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 380 -~------------------------~~~~~---~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
+ ....| ..++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 00111 134568999999999999999999999999999975
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=325.87 Aligned_cols=253 Identities=24% Similarity=0.511 Sum_probs=212.5
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-CCce
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-TDNV 234 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~-~~~~ 234 (455)
+|++.+.||+|++|.||++.... +++.||+|.+.... ......+.+.+|+++++++. |+|++++++.+.. ++.+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---DGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---CCcEEEEEEEehhh-cCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEE
Confidence 48999999999999999999766 47899999986533 23344567889999999998 9999999998864 4468
Q ss_pred EEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 235 YVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
++||||+++++|.+++... ...+++.+++.++.+++.||.|||+.||+||||||+||++ +.++.++|+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVL 152 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEe
Confidence 9999999999999988764 4568999999999999999999999999999999999999 67889999999998766
Q ss_pred CCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
.... ......++..|+|||++. ..++.++||||||+++|+|++|+.||...........+....... ....++.+
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 229 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPE 229 (257)
T ss_pred cccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHH
Confidence 4322 223456889999999876 568889999999999999999999998777666555554433211 22367899
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
+.+||.+||+.||++||++.++++||||
T Consensus 230 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 230 LGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=337.48 Aligned_cols=256 Identities=26% Similarity=0.455 Sum_probs=210.3
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||++.... ++..||+|.+... .......++.+|++++.+++ |+||+++++++.+++.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP---SGLIMARKLIHLE--IKPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC---CCeEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEE
Confidence 469999999999999999998765 5788999998643 23445567889999999997 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
++||||+++++|.+++.. .+.+++..+..++.||+.||.|||+ .+++||||||+|||+ +.++.+||+|||++...
T Consensus 75 ~lv~ey~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 75 SICMEHMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL 150 (308)
T ss_pred EEEeeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCcccc
Confidence 999999999999998754 4678999999999999999999998 589999999999999 67788999999998765
Q ss_pred CCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC-------------
Q 012825 314 RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------------- 379 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~------------- 379 (455)
.. .......++..|+|||++.+ .++.++||||||+++|+|++|+.||........ ...+.....
T Consensus 151 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 151 ID-SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred cc-cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccC
Confidence 32 22345678999999998764 588899999999999999999999965443222 111111100
Q ss_pred ----------------------CCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 380 ----------------------FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 380 ----------------------~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
....+...++.++.+||.+||..||++||++.+++.||||+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0011112367889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=333.08 Aligned_cols=256 Identities=29% Similarity=0.528 Sum_probs=209.5
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|.... +|+.||+|++.... ......+.+.+|+.+++++. |+||+++++++...+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE---TGQIVAIKKFVESE-DDPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC---CCcEEEEEEEeecc-cCccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEE
Confidence 479999999999999999998775 58899999986442 12223356789999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||++++.|..++ .....+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++....
T Consensus 76 ~~v~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 76 HLVFEYCDHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILT 151 (286)
T ss_pred EEEEeccCccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecC
Confidence 9999999887666544 455679999999999999999999999999999999999999 677889999999998765
Q ss_pred CCC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC------------
Q 012825 315 PDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------------ 379 (455)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~------------ 379 (455)
... ......++..|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+......
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 433 2334567889999998753 4788999999999999999999999876655444333221100
Q ss_pred -------CCC--------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 380 -------FDE--------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 380 -------~~~--------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
... ...+.++..+.+||.+||+.||++||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 1123568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=333.64 Aligned_cols=256 Identities=33% Similarity=0.526 Sum_probs=214.5
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||+|+||.||+|.... +|+.||+|++..... .......+.+|+.+++++. |+||+++++++..++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRL-EGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---CCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeE
Confidence 58999999999999999999766 488999999875432 2334567889999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
+||||+ +++|.+++......+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++.....
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSE 151 (286)
T ss_pred EEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccC
Confidence 999999 999999887767789999999999999999999999999999999999999 6788899999999887654
Q ss_pred CC--cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC-----------
Q 012825 316 DE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF----------- 380 (455)
Q Consensus 316 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~----------- 380 (455)
.. ......++..|+|||++.+ .++.++||||||+++|+|++|..+|........+..++......
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 33 2344578999999998753 46889999999999999999988887766655555444321110
Q ss_pred --------C-------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccC
Q 012825 381 --------D-------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (455)
Q Consensus 381 --------~-------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~ 420 (455)
. ....+..+..+.+||++||+.||++||+++++|.||||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 011235678999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=325.84 Aligned_cols=254 Identities=28% Similarity=0.500 Sum_probs=217.0
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||+|+||.||++.... +++.||||.+..... .....+.+.+|+.++++++ |+||+++++.+..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---DQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---CCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEE
Confidence 58999999999999999998765 588999999876543 3344678899999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+||||+++++|.+++.... ..+++..+..++.+++.||.|||++||+|+||+|+||+++ +.+..+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecC
Confidence 9999999999999987653 4589999999999999999999999999999999999994 345578999999998776
Q ss_pred CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 315 PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
.........++..|+|||.+. ..++.++||||||+++|+|++|..||...........+....... ....++.++.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~ 230 (256)
T cd08220 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSPDLR 230 (256)
T ss_pred CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCHHHH
Confidence 555445567899999999887 457889999999999999999999998877666555554433221 1235789999
Q ss_pred HHHHHhccCCccCCCCHHHHHcCccc
Q 012825 394 DFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 394 ~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
++|.+||+.||++|||+.+++.||||
T Consensus 231 ~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 231 QLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=332.58 Aligned_cols=253 Identities=29% Similarity=0.481 Sum_probs=208.3
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC--Cce
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--DNV 234 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~--~~~ 234 (455)
|++.+.||+|+||.||+|.... +++.||+|++..... +.. .....+|+.++.++.+|+||+++++++.+. +..
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~-~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---TGKYYAIKCMKKHFK-SLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcC---CCcEEEEEEehhccC-Cch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 6789999999999999998765 588999999865432 222 223457999999997899999999999987 889
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||++ ++|.+.+......+++..++.++.||+.||.|||+.||+||||||+||++ +. +.+||+|||++....
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 76 ALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---KD-DILKLADFGSCRGIY 150 (282)
T ss_pred EEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---cC-CCeEEEecccccccc
Confidence 99999996 58888887766789999999999999999999999999999999999999 55 899999999998775
Q ss_pred CCCcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC------------
Q 012825 315 PDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF------------ 380 (455)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~------------ 380 (455)
.........++..|+|||++. +.++.++|||||||++|||++|..||...+..+.+..+.......
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred cCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 554445567889999999764 347889999999999999999999998776655444443211110
Q ss_pred ------CC-------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 381 ------DE-------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 381 ------~~-------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.. ...+.++.++.+||.+||+.||++||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00 0012568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=331.45 Aligned_cols=263 Identities=25% Similarity=0.402 Sum_probs=210.4
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|+... +|+.||+|++..... ......+..|+.++.+..+|+||+++++++..++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---TGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---CCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcE
Confidence 479999999999999999999776 589999999865432 222345666777655555599999999999999999
Q ss_pred EEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 235 YVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
|+||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+|||+ +.++.+||+|||++
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccc
Confidence 99999996 577776654 345799999999999999999999998 99999999999999 77889999999999
Q ss_pred cccCCCCcccccccCCCcccccccCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCC-hhHHHHHHHhcCCCCCCCC
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLHR-----SYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKADPSFDEAP 384 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlG~~l~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~ 384 (455)
.............++..|+|||++.+ .++.++|+||||+++|+|++|+.||.... ..+.+..+..... ....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~ 229 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQLP 229 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--CCCC
Confidence 87654333344568889999998753 46889999999999999999999996533 2233333333211 1111
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCc
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p 428 (455)
...++.++.+||.+||..+|.+||++.+++.|+||+........
T Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~ 273 (283)
T cd06617 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTD 273 (283)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccccHH
Confidence 23578999999999999999999999999999999997655443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=334.53 Aligned_cols=259 Identities=29% Similarity=0.491 Sum_probs=217.8
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||++.... .++.|++|.+.............+.+|+++++.+. |+||+++++.+..++.+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 76 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE---TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHL 76 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC---CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEE
Confidence 469999999999999999998766 57899999987654334445667889999999997 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||++|++|.+++.. .+.+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||+++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 77 CMVMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccC
Confidence 999999999999988754 4678999999999999999999999999999999999999 778899999999886421
Q ss_pred CCC----------------cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcC
Q 012825 315 PDE----------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (455)
Q Consensus 315 ~~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~ 377 (455)
... ......++..|+|||++. ..++.++||||||+++|+|++|..||.+....+....+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 110 011245788899999876 568999999999999999999999998887777666666554
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCccCCCC---HHHHHcCcccCCC
Q 012825 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT---AAQALSHPWIKNS 422 (455)
Q Consensus 378 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps---~~elL~hp~~~~~ 422 (455)
....... ..++.++.+||.+||+.||++||+ +.++|+||||+..
T Consensus 233 ~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 233 IEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred cCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 3333322 257899999999999999999998 7999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=333.76 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=205.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCc-------------ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-------------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-------------~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~ 220 (455)
.++|++.++||+|+||.||+|++.... ..+..||+|++... .......++.+|++++.++. |+|
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD--ANKNARNDFLKEVKILSRLK-DPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC--CCHHHHHHHHHHHHHHhhcC-CCC
Confidence 568999999999999999999864321 13557999998653 23445678999999999998 999
Q ss_pred eeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCE
Q 012825 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG------------------GKYTEDDAKAVMIQILNVVAFCHLQGVV 282 (455)
Q Consensus 221 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------------~~l~~~~~~~i~~qi~~gL~~LH~~~iv 282 (455)
|+++++++.+.+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999875431 2468889999999999999999999999
Q ss_pred EeeccCCceEEeecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc--
Q 012825 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-- 356 (455)
Q Consensus 283 HrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-- 356 (455)
||||||+|||+ +.++.+||+|||++........ .....++..|+|||++. +.++.++||||||+++|||++
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999 6788999999999976543321 22344578899999875 678999999999999999986
Q ss_pred CCCCCCCCChhHHHHHHHhc---C-CCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHH
Q 012825 357 GSRPFWARTESGIFRAVLKA---D-PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (455)
Q Consensus 357 g~~Pf~~~~~~~~~~~i~~~---~-~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL 414 (455)
+..||........+..+... . ........+.++..+.+||.+||+.||++|||+.+|.
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 66788776665554443221 1 1111112246789999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=332.83 Aligned_cols=258 Identities=31% Similarity=0.482 Sum_probs=208.7
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc-
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN- 233 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~- 233 (455)
++|++.+.||+|+||.||+|.... +|+.||||++.... ........+.+|+.+++++.+|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 76 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN---TGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKN 76 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC---CCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCC
Confidence 479999999999999999999765 58899999986532 2222335678899999999868999999999987665
Q ss_pred ----eEEEEeecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCC-CceEEE
Q 012825 234 ----VYVVMELCEGGELLDRILSR----GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKA 304 (455)
Q Consensus 234 ----~~lV~E~~~ggsL~~~l~~~----~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~-~~~vkL 304 (455)
.|+||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+||++ +. ++.+||
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~---~~~~~~~kl 152 (295)
T cd07837 77 GKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKI 152 (295)
T ss_pred CCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---ecCCCeEEE
Confidence 8999999976 788877653 2458999999999999999999999999999999999999 55 788999
Q ss_pred eecccccccCCC-CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC
Q 012825 305 IDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (455)
Q Consensus 305 ~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (455)
+|||++...... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||...........+........
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 153 ADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232 (295)
T ss_pred eecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999998765322 22233456888999998753 478999999999999999999999987766655554443211000
Q ss_pred ------------------------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccC
Q 012825 382 ------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (455)
Q Consensus 382 ------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~ 420 (455)
....+.++.++.+||.+||..||.+||++.++|.||||+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 011135788999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=326.92 Aligned_cols=254 Identities=33% Similarity=0.503 Sum_probs=211.1
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|.... .|+.||+|++.+...........+..|..++....+|+||+++++++..++..|+||||
T Consensus 2 ~~l~~g~~~~v~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecC---CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 578999999999998765 57899999986544333334445566766665555699999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCccc
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~ 320 (455)
+++++|.+++. ..+.+++..+..++.||+.||.|||+.+++|+||+|+||++ ++++.+||+|||++..... ..
T Consensus 79 ~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~ 151 (260)
T cd05611 79 LNGGDCASLIK-TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NK 151 (260)
T ss_pred cCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cc
Confidence 99999998775 44578999999999999999999999999999999999999 6788899999999876543 23
Q ss_pred ccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 012825 321 DIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399 (455)
Q Consensus 321 ~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~ 399 (455)
...++..|++||.+.+ .++.++||||||+++|+|++|..||........+..+..............++.++.++|.+|
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 4568889999998764 478999999999999999999999988877776666655554444444446889999999999
Q ss_pred ccCCccCCC---CHHHHHcCcccCCCCC
Q 012825 400 LNKDPRKRL---TAAQALSHPWIKNSND 424 (455)
Q Consensus 400 L~~dP~~Rp---s~~elL~hp~~~~~~~ 424 (455)
|+.||++|| ++.|+|.||||+..+.
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 999999999 5579999999987653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=334.24 Aligned_cols=261 Identities=31% Similarity=0.488 Sum_probs=213.9
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC--CHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
+|++.+.||+|+||.||+|.... +|+.||||.+...... .......+.+|++++++++ |+||+++++++.+.+.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCE
Confidence 58899999999999999999766 4889999999755433 1233456778999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+ +++|.+++......+++..++.++.||++||.|||++||+|+||||+|||+ +.++.++|+|||++...
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSF 152 (298)
T ss_pred EEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeec
Confidence 99999999 889999886544479999999999999999999999999999999999999 67888999999999876
Q ss_pred CCCC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC--------
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-------- 382 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 382 (455)
.... ......++..|+|||.+.+ .++.++|||||||++|+|++|..+|......+.+..+.........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 153 GSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred cCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 5432 2334456788999998753 5788999999999999999998888776665555444432111000
Q ss_pred ----------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 383 ----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 383 ----------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
......+..+.+||.+||++||++|||+.++|.|+||++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 011345788999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=323.10 Aligned_cols=253 Identities=27% Similarity=0.504 Sum_probs=217.5
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||.|+||.||.++... +++.+++|.+.... .+....+++.+|++++++++ |+||+++++++.+.+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---DDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---CCcEEEEEEEeecc-cchhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEE
Confidence 58999999999999999988665 58899999986543 23345567889999999997 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 236 VVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++|||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||++ ++++.+||+|||++....
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILG 152 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEcc
Confidence 999999999999988665 4578999999999999999999999999999999999999 677889999999987664
Q ss_pred CCC-cccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 315 PDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
... ......++..|+|||++.+ .++.++||||||+++|+|++|..||......+....+......... ..++.++
T Consensus 153 ~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (256)
T cd08221 153 SEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSEL 229 (256)
T ss_pred cccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHH
Confidence 333 2345578999999998764 5788999999999999999999999887777766666654433221 4678999
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.++|.+||+.||.+||++.++|+|+|+
T Consensus 230 ~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 230 ISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=325.94 Aligned_cols=253 Identities=29% Similarity=0.521 Sum_probs=210.9
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC------HHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT------AIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~------~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
+|.+...||.|+||.||+|.... .++.||+|.+....... .+..+.+.+|+.+++++. |+||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSL 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Confidence 47888999999999999998765 47899999886543222 233467889999999998 999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
+.+..++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||+
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~ 152 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGI 152 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCC
Confidence 99999999999999999988754 4678999999999999999999999999999999999999 7788899999999
Q ss_pred ccccCCCC-------cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC
Q 012825 310 SDFVRPDE-------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (455)
Q Consensus 310 a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (455)
++...... ......|+..|+|||++. +.++.++||||||+++|+|++|..||...........+.... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~ 229 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---S 229 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---C
Confidence 87664221 112345788999999886 468889999999999999999999998766555444443321 1
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 382 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
......++..+.++|++||+.||.+||++.++++|+||
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 11223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=331.25 Aligned_cols=241 Identities=20% Similarity=0.272 Sum_probs=205.3
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee----CCceEE
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED----TDNVYV 236 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~----~~~~~l 236 (455)
..||+|++|.||+|.+ +|+.||||++...........+.+.+|+.++++++ ||||+++++++.+ ...+++
T Consensus 26 ~~i~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~l 99 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSL 99 (283)
T ss_pred eEEeeCCceEEEEEEE-----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEE
Confidence 6799999999999985 37899999997655445555678889999999998 9999999999876 346899
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
||||+++|+|.+++.+ ...+++.....++.+++.||.|||+. +++||||||+|||+ ++++.+||+|||+++....
T Consensus 100 v~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 100 ILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSS 175 (283)
T ss_pred EEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcc
Confidence 9999999999998854 45789999999999999999999985 99999999999999 7788999999999876543
Q ss_pred CCcccccccCCCcccccccC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 316 DERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~---~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
. .....|+..|+|||++. +.++.++|||||||++|||++|+.||......+.+..+.......... ..++..+
T Consensus 176 ~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l 251 (283)
T PHA02988 176 P--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEI 251 (283)
T ss_pred c--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHH
Confidence 2 22346889999999985 468999999999999999999999999888777777766554333221 2578999
Q ss_pred HHHHHHhccCCccCCCCHHHHHc
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.+||.+||+.||++|||+.++++
T Consensus 252 ~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 252 KCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHhcCCcccCcCHHHHHH
Confidence 99999999999999999999985
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=336.80 Aligned_cols=261 Identities=28% Similarity=0.441 Sum_probs=213.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC--
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~-- 231 (455)
.++|++.+.||+|+||.||+|.+.. +|+.||+|++....... .....+.+|+.++++++ |+||+++++++.+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT---SGEIVALKKVRMDNERD-GIPISSLREITLLLNLR-HPNIVELKEVVVGKHL 80 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC---CCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCC-CCCCcceEEEEecCCC
Confidence 5789999999999999999999775 58899999986543222 12234567999999998 99999999998755
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+.+++||||+.+ +|.+++......+++..++.++.||+.||.|||+.|++||||||+||++ +.++.+||+|||++.
T Consensus 81 ~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~ 156 (309)
T cd07845 81 DSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLAR 156 (309)
T ss_pred CeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceee
Confidence 568999999965 8888877666789999999999999999999999999999999999999 778899999999998
Q ss_pred ccCCCC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCC----
Q 012825 312 FVRPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP---- 384 (455)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~---- 384 (455)
...... ......++..|+|||++.+ .++.++||||||+++|+|++|..||...+..+.+..+...........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 765332 2233446788999998753 578999999999999999999999988887777666654321110000
Q ss_pred ----------------------CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 385 ----------------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 385 ----------------------~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
...+++++.+||.+||++||++|||+.++|.||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 123578899999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=331.97 Aligned_cols=254 Identities=31% Similarity=0.490 Sum_probs=209.5
Q ss_pred EeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecC
Q 012825 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (455)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 242 (455)
||+|+||.||+|.... +|+.||+|++.............+.+|++++++++ |+||+++++++...+..|+||||++
T Consensus 1 lg~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKA---TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcC---CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCC
Confidence 6899999999998665 58899999986544333444556778999999998 9999999999999999999999999
Q ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcccc
Q 012825 243 GGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321 (455)
Q Consensus 243 ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~ 321 (455)
+++|.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||++ ++++.++|+|||.+...........
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCcccc
Confidence 999999886544 369999999999999999999999999999999999999 7788999999999877654444445
Q ss_pred cccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhc
Q 012825 322 IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400 (455)
Q Consensus 322 ~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L 400 (455)
..++..|+|||++. +.++.++||||||+++|+|++|+.||...........+..............+++.+.++|++||
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHc
Confidence 56788999999876 45888999999999999999999999765442222222222222222233457899999999999
Q ss_pred cCCccCCC-----CHHHHHcCcccCCCC
Q 012825 401 NKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 401 ~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
+.||.+|| ++.+++.||||+..+
T Consensus 234 ~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 234 QKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred cCChhHccCCCcccHHHHHhChhhhcCC
Confidence 99999999 899999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=329.56 Aligned_cols=254 Identities=28% Similarity=0.494 Sum_probs=208.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+... +++.||+|++... .......+.+|+.+++.+. |+||+++++++...+.
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~---~~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~ 80 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVN---TGELAAIKVIKLE---PGEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDK 80 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcC---CCcEEEEEEEecC---chhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCE
Confidence 4689999999999999999998765 5789999998643 2233456788999999997 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++. ..+.+++..++.++.|++.||.|||+.||+|+||||+||++ +.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 81 LWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQI 156 (267)
T ss_pred EEEEEeccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEc
Confidence 999999999999999774 44579999999999999999999999999999999999999 67788999999998765
Q ss_pred CCCC-cccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC-CCCCC
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-APWPS 387 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~ 387 (455)
.... ......|+..|+|||++. +.++.++|||||||++|+|++|..||..................... .....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06645 157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK 236 (267)
T ss_pred cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCC
Confidence 4221 223457899999999863 45888999999999999999999999665543333322222211111 11124
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcCcc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~hp~ 418 (455)
++..+.+||.+||+.||++||++.++++|||
T Consensus 237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 237 WSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 7789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=345.18 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=207.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.+.||+|+||.||+|+.... ..++..||||++.... .......+.+|+++++.+.+|+||++++++|.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 46899999999999999999986531 2245689999996542 3344567889999999995599999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC---------------------------------------------------------
Q 012825 232 DNVYVVMELCEGGELLDRILSRG--------------------------------------------------------- 254 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~--------------------------------------------------------- 254 (455)
+.+++|||||++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999885421
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcc---
Q 012825 255 ------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL--- 319 (455)
Q Consensus 255 ------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~--- 319 (455)
..+++..+++++.||+.||.|||++||+||||||+|||+ ++++.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcceeec
Confidence 247889999999999999999999999999999999999 67889999999999765433221
Q ss_pred cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012825 320 NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~ 397 (455)
....++..|+|||++. +.++.++|||||||++|+|++ |+.||........+........... ....++.++.++|.
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 349 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--RPDFAPPEIYSIMK 349 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc--CCCCCCHHHHHHHH
Confidence 1223456799999875 579999999999999999997 9999987665544444444332221 11246899999999
Q ss_pred HhccCCccCCCCHHHHHcC
Q 012825 398 RLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 398 ~~L~~dP~~Rps~~elL~h 416 (455)
+||+.||.+||++.++++.
T Consensus 350 ~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 350 MCWNLEPTERPTFSQISQL 368 (374)
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=330.29 Aligned_cols=254 Identities=30% Similarity=0.527 Sum_probs=209.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee---
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--- 230 (455)
.+.|++.+.||.|+||.||+|+... .++.||+|++... ......+..|+.+++++.+|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcC---CCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 5689999999999999999999776 5789999998542 23345688999999999779999999999853
Q ss_pred ---CCceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 231 ---TDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 231 ---~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
.+..|++|||+++++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~d 164 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVD 164 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEee
Confidence 45789999999999999988653 3568999999999999999999999999999999999999 6788899999
Q ss_pred cccccccCCC-CcccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC
Q 012825 307 FGLSDFVRPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (455)
Q Consensus 307 fG~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 379 (455)
||++...... .......|+..|+|||++. ..++.++|||||||++|+|++|..||...........+.+...
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~- 243 (282)
T cd06636 165 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP- 243 (282)
T ss_pred CcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC-
Confidence 9998765422 2234567899999999874 3478899999999999999999999976654443333332221
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 380 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.......++.++.+||.+||+.||.+||++.++|+||||
T Consensus 244 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 -PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 111223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.50 Aligned_cols=258 Identities=30% Similarity=0.515 Sum_probs=217.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||.|+||.||+|.... +|+.||+|.+.... ....+.+.+|+.+++.++ |+||+++++++..++.
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVA---TGQEVAIKQINLQK---QPKKELIINEILVMKELK-NPNIVNFLDSFLVGDE 90 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcC---CCcEEEEEEEeccc---CchHHHHHHHHHHHHhcC-CCceeeeeeeEecCce
Confidence 4679999999999999999998665 58899999986432 223466889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++|+||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||++ +.++.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQI 165 (296)
T ss_pred EEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhc
Confidence 9999999999999987743 458999999999999999999999999999999999999 67888999999998765
Q ss_pred CCCCc-ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
..... .....++..|+|||.+. +.++.++|||||||++|+|++|..||...........+...... .......++..
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 244 (296)
T cd06655 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSPI 244 (296)
T ss_pred ccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-ccCCcccCCHH
Confidence 43332 23456888999999876 45889999999999999999999999887765554444332211 11223468899
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
+.+||++||..||.+||++.+++.||||+....
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=326.59 Aligned_cols=252 Identities=30% Similarity=0.567 Sum_probs=213.4
Q ss_pred EeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecC
Q 012825 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (455)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 242 (455)
||.|+||.||+|+... +++.||+|++.+.........+.+.+|+.+++.+. |+||+++++++.+++..++||||++
T Consensus 1 lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKS---KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCC
Confidence 6999999999999765 58899999997655455556678999999999997 9999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCccccc
Q 012825 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322 (455)
Q Consensus 243 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~ 322 (455)
+++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||+|+||++ +.++.++|+|||++............
T Consensus 77 ~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~ 152 (262)
T cd05572 77 GGELWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTF 152 (262)
T ss_pred CCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccc
Confidence 9999998854 4568999999999999999999999999999999999999 67889999999999877654434455
Q ss_pred ccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC--hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 012825 323 VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART--ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399 (455)
Q Consensus 323 ~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~ 399 (455)
.++..|++||++. ..++.++|+||||+++|+|++|..||.... .......+........ ....++.++.++|.+|
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~ 230 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE--FPNYIDKAAKDLIKQL 230 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC--CCcccCHHHHHHHHHH
Confidence 7889999999876 468899999999999999999999998766 4444555543111111 1124578999999999
Q ss_pred ccCCccCCCC-----HHHHHcCcccCCCCC
Q 012825 400 LNKDPRKRLT-----AAQALSHPWIKNSND 424 (455)
Q Consensus 400 L~~dP~~Rps-----~~elL~hp~~~~~~~ 424 (455)
|+.||++|++ +.|+++||||+..+.
T Consensus 231 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 231 LRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred ccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 9999999999 999999999998654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=324.99 Aligned_cols=253 Identities=30% Similarity=0.557 Sum_probs=213.6
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||.|+||.||+|.... +++.|++|.+... ...+++.+|+++++++. |+||+++++++.+++.
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~~k~~~~~-----~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~ 72 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKE---TGQVVAIKVVPVE-----EDLQEIIKEISILKQCD-SPYIVKYYGSYFKNTD 72 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcC---CCcEEEEEEeecH-----HHHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCc
Confidence 3679999999999999999998776 4789999998532 12678999999999996 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.|+++||+++++|.+++......+++..++.++.|++.||.|||+.+|+|+||+|+||++ +.++.++|+|||++...
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQL 149 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhc
Confidence 999999999999999887767789999999999999999999999999999999999999 67888999999998876
Q ss_pred CCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
.... ......++..|+|||++. ..++.++||||||+++|+|++|+.||...........+...... .......++.+
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 228 (256)
T cd06612 150 TDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPE 228 (256)
T ss_pred ccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHH
Confidence 5433 233456888999999876 46888999999999999999999999766554433333222111 11112357789
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
+.+||.+||+.||++||++.++|.||||
T Consensus 229 ~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 229 FNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=329.23 Aligned_cols=253 Identities=33% Similarity=0.589 Sum_probs=216.3
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||.|+||.||+|.... +++.||+|++.+.........+.+.+|++++++++ ||||+++++++.+++..+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEE
Confidence 58999999999999999998765 58899999997655455566788999999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
+|+||+.|++|.+++... ..+++..+..++.||++||.|||+.|++|+||+|+||++ ++++.++|+|||++.....
T Consensus 77 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTP 152 (258)
T ss_pred EEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCC
Confidence 999999999999887554 679999999999999999999999999999999999999 7788999999999987765
Q ss_pred CCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCh--hHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 316 DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
........|+..|+|||++. ..++.++|+||||+++|+|++|..||..... ...+...... ........++.++
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 229 (258)
T cd05578 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---ADVLYPATWSTEA 229 (258)
T ss_pred CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---ccccCcccCcHHH
Confidence 54445567888999999876 4579999999999999999999999987664 2222222221 1122223578999
Q ss_pred HHHHHHhccCCccCCCCH--HHHHcCccc
Q 012825 393 RDFVKRLLNKDPRKRLTA--AQALSHPWI 419 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~--~elL~hp~~ 419 (455)
.++|.+||+.||.+||++ .|+++||||
T Consensus 230 ~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 230 IDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=344.94 Aligned_cols=256 Identities=26% Similarity=0.380 Sum_probs=206.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.+.||+|+||.||+|..... ..++..||||++.... .....+.+.+|+.+++.+..||||++++++|.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 46899999999999999999975421 2246789999986432 2334567889999999995599999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC---------------------------------------------------------
Q 012825 232 DNVYVVMELCEGGELLDRILSRG--------------------------------------------------------- 254 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~--------------------------------------------------------- 254 (455)
+..++|||||++|+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886432
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCC
Q 012825 255 -----------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317 (455)
Q Consensus 255 -----------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~ 317 (455)
..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCcc
Confidence 247888999999999999999999999999999999999 667889999999997664332
Q ss_pred cc---cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 318 RL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 318 ~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
.. ....++..|+|||++. ..++.++|||||||++|||++ |..||........+...+....... .....+.++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 346 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEM 346 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHH
Confidence 21 1233456799999876 568999999999999999997 8999977655544444444332221 123467899
Q ss_pred HHHHHHhccCCccCCCCHHHHHcC
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.+||.+||+.||++||++.++++.
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=361.16 Aligned_cols=253 Identities=26% Similarity=0.469 Sum_probs=210.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEE-Eee--
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDA-YED-- 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~-~~~-- 230 (455)
..++++.+.|-+|||+.||+|++.. .|..||+|++-. .+...++.+.+||++|++|++|+|||.++|. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~---~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVK---GGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecC---CCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 5678999999999999999999887 348999999843 4788899999999999999999999999993 321
Q ss_pred -C---CceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeeccCCceEEeecCCCceEE
Q 012825 231 -T---DNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLK 303 (455)
Q Consensus 231 -~---~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~--ivHrDikp~NILl~~~~~~~~vk 303 (455)
+ -+++|.||||.||.|.|++..+ ...|++.++++|+.++++|+.+||..+ |||||||-+|||| ..++++|
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~K 186 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYK 186 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCCEE
Confidence 1 2578999999999999998754 345999999999999999999999998 9999999999999 7788999
Q ss_pred EeecccccccCCCC-ccc---------ccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHH
Q 012825 304 AIDFGLSDFVRPDE-RLN---------DIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGI 369 (455)
Q Consensus 304 L~DfG~a~~~~~~~-~~~---------~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~ 369 (455)
|||||.+.-..... ... ...-|+.|+|||++. ...+.|+|||+|||+||-|+....||+.....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-- 264 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-- 264 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--
Confidence 99999986533222 111 124689999999874 35899999999999999999999999876432
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.|++....++. .+.++..+.+||+.||+.||.+||++.|++.+-+.-.
T Consensus 265 --aIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 265 --AILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred --eEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 34555544444 3689999999999999999999999999998755443
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=324.61 Aligned_cols=255 Identities=31% Similarity=0.514 Sum_probs=214.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||.|+||.||+|.... +++.+++|++.... ....+.+.+|++++++++ |+||+++++++.+++.
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIA---TGELVAIKVIKLEP---GDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecC---CCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCE
Confidence 4689999999999999999998766 46789999986532 235578899999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.|++|||+++++|.+++......+++..++.++.|++.||.|||++||+|+||+|+||++ +.++.+||+|||++...
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQL 151 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhh
Confidence 999999999999999887665789999999999999999999999999999999999999 77888999999998765
Q ss_pred CCCC-cccccccCCCcccccccC-C---CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC-CCCCCCC
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLH-R---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF-DEAPWPS 387 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~ 387 (455)
.... ......++..|+|||++. . .++.++||||||+++|+|++|..||...........+....... .......
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd06613 152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231 (262)
T ss_pred hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence 4332 234457888999999875 3 58889999999999999999999998776555444443332111 1111224
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcCcc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~hp~ 418 (455)
++.++.+||++||..||.+||++.+++.|+|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 6788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=325.27 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=210.1
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc---CCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM---TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+|++.+.||.|+||.||+|... +|+.+|+|.+..... ........+.+|+++++++. |+||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCC
Confidence 5888999999999999999753 478999998864321 12334466889999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++.+ ...+++..+..++.|++.||.|||+.+|+|+||+|+||++ +.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 76 TISIFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARR 151 (265)
T ss_pred eEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHh
Confidence 99999999999999998854 4568999999999999999999999999999999999999 7788999999999876
Q ss_pred cCCC-------CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 012825 313 VRPD-------ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (455)
Q Consensus 313 ~~~~-------~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (455)
.... .......++..|+|||++. ..++.++||||||+++|+|++|..||...........+........ ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 230 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RL 230 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC-CC
Confidence 4211 1123456889999999987 4578999999999999999999999987655544433333222211 12
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
...++.++.+||++||+.+|.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 23688999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=327.52 Aligned_cols=269 Identities=28% Similarity=0.492 Sum_probs=215.6
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC--C
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--D 232 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~--~ 232 (455)
++|+..+.||.|++|.||++.... +++.||+|.+... ........+.+|+++++.+. |+||++++++|.+. +
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN---TGMIFALKTITTD--PNPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSS 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC---CCeEEEEEEEecC--CchHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCC
Confidence 468999999999999999999876 5889999998654 22345577899999999998 99999999998653 4
Q ss_pred ceEEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 233 NVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
.+++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||+
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~ 151 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGV 151 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeeccc
Confidence 68999999999999887643 34568999999999999999999999999999999999999 6778899999999
Q ss_pred ccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC-----hhHHHHHHHhcCC-CCCC
Q 012825 310 SDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART-----ESGIFRAVLKADP-SFDE 382 (455)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~-----~~~~~~~i~~~~~-~~~~ 382 (455)
+....... .....++..|+|||.+. ..++.++||||||+++|+|++|..||.... ..+....+..... ....
T Consensus 152 ~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd06621 152 SGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230 (287)
T ss_pred cccccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhcc
Confidence 87654222 23456788999999876 568999999999999999999999997652 2222333222111 1111
Q ss_pred CCC--CCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHH
Q 012825 383 APW--PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVII 433 (455)
Q Consensus 383 ~~~--~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~ 433 (455)
... ..+++.+.+||.+||..||.+|||+.|++.|+||+.....+.++....
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~~~~~~ 283 (287)
T cd06621 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAKFV 283 (287)
T ss_pred CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccchhhHHHHH
Confidence 111 135678999999999999999999999999999988777666554443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=373.64 Aligned_cols=263 Identities=29% Similarity=0.476 Sum_probs=228.1
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
-.++|++++.||+|+||.|.+++.+. +++.||+|++.+-.+........|..|-++|.--. .+.|++++-.|.+++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~---t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKS---TEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDER 148 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeec---cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCcc
Confidence 36889999999999999999999887 68999999997744443444456777888886654 899999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
++|+||||++||+|..++-... .+++..++.++..|+.||.-||+.|+|||||||+|||| |..|++||+|||.+-.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLK 224 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHh
Confidence 9999999999999999775555 89999999999999999999999999999999999999 8999999999999887
Q ss_pred cCCCCc--ccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 012825 313 VRPDER--LNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (455)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (455)
+..+.. ....+|||.|.+||++. +.|+..+|+||+||++|||+.|..||....-.+.+.+|++....+....
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~ 304 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD 304 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence 775554 35678999999999984 3589999999999999999999999999999999999988743332222
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCC---HHHHHcCcccCCCCC
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLT---AAQALSHPWIKNSND 424 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps---~~elL~hp~~~~~~~ 424 (455)
-..+|.++++||+++|+ +|+.|.. +.++..||||.+..+
T Consensus 305 ~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 305 ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 23699999999999997 6788988 999999999999754
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=323.38 Aligned_cols=253 Identities=27% Similarity=0.550 Sum_probs=216.0
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||+|+||.||++.... +|+.||+|.+..... .....+++.+|+.++++++ |+||+++++++.+.+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---CCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEE
Confidence 58999999999999999998766 588999999865332 2334567899999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+||||+.+++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+|||+ +.++.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLN 152 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecC
Confidence 9999999999999886643 468999999999999999999999999999999999999 677889999999997664
Q ss_pred CCCc-ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 315 PDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 315 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
.... .....|+..|+|||++. +.++.++|+||||+++++|++|..||......+....++....... ...++.++
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 229 (256)
T cd08218 153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDL 229 (256)
T ss_pred cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHH
Confidence 3322 23346888999999876 4678899999999999999999999988777776666655443211 23578999
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.++|.+||+.+|.+||++.++++||||
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=328.27 Aligned_cols=257 Identities=28% Similarity=0.485 Sum_probs=211.1
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
..++|++.+.||+|+||.||+|.... +++.+|+|++.... .....+.+|+.+++++.+|+||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~---~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 46889999999999999999998766 58899999985432 12356778999999996699999999998753
Q ss_pred ----CceEEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEE
Q 012825 232 ----DNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (455)
Q Consensus 232 ----~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL 304 (455)
+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.||+||||||+||++ +.++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEE
Confidence 358999999999999987753 35678999999999999999999999999999999999999 67788999
Q ss_pred eecccccccCCCC-cccccccCCCcccccccCC------CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcC
Q 012825 305 IDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (455)
Q Consensus 305 ~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~ 377 (455)
+|||++....... ......|+..|+|||++.. .++.++|||||||++|+|++|+.||........+..+.+..
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 9999987654322 2234568889999998752 26889999999999999999999998776655554444332
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccC
Q 012825 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (455)
Q Consensus 378 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~ 420 (455)
.... .....++..+.+||.+||+.||++||++.++++||||+
T Consensus 250 ~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 250 PPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2211 11234678899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=327.65 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=207.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|.... +++.||+|++.... ......+.+|+.+++++. |+||+++++++..++.
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~ 80 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH---TGELAAVKIIKLEP---GDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREK 80 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC---CCeEEEEEEEecCc---cchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCE
Confidence 5689999999999999999998765 57899999985432 223356789999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++...
T Consensus 81 ~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKI 156 (267)
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceee
Confidence 9999999999999987754 4578999999999999999999999999999999999999 77888999999999765
Q ss_pred CCCC-cccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC-CCCCC
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-APWPS 387 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~ 387 (455)
.... ......++..|+|||.+. ..++.++||||||+++|||++|..||...........+......... .....
T Consensus 157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06646 157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236 (267)
T ss_pred cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccc
Confidence 4222 223456889999999873 34788999999999999999999999655433222222111111111 11125
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcCcc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~hp~ 418 (455)
++..+.+||++||+.||++||++.++|+|+|
T Consensus 237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 237 WSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 7889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=331.14 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=217.1
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|.... .|+.||+|++...........+++.+|+++++.++ |+||+++++++.+++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~ 88 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREH 88 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCC
Confidence 35679999999999999999998765 58899999986554455556678899999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+. |++.+.+......+++..+..++.||+.||.|||+.||+|+||+|+||++ +.++.++|+|||++..
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASL 164 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCccee
Confidence 9999999996 57778776666779999999999999999999999999999999999999 7788999999999876
Q ss_pred cCCCCcccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
.... ....++..|+|||++. +.++.++||||||+++|+|++|..||...........+...... ......+
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 239 (307)
T cd06607 165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLSSNDW 239 (307)
T ss_pred cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCchhh
Confidence 5432 3456788999999863 45888999999999999999999999877665544443332211 1112247
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+..+.+||.+||+.||++||++.+++.|+||....
T Consensus 240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 240 SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 88999999999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=328.83 Aligned_cols=257 Identities=31% Similarity=0.518 Sum_probs=207.8
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe--
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE-- 229 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~-- 229 (455)
...++|++.+.||+|+||.||+|.... +++.||+|++.... .....+.+|+.+++.+.+|+||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECC---CCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 457899999999999999999998766 57899999875321 123567889999999966999999999874
Q ss_pred ---eCCceEEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEE
Q 012825 230 ---DTDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (455)
Q Consensus 230 ---~~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vk 303 (455)
.++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+|+||||||+||++ +.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCEE
Confidence 34568999999999999887653 34578999999999999999999999999999999999999 6777899
Q ss_pred EeecccccccCCCC-cccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhc
Q 012825 304 AIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (455)
Q Consensus 304 L~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~ 376 (455)
|+|||++....... ......|+..|+|||++. ..++.++|||||||++|+|++|+.||........+......
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 99999987654322 223456899999999874 34788999999999999999999999776544333322221
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 377 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.. ........++..+.+||.+||+.||++||++.++++|+||
T Consensus 245 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 PP-PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CC-CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 11 1111112467899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=335.67 Aligned_cols=252 Identities=29% Similarity=0.468 Sum_probs=193.2
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee--CCceEEE
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--TDNVYVV 237 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--~~~~~lV 237 (455)
..+||+|+||.||+|+...+. ++..||+|.+..... ...+.+|++++++++ |+||+++++++.. +...++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~-~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGTGI-----SMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCC-ccceEEEEEecCCCC-----cHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEE
Confidence 468999999999999865432 468999999864321 235678999999998 9999999999853 5578999
Q ss_pred EeecCCCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec-CCCceEEEeecc
Q 012825 238 MELCEGGELLDRILSR--------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENSVLKAIDFG 308 (455)
Q Consensus 238 ~E~~~ggsL~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~-~~~~~vkL~DfG 308 (455)
|||+.+ +|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||+... +.++.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 999964 777776422 2358999999999999999999999999999999999999533 356789999999
Q ss_pred cccccCCCC----cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChh---------HHHHHH
Q 012825 309 LSDFVRPDE----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTES---------GIFRAV 373 (455)
Q Consensus 309 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~---------~~~~~i 373 (455)
+++...... ......||..|+|||++.+ .++.++|||||||++|||++|+.||...... ..+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 998764322 2234578999999998864 4789999999999999999999999643321 111111
Q ss_pred HhcCC--------------CC--------------------CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 374 LKADP--------------SF--------------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 374 ~~~~~--------------~~--------------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
..... .+ ........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 11000 00 000011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=329.65 Aligned_cols=256 Identities=28% Similarity=0.482 Sum_probs=205.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|++|.||+|.... +++.||||.+....... ....+.+|++++++++ |+||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 77 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKL---TGQLVALKEIRLEHEEG--APFTAIREASLLKDLK-HANIVTLHDIIHTKKT 77 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcC---CCcEEEEEEEecccccC--CchhHHHHHHHHhhCC-CcceeeEEEEEecCCe
Confidence 4789999999999999999998765 57899999986532211 2234668999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+.+ +|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 78 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 78 LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAK 153 (291)
T ss_pred EEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECcccccccc
Confidence 9999999975 8999887766789999999999999999999999999999999999999 77888999999998754
Q ss_pred CCCC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCh-hHHHHHHHhcCCCC---------
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSF--------- 380 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~-~~~~~~i~~~~~~~--------- 380 (455)
.... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||..... .+.+..+.+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 3221 2223356888999998753 478899999999999999999999976552 22222221110000
Q ss_pred -----------------CCCCCCCCC--HHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 381 -----------------DEAPWPSLS--SEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 381 -----------------~~~~~~~~s--~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.......++ .++.++|.+||++||++||++.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000011334 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=331.71 Aligned_cols=262 Identities=29% Similarity=0.486 Sum_probs=234.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
..+|.++..||+|+||.|.++..+. +...||||++++.........+.-..|-++|.....-|.+++++.+|+.-++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkg---tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ecccceEEEeccCccceeeeecccC---cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 6789999999999999999998666 5689999999988776666666667788888777667899999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+||||+.||+|.-+++ .-+++.+..+..++.+|+.||-|||++|||+||||.+|||+ |.+|++||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQ-Q~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQ-QVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHH-HhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeeccccccc
Confidence 999999999999988774 45779999999999999999999999999999999999999 89999999999999764
Q ss_pred -CCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 -RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 -~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
-.+..+.+++||+.|+|||++. .+|+...|+|++||+||||+.|+.||++..+.+.++.|......++. .+|.+
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkE 576 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKE 576 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHH
Confidence 3345667899999999999876 78999999999999999999999999999999999999999888776 68999
Q ss_pred HHHHHHHhccCCccCCCC-----HHHHHcCcccCCCCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNSNDVK 426 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps-----~~elL~hp~~~~~~~~~ 426 (455)
..++++.+|.+.|.+|.. -++|-.||||+.+.+.+
T Consensus 577 Av~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 577 AVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred HHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence 999999999999999974 46888999999865433
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=326.64 Aligned_cols=258 Identities=29% Similarity=0.542 Sum_probs=213.6
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEeEEEeeCCc
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hp~Iv~l~~~~~~~~~ 233 (455)
.|++.+.||+|+||.||+|.... +++.||+|++... .......++.+|+.+++++. .|+|++++++++.++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~iK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---TGRVVALKIINLD--TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---CCcEEEEEEecCC--CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 58889999999999999999765 5889999998653 23344567889999999986 59999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++.. +.+++..++.++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeec
Confidence 9999999999999987743 478999999999999999999999999999999999999 67889999999998876
Q ss_pred CCCC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
.... ......|+..|+|||++.+ .++.++|+||||+++|+|++|..||...........+.... ........++.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 229 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK--PPRLEDNGYSK 229 (277)
T ss_pred CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC--CCCCCcccCCH
Confidence 5433 2334578899999998763 46889999999999999999999997765544333222221 11111223788
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~ 425 (455)
++.+++.+||+.||++||++.+++.|+||+.....
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~ 264 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLKSKWIKAHSKT 264 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence 99999999999999999999999999999876543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=330.81 Aligned_cols=263 Identities=25% Similarity=0.384 Sum_probs=210.5
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|+..+.||+|+||.||++.... +++.||+|.+..... ......+.+|+.++.++.+|+||+++++++..++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKP---SGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECC---CCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence 467788999999999999998766 589999999865432 245567889999999997799999999999999999
Q ss_pred EEEEeecCCCcHHHHH---Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 235 YVVMELCEGGELLDRI---LS-RGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l---~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
+++|||+.+ ++.++. .. ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~ 154 (288)
T cd06616 79 WICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGI 154 (288)
T ss_pred EEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecch
Confidence 999999954 554433 22 346799999999999999999999985 99999999999999 6778899999999
Q ss_pred ccccCCCCcccccccCCCcccccccCC----CCCCcchHHHHHHHHHHHHcCCCCCCCCChh-HHHHHHHhcC-CCCCCC
Q 012825 310 SDFVRPDERLNDIVGSAYYVAPEVLHR----SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKAD-PSFDEA 383 (455)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~-~~~~~i~~~~-~~~~~~ 383 (455)
+.............|+..|+|||++.+ .++.++||||||+++|+|++|+.||...... +.+..+.... +.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd06616 155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNS 234 (288)
T ss_pred hHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCc
Confidence 976654443344568899999998863 4889999999999999999999999655421 2222222221 122222
Q ss_pred CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCC
Q 012825 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426 (455)
Q Consensus 384 ~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~ 426 (455)
....++.++.+||.+||+.||++||++.+++.||||+.....+
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~ 277 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERN 277 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcc
Confidence 2235889999999999999999999999999999999864433
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=346.54 Aligned_cols=259 Identities=34% Similarity=0.598 Sum_probs=232.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
...|.+.+.||.|.|+.|.+++... ++..||||++.+..... ..++.+.+|+++++.|. |||||+++.+.+....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~---t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHIL---TGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLN-HPNIVKLFSVIETEAT 129 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecC---CCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcC-Ccceeeeeeeeeecce
Confidence 4679999999999999999999666 68999999998876444 34445889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+||||+.+|.+++++. +++.+.+..++.++.|+..+++|||+++|||||||.+|||| +.+.++||+|||++..+
T Consensus 130 lylV~eya~~ge~~~yl~-~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLV-KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFF 205 (596)
T ss_pred eEEEEEeccCchhHHHHH-hcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceee
Confidence 999999999999999985 45667789999999999999999999999999999999999 89999999999999999
Q ss_pred CCCCcccccccCCCcccccccCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
.......+++|++.|.|||++.+. ..+++|+||+|++||-|++|.+||++.+-.+....++......+. .++.+
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~d 281 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCD 281 (596)
T ss_pred cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeech
Confidence 988888999999999999999853 577899999999999999999999999888777777776655554 47889
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~ 425 (455)
..++|+++|-.+|.+|++..+++.|.|.....+.
T Consensus 282 ce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 282 CEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred hHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 9999999999999999999999999999876443
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=329.95 Aligned_cols=256 Identities=29% Similarity=0.518 Sum_probs=209.3
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|.... +++.||+|++...... ....+.+.+|+++++.+. |+||+++++++..++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---CCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeE
Confidence 479999999999999999999765 4789999998654322 234567889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++++|.++. .....+++..++.++.||+.||.|||+.||+|+||+|+||++ ++++.++|+|||++....
T Consensus 76 ~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 76 YLVFEFVDHTVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLA 151 (286)
T ss_pred EEEEecCCccHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeecc
Confidence 9999999987776654 444568999999999999999999999999999999999999 778899999999987654
Q ss_pred CCC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC-----------
Q 012825 315 PDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF----------- 380 (455)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~----------- 380 (455)
... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||......+....+......+
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 332 2334568889999998763 47889999999999999999999997665444333332211100
Q ss_pred --------C--------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 381 --------D--------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 381 --------~--------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
. ....+.++..+.+|+.+||+.||++||++.+++.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 01134578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=325.32 Aligned_cols=256 Identities=31% Similarity=0.535 Sum_probs=210.8
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|++|.||+|.... +++.|++|++.... ...+.+.+|+.+++++.+|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECC---CCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 36889999999999999999999765 47899999986432 234678899999999966999999999997644
Q ss_pred ------ceEEEEeecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEE
Q 012825 233 ------NVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (455)
Q Consensus 233 ------~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vk 303 (455)
.+++||||+++++|.+++... +..+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~ 153 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVK 153 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEE
Confidence 489999999999998877542 4679999999999999999999999999999999999999 6788999
Q ss_pred EeecccccccCCCC-cccccccCCCcccccccCC------CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhc
Q 012825 304 AIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (455)
Q Consensus 304 L~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~ 376 (455)
|+|||++....... ......|+..|+|||++.. .++.++||||||++||+|++|..||...........+...
T Consensus 154 l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 154 LVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred ECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 99999987654322 2234568899999998742 3678899999999999999999999766555544444433
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 377 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.... ......++.++.+||.+||..||++|||+.+++.|||+
T Consensus 234 ~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 234 PPPT-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCC-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2211 11112378899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=331.91 Aligned_cols=256 Identities=32% Similarity=0.487 Sum_probs=210.6
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC--C
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--D 232 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~--~ 232 (455)
++|++.+.||.|+||.||+|.... +++.||+|.+...... ......+.+|+.+++++. |+||+++++++... +
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK---TGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC---CCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCC
Confidence 579999999999999999998765 5789999998654322 223345678999999998 99999999999877 8
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..|+||||+++ +|.+++......+++..++.++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||++..
T Consensus 80 ~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 80 KIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLARE 155 (293)
T ss_pred cEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceee
Confidence 89999999975 8888887666679999999999999999999999999999999999999 7788999999999887
Q ss_pred cCCC-CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC---------
Q 012825 313 VRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF--------- 380 (455)
Q Consensus 313 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~--------- 380 (455)
.... .......++..|+|||++.+ .++.++||||||+++|+|++|..||........+..+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 6543 23344567889999998764 36889999999999999999999998777665554443321100
Q ss_pred -----------------CCCCCCC--CCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 381 -----------------DEAPWPS--LSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 381 -----------------~~~~~~~--~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.....+. +++.+.+||++||+.||++|||+.|+|.|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0011112 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=330.22 Aligned_cols=260 Identities=29% Similarity=0.493 Sum_probs=214.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||++.... +++.||+|.+.... ....+.+.+|+.+++.+. |+||+++++++..++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~ 89 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIA---TGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGD 89 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECC---CCCEEEEEEEecCc---cchHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 35789999999999999999998665 58899999986532 223456789999999997 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQ 164 (297)
T ss_pred EEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceE
Confidence 99999999999999998743 458999999999999999999999999999999999999 7788999999999876
Q ss_pred cCCCCc-ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 313 VRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 313 ~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
...... .....++..|+|||.+. ..++.++||||||+++|+|++|..||...........+.... .........++.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 243 (297)
T cd06656 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSA 243 (297)
T ss_pred ccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCH
Confidence 543332 23456889999999876 458899999999999999999999997665433322222211 111112235788
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~ 425 (455)
.+.+||.+||..||++||++.+++.||||+..+..
T Consensus 244 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 244 VFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 99999999999999999999999999999977543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=321.17 Aligned_cols=253 Identities=35% Similarity=0.559 Sum_probs=213.9
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee--CCc
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--TDN 233 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--~~~ 233 (455)
+|++.+.||.|+||.||++.... +++.||+|++..... .....+.+.+|++++++++ |+||+++++++.. +..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---CCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCE
Confidence 58999999999999999998766 578999999865432 3455677889999999998 9999999998764 456
Q ss_pred eEEEEeecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----HcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 234 VYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCH-----LQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~~LH-----~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
.+++|||+++++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||++ +.++.+||+
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~ 152 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLG 152 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEe
Confidence 89999999999999988653 567999999999999999999999 8899999999999999 678899999
Q ss_pred ecccccccCCCCc-ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 012825 306 DFGLSDFVRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (455)
Q Consensus 306 DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (455)
|||++........ .....++..|+|||++. ..++.++|+||||+++|+|++|..||...........+...... .
T Consensus 153 d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~ 229 (265)
T cd08217 153 DFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR---R 229 (265)
T ss_pred cccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC---C
Confidence 9999987754443 34567899999999886 45888999999999999999999999887755555544443321 1
Q ss_pred CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 384 ~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
....++..+.+++.+||+.+|++||++.++++|||+
T Consensus 230 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 230 IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 223678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=326.99 Aligned_cols=256 Identities=27% Similarity=0.484 Sum_probs=213.4
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||.|+||.||++..+. +++.||+|++.... .....+.+.+|+++++++. |+||+++++++..++..
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP---TGKIMAVKTIRLEI--NEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC---CCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEE
Confidence 468899999999999999999776 58899999986542 2355677899999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
++|+||+++++|.+++......+++..+..++.||+.||.|||+ .|++|+||||+||++ +.++.++|+|||.+...
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQL 151 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhh
Confidence 99999999999999887655789999999999999999999999 999999999999999 67888999999998765
Q ss_pred CCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC-----hhHHHHHHHhcCCCCCCCCCCC
Q 012825 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART-----ESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
..... ....++..|+|||++. ..++.++||||||+++|+|++|..||.... ....+..+...... ......
T Consensus 152 ~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 228 (265)
T cd06605 152 VNSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP--RLPSGK 228 (265)
T ss_pred HHHHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC--CCChhh
Confidence 43222 2267888999999876 468899999999999999999999996542 22223333322211 111112
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
++.++.++|.+||..||++||++.+++.||||+.-
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 78899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=356.34 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=219.4
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCc--ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
-..+.+..+.||+|+||.||+|+..... ...+.||||.++.. .+.+..++|++|++++..|+ |||||+|+|+|.+
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQ-HPNIVRLLGVCRE 560 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEcc
Confidence 3567888999999999999999877543 24578999999754 56668899999999999999 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC
Q 012825 231 TDNVYVVMELCEGGELLDRILSRG-------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~-------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~ 297 (455)
++-+|+|+|||..|+|.++|.... ..++..+...|+.||+.|++||-++.+|||||-..|+|| +
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---g 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---G 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---c
Confidence 999999999999999999987532 238899999999999999999999999999999999999 8
Q ss_pred CCceEEEeecccccccCCCCccc---ccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 012825 298 ENSVLKAIDFGLSDFVRPDERLN---DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (455)
Q Consensus 298 ~~~~vkL~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~ 372 (455)
++..|||+|||+++.....+... ...-..+||+||.+. +.|+.+||||||||+|||+++ |+.||.+..+.+++..
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 99999999999998765444332 234457899999654 899999999999999999998 9999999999999988
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHH
Q 012825 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 413 (455)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~el 413 (455)
+..+.. . .....++.++.+|+..||+.+|++||++.||
T Consensus 718 i~~g~l-L--~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 718 IRAGQL-L--SCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHcCCc-c--cCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 877664 2 2224789999999999999999999999998
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=330.73 Aligned_cols=257 Identities=29% Similarity=0.439 Sum_probs=203.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC-
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~- 232 (455)
.++|++.++||+|+||.||+|.... +++.||||.+..... .......+.+|+++++++. |+||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKAT 85 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC---CCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCC-CCCccceEEEEecccc
Confidence 4579999999999999999998765 589999998864322 1222234568999999998 999999999987544
Q ss_pred -------ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 233 -------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 233 -------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
..++||||+. ++|.+.+......+++..++.++.||+.||.|||++|++|+||||+||++ +.++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~ 161 (310)
T cd07865 86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLA 161 (310)
T ss_pred cccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEEC
Confidence 4599999995 48888887666689999999999999999999999999999999999999 778899999
Q ss_pred ecccccccCCCCc-----ccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC
Q 012825 306 DFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (455)
Q Consensus 306 DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (455)
|||++........ .....++..|+|||++.+ .++.++||||||+++|+|++|+.||...........+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999976543221 123457888999998764 378899999999999999999999977665443333222111
Q ss_pred CCCCCC----------------------------CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 379 SFDEAP----------------------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 379 ~~~~~~----------------------------~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
...... ....+..+.+||.+||+.||.+|||+.++|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 110000 00135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=326.64 Aligned_cols=254 Identities=20% Similarity=0.348 Sum_probs=212.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCc--ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.+.||+|+||.||+|...... .....||+|.+... ........+.+|+.++.+++ |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~ 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKE 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC--CCHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCC
Confidence 357999999999999999999876532 23478999998643 34455677899999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec
Q 012825 232 DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~ 296 (455)
+..+++|||+++++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+|||+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~--- 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV--- 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---
Confidence 99999999999999999886532 458899999999999999999999999999999999999
Q ss_pred CCCceEEEeecccccccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 012825 297 DENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~ 371 (455)
+.++.+||+|||++....... ......++..|+|||++. +.++.++|||||||++|||++ |..||.+....+...
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 678889999999987653322 123345678899999875 678999999999999999998 999998887777666
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.+....... ....++.++.+|+.+||+.||.+||++.+++++
T Consensus 238 ~i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 655443221 124688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=320.44 Aligned_cols=246 Identities=26% Similarity=0.446 Sum_probs=207.3
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+++.+. +..+|+|.+..... ....+.+|+.+++++. |+||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----QIKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----CceEEEEecccCCc----cHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCE
Confidence 568999999999999999998764 56799998764322 2356888999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++++|.+++....+.+++..++.++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++....
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccC
Confidence 99999999999999887666679999999999999999999999999999999999999 678899999999987654
Q ss_pred CCCcc--cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 315 PDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 315 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
..... ....++..|+|||++. ..++.++||||||+++|+|++ |+.||......+....+.+...... ....+.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~ 228 (256)
T cd05114 152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---PKLASM 228 (256)
T ss_pred CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCH
Confidence 32222 2223456799999886 568899999999999999999 8999988877776666655432221 124678
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHc
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.+.+++.+||+.||.+||++.++++
T Consensus 229 ~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 229 TVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 8999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=327.68 Aligned_cols=261 Identities=29% Similarity=0.464 Sum_probs=211.9
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|++|.||+|.... +|+.||+|.+..... .....+.+.+|+++++++. |+||+++++++.+++..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV---TNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC---CCcEEEEEehhhccc-cccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeE
Confidence 579999999999999999998765 588999999865432 2233456788999999997 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 235 YVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
|+||||++ ++|.+++..... .+++..++.++.||+.||.|||+++|+|+||+|+||+++ ..++.+||+|||++...
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEccccccccc
Confidence 99999996 578887755433 468899999999999999999999999999999999994 24567999999999765
Q ss_pred CCCC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC--------
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-------- 382 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 382 (455)
.... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||......+.+..+.........
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 4322 2234467889999998754 4788999999999999999999999877666655554432111100
Q ss_pred -----------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 383 -----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 383 -----------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
...+.++.++.++|.+||+.||++||++.+++.||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 01235788999999999999999999999999999999764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=327.01 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=199.8
Q ss_pred eEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHh--cCCCCeeEEeEEEeeCCceEEEEe
Q 012825 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGHNNLVKFFDAYEDTDNVYVVME 239 (455)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l--~~hp~Iv~l~~~~~~~~~~~lV~E 239 (455)
.||+|+||.||++.... +++.||+|++.+...........+.+|..++..+ ..|+||+.+++++..++..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECC---CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 48999999999998765 5889999998765433333333444555444433 249999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcc
Q 012825 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319 (455)
Q Consensus 240 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~ 319 (455)
|+++++|.+++.. .+.+++..+..++.|++.||.|||+.+|+||||||+|||+ ++++.++|+|||++...... ..
T Consensus 78 ~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~-~~ 152 (279)
T cd05633 78 LMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKK-KP 152 (279)
T ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceecccc-Cc
Confidence 9999999887754 4579999999999999999999999999999999999999 77889999999998755432 22
Q ss_pred cccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012825 320 NDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~ 397 (455)
....|+..|+|||.+. ..++.++|||||||++|+|++|..||......... .+..............++.++.++|+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~ 231 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPDSFSPELKSLLE 231 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCcCCccccCHHHHHHHH
Confidence 3456899999999875 34789999999999999999999999654322111 11111111122223468899999999
Q ss_pred HhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 398 RLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 398 ~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
+||+.||.+|+ ++.++++||||++.+
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 99999999999 699999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=320.03 Aligned_cols=255 Identities=32% Similarity=0.557 Sum_probs=211.3
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||+|+||.||+|.... +++.|++|++...... ....+.+.+|+.+++.+. |+||+++++++...+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---TGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---CCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEE
Confidence 68999999999999999998765 4789999998765432 456788999999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
+|+||+++++|.+++.. +..+++..++.++.+++.||.|||+.||+|+||+|+||++ ++++.+||+|||++.....
T Consensus 76 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 76 IFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred EEEecCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCC
Confidence 99999999999998754 4568999999999999999999999999999999999999 6788999999999887653
Q ss_pred CCc-----ccccccCCCcccccccCC-C---CCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 316 DER-----LNDIVGSAYYVAPEVLHR-S---YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 316 ~~~-----~~~~~gt~~y~aPE~~~~-~---~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
... .....++..|+|||++.+ . ++.++||||||+++|+|++|+.||.........................
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSL 231 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCccc
Confidence 322 123567889999999863 3 7889999999999999999999997653333222222222221222223
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.++..+.+||++||+.||.+||++.+++.|||+
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 232 QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 468999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=321.91 Aligned_cols=255 Identities=25% Similarity=0.449 Sum_probs=207.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc--CCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee--
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~-- 230 (455)
.+|++.+.||+|+||.||+|.... ++..||+|++..... ........+.+|+.++++++ |+||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 77 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD---TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRA 77 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC---CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCC
Confidence 368999999999999999998765 588999998864432 22344567899999999998 9999999998875
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
++..+++|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||||+||++ +.++.+||+|||++
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~ 153 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGAS 153 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCc
Confidence 3568899999999999988754 4468999999999999999999999999999999999999 77888999999998
Q ss_pred cccCCC----CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 311 DFVRPD----ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 311 ~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
...... .......++..|+|||++. ..++.++|||||||++|+|++|+.||.................. ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~ 231 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN--PQLP 231 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC--CCCc
Confidence 765321 1223356888999999886 45889999999999999999999999876555444433322211 1112
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~ 420 (455)
..+++.+.++| +||..+|++||+++|+++||||+
T Consensus 232 ~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 232 SHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 35678899999 67778999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=326.63 Aligned_cols=256 Identities=28% Similarity=0.444 Sum_probs=204.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|.+.+.||+|+||.||+|.... +|+.||+|++...... .....+.+|+.+++.+. |+||+++++++..++.
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~ 77 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI---NGQLVALKVISMKTEE--GVPFTAIREASLLKGLK-HANIVLLHDIIHTKET 77 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC---CCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCe
Confidence 5789999999999999999998766 5789999998654322 22235678999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.|+||||+. ++|.+++......+++..+..++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||+++..
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAK 153 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEecccccccc
Confidence 999999995 68887776666678899999999999999999999999999999999999 67888999999998764
Q ss_pred CCC-CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChh-HHHHHHHhcC------------
Q 012825 314 RPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKAD------------ 377 (455)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~-~~~~~i~~~~------------ 377 (455)
... .......++..|+|||++.+ .++.++||||||+++|+|++|..||...... +.+..+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 322 22334467889999998864 4788999999999999999999999765432 1111111100
Q ss_pred --CCCCCC------------CCC--CCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 378 --PSFDEA------------PWP--SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 378 --~~~~~~------------~~~--~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
+.+... .+. ..+.++.++|.+||..||++|||+.|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000000 000 135688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=321.28 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=212.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|...........||||++... ........+.+|+.++++++ |+||+++++++.+++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--SSDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC--CChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCc
Confidence 35799999999999999999998764334578999998654 34445567889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++....+.+++..+..++.|++.||.|||+.+|+|+||||+|||+ ++++.++|+|||++...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRL 156 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhcc
Confidence 999999999999999987767789999999999999999999999999999999999999 77888999999999876
Q ss_pred CCC-Ccc--cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 314 RPD-ERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 314 ~~~-~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
... ... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+...... + ....+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~ 233 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-P--PPMDC 233 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-C--CCCCC
Confidence 421 111 1223457899999876 568999999999999999998 99999887766665555443211 1 12357
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+..+.+|+.+||+.||++||++.+++++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=326.32 Aligned_cols=262 Identities=27% Similarity=0.425 Sum_probs=219.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.+.|...+.||+|+||.||+|+... +|..|++|++.............+.+|+++++.++ |+|++++++++.+.+.
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 95 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSH---TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHT 95 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECC---CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCE
Confidence 3447778889999999999998655 58899999987654445555677889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.|+||||+. +++.+.+......+++..+..++.||+.+|.|||+.||+|+||+|+||++ +.++.+||+|||++...
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKS 171 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCccc
Confidence 999999995 58888887767789999999999999999999999999999999999999 67788999999998653
Q ss_pred CCCCcccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
. ......|+..|+|||++. +.++.++||||||+++|+|++|..||...........+....... .....++
T Consensus 172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 246 (313)
T cd06633 172 S---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT--LQSNEWT 246 (313)
T ss_pred C---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCccccC
Confidence 3 223457889999999873 458889999999999999999999998776655555544433221 2223577
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCc
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p 428 (455)
..+.+||.+||+.+|.+||++.+++.||||+.....+++
T Consensus 247 ~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~~ 285 (313)
T cd06633 247 DSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVL 285 (313)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchhHHH
Confidence 889999999999999999999999999999986544444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=319.16 Aligned_cols=254 Identities=31% Similarity=0.507 Sum_probs=213.4
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc--CCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
+|+..+.||+|+||.||+|.... ++..|++|.+..... ...+..+.+.+|+.+++.+. |+||+++++++.+++.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCe
Confidence 57888999999999999998775 478999999864322 23445678999999999997 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||++ +.++.+||+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEEEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceec
Confidence 9999999999999988754 4568999999999999999999999999999999999999 67889999999998876
Q ss_pred CCCCcccccccCCCcccccccC-CC-CCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPDERLNDIVGSAYYVAPEVLH-RS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
..........++..|++||.+. .. ++.++|+||||+++|+|++|+.||...........+..... . ......++..
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~ 230 (258)
T cd06632 153 VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-L-PPIPDHLSDE 230 (258)
T ss_pred cccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-C-CCcCCCcCHH
Confidence 5444445567899999999875 34 88999999999999999999999977665444444333111 1 1122457899
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
+.+||++||+.+|.+||++.+++.|||+
T Consensus 231 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 231 AKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=338.14 Aligned_cols=257 Identities=27% Similarity=0.497 Sum_probs=208.2
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
+.++|++.+.||+|+||.||+|.... +|+.||+|++.+.. ........+.+|+.+++++. |+||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 88 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV---TGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQK 88 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC---CCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCC
Confidence 46889999999999999999998776 58899999986532 23344566778999999998 99999999988643
Q ss_pred -----CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 232 -----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
...|+||||+.+ +|.+.+... +++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~D 161 (353)
T cd07850 89 SLEEFQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 161 (353)
T ss_pred CccccCcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEcc
Confidence 357999999964 888776432 8999999999999999999999999999999999999 7788999999
Q ss_pred cccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC------
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------ 379 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~------ 379 (455)
||++.............++..|+|||++. ..++.++|||||||++|+|++|+.||...........+......
T Consensus 162 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 162 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred CccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99998765444444567889999999876 56899999999999999999999999776654444333221100
Q ss_pred ----------------CC---------CCC--------CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 380 ----------------FD---------EAP--------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 380 ----------------~~---------~~~--------~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.. ... ....+..+.+||.+||+.||++|||+.|+|.||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 00 000 1124567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=324.79 Aligned_cols=256 Identities=28% Similarity=0.502 Sum_probs=214.8
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
..|+..+.||.|+||.||+|.... .+..||+|++... ........+.+|+.+++++. |+||+++++++.+++..
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLE--EAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc---CCEEEEEEEEecc--ccHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEE
Confidence 468889999999999999998766 5789999998654 23445678899999999997 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++++|.+++.. +.+++..+..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceecc
Confidence 999999999999998743 568999999999999999999999999999999999999 677889999999997664
Q ss_pred CCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 315 PDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
... ......++..|+|||++. ..++.++|+||||+++|+|++|..||...........+..... ......++..+
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 229 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPF 229 (277)
T ss_pred CCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHH
Confidence 333 223346788999999876 4688999999999999999999999987665554443322221 11223567889
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
.+||.+||+.+|++||++.+++.|+||.....
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 230 KEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=322.52 Aligned_cols=256 Identities=28% Similarity=0.492 Sum_probs=210.5
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-------CHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-------TAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-------~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
+|.+.+.||.|+||.||+|.... +|+.||+|.+...... .....+.+.+|+.+++++. |+||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFE 77 (272)
T ss_pred ceeecceecccCceEEEEEeecC---CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEe
Confidence 58899999999999999998665 5889999987532111 1223456889999999998 99999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
...+..++||||+++++|.+++... +.+++..+..++.||+.||.|||+.+++||||+|+||++ +.++.++|+|||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~ 153 (272)
T cd06629 78 TTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFG 153 (272)
T ss_pred ccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecc
Confidence 9999999999999999999987554 679999999999999999999999999999999999999 778899999999
Q ss_pred cccccCCCC---cccccccCCCcccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhc--CCCC
Q 012825 309 LSDFVRPDE---RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA--DPSF 380 (455)
Q Consensus 309 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~--~~~~ 380 (455)
++....... ......++..|+|||++.. .++.++|+||||+++|+|++|..||...........+... ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI 233 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence 987654221 1233468889999998763 3788999999999999999999999765544433333222 2223
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.......++.++.+||.+||..||.+||++.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 333445678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=327.46 Aligned_cols=255 Identities=31% Similarity=0.501 Sum_probs=208.7
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||.|++|.||+|+... +|+.||||.+.... ........+.+|++++++++ |+||+++++++.+++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDT-ETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---CCCEEEEEEccccc-cccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEE
Confidence 48999999999999999998765 58899999986543 22233356889999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 236 VVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+||||+. ++|.+++... ...+++..++.++.||+.||.|||+.+++|+||+|+||++ +.++.+||+|||++....
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcc
Confidence 9999996 5888877543 4578999999999999999999999999999999999999 778889999999987654
Q ss_pred CCC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC---------
Q 012825 315 PDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE--------- 382 (455)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 382 (455)
... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||...........+.+.......
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 322 2233457889999998764 3688999999999999999999999877665544444332111110
Q ss_pred ----------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 383 ----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 383 ----------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
...+.++.++.++|.+||+.||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 1123577889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=347.04 Aligned_cols=254 Identities=25% Similarity=0.449 Sum_probs=216.2
Q ss_pred EEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCC-CcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc--e
Q 012825 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH-KMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN--V 234 (455)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~--~ 234 (455)
+...+||+|+|-+||+|.+.. +|..||.-.++.. .......++++..|+.+|+.|+ |+||+++|++|.+... +
T Consensus 43 k~~evLGrGafKtVYka~De~---~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE---EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ehhhhcccccceeeeeccccc---cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCcee
Confidence 456789999999999999754 6888886555322 2345667789999999999999 9999999999997665 8
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+|+|.+..|+|..|+ .+.+.++...++.|++||++||.|||++. |||||||.+||||+ +..|.|||+|+|+|..
T Consensus 119 n~iTEL~TSGtLr~Y~-kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 119 NFITELFTSGTLREYR-KKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeecccCCcHHHHH-HHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHH
Confidence 8999999999999987 45577899999999999999999999995 99999999999998 7789999999999998
Q ss_pred cCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-ChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
...... ...+||+.|||||+....|+...||||||++|+||+|+..||... +...+++++..+..+..... --.++
T Consensus 196 ~r~s~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dPe 272 (632)
T KOG0584|consen 196 LRKSHA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK--VKDPE 272 (632)
T ss_pred hhcccc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCHH
Confidence 864433 448999999999999999999999999999999999999999764 45566777766554332221 23688
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+++||.+||.. .++|+|+.|+|.|+||...
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 99999999999 8999999999999999985
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=322.98 Aligned_cols=257 Identities=25% Similarity=0.430 Sum_probs=208.6
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC---HHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+|+..+.||+|+||.||++.... +++.||+|++....... ....+.+.+|++++++++ |+||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCC
Confidence 47888999999999999998755 58899999986543221 234578899999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCC-ceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~-~~vkL~DfG~a~ 311 (455)
..++||||+++++|.+++.. .+.+++..++.++.||+.||.|||++|++|+||+|+||++ +.+ ..+||+|||++.
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~---~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI---DSTGQRLRIADFGAAA 152 (268)
T ss_pred eEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEccccccc
Confidence 99999999999999987754 4578999999999999999999999999999999999999 444 469999999987
Q ss_pred ccCCCC-----cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC-CCCCCC
Q 012825 312 FVRPDE-----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP-SFDEAP 384 (455)
Q Consensus 312 ~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~ 384 (455)
...... ......++..|+|||++. ..++.++||||||+++|+|++|..||...........+.+... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCC
Confidence 664321 112346788999999876 4688999999999999999999999965443322222222111 111122
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccC
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~ 420 (455)
...++.++.++|.+||..||.+||++.+++.||||+
T Consensus 233 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred chhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 235789999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=327.10 Aligned_cols=261 Identities=27% Similarity=0.431 Sum_probs=213.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||.|+||.||+|.... +++.||||++.... .......+..|+.++.++.+|+||+++++++.++..
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECC---CCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4779999999999999999998765 57899999986543 233445677788888888779999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.|+||||+. +++.+.+......+++..+..++.||+.||.|||+ .||+||||+|+||++ ++++.+||+|||++..
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGR 164 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchh
Confidence 999999995 47777766656789999999999999999999997 599999999999999 7788999999999877
Q ss_pred cCCCCcccccccCCCcccccccCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCCh-hHHHHHHHhcCCCCCCCCCC
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLHR-----SYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlG~~l~elltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~ 386 (455)
...........++..|+|||++.+ .++.++||||||+++|+|++|+.||..... .+.+..++........ ...
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 243 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP-PNE 243 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC-CCC
Confidence 654444444567889999998763 378899999999999999999999976332 3334444443322111 112
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
.++.++.+||.+||+.||.+||++.+++.|+||+....
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 47899999999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=325.15 Aligned_cols=254 Identities=28% Similarity=0.509 Sum_probs=209.0
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||.|++|.||+|+... +|..||||++..... ......+.+|+.++++++ |+||+++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---TGEIVALKEIHLDAE--EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---CCeEEEEEEeccccc--ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEE
Confidence 58999999999999999999765 588999999865432 222355678999999997 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 236 VVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+||||+++ +|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||++ ++++.++|+|||++...
T Consensus 75 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAF 150 (284)
T ss_pred EEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhh
Confidence 99999975 8888876544 468999999999999999999999999999999999999 77888999999998765
Q ss_pred CCCC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC---------
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--------- 381 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--------- 381 (455)
.... ......++..|++||++.+ .++.++||||||+++|+|++|..||......+.+..+.+......
T Consensus 151 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 151 GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred cCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 4322 2234467889999998754 468899999999999999999999987776665555443211000
Q ss_pred -----C-----------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 382 -----E-----------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 382 -----~-----------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
. ...+.++..+.++|.+||+.||.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 0012457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=319.72 Aligned_cols=256 Identities=31% Similarity=0.497 Sum_probs=216.0
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|++|.||+|.... +++.|+||++..... ......+.+|+..+.+++ |+||+++++++...+..
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeE
Confidence 468999999999999999998776 588999999865432 245678999999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
++||||+++++|.+++... ..+++..++.++.||++||.|||+ .|++|+||+|+||++ +.++.++|+|||++...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVL 150 (264)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceec
Confidence 9999999999999988544 679999999999999999999999 999999999999999 77889999999998876
Q ss_pred CCCCcc-cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC---hhHHHHHHHhcCCCCCCCCCCC-
Q 012825 314 RPDERL-NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDEAPWPS- 387 (455)
Q Consensus 314 ~~~~~~-~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~- 387 (455)
...... ....++..|+|||.+. +.++.++||||||+++|+|++|..||.... .......+...... .....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 227 (264)
T cd06623 151 ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP---SLPAEE 227 (264)
T ss_pred ccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC---CCCccc
Confidence 543332 2556889999999876 468889999999999999999999997764 33333333322211 11123
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
++..+.++|.+||..+|++||++.++++||||+..+
T Consensus 228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 228 FSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 789999999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=319.08 Aligned_cols=255 Identities=27% Similarity=0.479 Sum_probs=208.4
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCC--cCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK--MTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
++|++.+.||+|+||.||++.... +|..||||.+.... .......+.+.+|+.+++++. |+||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD---TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPM 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC---CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCC
Confidence 479999999999999999998765 58899999875332 123345678899999999998 99999999998763
Q ss_pred -CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 232 -DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 232 -~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+|+|+||||+|||+ +.++.++|+|||++
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~ 153 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGAS 153 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccc
Confidence 4688999999999999987543 568999999999999999999999999999999999999 67888999999998
Q ss_pred cccCCC----CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 311 DFVRPD----ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 311 ~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
...... .......++..|+|||++. ..++.++||||||+++|+|++|+.||................ .. ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~-~~~~ 231 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-TN-PVLP 231 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCC-CC-CCCc
Confidence 765321 1223456888999999876 468899999999999999999999998765554444333221 11 1122
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~ 420 (455)
..++..+.++|++|+. +|++||++.+++.|||++
T Consensus 232 ~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 232 PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 3577889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=322.11 Aligned_cols=253 Identities=28% Similarity=0.502 Sum_probs=212.4
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
-|++.+.||.|+||.||+|.... ++..||||++... ........+.+|+.+++++. |+||+++++++.+++..+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~---~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLE--EAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECC---CCcEEEEEEeccc--cchHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEE
Confidence 47788999999999999998665 4789999998543 22344567889999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
+||||+++++|.+++. ...+++..+..++.|++.+|.|||+.|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 79 IIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred EEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceeccc
Confidence 9999999999998774 3568999999999999999999999999999999999999 6778899999999876543
Q ss_pred CC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 316 DE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
.. ......++..|+|||++. ..++.++|+|||||++|+|++|..||...........+...... .....++.++.
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (277)
T cd06641 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLK 230 (277)
T ss_pred chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC---CCCcccCHHHH
Confidence 22 223456888999999876 46788999999999999999999999876655544444332211 12235789999
Q ss_pred HHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 394 DFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 394 ~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
++|.+||+.+|.+||++.+++.||||+..
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 231 EFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=352.31 Aligned_cols=271 Identities=20% Similarity=0.300 Sum_probs=202.2
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEE--------------EccCCCcCCHHHHHHHHHHHHHHHHh
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVK--------------VIPKHKMTTAIAIEDVRREVKILRAL 215 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK--------------~~~~~~~~~~~~~~~~~~Ei~~l~~l 215 (455)
...+.++|++++.||+|+||.||++..+... +..+++| ++.+...........+.+|+.+++++
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l 220 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRAST--EEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL 220 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccc--hhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC
Confidence 3456789999999999999999998765421 2222222 11111112334456788999999999
Q ss_pred cCCCCeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCce
Q 012825 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR----GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291 (455)
Q Consensus 216 ~~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~----~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NI 291 (455)
. |+||+++++++.+.+..|+|+|++. ++|.+++... ........++.|+.||+.||.|||++|||||||||+||
T Consensus 221 ~-HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NI 298 (501)
T PHA03210 221 N-HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI 298 (501)
T ss_pred C-CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 8 9999999999999999999999995 5777776532 22345677889999999999999999999999999999
Q ss_pred EEeecCCCceEEEeecccccccCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC---
Q 012825 292 LFTTKDENSVLKAIDFGLSDFVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART--- 365 (455)
Q Consensus 292 Ll~~~~~~~~vkL~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~--- 365 (455)
|+ +.++.+||+|||++........ .....||..|+|||++. ..++.++|||||||+||||++|..++....
T Consensus 299 Ll---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 299 FL---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred EE---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 99 7788999999999987653322 23467999999999987 468999999999999999999886543322
Q ss_pred hhHHHHHHHhcCCC----CCC----------------C--------CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCc
Q 012825 366 ESGIFRAVLKADPS----FDE----------------A--------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (455)
Q Consensus 366 ~~~~~~~i~~~~~~----~~~----------------~--------~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp 417 (455)
....+..++..... ++. . ....++.++.++|.+||++||++|||+.|+|.||
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 22222222221100 000 0 0013567788999999999999999999999999
Q ss_pred ccCCCCCCCC
Q 012825 418 WIKNSNDVKV 427 (455)
Q Consensus 418 ~~~~~~~~~~ 427 (455)
||....++.+
T Consensus 456 ~f~~~~~~~~ 465 (501)
T PHA03210 456 LFSAEEEEEI 465 (501)
T ss_pred hhhcCCchHH
Confidence 9998654433
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=329.35 Aligned_cols=254 Identities=28% Similarity=0.497 Sum_probs=211.6
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
+.|++.+.||+|+||.||+|.... ++..||+|++.... .....+.+.+|+++++++. |+||+++++++..++..
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR---TKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC---CCeEEEEEEecccc--chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCce
Confidence 457888999999999999998765 57899999986442 2345567899999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++++|.+++. ...+++..++.++.||+.||.|||++|++|+||+|+||++ ++++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 78 WIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEEccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEcccccccccc
Confidence 99999999999998774 3568999999999999999999999999999999999999 677889999999987765
Q ss_pred CCC-cccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 315 PDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
... ......++..|+|||++.+ .++.++||||||+++|||++|+.||...........+...... .....++.++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 229 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPF 229 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHH
Confidence 332 2233467889999999874 5888999999999999999999999766554443333222211 1112577899
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.++|.+||+.+|.+||++.+++.|+||+..
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 230 KEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=342.04 Aligned_cols=237 Identities=27% Similarity=0.406 Sum_probs=204.0
Q ss_pred EeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEE
Q 012825 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVM 238 (455)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~ 238 (455)
.++-||.|+.|.||+|++. ++.||||.+.. .-..+|+-|++|+ |+||+.|.|+|.....+||||
T Consensus 128 ELeWlGSGaQGAVF~Grl~-----netVAVKKV~e----------lkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-----NETVAVKKVRE----------LKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred hhhhhccCcccceeeeecc-----CceehhHHHhh----------hhhhhHHHHHhcc-CcceeeEeeeecCCceeEEee
Confidence 3678999999999999965 57899997632 1236888999999 999999999999999999999
Q ss_pred eecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCc
Q 012825 239 ELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318 (455)
Q Consensus 239 E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~ 318 (455)
|||..|.|...| +.+..++......|..+|+.|+.|||.++|||||||.-||||. .+..|||+|||-++.......
T Consensus 192 EfCa~GqL~~VL-ka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~ST 267 (904)
T KOG4721|consen 192 EFCAQGQLYEVL-KAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKST 267 (904)
T ss_pred eccccccHHHHH-hccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhh
Confidence 999999999876 5567799999999999999999999999999999999999994 555799999999988876666
Q ss_pred ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 012825 319 LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVK 397 (455)
Q Consensus 319 ~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~ 397 (455)
.-.++||..|||||+++ ...+.|.|||||||+|||||||..||.+.....++..+-... ........+++.|+-||+
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNs--L~LpvPstcP~GfklL~K 345 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNS--LHLPVPSTCPDGFKLLLK 345 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCc--ccccCcccCchHHHHHHH
Confidence 67889999999999998 579999999999999999999999997766555444433222 222223478899999999
Q ss_pred HhccCCccCCCCHHHHHcCc
Q 012825 398 RLLNKDPRKRLTAAQALSHP 417 (455)
Q Consensus 398 ~~L~~dP~~Rps~~elL~hp 417 (455)
+||+-.|..||++++||.|-
T Consensus 346 qcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 346 QCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHhcCCCCCccHHHHHHHH
Confidence 99999999999999999994
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=320.00 Aligned_cols=253 Identities=25% Similarity=0.499 Sum_probs=209.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|+... +++.||||.+.............+.+|+++++.++ |+||+++++++.+.+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL---DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC---CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeE
Confidence 579999999999999999999776 58899999886544455666677899999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 235 YVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccce
Confidence 999999999999887753 34568999999999999999999999999999999999999 677889999999987
Q ss_pred ccCCCCc-ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCh--hHHHHHHHhcCCCCCCCCCCC
Q 012825 312 FVRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 312 ~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 387 (455)
....... .....++..|+|||++. ..++.++||||||+++|+|++|+.||..... ......+... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--DYPPLPTEH 232 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--CCCCCChhh
Confidence 7643322 23456888999999876 4688899999999999999999999965432 2333322221 122222235
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++..+.++|.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 233 YSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred cCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 77899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=322.37 Aligned_cols=250 Identities=24% Similarity=0.426 Sum_probs=199.1
Q ss_pred CCCeEEeceE--eecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEV--GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~L--G~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.+.+ |.|+||.||+++.+. ++..+|+|++....... .|+.....+.+|+||+++++++...
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKP---TQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcC---CCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 4567777776 999999999998766 58899999986532211 1333333334599999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCc-eEEEeecccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLS 310 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~-~vkL~DfG~a 310 (455)
+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||++ +.++ .++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY---DRAKDRIYLCDYGLC 157 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---eCCCCeEEEecCccc
Confidence 9999999999999999988554 489999999999999999999999999999999999999 4555 8999999998
Q ss_pred cccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
...... ....++..|+|||++. ..++.++||||||+++|+|++|..||............+.............++
T Consensus 158 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T PHA03390 158 KIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVS 234 (267)
T ss_pred eecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccC
Confidence 765432 2346889999999986 468899999999999999999999997554433211111111122223334689
Q ss_pred HHHHHHHHHhccCCccCCCC-HHHHHcCcccCC
Q 012825 390 SEARDFVKRLLNKDPRKRLT-AAQALSHPWIKN 421 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps-~~elL~hp~~~~ 421 (455)
..+.+||.+||+.||.+|++ +.++|+||||+.
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 99999999999999999996 699999999973
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=319.49 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=204.8
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
+.+.....||+|+||.||+|.+.. ++..||+|.+... .....+.+.+|+.++++++ |+||+++++++..++..
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLS---TQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFF 80 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecC---CCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEE
Confidence 334445689999999999998765 5789999988543 3445568899999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 235 YVVMELCEGGELLDRILSRGGKY--TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l--~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
++|+||+++++|.+++......+ ++..+..++.||+.||.|||+.||+||||||+||+++ ..++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhhee
Confidence 99999999999999887655555 8899999999999999999999999999999999994 2356899999999876
Q ss_pred cCCCC-cccccccCCCcccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDE-RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
..... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||................ .........+
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF-KIHPEIPESL 237 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh-ccCCCCCccc
Confidence 54322 2234468899999998753 37889999999999999999999996543322111111100 1111122357
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
+.++.+|+++||+.+|.+||++.+++.||||
T Consensus 238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 238 SAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 8899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=322.42 Aligned_cols=249 Identities=29% Similarity=0.495 Sum_probs=204.2
Q ss_pred EEeceEeecCCeEEEEEEEe-cCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~-~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
.+.+.||.|.||.||+|.+. .....+..|+||.+... ......+.+.+|++.+++++ |+||++++|++...+..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccc-ccccccccccccccccccc
Confidence 56789999999999999999 44456789999999542 45556788999999999996 9999999999998888999
Q ss_pred EEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 237 VMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
||||+++|+|.+++... ...+++..+..|+.||+.||.|||+++|+|+||+++|||+ +.++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence 99999999999999877 6789999999999999999999999999999999999999 6788999999999987632
Q ss_pred CCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 316 DER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 316 ~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
... .........|+|||.+. ..++.++||||||+++|||++ |+.||...........+.+..... ....++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---IPDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---SBTTSBH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce---eccchhH
Confidence 222 23345677899999986 458999999999999999999 789998887777666664433221 1235889
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHc
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.+.++|.+||+.||++||++.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=324.90 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=220.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.+.|+..+.||+|+||.||+++... ++..||+|++.............+.+|+++++++. |+|++++++++.+++.
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHT 99 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcC---CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCe
Confidence 4558899999999999999998766 57899999987654455556678899999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+.| +|.+.+......+++..+..++.||+.||.|||+.||+||||+|+||++ +.++.+||+|||++...
T Consensus 100 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 100 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIA 175 (317)
T ss_pred EEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCcccc
Confidence 9999999965 8888776667789999999999999999999999999999999999999 67888999999998754
Q ss_pred CCCCcccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
.. .....++..|+|||++. +.++.++|||||||++|+|++|..||...........+........ ....++
T Consensus 176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 250 (317)
T cd06635 176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWS 250 (317)
T ss_pred CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCcccc
Confidence 32 23456888999999863 4588899999999999999999999987766655555554432221 123578
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCc
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p 428 (455)
..+.+||.+||+.+|.+||++.++++|+|+.....+.++
T Consensus 251 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~ 289 (317)
T cd06635 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVL 289 (317)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccch
Confidence 899999999999999999999999999999876555544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=323.84 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=199.9
Q ss_pred eEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHh--cCCCCeeEEeEEEeeCCceEEEEe
Q 012825 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL--TGHNNLVKFFDAYEDTDNVYVVME 239 (455)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l--~~hp~Iv~l~~~~~~~~~~~lV~E 239 (455)
.||+|+||.||+|.... +++.||+|++.+...........+..|..+++.+ .+|++|+++++++.+.+..++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEec---CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence 48999999999998765 5889999998765433333233344444443333 249999999999999999999999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcc
Q 012825 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319 (455)
Q Consensus 240 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~ 319 (455)
|+.|++|.+++. ..+.+++..++.++.|++.||.|||+.+|+||||||+||++ +.++.+||+|||++...... ..
T Consensus 78 ~~~g~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~-~~ 152 (278)
T cd05606 78 LMNGGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKK-KP 152 (278)
T ss_pred cCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCcc-CC
Confidence 999999988774 45679999999999999999999999999999999999999 77888999999998765422 22
Q ss_pred cccccCCCcccccccC-C-CCCCcchHHHHHHHHHHHHcCCCCCCCCCh---hHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 012825 320 NDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADPSFDEAPWPSLSSEARD 394 (455)
Q Consensus 320 ~~~~gt~~y~aPE~~~-~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~l~~ 394 (455)
....|+..|+|||++. + .++.++||||+|+++|+|++|+.||..... ............. ....++.++.+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~ 228 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----LPDSFSPELRS 228 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC----CCCcCCHHHHH
Confidence 3457899999999986 3 488999999999999999999999976532 2222222222222 22357899999
Q ss_pred HHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 395 FVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 395 li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
+|.+||..||.+|+ ++.++++||||++..
T Consensus 229 li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 99999999999999 999999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=325.62 Aligned_cols=260 Identities=31% Similarity=0.544 Sum_probs=214.0
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-CHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
.|++.+.||.|+||.||+|+...+..+|..||+|++...... .....+.+.+|++++.++.+|+||+.+++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 488999999999999999987655456899999998653221 2233466789999999997799999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++||||+|+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecc
Confidence 999999999999998864 4568999999999999999999999999999999999999 678899999999987764
Q ss_pred CCC--cccccccCCCcccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCh----hHHHHHHHhcCCCCCCCCC
Q 012825 315 PDE--RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~ 385 (455)
... ......|+..|+|||++.+ .++.++||||||+++|+|++|..||..... ......+......+.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 232 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---- 232 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC----
Confidence 332 2234568899999998753 467899999999999999999999964332 223333333333222
Q ss_pred CCCCHHHHHHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
..++..+.+|+++||+.||++|+ ++.+++.||||+..+
T Consensus 233 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 35789999999999999999997 899999999999865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=324.94 Aligned_cols=256 Identities=34% Similarity=0.562 Sum_probs=209.4
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|.... +++.||+|++.... ......+.+.+|+++++++. |+||+++++++..++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA---TGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC---CCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEE
Confidence 479999999999999999998776 47899999986532 23344567899999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||++++.+ +.+......+++..++.++.||+.||.|||+.+|+|+||+|+||++ ++++.+||+|||++....
T Consensus 76 ~iv~e~~~~~~l-~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 76 YLVFEYVERTLL-ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALR 151 (288)
T ss_pred EEEEecCCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccC
Confidence 999999987554 4454555679999999999999999999999999999999999999 778899999999988765
Q ss_pred CCC--cccccccCCCcccccccC-C-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC------------
Q 012825 315 PDE--RLNDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------------ 378 (455)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~-~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~------------ 378 (455)
... ......++..|+|||++. . .++.++||||||+++|+|++|+.||......+.+..+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 443 334467888999999876 4 578899999999999999999999976655443333221100
Q ss_pred --CCCC--------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 379 --SFDE--------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 379 --~~~~--------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.... .....++.++.+||++||..||++||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 0111248889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=317.68 Aligned_cols=249 Identities=31% Similarity=0.541 Sum_probs=211.0
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||+|+||.||++.... +++.||+|.+.... .....+.+.+|+.+++.+. |+||+++++.+.+++.+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---SDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---CCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEE
Confidence 58999999999999999998765 58899999986432 3345567889999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 236 VVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++....
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLT 151 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeec
Confidence 99999999999998765 34568999999999999999999999999999999999999 778889999999987664
Q ss_pred CCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 315 PDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
... ......|+..|+|||++. ..++.++|+||||+++|+|++|..||...........+....... ....++..+
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 228 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP---LPSHYSYEL 228 (255)
T ss_pred ccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC---CCcccCHHH
Confidence 332 223457889999999986 458899999999999999999999998877666555554433221 123578899
Q ss_pred HHHHHHhccCCccCCCCHHHHHcC
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.+||.+||+.||++||++.+++.-
T Consensus 229 ~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 229 RSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=323.52 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=212.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|.+.+.||+|+||.||+|..... ...+..||||++... ...+..+.+.+|+++++.+. |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQ-HENIVKFYGVCTEG 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc--CCHHHHHHHHHHHHHHHhcC-CCCchheeeEEecC
Confidence 45799999999999999999987653 234688999998653 33445678999999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCC
Q 012825 232 DNVYVVMELCEGGELLDRILSRG-------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~-------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~ 298 (455)
+..++||||+++++|.+++...+ ..+++..+..++.||+.||.|||++|++||||||+|||+ +.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cC
Confidence 99999999999999999986542 357899999999999999999999999999999999999 77
Q ss_pred CceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 012825 299 NSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAV 373 (455)
Q Consensus 299 ~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i 373 (455)
++.+||+|||++........ .....++..|+|||++. +.++.++||||||+++|+|++ |..||...........+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 89999999999876532221 12334577899999876 568999999999999999998 99999887777766666
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
........ ...++..+.+||.+||+.||++||++.|+++
T Consensus 238 ~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 54432222 2368899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=329.68 Aligned_cols=257 Identities=31% Similarity=0.549 Sum_probs=213.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.+.|.....||+|+||.||++.... ++..||||.+.. ......+.+.+|+.+++.+. |+||+++++.+..++.
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~---~~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKH---TGKQVAVKKMDL---RKQQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDE 93 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECC---CCCEEEEEEEec---chHHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCe
Confidence 4556667889999999999998665 578999999853 23344567889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 94 LWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQV 168 (292)
T ss_pred EEEEEeCCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhc
Confidence 999999999999988763 3468999999999999999999999999999999999999 67788999999998754
Q ss_pred CCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
.... ......|+..|+|||++. ..++.++||||||+++|||++|..||........+..+........ .....++..
T Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 247 (292)
T cd06658 169 SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-KDSHKVSSV 247 (292)
T ss_pred ccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-ccccccCHH
Confidence 3222 223456889999999876 4688999999999999999999999987766555554443322211 112357889
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+.+||.+||..||.+|||+.++++|+||+...
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 99999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=323.15 Aligned_cols=254 Identities=31% Similarity=0.495 Sum_probs=210.7
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC--Cce
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--DNV 234 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~--~~~ 234 (455)
|++.+.||.|+||.||+|.... +|+.||+|++.... ........+.+|+++++++. |+|++++++++.+. +..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---TGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---CCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcE
Confidence 6789999999999999998776 57899999997643 23334456889999999998 99999999999988 889
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++ +|.+++......+++..++.++.||+.||.|||+.|++|+||+|+|||+ ++++.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 76 YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYT 151 (287)
T ss_pred EEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeecc
Confidence 999999975 8888876665689999999999999999999999999999999999999 778899999999998765
Q ss_pred CCC--cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCC------
Q 012825 315 PDE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP------ 384 (455)
Q Consensus 315 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~------ 384 (455)
... ......++..|+|||.+.+ .++.++||||||+++|+|++|+.||........+..+...........
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 443 2334467888999997653 478999999999999999999999988776665555544221111100
Q ss_pred --------------------CCC-CCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 385 --------------------WPS-LSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 385 --------------------~~~-~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
... ++..+.++|++||+.||.+||++.+++.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 011 37889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=320.74 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=210.7
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
.+++|.+.+.||+|+||.||+|.+... ...+..||+|.+... ........+.+|+.+++.+. |+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFN-HQNIVRLIGVSFE 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcc
Confidence 357899999999999999999987652 224678999988543 33444567889999999998 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEE
Q 012825 231 TDNVYVVMELCEGGELLDRILSRG------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL 304 (455)
.+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+++||||||+|||++..+....+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999999886543 25899999999999999999999999999999999999965444567999
Q ss_pred eecccccccCCCCcc---cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCC
Q 012825 305 IDFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPS 379 (455)
Q Consensus 305 ~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~ 379 (455)
+|||++......... .....+..|+|||++. +.++.++|||||||++|+|++ |..||...........+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 999999876322211 1223356799999876 569999999999999999997 99999887766655554433221
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 380 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.....++..+.+++.+||+.||++||++.++++|
T Consensus 241 ---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 ---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1224678999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=321.77 Aligned_cols=261 Identities=20% Similarity=0.320 Sum_probs=211.8
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
..++|++.+.||+|+||.||+|..+. ....+..||+|.+... ........+.+|+.+++.+. |+||+++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFT-CHHVVRLLGVVSK 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc--CCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence 35789999999999999999997653 1223568999998643 23333456788999999997 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCce
Q 012825 231 TDNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~ 301 (455)
.+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCc
Confidence 999999999999999999986532 235678899999999999999999999999999999999 67888
Q ss_pred EEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhc
Q 012825 302 LKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 376 (455)
Q Consensus 302 vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~ 376 (455)
++|+|||+++....... .....++..|+|||.+. +.++.++|||||||++|||++ |..||......+....+...
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876533221 12224567899999876 568999999999999999998 78899877766665555443
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc------CcccCCC
Q 012825 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS------HPWIKNS 422 (455)
Q Consensus 377 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~------hp~~~~~ 422 (455)
..... ...++..+.++|.+||+.||++||++.++++ ||||++.
T Consensus 238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 238 GYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 22111 1246789999999999999999999999987 9999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=333.45 Aligned_cols=259 Identities=30% Similarity=0.546 Sum_probs=207.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
++++|++.+.||+|+||.||+|.... +|+.||||++... ........+.+|+.++++++ |+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 76 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKP---TGVKVAIKKISPF--EHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPS 76 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcC---CCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCC-CCCcCchhheeeccc
Confidence 46899999999999999999998765 5889999998532 23344566788999999998 99999999987644
Q ss_pred ----CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeec
Q 012825 232 ----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 232 ----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
..+|+|+||+.+ +|.+.+. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+||
T Consensus 77 ~~~~~~~~lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~df 150 (336)
T cd07849 77 FESFNDVYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDF 150 (336)
T ss_pred ccccceEEEEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcc
Confidence 358999999964 8877663 4569999999999999999999999999999999999999 77889999999
Q ss_pred ccccccCCCCc----ccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC---
Q 012825 308 GLSDFVRPDER----LNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP--- 378 (455)
Q Consensus 308 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~--- 378 (455)
|++........ .....|+..|+|||++. ..++.++||||||+++|+|++|+.||...........+.....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99876543221 23356889999999864 3588999999999999999999999976554333222211000
Q ss_pred --------------------CCCC----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 379 --------------------SFDE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 379 --------------------~~~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.... ...+.++.++.+||.+||+.||++||++.++++||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000 01235678899999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.20 Aligned_cols=255 Identities=19% Similarity=0.307 Sum_probs=208.4
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
.+++|++.+.||+|+||.||+|..... ...+..||+|.+... .......++.+|+.+++.+. |+||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence 467899999999999999999986531 224678999998543 23344567889999999998 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCce
Q 012825 231 TDNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~ 301 (455)
++..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+|||+ ++++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCC
Confidence 999999999999999999886532 235788899999999999999999999999999999999 67888
Q ss_pred EEEeecccccccCCCCcc---cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhc
Q 012825 302 LKAIDFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 376 (455)
Q Consensus 302 vkL~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~ 376 (455)
++|+|||++......... ....++..|+|||++. +.++.++||||||+++|||++ |..||...........+...
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998765332211 1234567899999876 568999999999999999998 78999877776666555544
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 377 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..... ...++..+.++|.+||+.||++||++.+++++
T Consensus 238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 238 GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32211 23578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=324.07 Aligned_cols=254 Identities=33% Similarity=0.656 Sum_probs=218.6
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|.+.+.||.|+||.||+|.... +|+.||+|++.+.........+.+.+|+++++++.+|+||+++++++..++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceE
Confidence 479999999999999999999776 58999999987654445555678899999999997799999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 78 YFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccC
Confidence 999999999999998754 4579999999999999999999999999999999999999 678889999999987654
Q ss_pred CCC---------------------cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 012825 315 PDE---------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372 (455)
Q Consensus 315 ~~~---------------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~ 372 (455)
... ......++..|+|||++. ..++.++||||||++++++++|+.||........+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 322 122346788999999876 4588899999999999999999999988876666666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCH----HHHHcCccc
Q 012825 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA----AQALSHPWI 419 (455)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~----~elL~hp~~ 419 (455)
+......+. ..+++.+.+||++||+.||.+||++ .+++.||||
T Consensus 234 ~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 654433333 3578999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=323.85 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=206.1
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|....+. ....+++|.++.. ......+.+.+|+.++.++.+||||+++++++.+.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-LKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-CcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 57999999999999999999876632 1245788887532 34445677899999999996699999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCC
Q 012825 235 YVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~ 299 (455)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GEN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCC
Confidence 99999999999999886532 358899999999999999999999999999999999999 678
Q ss_pred ceEEEeecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcC
Q 012825 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 377 (455)
Q Consensus 300 ~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~ 377 (455)
+.+||+|||++..............+..|+|||++. ..++.++|||||||++|||++ |..||...........+....
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 889999999986432211111222345799999876 568999999999999999997 999998887776666554432
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 378 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.. .....++..+.+||.+||+.||.+||++.++++.
T Consensus 236 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RM---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 1123588999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=338.82 Aligned_cols=256 Identities=26% Similarity=0.387 Sum_probs=218.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcc-cCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.++..+.++||+|+||.||+|.++.... ....||||............+.++.+|.+++++++ |+|||++||++....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLEE 234 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCC
Confidence 4566678999999999999999987543 12239999987544466788899999999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
-++||||+|.||+|.+++.+..+.++..+...++.+++.||+|||++++|||||-.+|+|+ ..++.+||+|||+++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDFGLSRA 311 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCccccccC
Confidence 9999999999999999998877789999999999999999999999999999999999999 6777799999999877
Q ss_pred cCCCCccc-ccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 313 VRPDERLN-DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 313 ~~~~~~~~-~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
........ ...-...|+|||.+. +.|+.++|||||||++||+++ |..||.+....+....+.......... ...+
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p 389 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTP 389 (474)
T ss_pred CcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCH
Confidence 54221111 112456899999987 679999999999999999998 889999999999888886654333322 2677
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.++..++.+|+..||++||++.++.+
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHH
Confidence 88999999999999999999998853
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=328.25 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=207.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCc-ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..+|++.+.||+|+||.||+|.+.... .....||+|++... ......+++.+|+.+++.+. |+||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-
Confidence 467999999999999999999876432 22446999998643 34455677889999999998 99999999998764
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++|+||+++|+|.+++......+++..+..++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 158 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEcccccccc
Confidence 5789999999999999998777789999999999999999999999999999999999999 6778899999999987
Q ss_pred cCCCCcc---cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 313 VRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 313 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
....... ....++..|+|||++. ..++.++||||||+++|||++ |..||.+....... .++........ .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~--~~~ 235 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQ--PPI 235 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCC--CCC
Confidence 6543322 1223456799999876 568999999999999999997 99999876655543 33333322222 235
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++.++.+++.+||..||.+||++.+++.+
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 78899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.82 Aligned_cols=247 Identities=25% Similarity=0.411 Sum_probs=207.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||++.... +..||+|.+..... ....+.+|+.+++++. ||||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPI 74 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCc
Confidence 579999999999999999997654 45699998864322 2356889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+.+++|.+++......+++..++.++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecC
Confidence 99999999999999887655679999999999999999999999999999999999999 677889999999987654
Q ss_pred CCCcc--cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 315 PDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 315 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
..... ....++..|++||++. +.++.++||||||+++|+|++ |..||...........+......... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 228 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASE 228 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCH
Confidence 33221 1223556799999986 568899999999999999998 99999877776666666554332221 24688
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.+.+++.+||+.||.+||++.+++.+
T Consensus 229 ~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 229 KVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=320.22 Aligned_cols=251 Identities=35% Similarity=0.586 Sum_probs=213.4
Q ss_pred EeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecC
Q 012825 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (455)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 242 (455)
||.|+||.||+++... +|+.|++|++...........+.+.+|+++++++. |+||+++++.+..++..|+||||++
T Consensus 1 lg~g~~~~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCC
Confidence 6899999999999765 58899999997654444456678999999999998 9999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCC-----
Q 012825 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----- 317 (455)
Q Consensus 243 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~----- 317 (455)
+++|.+++... +.+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 77 GGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccc
Confidence 99999887554 479999999999999999999999999999999999999 778899999999987654331
Q ss_pred ----cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 318 ----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 318 ----~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
......++..|++||++. ..++.++||||||+++|+|++|..||........+..+.......... ..++..+
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 230 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEA 230 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHH
Confidence 223456788999999876 458889999999999999999999998888777776666544333221 1248999
Q ss_pred HHHHHHhccCCccCCCCH---HHHHcCcccCCCC
Q 012825 393 RDFVKRLLNKDPRKRLTA---AQALSHPWIKNSN 423 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~---~elL~hp~~~~~~ 423 (455)
.+||++||+.+|.+||++ .++|+||||++.+
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 999999999999999999 9999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=336.89 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=206.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCc--ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|+++++||+|+||.||+|...... ..+..||||++... ......+.+.+|+++++++..||||++++++|.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 578999999999999999999865321 23567999998653 33444567899999999996799999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC---------------------------------------------------------
Q 012825 232 DNVYVVMELCEGGELLDRILSRG--------------------------------------------------------- 254 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~--------------------------------------------------------- 254 (455)
+.+|||||||++|+|.+++....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999998875421
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec
Q 012825 255 --------------------------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (455)
Q Consensus 255 --------------------------------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~ 296 (455)
..+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill--- 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL--- 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---
Confidence 247888899999999999999999999999999999999
Q ss_pred CCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 012825 297 DENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~ 371 (455)
+.++.+||+|||+++....... .....++..|+|||++. ..++.++|||||||++|||++ |..||........+.
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 6778899999999976543222 22335677899999876 568999999999999999996 999997765444443
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.......... ....++.++.++|.+||+.||++||++.++.+
T Consensus 351 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3333332221 22367899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=314.34 Aligned_cols=253 Identities=31% Similarity=0.584 Sum_probs=217.7
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||.|+||.||++.... +++.|++|++.... ........+.+|++++++++ |+|++++++.+..++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSN-MSEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---CCcEEEEEEeeccc-CChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEE
Confidence 58999999999999999999775 57899999986543 23455677899999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 236 VVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+|+||+++++|.+++... +..+++..+..++.+++.||.|||+.|++|+||+|+||++ +.++.++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceee
Confidence 999999999999988765 4789999999999999999999999999999999999999 6778899999999987
Q ss_pred cCCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 313 VRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 313 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
..... ......|+..|+|||.+. ..++.++|+||||+++++|++|..||................... ....++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (258)
T cd08215 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYSS 229 (258)
T ss_pred cccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCH
Confidence 65443 234457888999999876 568899999999999999999999998877666666555443221 1226789
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
++.++|++||..+|.+||++.++|+||||
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=317.26 Aligned_cols=254 Identities=28% Similarity=0.550 Sum_probs=212.1
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||+|+||.||+|.... .|..||+|.+..... .....+.+.+|++++++++ |+||+++++.+.+++..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---CCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEE
Confidence 58999999999999999999776 578899999865432 2233457789999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 236 VVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+|+|+||||+||+++ +.+..+||+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhcc
Confidence 9999999999999886543 3589999999999999999999999999999999999994 223467999999987765
Q ss_pred CCCc-ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 315 PDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 315 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
.... .....|+..|+|||++. ..++.++|+||||+++|+|++|..||...........+...... ...+.++.++
T Consensus 154 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (257)
T cd08225 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRDL 230 (257)
T ss_pred CCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCHHH
Confidence 3322 23346888999999876 56889999999999999999999999877666555554433221 1224678899
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.++|.+||..+|++||++.+++.||||
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=332.60 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=205.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~- 230 (455)
.++|++.+.||+|+||.||+|+.... ..+++.||+|++... ......+.+.+|+.++.++.+|+||++++++|..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG--ATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC--CCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 46899999999999999999975432 224689999998643 2334456788999999999669999999998864
Q ss_pred CCceEEEEeecCCCcHHHHHHhcC--------------------------------------------------------
Q 012825 231 TDNVYVVMELCEGGELLDRILSRG-------------------------------------------------------- 254 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~-------------------------------------------------------- 254 (455)
+..++++|||+++++|.+++....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 456899999999999998875421
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCc---ccccccCCC
Q 012825 255 ----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAY 327 (455)
Q Consensus 255 ----~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~ 327 (455)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+..... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 268999999999999999999999999999999999999 6678899999999987543221 223455678
Q ss_pred cccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCcc
Q 012825 328 YVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPR 405 (455)
Q Consensus 328 y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 405 (455)
|+|||++. ..++.++|||||||++|||++ |..||......+.+...+........ ...++.++.+++.+||+.+|+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCHHHHHHHHHHccCChh
Confidence 99999875 569999999999999999997 99999775554444444433322211 135778999999999999999
Q ss_pred CCCCHHHHHcC
Q 012825 406 KRLTAAQALSH 416 (455)
Q Consensus 406 ~Rps~~elL~h 416 (455)
+||++.++++|
T Consensus 319 ~RPs~~ell~~ 329 (337)
T cd05054 319 DRPTFSELVEI 329 (337)
T ss_pred hCcCHHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=317.88 Aligned_cols=277 Identities=29% Similarity=0.444 Sum_probs=219.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcc-cCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-C
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-T 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~-~ 231 (455)
...|++...||+|.||.||+|..++... ....+|+|.++.+...+ -......+|+.+++.|+ |+||+.|..+|.. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELK-HPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhc-CCcchhHHHHHhccC
Confidence 4569999999999999999996555432 23589999986553222 22245679999999999 9999999999987 7
Q ss_pred CceEEEEeecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec-CCCceEEEee
Q 012825 232 DNVYVVMELCEGGELLDRILSR----GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENSVLKAID 306 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~----~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~-~~~~~vkL~D 306 (455)
..+++++||.+. +|+..|... ...++...++.|+.||+.|+.|||++-|+||||||.||||..+ .+.|.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 789999999977 888877643 3468999999999999999999999999999999999999643 3569999999
Q ss_pred cccccccCCC----CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCh---------hHHHH
Q 012825 307 FGLSDFVRPD----ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTE---------SGIFR 371 (455)
Q Consensus 307 fG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~---------~~~~~ 371 (455)
||+++.+... ......+-|.+|+|||.+.| .|+.+.|||++|||+.||++.+..|.+... .+.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999987533 23456678999999999875 599999999999999999999988854332 34556
Q ss_pred HHHhcCCCCCCCCCCC---------------------------------CCHHHHHHHHHhccCCccCCCCHHHHHcCcc
Q 012825 372 AVLKADPSFDEAPWPS---------------------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418 (455)
Q Consensus 372 ~i~~~~~~~~~~~~~~---------------------------------~s~~l~~li~~~L~~dP~~Rps~~elL~hp~ 418 (455)
.|++......+..|+. -++...+|+.+||..||.+|.|++++|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 6665544444444432 1345789999999999999999999999999
Q ss_pred cCCCCCCCCchhHHH
Q 012825 419 IKNSNDVKVPLDVII 433 (455)
Q Consensus 419 ~~~~~~~~~p~~~~~ 433 (455)
|+...-...|.++.+
T Consensus 340 F~~d~lpp~pt~~~v 354 (438)
T KOG0666|consen 340 FTEDPLPPLPTSDNV 354 (438)
T ss_pred cccCCCCCCccccee
Confidence 998654445555544
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=292.01 Aligned_cols=259 Identities=31% Similarity=0.528 Sum_probs=223.7
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|...++||+|.||+||+|+.++ ++..||+|.+......+ ..-....+|+-+++.|+ |.|||+++++...+..+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~---t~eivalkrvrldddde-gvpssalreicllkelk-hknivrl~dvlhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE---THEIVALKRVRLDDDDE-GVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC---ccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeE
Confidence 57778999999999999999776 68999999986553222 22245679999999999 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
+|+|||+ .+|..++..-++.++.+.++.++.|+++||.|+|++++.|||+||.|.|| +.+|.+||+|||+++.+..
T Consensus 78 lvfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgi 153 (292)
T KOG0662|consen 78 LVFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGI 153 (292)
T ss_pred EeHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCC
Confidence 9999995 48899988889999999999999999999999999999999999999999 7889999999999988754
Q ss_pred CC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC----
Q 012825 316 DE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS---- 387 (455)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~---- 387 (455)
.- -.+..+.|.+|++|+++.+ -|+...|+||.||++.|+.. |+..|.+....+.+..+.+......+..|+.
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 32 3456678999999999875 48999999999999999987 7777888888888888888766665555543
Q ss_pred ---------------------CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 388 ---------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 388 ---------------------~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
++...+||++++|..+|.+|.+++++|+||||.+..
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 234568999999999999999999999999998764
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=320.89 Aligned_cols=257 Identities=32% Similarity=0.569 Sum_probs=214.6
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
.+|...+.||+|++|.||++.... .++.|++|++.. ......+.+.+|+.+++.+. |+||+++++++...+..
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~---~~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKS---TGRQVAVKKMDL---RKQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECC---CCCEEEEEEEec---cchhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeE
Confidence 456667899999999999998665 478999998843 23334466889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++|+||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||+|+||++ +.++.++|+|||++....
T Consensus 92 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred EEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhc
Confidence 999999999999998755 568999999999999999999999999999999999999 778899999999887654
Q ss_pred CCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 315 PDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
... ......|+..|+|||++. ..++.++||||||+++|+|++|..||...........+......... ....++..+
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l 245 (285)
T cd06648 167 KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRL 245 (285)
T ss_pred cCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHH
Confidence 322 223356889999999876 46889999999999999999999999877666655555544322211 123478899
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
.+||.+||+.||++||++.++++|+||+...+
T Consensus 246 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 246 RSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 99999999999999999999999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=314.75 Aligned_cols=243 Identities=24% Similarity=0.387 Sum_probs=200.9
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|+... +++.||+|.+... ........+.+|+++++++. |+||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---DNTPVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEec---CCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEee
Confidence 468999999999999876 5889999987543 33455577899999999997 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcc-
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL- 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~- 319 (455)
+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~ 151 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYAS 151 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccc
Confidence 99999999887666679999999999999999999999999999999999999 67788999999998764422111
Q ss_pred --cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 012825 320 --NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395 (455)
Q Consensus 320 --~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l 395 (455)
.....+..|+|||.+. +.++.++||||||+++|+|++ |..||...........+...... .....++..+.+|
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 228 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPELCPDAVYRL 228 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCcccCCHHHHHH
Confidence 1112245699999876 568999999999999999997 89999776665554444432211 1223578999999
Q ss_pred HHHhccCCccCCCCHHHHHc
Q 012825 396 VKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 396 i~~~L~~dP~~Rps~~elL~ 415 (455)
+.+||+.||++||++.++++
T Consensus 229 i~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 229 MERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.82 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=204.6
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|.+.... ....+|+|.+... ........+.+|++++.++.+|+||+++++++.+++.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~-~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCC-ceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 468999999999999999999976521 1235677776532 3445567888999999999559999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCC
Q 012825 234 VYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~ 298 (455)
.|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cC
Confidence 999999999999999886432 358899999999999999999999999999999999999 67
Q ss_pred CceEEEeecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhc
Q 012825 299 NSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 376 (455)
Q Consensus 299 ~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~ 376 (455)
++.+||+|||++.............++..|+|||++. ..++.++||||||+++|||++ |..||......+....+...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 8889999999986432111112223456799999876 457899999999999999998 99999877766655544322
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 377 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
. .......++.++.+||.+||+.+|++||++.++|.+
T Consensus 240 ~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 Y---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred C---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 111122478899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=310.90 Aligned_cols=252 Identities=35% Similarity=0.609 Sum_probs=213.4
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||.|++|.||++.... +++.|++|++..... ...+.+.+|+.+++++. |+||+++++++..++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---CCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEE
Confidence 48899999999999999999776 578999999865422 45578899999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
+++||+++++|.+++......+++..+..++.|++.+|.|||+.|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeeccccccccc
Confidence 9999999999999887665789999999999999999999999999999999999999 6788999999999987765
Q ss_pred CCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 012825 316 DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (455)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~ 394 (455)
........++..|++||.+. ..++.++||||||+++|+|++|+.||................... ......++..+.+
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 229 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG-LRNPEKWSDEFKD 229 (253)
T ss_pred cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCC-cCcccccCHHHHH
Confidence 44344567889999999876 457889999999999999999999998765444443333322111 1111234899999
Q ss_pred HHHHhccCCccCCCCHHHHHcCcc
Q 012825 395 FVKRLLNKDPRKRLTAAQALSHPW 418 (455)
Q Consensus 395 li~~~L~~dP~~Rps~~elL~hp~ 418 (455)
+|.+||+.||++|||+.+++.|||
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=323.26 Aligned_cols=256 Identities=25% Similarity=0.433 Sum_probs=211.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||++.... +|+.||+|++... ......+.+.+|+++++.+. |+||+++++++...+.
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP---TGTVMAKKVVHIG--AKSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENN 77 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC---CCcEEEEEEEEec--CcchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCE
Confidence 3679999999999999999998766 5789999988643 23445678899999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+++||||+++++|.+++.. .+.+++..+..++.+++.+|.|||+ .+++||||||+||++ +.++.++|+|||++..
T Consensus 78 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGE 153 (284)
T ss_pred EEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccc
Confidence 9999999999999887654 4578999999999999999999997 589999999999999 7788899999999865
Q ss_pred cCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh-----------HHHHHHHhcCCCC
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES-----------GIFRAVLKADPSF 380 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~-----------~~~~~i~~~~~~~ 380 (455)
... .......|+..|+|||++. +.++.++|||||||++|+|++|+.||...... +.+..+......
T Consensus 154 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 231 (284)
T cd06620 154 LIN-SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP- 231 (284)
T ss_pred hhh-hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC-
Confidence 432 2233457899999999875 57889999999999999999999999754432 222222222211
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
......++.++.+||.+||+.||.+||++.++++|+||...
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 232 -RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred -CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 11112377899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=320.11 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=209.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
..+|.+.+.||+|+||.||++..... ..++..+|+|.+.. ......+.+.+|+++++++. |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~---~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC---cCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Confidence 46799999999999999999986442 22456799998854 23445677899999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCC
Q 012825 232 DNVYVVMELCEGGELLDRILSRG------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~ 299 (455)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||+ +.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccC
Confidence 99999999999999999886432 258999999999999999999999999999999999999 778
Q ss_pred ceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 012825 300 SVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVL 374 (455)
Q Consensus 300 ~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~ 374 (455)
+.+||+|||++........ .....++..|+|||++. ..++.++||||||+++|+|++ |..||...........+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 8999999999976543221 12234567899999887 568999999999999999998 999998877777666665
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 375 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
....... ...++.++.+|+.+||+.||.+|||+.+++.
T Consensus 237 ~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5442221 1257889999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=308.33 Aligned_cols=252 Identities=24% Similarity=0.384 Sum_probs=205.5
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
-.+||++.++||+|||+.||+++... ++..||+|.+.. ...+.++...+|++..++++ |||+++++++...+
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s---~~~~YAlKkI~c---~~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLS---TGHLYALKKILC---HSQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREE 91 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccC---cccchhhheeec---cchHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhh
Confidence 36899999999999999999998443 688999999854 34567788999999999998 99999999987543
Q ss_pred ----CceEEEEeecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeeccCCceEEeecCCCceE
Q 012825 232 ----DNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVL 302 (455)
Q Consensus 232 ----~~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~--ivHrDikp~NILl~~~~~~~~v 302 (455)
...||++.|...|+|.+.+... +..+++.++..|+.+|++||++||+.. +.||||||.|||+ .+.+.+
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl---s~~~~~ 168 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL---SDSGLP 168 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe---cCCCce
Confidence 3499999999999999988653 457999999999999999999999998 9999999999999 567889
Q ss_pred EEeecccccccCCCCc----------ccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhH
Q 012825 303 KAIDFGLSDFVRPDER----------LNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESG 368 (455)
Q Consensus 303 kL~DfG~a~~~~~~~~----------~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~ 368 (455)
+|.|||.++...-.-. ......|..|+|||.+. ...+.++|||||||+||.|+.|..||+.....+
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G 248 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG 248 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence 9999999876532111 11235788999999986 247889999999999999999999995322211
Q ss_pred --HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 369 --IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 369 --~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
....+.+....++... .+++.+.+||+.||+.||.+||++.+++.+
T Consensus 249 gSlaLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEEEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1122333344444443 489999999999999999999999999865
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=331.86 Aligned_cols=261 Identities=31% Similarity=0.517 Sum_probs=209.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
+.++|.+.+.||+|+||.||+|+... +++.||||.+.... ........+.+|+.+++.+. |+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~ 77 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSE---TNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPH 77 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecC---CCCeEEEEEecccc-cccchhHHHHHHHHHHHhcC-CCCccchHHheeccc
Confidence 45789999999999999999998765 68999999986532 23333456778999999997 99999999988644
Q ss_pred ----CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeec
Q 012825 232 ----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 232 ----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
...|+||||+. ++|.+++. ..+.+++..++.++.||+.||.|||+++++||||||+||++ +.++.+||+||
T Consensus 78 ~~~~~~~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Df 152 (337)
T cd07858 78 REAFNDVYIVYELMD-TDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDF 152 (337)
T ss_pred ccccCcEEEEEeCCC-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcC
Confidence 35899999995 68887764 45679999999999999999999999999999999999999 67788999999
Q ss_pred ccccccCCC-CcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhc--------
Q 012825 308 GLSDFVRPD-ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA-------- 376 (455)
Q Consensus 308 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~-------- 376 (455)
|++...... .......++..|+|||++. ..++.++||||||+++|+|++|+.||...........+...
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 153 GLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred ccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 999876433 2234456788999999875 35889999999999999999999999765543322222111
Q ss_pred ---------------CCCCC----CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 377 ---------------DPSFD----EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 377 ---------------~~~~~----~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
..... ....+.++.++.+||++||+.||++|||+.++|+||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00000 111346789999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=315.54 Aligned_cols=253 Identities=24% Similarity=0.402 Sum_probs=210.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
..+|++.+.||+|+||.||+|+.......+..+|+|.+... ......+.+.+|+.++++++ ||||+++++++..++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCc
Confidence 35799999999999999999987654334568999998643 23445578899999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++......+++..+..++.|++.||.|||+.|++||||||+|||+ +.++.++|+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 156 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCccccc
Confidence 999999999999999987776789999999999999999999999999999999999999 77889999999999876
Q ss_pred CCCCcc----cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 314 RPDERL----NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 314 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
...... ....++..|++||++. +.++.++|+||||+++|++++ |..||......+....+.... ..+ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~ 233 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RLP--APMD 233 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cCC--CCCC
Confidence 433211 1122356799999887 578999999999999999886 999998877666555554432 111 1235
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
++..+.+++.+||+.+|.+||++.++++
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 234 CPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 7899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=320.80 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=210.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCc--ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.+.||+|+||.||++...... .....||+|.+... .......++.+|+.+++++.+|+||+++++++..+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC--CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 578999999999999999999876532 24578999998654 33445567889999999995599999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec
Q 012825 232 DNVYVVMELCEGGELLDRILSR---------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~ 296 (455)
+..++||||+++++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~--- 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--- 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---
Confidence 9999999999999999988642 3468999999999999999999999999999999999999
Q ss_pred CCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 012825 297 DENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~ 371 (455)
+.++.+||+|||+++....... .....++..|+|||++. ..++.++|||||||++|||++ |..||......+.+.
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 6788999999999987643321 12223456799999876 568999999999999999997 999998877666655
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.+..... .. ....++..+.+|+.+||+.||++|||+.+++++
T Consensus 246 ~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYR-ME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCc-CC--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5543321 11 123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=318.20 Aligned_cols=253 Identities=19% Similarity=0.323 Sum_probs=208.5
Q ss_pred CCeEEeceEeecCCeEEEEEEEecC-cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
++|++.+.||+|+||.||+|..... ...+..||+|.+... ...+....+.+|+.++++++ |+||+++++++..++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence 5789999999999999999986432 225689999998643 34455678899999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC
Q 012825 234 VYVVMELCEGGELLDRILSRG----------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~----------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~ 297 (455)
.|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence 999999999999999885321 247889999999999999999999999999999999999 6
Q ss_pred CCceEEEeecccccccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 012825 298 ENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (455)
Q Consensus 298 ~~~~vkL~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~ 372 (455)
.++.+||+|||++....... ......++..|+|||++. +.++.++||||||+++|||++ |..||...........
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 77889999999997654332 123344567899999876 568999999999999999998 9999987766555554
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+...... .....++..+.+++.+||+.||.+||++.+++++
T Consensus 239 ~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 4433221 1223578999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.88 Aligned_cols=254 Identities=30% Similarity=0.480 Sum_probs=207.8
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
|++.+.||.|++|.||+|.... +|..||+|++..... .......+.+|+++++.+. |+||+++++++.+++..|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---TGEIVALKKIRLETE-DEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---CCCEEEEEEeecccc-cccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEE
Confidence 6788999999999999999766 588999999865432 2223356778999999998 9999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 237 VMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
||||++ ++|.+++.... ..+++..+..++.||+.||.|||+.+++||||+|+||++ +.++.++|+|||++.....
T Consensus 76 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCC
Confidence 999995 58888876543 468999999999999999999999999999999999999 6688999999999876542
Q ss_pred CC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC------------
Q 012825 316 DE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF------------ 380 (455)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~------------ 380 (455)
.. ......++..|+|||++.+ .++.++||||||+++|+|++|..||........+..+.+.....
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 22 2233456889999998753 47889999999999999999999998776655444443321110
Q ss_pred -------------CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 381 -------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 381 -------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.....+.++..+.++|.+||+.||.+||++.+++.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 011134577899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=327.03 Aligned_cols=261 Identities=32% Similarity=0.513 Sum_probs=203.3
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC--Cc
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--DN 233 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~--~~ 233 (455)
+|++.++||+|+||.||+|..... ..++.||+|++...........+.+.+|+.+++++. |+||+++++++.+. +.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCce
Confidence 589999999999999999997653 147899999997643222333456788999999998 99999999999988 78
Q ss_pred eEEEEeecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEee-cCCCceEEEeecc
Q 012825 234 VYVVMELCEGGELLDRILSR----GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT-KDENSVLKAIDFG 308 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~----~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~-~~~~~~vkL~DfG 308 (455)
+++||||+++ +|.+.+... ...+++..++.++.||+.||.|||+.+|+||||||+|||++. .+.++.+||+|||
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999999965 677666432 236899999999999999999999999999999999999932 1128899999999
Q ss_pred cccccCCCCc----ccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhH---------HHHHH
Q 012825 309 LSDFVRPDER----LNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESG---------IFRAV 373 (455)
Q Consensus 309 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~---------~~~~i 373 (455)
++........ .....++..|+|||++.+ .++.++||||||+++|+|++|+.||....... .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9887543222 234567889999998764 47899999999999999999999997544321 11111
Q ss_pred HhcCC---------------------CCCCCCCC------------CCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 374 LKADP---------------------SFDEAPWP------------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 374 ~~~~~---------------------~~~~~~~~------------~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
+.... .......+ ..+.++.++|.+||++||++|||+.+++.||||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 11000 00001111 466789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=314.50 Aligned_cols=247 Identities=24% Similarity=0.430 Sum_probs=207.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.++||+|+||.||+|.... +..||+|.+.... ...+.+.+|+.+++.++ |+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~----~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN----STKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC----CceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCC
Confidence 4789999999999999999998654 5679999875432 23467889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+++||||||+||++ +.++.+||+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~ 152 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARV 152 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCcccee
Confidence 99999999999999988654 4578999999999999999999999999999999999999 7788999999999987
Q ss_pred cCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
...... .....++..|+|||++. +.++.++||||||+++|+|++ |..||...........+...... .....+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 229 (261)
T cd05072 153 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM---PRMENC 229 (261)
T ss_pred cCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---CCCCCC
Confidence 643321 12234567899999876 568889999999999999998 99999887776666655543221 122357
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+.++.+++.+||+.||++||++.++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=323.99 Aligned_cols=259 Identities=29% Similarity=0.481 Sum_probs=210.6
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.+.||+|+||.||+|..+. +|+.||+|++..... .......+.+|++++++++ |+||+++++++.+.
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~ 78 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKD---TGELVALKKVRLDNE-KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECC---CCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCc
Confidence 456789999999999999999999876 578999999865432 2222346778999999998 99999999998765
Q ss_pred C----------ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCce
Q 012825 232 D----------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (455)
Q Consensus 232 ~----------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~ 301 (455)
+ .+++|+||+++ ++.+.+......+++..++.++.||+.||.|||+.||+|+||||+||++ ++++.
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~ 154 (302)
T cd07864 79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQ 154 (302)
T ss_pred chhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCc
Confidence 4 79999999976 7777776666679999999999999999999999999999999999999 78889
Q ss_pred EEEeecccccccCCCC--cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcC
Q 012825 302 LKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (455)
Q Consensus 302 vkL~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~ 377 (455)
+||+|||++....... ......++..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+....
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999999987764332 1223346778999998753 47889999999999999999999998776665555544421
Q ss_pred CCCCC--------------------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 378 PSFDE--------------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 378 ~~~~~--------------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
..... ..+..++..+.++|.+||+.||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 11000 1123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=317.95 Aligned_cols=252 Identities=26% Similarity=0.521 Sum_probs=207.6
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||.|+||.||+++... ++..||||.+............++.+|+.+++.+. |+||+++++++.+++..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~ 77 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNEL 77 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC---CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeE
Confidence 468999999999999999999765 58899999886544445555678899999999997 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 235 YVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+++|||+++++|.+++.. ....+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~ 154 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhh
Confidence 999999999999987753 24568999999999999999999999999999999999999 678889999999987
Q ss_pred ccCCCCc-ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh--HHHHHHHhcCCCCCCCCCCC
Q 012825 312 FVRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 312 ~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 387 (455)
....... .....++..|+|||++. ..++.++||||||+++|+|++|..||...... .....+... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDH 232 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCccc
Confidence 6643322 23456889999999886 46888999999999999999999999654332 222222211 122222235
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
++..+.++|.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 233 YSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 7889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=315.08 Aligned_cols=252 Identities=24% Similarity=0.403 Sum_probs=210.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|........+..||||++... .......++..|+.+++++. |+||+++++++.+++..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCce
Confidence 4689999999999999999998765434567999998643 34555678999999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++++|.+++....+.+++..++.++.|++.||.|||++|++|+||||+||++ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCccccccc
Confidence 99999999999999887767789999999999999999999999999999999999999 778899999999987654
Q ss_pred CCCcccc----cc--cCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 315 PDERLND----IV--GSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 315 ~~~~~~~----~~--gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
....... .. .+..|+|||++. +.++.++||||||+++|||++ |..||+..........+.... . .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-~--~~~~~ 234 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-R--LPPPM 234 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-c--CCCcc
Confidence 3221111 11 134799999886 568999999999999999886 999998877766666554321 1 11224
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.++..+.+++.+||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=322.72 Aligned_cols=257 Identities=30% Similarity=0.512 Sum_probs=212.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||++.... ++..||+|.+... .....+.+.+|+.++++++ |+||+++++++...+.
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA---TGQEVAIKQMNLQ---QQPKKELIINEILVMRENK-HPNIVNYLDSYLVGDE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC---CCCEEEEEEeccc---cchHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCc
Confidence 4789999999999999999998655 4788999998532 2223466889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.|+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI 165 (293)
T ss_pred EEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecc
Confidence 9999999999999998754 357899999999999999999999999999999999999 67788999999988765
Q ss_pred CCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
.... ......++..|++||.+. +.++.++||||||+++|++++|+.||...........+.... .........++..
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAI 244 (293)
T ss_pred cccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHH
Confidence 4332 223456888999999875 568899999999999999999999997665443332222211 1111122356788
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+.+||++||+.+|.+||++.+++.|+||+..+
T Consensus 245 l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 99999999999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=314.03 Aligned_cols=249 Identities=22% Similarity=0.372 Sum_probs=208.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
..+|.+.+.||+|+||.||+|...+ .++.||+|++... .....++.+|+++++++. |+||+++++++..++.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPP 76 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEec---CCceEEEEEecCC----chHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCC
Confidence 4569999999999999999999876 5789999998643 223467889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||+ ++++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~ 153 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRL 153 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccc
Confidence 999999999999999886543 468999999999999999999999999999999999999 6788899999999977
Q ss_pred cCCCCcc--cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
....... ....++..|+|||++. ..++.++||||||+++|||++ |..||......+....+..... ......+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 230 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGC 230 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCC
Confidence 6533221 1223456799999876 568899999999999999998 9999987776665555544321 1222467
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+.++.++|.+||+.||++||++.++++.
T Consensus 231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 231 PPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 8999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=354.83 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=206.4
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.++||+|+||.||+|++.. +|+.||||++...........+++.+|+++++++. ||||+++++++.+++..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~l 77 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---CSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPV 77 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEE
Confidence 589999999999999999998765 58899999997654445556678999999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEE
Q 012825 235 YVVMELCEGGELLDRILSR----------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~----------~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL 304 (455)
++||||++|++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEE
Confidence 9999999999999987532 2345677889999999999999999999999999999999 77888999
Q ss_pred eecccccccCCCC-------------------cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 012825 305 IDFGLSDFVRPDE-------------------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR 364 (455)
Q Consensus 305 ~DfG~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~ 364 (455)
+|||++....... .....+||+.|+|||++. ..++.++|||||||++|||++|+.||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999997652110 112356999999999886 46899999999999999999999999775
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 365 ~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.............+ ........++..+.+++.+||+.||++|++..+.+.+
T Consensus 235 ~~~ki~~~~~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYRDVILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhhhhccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 54333222111111 1112234688999999999999999999887766644
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=321.40 Aligned_cols=262 Identities=26% Similarity=0.427 Sum_probs=217.6
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..+.|...+.||+|+||.||+|+... ++..||+|.+...........+++.+|+++++.++ |+|++++++++...+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 88 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH 88 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcC---CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCC
Confidence 45668889999999999999999776 57899999986543344455667889999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+. +++.+.+......+++..+..++.|++.||.|||+.+++||||||+|||+ +.++.++|+|||++..
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASI 164 (308)
T ss_pred eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCccccee
Confidence 9999999996 58888776666779999999999999999999999999999999999999 6778899999999876
Q ss_pred cCCCCcccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
.... ....++..|+|||++. +.++.++|||||||++|+|++|..||...........+...... ......+
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 239 (308)
T cd06634 165 MAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHW 239 (308)
T ss_pred ecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC--CcCcccc
Confidence 5432 3346788999999863 45788999999999999999999999776655444444433221 1112357
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~ 427 (455)
+..+.+||++||+.+|++||++.+++.|+|+........
T Consensus 240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~~ 278 (308)
T cd06634 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278 (308)
T ss_pred cHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCChhH
Confidence 889999999999999999999999999999998644333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=315.09 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=206.6
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc---
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN--- 233 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~--- 233 (455)
|.+++.||+|+||.||.|....+...+..||+|++.... ........+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence 578899999999999999887654456889999986543 33445677899999999998 9999999998876554
Q ss_pred ---eEEEEeecCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 234 ---VYVVMELCEGGELLDRILSR-----GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 234 ---~~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+||++ ++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence 79999999999998887542 2368999999999999999999999999999999999999 778899999
Q ss_pred ecccccccCCCCcc---cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCC
Q 012825 306 DFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (455)
Q Consensus 306 DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (455)
|||+++........ ....++..|+|||++. ..++.++||||||+++|||++ |..||........+..+.......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999866433221 1223467899999876 568999999999999999999 899998777766665555433211
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
....++.++.++|.+||+.||++||++.+++++
T Consensus 236 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 236 ---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 123678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=355.06 Aligned_cols=254 Identities=22% Similarity=0.397 Sum_probs=220.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCccc--CeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
-.+...+.+.||+|+||.||.|........ -..||||.+.+. .+.+...+|.+|..+|+++. |||||+++|++.+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLD 766 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecC
Confidence 356788899999999999999998875432 345888887644 67788899999999999998 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEE
Q 012825 231 TDNVYVVMELCEGGELLDRILSR------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~------~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL 304 (455)
.+..+|++|||+||+|+.+|.+. ...++..++..++.+|++|+.||+++++|||||-.+|+|| ++...|||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKI 843 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKI 843 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEE
Confidence 99999999999999999999876 6679999999999999999999999999999999999999 77899999
Q ss_pred eecccccccCCCCccc---ccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCC
Q 012825 305 IDFGLSDFVRPDERLN---DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPS 379 (455)
Q Consensus 305 ~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~ 379 (455)
+|||||+.....+... ...-...|||||.+. +.|+.++|||||||+|||+++ |..||.+....+++..+++.. .
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R 922 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R 922 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c
Confidence 9999999554333221 112345799999987 789999999999999999998 999999999998888777776 2
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 380 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
. ...+.+++.+.+++..||+.+|++||++..|++
T Consensus 923 L--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 L--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred c--CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 2 223478999999999999999999999999987
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=314.38 Aligned_cols=247 Identities=25% Similarity=0.433 Sum_probs=205.4
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
.+|++.+.||+|+||.||++.... +..+|+|++...... ...+.+|+++++++. |+||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~----~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG----KIDVAIKMIREGAMS----EDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPI 74 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC----CccEEEEEeccCCCC----HHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCce
Confidence 468999999999999999997653 567999998643322 245778999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||+++...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVL 151 (256)
T ss_pred EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceecc
Confidence 99999999999999987766789999999999999999999999999999999999999 778899999999987654
Q ss_pred CCCccc--ccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 315 PDERLN--DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 315 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
...... ...++..|+|||++. ..++.++||||||+++|+|++ |..||......+....+..... .. ....++.
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 228 (256)
T cd05059 152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-LY--RPKLAPT 228 (256)
T ss_pred cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-CC--CCCCCCH
Confidence 322211 122345799999876 568999999999999999998 8999987776666555543321 11 1235789
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++.+++.+||+.+|++||++.++++.
T Consensus 229 ~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 229 EVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=319.36 Aligned_cols=256 Identities=21% Similarity=0.278 Sum_probs=209.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCc-------------ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-------------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-------------~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~ 220 (455)
.++|++++.||+|+||.||+|...... ..+..||+|.+... ......+.+.+|+++++++. |+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD--ASDNAREDFLKEVKILSRLS-DPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhcC-CCC
Confidence 468999999999999999999876422 12467999998654 33455678999999999998 999
Q ss_pred eeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCc
Q 012825 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG----------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290 (455)
Q Consensus 221 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~N 290 (455)
|+++++++..++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999886543 268999999999999999999999999999999999
Q ss_pred eEEeecCCCceEEEeecccccccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc--CCCCCCCC
Q 012825 291 FLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC--GSRPFWAR 364 (455)
Q Consensus 291 ILl~~~~~~~~vkL~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt--g~~Pf~~~ 364 (455)
|++ +.++.++|+|||++....... ......++..|+|||++. +.++.++||||||+++|||++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999 677899999999987654332 122345677899999876 478999999999999999998 78888877
Q ss_pred ChhHHHHHHHhc----CCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 365 TESGIFRAVLKA----DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 365 ~~~~~~~~i~~~----~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.....+..+... ...........++.++.+||.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 766665555433 111111122356789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=327.90 Aligned_cols=259 Identities=27% Similarity=0.522 Sum_probs=212.5
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||++.... +|..||||++.... ........+.+|+.+++++. |+||+++++++..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 86 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPD 86 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECC---CCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCC
Confidence 357889999999999999999998665 58899999986432 33444567889999999998 99999999998755
Q ss_pred C------ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 232 D------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 232 ~------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
. ..++||||+ +++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~ 160 (343)
T cd07880 87 LSLDRFHDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKIL 160 (343)
T ss_pred ccccccceEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEe
Confidence 4 358999999 778887664 3568999999999999999999999999999999999999 678889999
Q ss_pred ecccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC--
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-- 381 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-- 381 (455)
|||++..... ......++..|+|||++.+ .++.++|+||||+++|+|++|..||........+..++.......
T Consensus 161 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 161 DFGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred eccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999876542 2234567889999998764 478899999999999999999999987766555444433221110
Q ss_pred -------------------------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 382 -------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 382 -------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
...++.++.++.++|.+||+.||++|||+.+++.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 011245788899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=312.53 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=210.0
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|........+..|++|++..... ....+.+.+|++++..+. |+||+++++++.+++..++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence 479999999999999886433478999999875432 225678999999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 241 CEGGELLDRILSR--------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 241 ~~ggsL~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence 9999999988765 4789999999999999999999999999999999999999 7789999999999987
Q ss_pred cCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 313 VRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 313 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
..... ......++..|+|||++. ..++.++||||||+++|+|++ |..||...........+...... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL---PKPEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence 65432 233456788999999886 468999999999999999998 69999888776666666543211 11235
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++.++.+++.+||+.||++||++.+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 78999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=312.68 Aligned_cols=252 Identities=27% Similarity=0.540 Sum_probs=207.9
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|.... +|+.||+|.+...........+.+.+|+++++++. |+||+++++++.+++..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeE
Confidence 579999999999999999999775 58899999987544455555678999999999997 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 235 YVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
++||||+++++|.+++.. ....+++..++.++.+|+.||.|||+.||+||||+|+||++ +.++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceee
Confidence 999999999999988753 24568999999999999999999999999999999999999 778889999999987
Q ss_pred ccCCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh--HHHHHHHhcCCCCCCCCCCC
Q 012825 312 FVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 387 (455)
...... ......++..|+|||++. ..++.++||||||+++|+|++|..||...... .....+... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 232 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADH 232 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC--CCCCCChhh
Confidence 654322 223456888999999876 46899999999999999999999999654321 222222221 112222235
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
++..+.++|.+||..+|++||++.+|++
T Consensus 233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 233 YSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=319.26 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=209.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.+.||+|+||.||++..... ...+..||||++... ......+.+.+|+++++++.+|+||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT--AHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc--CChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 57899999999999999999986432 224678999998654 23444567899999999995599999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
+..++||||+.+++|.+++.... ..+++..+..++.||+.||.|||+++|+|+||||+|||+ +.++.++|+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCccc
Confidence 99999999999999999886543 348999999999999999999999999999999999999 67888999999998
Q ss_pred cccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 311 DFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 311 ~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||........+........... ..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~ 266 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--QP 266 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--CC
Confidence 76543321 12234567899999876 568999999999999999998 9999987666555544444332221 12
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
...+.++.+|+.+||+.+|++||++.+++.
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 356889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=309.01 Aligned_cols=253 Identities=32% Similarity=0.542 Sum_probs=212.4
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC--Cc
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--DN 233 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~--~~ 233 (455)
+|.+.+.||+|++|.||+|.... +++.|++|++..... .....+.+.+|+.+++++. |+||+++++.+.+. +.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---TGELMAVKSVELSGD-SEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---CCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCe
Confidence 58889999999999999998775 588999999865432 2455678999999999998 99999999999988 88
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++|+||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+...
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEec
Confidence 999999999999999876544 89999999999999999999999999999999999999 66888999999999877
Q ss_pred CCCCc---ccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChh-HHHHHHHhcCCCCCCCCCCCC
Q 012825 314 RPDER---LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 314 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 388 (455)
..... .....++..|++||.+.+ .++.++||||||+++|+|++|..||...... .....+.. . .........+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~-~~~~~~~~~~ 229 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-S-GEPPEIPEHL 229 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-c-CCCcCCCccc
Confidence 65543 445678899999998874 5899999999999999999999999776522 22222221 0 1111222356
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
+..+.+||.+||+.||++||++.+++.||||
T Consensus 230 ~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.59 Aligned_cols=253 Identities=30% Similarity=0.573 Sum_probs=211.0
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
|+....||+|+||.||++.... +++.||+|++.... ....+.+.+|+.+++.+. |+||+++++++..++..++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~---~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKH---SGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcC---CCCEEEEEEEEecc---cchHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEE
Confidence 4456689999999999998765 57899999985432 223456889999999998 9999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCC
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~ 316 (455)
||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++......
T Consensus 96 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 96 LMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred EEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccc
Confidence 9999999999886633 568999999999999999999999999999999999999 78889999999998755432
Q ss_pred C-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 012825 317 E-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (455)
Q Consensus 317 ~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~ 394 (455)
. ......++..|+|||++. ..++.++||||||+++|||++|..||...........+.... .........++..+.+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 249 (297)
T cd06659 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRD 249 (297)
T ss_pred cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCCccccCCCCHHHHH
Confidence 2 223457899999999886 468899999999999999999999998776655555443322 2222223467889999
Q ss_pred HHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 395 FVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 395 li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+|++||+.+|.+||++.++++|+||...
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 250 FLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 9999999999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=317.84 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=208.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
..+|.+.+.||+|+||.||+|..... ...+..+++|.+.. ......+.+.+|+++++++. |+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD---PTLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDG 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC---ccHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccC
Confidence 35799999999999999999986542 22466799998843 33444567899999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec
Q 012825 232 DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~ 296 (455)
+..++||||+++++|.+++.... +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~--- 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV--- 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---
Confidence 99999999999999999886532 358999999999999999999999999999999999999
Q ss_pred CCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 012825 297 DENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~ 371 (455)
+.++.++|+|||++........ .....++..|+|||++. ..++.++||||||+++|+|++ |..||..........
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 7788999999999976543221 23345678899999876 568899999999999999998 999998777666555
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.+....... ....++..+.+++.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 554433221 12356889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=330.76 Aligned_cols=260 Identities=32% Similarity=0.547 Sum_probs=208.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee---
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--- 230 (455)
.++|++.+.||+|+||.||+|.... +|+.||+|++.... ........+.+|+.++++++ |+||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGA 78 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC---CCCEEEEEEecccc-ccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCC
Confidence 5789999999999999999998776 58899999986532 22334566788999999998 9999999998763
Q ss_pred -CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 231 -TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 231 -~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
...+++||||+. ++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~ 153 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGM 153 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEeccccc
Confidence 346899999995 58888764 44569999999999999999999999999999999999999 7788999999999
Q ss_pred ccccCCCCc-----ccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhc------
Q 012825 310 SDFVRPDER-----LNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA------ 376 (455)
Q Consensus 310 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~------ 376 (455)
+........ .....++..|+|||++.+ .++.++||||||+++|+|++|+.||........+..+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 876543221 134578899999998753 5889999999999999999999999766543332222211
Q ss_pred -----------------CCCCCCC----CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 377 -----------------DPSFDEA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 377 -----------------~~~~~~~----~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
....... ..+.++.++.++|++||+.||.+||++.+++.||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 1111111 1245789999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=320.63 Aligned_cols=255 Identities=23% Similarity=0.400 Sum_probs=208.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCc----ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
.++|.+.+.||+|+||.||+++..... ..+..||+|.+... .......++.+|+++++++.+|+||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC--CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 578999999999999999999865321 23467999998654 234445678899999999966999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEe
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~ 294 (455)
.++..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill- 173 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 173 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE-
Confidence 9999999999999999999987542 358899999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 012825 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (455)
Q Consensus 295 ~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 369 (455)
+.++.+||+|||++........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||......+.
T Consensus 174 --~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 174 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred --cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 6778899999999876543221 11223456899999876 468999999999999999998 8899987766555
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
...+.... .. .....++.++.+||.+||..+|.+||++.+++++
T Consensus 252 ~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 252 FKLLKEGH-RM--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHcCC-CC--CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 55443332 11 1223678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=314.57 Aligned_cols=254 Identities=21% Similarity=0.335 Sum_probs=210.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCc--ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.+.||+|+||.||+|..+... ..+..||+|.+... ........+.+|+.+++.+. |+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc--cCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcCC
Confidence 578999999999999999999887532 34688999998543 23344567889999999997 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceE
Q 012825 232 DNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~v 302 (455)
+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||+ +.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCE
Confidence 99999999999999999886432 347889999999999999999999999999999999999 778899
Q ss_pred EEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcC
Q 012825 303 KAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 377 (455)
Q Consensus 303 kL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~ 377 (455)
||+|||+++....... .....++..|+|||++. +.++.++||||||+++|||++ |..||...........+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 9999999876543321 22345678899999876 568999999999999999998 999998877766665555322
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 378 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
. . .....++.++.++|.+||+.+|++|||+.++++.
T Consensus 239 ~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 239 H-L--DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred C-C--CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1 1 1123468999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=323.24 Aligned_cols=268 Identities=29% Similarity=0.488 Sum_probs=216.2
Q ss_pred CcCcccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCC-C----C
Q 012825 146 SFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-N----N 220 (455)
Q Consensus 146 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-p----~ 220 (455)
-+..++.++++|+++..+|+|+||.|..+.+.+ .+..||||+++. -....+..+-|++++.++..+ | -
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---~~~~vAlKIik~----V~kYreAa~iEi~vLqki~~~DP~g~~r 152 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---TKEHVALKIIKN----VDKYREAALIEIEVLQKINESDPNGKFR 152 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecC---CCceehHHHHHH----HHHHhhHHHHHHHHHHHHHhcCCCCceE
Confidence 345567789999999999999999999998777 488999999853 233445567799999999522 2 4
Q ss_pred eeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC--
Q 012825 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-- 297 (455)
Q Consensus 221 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~-- 297 (455)
+|++.++|+..+++|||+|.+ |.|+.+++.+.+ .+++...++.++.||+++++|||+.+++|.||||+|||+.+.+
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence 788999999999999999999 779999986644 4799999999999999999999999999999999999996421
Q ss_pred ---------------CCceEEEeecccccccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCC
Q 012825 298 ---------------ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPF 361 (455)
Q Consensus 298 ---------------~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf 361 (455)
.+..++|+|||.|+... +....++.|..|+|||++.+ +|+.++||||+||||+|+.+|...|
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 14469999999998764 34477889999999999875 8999999999999999999999999
Q ss_pred CCCChhH---HHHHHHhcCCCCC-------------CCCCCC--------------------------CCHHHHHHHHHh
Q 012825 362 WARTESG---IFRAVLKADPSFD-------------EAPWPS--------------------------LSSEARDFVKRL 399 (455)
Q Consensus 362 ~~~~~~~---~~~~i~~~~~~~~-------------~~~~~~--------------------------~s~~l~~li~~~ 399 (455)
+...+.+ +++.++...+... ...|++ -..++.|||++|
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 8777655 4444433211100 000110 123588999999
Q ss_pred ccCCccCCCCHHHHHcCcccCCCC
Q 012825 400 LNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 400 L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
|..||.+|+|+.|+|.||||+...
T Consensus 390 L~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 390 LEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HccCccccccHHHHhcCHHhhcCC
Confidence 999999999999999999998753
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=311.55 Aligned_cols=247 Identities=24% Similarity=0.374 Sum_probs=205.6
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|++|.||+|.... ++.||+|.+..... ..+++.+|+.++++++ |+||+++++++...+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN----TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC----CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCC
Confidence 5779999999999999999998644 57899999865432 2456889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARV 152 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEE
Confidence 999999999999999886543 468999999999999999999999999999999999999 6788899999999987
Q ss_pred cCCCCcc--cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
....... .....+..|+|||++. ..++.++||||||+++|+|++ |+.||...........+...... .....+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 229 (261)
T cd05068 153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM---PCPPGC 229 (261)
T ss_pred ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCcC
Confidence 6532211 1122345799999876 468999999999999999999 99999887766655555433211 122357
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+..+.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=312.31 Aligned_cols=253 Identities=21% Similarity=0.347 Sum_probs=210.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|+..+.||+|+||.||+|...........+|+|.+... ......+.+.+|+++++++. |+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCC
Confidence 45789999999999999999998764334558999998643 23444567889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++....+.+++..+..++.|++.||.|||+.|++||||||+||++ +.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVL 157 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceec
Confidence 999999999999999887777789999999999999999999999999999999999999 67888999999998765
Q ss_pred CCCCcc----cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 314 RPDERL----NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 314 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
...... .....+..|+|||++. +.++.++||||||+++|||++ |..||+.....+....+...... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~ 234 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL---PAPMD 234 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC---CCCCC
Confidence 432211 1112345799999876 568999999999999999997 99999887777666666543211 11225
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
++.++.+++.+||+.||++||++.++++
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=318.50 Aligned_cols=253 Identities=19% Similarity=0.301 Sum_probs=209.5
Q ss_pred CCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.+|++.++||+|+||.||+|..... ...++.||+|++... ......+.+.+|+.++..++ |+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK--AEGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCC
Confidence 4688999999999999999987642 124678999998643 23344567889999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC
Q 012825 233 NVYVVMELCEGGELLDRILSR---------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~ 297 (455)
..++++||+.+++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+|||+ +
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---F 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---c
Confidence 999999999999999987532 2358889999999999999999999999999999999999 6
Q ss_pred CCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 012825 298 ENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (455)
Q Consensus 298 ~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~ 372 (455)
+++.+||+|||+++....... .....++..|+|||++. +.++.++||||||+++|||++ |..||......+....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 777899999999876543221 22344577899999875 678999999999999999998 8889988777776666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+....... ....++..+.+|+.+||+.||.+||++.+|+..
T Consensus 239 i~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 65554322 123688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=316.09 Aligned_cols=255 Identities=29% Similarity=0.456 Sum_probs=208.3
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEeEEEeeCCc-
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYEDTDN- 233 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hp~Iv~l~~~~~~~~~- 233 (455)
|++.+.||+|+||.||+|+... +++.||+|++..... .......+.+|+.+++++. .|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---CCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 6889999999999999999765 588999999865432 2222345667888887774 49999999999988776
Q ss_pred ----eEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 234 ----VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 234 ----~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
.+++|||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.+++|+||+|+||++ +.++.+||+|||
T Consensus 77 ~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg 152 (287)
T cd07838 77 RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFG 152 (287)
T ss_pred CCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccC
Confidence 9999999965 8888776543 369999999999999999999999999999999999999 677899999999
Q ss_pred cccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC-------
Q 012825 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF------- 380 (455)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~------- 380 (455)
++.............++..|+|||++. ..++.++||||||+++|+|++|..||......+.+..+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 153 LARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred cceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 998775554444556788999999876 468899999999999999999999998877766666554421100
Q ss_pred ---------C-------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 381 ---------D-------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 381 ---------~-------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
. ....+.++..+.+||.+||+.||.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 00012356788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=318.12 Aligned_cols=254 Identities=35% Similarity=0.532 Sum_probs=209.5
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
|++.+.||+|+||.||+|.... +++.|+||++...... .......+|+..++++.+|+||+++++++.+++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---TGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---CCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence 6789999999999999999766 4789999998654221 2223455799999999889999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 237 VMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
||||+ +++|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccC
Confidence 99999 779988886654 578999999999999999999999999999999999999 7788999999999987765
Q ss_pred CCcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC-----------
Q 012825 316 DERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE----------- 382 (455)
Q Consensus 316 ~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 382 (455)
........++..|+|||++. ..++.++|+||||+++++|++|+.||......+.+..+.........
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 54555567889999999874 34789999999999999999999999777665555444322111100
Q ss_pred ---------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 383 ---------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 383 ---------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
...+..+..+.+||++||+.||++||++.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0112336789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.02 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=210.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEec----CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKK----GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~----~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
.++|.+.+.||+|+||.||+|+... ....+..||+|.+... ......+.+.+|+.+++.+.+|+||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 6789999999999999999997542 2224568999998643 234456788999999999956999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEe
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~ 294 (455)
..+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili- 170 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV- 170 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE-
Confidence 9999999999999999999886532 357888999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 012825 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (455)
Q Consensus 295 ~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 369 (455)
+.++.+||+|||+++....... .....++..|+|||++. ..++.++||||||+++|+|++ |..||......+.
T Consensus 171 --~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 171 --TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred --cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 6778899999999987643221 22234567899999876 468999999999999999998 8889988777776
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
...+....... ....++.++.+||.+||+.+|.+||++.++++.
T Consensus 249 ~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 66554433221 123678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=314.65 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=205.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcc-cCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.++|++.+.||+|+||.||+|.+..... ....||+|++... ......+.+.+|+.++..+. |+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVG-SPYVCRLLGICLT-S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-C
Confidence 5789999999999999999998665321 2335899998643 34455677899999999998 9999999999875 4
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..+++|||+++|+|.+++....+.+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGLARL 158 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCceee
Confidence 5789999999999999987767789999999999999999999999999999999999999 6677899999999987
Q ss_pred cCCCCcc---cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 313 VRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 313 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
....... ....++..|+|||++. ..++.++|||||||++|||++ |..||...........+.. ...... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~--~~~ 235 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERLPQ--PPI 235 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCCC--Ccc
Confidence 6533221 1223467899999876 568999999999999999998 8999976665554443333 222221 236
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
++.++.++|.+||+.||++||++.++++
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=317.01 Aligned_cols=260 Identities=29% Similarity=0.509 Sum_probs=218.3
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...+.|++.+.||.|++|.||+|.... .+..|++|++..... ..+.+.+|+++++++. |+||+++++++...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 87 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVG 87 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEcc---CCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEEC
Confidence 457789999999999999999998775 478999999865322 4567889999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..++|+||+++++|.+++......+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~ 164 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAA 164 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhh
Confidence 99999999999999999887665589999999999999999999999999999999999999 678889999999887
Q ss_pred ccCCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
...... ......++..|++||++. ..++.++||||||+++|+|++|..||...........+...... .......++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 243 (286)
T cd06614 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWS 243 (286)
T ss_pred hhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCC
Confidence 654322 223445788999999876 45899999999999999999999999876655444444332221 111223478
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
..+.+||++||+.+|.+||++.+++.|+||+..+
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 9999999999999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=320.08 Aligned_cols=260 Identities=32% Similarity=0.559 Sum_probs=211.8
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-CHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
+|++.+.||+|+||.||+++......++..||||++.+.... .....+.+.+|++++.++.+|+||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488999999999999999987655456889999998643222 2334467889999999997799999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++++|.+++.. ...+++..++.++.|+++||.|||+.|++||||||+||++ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccc
Confidence 999999999999988754 4568999999999999999999999999999999999999 778889999999987654
Q ss_pred CCCc--ccccccCCCcccccccCCC---CCCcchHHHHHHHHHHHHcCCCCCCCCCh----hHHHHHHHhcCCCCCCCCC
Q 012825 315 PDER--LNDIVGSAYYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~~~---~~~~sDiwSlG~~l~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~ 385 (455)
.... .....|+..|+|||++.+. .+.++||||||+++|+|++|..||..... ......+....... .
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~ 232 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF----P 232 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC----C
Confidence 3322 2234688999999987642 68899999999999999999999954322 22223333332222 2
Q ss_pred CCCCHHHHHHHHHhccCCccCCCC---HHHHHcCcccCCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLT---AAQALSHPWIKNSN 423 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps---~~elL~hp~~~~~~ 423 (455)
..++..+.++|.+||+.||++||| +.++|+||||+...
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 357889999999999999999998 56779999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=323.24 Aligned_cols=257 Identities=30% Similarity=0.482 Sum_probs=206.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC--
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~-- 231 (455)
.++|++.+.||+|+||.||+|.... +++.||||++......+ .....+.+|+++++.++ |+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHNEKD-GFPITALREIKILKKLK-HPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcC-CCCccchhhheecccc
Confidence 5789999999999999999999766 57899999986543222 12235678999999998 99999999987543
Q ss_pred ------CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 232 ------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 232 ------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
..+++||||+.+ +|...+......+++..++.++.||++||.|||+.||+|+||||+|||+ ++++.+||+
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~ 157 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIA 157 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEC
Confidence 347999999965 7777776666789999999999999999999999999999999999999 788899999
Q ss_pred ecccccccCCCCc------------ccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 012825 306 DFGLSDFVRPDER------------LNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 371 (455)
Q Consensus 306 DfG~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~ 371 (455)
|||++........ .....++..|+|||++.+ .++.++||||||+++|+|++|+.||...+......
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~ 237 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999876543221 123456888999998753 47889999999999999999999998777665555
Q ss_pred HHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 372 AVLKADPSFDE--------------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 372 ~i~~~~~~~~~--------------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.+......... ..+..+...+.+||.+||+.||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 44432111000 0012355788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=329.26 Aligned_cols=258 Identities=31% Similarity=0.523 Sum_probs=207.6
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
+..+|++.+.||.|+||.||+|.... +|+.||+|.+.... ....+.+.+|++++++++ |+||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~---~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~ 75 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSD---CDKRVAVKKIVLTD---PQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSG 75 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECC---CCcEEEEEEEecCC---CchHHHHHHHHHHHHhcC-CCcchhhHhhhcccc
Confidence 46899999999999999999998766 58899999985543 234567889999999997 99999999876543
Q ss_pred -------------CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCC
Q 012825 232 -------------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298 (455)
Q Consensus 232 -------------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~ 298 (455)
...|+||||++ ++|.+++. .+.+++..++.++.||+.||.|||+.||+||||||+||+++ .+
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~ 150 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TE 150 (342)
T ss_pred cccccccccccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CC
Confidence 35799999996 58887663 34689999999999999999999999999999999999994 35
Q ss_pred CceEEEeecccccccCCCCc----ccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 012825 299 NSVLKAIDFGLSDFVRPDER----LNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372 (455)
Q Consensus 299 ~~~vkL~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~ 372 (455)
++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++|+.||...........
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 230 (342)
T cd07854 151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230 (342)
T ss_pred CceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 56799999999876532211 12345788999999764 3578899999999999999999999987766555554
Q ss_pred HHhcCCCCC----------------------C----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 373 VLKADPSFD----------------------E----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 373 i~~~~~~~~----------------------~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
++...+... . ...+.++.++.+||++||+.||++||++.++|.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 443211100 0 0123578899999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=319.45 Aligned_cols=254 Identities=22% Similarity=0.386 Sum_probs=207.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecC----cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKG----ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
.++|.+.+.||+|+||.||+|+.... ......||+|++... ........+.+|+.+++++.+|+||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC--CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 47899999999999999999986421 123568999998643 334556778899999999966999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEe
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~ 294 (455)
+++..++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill- 167 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV- 167 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE-
Confidence 9999999999999999999986532 358899999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 012825 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (455)
Q Consensus 295 ~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 369 (455)
+.++.+||+|||+++....... .....++..|+|||++. +.++.++||||||+++|+|++ |..||......+.
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 168 --TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred --cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 6778899999999976543221 11223446799999876 568999999999999999999 8999988776666
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+..+...... .....++.++.+||.+||+.||++||++.++++
T Consensus 246 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 6555443211 112367889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=324.70 Aligned_cols=263 Identities=28% Similarity=0.456 Sum_probs=210.9
Q ss_pred cCCCeEE-eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHH-----------HHHHHHHHHHHHHHhcCCCC
Q 012825 153 FANKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAI-----------AIEDVRREVKILRALTGHNN 220 (455)
Q Consensus 153 ~~~~y~~-~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~-----------~~~~~~~Ei~~l~~l~~hp~ 220 (455)
+.++|.. .+.||.|+||.||+|.+.. .++.||||++......... ....+.+|+++++.+. |+|
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ 81 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTL---TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HEN 81 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECC---CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccc
Confidence 4677875 5779999999999998765 5889999998654322100 1124778999999998 999
Q ss_pred eeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCc
Q 012825 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (455)
Q Consensus 221 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~ 300 (455)
|+++++++..++..++||||+. ++|.+++. ....+++..+..++.||+.||.|||+.||+|+||+|+|||+ +.++
T Consensus 82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~ 156 (335)
T PTZ00024 82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKG 156 (335)
T ss_pred eeeeeEEEecCCcEEEEEeccc-cCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCC
Confidence 9999999999999999999996 58888774 45569999999999999999999999999999999999999 7788
Q ss_pred eEEEeecccccccCCC---------------CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCC
Q 012825 301 VLKAIDFGLSDFVRPD---------------ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWA 363 (455)
Q Consensus 301 ~vkL~DfG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~ 363 (455)
.++|+|||++...... .......++..|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998765411 11223356788999998864 478899999999999999999999988
Q ss_pred CChhHHHHHHHhcCCCCCCC------------------------CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 364 RTESGIFRAVLKADPSFDEA------------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
....+.+..+.......... ....++.++.++|.+||+.||++||++.++|.|+||
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 77766555544321111100 012457889999999999999999999999999999
Q ss_pred CCCCC
Q 012825 420 KNSND 424 (455)
Q Consensus 420 ~~~~~ 424 (455)
+....
T Consensus 317 ~~~~~ 321 (335)
T PTZ00024 317 KSDPL 321 (335)
T ss_pred CCCCC
Confidence 97643
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=367.68 Aligned_cols=261 Identities=33% Similarity=0.556 Sum_probs=222.9
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
....-+|+-...||.|.||.||.|...+ +|...|+|.+...... ....+.+.+|..++..+. |||+|+++|+-.+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~---tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLD---TGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVH 1305 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCC---ccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceeec
Confidence 3456678889999999999999998666 7999999998765533 556678999999999998 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
.+.++|.||||++|+|.+.+ +.++..++...+.+..|++.||.|||++|||||||||+|||+ +.+|.+|++|||.|
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccce
Confidence 99999999999999999865 677778888999999999999999999999999999999999 88899999999999
Q ss_pred cccCCCC-----cccccccCCCcccccccCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCChhHHH-HHHHh-cCCC
Q 012825 311 DFVRPDE-----RLNDIVGSAYYVAPEVLHRS----YSTEADVWSIGVIAYILLCGSRPFWARTESGIF-RAVLK-ADPS 379 (455)
Q Consensus 311 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~-~~i~~-~~~~ 379 (455)
..+.... ..+..+||+.|||||++.+. ...++|||||||+++||+||+.||........+ ..+.. ..+.
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC
Confidence 8875442 23567899999999999753 567899999999999999999999776555433 33322 2344
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 380 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
+++ .++.+..+||.+||..||++|+++.|+|+|-|=+.-.+
T Consensus 1462 ~P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1462 IPE----RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred Cch----hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence 444 48999999999999999999999999999999876544
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=317.46 Aligned_cols=254 Identities=34% Similarity=0.561 Sum_probs=211.4
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
|++.+.||.|++|.||++.... +|+.+++|.+..... .......+.+|+.+++++. |+||+++++++..++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---TGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---CCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEE
Confidence 6778899999999999998765 588999999865432 2234567889999999998 9999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCC
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~ 316 (455)
||||+++ +|.+.+......+++..+..++.||+.||.|||+.+|+|+||||+||++ +.++.++|+|||.+......
T Consensus 76 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred EEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCC
Confidence 9999975 8888887766789999999999999999999999999999999999999 67888999999998776544
Q ss_pred C-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC------------
Q 012825 317 E-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD------------ 381 (455)
Q Consensus 317 ~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~------------ 381 (455)
. ......++..|+|||.+.+ .++.++||||||+++|+|++|+.||...+..+.+..+........
T Consensus 152 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 152 VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 3 2334567888999998753 588899999999999999999999987776555444433211100
Q ss_pred --------------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 382 --------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 382 --------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
....+.++.++.+||.+||+.||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 01123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=335.00 Aligned_cols=263 Identities=26% Similarity=0.499 Sum_probs=238.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++++++..||-||||.|-++..... ...+|+|++++...-+....+.+..|-.+|..+. .+.||++|..|.+...
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~---~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQ---KATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKY 494 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEeccc---chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchh
Confidence 35677788999999999999987763 3369999999888888888899999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|++||-|-||.|+..+ ...+.|++..++.++..+++|++|||++|||+|||||+|.|+ +.+|-+||.|||+|+.+
T Consensus 495 vYmLmEaClGGElWTiL-rdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTIL-RDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhhHHhhcCchhhhhh-hhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHh
Confidence 99999999999999976 456789999999999999999999999999999999999999 89999999999999999
Q ss_pred CCCCcccccccCCCccccccc-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 314 RPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
..+..+.++|||+.|.|||++ .+..+..+|.|+||+++|||++|..||.+...-..+..|+++....... ..+++..
T Consensus 571 ~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a 648 (732)
T KOG0614|consen 571 GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTA 648 (732)
T ss_pred ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhH
Confidence 999999999999999999975 5789999999999999999999999999999999999998875443322 4688999
Q ss_pred HHHHHHhccCCccCCCC-----HHHHHcCcccCCCCCCC
Q 012825 393 RDFVKRLLNKDPRKRLT-----AAQALSHPWIKNSNDVK 426 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps-----~~elL~hp~~~~~~~~~ 426 (455)
.+||+++...+|.+|.. +.+|-+|.||.++++..
T Consensus 649 ~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg 687 (732)
T KOG0614|consen 649 TDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG 687 (732)
T ss_pred HHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence 99999999999999985 89999999999987544
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=314.45 Aligned_cols=252 Identities=18% Similarity=0.305 Sum_probs=203.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcc-cCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.++|++.+.||+|+||.||+|.+..... ....|++|.+... .......++..|+.+++++. |+||+++++++. +.
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~-~~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP-GA 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC-CC
Confidence 3679999999999999999998765211 1235788887432 23344567888999999998 999999999875 45
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++++||+++|+|.+++....+.+++..+..|+.||+.||.|||+.+++||||||+|||+ ++++.+||+|||+++.
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADL 158 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCcccee
Confidence 5789999999999999998777789999999999999999999999999999999999999 7788999999999986
Q ss_pred cCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 313 VRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 313 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
...... .....++..|+|||++. +.++.++||||||+++|||++ |..||...........+ ........ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~--~~~ 235 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQ--PQI 235 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCC--CCC
Confidence 543321 23345677899999876 578999999999999999998 99999876655443333 32222211 124
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
++.++.+++.+||..||++||++.++++
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 6788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=327.10 Aligned_cols=259 Identities=36% Similarity=0.581 Sum_probs=215.1
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC---
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD--- 232 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~--- 232 (455)
+|++.+.||.|+||.||+|+... +++.||||++.... ......+.+.+|+.+++.+. |+||+++++++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---CCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCccc
Confidence 58999999999999999999765 58899999986532 22445567889999999998 999999999988775
Q ss_pred --ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 233 --NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 233 --~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
.+|+||||++ ++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~ 150 (330)
T cd07834 76 FNDVYIVTELME-TDLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLA 150 (330)
T ss_pred ccceEEEecchh-hhHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCce
Confidence 7899999997 47887764 44589999999999999999999999999999999999999 77789999999999
Q ss_pred cccCCCC----cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC--
Q 012825 311 DFVRPDE----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE-- 382 (455)
Q Consensus 311 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-- 382 (455)
....... ......++..|+|||++.+ .++.++||||||+++|+|++|..||......+.+..+.........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 8765443 2344568889999998863 5888999999999999999999999887776655555443221110
Q ss_pred -------------------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 383 -------------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 383 -------------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
...+.++.++.+||.+||++||++||++.+++.||||+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 012346788999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=309.17 Aligned_cols=244 Identities=23% Similarity=0.356 Sum_probs=200.2
Q ss_pred eEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeec
Q 012825 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241 (455)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~ 241 (455)
.||+|+||.||+|.+.... .+..||+|++... ......+.+.+|+.+++++. |+||+++++++. .+..++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~-~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-~~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCC-CceeEEEEEcccc--cChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-CCCeEEEEEeC
Confidence 4899999999999876422 3667999998654 33445577999999999998 999999999885 45789999999
Q ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcc--
Q 012825 242 EGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-- 319 (455)
Q Consensus 242 ~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~-- 319 (455)
++++|.+++......+++..++.++.||+.||.|||++|++||||||+|||+ +.++.+||+|||++.........
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCcccee
Confidence 9999999887667789999999999999999999999999999999999999 67788999999998765433221
Q ss_pred --cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 012825 320 --NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395 (455)
Q Consensus 320 --~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l 395 (455)
....++..|+|||++. +.++.++||||||+++|+|++ |..||......+....+...... .....++.++.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l 230 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL---DCPAECPPEMYAL 230 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCCHHHHHH
Confidence 1122356899999876 568999999999999999996 99999887776665555443321 1223578999999
Q ss_pred HHHhccCCccCCCCHHHHHcC
Q 012825 396 VKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 396 i~~~L~~dP~~Rps~~elL~h 416 (455)
|.+||..||++||++.++++.
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=329.63 Aligned_cols=260 Identities=30% Similarity=0.573 Sum_probs=213.5
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|+... +++.||||++.... ......+.+.+|+.+++++. |+||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 86 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPA 86 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECC---CCcEEEEEeccccc-chhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcc
Confidence 357889999999999999999999776 57899999986532 23344566788999999997 99999999988765
Q ss_pred Cc------eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 232 DN------VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 232 ~~------~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
+. .++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~ 160 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKIL 160 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEc
Confidence 54 89999999 6699887743 569999999999999999999999999999999999999 678889999
Q ss_pred ecccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC--
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-- 381 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-- 381 (455)
|||++...... .....++..|+|||.+.+ .++.++||||||+++|+|++|+.||........+..++.......
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99999766432 344567889999998753 578899999999999999999999987766655555443221110
Q ss_pred ---------------------C----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 382 ---------------------E----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 382 ---------------------~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
. .....++.++.+||++||+.||.+|||+.+++.||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 0 011246889999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=309.01 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=199.4
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
++||+|+||.||+|.+.... ++..||+|++.... ......+++.+|+.+++.+. |+||+++++++. ++..++||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~-~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~ 76 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKK-SEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMEL 76 (257)
T ss_pred CcCCCcCCcceEEeEEecCC-CceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEec
Confidence 36899999999999765322 47889999986443 34455678899999999997 999999999875 4567999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCc--
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-- 318 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~-- 318 (455)
+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||.|||+ +.++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 77 AELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCee
Confidence 999999988754 4578999999999999999999999999999999999999 6788999999999987643322
Q ss_pred --ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 012825 319 --LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (455)
Q Consensus 319 --~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~ 394 (455)
.....++..|+|||++. +.++.++||||||+++|||++ |..||......+....+.+... . .....++.++.+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~--~~~~~~~~~l~~ 229 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-M--ECPQRCPPEMYD 229 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-C--CCCCCCCHHHHH
Confidence 12223457899999876 468889999999999999997 9999987776666555544322 1 122358899999
Q ss_pred HHHHhccCCccCCCCHHHHHc
Q 012825 395 FVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 395 li~~~L~~dP~~Rps~~elL~ 415 (455)
||.+||+.||++||++.+|..
T Consensus 230 li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 230 LMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHhccCchhCcCHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=309.42 Aligned_cols=246 Identities=25% Similarity=0.409 Sum_probs=206.3
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|++|.||+|.+.........||||.+...... ...+.+.+|+.++++++ |+||+++++++.+ ...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence 4689999999999998764334457999999765432 56678999999999998 9999999999988 889999999
Q ss_pred cCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCc-
Q 012825 241 CEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER- 318 (455)
Q Consensus 241 ~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~- 318 (455)
+++++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc
Confidence 99999999987655 578999999999999999999999999999999999999 6778999999999987643221
Q ss_pred ---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 319 ---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 319 ---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
.....++..|+|||++. ..++.++||||||+++|+|++ |..||......+....+........ ....++..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence 12245678899999886 568999999999999999998 9999988777776666654322222 1235788999
Q ss_pred HHHHHhccCCccCCCCHHHHHc
Q 012825 394 DFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 394 ~li~~~L~~dP~~Rps~~elL~ 415 (455)
+++.+||+.+|++||++.++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=314.76 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=204.2
Q ss_pred CeEEeceEeecCCeEEEEEEEecCc--ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
+|++.+.||+|+||.||+|...... .....+++|.+... ........+.+|+.+++.+. |+||+++++.+..++.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC--CCHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence 5889999999999999999865321 13467999988654 23445577899999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCc
Q 012825 234 VYVVMELCEGGELLDRILSR-----------------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~N 290 (455)
.++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999987542 1347899999999999999999999999999999999
Q ss_pred eEEeecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCC
Q 012825 291 FLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWART 365 (455)
Q Consensus 291 ILl~~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~ 365 (455)
||+ ++++.+||+|||++........ .....++..|+|||++. ..++.++||||||+++|||++ |..||....
T Consensus 158 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999 6778999999999876533221 12234567899999875 568999999999999999998 999998777
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 366 ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 366 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.......+.... .. .....++.++.+|+.+||+.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~-~~--~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGY-RM--ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCC-CC--CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 665554443321 11 122367899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=329.27 Aligned_cols=256 Identities=24% Similarity=0.364 Sum_probs=207.6
Q ss_pred CCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|.+.+.||+|+||.||+|++.. ....+..||||++.... .....+.+.+|++++.++..|+||++++++|...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 4679999999999999999998753 12246789999996542 2333457889999999997799999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC---------------------------------------------------------
Q 012825 232 DNVYVVMELCEGGELLDRILSRG--------------------------------------------------------- 254 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~--------------------------------------------------------- 254 (455)
+.+++||||+++|+|.+++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999886431
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEe
Q 012825 255 ----------------------------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (455)
Q Consensus 255 ----------------------------------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~ 294 (455)
..+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl- 272 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI- 272 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE-
Confidence 136778889999999999999999999999999999999
Q ss_pred ecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 012825 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (455)
Q Consensus 295 ~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 369 (455)
++++.+||+|||+++....... .....++..|+|||++. ..++.++||||||+++|||++ |..||......+.
T Consensus 273 --~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 273 --CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred --eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 6678899999999976532221 12345678899999876 568899999999999999998 8999977665555
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
....+....... ....++.++.+||.+||+.+|.+||++.+|+..
T Consensus 351 ~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 351 FYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 444444332221 123578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=312.87 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=209.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
..+|++.++||.|+||.||+|.... +..+|+|++... .......+.+|+.+++.++ |+||+++++++.+.+.
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~----~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 76 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN----RVRVAIKILKSD---DLLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEP 76 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC----CCcEEEEecccc---chhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCC
Confidence 4679999999999999999998766 678999998643 2334567889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.++||||+++++|.+++... +..+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARL 153 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhh
Confidence 99999999999999988653 4568999999999999999999999999999999999999 7788999999999976
Q ss_pred cCCCCc-ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 313 VRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 313 ~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
...... .....++..|++||++. +.++.++||||||+++|+|++ |+.||......+.+..+...... .....++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 230 (261)
T cd05148 154 IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---PCPAKCP 230 (261)
T ss_pred cCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---CCCCCCC
Confidence 643221 12234567899999876 568899999999999999998 89999887777666666543221 1224688
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
..+.++|.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=322.79 Aligned_cols=260 Identities=31% Similarity=0.509 Sum_probs=206.9
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC----
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT---- 231 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~---- 231 (455)
+|++.+.||+|+||.||+++..... .+..||+|++.... ......+.+.+|+.+++++.+|+||+++++++...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~-~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC-cCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 5889999999999999999976521 27889999986432 23334566788999999997799999999975432
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
..+++++||+. ++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 79 NELYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLAR 153 (332)
T ss_pred CcEEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCce
Confidence 45789999995 58888764 45679999999999999999999999999999999999999 778889999999997
Q ss_pred ccCCCC-----cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC------
Q 012825 312 FVRPDE-----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------ 378 (455)
Q Consensus 312 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~------ 378 (455)
...... ......|+..|+|||++.+ .++.++||||||+++|+|++|..||........+..++....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 654322 1234578999999998753 588999999999999999999999977654444333322110
Q ss_pred ---------------------CCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 379 ---------------------SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 379 ---------------------~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
......++.++..+.+||.+||+.||++|||+.+++.||||+.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 00111234568899999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=311.83 Aligned_cols=259 Identities=28% Similarity=0.522 Sum_probs=231.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|.+++.||+|+|..|.+++.++ +.+.||+|+++++-..+++.+..++.|-.+..+..+||.+|-|+.+|..+..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~---t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKK---TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred cccceeeeeecCcchhhhhheehcc---cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 4789999999999999999999888 6899999999998888888899999999999999999999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc-
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF- 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~- 312 (455)
+++|.||++||+|.-++ ++..+++++.++.+...|+.||.|||++|||+||||.+|||+ |.++++||+|+|+.+.
T Consensus 326 lffvieyv~ggdlmfhm-qrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~ 401 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEEEecCcceeeeh-hhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcC
Confidence 99999999999987665 456789999999999999999999999999999999999999 8999999999999876
Q ss_pred cCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCC--------CCChhHHHHHHHhcCCCCCCC
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFW--------ARTESGIFRAVLKADPSFDEA 383 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~--------~~~~~~~~~~i~~~~~~~~~~ 383 (455)
+.++..+++++||+.|.|||++++ .|....|+|+|||+|+||+.|+.||. ..++.-.++.+++.....+.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr- 480 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR- 480 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc-
Confidence 355667889999999999999996 69999999999999999999999994 23344566677776665554
Q ss_pred CCCCCCHHHHHHHHHhccCCccCCC------CHHHHHcCcccCCCC
Q 012825 384 PWPSLSSEARDFVKRLLNKDPRKRL------TAAQALSHPWIKNSN 423 (455)
Q Consensus 384 ~~~~~s~~l~~li~~~L~~dP~~Rp------s~~elL~hp~~~~~~ 423 (455)
.++-....+++..|++||.+|. ...++..|+||+...
T Consensus 481 ---slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 481 ---SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred ---eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 5778889999999999999996 578999999999653
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=313.38 Aligned_cols=252 Identities=24% Similarity=0.401 Sum_probs=208.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
..+|++.++||+|+||.||++.... ...++..+|+|.+.. ........+.+|+++++.++ |+||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTVLQ-HQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc---CCHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecC
Confidence 4678999999999999999997543 222467899998754 33455678999999999997 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC
Q 012825 232 DNVYVVMELCEGGELLDRILSRG--------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~ 297 (455)
+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---G 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---c
Confidence 99999999999999999886542 358899999999999999999999999999999999999 6
Q ss_pred CCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 012825 298 ENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (455)
Q Consensus 298 ~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~ 372 (455)
+++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||......+....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 788899999999875543221 12234567899999876 568999999999999999998 9999987777666666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+....... ....++..+.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 55443221 12357899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=308.84 Aligned_cols=254 Identities=27% Similarity=0.488 Sum_probs=209.3
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCC--cCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK--MTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
.+|++.+.||+|+||.||+|+... ++..||+|++.... ....+....+.+|++++++++ |+||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCC
Confidence 479999999999999999998765 58899999875322 123445678899999999998 99999999998764
Q ss_pred -CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 232 -DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 232 -~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
+.+++||||+++++|.+++... +.+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~ 153 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGAS 153 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccc
Confidence 4588999999999999987543 458999999999999999999999999999999999999 67788999999999
Q ss_pred cccCCC----CcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 311 DFVRPD----ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 311 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
...... .......++..|+|||++.+ .++.++||||||+++|+|++|+.||...........+..... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p 231 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLP 231 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCC
Confidence 765321 12234568899999998864 588999999999999999999999987665555544433221 12223
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
..+++.+.++|.+||. ++.+||++.+++.|||.
T Consensus 232 ~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 232 DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred cccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 4688999999999999 46999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=324.86 Aligned_cols=255 Identities=20% Similarity=0.329 Sum_probs=201.1
Q ss_pred ceEeec--CCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEE
Q 012825 161 EEVGRG--HFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVM 238 (455)
Q Consensus 161 ~~LG~G--~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~ 238 (455)
..||.| +||+||++++.. .|+.||+|++.... ......+.+.+|+.+++.++ |+||++++++|..++..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP---TGTLVTVRITDLEN-CTEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcC---CCcEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEE
Confidence 456666 899999998765 58999999986543 23345578899999999888 999999999999999999999
Q ss_pred eecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCC
Q 012825 239 ELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317 (455)
Q Consensus 239 E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~ 317 (455)
||+.+++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++++||+.+.......
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccC
Confidence 9999999998876543 458999999999999999999999999999999999999 677889999998654322111
Q ss_pred cc--------cccccCCCcccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC-----
Q 012825 318 RL--------NDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD----- 381 (455)
Q Consensus 318 ~~--------~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~----- 381 (455)
.. ....++..|+|||++.+ .++.++|||||||++|+|++|..||............+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence 10 11234567999999864 378899999999999999999999977655444433332211100
Q ss_pred --------------------------------------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 382 --------------------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 382 --------------------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
......++..+.+||++||+.||++|||+.++|+|+||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 000123567899999999999999999999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=305.87 Aligned_cols=252 Identities=33% Similarity=0.607 Sum_probs=213.3
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||+|++|.||++.... .++.|++|.+..... .......+.+|++++.++. |+|++++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---TGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---CCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEE
Confidence 58899999999999999998765 478999999976542 2345678999999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||+|+||++ +.++.++|+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 76 IILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLND 151 (254)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCC
Confidence 999999999999887544 679999999999999999999999999999999999999 6678899999999987654
Q ss_pred CCc-ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 316 DER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 316 ~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
... .....++..|+|||.+. ..++.++|||+||+++|+|++|..||................. ......++..+.
T Consensus 152 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 228 (254)
T cd06627 152 VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH---PPLPEGISPELK 228 (254)
T ss_pred CcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC---CCCCCCCCHHHH
Confidence 332 23456888999999876 4578899999999999999999999987665444444332211 122236789999
Q ss_pred HHHHHhccCCccCCCCHHHHHcCccc
Q 012825 394 DFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 394 ~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
++|.+||..+|++||++.+++.|+||
T Consensus 229 ~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.93 Aligned_cols=258 Identities=30% Similarity=0.534 Sum_probs=207.8
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|.... +|+.||+|++.... ......+.+.+|+.++++++ |+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~ 88 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA 88 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcC---CCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeec
Confidence 457899999999999999999998765 58899999986532 23334466788999999998 99999999988643
Q ss_pred ------CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 232 ------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 232 ------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
...|++++++ +++|.+.+. ...+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEe
Confidence 3478888887 778887663 3468999999999999999999999999999999999999 778889999
Q ss_pred ecccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC-----
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP----- 378 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~----- 378 (455)
|||++..... ......++..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+.....
T Consensus 163 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 163 DFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred cccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999876532 3344578899999998754 578899999999999999999999976665444333322111
Q ss_pred ------------------CCCC----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 379 ------------------SFDE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 379 ------------------~~~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.... ......+.++.+||.+||+.||.+|+++.+++.||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 0000 0112357889999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=313.30 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=197.7
Q ss_pred CCCe-EEeceEeecCCeEEEEEEEecC-cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKY-ELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y-~~~~~LG~G~fg~V~~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++| ++.+.||+|+||.||++..... ...++.||+|++... ........+.+|+++++++. |+||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 78 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQ 78 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc--cChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 3556 9999999999999998765422 235789999998654 23344567889999999998 99999999988653
Q ss_pred --CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 232 --DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 232 --~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
..+++||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~ 153 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGL 153 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeeccc
Confidence 458999999999999998854 359999999999999999999999999999999999999 6778899999999
Q ss_pred ccccCCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhH--------------HH
Q 012825 310 SDFVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESG--------------IF 370 (455)
Q Consensus 310 a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~--------------~~ 370 (455)
+........ .....++..|+|||++. +.++.++||||||+++|+|++|..||....... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233 (283)
T ss_pred ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence 886643322 11223566799999876 568999999999999999999999985432210 01
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 371 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.......... .....++.++.+++.+||+.||++||++.++++
T Consensus 234 ~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 234 IELLERGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111111111 112357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.89 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=203.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.+.||+|+||.||+|.+.. ...+++.||||++.... .......+.+|+.++.++.+|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4789999999999999999998643 22357899999986532 3344567889999999997699999999988654
Q ss_pred -CceEEEEeecCCCcHHHHHHhcC--------------------------------------------------------
Q 012825 232 -DNVYVVMELCEGGELLDRILSRG-------------------------------------------------------- 254 (455)
Q Consensus 232 -~~~~lV~E~~~ggsL~~~l~~~~-------------------------------------------------------- 254 (455)
..+++||||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 56899999999999999886432
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCc---ccc
Q 012825 255 ----------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LND 321 (455)
Q Consensus 255 ----------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~---~~~ 321 (455)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........ ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcCC
Confidence 236788889999999999999999999999999999999 6788999999999876532221 122
Q ss_pred cccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 012825 322 IVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399 (455)
Q Consensus 322 ~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~ 399 (455)
..++..|+|||++. ..++.++||||||+++|+|++ |..||........+...+........ ...++.++.+++.+|
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~c 318 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC--CCCCCHHHHHHHHHH
Confidence 34567799999875 568999999999999999996 99999765443333333333222211 124678999999999
Q ss_pred ccCCccCCCCHHHHHcC
Q 012825 400 LNKDPRKRLTAAQALSH 416 (455)
Q Consensus 400 L~~dP~~Rps~~elL~h 416 (455)
|+.||++||++.++++|
T Consensus 319 l~~~p~~Rps~~eil~~ 335 (343)
T cd05103 319 WHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=325.12 Aligned_cols=257 Identities=30% Similarity=0.568 Sum_probs=207.6
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+.++|.+.+.||+|+||.||+|.... +|+.||||++.+.. ........+.+|+.+++.+. |+||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 87 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAV 87 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCC---CCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcC-CCCccchhheecccc
Confidence 45789999999999999999998765 58899999986532 22333456789999999997 999999999987543
Q ss_pred ------ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 233 ------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 233 ------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
..++|+||+.. +|...+ +..+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~d 160 (342)
T cd07879 88 SGDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILD 160 (342)
T ss_pred cCCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEee
Confidence 46999999964 666543 3468999999999999999999999999999999999999 6788999999
Q ss_pred cccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC------
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------ 378 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~------ 378 (455)
||++..... ......++..|+|||++.+ .++.++|||||||++|||++|+.||........+..++....
T Consensus 161 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 161 FGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999876532 2334567889999998764 478899999999999999999999987765554444333110
Q ss_pred -----------------CCCC----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 379 -----------------SFDE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 379 -----------------~~~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.... ..++.++..+.+||.+||+.||++||++.+++.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000 01235678899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.65 Aligned_cols=245 Identities=36% Similarity=0.653 Sum_probs=210.7
Q ss_pred EeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecC
Q 012825 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (455)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 242 (455)
||.|+||.||++.... +++.||+|++.+...........+.+|+++++++. |+||+++++.+..++..++||||++
T Consensus 1 lg~G~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCC
Confidence 6999999999998765 57899999997765555556778999999999998 9999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCC-Ccccc
Q 012825 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLND 321 (455)
Q Consensus 243 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~-~~~~~ 321 (455)
+++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++...... .....
T Consensus 77 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (250)
T cd05123 77 GGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNT 152 (250)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccC
Confidence 99999987544 468999999999999999999999999999999999999 67788999999998776543 23445
Q ss_pred cccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhc
Q 012825 322 IVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400 (455)
Q Consensus 322 ~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L 400 (455)
..++..|++||.+.+ ..+.++|+||||+++|+|++|..||...........+......+. ..++..+.++|++||
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l 228 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLL 228 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHh
Confidence 678889999998764 578899999999999999999999987776565566555332222 246899999999999
Q ss_pred cCCccCCCCH---HHHHcCccc
Q 012825 401 NKDPRKRLTA---AQALSHPWI 419 (455)
Q Consensus 401 ~~dP~~Rps~---~elL~hp~~ 419 (455)
..||++||++ .+++.||||
T Consensus 229 ~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 229 QKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred cCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=348.17 Aligned_cols=150 Identities=28% Similarity=0.481 Sum_probs=135.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|.+.++||+|+||.||+|++.. .++.||||++.............+.+|+.+++.+. |+||+++++++...+.
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~ 78 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANN 78 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCE
Confidence 3689999999999999999999776 58899999997665556666778999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+||||||+.|++|.+++.. .+.+++..++.|+.||+.||.|||.+|||||||||+|||| +.++.+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9999999999999998754 4568999999999999999999999999999999999999 677899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=314.95 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=204.6
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCc-----------ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCee
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-----------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-----------~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv 222 (455)
..+|++.+.||+|+||.||+++..... .....||+|.+... ........+.+|+++++++. |+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~-h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLK-NPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCC-CCCcC
Confidence 468999999999999999998864321 12346999998653 23445567899999999998 99999
Q ss_pred EEeEEEeeCCceEEEEeecCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCce
Q 012825 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-----------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291 (455)
Q Consensus 223 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NI 291 (455)
++++++...+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999885432 2368899999999999999999999999999999999
Q ss_pred EEeecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc--CCCCCCCCC
Q 012825 292 LFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC--GSRPFWART 365 (455)
Q Consensus 292 Ll~~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt--g~~Pf~~~~ 365 (455)
|+ +.++.+||+|||++........ .....++..|+|||++. +.++.++||||||+++|+|++ |..||....
T Consensus 161 ll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 161 LV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99 6777899999999876543221 12234567899999875 568999999999999999988 678888776
Q ss_pred hhHHHHHHHhcC----CCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 366 ESGIFRAVLKAD----PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 366 ~~~~~~~i~~~~----~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.......+.... ........+.++..+.+||.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 665554443211 11111122357899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=321.32 Aligned_cols=260 Identities=22% Similarity=0.328 Sum_probs=200.7
Q ss_pred EeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEE
Q 012825 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVM 238 (455)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~ 238 (455)
+.+.+|.|+ .||+++... +++.||||++.... ......+.+.+|+++++.++ |+||+++++++.+.+..+++|
T Consensus 6 i~~~~~~~~--~v~~~~~~~---~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 78 (314)
T cd08216 6 IGKCFEDLM--IVHLAKHKP---TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVS 78 (314)
T ss_pred hhHhhcCCc--eEEEEEecC---CCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEE
Confidence 344444444 455554444 58899999987543 34456678999999999998 999999999999999999999
Q ss_pred eecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCC
Q 012825 239 ELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317 (455)
Q Consensus 239 E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~ 317 (455)
||+++++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||.+.......
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 79 PLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred eccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeecccc
Confidence 999999999988654 4568999999999999999999999999999999999999 677889999999886543221
Q ss_pred --------cccccccCCCcccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC------
Q 012825 318 --------RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF------ 380 (455)
Q Consensus 318 --------~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~------ 380 (455)
......++..|+|||++.+ .++.++|||||||++|||++|..||...................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCc
Confidence 1233456778999999864 47889999999999999999999997655443332222111000
Q ss_pred ------------------------CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCc
Q 012825 381 ------------------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428 (455)
Q Consensus 381 ------------------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p 428 (455)
.......++.++.+||.+||++||++|||+.++|+||||+...+.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~~ 307 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTS 307 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccchh
Confidence 000001235678999999999999999999999999999977544443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=320.78 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=208.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCc----ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
..+|++++.||+|+||.||+|+..... ..+..||+|.+... ......+++.+|+++++++.+|+||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 467999999999999999999865321 13457999988643 344556788999999999956999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEe
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~ 294 (455)
.++.++++|||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill- 167 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV- 167 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE-
Confidence 9999999999999999999886532 247889999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 012825 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (455)
Q Consensus 295 ~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 369 (455)
+.++.+||+|||+++....... .....++..|+|||++. ..++.++||||||+++|||++ |..||......+.
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 168 --TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred --cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 6778899999999876543221 12223456799999876 568999999999999999998 8899988777666
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
...+...... . ....++.++.+||.+||+.+|++||++.+++++
T Consensus 246 ~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 246 FKLLKEGHRM-D--KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHcCCCC-C--CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 6555443221 1 123578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=324.83 Aligned_cols=261 Identities=31% Similarity=0.501 Sum_probs=209.9
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|.+.. +|+.||+|.+.... ........+.+|+.+++++.+|+||+++++++...
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcC---CCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 457899999999999999999998765 57899999885432 23334456778999999994499999999998654
Q ss_pred --CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 232 --DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 232 --~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
...|+||||++ ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~ 153 (337)
T cd07852 80 NDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGL 153 (337)
T ss_pred CCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccc
Confidence 36899999996 4888877543 78999999999999999999999999999999999999 7889999999999
Q ss_pred ccccCCCC------cccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC--
Q 012825 310 SDFVRPDE------RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS-- 379 (455)
Q Consensus 310 a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~-- 379 (455)
+....... ......|+..|+|||++. ..++.++||||||+++|+|++|+.||...........+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 87654322 223456889999999875 35788999999999999999999999766544433332221110
Q ss_pred -------------------------CCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 380 -------------------------FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 380 -------------------------~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
......+.++.++.+||.+||+.||.+|||+.++++|+||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0111223478899999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=307.23 Aligned_cols=244 Identities=23% Similarity=0.345 Sum_probs=199.7
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
++||+|+||.||+|.+......+..||+|.+...... ...+.+.+|+.+++.+. |+||+++++++. .+..++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEe
Confidence 4799999999999987664434589999998755332 45567899999999997 999999999876 4568999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcc-
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL- 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~- 319 (455)
+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+|||+ +.++.+||+|||++.........
T Consensus 77 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 77 APLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCccc
Confidence 9999999988644 478999999999999999999999999999999999999 67888999999998866433321
Q ss_pred ---cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 012825 320 ---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (455)
Q Consensus 320 ---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~ 394 (455)
....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+...... .....++..+.+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 229 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYS 229 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHH
Confidence 1112345799999876 568999999999999999998 99999877665555544433221 222467899999
Q ss_pred HHHHhccCCccCCCCHHHHHc
Q 012825 395 FVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 395 li~~~L~~dP~~Rps~~elL~ 415 (455)
+|.+||..||++||++.++++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.91 Aligned_cols=254 Identities=31% Similarity=0.564 Sum_probs=211.0
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
|+...+||+|+||.||++.... +|+.||||.+.. ........+.+|+.+++.+. |+||+++++++..++..++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~---~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 94 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKS---SGKLVAVKKMDL---RKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWV 94 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcC---CCeEEEEEEecc---cchhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEE
Confidence 4445789999999999998765 588999998743 23344567899999999998 9999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCC
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~ 316 (455)
||||+++++|.+++. ...+++..+..++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||++......
T Consensus 95 v~e~~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 95 VMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred EEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccc
Confidence 999999999988653 3468999999999999999999999999999999999999 77888999999998765432
Q ss_pred C-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 012825 317 E-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (455)
Q Consensus 317 ~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~ 394 (455)
. ......++..|++||++. ..++.++|+||||+++|+|++|..||...........+....+.. ......++..+.+
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 248 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK-LKNLHKVSPSLKG 248 (292)
T ss_pred cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-cCCcccCCHHHHH
Confidence 2 223456889999999876 468899999999999999999999998766555444443322221 1122457899999
Q ss_pred HHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 395 FVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 395 li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+|.+||+.||.+||++.+++.|+||....
T Consensus 249 li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 249 FLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 99999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=304.67 Aligned_cols=243 Identities=25% Similarity=0.364 Sum_probs=201.1
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|.... ++.||+|++... ........+.+|+++++++. |+||+++++++...+..++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~~----~~~~a~K~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD----KTPVAVKTCKED--LPQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEecC----CcEEEEEecCCc--CCHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEEC
Confidence 468999999999998543 678999998653 23444457889999999997 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcc-
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL- 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~- 319 (455)
+++++|.+++......+++..+..++.|++.+|.|||++|++||||||+||++ +.++.+||+|||++.........
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~ 150 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSS 150 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceecccccccc
Confidence 99999999887666678999999999999999999999999999999999999 77889999999998754322211
Q ss_pred -cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 012825 320 -NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFV 396 (455)
Q Consensus 320 -~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li 396 (455)
....++..|+|||++. +.++.++||||||+++|+|++ |..||...........+...... .....++..+.+|+
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li 227 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVM 227 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHH
Confidence 1223456799999886 568899999999999999998 99999877766655555433211 12235789999999
Q ss_pred HHhccCCccCCCCHHHHHcC
Q 012825 397 KRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 397 ~~~L~~dP~~Rps~~elL~h 416 (455)
.+||+.+|++||++.++++.
T Consensus 228 ~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 228 QRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHcccCcccCCCHHHHHHH
Confidence 99999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=309.51 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=202.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.++||+|+||.||+|.+.. ...||+|++..... ..+.+.+|+++++++. |+||+++++++. .+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----~~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVS-EEP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----CceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEEC-CCC
Confidence 4689999999999999999998654 34699999865322 2256889999999998 999999999875 456
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+||++ +.++.+||+|||.+..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL 151 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceee
Confidence 89999999999999988654 3468999999999999999999999999999999999999 6788899999999976
Q ss_pred cCCCCcc--cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
....... ....++..|+|||++. +.++.++||||||+++|+|++ |..||......+....+....... ....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 228 (262)
T cd05071 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPEC 228 (262)
T ss_pred ccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC---Ccccc
Confidence 5433221 2334567899999875 568999999999999999999 888998777666655554332111 12367
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+..+.+||.+||+.||++||++.++++
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=309.67 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=201.3
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-----
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT----- 231 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~----- 231 (455)
|.+.+.||+|+||.||+|++.... ....||+|.+.... ......+.+.+|+++++.++ |+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~-~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD-SILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCC-CeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccC
Confidence 356789999999999999876531 12369999986542 34455678899999999997 99999999987532
Q ss_pred -CceEEEEeecCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 232 -DNVYVVMELCEGGELLDRILSR-----GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 232 -~~~~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
...++||||+++++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||+ ++++.+||+
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~ 154 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVA 154 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEEC
Confidence 2478999999999998877432 2358999999999999999999999999999999999999 778889999
Q ss_pred ecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCC
Q 012825 306 DFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (455)
Q Consensus 306 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (455)
|||++........ .....++..|++||++. ..++.++||||||+++|||++ |+.||...........+.......
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999987643321 12224567899999886 468999999999999999999 889998776666555554433211
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..+.++..+.++|.+||+.||++|||+.+++++
T Consensus 235 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 ---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 123678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=306.23 Aligned_cols=247 Identities=26% Similarity=0.471 Sum_probs=206.4
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
.+|++.+.||+|+||.||++.+.. +..+|+|.+...... ...+.+|+++++++. |+||+++++++......
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~----~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE----KRKVAIKTIREGAMS----EEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPI 74 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC----CCeEEEEECCCCCCC----HHHHHHHHHHHHhCC-CCCeeeEEEEEccCCce
Confidence 579999999999999999998654 568999998654332 245788999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++++|.+++....+.+++..++.++.|++.+|.|||+.+++|+||||+||++ +.++.+||+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecc
Confidence 99999999999999887766778999999999999999999999999999999999999 678889999999987654
Q ss_pred CCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 315 PDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
.... .....++..|+|||++. +.++.++||||||+++|||++ |..||...........+......... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 228 (256)
T cd05112 152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQ 228 (256)
T ss_pred cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCH
Confidence 3221 11223456899999876 568889999999999999998 99999877766666555433222211 24678
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.+.+|+.+||+.+|++||++.+++++
T Consensus 229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 229 SVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=307.81 Aligned_cols=252 Identities=27% Similarity=0.471 Sum_probs=213.1
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|++.+.||+|+||.||++.... +++.+|+|.+..... .......+.+|+++++.++ |+||+++++++.+....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---DNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---CCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEE
Confidence 58999999999999999998665 578999999865432 3344567788999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 236 VVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.+||+|||++..
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL---VANDLVKIGDLGISKV 152 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---ecCCcEEEeeccchhh
Confidence 999999999999887552 3568999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
.... ......++..|++||.+. ..++.++|+||||+++|+|++|+.||...........+...... .. ...++.+
T Consensus 153 ~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~ 228 (256)
T cd08530 153 LKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP--PI-PPIYSQD 228 (256)
T ss_pred hccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CC-chhhCHH
Confidence 6544 333456888999999876 45888999999999999999999999887766555544433221 11 1257899
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
+.++|.+||+.+|++||++.+++.||++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=315.15 Aligned_cols=254 Identities=33% Similarity=0.545 Sum_probs=210.8
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
|++.+.||+|++|.||+|.... +++.||+|++.... ......+.+.+|+.+++++. |+||+++++++.+.+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecC---CCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEE
Confidence 6778899999999999999776 58899999987643 22333466788999999998 9999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCC
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~ 316 (455)
||||++ ++|.+++......+++..++.++.|++.||.|||+.||+||||+|+||++ ++++.++|+|||++......
T Consensus 76 v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred EecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCC
Confidence 999997 58999887765679999999999999999999999999999999999999 77889999999998776433
Q ss_pred C-cccccccCCCcccccccC-C-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC-------------
Q 012825 317 E-RLNDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF------------- 380 (455)
Q Consensus 317 ~-~~~~~~gt~~y~aPE~~~-~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~------------- 380 (455)
. ......++..|+|||++. . .++.++||||||+++|||++|..||......+.+..+.......
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 152 LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 2 233445678899999875 3 68889999999999999999999998877665555443321100
Q ss_pred ------------CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 381 ------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 381 ------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.....+.++..+.++|++||..||++||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 001123457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=313.83 Aligned_cols=256 Identities=18% Similarity=0.280 Sum_probs=203.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEec-------------CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKK-------------GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~-------------~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~ 220 (455)
.++|++.+.||+|+||.||+++... ....+..||+|++... ........+.+|+++++.++ |+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~E~~~l~~l~-~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNARNDFLKEIKIMSRLK-DPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCC
Confidence 4689999999999999999986432 1113457999998643 23445678899999999998 999
Q ss_pred eeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCc
Q 012825 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG----------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290 (455)
Q Consensus 221 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~N 290 (455)
|+++++++..++..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999886532 247788999999999999999999999999999999
Q ss_pred eEEeecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc--CCCCCCCC
Q 012825 291 FLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC--GSRPFWAR 364 (455)
Q Consensus 291 ILl~~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt--g~~Pf~~~ 364 (455)
||+ +.++.++|+|||++........ .....++..|++||+.. +.++.++|||||||++|||++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999 6788899999999876543221 12233467899999754 679999999999999999998 78899776
Q ss_pred ChhHHHHHHHhc---C-CCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 365 TESGIFRAVLKA---D-PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 365 ~~~~~~~~i~~~---~-~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
...+........ . ..........++..+.+|+.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 665544433221 1 11111112357789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=318.87 Aligned_cols=259 Identities=33% Similarity=0.555 Sum_probs=208.4
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~- 230 (455)
.++++|++.+.||.|+||.||+|.... +++.||||++.+.. ......+.+.+|+++++++. ||||++++++|..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 81 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQL---TGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLR-HENIISLSDIFISP 81 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECC---CCCEEEEEEecccc-cccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecC
Confidence 357899999999999999999998665 58899999886532 22334466789999999998 9999999999875
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
.+..++||||+ +++|.+++. ...+++..+..++.||++||.|||+.||+||||+|+|||+ ++++.++|+|||++
T Consensus 82 ~~~~~lv~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~ 155 (328)
T cd07856 82 LEDIYFVTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLA 155 (328)
T ss_pred CCcEEEEeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccc
Confidence 56789999999 568887663 3468899999999999999999999999999999999999 77889999999998
Q ss_pred cccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcC-----------
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD----------- 377 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~----------- 377 (455)
..... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||...........+.+..
T Consensus 156 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 156 RIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 75432 2334567889999998753 58899999999999999999999997665432222111100
Q ss_pred ----------------CCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 378 ----------------PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 378 ----------------~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
........+.++..+.++|++||+.+|++||++.+++.|+||...+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 0000011235788999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=309.28 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=198.2
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|+..++. ....+++|.+... ......+.+.+|++++.++.+|+||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-CeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 46899999999999987631 1245788887532 33445567889999999996699999999999999999999999
Q ss_pred cCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 241 CEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 241 ~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
+++++|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+|||+ ++++.+||+
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~ 154 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIA 154 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEEC
Confidence 99999999886532 247899999999999999999999999999999999999 778899999
Q ss_pred ecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCC
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEA 383 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (455)
|||++..............+..|+|||++. ..++.++||||||+++|||++ |..||......+....+..... . .
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~--~ 231 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-L--E 231 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC-C--C
Confidence 999985432111111123356799999876 568899999999999999997 9999987776665555543221 1 1
Q ss_pred CCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 384 ~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
....++.++.+|+.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 12357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=308.09 Aligned_cols=246 Identities=24% Similarity=0.387 Sum_probs=202.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.++||+|+||.||+|.... +..||+|.+...... .+.+.+|+.+++++. |+||+++++++. .+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG----NTKVAVKTLKPGTMS----PESFLEEAQIMKKLR-HDKLVQLYAVVS-EEP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC----CceeEEEEecCCCCC----HHHHHHHHHHHHhcC-CCceEEEEeEEC-CCC
Confidence 5689999999999999999997654 567999998654322 246889999999998 999999999885 456
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+||++ ++++.++|+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeee
Confidence 89999999999999988654 3468999999999999999999999999999999999999 6788999999999976
Q ss_pred cCCCCcc--cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
....... ....++..|+|||++. ..++.++||||||+++|+|++ |..||......+....+...... .....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (260)
T cd05070 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---PCPQDC 228 (260)
T ss_pred ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCcC
Confidence 5433211 2233556799999876 568899999999999999999 89999887766666655443221 112357
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+..+.+|+.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 229 PISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=312.58 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=208.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.+.||+|+||.||+|..... ..++..||+|++... .......++.+|+.+++++. |+||+++++++.++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD-HPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC--cCHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC
Confidence 46899999999999999999986531 124688999998643 33455677999999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCc
Q 012825 232 DNVYVVMELCEGGELLDRILSRG---------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~N 290 (455)
+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999886432 247888999999999999999999999999999999
Q ss_pred eEEeecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCC
Q 012825 291 FLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWART 365 (455)
Q Consensus 291 ILl~~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~ 365 (455)
||+ +.++.++|+|||++........ ......+..|+|||++. +.++.++|||||||++|+|++ |..||....
T Consensus 161 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999 7788999999999876532221 12233456799999876 568999999999999999997 888998877
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 366 ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 366 ~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
..+....+....... ....++.++.+||.+||+.||.+||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 776666555443221 12357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=307.91 Aligned_cols=247 Identities=23% Similarity=0.398 Sum_probs=204.2
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.++||+|+||.||+|.... ++.||+|.+..... ....+.+|+.++++++ |+||+++++++. .+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~----~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~ 73 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNG----HTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QE 73 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCC----CceEEEEEecCCCC----cHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cC
Confidence 45789999999999999999998654 67899999865432 2356889999999998 999999999874 55
Q ss_pred ceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
..++||||+.+++|.+++... +..+++..+..++.|++.||.|||+.|++||||||+||++ +.++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~ 150 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCccee
Confidence 689999999999999988653 3578999999999999999999999999999999999999 778889999999987
Q ss_pred ccCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
....... .....++..|+|||++. +.++.++||||||+++|+|++ |+.||......+....+..... . .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~ 227 (260)
T cd05067 151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR-M--PRPDN 227 (260)
T ss_pred ecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-C--CCCCC
Confidence 6652221 12334567899999886 568889999999999999998 9999987776665555433221 1 12235
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
++.++.++|.+||+.||++||++.+++.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 228 CPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 7889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=308.26 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=207.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|.+.+.||+|+||.||+|...........||||.+... ......+.+.+|+.+++++. |+||+++++++.+ +.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--CCHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CC
Confidence 46799999999999999999987654323457999988543 23455678899999999998 9999999998875 55
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++......+++..+..++.||+.||.|||+.|++|+||||+|||+ +.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeec
Confidence 789999999999999987666679999999999999999999999999999999999999 66788999999998766
Q ss_pred CCCCcc--cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 314 RPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 314 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
...... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||......+....+.+.... .....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~ 234 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCP 234 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCC
Confidence 433221 1223446799999876 568899999999999999886 99999887766665555443322 1224678
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.++.++|.+||..+|.+|||+.+++..
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=306.75 Aligned_cols=247 Identities=22% Similarity=0.324 Sum_probs=198.2
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe-eCCceEEEEe
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE-DTDNVYVVME 239 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~-~~~~~~lV~E 239 (455)
+.||+|+||.||+|........+..||+|.+... ......+.+.+|+.+++.+. |+||+++++++. .++..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence 4689999999999987654444678999987532 34445677889999999997 999999999776 4556899999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCC--
Q 012825 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-- 317 (455)
Q Consensus 240 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~-- 317 (455)
|+.+++|.+++......+++..+..++.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence 999999999987666677888999999999999999999999999999999999 678889999999987654221
Q ss_pred ---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcC-CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 318 ---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 318 ---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
......++..|+|||++. ..++.++||||||+++|||++| ..||...........+........ ...++..+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHH
Confidence 112334567899999875 5689999999999999999995 566766555555544443322211 12467899
Q ss_pred HHHHHHhccCCccCCCCHHHHHcC
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.+++.+||+.+|++||++.+++..
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.85 Aligned_cols=247 Identities=36% Similarity=0.575 Sum_probs=208.4
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.+.|++...+|.|+|+.|-.+.... +++.++||++.+.. .+..+|+.++....+|+||+++.+.+.++
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~---t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSP---TDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccc---cccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCC
Confidence 467889999999999999998887666 68999999997652 22346887888888899999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
.+.|+|||.+.|+.+++.+.... .....+..|+.+|+.++.|||++|||||||||+|||+. +..++++|+|||.++
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWS 464 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhh
Confidence 99999999999999988775432 23377888999999999999999999999999999995 477889999999998
Q ss_pred ccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
..... ....+-|..|.|||++. ..|+.++||||||++||+|++|+.||........+...+... .+. ..+|.
T Consensus 465 ~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~-~~s----~~vS~ 537 (612)
T KOG0603|consen 465 ELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP-KFS----ECVSD 537 (612)
T ss_pred hCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC-ccc----cccCH
Confidence 87654 44456788999999987 579999999999999999999999998777663322222221 122 36899
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.+++||++||+.||.+|+++.+++.|+||
T Consensus 538 ~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 538 EAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHHHHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999999999
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=305.76 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=202.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|.... +..+|+|.+..... ..+.+.+|+.+++++. |+|++++++++. .+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNG----TTKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPLYAVVS-EEP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcC----CceEEEEEcccCCc----cHHHHHHHHHHHHhCC-CCCeeeEEEEEc-CCC
Confidence 4679999999999999999998654 34699998754321 2356788999999998 999999999875 456
Q ss_pred eEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||++ ++++.++|+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceE
Confidence 899999999999999886543 458999999999999999999999999999999999999 7788999999999976
Q ss_pred cCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
...... .....++..|+|||++. +.++.++||||||+++|+|++ |..||......+....+..... . .....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~ 228 (260)
T cd05069 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-M--PCPQGC 228 (260)
T ss_pred ccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--CCCccc
Confidence 543221 12234567899999876 568899999999999999999 9999988777666655544321 1 112357
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+..+.+++++||+.||++||++.++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=350.53 Aligned_cols=270 Identities=33% Similarity=0.535 Sum_probs=207.4
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe---
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE--- 229 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~--- 229 (455)
+..+|+.++.||+||||.||+++.+- +|+.||||.|.... +......+.+|+.++.+|+ |||||+++..|.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKl---DGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKL---DGREYAIKKIPLKA--SDKLYSKILREVKLLARLN-HPNVVRYYSAWVEST 550 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecc---cchhhhhhhccCch--HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccC
Confidence 56789999999999999999999776 69999999997643 5666778999999999999 999999987650
Q ss_pred ---------------------------------------------------------------------------eC---
Q 012825 230 ---------------------------------------------------------------------------DT--- 231 (455)
Q Consensus 230 ---------------------------------------------------------------------------~~--- 231 (455)
++
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence 00
Q ss_pred --------------------------------------CceEEEEeecCCCcHHHHHHhcCCCC-CHHHHHHHHHHHHHH
Q 012825 232 --------------------------------------DNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNV 272 (455)
Q Consensus 232 --------------------------------------~~~~lV~E~~~ggsL~~~l~~~~~~l-~~~~~~~i~~qi~~g 272 (455)
..+||.||||+...+.+++ .++... ....+|+++++|++|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI-~~N~~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDII-RRNHFNSQRDEAWRLFREILEG 709 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHH-HhcccchhhHHHHHHHHHHHHH
Confidence 1268999999885555544 444333 577899999999999
Q ss_pred HHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC-------------------CCCcccccccCCCcccccc
Q 012825 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-------------------PDERLNDIVGSAYYVAPEV 333 (455)
Q Consensus 273 L~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~ 333 (455)
|.|+|+.|||||||||.||++ +++..|||+|||+|+... .+...+..+||..|+|||+
T Consensus 710 LaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHhCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 999999999999999999999 788899999999998721 0113355789999999999
Q ss_pred cCC----CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCC--CCCCCCHHHHHHHHHhccCCccCC
Q 012825 334 LHR----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA--PWPSLSSEARDFVKRLLNKDPRKR 407 (455)
Q Consensus 334 ~~~----~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~s~~l~~li~~~L~~dP~~R 407 (455)
+.+ .|+.|+|+|||||+|+||+. ||....+....-.-++ .+.++.. .+..--+.-..+|++||+.||.+|
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccC
Confidence 862 59999999999999999984 5765544443333333 3333332 122223556799999999999999
Q ss_pred CCHHHHHcCcccCC-CCCCCCchhHHHHHH
Q 012825 408 LTAAQALSHPWIKN-SNDVKVPLDVIIFKL 436 (455)
Q Consensus 408 ps~~elL~hp~~~~-~~~~~~p~~~~~~~~ 436 (455)
|||.|+|.+.||-- -.+..+.+...+.+.
T Consensus 863 PtA~eLL~s~llppe~~el~~~~~h~~~~~ 892 (1351)
T KOG1035|consen 863 PTATELLNSELLPPEESELLVFLQHLYIEQ 892 (1351)
T ss_pred CCHHHHhhccCCCccchHHHHHHHHHHHHH
Confidence 99999999999994 223334444444433
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=308.49 Aligned_cols=252 Identities=21% Similarity=0.306 Sum_probs=208.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcc-cCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..+|++.+.||+|+||.||+|....... ....||+|.+.... .......+.+|+.+++++. |+||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVD-HPHVVRLLGICLS-S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-C
Confidence 4789999999999999999998765321 23469999886542 3455677899999999997 9999999999987 7
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 158 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccccc
Confidence 8999999999999999988777779999999999999999999999999999999999999 6788899999999987
Q ss_pred cCCCCccc---ccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 313 VRPDERLN---DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 313 ~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
........ ...++..|+|||.+. +.++.++||||||+++||+++ |+.||......+....+..... ... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~ 235 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LPQ--PPI 235 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-CCC--CCC
Confidence 65332211 122356799999876 578999999999999999998 9999988776666555554322 111 124
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
++..+.+++.+||..||++||++.++++
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=304.67 Aligned_cols=244 Identities=27% Similarity=0.427 Sum_probs=205.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.+++++. |+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-----~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-----GQKVAVKCLKDDST----AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-----CcEEEEEEeccchh----HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCC
Confidence 467999999999999999999743 68899999864321 4577899999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.||+|+||||+||++ +.++.+||+|||.+..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKE 151 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccc
Confidence 9999999999999998865543 68999999999999999999999999999999999999 7788999999999987
Q ss_pred cCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
...... ....+..|+|||++. +.++.++||||||+++|+|++ |..||...........+..... . .....+++
T Consensus 152 ~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~ 226 (256)
T cd05039 152 ASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-M--EAPEGCPP 226 (256)
T ss_pred cccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-C--CCccCCCH
Confidence 632222 334466799999876 568889999999999999997 9999987776665544433221 1 11235789
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHc
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.+.++|.+||..+|++||++.++++
T Consensus 227 ~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 227 EVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=304.02 Aligned_cols=250 Identities=28% Similarity=0.442 Sum_probs=209.1
Q ss_pred eEEeceEeecCCeEEEEEEEecCc-ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+++.+.||.|+||.||++...... ..+..||+|++... ......+.+.+|+.++..+. |+||+++++++.+.+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED--ADEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC--CChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeE
Confidence 457889999999999999977632 23488999998654 23335678999999999996 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 236 VVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~-l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++|||+++++|.+++...... +++..+..++.||+.||.|||+.|++|+||||+||++ +.++.++|+|||++....
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecc
Confidence 999999999999988665544 9999999999999999999999999999999999999 778899999999997765
Q ss_pred CCCccc--ccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 315 PDERLN--DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 315 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
...... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+........ ...++.
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 231 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPP 231 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCH
Confidence 442222 123678899999885 568999999999999999998 8899988777776666655443222 234789
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHc
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
++.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=306.37 Aligned_cols=243 Identities=25% Similarity=0.407 Sum_probs=201.6
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe-eCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE-DTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~-~~~ 232 (455)
.++|++.+.||+|+||.||++... |..||+|.+... ...+.+.+|+.+++++. |+|++++++++. +++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 73 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 73 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-----CCcEEEEEeCCC-----chHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCC
Confidence 357999999999999999998643 678999988532 22456889999999998 999999999764 556
Q ss_pred ceEEEEeecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
..++||||+++++|.+++.+... .+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~ 150 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 150 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccce
Confidence 79999999999999998876544 48999999999999999999999999999999999999 778899999999987
Q ss_pred ccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
...... ....++..|+|||++. ..++.++||||||+++|+|++ |+.||...........+.+.... .....++
T Consensus 151 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 225 (256)
T cd05082 151 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCP 225 (256)
T ss_pred eccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCC
Confidence 654322 2334466899999876 468899999999999999997 99999877666655555443221 2234678
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
..+.++|.+||+.||++|||+.++++
T Consensus 226 ~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 226 PVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=305.48 Aligned_cols=247 Identities=27% Similarity=0.418 Sum_probs=206.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|.+.+.||+|+||.||+|.... ++.||||.+..... ..+++.+|+.+++++. |+||+++++++..+..
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~----~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG----TTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEP 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC----CceEEEEEecCCcc----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCc
Confidence 5789999999999999999998654 57799999865432 2356889999999998 9999999999999899
Q ss_pred eEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++..
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARL 152 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECcccccee
Confidence 999999999999999886644 478999999999999999999999999999999999999 7788999999999877
Q ss_pred cCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
...... .....++..|+|||.+. +.++.++||||||+++|+|++ |+.||...........+........ ....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 229 (261)
T cd05034 153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---PPNC 229 (261)
T ss_pred ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCC
Confidence 643221 11223456799999887 468889999999999999998 9999988777776666654322111 1346
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+.++.+++.+||+.||++||++.++++
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=310.15 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=202.0
Q ss_pred CCeEEeceEeecCCeEEEEEEEec-CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC--
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~-- 231 (455)
.-|++++.||+|+||.||++.+.. +..++..||+|.+... ........+.+|+.+++++. |+||+++++++.+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--ccHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCC
Confidence 347899999999999999997642 2335889999998643 33445567999999999998 99999999998875
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
...++||||++|++|.+++.+....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTK 157 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCcccc
Confidence 56899999999999999886665678999999999999999999999999999999999999 677889999999998
Q ss_pred ccCCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCh--------------hHHHHH
Q 012825 312 FVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--------------SGIFRA 372 (455)
Q Consensus 312 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~--------------~~~~~~ 372 (455)
....... .....++..|+|||++. +.++.++||||||+++|+|++++.|+..... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 7643322 12345677899999876 5688999999999999999998776532111 011111
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
........ .....++..+.+||.+||+.||.+||++.+++++
T Consensus 238 ~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 238 VLEEGKRL--PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHcCccC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 12211111 1234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=306.38 Aligned_cols=248 Identities=20% Similarity=0.333 Sum_probs=197.0
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
++||+|+||.||+|....+ .....+|+|.+... ........+.+|+.+++.+. |+||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecC-CCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEe
Confidence 4689999999999976553 24668999987543 33444567889999999997 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCC
Q 012825 241 CEGGELLDRILSRGG----KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~----~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~ 316 (455)
+++|+|.+++..... ..++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccc
Confidence 999999998865432 35678889999999999999999999999999999999 77889999999998654322
Q ss_pred Cc---ccccccCCCcccccccC--------CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCC-CCCC-
Q 012825 317 ER---LNDIVGSAYYVAPEVLH--------RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADP-SFDE- 382 (455)
Q Consensus 317 ~~---~~~~~gt~~y~aPE~~~--------~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~-~~~~- 382 (455)
.. .....++..|+|||++. ..++.++|||||||++|||++ |..||......+.+..+..... ....
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 21 12334567799999863 246789999999999999998 7889887776665555544332 1111
Q ss_pred CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 383 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.....++..+.+++..|+ .||++||++.++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred cccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 122357888999999998 599999999999763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=319.00 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=215.1
Q ss_pred cccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 149 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
..+...+...++++||+|-||.|.++.... +..||||.++.. ......++|.+|+++|.+|+ ||||++|+|+|
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg----~lkVAVK~Lr~~--a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC 604 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEG----PLKVAVKILRPD--ATKNARNDFLKEIKILSRLK-HPNIVELLGVC 604 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecC----ceEEEEeecCcc--cchhHHHHHHHHHHHHhccC-CCCeeEEEeee
Confidence 344456788999999999999999998655 689999999755 44555689999999999997 99999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeec
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~-l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
..++.+++|+||+++|+|.+++.+.... +.......|+.||+.||+||.+.++|||||.+.|+|+ |.++++||+||
T Consensus 605 ~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadf 681 (807)
T KOG1094|consen 605 VQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADF 681 (807)
T ss_pred ecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCc
Confidence 9999999999999999999999776433 3556677799999999999999999999999999999 89999999999
Q ss_pred ccccccCCCCcc---cccccCCCcccccc-cCCCCCCcchHHHHHHHHHHHH--cCCCCCCCCChhHHHHHHHhcCCCCC
Q 012825 308 GLSDFVRPDERL---NDIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILL--CGSRPFWARTESGIFRAVLKADPSFD 381 (455)
Q Consensus 308 G~a~~~~~~~~~---~~~~gt~~y~aPE~-~~~~~~~~sDiwSlG~~l~ell--tg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (455)
|+++.+...... ...+-...|||+|. +.+.++.++|+|+||+++||++ |...||...+++...++.........
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG 761 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence 999977654433 23456688999996 4599999999999999999975 57899999888887776654332222
Q ss_pred C----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHH
Q 012825 382 E----APWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (455)
Q Consensus 382 ~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL 414 (455)
. ...+.++..+.+++.+|++.|-++||+.+++.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 1 12346889999999999999999999999984
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=308.23 Aligned_cols=253 Identities=28% Similarity=0.509 Sum_probs=205.0
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC--CHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
+|.+.+.||+|+||.||++..... +..+++|+++..... ......++.+|+.++++++ ||||+++++++.+.+.
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA---VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC---CCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCc
Confidence 689999999999999999987653 444555554332211 1223345678999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 234 VYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
.++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.|++|+||+|+||++. ++.++|+|||++
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~ 152 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVS 152 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCce
Confidence 9999999999999887754 345799999999999999999999999999999999999994 245999999998
Q ss_pred cccCCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 311 DFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 311 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
....... ......++..|+|||.+. ..++.++|+||||+++|+|++|..||...........+........ ...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 229 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL---PETY 229 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC---cchh
Confidence 7764332 233456788999999876 4578899999999999999999999987666555555544322211 2357
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
+.++.++|.+||+.||++||++.++++||||
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred cHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 8899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=307.42 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=209.3
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCc--ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
++|++.+.||+|+||.||+|+.+... ...+.|++|.+... ......+.+.+|+++++++. |+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence 67999999999999999999976532 24578999988543 23335678999999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEE
Q 012825 233 NVYVVMELCEGGELLDRILSRG--------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~--------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL 304 (455)
..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||+ +.++.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence 9999999999999999886543 158999999999999999999999999999999999999 67788999
Q ss_pred eecccccccCCCC--cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCC
Q 012825 305 IDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (455)
Q Consensus 305 ~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (455)
+|||++....... ......++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999987543222 223345677899999876 567889999999999999998 888997766666555554333222
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
. ....++..+.++|.+||+.||.+||++.+++..
T Consensus 239 ~--~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 P--VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred C--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 2 123578999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=307.02 Aligned_cols=244 Identities=20% Similarity=0.239 Sum_probs=192.6
Q ss_pred ceEeecCCeEEEEEEEecCc---------ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 161 EEVGRGHFGYTCAAKFKKGE---------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~---------~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
+.||+|+||.||+|...... .....|++|++... .......+.+|+.+++.+. ||||+++++++..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVS-HKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 46899999999999864321 12446899987542 2334457888999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC----CCceEEEeec
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----ENSVLKAIDF 307 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~----~~~~vkL~Df 307 (455)
...++||||+++++|..++......+++..++.++.||+.||.|||+++|+||||||+|||+.... ....++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999999888766667899999999999999999999999999999999999995321 1224899999
Q ss_pred ccccccCCCCcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHH-cCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 012825 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKADPSFDEAP 384 (455)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~ell-tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (455)
|++...... ....++..|+|||++. +.++.++|||||||++|||+ +|..||......+... ....... .
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~----~ 228 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCM----L 228 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCcc----C
Confidence 998654322 2346788899999875 45899999999999999997 5888887655433322 2222111 1
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
....+.++.+||.+||+.||.+||++.+|+++
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 12346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.38 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=199.6
Q ss_pred CCeEEeceEeecCCeEEEEEEEec-CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee--C
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--~ 231 (455)
++|++.+.||+|+||.||++.... +..++..||+|.+.. ......+.+.+|+++++++. |+||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~---~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH---STAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence 579999999999999999997642 223578999999854 33455678899999999998 9999999998753 3
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
..+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccc
Confidence 46899999999999999987666679999999999999999999999999999999999999 778899999999998
Q ss_pred ccCCCCcc----cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh---------------HHHH
Q 012825 312 FVRPDERL----NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES---------------GIFR 371 (455)
Q Consensus 312 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~---------------~~~~ 371 (455)
........ ....++..|+|||++. +.++.++||||||+++|||++|..++...... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 76433221 1122345699999876 46889999999999999999987765332211 0111
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.++....... ....++.++.+||.+||+.+|++|||+.+++.
T Consensus 237 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1222221111 12357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=332.58 Aligned_cols=276 Identities=28% Similarity=0.504 Sum_probs=233.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe----
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE---- 229 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~---- 229 (455)
++.|++.+.||.|.+|.||+++.++ +++..|+|++.... ...++++.|.++++.+..|||++.++++|.
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~---~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVK---TGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeee---cCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 5779999999999999999999777 68899999975432 233678889999999999999999999986
Q ss_pred -eCCceEEEEeecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeec
Q 012825 230 -DTDNVYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 230 -~~~~~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
.++++|||||||.||++-|++.. .+.++.|..+..|++.++.||.+||.+.++|||||-.|||+ ..++.|||+||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDF 167 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDF 167 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeee
Confidence 35789999999999999998864 36689999999999999999999999999999999999999 67888999999
Q ss_pred ccccccCCC-CcccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC
Q 012825 308 GLSDFVRPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380 (455)
Q Consensus 308 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 380 (455)
|.+..+... ...++.+||+.|||||++. ..|+..+|+||||++..||.-|..|+.....-..+..+-+. +..
T Consensus 168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPP 246 (953)
T KOG0587|consen 168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPP 246 (953)
T ss_pred eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCc
Confidence 998776533 3557789999999999984 23778899999999999999999999777654444333332 222
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHHHHHHHHHHhccH
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSS 445 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 445 (455)
....+..++++|.+||..||.+|-.+||+..++|+|||++.. ++++++.+.++++..++.
T Consensus 247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~-----~~e~qir~~ik~~~~~~r 306 (953)
T KOG0587|consen 247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ-----PNERQVRIQIKDHIDRSR 306 (953)
T ss_pred cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc-----ccHHHHHHHHHHHHhhcc
Confidence 333345789999999999999999999999999999999943 289999999988887765
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=304.95 Aligned_cols=247 Identities=21% Similarity=0.330 Sum_probs=195.1
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
+.||+|+||.||+|....+ .++..+|+|.+.... .......+.+|+.++++++ |+||+++++++.+....++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG-YTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCC-CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEEC
Confidence 4689999999999987642 346789999886542 2344457889999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCC
Q 012825 241 CEGGELLDRILSRG----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (455)
Q Consensus 241 ~~ggsL~~~l~~~~----~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~ 316 (455)
+++++|.+++.... ...++..+..++.|++.||.|||+.+++||||||+||++ +.++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCc
Confidence 99999999886432 246778889999999999999999999999999999999 67888999999998754322
Q ss_pred Cc---ccccccCCCcccccccCC--------CCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhc-CCCCCCC
Q 012825 317 ER---LNDIVGSAYYVAPEVLHR--------SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA-DPSFDEA 383 (455)
Q Consensus 317 ~~---~~~~~gt~~y~aPE~~~~--------~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 383 (455)
.. .....++..|+|||++.+ .++.++||||||+++|||++ |+.||............... .......
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 21 123456788999998753 25789999999999999996 99999776655544333222 1212111
Q ss_pred -CCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 384 -PWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 384 -~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.....++.+.+++++|+ .+|++|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 11246788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=306.28 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=207.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCc-ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-C
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-T 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~-~ 231 (455)
.++|++.+.||+|+||.||+|...... ..+..|++|.+... ......+.+.+|+.+++++. |+||+++++++.. +
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLS-HQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 578999999999999999999977532 23678999988643 44556678899999999997 9999999998776 5
Q ss_pred CceEEEEeecCCCcHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEE
Q 012825 232 DNVYVVMELCEGGELLDRILSRG-------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~-------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL 304 (455)
...++++||+++++|.+++.... ..+++..++.++.||+.||.|||+.+++||||||+|||+ +.++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence 67899999999999999886532 458999999999999999999999999999999999999 67789999
Q ss_pred eecccccccCCCCcc---cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCC
Q 012825 305 IDFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPS 379 (455)
Q Consensus 305 ~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~ 379 (455)
+|||+++........ ....++..|+|||++. ..++.++||||||+++||+++ |+.||......+....+... ..
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CC
Confidence 999999865433211 2234567799999876 458999999999999999998 99999876655544433332 22
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 380 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
... ...++.++.+++.+||+.||++|||+.++++
T Consensus 238 ~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 LAQ--PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCC--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 221 2357899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=302.68 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=203.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.++||+|+||.||++.... +..+|+|.+... ....+.+.+|+.++++++ |+||+++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~----~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~ 73 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK----HTKVAVKTMKPG----SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-E 73 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC----CccEEEEecCCC----hhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-C
Confidence 46789999999999999999997554 567999987542 233467889999999998 9999999999887 7
Q ss_pred ceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
..+++|||+++++|.+++... ...+++..+..++.||+.||.|||+.|++|+||||+||++ +.++.+||+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~ 150 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLAR 150 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCccee
Confidence 789999999999999988654 4568899999999999999999999999999999999999 778899999999987
Q ss_pred ccCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
....... .....++..|+|||++. +.++.++||||||+++|+|++ |..||...........+..... . .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~ 227 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-M--PRPEN 227 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-C--CCccc
Confidence 6543221 12234556799999886 468889999999999999998 9999987776665554443321 1 12246
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
++.++.+++.+||+.||++||++.++++
T Consensus 228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 228 CPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 7899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=308.14 Aligned_cols=243 Identities=19% Similarity=0.238 Sum_probs=193.2
Q ss_pred eEeecCCeEEEEEEEecCc---------------------ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCC
Q 012825 162 EVGRGHFGYTCAAKFKKGE---------------------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN 220 (455)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~---------------------~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~ 220 (455)
+||+|+||.||+|...... .....|++|++... .......+.+|+.+++.++ |+|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~-h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVS-HIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCC-CCC
Confidence 6999999999999864311 12346899988532 2334456888999999998 999
Q ss_pred eeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec----
Q 012825 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK---- 296 (455)
Q Consensus 221 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~---- 296 (455)
|+++++++.+++..++||||+++++|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++..
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999988887667789999999999999999999999999999999999999532
Q ss_pred CCCceEEEeecccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHH-HcCCCCCCCCChhHHHHHH
Q 012825 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYIL-LCGSRPFWARTESGIFRAV 373 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~el-ltg~~Pf~~~~~~~~~~~i 373 (455)
+....+||+|||++...... ....++..|+|||++.+ .++.++||||||+++||| ++|..||.......... .
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-F 233 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-H
Confidence 12345899999987644221 22357788999998863 588999999999999998 47999998766544332 2
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
......... ..+..+.++|.+||+.+|++||++.++|++
T Consensus 234 ~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 234 YEKKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHhccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 222222222 345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=301.02 Aligned_cols=242 Identities=24% Similarity=0.371 Sum_probs=200.6
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
++||+|+||.||++.... ++.||+|++.... .......+.+|+++++++. |+||+++++++.+.+..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~----~~~v~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG----NTEVAVKTCRSTL--PPDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC----CCcEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEc
Confidence 479999999999998654 7899999986543 2345678899999999998 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcc-
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL- 319 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~- 319 (455)
+.+++|.+++......+++..+..++.+++.+|.|||+++++||||||+|||+ +.++.+||+|||++.........
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~ 150 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTV 150 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCccee
Confidence 99999999987766778999999999999999999999999999999999999 77888999999998765422111
Q ss_pred --cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 012825 320 --NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395 (455)
Q Consensus 320 --~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~l 395 (455)
....++..|+|||++. +.++.++||||||+++|+|++ |..||...........+.... .. .....++.++.++
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~l 227 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RM--PAPQLCPEEIYRL 227 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CC--CCCccCCHHHHHH
Confidence 1122356799999876 568999999999999999998 889997776655444443321 11 1123578899999
Q ss_pred HHHhccCCccCCCCHHHHHc
Q 012825 396 VKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 396 i~~~L~~dP~~Rps~~elL~ 415 (455)
|.+||+.+|.+||++.++++
T Consensus 228 i~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 228 MLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=324.83 Aligned_cols=260 Identities=30% Similarity=0.514 Sum_probs=224.5
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
.-|..++.||-|+||.|++++..+ +...||+|.+.+...........++.|-+||.... .+.||+||-.|.+.+.+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvD---T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVD---TRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred cceEEEeeecccccceeEEEeecc---hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCce
Confidence 348889999999999999998666 57889999998877777778888999999999987 89999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|+||||++||++..+|.+ -+-|.|..++.++.++..|+++.|..|+|||||||+|||| |.+|++||+|||+++-+.
T Consensus 705 YFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccce
Confidence 999999999999987754 4679999999999999999999999999999999999999 999999999999974321
Q ss_pred ---------CCCc----------------------------------ccccccCCCcccccccC-CCCCCcchHHHHHHH
Q 012825 315 ---------PDER----------------------------------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVI 350 (455)
Q Consensus 315 ---------~~~~----------------------------------~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~ 350 (455)
.+.. ....+||+.|+|||++. ..|+.-+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 0000 11257999999999987 579999999999999
Q ss_pred HHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCC---CHHHHHcCcccCCCC
Q 012825 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQALSHPWIKNSN 423 (455)
Q Consensus 351 l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~elL~hp~~~~~~ 423 (455)
||||+.|+.||...+..+...++++....+.....-.+++++.++|.++.+ +++.|. .+.|+..||||+++.
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccc
Confidence 999999999999888888777777776666666667899999999998764 567776 567799999999864
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=307.37 Aligned_cols=244 Identities=19% Similarity=0.269 Sum_probs=194.1
Q ss_pred ceEeecCCeEEEEEEEecCc----ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 161 EEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
+.||+|+||.||+|...... .....||+|.+.. ......+.+.+|+.+++.+. |+||+++++++..++..++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK---SHRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc---hhHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence 46899999999999876422 1244588888743 22344567888999999998 9999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCC-----CceEEEeeccccc
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-----NSVLKAIDFGLSD 311 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~-----~~~vkL~DfG~a~ 311 (455)
||||+++|+|.+++......+++..+..++.||+.||.|||+.||+||||||+|||++.++. .+.++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999988776667999999999999999999999999999999999999964321 1347999999986
Q ss_pred ccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCC-CCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGS-RPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
..... ....++..|+|||++.+ .++.++||||||+++|+|++|. .||........ ..........+. ..
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~----~~ 228 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPA----PK 228 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCC----CC
Confidence 65422 33467889999999874 4788999999999999999985 55554444332 223333322222 35
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+.++.+||.+||+.||++|||++++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 6889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.48 Aligned_cols=276 Identities=28% Similarity=0.468 Sum_probs=214.0
Q ss_pred CccCCCCCcCcccccC-CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcC
Q 012825 139 PAAGLNKSFGFSKHFA-NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217 (455)
Q Consensus 139 ~~~~~~~~~~~~~~~~-~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~ 217 (455)
+..+-...+.+++.|. .+|.+.++||+|.|++||++++.. ..+.||+|+.+.. ....+....||++|+++..
T Consensus 61 Y~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq---~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~ 133 (590)
T KOG1290|consen 61 YRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQ---NKRYVALKVVKSA----QHYTEAALDEIKLLQQVRE 133 (590)
T ss_pred hhcCCCceeeccccccCceEEEEEeccccccceeEEEeecc---CCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHh
Confidence 4455566777888887 999999999999999999999776 5789999998532 3344567899999999874
Q ss_pred C-------CCeeEEeEEEee----CCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc-CCEEe
Q 012825 218 H-------NNLVKFFDAYED----TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQ-GVVHR 284 (455)
Q Consensus 218 h-------p~Iv~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHr 284 (455)
+ .+||+|+++|.. +.++|+|+|++ |.+|+.+|...+ +.++...++.|++||+.||.|||.. ||||.
T Consensus 134 ~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHT 212 (590)
T KOG1290|consen 134 GDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHT 212 (590)
T ss_pred cCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 3 379999999974 56899999999 889999887644 4699999999999999999999987 99999
Q ss_pred eccCCceEEeecCC------------------------------------------------------------------
Q 012825 285 DLKPENFLFTTKDE------------------------------------------------------------------ 298 (455)
Q Consensus 285 Dikp~NILl~~~~~------------------------------------------------------------------ 298 (455)
||||+|||+...+.
T Consensus 213 DlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~ 292 (590)
T KOG1290|consen 213 DLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLE 292 (590)
T ss_pred CCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccc
Confidence 99999999953200
Q ss_pred ---------------------------------------------C----------------------------------
Q 012825 299 ---------------------------------------------N---------------------------------- 299 (455)
Q Consensus 299 ---------------------------------------------~---------------------------------- 299 (455)
.
T Consensus 293 ~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~ 372 (590)
T KOG1290|consen 293 GIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPG 372 (590)
T ss_pred cccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcc
Confidence 0
Q ss_pred ------------------ceEEEeecccccccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCC
Q 012825 300 ------------------SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRP 360 (455)
Q Consensus 300 ------------------~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~P 360 (455)
..+||+|||-|+.+ ...++.-+.|..|+|||++.+ .|+..+||||++|++|||+||...
T Consensus 373 ~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~--~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyL 450 (590)
T KOG1290|consen 373 TIASNPLVNPDIPLPECDIRVKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYL 450 (590)
T ss_pred ccccccccCCCCCCCccceeEEEeeccchhhh--hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCcee
Confidence 02677777777665 334455578899999999875 699999999999999999999999
Q ss_pred CCCCC------hhHHHHHHHhcCCCCC-------------------------CCCCC---------CC----CHHHHHHH
Q 012825 361 FWART------ESGIFRAVLKADPSFD-------------------------EAPWP---------SL----SSEARDFV 396 (455)
Q Consensus 361 f~~~~------~~~~~~~i~~~~~~~~-------------------------~~~~~---------~~----s~~l~~li 396 (455)
|.... +++.+..+++.....+ ..+|+ .+ ..++.+||
T Consensus 451 FePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL 530 (590)
T KOG1290|consen 451 FEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFL 530 (590)
T ss_pred ecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHH
Confidence 95322 2223333322111111 01121 12 34688999
Q ss_pred HHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 397 KRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 397 ~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
.-||+.+|++|+||.++|+||||+....
T Consensus 531 ~PmLef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 531 SPMLEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred HHHHhcCccccccHHHHhcCccccCCCC
Confidence 9999999999999999999999997644
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=303.02 Aligned_cols=254 Identities=27% Similarity=0.514 Sum_probs=208.7
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCC-------cCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-------MTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~-------~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
.|++.+.||+|+||.||+|....+ .++.+|+|.+.... ........++.+|+.++.+..+|+||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE
Confidence 478899999999999999997663 36789999875321 123445566788999888754599999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEeecCCCceEEE
Q 012825 229 EDTDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKA 304 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~~~~~~~vkL 304 (455)
.+++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+|+|+||+|+|||+ +.++.+||
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l 155 (269)
T cd08528 79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTI 155 (269)
T ss_pred ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEE
Confidence 999999999999999999887643 45679999999999999999999996 689999999999999 77889999
Q ss_pred eecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 012825 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (455)
Q Consensus 305 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (455)
+|||++.............++..|++||++. +.++.++||||||+++|+|++|+.||...........+........
T Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 233 (269)
T cd08528 156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-- 233 (269)
T ss_pred ecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--
Confidence 9999998765544445667899999999876 4588999999999999999999999977665555554444332211
Q ss_pred CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 384 ~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
....++..+.+||++||+.||++||++.|+..+
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 112578999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=303.44 Aligned_cols=260 Identities=22% Similarity=0.337 Sum_probs=217.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++.+-+..||.|+||+|++-.++. .|+..|||+|.... .....++++.|++...+-.++||||++||.+..++.
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~---sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKP---SGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCc---cCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 4567778899999999999988777 69999999997653 345667899999999988889999999999999999
Q ss_pred eEEEEeecCCCcHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 234 VYVVMELCEGGELLDRIL----SRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~----~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
.||.||.|+- ||..+.. -....++|..+..|....+.||.||.+. +|||||+||+|||+ +..|.+||||||
T Consensus 138 cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFG 213 (361)
T KOG1006|consen 138 CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFG 213 (361)
T ss_pred eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeeccc
Confidence 9999999954 6654432 1356799999999999999999999865 89999999999999 889999999999
Q ss_pred cccccCCCCcccccccCCCcccccccC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCh-hHHHHHHHhcCCCCCCCC
Q 012825 309 LSDFVRPDERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAP 384 (455)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~ 384 (455)
.+..+...-..+.-.|-..|||||.+. ..|+.++||||||++|||+.||..||..-.. .+.+..+..+++......
T Consensus 214 IcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 214 ICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred chHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc
Confidence 987776555556667888999999986 3499999999999999999999999965433 344555555555443222
Q ss_pred --CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 385 --WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 385 --~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.-.++..+..||..||.+|-+.||...++++++|++.-
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 23588999999999999999999999999999999964
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=307.62 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=204.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcc-cCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.++|++.+.||+|+||.||+|.+..... ....||+|++... ........+.+|+.+++++. |+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TGPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-
Confidence 4678999999999999999998765321 1236899988643 23344457889999999997 99999999998754
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++++||+++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARL 158 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEcccccccc
Confidence 4689999999999999987777789999999999999999999999999999999999999 6678899999999987
Q ss_pred cCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 313 VRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 313 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
...... .....++..|+|||++. ..++.++||||||+++|||++ |..||.+........ ++........ .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~--~~~ 235 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGERLPQ--PPI 235 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCCCC--CCC
Confidence 643322 12234567899999876 568999999999999999997 999997765444333 3333322222 235
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++..+.+++.+||..||++||++.++++.
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=304.62 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=204.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecC-cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee--C
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--~ 231 (455)
++|++.+.||+|+||.||+|..... ..++..||||++..... ....+.+.+|+++++.+. |+||+++++++.. +
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence 5688899999999999999986542 23578999999865432 245678999999999997 9999999999887 5
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
...++||||+++++|.+++......+++..+..++.||+.||.|||+.||+|+||||+|||+ +.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence 57999999999999999987766679999999999999999999999999999999999999 677899999999998
Q ss_pred ccCCCCcc----cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhH--------------HHHH
Q 012825 312 FVRPDERL----NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESG--------------IFRA 372 (455)
Q Consensus 312 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~--------------~~~~ 372 (455)
........ ....++..|++||.+. ..++.++||||||+++|||++|..|+....... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532221 1234456799999876 568889999999999999999999985432211 1122
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.+........ ...++.++.+|+.+||+.+|.+||++.++++
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2222222221 2356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=301.63 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=203.7
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC----
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD---- 232 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~---- 232 (455)
|.+.+.||+|+||.||+|.+.....+++.||||++.... ......+++.+|+++++++. |+||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence 677889999999999999987765568999999986543 34455677899999999998 999999999886532
Q ss_pred --ceEEEEeecCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 233 --NVYVVMELCEGGELLDRILSR-----GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 233 --~~~lV~E~~~ggsL~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
..++++||+.+++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence 247899999999998876432 1257899999999999999999999999999999999999 678889999
Q ss_pred ecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCC
Q 012825 306 DFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 380 (455)
Q Consensus 306 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~ 380 (455)
|||+++....... .....++..|++||.+. +.++.++||||||+++|+|++ |..||...........+.......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9999886543221 12234557799999876 568889999999999999999 889997776655555444332211
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..+.++..+.+++.+||+.+|++||++.+++.+
T Consensus 236 ---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 236 ---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 113577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=299.81 Aligned_cols=247 Identities=19% Similarity=0.283 Sum_probs=195.6
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
++||+|+||.||++....+. ....+++|.+... ......+.+.+|+.+++.++ ||||+++++++.+....|+||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDT-GVARVVVKELKAN--ASSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred CcCCCCcCceEEEEEEEcCC-CcceEEEEEecCC--CChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEec
Confidence 46999999999999765432 2456777876543 23445678899999999997 99999999999999999999999
Q ss_pred cCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCC
Q 012825 241 CEGGELLDRILSRG---GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317 (455)
Q Consensus 241 ~~ggsL~~~l~~~~---~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~ 317 (455)
+++++|.+++.+.. ..+++..++.++.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcch
Confidence 99999999886532 346777889999999999999999999999999999999 678889999999986432221
Q ss_pred ---cccccccCCCcccccccCC--------CCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCC--CCC
Q 012825 318 ---RLNDIVGSAYYVAPEVLHR--------SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF--DEA 383 (455)
Q Consensus 318 ---~~~~~~gt~~y~aPE~~~~--------~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~--~~~ 383 (455)
......++..|+|||++.. .++.++||||||+++|||++ |..||......+.+..+++..... ...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence 1234567889999998742 35778999999999999996 577887777766666655443221 112
Q ss_pred CCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 384 ~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
....++..+.+++..|+ .+|++||++.++++
T Consensus 234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 22357889999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.17 Aligned_cols=260 Identities=29% Similarity=0.516 Sum_probs=214.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee---
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--- 230 (455)
.+.|+-..+||+|.||.||+|+.+. +|+.||+|.+-.+.-...-. ....+|+++|..|+ |+|++.++..|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n---~~kkvalkkvlmeneKeGfp-italreikiL~~lk-Henv~nliEic~tk~T 90 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKN---TGKKVALKKVLMENEKEGFP-ITALREIKILQLLK-HENVVNLIEICRTKAT 90 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcC---ccchhHHHHHHHhccccCCc-HHHHHHHHHHHHhc-chhHHHHHHHHhhccC
Confidence 5678889999999999999999777 57889998763321111111 23468999999998 9999999988753
Q ss_pred -----CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 231 -----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 231 -----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
...+|+||++|+. +|...+.....+++..++++++.++..||.|+|...|+|||+|++|+|| +.++.+||+
T Consensus 91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklA 166 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLA 166 (376)
T ss_pred CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEee
Confidence 2348999999976 8888887777899999999999999999999999999999999999999 889999999
Q ss_pred ecccccccCCCC-----cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC
Q 012825 306 DFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (455)
Q Consensus 306 DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (455)
|||+++.+.... ..+..+.|.+|++||.+.| .|+.+.|||..||++.||.++...+.+.++...+..+-..-.
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 999997654322 3445567999999998764 699999999999999999999999999888877766655544
Q ss_pred CCCCCCCCCC-------------------------------CHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 379 SFDEAPWPSL-------------------------------SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 379 ~~~~~~~~~~-------------------------------s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.+....||++ +++..+|+.+||..||.+|+++.++|.|.||...
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 5544445432 3467899999999999999999999999999863
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=299.33 Aligned_cols=242 Identities=26% Similarity=0.442 Sum_probs=199.8
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||++.. .++.||+|.+... .....+.+|+.++++++ |+||+++++++..+ ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----TGQKVAVKNIKCD-----VTAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----CCCceEEEeecCc-----chHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-Cc
Confidence 5799999999999999998752 4678999998542 12356889999999998 99999999998765 47
Q ss_pred EEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 235 YVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++ +.++.+||+|||++...
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVG 150 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceec
Confidence 99999999999999886553 368999999999999999999999999999999999999 67788999999998764
Q ss_pred CCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
... ......+..|+|||++. +.++.++||||||+++|+|++ |+.||......+....+.+.. . ......++..
T Consensus 151 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~ 225 (254)
T cd05083 151 SMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-R--MEPPEGCPAD 225 (254)
T ss_pred ccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-C--CCCCCcCCHH
Confidence 322 22233456799999876 578999999999999999997 999998777666555444332 1 1223467899
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+.+++.+||+.+|++||++.+++..
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=299.79 Aligned_cols=241 Identities=20% Similarity=0.235 Sum_probs=189.8
Q ss_pred ceEeecCCeEEEEEEEecCc-------ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 161 EEVGRGHFGYTCAAKFKKGE-------LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~-------~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
+.||+|+||.||+|...... .....|++|++.... . ....+.+|+.+++++. |+||+++++++.. +.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---R-DSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---h-hHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence 46899999999999987632 012457888774332 1 1567889999999998 9999999999988 77
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC----CCceEEEeeccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----ENSVLKAIDFGL 309 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~----~~~~vkL~DfG~ 309 (455)
.++||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.+. ....+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 8999999999999998876665899999999999999999999999999999999999994222 112799999999
Q ss_pred ccccCCCCcccccccCCCcccccccCC---CCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 310 SDFVRPDERLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
+..... .....++..|+|||++.+ .++.++||||||+++|+|++ |..||............. .......
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~--- 227 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPM--- 227 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCC---
Confidence 887543 223456778999999864 48889999999999999999 578886664333322222 1111111
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.....+.++|.+||..+|.+||++.++++
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 228 -PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=302.21 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=198.8
Q ss_pred ceEeecCCeEEEEEEEecCc---ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEE
Q 012825 161 EEVGRGHFGYTCAAKFKKGE---LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVV 237 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV 237 (455)
+.||+|+||.||+|+..... ..++.||+|.+... ........+.+|+.+++.+. |+||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG--ATDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc--cchhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence 46899999999999876422 23478999988643 22334567889999999998 99999999999999999999
Q ss_pred EeecCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC--CCceEEEeeccc
Q 012825 238 MELCEGGELLDRILSR------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFGL 309 (455)
Q Consensus 238 ~E~~~ggsL~~~l~~~------~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~--~~~~vkL~DfG~ 309 (455)
|||+++++|.+++... ...+++..+..++.||+.||.|||+.+++|+||||+|||++..+ ....++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999988642 23478999999999999999999999999999999999995322 223799999999
Q ss_pred ccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 012825 310 SDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAP 384 (455)
Q Consensus 310 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (455)
+........ .....++..|+|||++. +.++.++||||||+++|+|++ |..||...........+.... .. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~--~~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RL--QK 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-cc--CC
Confidence 876543221 12234567899999876 568999999999999999998 999998776655544443222 11 12
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
...++..+.+||.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2357899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=323.54 Aligned_cols=258 Identities=23% Similarity=0.363 Sum_probs=219.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++..+.++||+|.||.|++|.+.....+...||||++...... ....+|.+|+.+|.+|+ |+|+++|||+..+ ..
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhcc-CcceeEEeeeecc-ch
Confidence 45677889999999999999998875545678999999765432 26678999999999999 9999999999987 67
Q ss_pred eEEEEeecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILS-RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+.+|||++++|+|++.+.+ ....|....+..++.||+.||.||..+++|||||-..|||| -....|||+|||+.+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll---asprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL---ASPRTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee---cccceeeeecccceec
Confidence 8999999999999999987 55678999999999999999999999999999999999999 5677899999999998
Q ss_pred cCCCCccccc----ccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 313 VRPDERLNDI----VGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 313 ~~~~~~~~~~----~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
+..++..-.. .-...|+|||.++ +.|+.++|||+|||+||||++ |+.||.+.....++.++-... .... .+
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e-rLpR--Pk 338 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE-RLPR--PK 338 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc-cCCC--CC
Confidence 8765543322 2345699999887 789999999999999999998 899999999888888776332 2222 24
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.+++++.+++++||..+|.+||++.+|.+.-+++.
T Consensus 339 ~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 339 YCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred CChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 68999999999999999999999999976655554
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=295.68 Aligned_cols=228 Identities=25% Similarity=0.329 Sum_probs=185.2
Q ss_pred cCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecCCCc
Q 012825 166 GHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGE 245 (455)
Q Consensus 166 G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ggs 245 (455)
|.+|.||++++.. +++.||+|.+.... ...+|...+.... ||||+++++++.+.+..++||||++|++
T Consensus 4 g~~~~v~~~~~~~---~~~~~~~K~i~~~~--------~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTR---TQQTFILKGLRKSS--------EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEcc---CCcEEEEEeecchh--------hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCC
Confidence 8999999999776 68999999986532 1234444444555 9999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcccccccC
Q 012825 246 LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325 (455)
Q Consensus 246 L~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~~gt 325 (455)
|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||.+...... .....++
T Consensus 72 L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~ 145 (237)
T cd05576 72 LWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVE 145 (237)
T ss_pred HHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcC
Confidence 99988654 468999999999999999999999999999999999999 77888999999987655422 2334567
Q ss_pred CCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCc
Q 012825 326 AYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDP 404 (455)
Q Consensus 326 ~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP 404 (455)
..|+|||++. +.++.++||||+|+++|+|++|..+|....... ...... .....++..+.+||.+||+.||
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~--~~~~~~~~~~~~li~~~l~~dp 217 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTL--NIPEWVSEEARSLLQQLLQFNP 217 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------cccccc--CCcccCCHHHHHHHHHHccCCH
Confidence 7899999886 468899999999999999999998875432110 000011 1123578999999999999999
Q ss_pred cCCCCH-----HHHHcCccc
Q 012825 405 RKRLTA-----AQALSHPWI 419 (455)
Q Consensus 405 ~~Rps~-----~elL~hp~~ 419 (455)
++|+++ .+++.||||
T Consensus 218 ~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 218 TERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHhcCCCccchHHHHcCCCC
Confidence 999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=326.94 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=224.0
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
....|.+.||.|.||.||+|+++........||||.++.. ..+....+|+.|..||-++. ||||++|.|+.....-+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCcee
Confidence 4567899999999999999999986666788999999755 56667789999999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+||.|||++|+|..+|.++.+.|+..++..+++.|+.|++||-+.|+|||||-..|||| +.+...|++|||+++.+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecc
Confidence 99999999999999999999999999999999999999999999999999999999999 889999999999999886
Q ss_pred CCCc--cccccc--CCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 315 PDER--LNDIVG--SAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 315 ~~~~--~~~~~g--t~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
++.. .+..-| ..+|.|||.+. +.++.++||||+|++|||.++ |..|||.....+.+..+.++-...+ ..++
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp---PmDC 859 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP---PMDC 859 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC---CCCC
Confidence 5541 122222 35799999886 889999999999999999775 9999999999999988877643322 3479
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+..+.+|+..||++|-.+||...||+.+
T Consensus 860 P~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred cHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999999999999999999998754
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=301.47 Aligned_cols=259 Identities=15% Similarity=0.196 Sum_probs=188.0
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHH--------HHHHHHHHHHHHhcCCCCee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI--------EDVRREVKILRALTGHNNLV 222 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~--------~~~~~Ei~~l~~l~~hp~Iv 222 (455)
+...++|++.++||+|+||.||+|....+...+..+|+|+............ .....++..+..+. |++|+
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~ 86 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIP 86 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCC
Confidence 4557899999999999999999999776433356778886533221110000 11122333344455 99999
Q ss_pred EEeEEEeeCC----ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCC
Q 012825 223 KFFDAYEDTD----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298 (455)
Q Consensus 223 ~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~ 298 (455)
++++++.... ..++++|++. .++.+.+ ......++..++.|+.||+.||.|||+.+|+||||||+|||+ +.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~ 161 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIF-KRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DG 161 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhc-cCHHHHH-HhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cC
Confidence 9999776543 3478888874 3666554 334456889999999999999999999999999999999999 67
Q ss_pred CceEEEeecccccccCCCC--------cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHH
Q 012825 299 NSVLKAIDFGLSDFVRPDE--------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGI 369 (455)
Q Consensus 299 ~~~vkL~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~ 369 (455)
++.++|+|||+++...... ......||+.|+|||++. ..++.++|||||||++|||++|..||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 7889999999997654221 112346999999999887 4589999999999999999999999987643222
Q ss_pred HHHHHh----cCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 370 FRAVLK----ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 370 ~~~i~~----~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
...... ..........+.+++.+.++++.|+..+|++||+..++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111110 0111111123457899999999999999999999999875
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=312.62 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=212.0
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCc-ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
+...+.++||+|-||.||.|.+...+ ...-.||||.-+.+ ...+..+.|..|..+++.+. ||||++|+|+|.+. .
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfd-HphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVEQ-P 464 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCC-Ccchhheeeeeecc-c
Confidence 44455778999999999999887652 23456899987654 33444678999999999998 99999999999765 4
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|||||.++.|.|..++..+...++...+..++.||+.+|.|||+.++|||||-..|||+ .....|||+|||+++.+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV---sSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV---SSPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee---cCcceeeecccchhhhc
Confidence 799999999999999999888999999999999999999999999999999999999999 56678999999999998
Q ss_pred CCCCccccccc--CCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 314 RPDERLNDIVG--SAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 314 ~~~~~~~~~~g--t~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
..+.......| ..-|||||-++ +.++.++|||.|||++||++. |..||.+....+.+-.+.+++... ..+.++
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP---~P~nCP 618 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP---CPPNCP 618 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC---CCCCCC
Confidence 87665544333 45699999887 789999999999999999876 999999888877766655554322 234789
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+.+..|+.+||+.||.+||...+|..
T Consensus 619 p~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 619 PALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred hHHHHHHHHHhccCcccCCcHHHHHH
Confidence 99999999999999999999998753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=308.57 Aligned_cols=266 Identities=30% Similarity=0.498 Sum_probs=218.4
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC----HHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT----AIAIEDVRREVKILRALTGHNNLVKFF 225 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~----~~~~~~~~~Ei~~l~~l~~hp~Iv~l~ 225 (455)
...+.++|-++.+||+|||+.||+|.+.. ..++||||+-....... ....+...+|..|.+.|. ||.||++|
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~---EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlY 533 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLT---EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLY 533 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccc---hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeee
Confidence 34567889999999999999999998766 57899999975544332 234566789999999998 99999999
Q ss_pred EEEe-eCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeeccCCceEEeecCCCceE
Q 012825 226 DAYE-DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVL 302 (455)
Q Consensus 226 ~~~~-~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--ivHrDikp~NILl~~~~~~~~v 302 (455)
++|. +.+.+|-|+|||+|.+|.-++ +.+..+++.+++.|+.||+.||.||.+.. |||-||||.|||+.....-|.+
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccccee
Confidence 9997 556799999999998866554 67788999999999999999999999985 9999999999999877788899
Q ss_pred EEeecccccccCCCCc--------ccccccCCCcccccccC-C----CCCCcchHHHHHHHHHHHHcCCCCCCCCCh-hH
Q 012825 303 KAIDFGLSDFVRPDER--------LNDIVGSAYYVAPEVLH-R----SYSTEADVWSIGVIAYILLCGSRPFWARTE-SG 368 (455)
Q Consensus 303 kL~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~----~~~~~sDiwSlG~~l~elltg~~Pf~~~~~-~~ 368 (455)
||+|||+++.+..+.. ++...||.+|++||.+- + ..+.+.||||+||++|..+.|+.||..... .+
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 9999999999865432 34568999999999864 3 378899999999999999999999954332 22
Q ss_pred HHHH--HHhc-CCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 369 IFRA--VLKA-DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 369 ~~~~--i~~~-~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+++. |++. ...|+. -|.++.+.++||++||++.-++|....++-.||||.-.
T Consensus 693 ILqeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 693 ILQENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred HHhhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 2221 2221 223333 35799999999999999999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=315.96 Aligned_cols=267 Identities=26% Similarity=0.474 Sum_probs=224.3
Q ss_pred CCCcCcccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcC-----C
Q 012825 144 NKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG-----H 218 (455)
Q Consensus 144 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~-----h 218 (455)
.+.+.+++.+-++|.+....|+|-|++|..|.+.. .|+.||||+|..+. ...+.=+.|+++|++|.. -
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~---r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk 493 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA---RGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDK 493 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccC---CCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhh
Confidence 45667788889999999999999999999999776 57899999996543 333455689999999983 3
Q ss_pred CCeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec
Q 012825 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (455)
Q Consensus 219 p~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~ 296 (455)
-|+++|+..|...+++|||+|.+ ..+|.+.+.+.+ -.|....+..++.||+.||..|-..||+|.||||+||||+
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN-- 570 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN-- 570 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--
Confidence 48999999999999999999999 458999887654 3588899999999999999999999999999999999996
Q ss_pred CCCceEEEeecccccccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHh
Q 012825 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~ 375 (455)
.....+||||||.|.....+ ..+.+..+..|.|||++.| .|+...|+||+||+||||.||+..|.+.+...+++..+.
T Consensus 571 E~k~iLKLCDfGSA~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred cCcceeeeccCccccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 45678999999999887644 3445556778999998876 799999999999999999999999999999988887776
Q ss_pred cCCCCCCCCCC-------------------------------------------------CCC-------HHHHHHHHHh
Q 012825 376 ADPSFDEAPWP-------------------------------------------------SLS-------SEARDFVKRL 399 (455)
Q Consensus 376 ~~~~~~~~~~~-------------------------------------------------~~s-------~~l~~li~~~ 399 (455)
....++..... .++ .+|.+||.+|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 55554422110 011 3588999999
Q ss_pred ccCCccCCCCHHHHHcCcccCC
Q 012825 400 LNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 400 L~~dP~~Rps~~elL~hp~~~~ 421 (455)
|..||++|.|..|+|.||||+.
T Consensus 730 l~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred hccChhhcCCHHHHhcCCcccC
Confidence 9999999999999999999985
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=320.82 Aligned_cols=248 Identities=29% Similarity=0.489 Sum_probs=200.8
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC--
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD-- 232 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~-- 232 (455)
.-|...+.||+|+||.||+++.++ +|+.||||.+.... .....+.+.+|++++++|+ |+|||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnke---tG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKE---TGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLG 86 (732)
T ss_pred cceeehhhhcCCccceeeeecccc---cccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccC
Confidence 446778899999999999999777 79999999987643 3444577889999999999 999999999876543
Q ss_pred ----ceEEEEeecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC-CCceEEEe
Q 012825 233 ----NVYVVMELCEGGELLDRILSR--GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAI 305 (455)
Q Consensus 233 ----~~~lV~E~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~-~~~~vkL~ 305 (455)
...+|||||.||+|+..+.+. ...+++..+..++.++..||.|||++||+||||||.||++.... ..-..||+
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 578999999999999988643 45799999999999999999999999999999999999986433 45679999
Q ss_pred ecccccccCCCCcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCC----hhHHHHHHHhcCCC
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPS 379 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~----~~~~~~~i~~~~~~ 379 (455)
|||.|+.+..+......+||..|++||... +.|+...|.|||||++|+.+||..||.... ..++...+....+.
T Consensus 167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 167 DFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred cccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 999999999888899999999999999886 578999999999999999999999994322 22333333322211
Q ss_pred CC---------------------CCCCCCCCHHHHHHHHHhccCCccCCC
Q 012825 380 FD---------------------EAPWPSLSSEARDFVKRLLNKDPRKRL 408 (455)
Q Consensus 380 ~~---------------------~~~~~~~s~~l~~li~~~L~~dP~~Rp 408 (455)
-. ....+.+-..+..++..+|.+++++|.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 10 000111223466888899999999999
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=323.27 Aligned_cols=261 Identities=22% Similarity=0.309 Sum_probs=177.8
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecC-cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEE----
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDA---- 227 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~---- 227 (455)
..++|++.+.||+|+||.||+|++..+ ...+..||||.+.... . .+....| . +.... +.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~---~e~~~~e-~-l~~~~-~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--A---VEIWMNE-R-VRRAC-PNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--h---hHHHHHH-H-HHhhc-hhhHHHHHHhhhcc
Confidence 357899999999999999999998762 1127899999875321 1 1111111 1 11111 2222222211
Q ss_pred --EeeCCceEEEEeecCCCcHHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHHcCCEEeec
Q 012825 228 --YEDTDNVYVVMELCEGGELLDRILSRGGK-------------------YTEDDAKAVMIQILNVVAFCHLQGVVHRDL 286 (455)
Q Consensus 228 --~~~~~~~~lV~E~~~ggsL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~gL~~LH~~~ivHrDi 286 (455)
...++..+|||||+.+++|.+++...... ..+..+..++.||+.||.|||+++|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 24566799999999999999887644311 123456789999999999999999999999
Q ss_pred cCCceEEeecCCCceEEEeecccccccCCCC--cccccccCCCcccccccC-C----------------------CCCCc
Q 012825 287 KPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLH-R----------------------SYSTE 341 (455)
Q Consensus 287 kp~NILl~~~~~~~~vkL~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~----------------------~~~~~ 341 (455)
||+|||++ +.++.+||+|||+++...... ......+++.|+|||++. . .++.+
T Consensus 282 KP~NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 282 KPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CHHHEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999994 245789999999998654322 234568899999999652 1 13446
Q ss_pred chHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC-C-------CCCC----------CCCCCHHHHHHHHHhccCC
Q 012825 342 ADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS-F-------DEAP----------WPSLSSEARDFVKRLLNKD 403 (455)
Q Consensus 342 sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~-~-------~~~~----------~~~~s~~l~~li~~~L~~d 403 (455)
+|||||||+||||+++..++... ...+...+..... . .... .........+||++||+.|
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 69999999999999987765322 1122222111100 0 0000 0112334669999999999
Q ss_pred ccCCCCHHHHHcCcccCCCCCC
Q 012825 404 PRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 404 P~~Rps~~elL~hp~~~~~~~~ 425 (455)
|++|||+.++|+||||+.....
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCcc
Confidence 9999999999999999986543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.34 Aligned_cols=268 Identities=22% Similarity=0.363 Sum_probs=217.6
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
.+....++||-|.||.||.|.+++ ....||||.++. +.-..++|+.|..+|+.++ |||+|+|+|+|..+--+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKk---yslTvAVKtLKE----DtMeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeec---cceeeehhhhhh----cchhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCe
Confidence 345567899999999999999998 457899999864 3456688999999999999 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 235 YVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
|||+|||..|+|++++.+-+. .++.-.+..++.||..|++||..+++|||||-..|+|+ .++..|||+|||+++.+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhh
Confidence 999999999999999987554 56777889999999999999999999999999999999 89999999999999998
Q ss_pred CCCCccccccc---CCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 314 RPDERLNDIVG---SAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 314 ~~~~~~~~~~g---t~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
..+. ++...| ..-|.|||-+. ..++.++|||+|||+|||+.| |..||.+.....++..+.+ ..... ....|
T Consensus 416 tgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-gyRM~--~PeGC 491 (1157)
T KOG4278|consen 416 TGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-GYRMD--GPEGC 491 (1157)
T ss_pred cCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-ccccc--CCCCC
Confidence 7443 333333 35699999876 789999999999999999998 8899988776665544433 32222 22479
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHHHHHHHHH
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAY 440 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~~~~~~~~ 440 (455)
++...+|++.||+|.|.+||+.+|+-+ =|.. +...-.+.++++|.++..
T Consensus 492 PpkVYeLMraCW~WsPsDRPsFaeiHq--afEt-mf~~sSisdEV~keLgk~ 540 (1157)
T KOG4278|consen 492 PPKVYELMRACWNWSPSDRPSFAEIHQ--AFET-MFSSSSISDEVQKELGKN 540 (1157)
T ss_pred CHHHHHHHHHHhcCCcccCccHHHHHH--HHHH-HhccccccHHHHHHHhhc
Confidence 999999999999999999999999832 2322 122233445555555443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.75 Aligned_cols=263 Identities=23% Similarity=0.314 Sum_probs=189.7
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEec-------------CcccCeEEEEEEccCCCcCCHH-----------HHHHHHHH
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKK-------------GELKGQQVAVKVIPKHKMTTAI-----------AIEDVRRE 208 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~-------------~~~~g~~vavK~~~~~~~~~~~-----------~~~~~~~E 208 (455)
-.++|++.++||+|+||.||+|.... ....++.||||.+........+ ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 36789999999999999999997522 1124678999998532111000 01223457
Q ss_pred HHHHHHhcCCCC-----eeEEeEEEee--------CCceEEEEeecCCCcHHHHHHhcC---------------------
Q 012825 209 VKILRALTGHNN-----LVKFFDAYED--------TDNVYVVMELCEGGELLDRILSRG--------------------- 254 (455)
Q Consensus 209 i~~l~~l~~hp~-----Iv~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~--------------------- 254 (455)
+.++.+++ |.+ +++++++|.. .+..+|||||+++++|.+++....
T Consensus 223 ~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 77777877 544 4677777753 356899999999999999876422
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCccccc--ccCCCccc
Q 012825 255 --GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI--VGSAYYVA 330 (455)
Q Consensus 255 --~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~--~gt~~y~a 330 (455)
..+++..++.++.||+.+|.|||+.+|+||||||+|||+ +.++.+||+|||++............ .+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 124677889999999999999999999999999999999 67788999999999765433332222 34789999
Q ss_pred ccccCCC---------------------C--CCcchHHHHHHHHHHHHcCCC-CCCCCChhH-----------HHHHHHh
Q 012825 331 PEVLHRS---------------------Y--STEADVWSIGVIAYILLCGSR-PFWARTESG-----------IFRAVLK 375 (455)
Q Consensus 331 PE~~~~~---------------------~--~~~sDiwSlG~~l~elltg~~-Pf~~~~~~~-----------~~~~i~~ 375 (455)
||++... + ..+.||||+||++|+|++|.. ||....... ..+.+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~- 457 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK- 457 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc-
Confidence 9986421 1 124699999999999999875 664321111 111111
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhccCCc---cCCCCHHHHHcCcccCC
Q 012825 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDP---RKRLTAAQALSHPWIKN 421 (455)
Q Consensus 376 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP---~~Rps~~elL~hp~~~~ 421 (455)
........+...++..+||+.+||..+| .+|+|+.|+|+||||..
T Consensus 458 -~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 458 -GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred -ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 1122233455788999999999999866 78999999999999964
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=277.50 Aligned_cols=255 Identities=29% Similarity=0.592 Sum_probs=209.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+++|+|.++.||.|.... +++.++||+++. ...+.+.+|+++|..|.||+||++|++...+..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~---~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINIT---NNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccC---CCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 46889999999999999999998665 578899999853 234678999999999999999999999987654
Q ss_pred --ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 233 --NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 233 --~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
...||+||+.+.+..... ..++..+++.++.+|+.||.|||+.||+|||+||.|++|+ .+...++|+|+|+|
T Consensus 107 SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLA 180 (338)
T ss_pred ccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchH
Confidence 578999999887654433 4578999999999999999999999999999999999996 45678999999999
Q ss_pred cccCCCCcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCC-CChhHHHHHHHh------------
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLK------------ 375 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~-~~~~~~~~~i~~------------ 375 (455)
.+.-++...+..+.+.+|--||.+- ..|+...|+|||||+|..|+..+.||.. ....+.+.++.+
T Consensus 181 EFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 181 EFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred hhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 9998888888888999999999875 5699999999999999999999999843 333333333211
Q ss_pred -----cCCCCC-------CCCCC---------CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 376 -----ADPSFD-------EAPWP---------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 376 -----~~~~~~-------~~~~~---------~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.++.+. ...|. -++++..||+.++|..|-.+|+|+.|++.||||...
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 111111 11111 246899999999999999999999999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=281.40 Aligned_cols=243 Identities=43% Similarity=0.726 Sum_probs=202.8
Q ss_pred CCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecCCCcH
Q 012825 167 HFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL 246 (455)
Q Consensus 167 ~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL 246 (455)
+||.||+|.... +|+.||+|++........ .+.+.+|++.+++++ |+||+++++++......++++||+++++|
T Consensus 1 ~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKK---TGKLVAIKVIKKEKIKKK--RERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECC---CCcEEEEEEecccccccH--HHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence 589999998776 578999999865432221 578899999999996 99999999999999999999999999899
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcccccccCC
Q 012825 247 LDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326 (455)
Q Consensus 247 ~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~ 326 (455)
.+++.... .+++..++.++.+++.+|.|||+.+++|+||+|+||++ +.++.++|+|||.+.............++.
T Consensus 75 ~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTP 150 (244)
T ss_pred HHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCc
Confidence 99875543 38999999999999999999999999999999999999 667899999999998876554556667889
Q ss_pred CcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCcc
Q 012825 327 YYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPR 405 (455)
Q Consensus 327 ~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 405 (455)
.|++||.+. ..++.++|||+||+++++|++|..||............+.............++.++.+++.+||..||+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 230 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPE 230 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCch
Confidence 999999876 5688899999999999999999999987444333333333332222222222789999999999999999
Q ss_pred CCCCHHHHHcCccc
Q 012825 406 KRLTAAQALSHPWI 419 (455)
Q Consensus 406 ~Rps~~elL~hp~~ 419 (455)
+||++.++++||||
T Consensus 231 ~Rp~~~~~~~~~~~ 244 (244)
T smart00220 231 KRLTAEEALQHPFF 244 (244)
T ss_pred hccCHHHHhhCCCC
Confidence 99999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=282.17 Aligned_cols=255 Identities=29% Similarity=0.526 Sum_probs=207.7
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee--
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~-- 230 (455)
...+|.-++.+|.|.- .|+.+-+. ..++.||+|.+... .......++..+|+.++..+. |+||++++.+|.-
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~---v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQ---VLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchh---hccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccc
Confidence 3578888999999997 66666533 36899999988654 344455577889999999998 9999999999863
Q ss_pred ----CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 231 ----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
....|+|||+|.. +|...++ -.++-+.+.+|+.|++.|++|||+.||+||||||+||++ ..+..+||.|
T Consensus 89 ~l~~~~e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~d 161 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILD 161 (369)
T ss_pred cHHHHHhHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeecc
Confidence 3468999999965 8887776 346889999999999999999999999999999999999 7788899999
Q ss_pred cccccccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC------
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------ 379 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~------ 379 (455)
||+|+....+-..+.++.|..|+|||++.+ .|...+||||+||++.||++|...|.+....+.+.++......
T Consensus 162 fg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 162 FGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred chhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 999998877767788899999999998764 5899999999999999999999999877665544443221111
Q ss_pred -------------------------CCCCCCC-------CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccC
Q 012825 380 -------------------------FDEAPWP-------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (455)
Q Consensus 380 -------------------------~~~~~~~-------~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~ 420 (455)
+++..++ --+..+.+++.+||-.||++|.+++++|.||||+
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1111111 1134688999999999999999999999999998
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=310.67 Aligned_cols=250 Identities=32% Similarity=0.501 Sum_probs=197.0
Q ss_pred EEeceEeecCCe-EEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 158 ELGEEVGRGHFG-YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 158 ~~~~~LG~G~fg-~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
.-.+.+|.|+-| .||+|.+ .|+.||||++-. +......+|+..|+.-..|||||++++.-.+.+..||
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y-----e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YI 580 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY-----EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYI 580 (903)
T ss_pred ccHHHcccCCCCcEEEEEee-----CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEE
Confidence 335678999998 6777764 378999998732 2234578999999999999999999999889999999
Q ss_pred EEeecCCCcHHHHHHhcCC--C-CCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec--CCCceEEEeeccccc
Q 012825 237 VMELCEGGELLDRILSRGG--K-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK--DENSVLKAIDFGLSD 311 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~--~-l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~--~~~~~vkL~DfG~a~ 311 (455)
+.|.|. .+|.+++..... . ......+.++.|++.||++||+.+||||||||.||||... +....++|+|||+++
T Consensus 581 alELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 581 ALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred EehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 999995 599999876311 1 1114568899999999999999999999999999999754 344689999999999
Q ss_pred ccCCCC----cccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcC-CCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 312 FVRPDE----RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 312 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
.+..+. ......||.+|+|||++.+ .-+.+.|||||||++|+.++| ..||......+ .+|+..........
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~- 736 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLE- 736 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeec-
Confidence 886554 3456789999999999985 456689999999999988885 99996554432 34555443332211
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+....++.+||.+||++||..||+|.++|.||||=..
T Consensus 737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 1111289999999999999999999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=258.47 Aligned_cols=217 Identities=26% Similarity=0.418 Sum_probs=183.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++..-+..||+|++|.|-+.++.. +|+..|+|.+... -..+..+++.+|+++..+...+|++|.+||.+..++
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~---sg~imAvKri~~t--vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQ---SGTIMAVKRIRAT--VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeecc---CCeEEEEeeehhh--cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 35666778899999999998877766 6999999999754 345666788899999998888999999999999999
Q ss_pred ceEEEEeecCCCcHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 233 NVYVVMELCEGGELLDRI---LSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l---~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
.+||.||.|.. ||..+. ..+++.++|..+-+|+..++.||.|||++ .|||||+||.|||+ +.+|+|||||||
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFG 194 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFG 194 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccc
Confidence 99999999954 766544 35688999999999999999999999998 89999999999999 889999999999
Q ss_pred cccccCCCCcccccccCCCcccccccC-----CCCCCcchHHHHHHHHHHHHcCCCCCCC-CChhHHHHHHHhcCC
Q 012825 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADP 378 (455)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~sDiwSlG~~l~elltg~~Pf~~-~~~~~~~~~i~~~~~ 378 (455)
.+..+.+.-..+...|-..|||||.+. ..|+.++||||||++++||.+++.||.. .+....+.++.+...
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 998876554445467888999999875 2589999999999999999999999965 455566666665543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=303.85 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=209.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCccc----CeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELK----GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
.++..+.+.||+|.||.|++|..+..... ...||||.++... .....+.+..|+++++.+..|+||+.++|+|.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 45556777999999999999987643322 5689999987653 33667889999999999999999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEe
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~ 294 (455)
..+.+++|+||+..|+|++++.... ..++..++..++.||+.|++||++.++|||||-..|||+
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi- 451 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI- 451 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe-
Confidence 9999999999999999999997765 348999999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecccccccCCCCccc--cccc--CCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCC-hh
Q 012825 295 TKDENSVLKAIDFGLSDFVRPDERLN--DIVG--SAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWART-ES 367 (455)
Q Consensus 295 ~~~~~~~vkL~DfG~a~~~~~~~~~~--~~~g--t~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~-~~ 367 (455)
.++..+||+|||+++......... ...+ ...|||||.+. ..|+.++|||||||+||||++ |..||.+.. ..
T Consensus 452 --~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 452 --TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred --cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 788899999999998655444332 2222 34599999887 579999999999999999998 899998754 44
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 368 GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 368 ~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+.+. .++....... ...++.++.++++.|++.+|++||+..++.+
T Consensus 530 ~l~~-~l~~G~r~~~--P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 530 ELLE-FLKEGNRMEQ--PEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHH-HHhcCCCCCC--CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 4444 3333322222 1257999999999999999999999999864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=294.59 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=210.5
Q ss_pred CeEEeceEeecCCeEEEEEEEecC-cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
..+..++||.|+||+||+|.+.-. +.-.-+||+|++... ...+...++.+|.-+|.+|. |+|+++|++++.... +
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-H
Confidence 455678999999999999987753 223567999998644 45556678999999999998 999999999998766 8
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
.||++|+++|.|+|+++.....+-......|+.||++||.|||++++|||||-..|||| .+-.++||.|||+++...
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccC
Confidence 89999999999999999999999999999999999999999999999999999999999 667789999999999887
Q ss_pred CCCcc---cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 315 PDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 315 ~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
.+..- ......+-|||=|.++ ..|+.++|||||||++||++| |..||.+....++-..+...+. .. ..+.++
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-Ls--qPpiCt 926 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LS--QPPICT 926 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CC--CCCCcc
Confidence 65532 2222345699999876 679999999999999999988 9999998887776544444433 22 235789
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.++.-++.+||..|+..||+++++..
T Consensus 927 iDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 927 IDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHHhccCcccCccHHHHHH
Confidence 99999999999999999999998753
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=320.26 Aligned_cols=240 Identities=24% Similarity=0.333 Sum_probs=182.5
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
..|...+.||+|+||.||+|+... ++..||||.+...... ...|++.+++++ |||||+++++|.+.+..
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-------~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIK---NGMQFVVKEINDVNSI-------PSSEIADMGKLQ-HPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECC---CCcEEEEEEccCCccc-------cHHHHHHHhhCC-CCCcceEEEEEEcCCCC
Confidence 457778899999999999998765 5789999998543211 124688899997 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH---LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH---~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
|+||||+++|+|.+++. .+++..+..|+.||+.||+||| +.+|+||||||+||++ +.++..++. ||...
T Consensus 759 ~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPG 830 (968)
T ss_pred EEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-ecccc
Confidence 99999999999999884 3899999999999999999999 6699999999999999 556666664 66544
Q ss_pred ccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh--HHH---HHHHhc-------CC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES--GIF---RAVLKA-------DP 378 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~--~~~---~~i~~~-------~~ 378 (455)
..... ....++..|+|||++. +.++.++|||||||++|||++|+.||...... ... +..... ++
T Consensus 831 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 831 LLCTD---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred ccccC---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 33211 2236789999999887 56999999999999999999999998532211 111 110000 01
Q ss_pred CCCCCC--CCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 379 SFDEAP--WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 379 ~~~~~~--~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
...... ......++.+++.+||+.||++||++.|+++.
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 110000 00112356789999999999999999998754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=279.41 Aligned_cols=276 Identities=25% Similarity=0.411 Sum_probs=210.3
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
..+.+.|.++++||+|.|++||++.+.........||+|.+.... .-..+.+|+++|..+.++.||+.+.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 345678999999999999999999887744457899999985432 224588999999999999999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
++.+++||||++..+-.+++. .++...++.+++.++.||.++|.+|||||||||.|+|.+ ...+...|+|||+|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLA 180 (418)
T ss_pred CCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhH
Confidence 999999999999988777663 367999999999999999999999999999999999997 45667888999998
Q ss_pred cccCCCC----------------------------------c-----------ccccccCCCcccccccC--CCCCCcch
Q 012825 311 DFVRPDE----------------------------------R-----------LNDIVGSAYYVAPEVLH--RSYSTEAD 343 (455)
Q Consensus 311 ~~~~~~~----------------------------------~-----------~~~~~gt~~y~aPE~~~--~~~~~~sD 343 (455)
....... . .-...||++|+|||++. +.-+.+.|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 6210000 0 01236999999999986 45788999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCChh-HH------------HHHHHhcCCC-------------------------------
Q 012825 344 VWSIGVIAYILLCGSRPFWARTES-GI------------FRAVLKADPS------------------------------- 379 (455)
Q Consensus 344 iwSlG~~l~elltg~~Pf~~~~~~-~~------------~~~i~~~~~~------------------------------- 379 (455)
|||.|++++.+++++.||....+. +. +++.......
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999999322211 00 0000000000
Q ss_pred ----CCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHHHHHH
Q 012825 380 ----FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLM 437 (455)
Q Consensus 380 ----~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~~~~~ 437 (455)
..+......+..+.+|+.+||..||.+|.|++++|.||||....+..--.+....+..
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~~~~~~~~~~~~ 402 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTERGLQDLLQEGT 402 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhhhhhHHHhhcCc
Confidence 0011112245578999999999999999999999999999976544444444443333
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=268.75 Aligned_cols=255 Identities=29% Similarity=0.507 Sum_probs=203.6
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-----
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT----- 231 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~----- 231 (455)
.+-.+.||.|+||.||.+.+.. +|+.||+|.+.. ...+-...+.+.+|+++|.-++ |.|++..++...-.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPR---dgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPR---SGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFF 129 (449)
T ss_pred CCCCCcccccceeEEEeccCCC---CccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHH
Confidence 3446789999999999998665 699999998743 3344555678999999999998 99999998876533
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+++|.++|.|. .+|...+. ....++...++-++.||++||+|||+.+|+||||||.|.|+ +.+-.+||||||+++
T Consensus 130 qEiYV~TELmQ-SDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 130 QELYVLTELMQ-SDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHHH-hhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEeccccccc
Confidence 35788999984 36666553 44678999999999999999999999999999999999999 788899999999999
Q ss_pred ccCCCCc--ccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHh------------
Q 012825 312 FVRPDER--LNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK------------ 375 (455)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~------------ 375 (455)
....++. .+..+-|.+|+|||++.| .|+...||||+||++.|++..+..|......+.++.+..
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 8765543 455678999999999875 599999999999999999999999987776655444422
Q ss_pred -----------cCCCCCCCC-------CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 376 -----------ADPSFDEAP-------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 376 -----------~~~~~~~~~-------~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.....+... ...-..+..+++..+|..||++|.+..+.+.|+++.+
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 111111100 0122346789999999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=271.51 Aligned_cols=242 Identities=24% Similarity=0.368 Sum_probs=186.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc-CCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-GHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-~hp~Iv~l~~~~~~~~ 232 (455)
....++.++||+|.||.||+|.+. ++.||||++. .+..+.+.+|-+|..... .|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-----~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-----NRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-----CceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 345678899999999999999855 5899999984 334466778887776432 4999999999876554
Q ss_pred ----ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCEEeeccCCceEEeecCCC
Q 012825 233 ----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ---------GVVHRDLKPENFLFTTKDEN 299 (455)
Q Consensus 233 ----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~---------~ivHrDikp~NILl~~~~~~ 299 (455)
.++||+||.+.|+|.+++.. ..++|....+|+..|++||+|||+. .|+|||||..|||| ..+
T Consensus 278 ~~~~eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~D 352 (534)
T KOG3653|consen 278 ADRMEYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KND 352 (534)
T ss_pred ccccceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccC
Confidence 79999999999999999854 4589999999999999999999974 49999999999999 788
Q ss_pred ceEEEeecccccccCCCCc---ccccccCCCcccccccCCCCCC-------cchHHHHHHHHHHHHcCCCC---------
Q 012825 300 SVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLHRSYST-------EADVWSIGVIAYILLCGSRP--------- 360 (455)
Q Consensus 300 ~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~-------~sDiwSlG~~l~elltg~~P--------- 360 (455)
+...|+|||+|..+..+.. ....+||.+|||||++.+..+. +.||||+|.+||||++....
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 9999999999988765542 3347899999999999875333 47999999999999985432
Q ss_pred ---CC-----CCChhHHHHHHHh--cCCCCCCCCCC-CCCHHHHHHHHHhccCCccCCCCHH
Q 012825 361 ---FW-----ARTESGIFRAVLK--ADPSFDEAPWP-SLSSEARDFVKRLLNKDPRKRLTAA 411 (455)
Q Consensus 361 ---f~-----~~~~~~~~~~i~~--~~~~~~~~~~~-~~s~~l~~li~~~L~~dP~~Rps~~ 411 (455)
|+ ..+-+++...+.+ ..+.++..+.. ..-..+.+.+..|++.|++.|.|+.
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 32 1111222222222 22333322211 1235688999999999999999986
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=288.76 Aligned_cols=260 Identities=29% Similarity=0.491 Sum_probs=214.9
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.-.++|++++.+|.|.||.||+++++. ++...|+|+++... .....-+.+|+-+++..+ |+|||.+++.|...
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~---s~elaavkvVkLep---~dd~~~iqqei~~~~dc~-h~nivay~gsylr~ 84 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKR---SGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRR 84 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccc---cCchhhheeeeccC---CccccccccceeeeecCC-CcChHHHHhhhhhh
Confidence 346889999999999999999999877 68999999996543 333456778999999988 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+.+||+||||.||+|.+.. .-.+.+++.++..+++..++||+|||..|-+|||||-.|||+ .+.+.+|+.|||.+.
T Consensus 85 dklwicMEycgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsa 160 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSA 160 (829)
T ss_pred cCcEEEEEecCCCccccee-eecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchh
Confidence 9999999999999998844 566789999999999999999999999999999999999999 678889999999876
Q ss_pred ccCCC-CcccccccCCCccccccc----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC-CCCC
Q 012825 312 FVRPD-ERLNDIVGSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-EAPW 385 (455)
Q Consensus 312 ~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~ 385 (455)
.+... .....++||++|||||+- .+.|...+|||++|++..|+---+.|.........+...-+.....+ ....
T Consensus 161 qitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk 240 (829)
T KOG0576|consen 161 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK 240 (829)
T ss_pred hhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence 54322 234567999999999984 36799999999999999999887777655444333322222221111 1112
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
..+++.|.+|++.+|.++|++||+++.+|.|||....
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 3578999999999999999999999999999999876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=264.94 Aligned_cols=247 Identities=26% Similarity=0.445 Sum_probs=190.4
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHH--hcCCCCeeEEeEE
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA--LTGHNNLVKFFDA 227 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~~hp~Iv~l~~~ 227 (455)
.+.++.+..+.+.||+|-||.||+|++. |..||||++... ..+.+.+|.++... |+ |+||+.+++.
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-----Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLR-HENILgFIaa 273 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-----GEDVAVKIFSSR------DERSWFRETEIYQTVMLR-HENILGFIAA 273 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-----CCceEEEEeccc------chhhhhhHHHHHHHHHhc-cchhhhhhhc
Confidence 3567889999999999999999999855 678999998532 12456777777654 55 9999999987
Q ss_pred EeeCC----ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCEEeeccCCceEEee
Q 012825 228 YEDTD----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ--------GVVHRDLKPENFLFTT 295 (455)
Q Consensus 228 ~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~--------~ivHrDikp~NILl~~ 295 (455)
-..++ ++|||.+|.+.|||.|++.. ..++.+...+++..++.||++||.. .|.|||||..||||
T Consensus 274 D~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV-- 349 (513)
T KOG2052|consen 274 DNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV-- 349 (513)
T ss_pred cccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE--
Confidence 54332 58999999999999999965 5689999999999999999999964 39999999999999
Q ss_pred cCCCceEEEeecccccccCCCC-----cccccccCCCcccccccCCCCC------C-cchHHHHHHHHHHHHcC------
Q 012825 296 KDENSVLKAIDFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLHRSYS------T-EADVWSIGVIAYILLCG------ 357 (455)
Q Consensus 296 ~~~~~~vkL~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~------~-~sDiwSlG~~l~elltg------ 357 (455)
..++...|+|+|+|.....+. ..+..+||.+|||||++..... . .+||||||+++||++..
T Consensus 350 -Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi 428 (513)
T KOG2052|consen 350 -KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGI 428 (513)
T ss_pred -ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence 889999999999997765442 3466799999999999975432 2 48999999999999753
Q ss_pred ----CCCCCCCC----hhHHHHHHHhcC---CCCCCCCCCCC--CHHHHHHHHHhccCCccCCCCHHHHH
Q 012825 358 ----SRPFWART----ESGIFRAVLKAD---PSFDEAPWPSL--SSEARDFVKRLLNKDPRKRLTAAQAL 414 (455)
Q Consensus 358 ----~~Pf~~~~----~~~~~~~i~~~~---~~~~~~~~~~~--s~~l~~li~~~L~~dP~~Rps~~elL 414 (455)
+.||.+.. ..+.++.+...+ +..+. .|... =..+..+++.|+..||..|.|+-.+-
T Consensus 429 ~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipn-rW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 429 VEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPN-RWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred ehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCc-ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 56775432 223344443222 22222 22221 13567899999999999999987653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=275.09 Aligned_cols=201 Identities=31% Similarity=0.582 Sum_probs=174.9
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHH-----HHHHHHHHHHHhc--CCCCeeEEeEE
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIE-----DVRREVKILRALT--GHNNLVKFFDA 227 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~-----~~~~Ei~~l~~l~--~hp~Iv~l~~~ 227 (455)
.+|..++.||+|+||.|++|.+++ +...|+||.|.++...-+...+ .+-.|++||..|+ .|+||++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~---n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKE---NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred ccceeeeeccccccceEEEeeecc---cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 459999999999999999999988 4789999999876554333222 2567999999987 48999999999
Q ss_pred EeeCCceEEEEeec-CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 228 YEDTDNVYVVMELC-EGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 228 ~~~~~~~~lV~E~~-~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
|++++.+||+||.. +|.+|.+++ +....++|.+++.|++|++.|+++||+.||||||||-+||.+ +.+|.+||+|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~I-E~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klid 713 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFI-EFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLID 713 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhh-hccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEee
Confidence 99999999999976 456888887 566789999999999999999999999999999999999999 8999999999
Q ss_pred cccccccCCCCcccccccCCCcccccccCCC--CCCcchHHHHHHHHHHHHcCCCCCCC
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWA 363 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~sDiwSlG~~l~elltg~~Pf~~ 363 (455)
||.+.... ...+..++||..|.|||++.|. ....-|||+||++||-++....||.+
T Consensus 714 fgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99997765 5567788999999999999864 46679999999999999998888854
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=237.86 Aligned_cols=211 Identities=44% Similarity=0.808 Sum_probs=183.5
Q ss_pred EeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecC
Q 012825 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (455)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 242 (455)
||+|.+|.||++.... +++.+++|++....... ..+.+.+|+..++.+. |++|+++++++......+++||++.
T Consensus 1 l~~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecC---CCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCC
Confidence 6899999999998765 57899999986543221 4567899999999998 8999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCC-CceEEEeecccccccCCCC-ccc
Q 012825 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDFGLSDFVRPDE-RLN 320 (455)
Q Consensus 243 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~-~~~vkL~DfG~a~~~~~~~-~~~ 320 (455)
+++|.+++......+++..++.++.+++.+|.+||+.|++|+||+|.||++ +. ++.++|+|||.+....... ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~---~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE---eCCCCcEEEecCCceEEccCCcchhh
Confidence 899999886554578999999999999999999999999999999999999 55 6789999999997765332 133
Q ss_pred ccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012825 321 DIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (455)
Q Consensus 321 ~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~ 398 (455)
...+...|++||.+.. .++.+.|+|++|+++++| ..+.+++..
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~ 196 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRK 196 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHH
Confidence 4567888999999875 688899999999999998 678999999
Q ss_pred hccCCccCCCCHHHHHcCc
Q 012825 399 LLNKDPRKRLTAAQALSHP 417 (455)
Q Consensus 399 ~L~~dP~~Rps~~elL~hp 417 (455)
||+.||++||++.++++|+
T Consensus 197 ~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 197 MLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HhhCCcccCcCHHHHhhCC
Confidence 9999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=248.39 Aligned_cols=257 Identities=24% Similarity=0.411 Sum_probs=202.5
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEE-EeeC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDA-YEDT 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~-~~~~ 231 (455)
+.+.|.|.+.||+|.||.+.+++++. +.+.+++|.+.+. ...+++|.+|...--.|..|.||+..|++ |+..
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~---s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQ---SKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccC---CceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 56889999999999999999999887 6789999998654 33457888999888888889999987764 6777
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..++++||++.|+|..-+.. ..+.|...++++.|+++||.|+|++++||||||.+||||-..| ...|||||||+.+
T Consensus 95 d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTR 171 (378)
T ss_pred ceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeeccccc
Confidence 888999999999999886633 4588999999999999999999999999999999999997544 3489999999987
Q ss_pred ccCCCCcccccccCCCcccccccC----CC--CCCcchHHHHHHHHHHHHcCCCCCCCCCh----hHHHHHHHhcCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLH----RS--YSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFD 381 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~----~~--~~~~sDiwSlG~~l~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~ 381 (455)
..+ ........+..|.+||+.. +. ..+.+|||.||+++|.++||..||+.... ...+.+.++......
T Consensus 172 k~g--~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 172 KVG--TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred ccC--ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 653 2233334566799999753 22 56789999999999999999999963221 112222333322222
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccCC---CCHHHHHcCcccCC
Q 012825 382 EAPWPSLSSEARDFVKRLLNKDPRKR---LTAAQALSHPWIKN 421 (455)
Q Consensus 382 ~~~~~~~s~~l~~li~~~L~~dP~~R---ps~~elL~hp~~~~ 421 (455)
......+++.+..++++-|..++++| .++.......|...
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 22334578999999999999999999 77777777777653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=234.56 Aligned_cols=211 Identities=42% Similarity=0.754 Sum_probs=177.2
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
|.+.+.||.|++|.||++...+ +++.+|+|.+...... ...+.+.+|++.++++. |+|++++++++...+..++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---TGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---CCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEE
Confidence 5678999999999999998775 4789999998654322 35678899999999997 9999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCC
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~ 316 (455)
++|++++++|.+++......+++..+..++.+++.+|.+||+.+++|+||++.||++ +.++.++|+|||.+......
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCc
Confidence 999999999999886544338999999999999999999999999999999999999 66789999999998877544
Q ss_pred C--cccccccCCCccccccc-C-CCCCCcchHHHHHHHHHHHHcCCCCCCC-CChh-HHHHHHHhc
Q 012825 317 E--RLNDIVGSAYYVAPEVL-H-RSYSTEADVWSIGVIAYILLCGSRPFWA-RTES-GIFRAVLKA 376 (455)
Q Consensus 317 ~--~~~~~~gt~~y~aPE~~-~-~~~~~~sDiwSlG~~l~elltg~~Pf~~-~~~~-~~~~~i~~~ 376 (455)
. ......++..|++||.+ . ..++.++|||+||+++++|++|+.||.. .... .+.+.+...
T Consensus 152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 3 33456788899999987 3 4577799999999999999999999977 3333 444444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=289.16 Aligned_cols=198 Identities=18% Similarity=0.266 Sum_probs=148.0
Q ss_pred CCeeEEeEEE-------eeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCce
Q 012825 219 NNLVKFFDAY-------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291 (455)
Q Consensus 219 p~Iv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NI 291 (455)
.||++++++| .+.+.++++|||+ +++|.+++......+++..++.++.||++||.|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777788877 2334678889988 5699999876666799999999999999999999999999999999999
Q ss_pred EEee----------------cCCCceEEEeecccccccCCCC-----------------cccccccCCCcccccccC-CC
Q 012825 292 LFTT----------------KDENSVLKAIDFGLSDFVRPDE-----------------RLNDIVGSAYYVAPEVLH-RS 337 (455)
Q Consensus 292 Ll~~----------------~~~~~~vkL~DfG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~-~~ 337 (455)
||.. .+.++.+||+|||+++...... .....+||+.|||||++. ..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 9942 1234567788888776432100 011246889999999876 56
Q ss_pred CCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCc
Q 012825 338 YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (455)
Q Consensus 338 ~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp 417 (455)
++.++|||||||+||||++|..|+..... .+..+.... ...... .......+++.+||++||.+||++.|+|+||
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV--LPPQIL-LNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh--cChhhh-hcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 99999999999999999999888753221 122221111 111111 1235567999999999999999999999999
Q ss_pred ccCCC
Q 012825 418 WIKNS 422 (455)
Q Consensus 418 ~~~~~ 422 (455)
||+..
T Consensus 267 ~~~~~ 271 (793)
T PLN00181 267 FINEP 271 (793)
T ss_pred hhhhh
Confidence 99864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=241.71 Aligned_cols=255 Identities=19% Similarity=0.265 Sum_probs=207.8
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcc--cCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGEL--KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
....|+++.-++-+|.||.||.|.+.+.+. +.+.|.+|.++.+ .+..+...+..|-.++..+. |||+..+.+++.
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~s-H~nll~V~~V~i 357 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSI 357 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCc-CCCccceeEEEe
Confidence 446789999999999999999998776432 3467888887654 56677788999999999998 999999999886
Q ss_pred eC-CceEEEEeecCCCcHHHHHH-----hc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCce
Q 012825 230 DT-DNVYVVMELCEGGELLDRIL-----SR--GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (455)
Q Consensus 230 ~~-~~~~lV~E~~~ggsL~~~l~-----~~--~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~ 301 (455)
++ +..+.++.++.-|+|..++. +. ...++..++..++.|++.|++|||++||||.||-..|++| |+...
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhhee
Confidence 54 56788899998899988886 22 2357788899999999999999999999999999999999 88899
Q ss_pred EEEeecccccccCCCCcc---cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhc
Q 012825 302 LKAIDFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKA 376 (455)
Q Consensus 302 vkL~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~ 376 (455)
|||+|=.+++.+.+.+.. ........||++|.+. ..|+..+|+|||||+||||+| |+.||......++..-+..+
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 999999999876554322 1223356799999876 679999999999999999988 89999877776655444433
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 377 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
...... -.+++++..++..||..+|++||+..|+..
T Consensus 515 -yRlaQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 -YRLAQP--FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -ceecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 332222 379999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=216.81 Aligned_cols=163 Identities=29% Similarity=0.404 Sum_probs=129.8
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcccccc
Q 012825 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323 (455)
Q Consensus 244 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~~ 323 (455)
|+|.+++..++..+++..++.|+.||+.||.|||+.+ ||+|||+ +.++.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence 6899988776778999999999999999999999998 9999999 77888998 99987764322 26
Q ss_pred cCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh-HHHHHHHhcCCCCCC---CCCCCCCH--HHHHHH
Q 012825 324 GSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDE---APWPSLSS--EARDFV 396 (455)
Q Consensus 324 gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~---~~~~~~s~--~l~~li 396 (455)
||..|+|||++. +.++.++|||||||++|||++|+.||...... ..+..+......... .....++. ++.++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999986 56899999999999999999999999765432 233333332221110 01112333 699999
Q ss_pred HHhccCCccCCCCHHHHHcCcccCC
Q 012825 397 KRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 397 ~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.+||+.||.+||++.++++|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-26 Score=226.14 Aligned_cols=255 Identities=24% Similarity=0.292 Sum_probs=196.9
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc---CCCCeeEEeEEE-eeC
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT---GHNNLVKFFDAY-EDT 231 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~---~hp~Iv~l~~~~-~~~ 231 (455)
+|.+.++||+|+||.||+|...... ...+|+|+......... ..+..|+.++..+. +-.++..+++.+ ..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 8999999999999999999977643 46899998754321111 15678899998887 346999999999 577
Q ss_pred CceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC--CCceEEEeecc
Q 012825 232 DNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFG 308 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~--~~~~vkL~DfG 308 (455)
+..||||+.+ |.+|.++..... +.++..++..|+.|++.+|++||+.|++||||||+|+++.... ....+.|.|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 8899999999 889999775554 7899999999999999999999999999999999999996443 12679999999
Q ss_pred ccc--ccCCCC--------c-ccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhc
Q 012825 309 LSD--FVRPDE--------R-LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (455)
Q Consensus 309 ~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~ 376 (455)
+++ ...... . .....||..|.++.+..+ ..+.+.|+||++.++.+++.|..||...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 321111 1 123559999999998774 6899999999999999999999999766543333332222
Q ss_pred CCCCCCC-CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 377 DPSFDEA-PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 377 ~~~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
....... .....+.++.++...+-..+...+|....+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 2111111 223456788888888888999999998877654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-25 Score=217.13 Aligned_cols=257 Identities=36% Similarity=0.625 Sum_probs=206.7
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
|.+.+.||.|+||.||++... ..+++|.+.............+.+|+.++..+..|++|+++++++......++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEE
Confidence 788999999999999999866 57899998766544444577899999999999933489999999977777899
Q ss_pred EEeecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCc-eEEEeeccccccc
Q 012825 237 VMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSDFV 313 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~-~vkL~DfG~a~~~ 313 (455)
+++++.++++.+.+.... ..+.......++.|++.++.|+|+.+++||||||+||++ +... .++++|||.+...
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCcceec
Confidence 999999999986554433 279999999999999999999999999999999999999 5555 7999999999765
Q ss_pred CCCC-------cccccccCCCcccccccCC----CCCCcchHHHHHHHHHHHHcCCCCCCCCCh----hHHHHHHHhcCC
Q 012825 314 RPDE-------RLNDIVGSAYYVAPEVLHR----SYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADP 378 (455)
Q Consensus 314 ~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~Pf~~~~~----~~~~~~i~~~~~ 378 (455)
.... ......|+..|++||++.+ .+....|+|++|++++++++|..||..... ......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 4333 2466789999999998864 578889999999999999999999876663 333333333332
Q ss_pred C-CCCCCCCCC----CHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 379 S-FDEAPWPSL----SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 379 ~-~~~~~~~~~----s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
. ......... ...+.+++..++..+|..|.+..+...++|....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 2 222211122 2578999999999999999999999988777654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-28 Score=254.30 Aligned_cols=261 Identities=31% Similarity=0.464 Sum_probs=196.2
Q ss_pred CCe-EEeceEeecCCeEEEEEEEecCcccCeEEEEEEccC---CCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 155 NKY-ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK---HKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 155 ~~y-~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~---~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
+.| ...+.+|.|++|.|+.+..... ...++.|.+.. ...........+..|+.+-..|. |+|++..+..+.+
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~---~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~ 392 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSD---LKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQE 392 (601)
T ss_pred cccCCccceeeecccCceEEEEecCC---CccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhh
Confidence 445 4577899999997776665442 33344443321 11122223333677888888888 9999888887777
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
.....-+||||++ +|..++. ..+.+...++..++.||+.||.|||+.||.|||||++|+++ ..++.+||+|||.+
T Consensus 393 ~~~~~~~mE~~~~-Dlf~~~~-~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 393 IDGILQSMEYCPY-DLFSLVM-SNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAA 467 (601)
T ss_pred cccchhhhhcccH-HHHHHHh-cccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcc
Confidence 7666666999998 9988774 44679999999999999999999999999999999999999 78889999999998
Q ss_pred cccCCCC-----cccccccCCCcccccccCC-CCCCc-chHHHHHHHHHHHHcCCCCCCCCChhHHH--HHHHhcCCCC-
Q 012825 311 DFVRPDE-----RLNDIVGSAYYVAPEVLHR-SYSTE-ADVWSIGVIAYILLCGSRPFWARTESGIF--RAVLKADPSF- 380 (455)
Q Consensus 311 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~-sDiwSlG~~l~elltg~~Pf~~~~~~~~~--~~i~~~~~~~- 380 (455)
....... .....+|+..|+|||++.+ .|+.. .||||.|+++++|.+|+.||......+.. ..........
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF 547 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence 7764332 2356789999999999874 57664 89999999999999999999654443321 1111111111
Q ss_pred --CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 381 --DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 381 --~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
....+..++...+.+|.+||++||.+|.|+.+|++.+||+...-
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 11223457788999999999999999999999999999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-28 Score=244.74 Aligned_cols=246 Identities=27% Similarity=0.458 Sum_probs=211.6
Q ss_pred EeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecC
Q 012825 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (455)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 242 (455)
+|.|+||.|++++...+...|..+|+|+..+......... ....|-.++...+.|+.+|++.-.++.+...++++++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 7999999999998777777789999999876543333222 556788888888889999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCccccc
Q 012825 243 GGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322 (455)
Q Consensus 243 ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~ 322 (455)
||.|...+. ....+.+.....+...++-+++++|+.+|+|||+|++||++ +.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~-~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLS-KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccc-cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc---
Confidence 999887663 44568888999999999999999999999999999999999 89999999999999876543333
Q ss_pred ccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccC
Q 012825 323 VGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK 402 (455)
Q Consensus 323 ~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 402 (455)
|||..|||||+++ ......|.||||++++||++|..||.. +....|++.....+. .++..+++++..++..
T Consensus 154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKR 224 (612)
T ss_pred ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhh
Confidence 9999999999998 778889999999999999999999977 777888887766655 5778899999999999
Q ss_pred CccCCCC-----HHHHHcCcccCCCCCC
Q 012825 403 DPRKRLT-----AAQALSHPWIKNSNDV 425 (455)
Q Consensus 403 dP~~Rps-----~~elL~hp~~~~~~~~ 425 (455)
+|..|.- +.++++|+||+.+.+.
T Consensus 225 ~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred CHHHHhccCcchhHHHhccchheeeeHh
Confidence 9999974 4799999999987543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=204.04 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=202.0
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
...+|.++++||.|+||.+|+|.... .|..||||+-+... . ..++..|..+.+.|++...|..+..+..+.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~---~ge~VAiK~Es~~a-~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISIT---SGEEVAIKLESSKA-K----HPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred eccceEEEEeecCCchhheeeeeecc---CCceEEEEeecccC-C----CcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 36889999999999999999998776 69999999864432 2 2357789999999998889999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.-.+|||.+ |.+|.+.+.--...++..++.-++-|++.-++|+|.+++|||||||+|+|+.-......+.|+|||+|+.
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 999999999 8899998876677899999999999999999999999999999999999997666677899999999988
Q ss_pred cCCCCc--------ccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhH---HHHHHHhcCCC-
Q 012825 313 VRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPS- 379 (455)
Q Consensus 313 ~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~---~~~~i~~~~~~- 379 (455)
..+... ...+.||..|.+=....+ .-+...|+-|+|.+|..+.-|..||++..... ....|.+....
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 754322 234678999988666554 45778999999999999999999998765443 34444443332
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCccCCCCHH
Q 012825 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA 411 (455)
Q Consensus 380 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ 411 (455)
..+..+..++.+|.-.+..|-...=++-|...
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 23334567888888888888777666777654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=224.63 Aligned_cols=166 Identities=21% Similarity=0.253 Sum_probs=129.9
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc--CCHHHHHHHHHHHHHHHHhcCCCCeeE-EeEEE
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVK-FFDAY 228 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~~hp~Iv~-l~~~~ 228 (455)
.+.++|.+.+.||+|+||.||+|++... +++.||||++..... ......+.+.+|++++++|. |+|++. +++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~-- 89 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD--PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLA-- 89 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC--CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEE--
Confidence 4578899999999999999999987652 367789998753211 13344567999999999998 889884 544
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeec-cCCceEEeecCCCceEEEeec
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDL-KPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDi-kp~NILl~~~~~~~~vkL~Df 307 (455)
.+..||||||++|++|.. + ... . ...++.|++++|.|||+.||+|||| ||+|||+ +.++.+||+||
T Consensus 90 --~~~~~LVmE~~~G~~L~~-~-~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDF 156 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHL-A-RPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDF 156 (365)
T ss_pred --cCCcEEEEEccCCCCHHH-h-Ccc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEEC
Confidence 246899999999998863 2 111 1 1467899999999999999999999 9999999 66778999999
Q ss_pred ccccccCCCCc---------ccccccCCCcccccccC
Q 012825 308 GLSDFVRPDER---------LNDIVGSAYYVAPEVLH 335 (455)
Q Consensus 308 G~a~~~~~~~~---------~~~~~gt~~y~aPE~~~ 335 (455)
|+++....... .....++..|+|||++.
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99987654321 13456888899999985
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=201.82 Aligned_cols=204 Identities=23% Similarity=0.423 Sum_probs=172.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.+-.|+++++||+|.||..+.|...- +++.||||.-.... ..-++..|....+.|.+.++|...|-+..++-
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~---nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLY---NNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred ecccceeccccccCcceeeecccccc---cCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 45679999999999999999887444 79999999864321 12457789999999999999999998888888
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec--CCCceEEEeecccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK--DENSVLKAIDFGLS 310 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~--~~~~~vkL~DfG~a 310 (455)
+-.||||.+ |.||+|++.--+..|+..++..++.|++.-++|+|++.+|+|||||+|+||... .....+.|+|||+|
T Consensus 98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 999999999 889999886667889999999999999999999999999999999999999642 23457999999999
Q ss_pred cccCCCCc--------ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 012825 311 DFVRPDER--------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART 365 (455)
Q Consensus 311 ~~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~ 365 (455)
+...+... .....||..||+=.... ..-+...|+-+||-++.++|-|.+||.+..
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 98764432 24567999999876544 457888999999999999999999997643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-24 Score=195.88 Aligned_cols=176 Identities=17% Similarity=0.166 Sum_probs=134.9
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHH------HHHHHHHHHHhcCCCCeeEE
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED------VRREVKILRALTGHNNLVKF 224 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~------~~~Ei~~l~~l~~hp~Iv~l 224 (455)
+.+.++|++.+.||.|+||.||++.. . +..+|||++............. +.+|+..+.++. |++|..+
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~----~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~ 100 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-D----YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASL 100 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-C----CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcc
Confidence 45678999999999999999998643 2 5679999997654444444344 579999999998 9999999
Q ss_pred eEEEeeC--------CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec
Q 012825 225 FDAYEDT--------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (455)
Q Consensus 225 ~~~~~~~--------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~ 296 (455)
.+++... +..+|||||++|.+|.+.. .+++ ....+++.+|..||+.|++||||||.||++
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili--- 168 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIV--- 168 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEE---
Confidence 9987643 3589999999999987752 1333 346699999999999999999999999999
Q ss_pred CCCceEEEeecccccccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHH
Q 012825 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILL 355 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~ell 355 (455)
+.++ ++|+|||............. =++...|+.++|+|+||+++..+.
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred eCCC-EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 4556 99999998865532222111 012345778999999999987543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=183.98 Aligned_cols=189 Identities=20% Similarity=0.209 Sum_probs=142.3
Q ss_pred EEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCH-HHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-IAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~-~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
.+...|++|+||+||++.. .+..++.+.+........ .....+.+|+++|++|.+|+++++++++ +..++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~l 75 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHL 75 (218)
T ss_pred ccceeecCCCcceEEEeec-----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEE
Confidence 4577899999999997653 267788777654332111 1223578999999999878999999986 45799
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeec-cCCceEEeecCCCceEEEeecccccccCC
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDL-KPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDi-kp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
+|||+.|.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||+ +.++.++|+|||++.....
T Consensus 76 vmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred EEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCC
Confidence 9999999887653311 1 2357889999999999999999999 7999999 6677899999999986554
Q ss_pred CCcc--------------cccccCCCcccccccC--CCCC-CcchHHHHHHHHHHHHcCCCCCCCCCh
Q 012825 316 DERL--------------NDIVGSAYYVAPEVLH--RSYS-TEADVWSIGVIAYILLCGSRPFWARTE 366 (455)
Q Consensus 316 ~~~~--------------~~~~gt~~y~aPE~~~--~~~~-~~sDiwSlG~~l~elltg~~Pf~~~~~ 366 (455)
.... .....++.|++|+... ...+ ...+.++.|+-+|.++|++.+++...+
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 3321 0123577788887533 3344 567899999999999999999877654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=195.95 Aligned_cols=235 Identities=24% Similarity=0.370 Sum_probs=153.1
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcC---------CCCeeEEeE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG---------HNNLVKFFD 226 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~---------hp~Iv~l~~ 226 (455)
.+...+.||.|+++.||.+++.. +|+.+|||++...........+.+++|.-....+.+ |-.++.-++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~---t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d 89 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVE---TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD 89 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred EEEEccccccCCceEEEEEEEcc---CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence 56778899999999999999777 799999999865543444566777777765554432 223333333
Q ss_pred EEe---------eC---C-----ceEEEEeecCCCcHHHHHH---hcCCC---CCHHHHHHHHHHHHHHHHHHHHcCCEE
Q 012825 227 AYE---------DT---D-----NVYVVMELCEGGELLDRIL---SRGGK---YTEDDAKAVMIQILNVVAFCHLQGVVH 283 (455)
Q Consensus 227 ~~~---------~~---~-----~~~lV~E~~~ggsL~~~l~---~~~~~---l~~~~~~~i~~qi~~gL~~LH~~~ivH 283 (455)
... .. . +.+++|+-+. ++|.+.+. ..... +.......+..|+++.+++||..||||
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVH 168 (288)
T PF14531_consen 90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVH 168 (288)
T ss_dssp EEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEe
Confidence 221 11 1 2467888884 58877653 22222 222334455689999999999999999
Q ss_pred eeccCCceEEeecCCCceEEEeecccccccCCCCcccccccCCCcccccccCC---------CCCCcchHHHHHHHHHHH
Q 012825 284 RDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR---------SYSTEADVWSIGVIAYIL 354 (455)
Q Consensus 284 rDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~sDiwSlG~~l~el 354 (455)
+||+|+|+|+ +.+|.++|+||+.....+.... ....+..|.+||.... .++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll---~~~G~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLL---DQDGGVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE----TTS-EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEE---cCCCCEEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999 8899999999998766543222 1345578999997532 267889999999999999
Q ss_pred HcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCC
Q 012825 355 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKR 407 (455)
Q Consensus 355 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 407 (455)
.||+.||........... ....+..+++.+++||+.+|++||.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999975543221110 122333789999999999999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=218.32 Aligned_cols=224 Identities=29% Similarity=0.479 Sum_probs=174.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
...+|+.++.|..|+||.||+++++. +.+.+|+|+=+.. .+.+- ++... +.|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~---trqrfa~kiNkq~---------lilRn--ilt~a-~npfvv---------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKE---TRQRFAMKINKQN---------LILRN--ILTFA-GNPFVV---------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccc---cccchhhcccccc---------hhhhc--ccccc-CCccee----------
Confidence 35789999999999999999999876 5688999643211 11111 12111 234443
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
|+..+.+ +.-+.++... +.+++|||+.||+|||+||+|.|| ..-|++|++|||+++.
T Consensus 136 -----------gDc~tll-k~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 -----------GDCATLL-KNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKK 192 (1205)
T ss_pred -----------chhhhhc-ccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhh
Confidence 3444433 2333444333 779999999999999999999999 6788899999999876
Q ss_pred cCCCCc----------------ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHh
Q 012825 313 VRPDER----------------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375 (455)
Q Consensus 313 ~~~~~~----------------~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~ 375 (455)
...... -...+||+.|.|||++. +.|....|+|++|+++||++-|+.||.+.+.++.+..++.
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 432211 13468999999999876 6799999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhccCCccCCC---CHHHHHcCcccCCCCCC
Q 012825 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL---TAAQALSHPWIKNSNDV 425 (455)
Q Consensus 376 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~elL~hp~~~~~~~~ 425 (455)
.+..+++.. ..+..+++++|.++|+.+|..|. .+.++.+|.||+...+.
T Consensus 273 d~i~wpE~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 273 DDIEWPEED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred hhccccccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 888887763 46789999999999999999995 67788999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.8e-23 Score=185.27 Aligned_cols=143 Identities=17% Similarity=0.186 Sum_probs=108.6
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHH-----------------------HHHHHHHHHHHHHHhc
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAI-----------------------AIEDVRREVKILRALT 216 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~-----------------------~~~~~~~Ei~~l~~l~ 216 (455)
...||+|+||.||+|... +|+.||||++......... ......+|++++.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05147 2 NGCISTGKEANVYHATTA----NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV 77 (190)
T ss_pred CCccccccceEEEEEECC----CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 468999999999999864 4899999999654211100 0123356999999997
Q ss_pred CCCCeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHcCCEEeeccCCceEEee
Q 012825 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC-HLQGVVHRDLKPENFLFTT 295 (455)
Q Consensus 217 ~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~L-H~~~ivHrDikp~NILl~~ 295 (455)
++++.....+.. ...+|||||++|+++..... ....+++..+..++.||+.+|.|| |+.||+||||||+|||++
T Consensus 78 -~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 78 -TAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred -HCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 777644333222 22389999998877655433 346789999999999999999999 799999999999999994
Q ss_pred cCCCceEEEeecccccccC
Q 012825 296 KDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 296 ~~~~~~vkL~DfG~a~~~~ 314 (455)
++.++|+|||++....
T Consensus 153 ---~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 ---DGKLYIIDVSQSVEHD 168 (190)
T ss_pred ---CCcEEEEEccccccCC
Confidence 3579999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=214.61 Aligned_cols=239 Identities=24% Similarity=0.325 Sum_probs=174.7
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCC-cCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-MTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
+|...+.||.+.|=.|++|++.+ |. |+||++-+.. ..+-....+...|++ .. +..|||.+.+..+.+.+..-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~-l~~~pn~lPfqk~~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FA-LMKAPNCLPFQKVLVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----ce-EEEEEEeccCCCCCchHHHHHHHHHH-HH-hhcCCcccchHHHHHhhHHH
Confidence 68889999999999999998776 54 9999986543 223333344445555 33 33499999998887778888
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|||-+|+.. +|.|.+- ...-+..-+.+.|+.||+.||..+|..||+|||||.+||||+ .-..+.|+||..-+...
T Consensus 97 ylvRqyvkh-nLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTY 171 (1431)
T ss_pred HHHHHHHhh-hhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCcc
Confidence 999999965 8999873 334577788899999999999999999999999999999994 55568999998654321
Q ss_pred --CCC--ccc----ccccCCCcccccccCC-----------C-CCCcchHHHHHHHHHHHHc-CCCCCCCC-------Ch
Q 012825 315 --PDE--RLN----DIVGSAYYVAPEVLHR-----------S-YSTEADVWSIGVIAYILLC-GSRPFWAR-------TE 366 (455)
Q Consensus 315 --~~~--~~~----~~~gt~~y~aPE~~~~-----------~-~~~~sDiwSlG~~l~ellt-g~~Pf~~~-------~~ 366 (455)
.++ .+. +...-.+|.|||.+.. . .+++.||||+||+++||++ |+.+|.-. ..
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~ 251 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN 251 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC
Confidence 111 111 1223346999998732 1 4678999999999999988 68887311 00
Q ss_pred hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 367 SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 367 ~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
....+.+++.. -+..++.+|..|++.||++|.++++.|+.
T Consensus 252 ~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11112222211 12467999999999999999999999876
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=177.45 Aligned_cols=144 Identities=17% Similarity=0.185 Sum_probs=111.2
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC---------------------H--HHHHHHHHHHHHHHHhc
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---------------------A--IAIEDVRREVKILRALT 216 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~---------------------~--~~~~~~~~Ei~~l~~l~ 216 (455)
...||+|+||.||+|+.. +|+.||||++....... . .....+.+|...+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05145 2 NGCISTGKEANVYHARTG----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY 77 (190)
T ss_pred CceeecCCCcEEEEEEcC----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 578999999999999855 48999999987542110 0 01223468999999998
Q ss_pred CCCCeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEee
Q 012825 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTT 295 (455)
Q Consensus 217 ~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~ 295 (455)
|+++.....+.... .+|||||++|+++..... ....++...+..++.|++.+|.+||+ .||+||||||+|||+
T Consensus 78 -~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll-- 151 (190)
T cd05145 78 -EAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY-- 151 (190)
T ss_pred -hCCCCCceEEEecC--CEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE--
Confidence 88875444433332 489999998876544333 23567889999999999999999999 999999999999999
Q ss_pred cCCCceEEEeecccccccCC
Q 012825 296 KDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 296 ~~~~~~vkL~DfG~a~~~~~ 315 (455)
+ ++.++|+|||++.....
T Consensus 152 -~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 -H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -E-CCCEEEEEcccceecCC
Confidence 4 57799999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-22 Score=188.70 Aligned_cols=252 Identities=28% Similarity=0.428 Sum_probs=172.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCccc-------------------------C-------eEEEEEEccCCCc--CCH
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELK-------------------------G-------QQVAVKVIPKHKM--TTA 199 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~-------------------------g-------~~vavK~~~~~~~--~~~ 199 (455)
-++|+|++.||+|.-..||.++...+..+ . -+.|||.+-.-.. .+.
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 57899999999999999999987652100 0 1245555422111 122
Q ss_pred HHHHHHHHHHHH--------------HH-------HhcCCCCeeEEeEEEee---------------------------C
Q 012825 200 IAIEDVRREVKI--------------LR-------ALTGHNNLVKFFDAYED---------------------------T 231 (455)
Q Consensus 200 ~~~~~~~~Ei~~--------------l~-------~l~~hp~Iv~l~~~~~~---------------------------~ 231 (455)
..++.+-+|+-- .+ .|..|||||++.++|.+ .
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 223333333311 11 12259999999988742 2
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec-CCCceEEEeecccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENSVLKAIDFGLS 310 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~-~~~~~vkL~DfG~a 310 (455)
..+|+||...+. +|.+++..+ ..+.....-|+.|+++|+.|||++||.|||+|.+|||+.-+ |+--.+.|+|||++
T Consensus 316 ~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 316 KTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred ceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 358999998855 899888544 36788888999999999999999999999999999999643 44557899999986
Q ss_pred cccCCCC-------cccccccCCCcccccccC---CC----CCCcchHHHHHHHHHHHHcCCCCCCCCChhHH-HHHHHh
Q 012825 311 DFVRPDE-------RLNDIVGSAYYVAPEVLH---RS----YSTEADVWSIGVIAYILLCGSRPFWARTESGI-FRAVLK 375 (455)
Q Consensus 311 ~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~----~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~-~~~i~~ 375 (455)
-.-.... ..-..-|.-.-||||+.. +. .-.++|.|+.|.+.||+++...||....+... .+...+
T Consensus 393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe 472 (598)
T KOG4158|consen 393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE 472 (598)
T ss_pred eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh
Confidence 4322110 111234677799999975 32 23479999999999999999999976332111 011111
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHH
Q 012825 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA 411 (455)
Q Consensus 376 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ 411 (455)
.. .......+++.+++++..+|+.||++|++..
T Consensus 473 ~q---LPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 473 SQ---LPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hh---CCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 11 1111235788999999999999999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=171.29 Aligned_cols=139 Identities=20% Similarity=0.280 Sum_probs=105.9
Q ss_pred EeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc----CCCCeeEEeEEEeeCC--
Q 012825 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT----GHNNLVKFFDAYEDTD-- 232 (455)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~----~hp~Iv~l~~~~~~~~-- 232 (455)
-.+.||+|+||.||. ... ++.. +||++.... ....+.+.+|+.+++.|. .|+||++++|+++++.
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~---~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPE---DAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred CcceecCCCceEEEE--CCC---CcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 357899999999995 332 2334 689885432 223467899999999994 3899999999998874
Q ss_pred -ceE-EEEee--cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHcCCEEeeccCCceEEeecC-CCceEEEee
Q 012825 233 -NVY-VVMEL--CEGGELLDRILSRGGKYTEDDAKAVMIQILNVV-AFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAID 306 (455)
Q Consensus 233 -~~~-lV~E~--~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL-~~LH~~~ivHrDikp~NILl~~~~-~~~~vkL~D 306 (455)
.++ +|+|| +.+++|.+++.+ +.+++. ..++.+++.++ +|||+++|+||||||+|||++..+ .+..++|+|
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 434 78999 557899998844 346665 36688888888 999999999999999999996433 345899999
Q ss_pred cccc
Q 012825 307 FGLS 310 (455)
Q Consensus 307 fG~a 310 (455)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=202.72 Aligned_cols=199 Identities=22% Similarity=0.301 Sum_probs=158.1
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
+.-+++|.|.++||+|+||.||+|...+ |+.||+|+-+.......-...++..-++ ... -+.|..+...+.-
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~----~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~---~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN----GKLVALKVEKPPNPWEFYICLQVMERLK-PQM---LPSIMHISSAHVF 765 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC----CcEEEEEeecCCCceeeeehHHHHHhhc-hhh---hcchHHHHHHHcc
Confidence 3447889999999999999999998665 8999999976554433222223333333 111 2345555555566
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEee----cCCCceEEEee
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT----KDENSVLKAID 306 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~----~~~~~~vkL~D 306 (455)
.+.-+||+||.+.|+|++++. ..+.++|..+..++.|++..++.||..+|||+||||+|+||.. +.+..-++|+|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 677799999999999999875 6678999999999999999999999999999999999999953 23356799999
Q ss_pred ccccccc---CCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCC
Q 012825 307 FGLSDFV---RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGS 358 (455)
Q Consensus 307 fG~a~~~---~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~ 358 (455)
||.+-.+ .++..+...++|..+-.+|...| .|+...|.|.|+.+++.||.|+
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 9987543 33446677889999999998874 7999999999999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.6e-21 Score=173.71 Aligned_cols=242 Identities=19% Similarity=0.248 Sum_probs=183.4
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++..+..+|.+...|..|+|++.. ..+++|++..... .....++|..|.-.|+-+. ||||+.+++.|....++
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqg-----ndivakil~vr~~-t~risrdfneefp~lrifs-hpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQG-----NDIVAKILNVREV-TARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNL 262 (448)
T ss_pred hhhhhhhhhccCCCcccccccccC-----cchhhhhhhhhhc-chhhcchhhhhCcceeeec-CCchhhhhhhccCCCCc
Confidence 445667788999999999988664 5577788755432 2333467888888888887 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC--CEEeeccCCceEEeecCCCceEEEe--eccc
Q 012825 235 YVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAI--DFGL 309 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~--ivHrDikp~NILl~~~~~~~~vkL~--DfG~ 309 (455)
.++..||+.|+|+..+++... ..+..++.+++.+|++|+.|||+.. |.---|....+++ |++...+|. |--+
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kf 339 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKF 339 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheeccccee
Confidence 999999999999999877544 5788899999999999999999985 4444688899999 777665553 3222
Q ss_pred ccccCCCCcccccccCCCcccccccCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 310 SDFVRPDERLNDIVGSAYYVAPEVLHRS----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
+.. .......+.||+||.+... .-..+|+|||++++||+.|...||.....-+.-.++.-+.. .....
T Consensus 340 sfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl--rv~ip 411 (448)
T KOG0195|consen 340 SFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL--RVHIP 411 (448)
T ss_pred eee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc--cccCC
Confidence 211 1122457889999988743 23468999999999999999999977665443333322221 22234
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHH
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL 414 (455)
|.++..+..|+.-|++.||.+||....++
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 58899999999999999999999887653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-19 Score=181.11 Aligned_cols=226 Identities=30% Similarity=0.389 Sum_probs=171.4
Q ss_pred HHhcCCCCeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCC-EEeeccCCce
Q 012825 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV-VHRDLKPENF 291 (455)
Q Consensus 213 ~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~i-vHrDikp~NI 291 (455)
+.+. |.|+.+++|.+.++...++|.+||..|+|.|.+......+++-....++++|+.||.|||...| +|+.++..|+
T Consensus 2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4566 9999999999999999999999999999999998878889999999999999999999999876 9999999999
Q ss_pred EEeecCCCceEEEeecccccccCCC---CcccccccCCCcccccccCCC--------CCCcchHHHHHHHHHHHHcCCCC
Q 012825 292 LFTTKDENSVLKAIDFGLSDFVRPD---ERLNDIVGSAYYVAPEVLHRS--------YSTEADVWSIGVIAYILLCGSRP 360 (455)
Q Consensus 292 Ll~~~~~~~~vkL~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~sDiwSlG~~l~elltg~~P 360 (455)
++ +..+.+||+|||+....... .......-...|.|||.+... .+.++||||||++++|+++...|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 89999999999998776421 111122244569999998642 46679999999999999999999
Q ss_pred CCCCCh----hHHHHHHHh-cCCCCCCCCC--CCCCHHHHHHHHHhccCCccCCCCHHHHHcC--cccCCCCCCCCchhH
Q 012825 361 FWARTE----SGIFRAVLK-ADPSFDEAPW--PSLSSEARDFVKRLLNKDPRKRLTAAQALSH--PWIKNSNDVKVPLDV 431 (455)
Q Consensus 361 f~~~~~----~~~~~~i~~-~~~~~~~~~~--~~~s~~l~~li~~~L~~dP~~Rps~~elL~h--p~~~~~~~~~~p~~~ 431 (455)
|..... .+.+..+.+ ....+....+ ....+++..++++|+..+|.+||+++++-.. ..++.. ..+-++++
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~-~~~~nl~D 236 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG-SSKGNLMD 236 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc-cccchhHH
Confidence 965322 234444444 2211211111 1455679999999999999999999988532 222211 12336677
Q ss_pred HHHHHHHHHHhc
Q 012825 432 IIFKLMKAYMRS 443 (455)
Q Consensus 432 ~~~~~~~~~~~~ 443 (455)
..++.+.+|...
T Consensus 237 ~m~~~le~Y~~n 248 (484)
T KOG1023|consen 237 SLFRMLESYADN 248 (484)
T ss_pred HHHHHHHHHHhh
Confidence 777766666544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=168.64 Aligned_cols=147 Identities=21% Similarity=0.203 Sum_probs=111.9
Q ss_pred CCeEEeceEeecCCeEEEEEE-EecCcccCeEEEEEEccCCCcC-------------------C--HHHHHHHHHHHHHH
Q 012825 155 NKYELGEEVGRGHFGYTCAAK-FKKGELKGQQVAVKVIPKHKMT-------------------T--AIAIEDVRREVKIL 212 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~-~~~~~~~g~~vavK~~~~~~~~-------------------~--~~~~~~~~~Ei~~l 212 (455)
.-|++.+.||+|+||.||+|. ... +|+.||||++...... . ......+.+|+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDG---SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCC---CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 358899999999999999997 333 5899999998653211 0 01123467899999
Q ss_pred HHhcCCC--CeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC-CEEeeccCC
Q 012825 213 RALTGHN--NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG-VVHRDLKPE 289 (455)
Q Consensus 213 ~~l~~hp--~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~-ivHrDikp~ 289 (455)
.++. +. .+.+++++ ...+|||||++|.+|..... ....+....+..++.||+.+|.+||+.| |+||||||+
T Consensus 105 ~~L~-~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~ 178 (237)
T smart00090 105 QRLY-EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY 178 (237)
T ss_pred HHHH-hcCCCCCeeeEe----cCceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence 9997 43 33444442 23589999999887765442 2345667778899999999999999999 999999999
Q ss_pred ceEEeecCCCceEEEeecccccccC
Q 012825 290 NFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 290 NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
||++ + ++.++|+|||.+....
T Consensus 179 NIli---~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILV---H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEE---E-CCCEEEEEChhhhccC
Confidence 9999 4 5679999999987654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-20 Score=186.20 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=166.3
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeE-------EEe
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD-------AYE 229 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~-------~~~ 229 (455)
+.+.+-.+..+++.+...+...+......+..+.... ..........+++-.+.-...|+..+. .+ .+.
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~---d~~~~~~~~~r~~~~l~~~~~~~~s~~-~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV---DSLCACKYTFRQLGVLVDSSHSNRSIL-EDLRPSLFESSK 321 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhc---cchhhhhhhhhhhhheeccccCCcccc-cCCCCchhhhcc
Confidence 4455556666666555444333211123333333321 222333444556655555553444332 22 111
Q ss_pred -----eCCceEEEEeecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceE
Q 012825 230 -----DTDNVYVVMELCEGGELLDRILSR--GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (455)
Q Consensus 230 -----~~~~~~lV~E~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~v 302 (455)
....+||.|++|...+|.+++..+ ....++...+.++.|++.|++| +|.+|+|+||.||+. ..+..+
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~ 395 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQL 395 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhh
Confidence 123589999999999999999633 3467888999999999999999 999999999999999 455589
Q ss_pred EEeecccccccCCCC-------cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 012825 303 KAIDFGLSDFVRPDE-------RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAV 373 (455)
Q Consensus 303 kL~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i 373 (455)
||.|||+........ ..+...||..||+||++. ..|+.++|||+||++|+|++. =...|. ....+..+
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~ 472 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDI 472 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhh
Confidence 999999988776555 456778999999999998 579999999999999999986 222221 11111111
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccC
Q 012825 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (455)
Q Consensus 374 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~ 420 (455)
- +..++...+..+ ++-.+|+.+||.+.|.+||++.+.-.|.|++
T Consensus 473 r--~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 473 R--DGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred h--cCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 1 122222222234 3456999999999999999888888888764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-18 Score=159.74 Aligned_cols=137 Identities=27% Similarity=0.380 Sum_probs=112.2
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCH-----HHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----IAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+.||+|++|.||+|.. .|..|++|+......... .....+.+|+.++..+. |++|.....++.+.+..+
T Consensus 2 ~~l~~G~~~~vy~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFI 75 (211)
T ss_pred cccccCceEEEEEEee-----CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCE
Confidence 6799999999999975 367799998654332221 12345788999999998 888887777777778899
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+||||++|++|.+.+.... . ....++.+++.+|.+||+.|++|+|++|.|||+. ++.++|+|||++..
T Consensus 76 lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 9999999999998775422 2 8889999999999999999999999999999994 56799999998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.2e-21 Score=200.12 Aligned_cols=261 Identities=27% Similarity=0.476 Sum_probs=211.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
..|.+.+.||+|+|+.|-++..... ....+|+|.+.... ........+..|..+-..+..|.|++.+++...+.+..
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~--~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRD--PESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred ccccccccccccccchhhhhhhcCC--CcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 4577788899999998877665432 34567777775433 33445566777898888888899999999999999999
Q ss_pred EEEEeecCCCcHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCEEeeccCCceEEeecCCCc-eEEEeeccccc
Q 012825 235 YVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQILNVVAFCH-LQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSD 311 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l-~~~~~~l~~~~~~~i~~qi~~gL~~LH-~~~ivHrDikp~NILl~~~~~~~-~vkL~DfG~a~ 311 (455)
++++||..|+++.+.+ .......+...+..++.|+..++.|+| ..++.|+||||+|.++ ++.+ .+++.|||+|.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLAT 173 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhc
Confidence 9999999999998877 333336888899999999999999999 9999999999999999 6666 89999999998
Q ss_pred ccCC-CC---ccccccc-CCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHH-HHHHhcCCCCCCC
Q 012825 312 FVRP-DE---RLNDIVG-SAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIF-RAVLKADPSFDEA 383 (455)
Q Consensus 312 ~~~~-~~---~~~~~~g-t~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~-~~i~~~~~~~~~~ 383 (455)
.... .. .....+| ++.|+|||...+ ......|+||.|+++.-+++|..||......... .........+...
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQL 253 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccC
Confidence 8765 22 2345678 999999998876 3567799999999999999999999655443322 2222233344566
Q ss_pred CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 384 ~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.|..++....+++.++|..+|..|.+.+++..++|+..
T Consensus 254 ~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 254 PWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 67788999999999999999999999999999999998
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=157.16 Aligned_cols=134 Identities=26% Similarity=0.337 Sum_probs=105.8
Q ss_pred eEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC-----HHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
.||+|+||.||+|.. .|..|++|+........ .....++.+|++++..+. |+++.....++...+..++
T Consensus 1 ~ig~G~~~~vy~~~~-----~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTI 74 (199)
T ss_pred CCCCCceEEEEEeec-----CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEE
Confidence 489999999999983 36789999865432221 122356789999999998 7766555555556777899
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
||||++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||++ + ++.++++|||++...
T Consensus 75 v~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~---~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV---R-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEE---E-CCcEEEEECCCCcCC
Confidence 9999999999887643211 889999999999999999999999999999 4 677999999998663
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=157.86 Aligned_cols=140 Identities=25% Similarity=0.284 Sum_probs=108.0
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC-------------------HHHHHHHHHHHHHHHHhc
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-------------------AIAIEDVRREVKILRALT 216 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~-------------------~~~~~~~~~Ei~~l~~l~ 216 (455)
.|.+.+.||+|+||.||++... +|+.||||++....... ........+|+.++.++.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 3888899999999999999754 48899999875432100 011123678999999997
Q ss_pred CCC--CeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEe
Q 012825 217 GHN--NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (455)
Q Consensus 217 ~hp--~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~ 294 (455)
|. .++..++ .+..++||||++|++|.+... ......++.+++.++.++|+.||+||||||+||++
T Consensus 92 -~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill- 158 (198)
T cd05144 92 -EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV- 158 (198)
T ss_pred -HcCCCCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE-
Confidence 66 4444443 345699999999988765431 14567889999999999999999999999999999
Q ss_pred ecCCCceEEEeecccccccC
Q 012825 295 TKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 295 ~~~~~~~vkL~DfG~a~~~~ 314 (455)
++++.++|+|||++....
T Consensus 159 --~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 --DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred --cCCCcEEEEECCccccCC
Confidence 678899999999996654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=179.88 Aligned_cols=143 Identities=21% Similarity=0.294 Sum_probs=112.9
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-----CHHHHHHHHHHHHHHHHhcCCCCeeEEeE
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRALTGHNNLVKFFD 226 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~ 226 (455)
.....|...++||+|+||.||++.+.. ..+++|+....... .....+.+.+|+++++.++ |++++..+.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~ 403 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLG-----RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVI 403 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecC-----ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEE
Confidence 334556778999999999999987544 23444432211111 1223456889999999998 999988887
Q ss_pred EEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 227 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
++.+.+..++||||++|++|.+++. ....++.+++.+|.+||+.||+||||||+|||+ + ++.++|+|
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl---~-~~~~~liD 470 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV---R-DDRLYLID 470 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE---E-CCcEEEEe
Confidence 7777778899999999999988774 357899999999999999999999999999999 2 45799999
Q ss_pred ccccccc
Q 012825 307 FGLSDFV 313 (455)
Q Consensus 307 fG~a~~~ 313 (455)
||+++..
T Consensus 471 FGla~~~ 477 (535)
T PRK09605 471 FGLGKYS 477 (535)
T ss_pred CcccccC
Confidence 9999764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-18 Score=174.88 Aligned_cols=263 Identities=22% Similarity=0.281 Sum_probs=207.5
Q ss_pred cccCCCeEEeceEee--cCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 151 KHFANKYELGEEVGR--GHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~--G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
..+...|.+.+.+|. |.+|.||.+.... ...+..+|+|.-+. ..........-.+|+....++..|.+.++.+..|
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCc-ccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCccc
Confidence 345677889999999 9999999988622 12578899997322 2222233344457888888888899999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHcCCEEeeccCCceEEeecCCC-ceEE
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN----VVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLK 303 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~----gL~~LH~~~ivHrDikp~NILl~~~~~~-~~vk 303 (455)
+..+..++-+|+| +.+|..+.......++...++.++.+... ||.++|..+++|-|+||+||++ ..+ ...+
T Consensus 188 e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~---~~~~~s~~ 263 (524)
T KOG0601|consen 188 EGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFT---TSDWTSCK 263 (524)
T ss_pred ccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheec---ccccceee
Confidence 9999999999999 57999988888888999999999999999 9999999999999999999999 555 7899
Q ss_pred EeecccccccCCCCccc------ccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcC
Q 012825 304 AIDFGLSDFVRPDERLN------DIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (455)
Q Consensus 304 L~DfG~a~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~ 377 (455)
++|||+...+....... ...|...|++||..++-++...|||+||.++++..++.............+ + ..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~-r~ 340 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--L-RQ 340 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--c-cc
Confidence 99999998876554221 225777899999999999999999999999999988876654331111110 0 01
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 378 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.......+...+.++...+..|++.++..|+++..++.|.++...
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 112333334567778889999999999999999999999999853
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-17 Score=147.77 Aligned_cols=141 Identities=23% Similarity=0.239 Sum_probs=99.0
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHH---------------------HHHHHHHHHHhcCC
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED---------------------VRREVKILRALTGH 218 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~---------------------~~~Ei~~l~~l~~h 218 (455)
.+.||+|+||.||+|... +|+.||||++............. ...|...+.++..+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECC----CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 578999999999999855 37899999986543221111111 14566777776522
Q ss_pred -CCeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEeec
Q 012825 219 -NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTK 296 (455)
Q Consensus 219 -p~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~~ 296 (455)
-.+.+.+++ ...++||||++++.+......... . ...+..++.+++.++.++|. .||+|+||||+||++
T Consensus 78 ~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili--- 148 (187)
T cd05119 78 GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV--- 148 (187)
T ss_pred CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---
Confidence 224445443 246999999998543221111110 1 16788999999999999999 999999999999999
Q ss_pred CCCceEEEeecccccccC
Q 012825 297 DENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~~ 314 (455)
+ ++.++|+|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 4 6789999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.3e-16 Score=147.50 Aligned_cols=139 Identities=22% Similarity=0.265 Sum_probs=103.4
Q ss_pred eceEe-ecCCeEEEEEEEecCcccCeEEEEEEccCCCc----------CCHHHHHHHHHHHHHHHHhcCCCCe--eEEeE
Q 012825 160 GEEVG-RGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM----------TTAIAIEDVRREVKILRALTGHNNL--VKFFD 226 (455)
Q Consensus 160 ~~~LG-~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~----------~~~~~~~~~~~Ei~~l~~l~~hp~I--v~l~~ 226 (455)
...|| .||.|+||.+... +..++||.+..... .+......+.+|++++.+|. |++| ++.++
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-----~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~ 109 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-----GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIA 109 (239)
T ss_pred CceeecCCCCccEEEEEeC-----CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEe
Confidence 35677 8888888888643 56799998853211 11233456889999999998 7774 67777
Q ss_pred EEeeCCc----eEEEEeecCC-CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCce
Q 012825 227 AYEDTDN----VYVVMELCEG-GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (455)
Q Consensus 227 ~~~~~~~----~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~ 301 (455)
+...... .++|||+++| .+|.+++.. ..+++.. +.+|+.+|.+||+.||+||||||.|||+ +.++.
T Consensus 110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv---~~~~~ 180 (239)
T PRK01723 110 ARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL---DPDGK 180 (239)
T ss_pred eeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE---cCCCC
Confidence 6543322 3599999997 588877643 3455543 5689999999999999999999999999 55668
Q ss_pred EEEeeccccccc
Q 012825 302 LKAIDFGLSDFV 313 (455)
Q Consensus 302 vkL~DfG~a~~~ 313 (455)
++|+|||.+...
T Consensus 181 v~LIDfg~~~~~ 192 (239)
T PRK01723 181 FWLIDFDRGELR 192 (239)
T ss_pred EEEEECCCcccC
Confidence 999999988764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=136.70 Aligned_cols=133 Identities=25% Similarity=0.333 Sum_probs=110.9
Q ss_pred EeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCC-CCeeEEeEEEeeCCceEEE
Q 012825 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-NNLVKFFDAYEDTDNVYVV 237 (455)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-p~Iv~l~~~~~~~~~~~lV 237 (455)
+++.||.|.++.||++.... ..+++|+...... ...+.+|+.+++.+..+ .+++++++++...+..+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-----~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v 71 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-----EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL 71 (155)
T ss_pred cceecccccccceEEEEecC-----CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence 46789999999999998543 6799999855422 45688999999999844 6899999988888889999
Q ss_pred EeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 238 MELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ---GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 238 ~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~---~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
|||++|+.+..+ +......++.+++.+|.+||.. +++|+||+|+|||+ +..+.++++|||.+..
T Consensus 72 ~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~---~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 72 MEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV---DDGKILGIIDWEYAGY 138 (155)
T ss_pred EEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE---ECCcEEEEEecccccC
Confidence 999988766542 5667788899999999999985 69999999999999 4567899999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.57 E-value=7e-14 Score=142.91 Aligned_cols=145 Identities=22% Similarity=0.255 Sum_probs=98.2
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC---------------------------H----HHHH-----
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---------------------------A----IAIE----- 203 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~---------------------------~----~~~~----- 203 (455)
.+.||.|++|+||+|+.++ |+.||||+........ . +...
T Consensus 122 ~~plasaSigQVh~A~l~~----G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVD----GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred CcceeeeehhheEEEEecC----CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 3579999999999999765 8899999985432100 0 0001
Q ss_pred -HHHHHHHHHHHhc----CCCCeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHH
Q 012825 204 -DVRREVKILRALT----GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN-VVAFCH 277 (455)
Q Consensus 204 -~~~~Ei~~l~~l~----~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~-gL~~LH 277 (455)
++.+|...+.++. +++++.--.-++......+|||||++|++|.+........+ ....++..++. .+..+|
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH
Confidence 2344555555443 34443322222333445799999999999887654322222 23456666665 468899
Q ss_pred HcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 278 ~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
..|++|+|+||.||++ +.++.++|+|||++..+.
T Consensus 275 ~~g~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RDGFFHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred hCCceeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 9999999999999999 677889999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.7e-16 Score=163.15 Aligned_cols=268 Identities=26% Similarity=0.399 Sum_probs=203.2
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
--+.+.+.+-+-.|.++.++.+.-.. .|...++|+............+.+..+-.++-... +|.+++..-.+....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~---sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAG---SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRS 877 (1205)
T ss_pred CCccceecccccCCCCcccccCCccc---cccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCC
Confidence 34678888899999999998776443 45566666654333222222333444444433233 566776555555677
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..+|+++|+.+++|...++.. +..+.+-++..+..+...++|||...++|+|++|.|+|. ..+++.++.|||....
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSK 953 (1205)
T ss_pred CcchhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccc
Confidence 899999999999988876544 356777788888889999999999999999999999999 7888999999984322
Q ss_pred cCCC--------------------------------CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCC
Q 012825 313 VRPD--------------------------------ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSR 359 (455)
Q Consensus 313 ~~~~--------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~ 359 (455)
.... .......||+.|.+||... ......+|+|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 1100 0012346899999999876 467888999999999999999999
Q ss_pred CCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHH---HHHcCcccCCCCCCCCch
Q 012825 360 PFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA---QALSHPWIKNSNDVKVPL 429 (455)
Q Consensus 360 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~---elL~hp~~~~~~~~~~p~ 429 (455)
||...+....++++++.+.....-. ...+...++++..+|..++.+|..+. ++-.|+||+......+..
T Consensus 1034 p~na~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred CCCCcchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccc
Confidence 9999999999999988876654432 25788899999999999999999988 899999999987666543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.2e-15 Score=138.91 Aligned_cols=207 Identities=18% Similarity=0.219 Sum_probs=147.0
Q ss_pred HHHHHhcCCCCeeEEeEEEeeC-----CceEEEEeecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC-
Q 012825 210 KILRALTGHNNLVKFFDAYEDT-----DNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQG- 280 (455)
Q Consensus 210 ~~l~~l~~hp~Iv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~- 280 (455)
.-|.++. |.|||+++.||.+. .+..++.||+..|++..+|.+. ...+.....++|+-||+.||.|||+..
T Consensus 119 dnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 119 DNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 3344555 99999999999754 3588999999999998888653 346889999999999999999999985
Q ss_pred -CEEeeccCCceEEeecCCCceEEEeecccccccCC-----CCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHH
Q 012825 281 -VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-----DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYI 353 (455)
Q Consensus 281 -ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~-----~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~e 353 (455)
|+|+++..+-|++ ..++.+||.----...... ........+-++|.+||.=. ...+..+|||+||+..+|
T Consensus 198 piihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred ccccCCcchhheee---cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 9999999999999 6788888753221111000 01112234567899999754 456778999999999999
Q ss_pred HHcCCCCCCCCCh-hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCC
Q 012825 354 LLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (455)
Q Consensus 354 lltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~ 427 (455)
|.-|..--..... ...-..+.+..... -....+++|.+||+..|..||+++++|.||-+.++...++
T Consensus 275 mailEiq~tnseS~~~~ee~ia~~i~~l-------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslkl 342 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEVEENIANVIIGL-------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLKL 342 (458)
T ss_pred HHHheeccCCCcceeehhhhhhhheeec-------cCccccCcCcccccCCCCCCcchhhhhcCceeeecchHHH
Confidence 9887643211111 11111111111111 1123468999999999999999999999999988765544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-13 Score=142.84 Aligned_cols=149 Identities=21% Similarity=0.372 Sum_probs=92.9
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC--------------------------C-----HHHHH
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--------------------------T-----AIAIE 203 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~--------------------------~-----~~~~~ 203 (455)
..|+. +.||.|++|+||+|+.++ +|+.||||++...... + .+..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~---~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD---NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC---CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 44666 789999999999999876 4899999999643200 0 02223
Q ss_pred HHHHHHHHHHH------hc---CCCCeeEEeEEE-eeCCceEEEEeecCCCcHHHHHH-hcCC----CCCHHHHHHHHHH
Q 012825 204 DVRREVKILRA------LT---GHNNLVKFFDAY-EDTDNVYVVMELCEGGELLDRIL-SRGG----KYTEDDAKAVMIQ 268 (455)
Q Consensus 204 ~~~~Ei~~l~~------l~---~hp~Iv~l~~~~-~~~~~~~lV~E~~~ggsL~~~l~-~~~~----~l~~~~~~~i~~q 268 (455)
.+.+|+++.+. +. .+...+.+-.++ +.....+|||||++|+.+.+.-. ...+ .+.+..+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 34444444433 32 122222222222 22445689999999999876422 1222 2334444444444
Q ss_pred HHHHHHHHHHcCCEEeeccCCceEEeecC-CCceEEEeecccccccC
Q 012825 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 269 i~~gL~~LH~~~ivHrDikp~NILl~~~~-~~~~vkL~DfG~a~~~~ 314 (455)
+ ...|++|+|+||.||++..++ ..+.++++|||++..+.
T Consensus 276 i-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 V-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4 458999999999999994221 12389999999987664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.3e-14 Score=145.04 Aligned_cols=252 Identities=22% Similarity=0.210 Sum_probs=185.2
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
...+|.++..||.|.|+.|+.+... ...+..|++|...+........+ .-..|+.+...+.-|.++++++..|...+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r--~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKR--PEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ecCCcceeEEccCCccccceeeeec--CCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3567889999999999999987733 23578999998866544433333 33568888888888999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+.||-.|||+++++...+ .-...+.+...+++..|++.++.++|+..++|+|+||+||++..++ +.-++.|||....
T Consensus 340 ~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTR 416 (524)
T ss_pred cccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccc
Confidence 999999999999876655 2233578889999999999999999999999999999999995322 7899999998864
Q ss_pred cCCCCcccccccCCCcc-cccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 313 VRPDERLNDIVGSAYYV-APEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~-aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
+. -........-+++ ..|++. ..+..+.|+|+||..+.|.++|...-+..... ..+.... .. ..+...
T Consensus 417 ~~--~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~~--~p--~~~~~~ 487 (524)
T KOG0601|consen 417 LA--FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSGD--TP--NLPGLK 487 (524)
T ss_pred cc--eecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeeccc--cc--CCCchH
Confidence 21 1111222333445 355554 35778999999999999999887543332211 1111111 11 112344
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.++..+.+.++..|+..|+.+.++..|.=|
T Consensus 488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 488 LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 788999999999999999999999887544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=8.6e-13 Score=117.35 Aligned_cols=129 Identities=17% Similarity=0.204 Sum_probs=94.8
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEe
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E 239 (455)
++.|+.|.++.||+++.. +..|++|+...... ....+.+|+.+++.+.+...+.+++.+.. +..++|||
T Consensus 3 ~~~l~~G~~~~vy~~~~~-----~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e 71 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-----NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITE 71 (170)
T ss_pred eeecCCcccCceEEEEEC-----CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEE
Confidence 457889999999998743 67899999754321 12345789999998874333456665443 34589999
Q ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCC-----EEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV-----VHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 240 ~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~i-----vHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
|++|.++.+. ......++.+++++|..||..++ +|+|+++.||+++ ++.++|+|||.+..
T Consensus 72 ~i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 72 FIEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred ecCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 9999876542 01123467899999999999985 9999999999994 45689999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.3e-12 Score=114.88 Aligned_cols=146 Identities=16% Similarity=0.141 Sum_probs=102.1
Q ss_pred eceEeecCCeEEEEEEEecC---cccCeEEEEEEccCCCc---------------C----CHHHHHH----HHHHHHHHH
Q 012825 160 GEEVGRGHFGYTCAAKFKKG---ELKGQQVAVKVIPKHKM---------------T----TAIAIED----VRREVKILR 213 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~---~~~g~~vavK~~~~~~~---------------~----~~~~~~~----~~~Ei~~l~ 213 (455)
...||.|--+.||.|...++ ...+..+|||++..... . .....+. .++|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 35789999999999974431 11357899999843210 0 0011222 348999999
Q ss_pred HhcCC-CCeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHcCCEEeeccCCce
Q 012825 214 ALTGH-NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC-HLQGVVHRDLKPENF 291 (455)
Q Consensus 214 ~l~~h-p~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~L-H~~~ivHrDikp~NI 291 (455)
++... -++.+.+++ ...+|||||+.+..+..... +...+++..+..+..+++.+|..| |+.||||+||++.||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-kd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-KDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-hccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 98733 356667654 45699999997643322111 122456677788899999999999 899999999999999
Q ss_pred EEeecCCCceEEEeecccccccC
Q 012825 292 LFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 292 Ll~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|+. ++.+.|+|||.+....
T Consensus 157 L~~----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE----CCcEEEEECCCceeCC
Confidence 994 3569999999886654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.2e-12 Score=111.63 Aligned_cols=149 Identities=19% Similarity=0.233 Sum_probs=111.2
Q ss_pred EeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC-----HHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
....|-+|+-+.|+++.+ .|+...||.-....... .-..++..+|.+++.++. --.|.--.-++.+...
T Consensus 11 ~l~likQGAEArv~~~~~-----~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~ 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYG 84 (229)
T ss_pred cceeeeccceeeEeeecc-----CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCC
Confidence 567889999999888764 46777777543322222 233456789999999887 3344443345666777
Q ss_pred eEEEEeecCC-CcHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 234 VYVVMELCEG-GELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 234 ~~lV~E~~~g-gsL~~~l~~~~~~-l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
-.|+|||++| .++.+++.+.... ........++..|-+.+.-||..+|+|+||..+||++..++....+.|+|||++.
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 7999999987 3677777665433 3333447889999999999999999999999999999887888888999999986
Q ss_pred cc
Q 012825 312 FV 313 (455)
Q Consensus 312 ~~ 313 (455)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 54
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-11 Score=126.95 Aligned_cols=162 Identities=22% Similarity=0.312 Sum_probs=123.0
Q ss_pred cCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHH
Q 012825 182 KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261 (455)
Q Consensus 182 ~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~ 261 (455)
++.+|.|.+++... ......+.+-++.++.|+ ||||+++++.++.++.+|||+|.+. -|..++.+. ....
T Consensus 36 ~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~ 105 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEE 105 (690)
T ss_pred cCCceEEEEEeCCC---chhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHH
Confidence 57788888875432 244556788889999999 9999999999999999999999985 345555443 3777
Q ss_pred HHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCc-ccccccCCCcccccccCCCCC
Q 012825 262 AKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLHRSYS 339 (455)
Q Consensus 262 ~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~ 339 (455)
+...+.||+.||.|||+ .+++|++|..+.|+| ++.|.+||++|.++........ .....--..|..|+.+... .
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s-~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS-E 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-c
Confidence 88889999999999985 579999999999999 7888999999998866542221 1111222235555544311 1
Q ss_pred CcchHHHHHHHHHHHHcC
Q 012825 340 TEADVWSIGVIAYILLCG 357 (455)
Q Consensus 340 ~~sDiwSlG~~l~elltg 357 (455)
-..|.|-||++++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 346999999999999998
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.4e-10 Score=110.96 Aligned_cols=248 Identities=17% Similarity=0.205 Sum_probs=168.3
Q ss_pred eEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe----eCCceEEEEeecCCC
Q 012825 169 GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE----DTDNVYVVMELCEGG 244 (455)
Q Consensus 169 g~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~----~~~~~~lV~E~~~gg 244 (455)
.+.|++.... +|..|++|++....... ......-++.++++. |.|+|.+.++|. .+..+++||+|.++.
T Consensus 290 ~Ttyk~~s~~---DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 290 ITTYKATSNV---DGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred ceeEeeeecc---CCceeeeeeeccccccC---cccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 3677777554 68999999994322111 112335678899998 999999999987 344689999999864
Q ss_pred -cHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 245 -ELLDRILS--------------RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 245 -sL~~~l~~--------------~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
+|.+.... .+...+|+.+|.++.||..||.++|+.|+.-+-|.+.+||+ ..+.+++|+..|.
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i 439 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGI 439 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEecccc
Confidence 66665432 23467899999999999999999999999999999999999 5666899988888
Q ss_pred ccccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 310 SDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
...+..+.. |-+. --.+-|.=-||.+++.|.||..--+........ .++ ...+.++
T Consensus 440 ~Dvl~~d~~-------------~~le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~~~-------~I~~~yS 495 (655)
T KOG3741|consen 440 MDVLQEDPT-------------EPLE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSS--HLT-------RITTTYS 495 (655)
T ss_pred eeeecCCCC-------------cchh--HHhhhhHHHHHHHHHHHhhcccccccccchHHH--HHH-------Hhhhhhh
Confidence 776654431 0000 112468889999999999996432222111111 011 1113688
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcC---cccCCCCCCCCchhHHHHHHHHHHHhccHHHHHHHh
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSH---PWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~h---p~~~~~~~~~~p~~~~~~~~~~~~~~~~~l~~~~~~ 452 (455)
.+++++|..+...++++ -++.+++.+ .||......-+-.|..- ..+.+.++.-.|=|..+|
T Consensus 496 ~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~q~~~d~mE-~~Ls~emENGRLfRll~K 559 (655)
T KOG3741|consen 496 TDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESVQLKTDVME-TELSREMENGRLFRLLLK 559 (655)
T ss_pred HHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhHHHHHHHHH-HHHHHHHhcchHHHHHHH
Confidence 99999999999999887 788888866 34443222222222222 233345566666666665
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.1e-11 Score=107.05 Aligned_cols=136 Identities=26% Similarity=0.328 Sum_probs=98.9
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHH-----HHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAI-----AIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~-----~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
..+++|+-+.+|.+.+. |..+++|.-........+ ...+-.+|..++.++. --.|..-+=+..+.+...
T Consensus 2 ~~i~~GAEa~i~~~~~~-----g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGL 75 (204)
T ss_pred chhhCCcceeEEeeecc-----CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCE
Confidence 35788999999988543 445777764333333322 2344578999999887 445554444556677789
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|+|||++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++. ++.+.++|||++....
T Consensus 76 I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~s~ 142 (204)
T COG3642 76 IVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEFSD 142 (204)
T ss_pred EEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCcccccc
Confidence 999999988877777544 256677777778889999999999999999994 3349999999997543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.3e-11 Score=109.86 Aligned_cols=144 Identities=26% Similarity=0.422 Sum_probs=103.9
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCC-CCeeEEeEEEeeC---CceEE
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-NNLVKFFDAYEDT---DNVYV 236 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-p~Iv~l~~~~~~~---~~~~l 236 (455)
+.|+.|..+.||++...+ |..+++|+....... .....+.+|++++..+..+ ..+.+++.+.... +..++
T Consensus 4 ~~l~~G~~n~~~~v~~~~----g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~ 77 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG----GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY 77 (223)
T ss_pred eecCCCccceEEEEEecC----CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence 568999999999988643 578999997543221 1235678999999999832 3457777776654 36789
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-------------------------------------- 278 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-------------------------------------- 278 (455)
||||++|.++.+.+.. ..+++.....++.+++++|..||+
T Consensus 78 v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 78 VMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 9999999877654321 346777777777777777777773
Q ss_pred ------------------cCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 279 ------------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 279 ------------------~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
..++|+|+++.|||++.. .++.+.|+||+.+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~g 207 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEeccccccC
Confidence 236999999999999421 1567899999987643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.1e-09 Score=102.62 Aligned_cols=128 Identities=17% Similarity=0.165 Sum_probs=91.7
Q ss_pred cCeEEEEEEccCCCcCCHHHHH----------HHHHHHHHHHHhcCCCCe--eEEeEEEee-----CCceEEEEeecCCC
Q 012825 182 KGQQVAVKVIPKHKMTTAIAIE----------DVRREVKILRALTGHNNL--VKFFDAYED-----TDNVYVVMELCEGG 244 (455)
Q Consensus 182 ~g~~vavK~~~~~~~~~~~~~~----------~~~~Ei~~l~~l~~hp~I--v~l~~~~~~-----~~~~~lV~E~~~gg 244 (455)
.|+.|.||....... .+..+ .+.+|...+.+|. ..+| +..+++++. ...-+||||++++.
T Consensus 44 ~g~~~~vKr~~~~~~--~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~ 120 (268)
T PRK15123 44 AGKSYFLKWHRGTGW--GEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFIITEDLAPT 120 (268)
T ss_pred CCEEEEEEEecCCcH--HHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEEEeeCCCC
Confidence 367889997632211 11111 3678999998886 2333 344555543 23478999999876
Q ss_pred -cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec----CCCceEEEeecccccc
Q 012825 245 -ELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK----DENSVLKAIDFGLSDF 312 (455)
Q Consensus 245 -sL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~----~~~~~vkL~DfG~a~~ 312 (455)
+|.+++... ....+......++.+++..+.-||+.||+|+|+++.|||+..+ +++..+.|+||+.+..
T Consensus 121 ~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 121 ISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 788876432 3456677888999999999999999999999999999999631 3467899999998854
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.6e-09 Score=105.68 Aligned_cols=241 Identities=17% Similarity=0.148 Sum_probs=158.4
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE------ee
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY------ED 230 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~------~~ 230 (455)
....+.||+|+.+.+|-.-.. + ..+-|++.+..... -...+..|.+.-.||-+-.=+.+- -+
T Consensus 13 i~~gr~LgqGgea~ly~l~e~-----~-d~VAKIYh~Pppa~------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~ 80 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV-----R-DQVAKIYHAPPPAA------QAQKVAELAATPDAPLLNYRVAWPQATLHGGR 80 (637)
T ss_pred cCCCccccCCccceeeecchh-----h-chhheeecCCCchH------HHHHHHHhccCCCCcchhhhhcccHHHhhCCC
Confidence 345678999999998864322 1 23448876542211 112344455555566443312111 12
Q ss_pred -CCceEEEEeecCCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEE
Q 012825 231 -TDNVYVVMELCEGGELLDRILS------RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (455)
Q Consensus 231 -~~~~~lV~E~~~ggsL~~~l~~------~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vk 303 (455)
...+.+.|..+.|..--..+.. ......|..+.++++.|+.+...||+.|.+-+|++++|+|+ .+++.|.
T Consensus 81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~ 157 (637)
T COG4248 81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVV 157 (637)
T ss_pred ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEE
Confidence 2237788988877532222221 12357899999999999999999999999999999999999 6778899
Q ss_pred EeecccccccCCCCcccccccCCCcccccccC-CC-----CCCcchHHHHHHHHHHHHcC-CCCCCCCChh----HHHH-
Q 012825 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RS-----YSTEADVWSIGVIAYILLCG-SRPFWARTES----GIFR- 371 (455)
Q Consensus 304 L~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~-----~~~~sDiwSlG~~l~elltg-~~Pf~~~~~~----~~~~- 371 (455)
|.|-..-....++......+|...|.+||..+ +. -+...|.|.||+++++++.| +.||.+.... .-..
T Consensus 158 LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 158 LVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred EEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 98866544444455556678999999999765 32 35679999999999998886 9999542211 0000
Q ss_pred HHH------------hcCCCCCCCCCCCCCHHHHHHHHHhccC--CccCCCCHHH
Q 012825 372 AVL------------KADPSFDEAPWPSLSSEARDFVKRLLNK--DPRKRLTAAQ 412 (455)
Q Consensus 372 ~i~------------~~~~~~~~~~~~~~s~~l~~li~~~L~~--dP~~Rps~~e 412 (455)
.|. ...+.....+|..+++++..|+.+|+.. ++.-|||++.
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 010 0112223344567889999999999875 4568999864
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.7e-11 Score=121.78 Aligned_cols=153 Identities=24% Similarity=0.286 Sum_probs=113.1
Q ss_pred HHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcc----------cccccCCCcccccccCC
Q 012825 268 QILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL----------NDIVGSAYYVAPEVLHR 336 (455)
Q Consensus 268 qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~----------~~~~gt~~y~aPE~~~~ 336 (455)
+++.||.|+|.. ++||++|.|++|.+ +..+.+||+.|+++......... ........|.|||++..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 344999999987 89999999999999 78899999999988665442111 11234567999998874
Q ss_pred -CCCCcchHHHHHHHHHHHH-cCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHH
Q 012825 337 -SYSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (455)
Q Consensus 337 -~~~~~sDiwSlG~~l~ell-tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL 414 (455)
..+.++|+||+|+++|-+. .|+..+...............+..-.......+++++++=|.++|..|...||++.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 5788999999999999888 45555544433222222222221111112246889999999999999999999999999
Q ss_pred cCcccCCCC
Q 012825 415 SHPWIKNSN 423 (455)
Q Consensus 415 ~hp~~~~~~ 423 (455)
..+||.+..
T Consensus 264 ~~~ff~D~~ 272 (700)
T KOG2137|consen 264 SIPFFSDPG 272 (700)
T ss_pred cccccCCch
Confidence 999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.06 E-value=9.7e-10 Score=99.16 Aligned_cols=130 Identities=25% Similarity=0.275 Sum_probs=82.3
Q ss_pred EEEEEEEecCcccCeEEEEEEccCCC-----------------------cCCHHHHHHHHHHHHHHHHhcCC-CCeeEEe
Q 012825 170 YTCAAKFKKGELKGQQVAVKVIPKHK-----------------------MTTAIAIEDVRREVKILRALTGH-NNLVKFF 225 (455)
Q Consensus 170 ~V~~~~~~~~~~~g~~vavK~~~~~~-----------------------~~~~~~~~~~~~Ei~~l~~l~~h-p~Iv~l~ 225 (455)
.||.|...+ |..+|||+..... ...........+|.+.|.++... -++.+.+
T Consensus 1 ~Vy~~~~~~----~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~ 76 (188)
T PF01163_consen 1 DVYHAIDPD----GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPY 76 (188)
T ss_dssp EEEEEEECT----TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EE
T ss_pred CEEEEECCC----CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEE
Confidence 378887554 7899999884321 01122334578999999999843 2566776
Q ss_pred EEEeeCCceEEEEeecC--CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHcCCEEeeccCCceEEeecCCCceE
Q 012825 226 DAYEDTDNVYVVMELCE--GGELLDRILSRGGKYTEDDAKAVMIQILNVVAF-CHLQGVVHRDLKPENFLFTTKDENSVL 302 (455)
Q Consensus 226 ~~~~~~~~~~lV~E~~~--ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~-LH~~~ivHrDikp~NILl~~~~~~~~v 302 (455)
++. ..+|||||++ |..+.. +.... ++......++.+++..+.. +|..||+|+||.+.|||+. ++ .+
T Consensus 77 ~~~----~~~ivME~I~~~G~~~~~-l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~---~~-~~ 145 (188)
T PF01163_consen 77 DYN----RNVIVMEYIGEDGVPLPR-LKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD---DG-KV 145 (188)
T ss_dssp EEE----TTEEEEE--EETTEEGGC-HHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE---TT-CE
T ss_pred EEe----CCEEEEEecCCCccchhh-HHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee---cc-eE
Confidence 542 3489999998 544433 32221 2245567788888885555 5799999999999999994 33 79
Q ss_pred EEeecccccccC
Q 012825 303 KAIDFGLSDFVR 314 (455)
Q Consensus 303 kL~DfG~a~~~~ 314 (455)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.3e-09 Score=95.87 Aligned_cols=142 Identities=18% Similarity=0.206 Sum_probs=98.1
Q ss_pred EEEEEEEecCcccCeEEEEEEccCCCcCC----HHHHHHHHHHHHHHHHhcCCCC--eeEEeEEEeeCC----ceEEEEe
Q 012825 170 YTCAAKFKKGELKGQQVAVKVIPKHKMTT----AIAIEDVRREVKILRALTGHNN--LVKFFDAYEDTD----NVYVVME 239 (455)
Q Consensus 170 ~V~~~~~~~~~~~g~~vavK~~~~~~~~~----~~~~~~~~~Ei~~l~~l~~hp~--Iv~l~~~~~~~~----~~~lV~E 239 (455)
.+|.+.....+..++.+-+|.+......+ ........+|...+..|. .-+ +.+.+++.+... .-+||+|
T Consensus 19 ~~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~-~~Gi~tP~pva~~~~r~~~~~~s~lite 97 (206)
T PF06293_consen 19 GGWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLR-EAGIPTPEPVAYGERRKGGGYRSYLITE 97 (206)
T ss_pred eEEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHH-HcCCCCCcEEEEEEEcCCCceeEEEEEE
Confidence 44444444334456677777543221111 122345778888888776 333 445666655422 3589999
Q ss_pred ecCCC-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 240 LCEGG-ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 240 ~~~gg-sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
++++. +|.+++..... .+......++.+++..+.-||+.||+|+|+++.|||+..++....+.|+||+-++..
T Consensus 98 ~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 98 ALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred eCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99885 67777654332 677888999999999999999999999999999999965555568999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.7e-09 Score=97.14 Aligned_cols=140 Identities=26% Similarity=0.285 Sum_probs=103.7
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCC-----------------cCC--HHHHHHHHHHHHHHHHhcC
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-----------------MTT--AIAIEDVRREVKILRALTG 217 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~-----------------~~~--~~~~~~~~~Ei~~l~~l~~ 217 (455)
+.++.+||.|--+.||.|...+ |..+|||.-.... ..+ .......++|.++|.+|..
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~----g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK----GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred HhhccccccCccceEEEEECCC----CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 4578899999999999998665 8899999642211 001 2223446789999999974
Q ss_pred C-CCeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec
Q 012825 218 H-NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (455)
Q Consensus 218 h-p~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~ 296 (455)
+ -.+.+-++ .+..++||||++|..|... +++.+....++..|++-+.-+-..||||+|+..-|||+
T Consensus 169 ~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV--- 235 (304)
T COG0478 169 EGVKVPKPIA----WNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV--- 235 (304)
T ss_pred cCCCCCCccc----cccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---
Confidence 3 25666654 5667999999998665432 12455666777777777777779999999999999999
Q ss_pred CCCceEEEeeccccccc
Q 012825 297 DENSVLKAIDFGLSDFV 313 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~ 313 (455)
++++.+.++||--+...
T Consensus 236 ~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 236 TEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ecCCCEEEEeCcccccC
Confidence 78888999999866543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=7.1e-08 Score=99.71 Aligned_cols=147 Identities=19% Similarity=0.243 Sum_probs=95.7
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc---------------------------CC----HHHHHHH----
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM---------------------------TT----AIAIEDV---- 205 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~---------------------------~~----~~~~~~~---- 205 (455)
+-|+.++-|+||.|+.+. |+.||||+...+.. .- .+..+.+
T Consensus 131 ~PiAsASIaQVH~A~L~s----G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 131 EPIASASIAQVHRAVLKS----GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred CchhhhhHhhheeEEecC----CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 578999999999999887 89999999854320 00 1111222
Q ss_pred --HHHHHHHHHhc----CCCCeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 012825 206 --RREVKILRALT----GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279 (455)
Q Consensus 206 --~~Ei~~l~~l~----~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~ 279 (455)
.+|...+.++. +.+++.--.-|++-.+...|+|||++|-.+.+...-+...++...+.....+++ +..+-..
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~d 284 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRD 284 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhc
Confidence 33333343333 345444333345556677999999999888876433334455333333222221 2334457
Q ss_pred CCEEeeccCCceEEeecCCCceEEEeecccccccCCC
Q 012825 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (455)
Q Consensus 280 ~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~ 316 (455)
|++|.|.+|.||++ +.++.+.+.|||+.......
T Consensus 285 gffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 GFFHADPHPGNILV---RSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred CccccCCCccceEE---ecCCcEEEEcCcceecCCHH
Confidence 99999999999999 77789999999998776543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.1e-07 Score=99.05 Aligned_cols=211 Identities=22% Similarity=0.264 Sum_probs=150.4
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce----EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 012825 200 IAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV----YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275 (455)
Q Consensus 200 ~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~----~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~ 275 (455)
..+.....|+..+.++. |+|++.++.|..+.... .+..|+|...++...+ +.-+.++...++.+..++.+||.|
T Consensus 224 ~~i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-q~v~~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-QSVGSIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-hhccccCHHHHHHHHHHHhhhHHH
Confidence 34455667888888888 99999999987655433 3445788887877765 455678999999999999999999
Q ss_pred HHHcCCEEeeccCCceEEeecCCCceEEEe--ecccccccCCCCcccccccCCCcccccccCCC---CCCcchHHHHHHH
Q 012825 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAI--DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS---YSTEADVWSIGVI 350 (455)
Q Consensus 276 LH~~~ivHrDikp~NILl~~~~~~~~vkL~--DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~sDiwSlG~~ 350 (455)
+|+....|.-+...-..-...+.++.+.++ ||+.+..............+..+.++|..... .....|+|.+|.+
T Consensus 302 ~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 302 LHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred HHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 999976666665553332222566777777 99988877655554455566678888877643 3444799999999
Q ss_pred HHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCC
Q 012825 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 351 l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~ 425 (455)
+..+..|..+-... ......+.. .......+++.+|+.-|.++|+++.+++.|+|.+...+.
T Consensus 382 ~~~~~~~~~i~~~~---~~~~~~l~~----------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~ 443 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKS---AVPVSLLDV----------LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDN 443 (1351)
T ss_pred HhhhhhcCcccccc---cchhhhhcc----------ccchhhhhhhhhhcchhhhhccchhhhhhchhccccccc
Confidence 99988876442111 111111111 111267899999999999999999999999999976443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.6e-07 Score=83.18 Aligned_cols=143 Identities=15% Similarity=0.137 Sum_probs=99.3
Q ss_pred EeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC---HHHHHHHHHHHHHHHHhcCC-CCeeEEeEEEee-----CCc
Q 012825 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGH-NNLVKFFDAYED-----TDN 233 (455)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~~h-p~Iv~l~~~~~~-----~~~ 233 (455)
-|+||.+.|+...+. |+.+-+|.-......+ ......|.+|+..+.+|... -.+.+.+ ++.. .-.
T Consensus 26 ~~rgG~SgV~r~~~~-----g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r 99 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR 99 (216)
T ss_pred cCCCCcceEEEEEeC-----CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence 456888888876543 3468888764221111 33456789999999988721 1244444 3321 123
Q ss_pred eEEEEeecCC-CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 234 VYVVMELCEG-GELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 234 ~~lV~E~~~g-gsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
-+||+|-+.| .+|.+++.+.. ...+......++.+++..|.-||+.|+.|+|+.+.|||+...+ +..++++||.-++
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r 178 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccc
Confidence 6899998854 37777664432 3567888889999999999999999999999999999994322 3359999998765
Q ss_pred c
Q 012825 312 F 312 (455)
Q Consensus 312 ~ 312 (455)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.57 E-value=8.6e-07 Score=81.07 Aligned_cols=143 Identities=21% Similarity=0.267 Sum_probs=90.6
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHH------HHHHHHHHHHhc--CCCCeeE
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED------VRREVKILRALT--GHNNLVK 223 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~------~~~Ei~~l~~l~--~hp~Iv~ 223 (455)
....+|.+.+.+-......|.+-. .+|..+++|............... ..+++..+.++. +...+..
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe-----i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~ 102 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE-----IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD 102 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE-----ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence 346788888888887777776544 247889999875432111111111 234444444443 2333333
Q ss_pred EeEEEe-----eCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCC
Q 012825 224 FFDAYE-----DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298 (455)
Q Consensus 224 l~~~~~-----~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~ 298 (455)
++-+.+ .....+|||||++|..|.+.. .+++ .+...|.+++.-||+.|++|+|++|.|+++.
T Consensus 103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~-----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~---- 169 (229)
T PF06176_consen 103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE-----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS---- 169 (229)
T ss_pred ceeeeeeeeccceeEEEEEEEEecCeecccch-----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----
Confidence 333322 223457899999998776532 1233 2446677889999999999999999999994
Q ss_pred CceEEEeecccccc
Q 012825 299 NSVLKAIDFGLSDF 312 (455)
Q Consensus 299 ~~~vkL~DfG~a~~ 312 (455)
++.++++||+..+.
T Consensus 170 ~~~i~iID~~~k~~ 183 (229)
T PF06176_consen 170 NNGIRIIDTQGKRM 183 (229)
T ss_pred CCcEEEEECccccc
Confidence 33499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.55 E-value=8.6e-07 Score=82.84 Aligned_cols=73 Identities=22% Similarity=0.245 Sum_probs=53.8
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCC-CeeEEeEEEeeCCceEEEEe
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDAYEDTDNVYVVME 239 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-~Iv~l~~~~~~~~~~~lV~E 239 (455)
..||.|..+.||+.. |..+++|+..... ....+.+|.++++.+.... .+.+.+++....+...+|||
T Consensus 7 ~~i~~G~t~~~y~~~-------~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-------TGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEec-------CCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence 578999999999731 4467889875421 1234688999999987332 25778888888888899999
Q ss_pred ecCCCc
Q 012825 240 LCEGGE 245 (455)
Q Consensus 240 ~~~ggs 245 (455)
+++|..
T Consensus 75 ~i~G~~ 80 (226)
T TIGR02172 75 LIVGKR 80 (226)
T ss_pred ecCCcc
Confidence 998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.6e-09 Score=109.14 Aligned_cols=246 Identities=17% Similarity=0.168 Sum_probs=170.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCC-eeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-LVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~-Iv~l~~~~~~~~ 232 (455)
++-+...+.+++|+++.+++.+... -+....+.+... ....-++++|.+++ ||| .+..++-++.++
T Consensus 241 ~kws~~fh~fvK~altknpKkRpta----eklL~h~fvs~~--------l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~ 307 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTA----EKLLQHPFVSQT--------LSRRLAIELLDKVN-NPNPVVRYLEDYDGED 307 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCCh----hhheeceeeccc--------hhhHHHHHHHHHcc-CCCCcccccccCCccc
Confidence 4557778889999999998877544 223335555322 34556899999998 999 777888788888
Q ss_pred ceEEEEeecCCC-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGG-ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
..+++++++.++ +...........+.+-....+++.-+++|++||+.--+|+| ||+.. +...+..||+...
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPP 379 (829)
T ss_pred ccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCc
Confidence 899999999877 22221111112344555667788888999999998878999 88873 4668999999988
Q ss_pred ccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
.+......+...+++.++|||+.. +.+...-|+|++|+-..+|.-|..|-...... ...+-.....+....-..++.
T Consensus 380 ~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~g~~p~s~~L~~~~aw~~ 457 (829)
T KOG0576|consen 380 QLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMIGNGPNSPMLTDKSAWSP 457 (829)
T ss_pred ccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccc--cCCCCCCCCccccchhhhcCc
Confidence 877666677889999999999765 67899999999998777777776664321000 000000000000000001112
Q ss_pred HHH-HHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 391 EAR-DFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 391 ~l~-~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.+. ++...|+..-|..|+....++.|-+|.+-
T Consensus 458 ~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 458 VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred ccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 222 58889999999999999999999999864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.1e-06 Score=79.89 Aligned_cols=79 Identities=22% Similarity=0.233 Sum_probs=56.5
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCC-CeeEEeEEEe---eCCceE
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDAYE---DTDNVY 235 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-~Iv~l~~~~~---~~~~~~ 235 (455)
++.|+.|..+.||++.... ..+++|+.. .......+.+|..+++.|..+- .+.+++.+.. .....+
T Consensus 2 i~~l~~G~~n~~~~v~~~~-----~~~vlK~~~-----~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-----GRYVLKFYR-----PPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-----SEEEEEEES-----SHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred CccCCCCCeeeEEEEEECC-----cEEEEEEeC-----CCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence 4679999999999987443 489999863 2255677889999999887442 2567776443 233478
Q ss_pred EEEeecCCCcHHH
Q 012825 236 VVMELCEGGELLD 248 (455)
Q Consensus 236 lV~E~~~ggsL~~ 248 (455)
++|++++|..+..
T Consensus 72 ~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 72 LLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEESSEEHHH
T ss_pred EEEEEeccccccc
Confidence 9999999987766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.1e-06 Score=75.16 Aligned_cols=130 Identities=24% Similarity=0.290 Sum_probs=92.8
Q ss_pred CCCeEEeceEeecCC-eEEEEEEEecCcccCeEEEEEEccC---CC-------cCC--------HHHHHHHHHHHHHHHH
Q 012825 154 ANKYELGEEVGRGHF-GYTCAAKFKKGELKGQQVAVKVIPK---HK-------MTT--------AIAIEDVRREVKILRA 214 (455)
Q Consensus 154 ~~~y~~~~~LG~G~f-g~V~~~~~~~~~~~g~~vavK~~~~---~~-------~~~--------~~~~~~~~~Ei~~l~~ 214 (455)
+.+++.++.||.|.- |.||+++. .|+.||+|++.. .. ... .....-|..|.+...+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I-----~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgR 110 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI-----DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGR 110 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE-----CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHH
Confidence 478999999999999 99999874 368999999321 00 000 0223457788888888
Q ss_pred hcC--CCCe--eEEeEEEeeC------------------CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHH
Q 012825 215 LTG--HNNL--VKFFDAYEDT------------------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272 (455)
Q Consensus 215 l~~--hp~I--v~l~~~~~~~------------------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~g 272 (455)
|+. +.++ |+++||..-. -...||.||++... .+.. .-+.+|.+-
T Consensus 111 Lke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~d 176 (207)
T PF13095_consen 111 LKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRD 176 (207)
T ss_pred HHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHH
Confidence 773 4455 9999987422 12468888886543 1222 334567778
Q ss_pred HHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 273 L~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
|..+|..||+-+|+++.|..= -||+|||.+
T Consensus 177 l~~~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 177 LKILHKLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred HHHHHHCCeeeccCccccccC--------CEEEecccC
Confidence 888999999999999999873 588999964
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.9e-06 Score=79.32 Aligned_cols=75 Identities=19% Similarity=0.215 Sum_probs=53.4
Q ss_pred EeecCC-eEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeec
Q 012825 163 VGRGHF-GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241 (455)
Q Consensus 163 LG~G~f-g~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~ 241 (455)
|-.|.. ..||++... +..+.||+..... ...+.+|+++++.+..+--+.+++++...++..++|||++
T Consensus 6 ~~~g~~~~~v~~~~~~-----~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 74 (244)
T cd05150 6 VTEGQSGATVYRLDGK-----NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV 74 (244)
T ss_pred cCCCCCcCeEEEEcCC-----CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence 444555 578887532 3578889874332 2356789999999986655668888887777789999999
Q ss_pred CCCcHHH
Q 012825 242 EGGELLD 248 (455)
Q Consensus 242 ~ggsL~~ 248 (455)
+|.++..
T Consensus 75 ~G~~l~~ 81 (244)
T cd05150 75 PGVPAAA 81 (244)
T ss_pred CCccHhH
Confidence 9876653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.6e-06 Score=77.19 Aligned_cols=147 Identities=20% Similarity=0.203 Sum_probs=92.1
Q ss_pred CCCeEEeceEe---ecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-------------------CH--HHHHHHHHHH
Q 012825 154 ANKYELGEEVG---RGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-------------------TA--IAIEDVRREV 209 (455)
Q Consensus 154 ~~~y~~~~~LG---~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-------------------~~--~~~~~~~~Ei 209 (455)
.++..+....| .|--+.||+|.... +..||||++...... +. ........|.
T Consensus 44 ~~rg~i~~~~g~istGKEA~Vy~a~~~~----~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf 119 (268)
T COG1718 44 LSRGVITELVGCISTGKEANVYLAETGD----GRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEF 119 (268)
T ss_pred hcCCceeeeEeeecCCcceEEEeeccCC----CceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHH
Confidence 44555555555 45555899987543 789999998532110 11 1112234566
Q ss_pred HHHHHhcC-CCCeeEEeEEEeeCCceEEEEeecCCCcHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeec
Q 012825 210 KILRALTG-HNNLVKFFDAYEDTDNVYVVMELCEGGELL-DRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDL 286 (455)
Q Consensus 210 ~~l~~l~~-hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~-~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDi 286 (455)
.-|+++.. +=.+.+-+.+. .-.|||||+....+- -.| +.-.+...++..+..++++.+.-|-. .++||+||
T Consensus 120 ~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDL 193 (268)
T COG1718 120 RNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDL 193 (268)
T ss_pred HHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccc
Confidence 66666651 12233333322 348999999432100 000 11223344788889999999988877 89999999
Q ss_pred cCCceEEeecCCCceEEEeecccccccC
Q 012825 287 KPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 287 kp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
..-|||+ . ++.+.|+|||-|....
T Consensus 194 SEyNiL~---~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 194 SEYNILV---H-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hhhheEE---E-CCeEEEEECccccccC
Confidence 9999999 4 6779999999887654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.2e-06 Score=75.10 Aligned_cols=131 Identities=22% Similarity=0.355 Sum_probs=92.3
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
.+..+.|++|++|.||++.+. |..+|+|+-.. +.....+..|.++|..+.+----.++|.|..+ ++
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-----~~~~a~Kvrr~-----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i 89 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-----GGEVALKVRRR-----DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FI 89 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-----CceEEEEEecC-----CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hh
Confidence 455788999999999999855 56899998633 22346788999999999866566677765543 45
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccC--CceEEeecCCCceEEEeeccccccc
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKP--ENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp--~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.|||++|-.|.+..... + ++-+..+++.-.-|-..||-|..|.- .||++ .++.+.|+||..|+..
T Consensus 90 ~me~i~G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~k 156 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhcCcchhhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhhc
Confidence 59999998877644211 2 23334455555556677999999863 36666 3347999999998754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.3e-06 Score=88.39 Aligned_cols=148 Identities=17% Similarity=0.231 Sum_probs=93.6
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC----------------------------CHHHHHHHHHHHHH
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT----------------------------TAIAIEDVRREVKI 211 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~----------------------------~~~~~~~~~~Ei~~ 211 (455)
.+.||.-+.|+|++|+.+. |+.||||+-+..... -++..+.+..|++.
T Consensus 166 ~~piaaASlaQVhrA~L~~----G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN----GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred cchhhhcchhheEEEEecC----CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 3679999999999999887 899999997543210 01122233334443
Q ss_pred HHHhc---------CCCC------eeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 012825 212 LRALT---------GHNN------LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276 (455)
Q Consensus 212 l~~l~---------~hp~------Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~L 276 (455)
+..-+ .|-+ |.+++ +.......|+||||+|..+.|.-.-....++...+..-+.++..- -+
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~--qI 317 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLE--QI 317 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHH--HH
Confidence 33222 1333 33443 333456799999999987765433333446666544444443322 23
Q ss_pred HHcCCEEeeccCCceEEeec-CCCceEEEeecccccccCC
Q 012825 277 HLQGVVHRDLKPENFLFTTK-DENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 277 H~~~ivHrDikp~NILl~~~-~~~~~vkL~DfG~a~~~~~ 315 (455)
=..|++|+|=+|.||++... ..+..+.+-|||+......
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 34589999999999999632 3567899999999877653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.9e-05 Score=71.97 Aligned_cols=139 Identities=20% Similarity=0.294 Sum_probs=96.0
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc-------------CCHHHHHHHHHHHHHHHHhc-----CCCCe
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-------------TTAIAIEDVRREVKILRALT-----GHNNL 221 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~-------------~~~~~~~~~~~Ei~~l~~l~-----~hp~I 221 (455)
...||+|+.=.||.-- ......||+...... ......++..+|+.....+. .+.+|
T Consensus 6 ~~~i~~G~~R~cy~HP------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i 79 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHI 79 (199)
T ss_pred CcccccCCCceEEECC------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccc
Confidence 4578999988887532 245678898865430 00112345566666665554 37899
Q ss_pred eEEeEEEeeCCceEEEEeecCC------CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEee
Q 012825 222 VKFFDAYEDTDNVYVVMELCEG------GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295 (455)
Q Consensus 222 v~l~~~~~~~~~~~lV~E~~~g------gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~ 295 (455)
.+++|+.+++....+|+|.+.. .+|.+++. .+.+++ .+...+-+-..||-+.+|+.+|++|.||++..
T Consensus 80 ~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 80 PRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred ccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 9999999999999999998743 26777663 334555 33334445557888999999999999999987
Q ss_pred cCCCc-eEEEee-cccc
Q 012825 296 KDENS-VLKAID-FGLS 310 (455)
Q Consensus 296 ~~~~~-~vkL~D-fG~a 310 (455)
.++.. .+.|+| ||..
T Consensus 154 ~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGEK 170 (199)
T ss_pred cCCCceEEEEEeCCCCc
Confidence 66555 788888 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.27 E-value=1e-05 Score=89.74 Aligned_cols=151 Identities=24% Similarity=0.413 Sum_probs=92.2
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCe--eEEeEEEeeC---Cce
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL--VKFFDAYEDT---DNV 234 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~I--v~l~~~~~~~---~~~ 234 (455)
++.|+.|.+..+|+.....+. ....+++|+....... .....+.+|.++++.|..|.++ .+++.++.+. +..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~-~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG-SVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC-cceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 567889999999987654321 1146788876443211 1234678999999999656654 7888887654 467
Q ss_pred EEEEeecCCCcHHH--------------------H---HHhcC----------CC--CCHHHHHHHHHH-----------
Q 012825 235 YVVMELCEGGELLD--------------------R---ILSRG----------GK--YTEDDAKAVMIQ----------- 268 (455)
Q Consensus 235 ~lV~E~~~ggsL~~--------------------~---l~~~~----------~~--l~~~~~~~i~~q----------- 268 (455)
|+||||++|..+.+ . |+.-. .. +...++..|..+
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 99999998764221 0 11100 00 111223222221
Q ss_pred ----HHHHHHHHHH-----------cCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 269 ----ILNVVAFCHL-----------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 269 ----i~~gL~~LH~-----------~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+...+.+|.. ..+||+|+++.|||+..+ +...+-|.||+++..-.
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~-~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPT-EDRVIGILDWELSTLGN 259 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCC-CCeEEEEEeeeccccCC
Confidence 2334566643 249999999999999521 23456899999986643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.1e-05 Score=72.77 Aligned_cols=73 Identities=21% Similarity=0.150 Sum_probs=45.8
Q ss_pred ceEeecCCe-EEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCC--CeeEEeEEEeeC---Cce
Q 012825 161 EEVGRGHFG-YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN--NLVKFFDAYEDT---DNV 234 (455)
Q Consensus 161 ~~LG~G~fg-~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp--~Iv~l~~~~~~~---~~~ 234 (455)
+.|+.|+.. .||+.. ..+++|+.... .....+.+|.+++..|..+- -+.+.++..... ...
T Consensus 3 ~~~~~gG~~n~vy~~~--------~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~ 69 (235)
T cd05155 3 EPVDSGGTDNATFRLG--------DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP 69 (235)
T ss_pred eeccCCCcccceEEcC--------CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence 457767766 477642 24778875331 12347889999999887431 344555544332 235
Q ss_pred EEEEeecCCCcH
Q 012825 235 YVVMELCEGGEL 246 (455)
Q Consensus 235 ~lV~E~~~ggsL 246 (455)
+++|++++|.++
T Consensus 70 ~~l~~~i~G~~l 81 (235)
T cd05155 70 WSVYRWLEGETA 81 (235)
T ss_pred eEEEEeecCCCC
Confidence 889999998665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.2e-05 Score=71.09 Aligned_cols=101 Identities=21% Similarity=0.247 Sum_probs=80.1
Q ss_pred HHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecCCCcHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHHc---C
Q 012825 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI--LSRGGKYTEDDAKAVMIQILNVVAFCHLQ---G 280 (455)
Q Consensus 206 ~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l--~~~~~~l~~~~~~~i~~qi~~gL~~LH~~---~ 280 (455)
..|.-+++.+++.+++++++|+|- .++|.||...+++.... ...-...+|..+.+|+.++++.+++|+.. .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888999986679999999982 27799999876654210 01112468999999999999999999983 4
Q ss_pred CEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 281 ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+.-.|++++|+-+ .+++.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEE---eCCCcEEEEechhcchh
Confidence 8889999999999 67788999999976543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00029 Score=71.01 Aligned_cols=81 Identities=19% Similarity=0.243 Sum_probs=54.5
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc---CC-HHHHHHHHHHHHHHHHhcCC--CCeeEEeEEEeeCCc
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM---TT-AIAIEDVRREVKILRALTGH--NNLVKFFDAYEDTDN 233 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~---~~-~~~~~~~~~Ei~~l~~l~~h--p~Iv~l~~~~~~~~~ 233 (455)
.+.||.|.+..||++...+ .++.|+||.-..... .. ....++...|.+.|..+..+ .++++++.+ +.+.
T Consensus 31 ~~elggGn~N~VyrV~~~~---g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~ 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTE---GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEEL 105 (401)
T ss_pred eeEcCCCceEEEEEEEeCC---CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCC
Confidence 4678999999999998654 125899997531110 10 12345667788888876533 457778766 4456
Q ss_pred eEEEEeecCCCc
Q 012825 234 VYVVMELCEGGE 245 (455)
Q Consensus 234 ~~lV~E~~~ggs 245 (455)
.++||||+++..
T Consensus 106 ~~lVME~L~~~~ 117 (401)
T PRK09550 106 AVTVMEDLSDHK 117 (401)
T ss_pred CEEEEecCCCcc
Confidence 799999998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=2.5e-05 Score=74.90 Aligned_cols=138 Identities=18% Similarity=0.269 Sum_probs=94.7
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc-----------------CCHHHHH--HHHHHHHHHHHhcC
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-----------------TTAIAIE--DVRREVKILRALTG 217 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~-----------------~~~~~~~--~~~~Ei~~l~~l~~ 217 (455)
+.++++||-|.-+.||.+-+.+ |++.++|+-..... .+=..+. ...+|...|+.|..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~----G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE----GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE 169 (465)
T ss_pred hhhccccccccccceEEEecCC----CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence 6789999999999999998665 78888886421110 0000111 23578888888875
Q ss_pred CCC-eeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec
Q 012825 218 HNN-LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (455)
Q Consensus 218 hp~-Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~ 296 (455)
|-. +.+.+ +.+..++|||++.|..|...- ....+..+...+..-+--|-.+|+||+|+.==||+|
T Consensus 170 ~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~-------~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv--- 235 (465)
T KOG2268|consen 170 RGFPVPKPI----DHNRHCVVMELVDGYPLRQVR-------HVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV--- 235 (465)
T ss_pred cCCCCCCcc----cccceeeHHHhhcccceeeee-------ecCChHHHHHHHHHHHHHHHHcCceecccchheeEE---
Confidence 543 33443 345679999999887765422 112233455555556667889999999999999999
Q ss_pred CCCceEEEeecccccc
Q 012825 297 DENSVLKAIDFGLSDF 312 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~ 312 (455)
+++..++++||--...
T Consensus 236 ~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVS 251 (465)
T ss_pred ecCCCEEEeechHhhc
Confidence 6677899999975543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00029 Score=68.67 Aligned_cols=81 Identities=11% Similarity=0.046 Sum_probs=57.7
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCC--CCeeEEeEEEee---
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH--NNLVKFFDAYED--- 230 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h--p~Iv~l~~~~~~--- 230 (455)
...-.+.||.|..+.||.....+ + .+++|..+. . . ....+.+|...++.|..+ -.+.++++++..
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~----~-~~~~k~~~~-~-~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQ----G-NPMPLMARS-F-S---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred hhheeeecCCccceeEEEEEcCC----C-CEEEEEecc-c-c---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 34456789999999999876333 3 477787432 1 0 114688999999999754 367888888754
Q ss_pred CCceEEEEeecCCCcH
Q 012825 231 TDNVYVVMELCEGGEL 246 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL 246 (455)
.+..+||||+++|.++
T Consensus 85 ~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 PGPDVLLLERLRGVSV 100 (297)
T ss_pred CCCeEEEEeccCCEec
Confidence 3668999999998654
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00012 Score=74.28 Aligned_cols=164 Identities=23% Similarity=0.260 Sum_probs=107.2
Q ss_pred HHHHHHHHHHHhcCCCCeeEEeEEEeeC-CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCE
Q 012825 204 DVRREVKILRALTGHNNLVKFFDAYEDT-DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282 (455)
Q Consensus 204 ~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~iv 282 (455)
.+.....+++.++ |+|+..++++-... ....+|||++ +.+|++.+..+. +-.... + .+++.
T Consensus 28 ~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s~----------~----~~~~~ 89 (725)
T KOG1093|consen 28 QILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDESL----------L----AHGVL 89 (725)
T ss_pred HHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhhh----------c----ccccc
Confidence 4566778888888 99999999887643 3478899999 669999776543 111111 1 12222
Q ss_pred EeeccCCceEEeecCCCceEEEeecccccccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCC
Q 012825 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFW 362 (455)
Q Consensus 283 HrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~ 362 (455)
|- || ++++| -++... |-. ..+|+|||++|.++.++..|...+.
T Consensus 90 ~~-----~~----------~~~td-~~~t~~-----------------~~~----~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 90 HL-----NI----------IYITD-HFLTKY-----------------PSP----IGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred ee-----hh----------hhccc-cccccC-----------------CCC----CCcchhhhhHHHHHHHHHHhhHHHH
Confidence 21 22 33344 111100 000 1149999999999999999998887
Q ss_pred CCChhHHHHHHHhcCCCCCCCC--------CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 363 ARTESGIFRAVLKADPSFDEAP--------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 363 ~~~~~~~~~~i~~~~~~~~~~~--------~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.....+....+++-........ .-.+++.+.++...|+-..|..||...++.+++-|.+.
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 7666666555554332211110 11356778899999999999999999999999988875
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=7.1e-06 Score=91.60 Aligned_cols=220 Identities=15% Similarity=0.026 Sum_probs=145.7
Q ss_pred HHHHHHHHHHhcCCCCeeEEeEEEe--eCCceEEEEeecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc
Q 012825 205 VRREVKILRALTGHNNLVKFFDAYE--DTDNVYVVMELCEGGELLDRILSRGG---KYTEDDAKAVMIQILNVVAFCHLQ 279 (455)
Q Consensus 205 ~~~Ei~~l~~l~~hp~Iv~l~~~~~--~~~~~~lV~E~~~ggsL~~~l~~~~~---~l~~~~~~~i~~qi~~gL~~LH~~ 279 (455)
...|.+.++.+. |+++.....-.. +....+.+++|+.+|.+.+.+.+.-. .+...-+.....+.+....-+|..
T Consensus 1276 ll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 445555566666 888877665443 34457899999999999998865432 344444444555546666666665
Q ss_pred C-----CEEeeccCCceEEeecCCCceEEEeecccccccCCC-CcccccccCCCcccccccCC-CCCCcchHHHHHHHHH
Q 012825 280 G-----VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAY 352 (455)
Q Consensus 280 ~-----ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ 352 (455)
. .+|+++|+.|.+| ..+.++|++++|+.+...+. .......+++.|+.+++.+. .++.++|+|..|+.+|
T Consensus 1355 tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred ccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 2 7999999999999 77888999999999944333 33456678889999998875 5777799999999999
Q ss_pred HHHcCCCCCCCCChhHHHHHHHhcCC----CCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCc
Q 012825 353 ILLCGSRPFWARTESGIFRAVLKADP----SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428 (455)
Q Consensus 353 elltg~~Pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p 428 (455)
+..-|..+|. ...+.+++... .+... .-.+.+.......+|-+.-..||.-...+.-+.|- ..+.+
T Consensus 1432 ~rs~~n~~fi-----~flq~~Lkgiidn~tf~sIe--~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a---~~~~d 1501 (2724)
T KOG1826|consen 1432 LRSDGNAYFI-----FFLQPALKGIIDNHTFFSIE--KLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA---VGLRD 1501 (2724)
T ss_pred HHhcccHHHH-----HHHHHHHcCccccccccccc--ccCCCcccHHHHHHHHHHhhhcchhhhhccccccc---ccccC
Confidence 9888877662 12222322211 11111 01234455555566666667888888888776665 33444
Q ss_pred hhHHHHHHHH
Q 012825 429 LDVIIFKLMK 438 (455)
Q Consensus 429 ~~~~~~~~~~ 438 (455)
.++-++..+.
T Consensus 1502 ~~k~i~~~a~ 1511 (2724)
T KOG1826|consen 1502 ICKMIYLLAY 1511 (2724)
T ss_pred cchhHHHHHh
Confidence 5555555443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00017 Score=68.67 Aligned_cols=135 Identities=19% Similarity=0.162 Sum_probs=74.3
Q ss_pred EeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecC
Q 012825 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCE 242 (455)
Q Consensus 163 LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 242 (455)
+..|-...+|+.. . .+..+++|+..... ....-...+|..+++.+..+.-..+++... . -++||||++
T Consensus 4 ~~~G~tn~~y~~~--~---~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIE--H---PGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEE--e---CCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEecc
Confidence 4456667888775 1 35678889764321 110013467999999887443334555443 2 378999998
Q ss_pred CCcHHH----------HH-------Hhc---CCCCCHH-HHHHHHHHH---------HHHHHHHHHc--------CCEEe
Q 012825 243 GGELLD----------RI-------LSR---GGKYTED-DAKAVMIQI---------LNVVAFCHLQ--------GVVHR 284 (455)
Q Consensus 243 ggsL~~----------~l-------~~~---~~~l~~~-~~~~i~~qi---------~~gL~~LH~~--------~ivHr 284 (455)
|..+.. .+ +.. ...++.. .+..+..++ ...+..+-.. .++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 865421 01 111 1112211 112221111 1112222221 48999
Q ss_pred eccCCceEEeecCCCceEEEeeccccccc
Q 012825 285 DLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 285 Dikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
|+.+.||+++ +++ +.|+||+.+...
T Consensus 152 Dl~~~Nil~~---~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 152 DVHAYNLVVT---PQG-LKLIDWEYASDG 176 (256)
T ss_pred CCCcCcEEEe---CCC-CEEEeccccCcC
Confidence 9999999994 444 789999988653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00063 Score=63.71 Aligned_cols=77 Identities=21% Similarity=0.280 Sum_probs=48.4
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEe
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E 239 (455)
++.|..|-...+|++....+ .+..|++|+..... . ..-...+|+.+++.+..+.-.+++++.+. + .+|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~--~~~~~vlR~~~~~~--~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e 72 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKED--NQDAVLVRVYGNKT--E--LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYE 72 (235)
T ss_pred EEEcCCcccceEEEEEcCCC--CCCeEEEEEccCCc--c--ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEE
Confidence 35667777789998864321 14678899764321 1 11234578999988874444556655433 2 47999
Q ss_pred ecCCCcH
Q 012825 240 LCEGGEL 246 (455)
Q Consensus 240 ~~~ggsL 246 (455)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9988664
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00053 Score=66.65 Aligned_cols=139 Identities=17% Similarity=0.166 Sum_probs=81.3
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCC-CeeEEeEE------EeeCC
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDA------YEDTD 232 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-~Iv~l~~~------~~~~~ 232 (455)
.+.|..|....+|++... +..+++|+... .. ...+..|+.++..|..+- .+.+++.. ...++
T Consensus 19 i~~i~~G~~n~~y~v~~~-----~~~~vLr~~~~---~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-----SGRYVLTLFEK---VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred eecccCccccceEEEEeC-----CCcEEEEEcCC---CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 556777777789987532 34688898743 11 245677888888886321 24454432 23345
Q ss_pred ceEEEEeecCCCcHHH----H----------HHhcCCC----------CCHHHH--H--------HHHHHHHHHHHHHHH
Q 012825 233 NVYVVMELCEGGELLD----R----------ILSRGGK----------YTEDDA--K--------AVMIQILNVVAFCHL 278 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~----~----------l~~~~~~----------l~~~~~--~--------~i~~qi~~gL~~LH~ 278 (455)
..++|++|++|..+.. . ++..... ..+... . .....+...+.++.+
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 6789999998865421 1 1110000 011100 0 011123344455543
Q ss_pred -------cCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 279 -------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 279 -------~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+++|+|+.|.|||+ +++..+.|+||+.+..
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLF---DGDELSGVIDFYFACT 205 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEE---eCCceEEEeehhhhcC
Confidence 369999999999999 5566678999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.001 Score=65.11 Aligned_cols=145 Identities=17% Similarity=0.165 Sum_probs=94.4
Q ss_pred EEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc----------------------CCHHHH-HHHHHHHHHHHH
Q 012825 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM----------------------TTAIAI-EDVRREVKILRA 214 (455)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~----------------------~~~~~~-~~~~~Ei~~l~~ 214 (455)
++...|..|--+.||.|.... |..+|||+++.... ...... -....|+.-|++
T Consensus 147 ~inGCiSTGKEANVYHat~~d----G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkR 222 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEED----GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKR 222 (520)
T ss_pred ecccccccCccceeEeeecCC----CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHH
Confidence 344567778888999987554 78899999853210 111111 234567777888
Q ss_pred hcCCCCeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCEEeeccCCceEE
Q 012825 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH-LQGVVHRDLKPENFLF 293 (455)
Q Consensus 215 l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH-~~~ivHrDikp~NILl 293 (455)
+. ...|.----... ....|||+++. .+=+-.=.-++..++...+..+-.+++.-+.-|. ..++||.||.=-|+|+
T Consensus 223 l~-~aGIP~PePIlL--k~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 223 LN-NAGIPCPEPILL--KNHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY 298 (520)
T ss_pred HH-hcCCCCCCceee--ecceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence 76 333322111111 12489999994 3212111123456788888888888888888775 4589999999999999
Q ss_pred eecCCCceEEEeecccccccC
Q 012825 294 TTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 294 ~~~~~~~~vkL~DfG~a~~~~ 314 (455)
.+|.+.|+|-+-+....
T Consensus 299 ----hdG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 299 ----HDGKLYIIDVSQSVEHD 315 (520)
T ss_pred ----ECCEEEEEEccccccCC
Confidence 47889999998775443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00074 Score=65.86 Aligned_cols=79 Identities=14% Similarity=0.172 Sum_probs=48.0
Q ss_pred ceEeecCCeEEEEEEEecC---cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEE
Q 012825 161 EEVGRGHFGYTCAAKFKKG---ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVV 237 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~---~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV 237 (455)
+.|..|--..+|++....+ ...++.|++|+..... ....+..+|.+++..+..+--..++++++.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 3455555558887764321 1125789999974421 1223467898888888744434566665532 358
Q ss_pred EeecCCCcHH
Q 012825 238 MELCEGGELL 247 (455)
Q Consensus 238 ~E~~~ggsL~ 247 (455)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00089 Score=65.56 Aligned_cols=141 Identities=17% Similarity=0.177 Sum_probs=79.1
Q ss_pred EeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCC-CeeEEeEEE------eeC
Q 012825 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDAY------EDT 231 (455)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-~Iv~l~~~~------~~~ 231 (455)
..+.++.|....+|++... +..+++|+.... .. ...+..|++++..|..+- .+.+++... ..+
T Consensus 26 ~i~~~~~G~~n~~y~v~t~-----~~~~vLK~~~~~--~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTD-----VGRYILTLYEKR--VK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred eccccCCccccceEEEEeC-----CCcEEEEEecCC--CC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 3566677777789987532 235778986432 11 134556777777775221 244444321 234
Q ss_pred CceEEEEeecCCCcHH----HH----------HHhcCCCC-----------CHHHH--H----------HHHHHHHHHHH
Q 012825 232 DNVYVVMELCEGGELL----DR----------ILSRGGKY-----------TEDDA--K----------AVMIQILNVVA 274 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~----~~----------l~~~~~~l-----------~~~~~--~----------~i~~qi~~gL~ 274 (455)
+..++++||++|..+. +. ++.....+ .|... . .....+...++
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 5678999999885431 11 11100100 00000 0 01112334555
Q ss_pred HHHH-------cCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 275 FCHL-------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 275 ~LH~-------~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
++.. .+++|+|+++.||++ +.++.+.|+||+.+..
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~---~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLF---DGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEE---ECCceEEEeecccccC
Confidence 5543 479999999999999 5556678999998743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0056 Score=60.16 Aligned_cols=30 Identities=37% Similarity=0.548 Sum_probs=25.1
Q ss_pred CCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 280 ~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+++|+|+++.|||+ +.+...-|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~---~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLF---EGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEE---ECCceEEEEecccccC
Confidence 79999999999999 4455568999998753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.003 Score=61.58 Aligned_cols=129 Identities=20% Similarity=0.299 Sum_probs=74.4
Q ss_pred CeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcC-CCCeeEEeEEEeeCC--ceEEEEeecCCCcHHH----------H
Q 012825 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG-HNNLVKFFDAYEDTD--NVYVVMELCEGGELLD----------R 249 (455)
Q Consensus 183 g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~-hp~Iv~l~~~~~~~~--~~~lV~E~~~ggsL~~----------~ 249 (455)
++.+++. ... ............+|..+++.+.. .--+...+++|.++. ..|.||+|++|..+.+ +
T Consensus 48 ~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~ 125 (321)
T COG3173 48 GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQF 125 (321)
T ss_pred CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHH
Confidence 5677777 332 12333445667789999998863 223445666666655 6799999998842211 1
Q ss_pred HH--------hc------C-------CCCCHHHHHHHHH--------------HHHHHHHHHHHc--------CCEEeec
Q 012825 250 IL--------SR------G-------GKYTEDDAKAVMI--------------QILNVVAFCHLQ--------GVVHRDL 286 (455)
Q Consensus 250 l~--------~~------~-------~~l~~~~~~~i~~--------------qi~~gL~~LH~~--------~ivHrDi 286 (455)
.. +- + +.+...++..+.. .+..-..||+.+ .++|+|+
T Consensus 126 ~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~ 205 (321)
T COG3173 126 ALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDY 205 (321)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCc
Confidence 11 00 0 0001111111111 122234455543 3899999
Q ss_pred cCCceEEeecCCCceEEEeecccccccCCC
Q 012825 287 KPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (455)
Q Consensus 287 kp~NILl~~~~~~~~vkL~DfG~a~~~~~~ 316 (455)
++.||++ +..+-+-|.||+++....+.
T Consensus 206 ~~gNlii---~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 206 RPGNLII---DPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred ccCCEEE---eCCCeeEEEeccccccCCcH
Confidence 9999999 45555899999999775543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0034 Score=60.50 Aligned_cols=31 Identities=32% Similarity=0.430 Sum_probs=24.9
Q ss_pred CCEEeeccCCceEEeecCC-CceEEEeeccccccc
Q 012825 280 GVVHRDLKPENFLFTTKDE-NSVLKAIDFGLSDFV 313 (455)
Q Consensus 280 ~ivHrDikp~NILl~~~~~-~~~vkL~DfG~a~~~ 313 (455)
.++|+|+++.|||++ . ....-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~---~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILID---EDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEe---CCCCEEEEECcHhcccC
Confidence 389999999999994 4 345679999988654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0035 Score=62.48 Aligned_cols=142 Identities=15% Similarity=0.224 Sum_probs=80.6
Q ss_pred ceEeecCCeEEEEEEEecCc-ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEe
Q 012825 161 EEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E 239 (455)
..|-.|-.-.+|++....+. ..++.|++|+..... ...+. ..+|..+++.+..+.--.++++.+..+ .|+|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 34434666688887654321 134689999875431 11222 367999998888554455677766332 5899
Q ss_pred ecCCCcHHHH----------H-------HhcC---C--CCCHHHHHHHHHHH-----------------HHHHHHHH---
Q 012825 240 LCEGGELLDR----------I-------LSRG---G--KYTEDDAKAVMIQI-----------------LNVVAFCH--- 277 (455)
Q Consensus 240 ~~~ggsL~~~----------l-------~~~~---~--~l~~~~~~~i~~qi-----------------~~gL~~LH--- 277 (455)
|+++.++... + +... . ...+..+.+++.++ ...+..|.
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9977654311 1 1111 0 11123333333221 11122221
Q ss_pred -----HcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 278 -----LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 278 -----~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
...++|+|+++.|||++ +.++.+.|+||.++..
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYASY 231 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhccc
Confidence 12489999999999995 2346799999998854
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0055 Score=60.67 Aligned_cols=146 Identities=14% Similarity=0.191 Sum_probs=79.7
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
..++..+ ..|=.-.+|++.......++..|++|+..... . . .-.-.+|..+++.+..+.--.++++++. ++
T Consensus 16 ~i~i~~l-~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~-~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 16 DFSVERI-SGGITNLLLKVSVKEENGNEVSVTVRLFGPNT--D-Y-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred ceEEEEe-CCcccceEEEEEecCCCCCCceEEEEEecCCc--C-e-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 3444433 33555678887654322123478899874321 1 1 1223578889988885444456776653 22
Q ss_pred EEEeecCCCcHHH----------HH-------HhcC---C-CC-CHHHHHHHHHHH----------------------HH
Q 012825 236 VVMELCEGGELLD----------RI-------LSRG---G-KY-TEDDAKAVMIQI----------------------LN 271 (455)
Q Consensus 236 lV~E~~~ggsL~~----------~l-------~~~~---~-~l-~~~~~~~i~~qi----------------------~~ 271 (455)
+|.+|++|..|.. .+ +... . .. -+..+..+..++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5889987764411 11 1111 0 01 123333333222 11
Q ss_pred HHHHHH----HcC----CEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 272 VVAFCH----LQG----VVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 272 gL~~LH----~~~----ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
-+..+. ..+ ++|.|+.+.|||+. ++++.++++||..|..
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~--~~~~~l~lID~EYag~ 213 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLN--EDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEe--CCCCcEEEEcccccCC
Confidence 122221 112 79999999999994 2346799999998854
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.015 Score=58.74 Aligned_cols=77 Identities=14% Similarity=0.120 Sum_probs=49.3
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc-CCH---HHHHHHHHHHHHHHHhcC--CCCeeEEeEEEeeCCc
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTA---IAIEDVRREVKILRALTG--HNNLVKFFDAYEDTDN 233 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~-~~~---~~~~~~~~Ei~~l~~l~~--hp~Iv~l~~~~~~~~~ 233 (455)
.+.||-|.--.||++... +..|+||.-..... ... ....+...|...|+.+.. ..++.+++.++. +.
T Consensus 37 ~~eiggGn~N~VyrV~~~-----~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TM 109 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CC
Confidence 677899999999997742 34688997642111 010 123344456666665542 247888888776 44
Q ss_pred eEEEEeecCC
Q 012825 234 VYVVMELCEG 243 (455)
Q Consensus 234 ~~lV~E~~~g 243 (455)
-+++||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5889999977
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.018 Score=56.33 Aligned_cols=29 Identities=28% Similarity=0.525 Sum_probs=23.9
Q ss_pred cCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 279 ~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
.+++|+|+++.||+++ . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence 3689999999999994 3 457899999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.019 Score=56.96 Aligned_cols=79 Identities=20% Similarity=0.180 Sum_probs=48.4
Q ss_pred eEeecCCeEEEEEEEecCcccCeEEEEEEccCCC----cCCHHHHHHHHHHHHHHHHhcCC-C-CeeEEeEEEeeCCceE
Q 012825 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK----MTTAIAIEDVRREVKILRALTGH-N-NLVKFFDAYEDTDNVY 235 (455)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~----~~~~~~~~~~~~Ei~~l~~l~~h-p-~Iv~l~~~~~~~~~~~ 235 (455)
.||-|....||++.... .++.|+||.-..-. ..-.-...+..-|.+.|+..... | ++.++|. .+.+...
T Consensus 2 EigdGnlN~VfrV~~~~---g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~ 76 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE---GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAV 76 (370)
T ss_pred cCCCCceEEEEEEEcCC---CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccce
Confidence 57899999999998532 23679999642100 01122334555677778766532 3 4556553 3455567
Q ss_pred EEEeecCCCc
Q 012825 236 VVMELCEGGE 245 (455)
Q Consensus 236 lV~E~~~ggs 245 (455)
+|||+++...
T Consensus 77 ~vMEdL~~~~ 86 (370)
T TIGR01767 77 TVMEDLSHHK 86 (370)
T ss_pred ehHhhCccch
Confidence 9999996543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.0076 Score=55.50 Aligned_cols=120 Identities=20% Similarity=0.200 Sum_probs=59.3
Q ss_pred CeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEeecCCCcHHH-------HH-----
Q 012825 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-------RI----- 250 (455)
Q Consensus 183 g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~-------~l----- 250 (455)
++.|+|++.... ....-...+|..+++.+..+-.-.++++++.. .+|+||++|..|.. .+
T Consensus 2 ~~~~~~Ri~g~~----t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~ 73 (211)
T PF01633_consen 2 PEKYLVRIPGEG----TENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAK 73 (211)
T ss_dssp TSEEEEEEEESC----GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHH
T ss_pred CCEEEEEeCCCC----cccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHH
Confidence 457888887543 11223456788888888855555677776533 35779986654311 11
Q ss_pred -----Hh--c--C--CCCCHHHHHHH----------------------HHHHHHHHHHHHH--------cCCEEeeccCC
Q 012825 251 -----LS--R--G--GKYTEDDAKAV----------------------MIQILNVVAFCHL--------QGVVHRDLKPE 289 (455)
Q Consensus 251 -----~~--~--~--~~l~~~~~~~i----------------------~~qi~~gL~~LH~--------~~ivHrDikp~ 289 (455)
+. . . ..--+..+..+ +..+..-+..+.+ .-+.|+|+.+.
T Consensus 74 ~l~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~ 153 (211)
T PF01633_consen 74 LLAKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPG 153 (211)
T ss_dssp HHHHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGG
T ss_pred HHHHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccc
Confidence 00 1 0 00111222222 1112222222221 24899999999
Q ss_pred ceEEeecCCCceEEEeecccccc
Q 012825 290 NFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 290 NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
|||+. +.++.++|+||..+..
T Consensus 154 Nil~~--~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 154 NILIN--NKDGEVKLIDFEYAGY 174 (211)
T ss_dssp GEEET--SSSSCEEE--GTT-EE
T ss_pred cEEec--cCCCeEEEecHHHHhh
Confidence 99993 4567799999998854
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.023 Score=55.89 Aligned_cols=106 Identities=14% Similarity=0.199 Sum_probs=71.6
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
....|++|++- |+.|.- .....++++..++.+.+..+.-+..+ .+-|||+...|||| + +|+|.|+||-+
T Consensus 298 ~~y~yl~~kdh-gt~is~-----ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfkl 367 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-----IKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFKL 367 (488)
T ss_pred ceEEEEEEecC-Cceeee-----eecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEeee
Confidence 34567788876 555432 22346788888998888777777665 68999999999999 6 89999999999
Q ss_pred ccccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHH
Q 012825 310 SDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 350 (455)
Q Consensus 310 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~ 350 (455)
++.-...... -....--|-.+.|.-+..-|||-+--.
T Consensus 368 sRl~~~q~~i----sy~rldhp~lF~G~dd~QFeIYrlMr~ 404 (488)
T COG5072 368 SRLSYSQGII----SYNRLDHPDLFNGVDDYQFEIYRLMRR 404 (488)
T ss_pred eecccCCcee----eccccCchhhhcCccceeeeHHHHHHH
Confidence 9854332221 112233344455555666777775444
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.058 Score=52.30 Aligned_cols=78 Identities=21% Similarity=0.209 Sum_probs=47.2
Q ss_pred eecCCeEEEEEEEec-----CcccCeEEEEEEccCCCcCC--HHHHHHHHHHHHHHHHhcC------------CCCeeEE
Q 012825 164 GRGHFGYTCAAKFKK-----GELKGQQVAVKVIPKHKMTT--AIAIEDVRREVKILRALTG------------HNNLVKF 224 (455)
Q Consensus 164 G~G~fg~V~~~~~~~-----~~~~g~~vavK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~~------------hp~Iv~l 224 (455)
|.|-.|.+|++...- +......++||......... ......+.+|+.+.+.+-. ...+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 667778888877644 12234578999976222111 1223557888888776531 1234566
Q ss_pred eEEEeeCCceEEEEeec
Q 012825 225 FDAYEDTDNVYVVMELC 241 (455)
Q Consensus 225 ~~~~~~~~~~~lV~E~~ 241 (455)
+....+.+..+||||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 66555555678999876
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.099 Score=51.63 Aligned_cols=69 Identities=12% Similarity=0.070 Sum_probs=40.1
Q ss_pred eEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCC-CeeEEe---E--EEeeCCceEEEEeecC
Q 012825 169 GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFF---D--AYEDTDNVYVVMELCE 242 (455)
Q Consensus 169 g~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-~Iv~l~---~--~~~~~~~~~lV~E~~~ 242 (455)
..||.+...+ |..+++|+..... . ....+..|++.+..|..+. .++... | ....++..+.++++++
T Consensus 39 N~vy~v~~~~----~~~~vlKv~r~~~-~---~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 39 NRVYQFGDED----GRRVVAKFYRPER-W---SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred ceEEEEecCC----CCEEEEEEcCccc-C---CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 5688776433 6679999875332 1 2345667888887776321 112211 1 1223566788999997
Q ss_pred CCc
Q 012825 243 GGE 245 (455)
Q Consensus 243 ggs 245 (455)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.18 Score=49.33 Aligned_cols=30 Identities=33% Similarity=0.469 Sum_probs=26.4
Q ss_pred CCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 280 ~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+++|+|+.++|||+ +.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence 69999999999999 6677799999998754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.059 Score=54.22 Aligned_cols=80 Identities=20% Similarity=0.187 Sum_probs=50.8
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCC-c--CCHHHHHHHHHHHHHHHHhcCC-C-CeeEEeEEEeeCCce
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-M--TTAIAIEDVRREVKILRALTGH-N-NLVKFFDAYEDTDNV 234 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~-~--~~~~~~~~~~~Ei~~l~~l~~h-p-~Iv~l~~~~~~~~~~ 234 (455)
.+.||-|.-..||++.... .+..|+||.-..-. . .-.-..++..-|.+.|+.+... | +++++|. .+.+..
T Consensus 34 ~~eigdGnlN~VfrV~~~~---~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~ 108 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMN 108 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHh
Confidence 6788999999999998643 24578998642110 0 1123345566777888766532 3 5666654 355566
Q ss_pred EEEEeecCCC
Q 012825 235 YVVMELCEGG 244 (455)
Q Consensus 235 ~lV~E~~~gg 244 (455)
.+|||+++..
T Consensus 109 ~~vMEdL~~~ 118 (409)
T PRK12396 109 CCVMEDLSDH 118 (409)
T ss_pred hHHHHhCccc
Confidence 8999998643
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.027 Score=56.13 Aligned_cols=60 Identities=23% Similarity=0.203 Sum_probs=44.6
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHcCCEEeeccCCceEEee
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC-HLQGVVHRDLKPENFLFTT 295 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~L-H~~~ivHrDikp~NILl~~ 295 (455)
..|+-+|.+|.++..++.... .+++..++++.-...+|.-+ --.+++|.|+.|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 467777898988888775443 46667777777767776443 4458999999999999953
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.11 Score=51.35 Aligned_cols=131 Identities=19% Similarity=0.251 Sum_probs=73.8
Q ss_pred CeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCC-----eeEEeEEE--eeCC--ceEEEE
Q 012825 168 FGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-----LVKFFDAY--EDTD--NVYVVM 238 (455)
Q Consensus 168 fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~-----Iv~l~~~~--~~~~--~~~lV~ 238 (455)
-..+|+....+ |+. ++|+.... ....++.-|+..+..|..+.- +..+=|-. .-.+ ..+-++
T Consensus 38 eN~~f~~~~~~----g~~-iLki~~~~-----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 38 ENSNFRVQTED----GRY-ILKIYRPG-----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cCceEEEEecC----CCe-EEEEecCC-----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 35677776544 444 99998654 122456678888877763321 12211111 1223 678899
Q ss_pred eecCCCcHHH-----HH----------HhcCC-----------CCCHH----HH---------HHHHHHHHHHHHHHHHc
Q 012825 239 ELCEGGELLD-----RI----------LSRGG-----------KYTED----DA---------KAVMIQILNVVAFCHLQ 279 (455)
Q Consensus 239 E~~~ggsL~~-----~l----------~~~~~-----------~l~~~----~~---------~~i~~qi~~gL~~LH~~ 279 (455)
+|++|..+.. .+ +.... ...|. .. .....++...+..+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9998876651 11 11000 11221 00 11233444455555532
Q ss_pred --------C--CEEeeccCCceEEeecCCCc-eEEEeeccccc
Q 012825 280 --------G--VVHRDLKPENFLFTTKDENS-VLKAIDFGLSD 311 (455)
Q Consensus 280 --------~--ivHrDikp~NILl~~~~~~~-~vkL~DfG~a~ 311 (455)
+ +||+|+.++|||+ +.+. .+.++||+-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~---d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLF---DDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeE---cCCCCeeeEEEccccc
Confidence 3 9999999999999 4444 58899999774
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.071 Score=53.81 Aligned_cols=78 Identities=18% Similarity=0.282 Sum_probs=46.3
Q ss_pred ceEeecCCeEEEEEEEecCc---ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEE
Q 012825 161 EEVGRGHFGYTCAAKFKKGE---LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVV 237 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV 237 (455)
+.|..|-...+|++....+. ...+.|.+++... .... .-+-.+|+.+++.|..+..-.++++.+.. ++|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l-~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l 127 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSL-VIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI 127 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCce-EeccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence 34444666788888654321 0112355554321 1111 11235789999999866666778777643 699
Q ss_pred EeecCCCcH
Q 012825 238 MELCEGGEL 246 (455)
Q Consensus 238 ~E~~~ggsL 246 (455)
+||++|..|
T Consensus 128 ~efIeGr~l 136 (383)
T PTZ00384 128 QEWVEGNTM 136 (383)
T ss_pred EEEeccccC
Confidence 999988755
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.05 Score=52.66 Aligned_cols=76 Identities=22% Similarity=0.214 Sum_probs=47.2
Q ss_pred EEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEeEEEeeCCceE
Q 012825 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hp~Iv~l~~~~~~~~~~~ 235 (455)
+-.+.|+-|....+|... . .++.+.||+-.. .....+..|.+-|+.|. .--.+.+.+++....+.-+
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~---~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~f 88 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--T---DGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAF 88 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--T---TS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCE
T ss_pred eeeEecCCCChhheEEEE--C---CCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCce
Confidence 445678888888888866 2 477899998642 12245778988888884 2345778999888777789
Q ss_pred EEEeecCCC
Q 012825 236 VVMELCEGG 244 (455)
Q Consensus 236 lV~E~~~gg 244 (455)
|||||++.+
T Consensus 89 Llle~l~~~ 97 (288)
T PF03881_consen 89 LLLEFLEMG 97 (288)
T ss_dssp EEEE-----
T ss_pred EEEEeecCC
Confidence 999999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.18 Score=57.47 Aligned_cols=34 Identities=29% Similarity=0.415 Sum_probs=24.9
Q ss_pred cCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 279 ~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.++||+|+++.|||++.+......-|+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3699999999999995322123445999998754
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.14 Score=47.34 Aligned_cols=58 Identities=21% Similarity=0.208 Sum_probs=43.8
Q ss_pred CeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcC--CCCeeEEeEEEeeCCceEEEEeecCCCcH
Q 012825 183 GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG--HNNLVKFFDAYEDTDNVYVVMELCEGGEL 246 (455)
Q Consensus 183 g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~--hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL 246 (455)
...|.||+ ........+..|+.-|..+.. --.+.+.+.+..+.++.|+||||++.+.+
T Consensus 39 ~~~~FvK~------n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 39 TDPFFVKC------NQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred CcceEEEe------cchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 46788897 344556678888888777762 23577888888899999999999987544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 455 | ||||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-57 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-56 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-56 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-56 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-55 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-55 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-55 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-55 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-54 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-54 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-54 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-54 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-54 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-54 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-54 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-54 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-53 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-53 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-53 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-52 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-48 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-48 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-48 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-48 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-48 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-46 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-45 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-45 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-45 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-45 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-45 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-45 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-45 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-45 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-45 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-45 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-44 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-44 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-44 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-44 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-44 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-44 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-44 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-44 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-44 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-44 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-44 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-44 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-44 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-44 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-44 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-44 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-44 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-43 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-43 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-42 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-42 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-42 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-41 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-41 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-41 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-41 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-41 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-40 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-40 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-40 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-40 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-40 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-39 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-39 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-39 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-39 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-39 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-39 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-39 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-39 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-39 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-39 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-39 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-38 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-38 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-38 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-37 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-37 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-37 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-37 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-37 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-37 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-37 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-37 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-37 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-37 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-37 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-37 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-37 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-36 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-36 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-36 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-36 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-36 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-35 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-35 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-35 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-35 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-35 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-35 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-34 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-34 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-34 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-34 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-34 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-34 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-34 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-34 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-34 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-34 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-34 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-34 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-34 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-34 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-34 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-34 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-34 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-34 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-34 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-34 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-33 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-33 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-33 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-33 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-33 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-33 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-33 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-33 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-33 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-33 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-33 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-33 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-33 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-33 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-33 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-33 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-33 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-33 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-33 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-33 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-33 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-33 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-32 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-32 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-32 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-32 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-32 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-32 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-32 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-32 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-32 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-31 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-31 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-31 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-30 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-30 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-29 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-29 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-29 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-28 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-28 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-28 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-28 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-28 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-28 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-28 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-28 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-28 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-28 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-28 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-28 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-28 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-28 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-28 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-28 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-28 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-28 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-28 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-28 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-28 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-28 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-28 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-28 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-28 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-28 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-28 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-28 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-28 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-27 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-27 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-27 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-27 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-27 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-27 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-27 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-27 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-27 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-27 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-27 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-27 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-27 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-27 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-27 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-27 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-27 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-27 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-27 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-27 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-27 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-27 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-27 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-27 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-27 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-27 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-27 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-27 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-27 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-27 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-27 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-27 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-27 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-27 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-27 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-27 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-27 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-27 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-27 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-27 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-27 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-27 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-27 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-27 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-27 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-26 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-26 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-26 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-26 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-26 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-26 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-26 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-26 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-26 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-26 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-26 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-26 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-26 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-26 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-26 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-26 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-26 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-26 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-26 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-26 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-26 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-26 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-26 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-26 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-26 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-26 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-26 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-26 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-26 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-26 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-26 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-26 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-26 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-26 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-26 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-26 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-25 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-25 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-25 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-25 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-25 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-25 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-25 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-25 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-25 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-25 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-25 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-25 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-25 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-25 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-25 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-25 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-25 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-25 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-25 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-25 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-24 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-24 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-24 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-24 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-24 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-24 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-24 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-24 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-24 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-24 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-24 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-24 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-24 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-24 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-24 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-24 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-24 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-24 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-24 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-24 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-23 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-23 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-23 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-23 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-23 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-23 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-23 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-23 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-23 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-23 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-23 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-23 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-23 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-23 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-23 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-23 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-23 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-23 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-23 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-23 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-23 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-23 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-23 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-23 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-23 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-23 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-23 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-23 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-22 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-22 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-22 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-22 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-22 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-22 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-22 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-22 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-22 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-22 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-22 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-22 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-22 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-22 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-22 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-22 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-22 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-22 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-22 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-22 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-22 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-22 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-22 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-22 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-22 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-22 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-22 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-22 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-22 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-22 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-22 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-22 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-22 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-22 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-22 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-22 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-22 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-22 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-22 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-22 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-22 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-22 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-22 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-22 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-22 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-22 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-22 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-22 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-22 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-21 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-21 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-21 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-21 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-21 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-21 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-21 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-21 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-21 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-21 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-21 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-21 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-21 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-21 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-21 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-21 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-21 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-21 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-21 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-21 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-21 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-21 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-21 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-21 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-21 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-21 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-21 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-21 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-21 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-21 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-21 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-21 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-21 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-21 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-21 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-21 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-21 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-21 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-21 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-21 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-21 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-21 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-21 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-21 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-21 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-21 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-21 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-21 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-21 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-21 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-21 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-21 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-21 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-21 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-21 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-21 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-21 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-21 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-21 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-21 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-21 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-21 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-21 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-21 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-20 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-20 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-20 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-20 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-20 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-20 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-20 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-20 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-20 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-20 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-20 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-20 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-20 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-20 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-20 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-20 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-20 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-20 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-19 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-19 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-19 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-19 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-19 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-19 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-19 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-19 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-18 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-18 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-18 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-18 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-18 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-18 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-18 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-18 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-18 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-18 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-18 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-18 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-18 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-18 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-18 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-18 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-18 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-18 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-18 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-18 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-18 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-18 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-18 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-18 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-18 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-18 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-17 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-17 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-17 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-17 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-17 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-17 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-17 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-17 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-17 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-17 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-17 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-17 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-17 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-17 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-16 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-16 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-16 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-16 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-15 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-15 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-15 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-14 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 5e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-12 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-12 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-12 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-12 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-12 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 8e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-12 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 8e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-11 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-11 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-10 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 7e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 7e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-07 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-07 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-06 |
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 483 bits (1244), Expect = e-169
Identities = 111/317 (35%), Positives = 175/317 (55%), Gaps = 11/317 (3%)
Query: 142 GLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA 201
++ F FA +Y + +G+G FG K + Q+ AVKVI K
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNK-D 64
Query: 202 IEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
+ REV++L+ L H N++K F+ ED+ + Y+V EL GGEL D I+ R +++E D
Sbjct: 65 TSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHD 122
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
A ++ Q+ + + + H +VHRDLKPEN L +K+++ +K IDFGLS + + ++ D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 322 IVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
+G+AYY+APEVL +Y + DVWS GVI YILL G+ PF+ + E I + V +FD
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK-----VPLDVIIFKL 436
W ++S +A+D ++++L P R+TA Q L HPWI+ + +P
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTN 302
Query: 437 MKAYMRSSSLRKAALRV 453
++ + L +AAL
Sbjct: 303 IRQFQAEKKLAQAALLY 319
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 470 bits (1212), Expect = e-166
Identities = 110/368 (29%), Positives = 168/368 (45%), Gaps = 26/368 (7%)
Query: 71 FYSPSPAHYFFSKKSSPARSSANSTPN------RFFKRPFPPPSPAKHIKAVLARRHGSV 124
+ S F+K+ AR PN R F R A++
Sbjct: 5 HHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA 64
Query: 125 KPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQ 184
+P P L + +K F KY+ + +GRG + G
Sbjct: 65 QPKGTENLYFQSMGPEDEL-PDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA---TGH 120
Query: 185 QVAVKVIPKHKMTTAI-----AIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239
+ AVK++ + E RRE ILR + GH +++ D+YE + +++V +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180
Query: 240 LCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299
L GEL D + + +E + +++M +L V+F H +VHRDLKPEN L D+N
Sbjct: 181 LMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDN 236
Query: 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-------HRSYSTEADVWSIGVIAY 352
++ DFG S + P E+L ++ G+ Y+APE+L H Y E D+W+ GVI +
Sbjct: 237 MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
LL GS PFW R + + R +++ F W SS +D + RLL DP RLTA Q
Sbjct: 297 TLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356
Query: 413 ALSHPWIK 420
AL HP+ +
Sbjct: 357 ALQHPFFE 364
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 473 bits (1219), Expect = e-165
Identities = 121/347 (34%), Positives = 175/347 (50%), Gaps = 22/347 (6%)
Query: 121 HGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE 180
H E +G P + K G Y ++G G +G K K G
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEG---KIGESYFKVRKLGSGAYGEVLLCKEKNG- 60
Query: 181 LKGQQVAVKVIPKHKMTTAIAI----------EDVRREVKILRALTGHNNLVKFFDAYED 230
+ A+KVI K + E++ E+ +L++L H N++K FD +ED
Sbjct: 61 --HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFED 117
Query: 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
Y+V E EGGEL ++I++R K+ E DA +M QIL+ + + H +VHRD+KPEN
Sbjct: 118 KKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPEN 176
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVI 350
L K+ +K +DFGLS F D +L D +G+AYY+APEVL + Y+ + DVWS GVI
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVI 236
Query: 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTA 410
YILLCG PF + + I + V K FD W ++S EA++ +K +L D KR TA
Sbjct: 237 MYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296
Query: 411 AQALSHPWIK----NSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRV 453
+AL+ WIK N N M+ + S L +AA+
Sbjct: 297 EEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILF 343
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 469 bits (1209), Expect = e-163
Identities = 112/308 (36%), Positives = 175/308 (56%), Gaps = 9/308 (2%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ F+++Y+ +G+G FG K K GQ+ AVKVI K ++ E + REV
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREV 77
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
++L+ L H N++K ++ +ED Y+V E+ GGEL D I+SR +++E DA ++ Q+
Sbjct: 78 QLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQV 135
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L+ + + H +VHRDLKPEN L +K +++ ++ IDFGLS +++ D +G+AYY+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195
Query: 330 APEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
APEVLH +Y + DVWS GVI YILL G PF E I + V K +F+ W +S
Sbjct: 196 APEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS 255
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND----VKVPLDVIIFKLMKAYMRSSS 445
A+D ++++L P R++A AL H WI+ V VP ++ + +
Sbjct: 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQK 315
Query: 446 LRKAALRV 453
L +AAL
Sbjct: 316 LAQAALLY 323
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 458 bits (1181), Expect = e-162
Identities = 106/286 (37%), Positives = 166/286 (58%), Gaps = 6/286 (2%)
Query: 139 PAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT 198
+ ++ F FA +Y + +G+G FG K + Q+ AVKVI K
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKN 62
Query: 199 AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYT 258
+ REV++L+ L H N++K F+ ED+ + Y+V EL GGEL D I+ R +++
Sbjct: 63 K-DTSTILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFS 119
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER 318
E DA ++ Q+ + + + H +VHRDLKPEN L +K+++ +K IDFGLS + + +
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
Query: 319 LNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378
+ D +G+AYY+APEVL +Y + DVWS GVI YILL G+ PF+ + E I + V
Sbjct: 180 MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
+FD W ++S +A+D ++++L P R+TA Q L HPWI+ +
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 464 bits (1197), Expect = e-162
Identities = 113/309 (36%), Positives = 183/309 (59%), Gaps = 11/309 (3%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
H + Y+ +++G G +G + K + A+K+I K ++T+ + + EV
Sbjct: 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVT---HVERAIKIIRKTSVSTS-SNSKLLEEV 87
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+L+ L H N++K +D +ED N Y+VME +GGEL D I+ R K+ E DA ++ Q+
Sbjct: 88 AVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQV 145
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L+ V + H +VHRDLKPEN L +K++++++K +DFGLS +++ + +G+AYY+
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 330 APEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
APEVL + Y + DVWSIGVI +ILL G PF +T+ I R V K +FD W ++S
Sbjct: 206 APEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKN-----SNDVKVPLDVIIFKLMKAYMRSS 444
A+D +K++L D ++R++A QAL HPWIK + +++P + M+ + S
Sbjct: 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQ 325
Query: 445 SLRKAALRV 453
L +AAL
Sbjct: 326 KLAQAALLY 334
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 453 bits (1167), Expect = e-160
Identities = 99/287 (34%), Positives = 160/287 (55%), Gaps = 10/287 (3%)
Query: 139 PAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT 198
+ ++ F + + ++G G FG + + G + +K I K +
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRS-- 60
Query: 199 AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GG 255
+ +E + E+++L++L H N++K F+ +ED N+Y+VME CEGGELL+RI+S G
Sbjct: 61 QVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK 119
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+E +M Q++N +A+ H Q VVH+DLKPEN LF +S +K IDFGL++ +
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
Query: 316 DERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375
DE + G+A Y+APEV R + + D+WS GV+ Y LL G PF + + +
Sbjct: 180 DEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239
Query: 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422
+P++ P L+ +A D +K++L KDP +R +AAQ L H W K +
Sbjct: 240 KEPNYAVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 450 bits (1161), Expect = e-159
Identities = 105/280 (37%), Positives = 165/280 (58%), Gaps = 9/280 (3%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
Y L +GRG +G A K + A K IPK+ + ++ ++E++I+
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGT---RIRRAAKKIPKYFVE---DVDRFKQEIEIM 60
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
++L H N+++ ++ +ED ++Y+VMELC GGEL +R++ + + E DA +M +L+
Sbjct: 61 KSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSA 118
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332
VA+CH V HRDLKPENFLF T +S LK IDFGL+ +P + + VG+ YYV+P+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 333 VLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
VL Y E D WS GV+ Y+LLCG PF A T+S + + + +F E W ++S +A
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
++RLL K P++R+T+ QAL H W + P +++
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEK-QLSSSPRNLL 277
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 450 bits (1161), Expect = e-159
Identities = 85/304 (27%), Positives = 150/304 (49%), Gaps = 13/304 (4%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K KY + E++GRG FG + K + V++E+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKGTD----QVLVKKEIS 53
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
IL H N++ +++E + + ++ E G ++ +RI + + E + + + Q+
Sbjct: 54 ILNIA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVA 330
+ F H + H D++PEN ++ T+ +S +K I+FG + ++P + + + Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 331 PEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
PEV H ST D+WS+G + Y+LL G PF A T I ++ A+ +FDE + +S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKA 449
EA DFV RLL K+ + R+TA++AL HPW+K + + + + +K +L K
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE---RVSTKVIRTLKHRRYYHTLIKK 288
Query: 450 ALRV 453
L +
Sbjct: 289 DLNM 292
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 445 bits (1148), Expect = e-155
Identities = 102/307 (33%), Positives = 159/307 (51%), Gaps = 9/307 (2%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
F +Y+L EE+G+G F GQ+ A +I K++ + + RE
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKLSA-RDHQKLEREA 61
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+I R L H N+V+ D+ + + Y++ +L GGEL + I++R Y+E DA + QI
Sbjct: 62 RICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQI 119
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYY 328
L V CH GVVHR+LKPEN L +K + + +K DFGL+ V + G+ Y
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
++PEVL + Y D+W+ GVI YILL G PFW + +++ + F W +
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV-KVPLDVIIFKLMKAYMRSSSL 446
++ EA+D + ++L +P KR+TAA+AL HPWI + + V +K + L
Sbjct: 240 VTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKL 299
Query: 447 RKAALRV 453
+ A L V
Sbjct: 300 KGAILTV 306
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 438 bits (1129), Expect = e-153
Identities = 94/312 (30%), Positives = 155/312 (49%), Gaps = 13/312 (4%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT--AIAIEDVRR 207
F + YEL E +G+G F ++ GQQ AVK++ K T+ ++ ED++R
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKR 75
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG---GKYTEDDAKA 264
E I L H ++V+ + Y +Y+V E +G +L I+ R Y+E A
Sbjct: 76 EASICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
M QIL + +CH ++HRD+KP L +K+ ++ +K FG++ V
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 324 GSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
G+ +++APEV+ R Y DVW GVI +ILL G PF+ T+ +F ++K +
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNP 253
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV-KVPLDVIIFKLMKAYM 441
W +S A+D V+R+L DP +R+T +AL+HPW+K + + ++ +
Sbjct: 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFN 313
Query: 442 RSSSLRKAALRV 453
L+ A L
Sbjct: 314 ARRKLKGAVLAA 325
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 438 bits (1128), Expect = e-153
Identities = 106/330 (32%), Positives = 170/330 (51%), Gaps = 10/330 (3%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ 185
P+ A++ G + + + S F++ Y++ EE+G+G F K G +
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNA--STKFSDNYDVKEELGKGAFSVVRRCVHKTT---GLE 56
Query: 186 VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGE 245
A K+I K++ A + + RE +I R L H N+V+ D+ ++ Y+V +L GGE
Sbjct: 57 FAAKIINTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGE 114
Query: 246 LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305
L + I++R Y+E DA + QIL +A+CH G+VHR+LKPEN L +K + + +K
Sbjct: 115 LFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWAR 364
DFGL+ V E + G+ Y++PEVL + YS D+W+ GVI YILL G PFW
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
+ ++ + + W +++ EA+ + +L +P+KR+TA QAL PWI N
Sbjct: 234 DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293
Query: 425 V-KVPLDVIIFKLMKAYMRSSSLRKAALRV 453
V +K + L+ A L
Sbjct: 294 VASAIHRQDTVDCLKKFNARRKLKGAILTT 323
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 431 bits (1112), Expect = e-152
Identities = 98/273 (35%), Positives = 153/273 (56%), Gaps = 7/273 (2%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
S F++ Y++ EE+G+G F K G + A K+I K++ A + + RE
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTT---GLEFAAKIINTKKLS-ARDFQKLEREA 56
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+I R L H N+V+ D+ ++ Y+V +L GGEL + I++R Y+E DA + QI
Sbjct: 57 RICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQI 114
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L +A+CH G+VHR+LKPEN L +K + + +K DFGL+ V E + G+ Y+
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 174
Query: 330 APEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
+PEVL + YS D+W+ GVI YILL G PFW + ++ + + W ++
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 234
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ EA+ + +L +P+KR+TA QAL PWI N
Sbjct: 235 TPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 425 bits (1094), Expect = e-148
Identities = 87/305 (28%), Positives = 150/305 (49%), Gaps = 9/305 (2%)
Query: 151 KHFANKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
++F N Y L +E+GRG F K GQ+ A K + K + ++ E+
Sbjct: 24 ENFNNFYILTSKELGRGKFAVVRQCISKST---GQEYAAKFLKKRRRG-QDCRAEILHEI 79
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQ 268
+L ++ + YE+T + +++E GGE+ L +E+D ++ Q
Sbjct: 80 AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
IL V + H +VH DLKP+N L ++ +K +DFG+S + L +I+G+ Y
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY 199
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
+APE+L+ +T D+W+IG+IAY+LL + PF + + + + + E + S
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS 259
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV--PLDVIIFKLMKAYMRSSS 445
+S A DF++ LL K+P KR TA LSH W++ + + P + + + SS
Sbjct: 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSS 319
Query: 446 LRKAA 450
K +
Sbjct: 320 EDKTS 324
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 422 bits (1088), Expect = e-148
Identities = 96/292 (32%), Positives = 145/292 (49%), Gaps = 20/292 (6%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI------E 203
+ F YE E +GRG K ++ AVK+I + A E
Sbjct: 12 THGFYENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 204 DVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
+EV ILR ++GH N+++ D YE ++V +L + GEL D + + +E + +
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETR 127
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+M +L V+ H +VHRDLKPEN L D++ +K DFG S + P E+L ++
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 324 GSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376
G+ Y+APE++ H Y E D+WS GVI Y LL GS PFW R + + R ++
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244
Query: 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428
+ F W S +D V R L P+KR TA +AL+HP+ + +V
Sbjct: 245 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-146
Identities = 116/351 (33%), Positives = 171/351 (48%), Gaps = 16/351 (4%)
Query: 105 PPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVG 164
S L + S AA S + ++ +E+ E+G
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRD---ALSDFFEVESELG 62
Query: 165 RGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKF 224
RG K K + A+KV+ K + VR E+ +L L+ H N++K
Sbjct: 63 RGATSIVYRCKQKG---TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKL 113
Query: 225 FDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHR 284
+ +E + +V+EL GGEL DRI+ +G Y+E DA + QIL VA+ H G+VHR
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHR 172
Query: 285 DLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEAD 343
DLKPEN L+ T ++ LK DFGLS V + + G+ Y APE+L +Y E D
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVD 232
Query: 344 VWSIGVIAYILLCGSRPFWART-ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK 402
+WS+G+I YILLCG PF+ + +FR +L + F W +S A+D V++L+
Sbjct: 233 MWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL 292
Query: 403 DPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALRV 453
DP+KRLT QAL HPW+ V +D K ++ + L+ A V
Sbjct: 293 DPKKRLTTFQALQHPWVTGKAANFVHMDTAQ-KKLQEFNARRKLKAAVKAV 342
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-145
Identities = 101/377 (26%), Positives = 161/377 (42%), Gaps = 31/377 (8%)
Query: 90 SSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGF 149
+S +P F P PPP P L P + + K+
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTP---ALPHPPAQPPPPPPQQFPQFHVKSGLQIKKN--- 57
Query: 150 SKHFANKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRRE 208
+ Y++ + +G G G K+ ++ A+K++ RRE
Sbjct: 58 --AIIDDYKVTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQD--------CPKARRE 104
Query: 209 VKILRALTGHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGK-YTEDDAK 263
V++ + ++V+ D YE+ + +VME +GGEL RI RG + +TE +A
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+M I + + H + HRD+KPEN L+T+K N++LK DFG + L
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 224
Query: 324 GSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADP 378
+ YYVAPEVL Y D+WS+GVI YILLCG PF++ G+ +
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV-KVPLDVIIFKLM 437
F W +S E + ++ LL +P +R+T + ++HPWI S V + PL
Sbjct: 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKE 344
Query: 438 KAYMRSSSLRKAALRVS 454
+ ++
Sbjct: 345 DKERWEDVKEEMTSALA 361
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 414 bits (1067), Expect = e-145
Identities = 102/284 (35%), Positives = 160/284 (56%), Gaps = 10/284 (3%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREV 209
+ YE+GEE+G G F + K G++ A K I K ++++ ++ E++ REV
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
ILR + H N++ D +E+ +V +++EL GGEL D + + TED+A + QI
Sbjct: 60 NILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQI 117
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
L+ V + H + + H DLKPEN + K+ N +K IDFG++ + +I G+ +
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177
Query: 329 VAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
VAPE+++ EAD+WSIGVI YILL G+ PF T+ + + FDE + +
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDV 431
S A+DF++RLL KDP++R+T AQ+L H WIK V +
Sbjct: 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGED 281
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 422 bits (1087), Expect = e-144
Identities = 99/364 (27%), Positives = 161/364 (44%), Gaps = 13/364 (3%)
Query: 85 SSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLN 144
+ S P P + + K ++ + +
Sbjct: 85 ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144
Query: 145 KSFGFSK--HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI 202
K H + Y++ EE+G G FG + G A K + +
Sbjct: 145 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHESD---K 198
Query: 203 EDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA 262
E VR+E++ + L H LV DA+ED + + ++ E GGEL +++ K +ED+A
Sbjct: 199 ETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 257
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
M Q+ + H VH DLKPEN +FTTK N LK IDFGL+ + P + +
Sbjct: 258 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVT 316
Query: 323 VGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
G+A + APEV + D+WS+GV++YILL G PF + R V D + D
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 376
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV--KVPLDVIIFKLMKA 439
++ + +S + +DF+++LL DP R+T QAL HPW+ N + + ++
Sbjct: 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRD 436
Query: 440 YMRS 443
+++
Sbjct: 437 SIKT 440
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 408 bits (1050), Expect = e-142
Identities = 103/308 (33%), Positives = 162/308 (52%), Gaps = 16/308 (5%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRR 207
++ + Y+ GEE+G G F + K G Q A K I K + + ++ ED+ R
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKST---GLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV IL+ + H N++ + YE+ +V +++EL GGEL D + + TE++A +
Sbjct: 64 EVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
QILN V + H + H DLKPEN + ++ +K IDFGL+ + +I G+
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 327 YYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
+VAPE+++ EAD+WSIGVI YILL G+ PF T+ V + F++ +
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSS 445
+ S+ A+DF++RLL KDP+KR+T +L HPWIK + + M+
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNME------K 295
Query: 446 LRKAALRV 453
+K A R
Sbjct: 296 FKKFAARK 303
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 403 bits (1037), Expect = e-140
Identities = 98/327 (29%), Positives = 162/327 (49%), Gaps = 33/327 (10%)
Query: 150 SKHFANKYELG---EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR 206
F Y+L + +G G F KK Q AVK+I K + +
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKRME------ANTQ 53
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
+E+ L+ GH N+VK + + D + ++VMEL GGEL +RI + ++E +A +M
Sbjct: 54 KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK-HFSETEASYIM 112
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGS 325
++++ V+ H GVVHRDLKPEN LFT +++N +K IDFG + PD + L +
Sbjct: 113 RKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT 172
Query: 326 AYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTES-------GIFRAVLKAD 377
+Y APE+L+++ Y D+WS+GVI Y +L G PF + S I + + K D
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
Query: 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV-KVPLDV----- 431
SF+ W ++S EA+D ++ LL DP KRL + + W+++ + + PL
Sbjct: 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILG 292
Query: 432 -----IIFKLMKAYMRSSSLRKAALRV 453
+ + + + ++ +
Sbjct: 293 SSGAAVHTCVKATFHAFNKYKREGFCL 319
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 400 bits (1029), Expect = e-138
Identities = 95/328 (28%), Positives = 150/328 (45%), Gaps = 54/328 (16%)
Query: 146 SFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIE 203
G KY L +G+G +G A + A+K++ K+K+ +E
Sbjct: 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQT---RAIRAIKIMNKNKIRQINPKDVE 73
Query: 204 DVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK------- 256
++ EV++++ L H N+ + ++ YED + +VMELC GG LLD++
Sbjct: 74 RIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 257 --------------------------------YTEDDAKAVMIQILNVVAFCHLQGVVHR 284
E +M QI + + + H QG+ HR
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 285 DLKPENFLFTTKDENSVLKAIDFGLSDFVRP-----DERLNDIVGSAYYVAPEVLH---R 336
D+KPENFLF+T +++ +K +DFGLS + G+ Y+VAPEVL+
Sbjct: 193 DIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251
Query: 337 SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFV 396
SY + D WS GV+ ++LL G+ PF ++ VL F+ + LS ARD +
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLL 311
Query: 397 KRLLNKDPRKRLTAAQALSHPWIKNSND 424
LLN++ +R A +AL HPWI +D
Sbjct: 312 SNLLNRNVDERFDAMRALQHPWISQFSD 339
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 401 bits (1033), Expect = e-138
Identities = 98/308 (31%), Positives = 151/308 (49%), Gaps = 10/308 (3%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ Y++ EE+G G FG K G+ K I V+ E+
Sbjct: 46 QGSVYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYPLD---KYTVKNEI 99
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
I+ L H L+ DA+ED + +++E GGEL DRI + K +E + M Q
Sbjct: 100 SIMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 158
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
+ H +VH D+KPEN + TK +S +K IDFGL+ + PDE + +A +
Sbjct: 159 CEGLKHMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFA 217
Query: 330 APEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
APE++ R D+W+IGV+ Y+LL G PF + + V + D FDE + S+
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 277
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND-VKVPLDVIIFKLMKAYMRSSSLR 447
S EA+DF+K LL K+PRKRLT AL HPW+K + + + + ++ ++
Sbjct: 278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
Query: 448 KAALRVSI 455
A + +I
Sbjct: 338 WPAPQPAI 345
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 400 bits (1031), Expect = e-138
Identities = 101/367 (27%), Positives = 170/367 (46%), Gaps = 20/367 (5%)
Query: 85 SSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSE------PE 138
SS + + K S + H +A + + + + P
Sbjct: 9 SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68
Query: 139 PAAGLNKSFGFSKH--FANKYELG--EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH 194
P A + +K + Y + E +G G FG + G ++A K+I
Sbjct: 69 PPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETAT---GLKLAAKIIKTR 125
Query: 195 KMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG 254
M E+V+ E+ ++ L H NL++ +DA+E +++ +VME +GGEL DRI+
Sbjct: 126 GMKD---KEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES 181
Query: 255 GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314
TE D M QI + H ++H DLKPEN L +D +K IDFGL+ +
Sbjct: 182 YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ-IKIIDFGLARRYK 240
Query: 315 PDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAV 373
P E+L G+ ++APEV++ S D+WS+GVIAY+LL G PF ++ +
Sbjct: 241 PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300
Query: 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN-DVKVPLDVI 432
L ++ + +S EA++F+ +LL K+ R++A++AL HPW+ + ++
Sbjct: 301 LACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360
Query: 433 IFKLMKA 439
+ A
Sbjct: 361 KNRGSDA 367
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 397 bits (1022), Expect = e-138
Identities = 99/310 (31%), Positives = 164/310 (52%), Gaps = 12/310 (3%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRR 207
+ + Y++GEE+G G F + K G + A K I K + ++ E++ R
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV ILR + H+N++ D YE+ +V +++EL GGEL D + + +E++A + +
Sbjct: 65 EVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIK 122
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKAIDFGLSDFVRPDERLNDIVGSA 326
QIL+ V + H + + H DLKPEN + K+ +K IDFGL+ + +I G+
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182
Query: 327 YYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
+VAPE+++ EAD+WSIGVI YILL G+ PF T+ + FDE +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSS 445
S A+DF+++LL K+ RKRLT +AL HPWI ++ + + ++ + +
Sbjct: 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYV 302
Query: 446 LRK--AALRV 453
R+ + +
Sbjct: 303 RRRWKLSFSI 312
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 396 bits (1019), Expect = e-136
Identities = 102/313 (32%), Positives = 162/313 (51%), Gaps = 13/313 (4%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRR 207
+ + Y++GEE+G G F + K G + A K I K + + E++ R
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV ILR + H N++ D YE+ +V +++EL GGEL D + + +E++A + +
Sbjct: 65 EVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIK 122
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
QIL+ V + H + + H DLKPEN + K+ +K IDFGL+ + +I G+
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182
Query: 327 YYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
+VAPE+++ EAD+WSIGVI YILL G+ PF T+ + FDE +
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLD---VIIFKLMKAYMR 442
S A+DF+++LL K+ RKRLT +AL HPWI + + + V+ + K
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYV 302
Query: 443 SSSLRKAALRVSI 455
+ + VS+
Sbjct: 303 RRRWKLSFSIVSL 315
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 394 bits (1015), Expect = e-136
Identities = 105/350 (30%), Positives = 165/350 (47%), Gaps = 38/350 (10%)
Query: 117 LARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEV-GRGHFGYTCAAK 175
+A H + +G EP+ + Y+L ++V G G G
Sbjct: 1 MAHHHHHHSSGLEVLFQGPEPK-----------KYAVTDDYQLSKQVLGLGVNGKVLECF 49
Query: 176 FKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN-- 233
++ GQ+ A+K++ R+EV +G ++V D YE+ +
Sbjct: 50 HRR---TGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98
Query: 234 --VYVVMELCEGGELLDRILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPEN 290
+ ++ME EGGEL RI RG + +TE +A +M I + F H + HRD+KPEN
Sbjct: 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPEN 158
Query: 291 FLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGV 349
L+T+K++++VLK DFG + + L + YYVAPEVL Y D+WS+GV
Sbjct: 159 LLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
Query: 350 IAYILLCGSRPFWARTES----GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPR 405
I YILLCG PF++ T G+ R + F W +S +A+ ++ LL DP
Sbjct: 218 IMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPT 277
Query: 406 KRLTAAQALSHPWIKNSNDV-KVPLD-VIIFKLMKAYMRSSSLRKAALRV 453
+RLT Q ++HPWI S V + PL + + K + +++
Sbjct: 278 ERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWD--EVKEEMTSA 325
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 393 bits (1012), Expect = e-136
Identities = 96/312 (30%), Positives = 148/312 (47%), Gaps = 38/312 (12%)
Query: 149 FSKHFANKYELGEEV-GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
FS F + Y+L E+V G G Q+ AVK+I K V R
Sbjct: 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLI---TSQEYAVKIIEKQPGHI---RSRVFR 59
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV++L GH N+++ + +E+ D Y+V E GG +L I R + E +A V+
Sbjct: 60 EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQ 118
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI----- 322
+ + + F H +G+ HRDLKPEN L ++ S +K DF L ++ + + I
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 323 ---VGSAYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFWAR--------- 364
GSA Y+APEV+ Y D+WS+GVI YILL G PF R
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238
Query: 365 ------TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
++ +F ++ + F + W +S A+D + +LL +D ++RL+AAQ L HPW
Sbjct: 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298
Query: 419 IKNSNDVKVPLD 430
++ + L
Sbjct: 299 VQGCAP-ENTLP 309
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 385 bits (990), Expect = e-133
Identities = 87/331 (26%), Positives = 142/331 (42%), Gaps = 48/331 (14%)
Query: 134 GSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK 193
G + + K+ + + +G G G K+ ++ A+K++
Sbjct: 1 GPHVKSGLQIKKNAIIDDY----KVTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQD 53
Query: 194 HKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDR 249
RREV++ + ++V+ D YE+ + +VME +GGEL R
Sbjct: 54 --------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR 105
Query: 250 ILSRGGK-YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
I RG + +TE +A +M I + + H + HRD+KPEN L+T+K N++LK DFG
Sbjct: 106 IQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165
Query: 309 LSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWA----R 364
A E Y D+WS+GVI YILLCG PF++
Sbjct: 166 F--------------------AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 205
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
G+ + F W +S E + ++ LL +P +R+T + ++HPWI S
Sbjct: 206 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265
Query: 425 V-KVPLD-VIIFKLMKAYMRSSSLRKAALRV 453
V + PL + K K R +++
Sbjct: 266 VPQTPLHTSRVLKEDKE--RWEDVKEEMTSA 294
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 385 bits (991), Expect = e-133
Identities = 97/316 (30%), Positives = 163/316 (51%), Gaps = 21/316 (6%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----AIAIE 203
+ K ++Y + + +G G G A +K ++VA+K+I K K A
Sbjct: 4 YPKALRDEYIMSKTLGSGACGEVKLAFERKT---CKKVAIKIISKRKFAIGSAREADPAL 60
Query: 204 DVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
+V E++IL+ L H ++K + ++ ++ Y+V+EL EGGEL D+++ + E K
Sbjct: 61 NVETEIEILKKL-NHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK-RLKEATCK 117
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
Q+L V + H G++HRDLKPEN L ++++E+ ++K DFG S + + +
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 324 GSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADP 378
G+ Y+APEVL Y+ D WS+GVI +I L G PF RT+ + +
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMK 438
+F W +S +A D VK+LL DP+ R T +AL HPW+++ + + D L+
Sbjct: 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD-----LLS 292
Query: 439 AYMRSSSLRKAALRVS 454
S++L + + S
Sbjct: 293 EENESTALPQVLAQPS 308
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 385 bits (992), Expect = e-133
Identities = 108/317 (34%), Positives = 157/317 (49%), Gaps = 24/317 (7%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
S F + YE+ E++G G + K + AVK+I K K D E+
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSK-------RDPTEEI 66
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+IL H N++ D Y+D VYVV EL +GGELLD+IL + ++E +A AV+ I
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTI 125
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKAIDFGLSDFVRPDER-LNDIVGSAY 327
V + H QGVVHRDLKP N L+ + N ++ DFG + +R + L +A
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKADPSFDEA 383
+VAPEVL R Y D+WS+GV+ Y +L G PF T I + S
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV-KVPLD-VIIFKLMKAYM 441
W S+S A+D V ++L+ DP +RLTAA L HPWI + + + + L+ L+K M
Sbjct: 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAM 305
Query: 442 RSS-----SLRKAALRV 453
++ + L
Sbjct: 306 AATYSALNRNQSPVLEP 322
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 374 bits (963), Expect = e-127
Identities = 92/294 (31%), Positives = 156/294 (53%), Gaps = 16/294 (5%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----AIAIE 203
+ K ++Y + + +G G G A +K ++VA+++I K K A
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKT---CKKVAIRIISKRKFAIGSAREADPAL 185
Query: 204 DVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
+V E++IL+ L H ++K + ++ ++ Y+V+EL EGGEL D+++ + E K
Sbjct: 186 NVETEIEILKKLN-HPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK-RLKEATCK 242
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
Q+L V + H G++HRDLKPEN L ++++E+ ++K DFG S + + +
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 302
Query: 324 GSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADP 378
G+ Y+APEVL Y+ D WS+GVI +I L G PF RT+ + +
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
+F W +S +A D VK+LL DP+ R T +AL HPW+++ + + D++
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL 416
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 332 bits (854), Expect = e-111
Identities = 79/308 (25%), Positives = 133/308 (43%), Gaps = 44/308 (14%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRRE 208
F + N + +G G G +G +G+ VAVK + + E
Sbjct: 9 FEQSLKNLVVSEKILGYGSSGTVV----FQGSFQGRPVAVKRMLIDFC------DIALME 58
Query: 209 VKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG------GKYTEDDA 262
+K+L H N+++++ + +Y+ +ELC L D + S+ E +
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----------ENSVLKAIDFGLSDF 312
+++ QI + VA H ++HRDLKP+N L +T EN + DFGL
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 313 VRPDE-----RLNDIVGSAYYVAPEVL--------HRSYSTEADVWSIGVIAYILLC-GS 358
+ + LN+ G++ + APE+L R + D++S+G + Y +L G
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 359 RPFWAR--TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
PF + ES I R + D SL +EA D + ++++ DP KR TA + L H
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDE-MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296
Query: 417 PWIKNSND 424
P +
Sbjct: 297 PLFWPKSK 304
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 331 bits (850), Expect = e-110
Identities = 69/281 (24%), Positives = 124/281 (44%), Gaps = 25/281 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ + +G G G +G + VAVK I REV++LR
Sbjct: 25 SFCPKDVLGHGAEGTIV----YRGMFDNRDVAVKRILPECF------SFADREVQLLRES 74
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N++++F +D Y+ +ELC L + + + + + ++ Q + +A
Sbjct: 75 DEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAI--DFGLSDFVRPDE----RLNDIVGSAYYV 329
H +VHRDLKP N L + + + +KA+ DFGL + R + + G+ ++
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 330 APEVL----HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFD-EA 383
APE+L + + D++S G + Y ++ GS PF + +L S D
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--ILLGACSLDCLH 251
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
P AR+ +++++ DP+KR +A L HP+ +
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 1e-93
Identities = 74/313 (23%), Positives = 134/313 (42%), Gaps = 43/313 (13%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
S +A+ +E +G+G FG A+ + A+K I + + + EV
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALD---SRYYAIKKIRHTEE----KLSTILSEV 53
Query: 210 KILRALTGHNNLVKFFDAYEDTDN-------------VYVVMELCEGGELLDRILSRGGK 256
+L +L H +V+++ A+ + N +++ ME CE G L D I S
Sbjct: 54 MLLASLN-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN 112
Query: 257 YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------ 310
D+ + QIL +++ H QG++HRDLKP N DE+ +K DFGL+
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRS 169
Query: 311 ---------DFVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSR 359
+ + L +G+A YVA EVL + Y+ + D++S+G+I + ++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-- 227
Query: 360 PFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
I + + F + + ++ L++ DP KR A L+ W+
Sbjct: 228 FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
Query: 420 KNSNDVKVPLDVI 432
+ +V + +
Sbjct: 288 PVKHQDEVIKEAL 300
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 1e-92
Identities = 70/315 (22%), Positives = 117/315 (37%), Gaps = 50/315 (15%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ + L + +G+G +G K G A+KV + + RE ++L
Sbjct: 9 HLWLLSDILGQGATA-----NVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVL 61
Query: 213 RALTGHNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQ 268
+ L H N+VK F E+ T + ++ME C G L + E + V+
Sbjct: 62 KKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 269 ILNVVAFCHLQGVVHRDLKPENFL-FTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
++ + G+VHR++KP N + +D SV K DFG + + DE+ + G+
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 328 YVAPEVL---------HRSYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVL 374
Y+ P++ + Y D+WSIGV Y GS PF R + ++
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 375 KADP-----------------SFDEAPWPSLSSEARD----FVKRLLNKDPRKRLTAAQA 413
P S D SLS + + +L D K Q
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 414 LSHPW-IKNSNDVKV 427
+ I + +
Sbjct: 301 FAETSDILHRGNSHH 315
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 4e-89
Identities = 70/284 (24%), Positives = 126/284 (44%), Gaps = 30/284 (10%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKG-ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y + +++G G K + K Q A+K + + ++ R E+ L
Sbjct: 28 RIYSILKQIGSGGSS-----KVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLN 81
Query: 214 ALTGHN-NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L H+ +++ +D +Y+VME C +L + + + K+ +L
Sbjct: 82 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEA 139
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYV 329
V H G+VH DLKP NFL + +LK IDFG+++ ++PD + VG+ Y+
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 330 APEVLHRS------------YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
PE + S ++DVWS+G I Y + G PF I + D
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIID 254
Query: 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
P+ + + +D +K L +DP++R++ + L+HP+++
Sbjct: 255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 1e-88
Identities = 85/269 (31%), Positives = 146/269 (54%), Gaps = 13/269 (4%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+++G +G+G F A+ G +VA+K+I K M A ++ V+ EVKI
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H ++++ ++ +ED++ VY+V+E+C GE+ + +R ++E++A+ M QI+ +
Sbjct: 68 LK-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEV 333
+ H G++HRDL N L N +K DFGL+ + P E+ + G+ Y++PE+
Sbjct: 127 YLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI 183
Query: 334 L-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
++ E+DVWS+G + Y LL G PF T V+ AD P LS EA
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLSIEA 239
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+D + +LL ++P RL+ + L HP++
Sbjct: 240 KDLIHQLLRRNPADRLSLSSVLDHPFMSR 268
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 2e-88
Identities = 85/270 (31%), Positives = 130/270 (48%), Gaps = 18/270 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+Y G +G+G F AK + + A K++PK + E + E+ I R
Sbjct: 16 RYVRGRFLGKGGF-----AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+L H ++V F +ED D V+VV+ELC LL+ R TE +A+ + QI+
Sbjct: 71 SLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGC 128
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPE 332
+ H V+HRDLK N +E+ +K DFGL+ V ER + G+ Y+APE
Sbjct: 129 QYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185
Query: 333 VL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
VL + +S E DVWSIG I Y LL G PF + + K + S P ++
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPV 241
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
A ++++L DP R T + L+ + +
Sbjct: 242 AASLIQKMLQTDPTARPTINELLNDEFFTS 271
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 3e-87
Identities = 70/284 (24%), Positives = 126/284 (44%), Gaps = 30/284 (10%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y + +++G G K + K Q A+K + + ++ R E+ L
Sbjct: 9 RIYSILKQIGSGGSS-----KVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLN 62
Query: 214 ALTGHN-NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L H+ +++ +D +Y+VME C +L + + + K+ +L
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEA 120
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYV 329
V H G+VH DLKP NFL + +LK IDFG+++ ++PD + VG+ Y+
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 330 APEVLHRS------------YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
PE + S ++DVWS+G I Y + G PF I + D
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIID 235
Query: 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
P+ + + +D +K L +DP++R++ + L+HP+++
Sbjct: 236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 5e-87
Identities = 90/307 (29%), Positives = 134/307 (43%), Gaps = 18/307 (5%)
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFK 177
G A P P A +Y G +G+G F AK
Sbjct: 4 PADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGF-----AKCF 58
Query: 178 KGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235
+ + A K++PK + E + E+ I R+L H ++V F +ED D V+
Sbjct: 59 EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF 117
Query: 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295
VV+ELC LL+ R TE +A+ + QI+ + H V+HRDLK N
Sbjct: 118 VVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL-- 174
Query: 296 KDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYI 353
+E+ +K DFGL+ V ER + G+ Y+APEVL + +S E DVWSIG I Y
Sbjct: 175 -NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 233
Query: 354 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA 413
LL G PF + + K + S P ++ A ++++L DP R T +
Sbjct: 234 LLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPVAASLIQKMLQTDPTARPTINEL 289
Query: 414 LSHPWIK 420
L+ +
Sbjct: 290 LNDEFFT 296
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 4e-86
Identities = 73/330 (22%), Positives = 120/330 (36%), Gaps = 49/330 (14%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ + L + +G+G +G K G A+KV + + RE ++L
Sbjct: 9 HLWLLSDILGQGATA-----NVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVL 61
Query: 213 RALTGHNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQ 268
+ L H N+VK F E+ T + ++ME C G L + E + V+
Sbjct: 62 KKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 269 ILNVVAFCHLQGVVHRDLKPENFL-FTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
++ + G+VHR++KP N + +D SV K DFG + + DE+ + G+
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 328 YVAPEVL---------HRSYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVL 374
Y+ P++ + Y D+WSIGV Y GS PF R + ++
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 375 KADP-----------------SFDEAPWPSLSSEARD----FVKRLLNKDPRKRLTAAQA 413
P S D SLS + + +L D K Q
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 414 LSHPWIKNSNDVKVPLDVIIFKLMKAYMRS 443
+ V + K Y+ S
Sbjct: 301 FAETSDILHRMVIHVFSLQQMTAHKIYIHS 330
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 265 bits (678), Expect = 6e-85
Identities = 75/334 (22%), Positives = 136/334 (40%), Gaps = 36/334 (10%)
Query: 105 PPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVG 164
P S K A + P+ + + + Y + +++G
Sbjct: 12 PRGSGMKETAA------AKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIG 65
Query: 165 RGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLV 222
G K + K Q A+K + + ++ R E+ L L H+ ++
Sbjct: 66 SGGSS-----KVFQVLNEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKII 119
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ +D +Y+VME C +L + + + K+ +L V H G+V
Sbjct: 120 RLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLHRS-- 337
H DLKP NFL + +LK IDFG+++ ++PD + VG+ Y+ PE +
Sbjct: 178 HSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 338 ----------YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
S ++DVWS+G I Y + G PF I + DP+ +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEFPDI 292
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ +D +K L +DP++R++ + L+HP+++
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 1e-83
Identities = 89/269 (33%), Positives = 146/269 (54%), Gaps = 19/269 (7%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y L + +G+G+F K K L G++VA+K+I K ++ +++ + REV+I++
Sbjct: 16 NYRLLKTIGKGNFA-----KVKLARHILTGREVAIKIIDKTQLNPT-SLQKLFREVRIMK 69
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L H N+VK F+ E +Y++ME GGE+ D +++ G + E +A++ QI++ V
Sbjct: 70 ILN-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAV 127
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+CH + +VHRDLK EN L D + +K DFG S+ +L+ G+ Y APE+
Sbjct: 128 QYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL 184
Query: 334 LH-RSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+ Y E DVWS+GVI Y L+ GS PF + + VL+ + + +S++
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFY--MSTD 240
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ +KR L +P KR T Q + WI
Sbjct: 241 CENLLKRFLVLNPIKRGTLEQIMKDRWIN 269
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 2e-83
Identities = 82/268 (30%), Positives = 137/268 (51%), Gaps = 14/268 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+E+G +G+G FG A+ K+ +A+KV+ K ++ A +RREV+I
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N+++ + + D VY+++E G + L + K+ E + ++ N ++
Sbjct: 66 LR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRE-LQKLSKFDEQRTATYITELANALS 123
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+CH + V+HRD+KPEN L LK DFG S P R D+ G+ Y+ PE++
Sbjct: 124 YCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMI 179
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
R + + D+WS+GV+ Y L G PF A T ++ + + + +F P ++ AR
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEGAR 235
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWIKN 421
D + RLL +P +R + L HPWI
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWITA 263
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 4e-82
Identities = 96/269 (35%), Positives = 137/269 (50%), Gaps = 18/269 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y LG+ +G G FG K K GE L G +VAVK++ + K+ + + ++RE++ L+
Sbjct: 12 HYVLGDTLGVGTFG-----KVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H +++K + + ++VME GGEL D I G + E +A+ + QIL+ V
Sbjct: 67 LFR-HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAV 124
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+CH VVHRDLKPEN L D + K DFGLS+ + E L GS Y APEV
Sbjct: 125 DYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181
Query: 334 L-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+ R Y+ E D+WS GVI Y LLCG+ PF +F+ + F + L+
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FYIPEY--LNRS 237
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ +L DP KR T H W K
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 5e-82
Identities = 48/304 (15%), Positives = 85/304 (27%), Gaps = 46/304 (15%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
K +L E + G + + + A+KV + +E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVER---LEDFALKVFTMGAENSRSELERLHEATFAAARL 119
Query: 216 TGHN-----------------------NLVKFFDAYEDTD--NVYVVMELCEG-----GE 245
G + + +D N ++M
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFS 179
Query: 246 LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305
LD + G + Q++ + A +G+VH P+N + L
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLG 236
Query: 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPFW 362
D + R Y E L+ S ++ + W +G+ Y + C PF
Sbjct: 237 DVSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
Query: 363 ARTESGIFRAVLKAD-----PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
T + S L + + R LN D R+RL +A+ P
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354
Query: 418 WIKN 421
Sbjct: 355 EFLQ 358
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 5e-82
Identities = 80/278 (28%), Positives = 142/278 (51%), Gaps = 15/278 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +++G +G+G FG A+ K+ +A+KV+ K ++ +RRE++I
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N+++ ++ + D +Y+++E GEL L + G++ E + M ++ + +
Sbjct: 71 LR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKE-LQKHGRFDEQRSATFMEELADALH 128
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+CH + V+HRD+KPEN L LK DFG S P R + G+ Y+ PE++
Sbjct: 129 YCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHA-PSLRRRTMCGTLDYLPPEMI 184
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
+++ + D+W GV+ Y L G PF + + + R ++ D F P P LS ++
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF---P-PFLSDGSK 240
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWI-KNSNDVKVPLD 430
D + +LL P +RL + HPW+ NS V P+
Sbjct: 241 DLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVY 278
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 262 bits (670), Expect = 9e-81
Identities = 65/324 (20%), Positives = 130/324 (40%), Gaps = 39/324 (12%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+E+ E +G G FG + + G+QVA+K + E E++I++
Sbjct: 15 PWEMKERLGTGGFG-----YVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMK 67
Query: 214 ALTGHNNLVKFFDAYED------TDNVYVVMELCEGGELLDRILSRG--GKYTEDDAKAV 265
L H N+V + + D + ME CEGG+L + E + +
Sbjct: 68 KLN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
+ I + + + H ++HRDLKPEN + + + K ID G + + E + VG+
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
Y+APE+L + Y+ D WS G +A+ + G RPF + + ++ +
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
Query: 385 W--------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
+ L+ + +++ +L R+R T Q + + +
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306
Query: 425 VKVPLDVIIFKLMKAYMRSSSLRK 448
+ + + ++ + + + +
Sbjct: 307 ILSLKLLSVMNMVSGRVHTYPVTE 330
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 2e-80
Identities = 78/271 (28%), Positives = 128/271 (47%), Gaps = 18/271 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
++L + +G G +G + + + VAVK++ + E++++E+ I + L
Sbjct: 8 DWDLVQTLGEGAYG---EVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML 62
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VKF+ + + Y+ +E C GGEL DRI E DA+ Q++ V +
Sbjct: 63 N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVY 120
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP---DERLNDIVGSAYYVAPE 332
H G+ HRD+KPEN L DE LK DFGL+ R + LN + G+ YVAPE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 333 VL-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLS 389
+L R + DVWS G++ +L G P+ ++S + + PW +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKID 235
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
S + ++L ++P R+T W
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 2e-80
Identities = 80/296 (27%), Positives = 137/296 (46%), Gaps = 41/296 (13%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM------------------ 196
N+Y L +E+G+G +G K E A+KV+ K K+
Sbjct: 13 NQYTLKDEIGKGSYG---VVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 197 -----TTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--TDNVYVVMELCEGGELLDR 249
IE V +E+ IL+ L H N+VK + +D D++Y+V EL G +++
Sbjct: 70 PGGCIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 250 ILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
+ED A+ ++ + + H Q ++HRD+KP N L E+ +K DFG+
Sbjct: 129 P--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGV 183
Query: 310 S-DFVRPDERLNDIVGSAYYVAPEVL---HRSYS-TEADVWSIGVIAYILLCGSRPFWAR 364
S +F D L++ VG+ ++APE L + +S DVW++GV Y + G PF
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ + F + P ++ + +D + R+L+K+P R+ + HPW+
Sbjct: 244 RIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 3e-80
Identities = 77/292 (26%), Positives = 112/292 (38%), Gaps = 20/292 (6%)
Query: 132 PEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVK 189
E SE + G + S S F ++ +G G +G + K + G+ AVK
Sbjct: 35 GEASETLQSPGYDPSRPES-FFQQSFQRLSRLGHGSYGEVFKV---RSKED--GRLYAVK 88
Query: 190 VIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDR 249
EV + H V+ A+E+ +Y+ ELC G L
Sbjct: 89 RSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQH 146
Query: 250 ILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
+ G E + L +A H QG+VH D+KP N K DFGL
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGL 203
Query: 310 SDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCG-SRPFWARTESG 368
+ G Y+APE+L SY T ADV+S+G+ + C P
Sbjct: 204 LVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263
Query: 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ + L P F LSSE R + +L DP+ R TA L+ P ++
Sbjct: 264 LRQGYLP--PEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 2e-79
Identities = 86/269 (31%), Positives = 135/269 (50%), Gaps = 19/269 (7%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y + E +G G FG K K Q+VA+K I + + + V RE+ L+
Sbjct: 10 PYIIRETLGEGSFG-----KVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK 64
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L H +++K +D ++ +V+E GGEL D I+ + + TED+ + QI+ +
Sbjct: 65 LLR-HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAI 121
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+CH +VHRDLKPEN L D+N +K DFGLS+ + L GS Y APEV
Sbjct: 122 EYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178
Query: 334 L-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+ + Y+ E DVWS G++ Y++L G PF +F+ V + + LS
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV--YVMPDF--LSPG 234
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
A+ ++R++ DP +R+T + PW
Sbjct: 235 AQSLIRRMIVADPMQRITIQEIRRDPWFN 263
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 3e-79
Identities = 78/271 (28%), Positives = 128/271 (47%), Gaps = 18/271 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
++L + +G G +G + + + VAVK++ + E++++E+ I + L
Sbjct: 8 DWDLVQTLGEGAYG---EVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML 62
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VKF+ + + Y+ +E C GGEL DRI E DA+ Q++ V +
Sbjct: 63 N-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVY 120
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP---DERLNDIVGSAYYVAPE 332
H G+ HRD+KPEN L DE LK DFGL+ R + LN + G+ YVAPE
Sbjct: 121 LHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 333 VL-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLS 389
+L R + DVWS G++ +L G P+ ++S + + PW +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKID 235
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
S + ++L ++P R+T W
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 6e-79
Identities = 70/344 (20%), Positives = 131/344 (38%), Gaps = 51/344 (14%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ 185
P + S LNK + N Y + + +G F K E +
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFN-----KIILCEKDNKF 56
Query: 186 VAVKVIPKH--------------KMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231
A+K K K++ +D + E++I+ + + + +
Sbjct: 57 YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGIITNY 115
Query: 232 DNVYVVMELCEGGELLDRILSRG-------GKYTEDDAKAVMIQILNVVAFCHLQ-GVVH 283
D VY++ E E +L K ++ +LN ++ H + + H
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH 175
Query: 284 RDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS---YST 340
RD+KP N L D+N +K DFG S+++ D+++ G+ ++ PE
Sbjct: 176 RDVKPSNILM---DKNGRVKLSDFGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGA 231
Query: 341 EADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSF---------------DEAP 384
+ D+WS+G+ Y++ PF + +F + + +
Sbjct: 232 KVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCS 291
Query: 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428
LS+E DF+K L K+P +R+T+ AL H W+ ++N +
Sbjct: 292 NNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLR 335
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 9e-79
Identities = 96/269 (35%), Positives = 139/269 (51%), Gaps = 18/269 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y LG+ +G G FG K K G+ L G +VAVK++ + K+ + + +RRE++ L+
Sbjct: 17 HYILGDTLGVGTFG-----KVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK 71
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H +++K + ++++VME GGEL D I G + E +++ + QIL+ V
Sbjct: 72 LFR-HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGV 129
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+CH VVHRDLKPEN L D + K DFGLS+ + E L GS Y APEV
Sbjct: 130 DYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186
Query: 334 L-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391
+ R Y+ E D+WS GVI Y LLCG+ PF +F+ + F + L+
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQY--LNPS 242
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+K +L DP KR T H W K
Sbjct: 243 VISLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-78
Identities = 83/306 (27%), Positives = 133/306 (43%), Gaps = 35/306 (11%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE--LKG 183
P G+ P G ++ + F +Y LG +G+G FG G
Sbjct: 7 LQGPPAPPGTPTPPPGGKDR-----EAFEAEYRLGPLLGKGGFG-----TVFAGHRLTDR 56
Query: 184 QQVAVKVIPKHKMTTAIAIED---VRREVKILRAL---TGHNNLVKFFDAYEDTDNVYVV 237
QVA+KVIP++++ + D EV +L + GH +++ D +E + +V
Sbjct: 57 LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116
Query: 238 MEL-CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
+E +L D I +G E ++ Q++ + CH +GVVHRD+K EN L +
Sbjct: 117 LERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLR 175
Query: 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYS-TEADVWSIGVIAYIL 354
K IDFG + DE D G+ Y PE + Y A VWS+G++ Y +
Sbjct: 176 RGC--AKLIDFGSGALL-HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDM 232
Query: 355 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+CG PF + I A L P+ +S + ++R L P R + + L
Sbjct: 233 VCGDIPF--ERDQEILEAELH-FPAH-------VSPDCCALIRRCLAPKPSSRPSLEEIL 282
Query: 415 SHPWIK 420
PW++
Sbjct: 283 LDPWMQ 288
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 4e-78
Identities = 83/320 (25%), Positives = 140/320 (43%), Gaps = 32/320 (10%)
Query: 117 LARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKH----FANKYELGEEVGRGHFGYTC 172
+ H + +P GS P L+ + ++Y++G +G G FG
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG--- 57
Query: 173 AAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIED---VRREVKILRALT-GHNNLVKFFD 226
G VA+K + K +++ + + V EV +L+ ++ G + +++ D
Sbjct: 58 --SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115
Query: 227 AYEDTDNVYVVMELCEG-GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRD 285
+E D+ +++E E +L D I RG E+ A++ Q+L V CH GV+HRD
Sbjct: 116 WFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRD 174
Query: 286 LKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYS-TEAD 343
+K EN L LK IDFG + D D G+ Y PE + + Y A
Sbjct: 175 IKDENILIDLNRGE--LKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAA 231
Query: 344 VWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKD 403
VWS+G++ Y ++CG PF + I R + +SSE + ++ L
Sbjct: 232 VWSLGILLYDMVCGDIPF--EHDEEIIRGQVF-FRQR-------VSSECQHLIRWCLALR 281
Query: 404 PRKRLTAAQALSHPWIKNSN 423
P R T + +HPW+++
Sbjct: 282 PSDRPTFEEIQNHPWMQDVL 301
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 8e-78
Identities = 81/302 (26%), Positives = 125/302 (41%), Gaps = 34/302 (11%)
Query: 136 EPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPK 193
EP A L ++ KY +G G FG K ++V VK I K
Sbjct: 5 EPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFG-----FVWTAVDKEKNKEVVVKFIKK 59
Query: 194 HKMTTAIAIED-----VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL-CEGGELL 247
K+ IED V E+ IL + H N++K D +E+ +VME G +L
Sbjct: 60 EKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLF 118
Query: 248 DRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307
I + E A + Q+++ V + L+ ++HRD+K EN + E+ +K IDF
Sbjct: 119 AFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDF 174
Query: 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYS-TEADVWSIGVIAYILLCGSRPF--WA 363
G + ++ + G+ Y APEVL Y E ++WS+GV Y L+ PF
Sbjct: 175 GSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234
Query: 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423
T P +S E V LL P +R T + ++ PW+
Sbjct: 235 ETVEAAIH-----PPYL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282
Query: 424 DV 425
++
Sbjct: 283 NL 284
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 1e-77
Identities = 87/273 (31%), Positives = 139/273 (50%), Gaps = 22/273 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+Y+ +++G G+FG A+ + +L + VAVK I + E+V+RE+ R+L
Sbjct: 21 RYDFVKDIGSGNFG---VARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSL 73
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+V+F + ++ ++ME GGEL +RI + G +++ED+A+ Q+L+ V++
Sbjct: 74 R-HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSY 131
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSV--LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
CH + HRDLK EN L D + LK DFG S + VG+ Y+APEV
Sbjct: 132 CHSMQICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188
Query: 334 L-HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFR----AVLKADPSFDEAPWPS 387
L + Y ADVWS GV Y++L G+ PF E +R +L S +
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR-- 246
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+S E + R+ DP R++ + +H W
Sbjct: 247 ISPECCHLISRIFVADPATRISIPEIKTHSWFL 279
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 4e-77
Identities = 80/280 (28%), Positives = 128/280 (45%), Gaps = 25/280 (8%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
YE+ +G G +G + K G+ + K + MT A + + EV +LR
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEA-EKQMLVSEVNLLRE 61
Query: 215 LTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRI--LSRGGKY-TEDDAKAVMIQI 269
L H N+V+++D D N +Y+VME CEGG+L I ++ +Y E+ VM Q+
Sbjct: 62 LK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 270 LNVVAFCH-----LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL-NDIV 323
+ CH V+HRDLKP N +K DFGL+ + D V
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKTFV 177
Query: 324 GSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
G+ YY++PE + SY+ ++D+WS+G + Y L PF A ++ + + +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR--- 234
Query: 383 APWPSL-SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
P S E + + R+LN R + + L +P I
Sbjct: 235 -RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-75
Identities = 74/271 (27%), Positives = 136/271 (50%), Gaps = 16/271 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
KY +++G G FG K + G+Q +K I +M++ E+ RREV +L
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTED---GRQYVIKEINISRMSSK-EREESRREVAVLAN 79
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVV 273
+ H N+V++ +++E+ ++Y+VM+ CEGG+L RI ++ G ED +QI +
Sbjct: 80 MK-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPE 332
H + ++HRD+K +N +F TKD ++ DFG++ E +G+ YY++PE
Sbjct: 139 KHVHDRKILHRDIKSQN-IFLTKDGT--VQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 333 VL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSS 390
+ ++ Y+ ++D+W++G + Y L F A + + ++ P S
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----PPVSLHYSY 251
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ R V +L ++PR R + L +I
Sbjct: 252 DLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 4e-75
Identities = 47/309 (15%), Positives = 93/309 (30%), Gaps = 60/309 (19%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
G +G+ A ++ G+ V V + + AI+ ++ EV LR L
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQET---GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 216 ------------------------TGHNNLVKFFDAYEDTD--NVYVVMELCEG-----G 244
+++ D + + + + G
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 245 ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304
E+L S + +Q++ ++A H G+VH L+P + + D+ +
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFL 247
Query: 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS------------YSTEADVWSIGVIAY 352
F D S + PE+ R + D W++G++ Y
Sbjct: 248 TGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
+ C P G + + ++ R ++ L RL Q
Sbjct: 305 WIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQ 356
Query: 413 ALSHPWIKN 421
A+ P +
Sbjct: 357 AMETPEYEQ 365
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 3e-74
Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 28/278 (10%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIED-VRREVKIL 212
KY +G+ +G G +G K K+ + AVK++ K K+ E V++E+++L
Sbjct: 6 KYLMGDLLGEGSYG-----KVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 213 RALTGHNNLVKFFD--AYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQ 268
R L H N+++ D E+ +Y+VME C G E+LD + ++ A Q
Sbjct: 61 RRLR-HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQ 117
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---DFVRPDERLNDIVGS 325
+++ + + H QG+VH+D+KP N L LK G++ D+ GS
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 326 AYYVAPEVL--HRSYS-TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
+ PE+ ++S + D+WS GV Y + G PF +F + K +
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--YAI 232
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
D +K +L +P KR + Q H W +
Sbjct: 233 PGD--CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 1e-72
Identities = 66/289 (22%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K F ++ E +G G FG AK + G+ +K + + E REVK
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN-------EKAEREVK 56
Query: 211 ILRALTGHNNLVKFFDAYEDTD----------------NVYVVMELCEGGELLDRILSRG 254
L L H N+V + ++ D +++ ME C+ G L I R
Sbjct: 57 ALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 115
Query: 255 GKY-TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313
G+ + A + QI V + H + +++RDLKP N + +K DFGL +
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSL 172
Query: 314 RPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372
+ D + G+ Y++PE + + Y E D++++G+I LL + ++ F
Sbjct: 173 KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--FFTD 230
Query: 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ S + + +++LL+K P R ++ L +
Sbjct: 231 LRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-68
Identities = 71/305 (23%), Positives = 134/305 (43%), Gaps = 18/305 (5%)
Query: 125 KPNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQ 184
+ P + +P L G++ + + +++GRG F A G
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNT--LANFRIEKKIGRGQFSEVYRAACLLD---GV 58
Query: 185 QVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGG 244
VA+K + + A A D +E+ +L+ L H N++K++ ++ + + + +V+EL + G
Sbjct: 59 PVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAG 117
Query: 245 ELLDRI---LSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301
+L I + E +Q+ + + H + V+HRD+KP N +F T V
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN-VFITAT--GV 174
Query: 302 LKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSR 359
+K D GL F + +VG+ YY++PE + Y+ ++D+WS+G + Y +
Sbjct: 175 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
Query: 360 PFWARTES--GIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417
PF+ + + + + + D + P S E R V +N DP KR
Sbjct: 235 PFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVA 292
Query: 418 WIKNS 422
++
Sbjct: 293 KRMHA 297
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 4e-67
Identities = 60/285 (21%), Positives = 100/285 (35%), Gaps = 32/285 (11%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
Y +++G G F Y + G A+K I H+ E+ +RE + R
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHD---GHFYALKRILCHEQQ---DREEAQREADMHRLF 83
Query: 216 TGHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRI---LSRGGKYTEDDAKAVMIQ 268
H N+++ ++++ + G L + I +G TED +++
Sbjct: 84 -NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD----------ER 318
I + H +G HRDLKP N L + +D G + +
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 319 LNDIVGSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL 374
+ Y APE+ H DVWS+G + Y ++ G P+ + G A L
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-L 258
Query: 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
P SS + ++ DP +R LS
Sbjct: 259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-65
Identities = 78/299 (26%), Positives = 125/299 (41%), Gaps = 42/299 (14%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ +E + +GRG FG AK K A+K I A E V REVK L
Sbjct: 3 YLTDFEPIQCLGRGGFGVVFEAKNKVD---DCNYAIKRIRLPNRELAR--EKVMREVKAL 57
Query: 213 RALTGHNNLVKFFDAYEDTDN------------VYVVMELCEGGELLDRILSRGGKYT-- 258
L H +V++F+A+ + + +Y+ M+LC L D + R
Sbjct: 58 AKLE-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-------- 310
+ +QI V F H +G++HRDLKP N FT + V+K DFGL
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEE 173
Query: 311 -----DFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR 364
+ R VG+ Y++PE +H SYS + D++S+G+I + LL PF +
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423
E ++ + F V+ +L+ P +R A + + ++ +
Sbjct: 231 MERVRTLTDVR-NLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-63
Identities = 61/299 (20%), Positives = 121/299 (40%), Gaps = 40/299 (13%)
Query: 148 GFSKHFANKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV 205
G + ++ E++G G FG + C + L G A+K K + ++
Sbjct: 4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKR-----LDGCIYAIKRSKKPLAGSVD-EQNA 57
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSR---GGKYTEDDA 262
REV L H+++V++F A+ + D++ + E C GG L D I + E +
Sbjct: 58 LREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK----------------DENSVLKAID 306
K +++Q+ + + H +VH D+KP N + + K D
Sbjct: 118 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWAR 364
G V G + ++A EVL ++ +AD++++ + G+ P
Sbjct: 178 LGH---VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPLPRN 233
Query: 365 TESGIFRAVLKADPSFDEAPWPS-LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422
+ + + + P LS E + +K +++ DP +R +A + H + ++
Sbjct: 234 GDQ--WHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 8e-61
Identities = 62/319 (19%), Positives = 120/319 (37%), Gaps = 46/319 (14%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ + + G F + A+ G++ A+K + ++ + +EV ++ L
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGS---GREYALKRLLSNEEE---KNRAIIQEVCFMKKL 82
Query: 216 TGHNNLVKFFDAY--------EDTDNVYVVMELCEGGELLDRILSR--GGKYTEDDAKAV 265
+GH N+V+F A ++ ELC+G L++ + G + D +
Sbjct: 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ-LVEFLKKMESRGPLSCDTVLKI 141
Query: 266 MIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD------- 316
Q V H Q ++HRDLK EN L +K DFG + +
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 317 ------ERLNDIVGSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTE 366
E + Y PE++ + + D+W++G I Y+L PF E
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----E 254
Query: 367 SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426
G ++ + P + + ++ +L +P +RL+ A+ + + +
Sbjct: 255 DGAKLRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ-EIAAARN 311
Query: 427 VPLDVIIFKLMKAYMRSSS 445
V I +L++ S
Sbjct: 312 VNPKSPITELLEQNGGYGS 330
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 201 bits (511), Expect = 5e-60
Identities = 49/306 (16%), Positives = 93/306 (30%), Gaps = 57/306 (18%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
G +G+ A ++ G+ V V + + AI+ ++ EV LR L
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQET---GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 217 G---------------------HNNLVKFFDAYEDTD-----NVYVVMELCEG-----GE 245
G K D + + + + GE
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 246 LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305
+L S + +Q++ ++A H G+VH L+P + + D+ +
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLT 253
Query: 306 DFGLSDFVRPDERLNDIVGSAY----YVAPEVLHRS------YSTEADVWSIGVIAYILL 355
F VR +G + A +L + D W++G+ Y +
Sbjct: 254 GFEHL--VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 356 CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
C P G + ++ ++ R ++ L RL QA+
Sbjct: 312 CADLPNTDDAALGGSEWIFRSC--------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363
Query: 416 HPWIKN 421
P +
Sbjct: 364 TPEYEQ 369
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 3e-59
Identities = 47/285 (16%), Positives = 96/285 (33%), Gaps = 30/285 (10%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ +G G F Y Q+ +KV + ++ L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERL 121
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG----GKYTEDDAKAVMIQ 268
+ + +KF+ A+ + +V EL G LL+ I + + ++
Sbjct: 122 KPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTK--------DENSVLKAIDFGLSDFVR---PDE 317
+L ++ H ++H D+KP+NF+ D ++ L ID G S ++
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 318 RLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376
++ + E+L ++ ++ + D + + Y +L G+ + E G +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV-KNEGGECKPEGLF 299
Query: 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
W +F +LN L + L K
Sbjct: 300 RRLPHLDMWN-------EFFHVMLNIPDCHHLPSLDLLRQKLKKV 337
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-56
Identities = 77/301 (25%), Positives = 126/301 (41%), Gaps = 31/301 (10%)
Query: 144 NKSFGFSKHFANKYEL-----GEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKM 196
+ S YE +G+G +G Y +A+K IP+
Sbjct: 6 EEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVY-AGRDLSNQVR----IAIKEIPERDS 60
Query: 197 TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGK 256
+ + E+ + + L H N+V++ ++ + + + ME GG L + S+ G
Sbjct: 61 RY---SQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP 116
Query: 257 --YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFV 313
E QIL + + H +VHRD+K +N L T + VLK DFG S
Sbjct: 117 LKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLA 174
Query: 314 RPDERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SG 368
+ G+ Y+APE++ R Y AD+WS+G + G PF+ E +
Sbjct: 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA 234
Query: 369 IFR-AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427
+F+ + K P E S+S+EA+ F+ + DP KR A L ++K S+ K
Sbjct: 235 MFKVGMFKVHPEIPE----SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKK 290
Query: 428 P 428
Sbjct: 291 T 291
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-55
Identities = 81/302 (26%), Positives = 140/302 (46%), Gaps = 28/302 (9%)
Query: 133 EGSEPEPAAGLNKSFGFSKHFANK------YELGEEVGRGHFGYTCAAKFKKGELKGQQV 186
+G+ EP G + ++ G+ +G G F A+ ++
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELAT---SREY 58
Query: 187 AVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL 246
A+K++ K + + V RE ++ L H VK + ++D + +Y + + GEL
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGEL 117
Query: 247 LDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306
L + + G + E + +I++ + + H +G++HRDLKPEN L +E+ ++ D
Sbjct: 118 LKY-IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITD 173
Query: 307 FGLS---DFVRPDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFW 362
FG + R N VG+A YV+PE+L +D+W++G I Y L+ G PF
Sbjct: 174 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 233
Query: 363 ARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA------LSH 416
A E IF+ ++K + F P +ARD V++LL D KRL + +H
Sbjct: 234 AGNEYLIFQKIIKLEYDF---P-EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 289
Query: 417 PW 418
P+
Sbjct: 290 PF 291
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-55
Identities = 65/274 (23%), Positives = 108/274 (39%), Gaps = 25/274 (9%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR-REVKILR 213
+ VGRG FG K K+ G Q AVK + +E R E+
Sbjct: 58 HWMTHQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVR---------LEVFRVEELVACA 105
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L+ +V + A + V + MEL EGG L ++ + G ED A + Q L +
Sbjct: 106 GLS-SPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRALYYLGQALEGL 163
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------DFVRPDERLNDIVGSAY 327
+ H + ++H D+K +N L + D + DFG + + + I G+
Sbjct: 164 EYLHTRRILHGDVKADNVL-LSSDGSRA-ALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
++APEV+ + D+WS + +L G P+ + + P E P P
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-P 280
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
S + ++ L K+P R +A +
Sbjct: 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-53
Identities = 60/274 (21%), Positives = 113/274 (41%), Gaps = 22/274 (8%)
Query: 157 YELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ E+GRG F Y +VA + K+T + + + E ++L+
Sbjct: 28 LKFDIEIGRGSFKTVYKG---LDTET--TVEVAWCELQDRKLTKS-ERQRFKEEAEMLKG 81
Query: 215 LTGHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
L H N+V+F+D++E T + +V EL G L L R ++ QIL
Sbjct: 82 LQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMKIKVLRSWCRQIL 139
Query: 271 NVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+ F H + ++HRDLK +N T +K D GL+ R ++G+ +
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKRASFA-KAVIGTPEF 196
Query: 329 VAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDEAPWPS 387
+APE+ Y DV++ G+ + P+ + I+R V +
Sbjct: 197 MAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKV 254
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
E ++ ++ + ++ +R + L+H + +
Sbjct: 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-52
Identities = 68/269 (25%), Positives = 135/269 (50%), Gaps = 20/269 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG C + + A+K + K K + +V +E++I++ L H LV
Sbjct: 23 IGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLV 78
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ +++D +++++V++L GG+L L + + E+ K + +++ + + Q ++
Sbjct: 79 NLWYSFQDEEDMFMVVDLLLGGDLRYH-LQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS----Y 338
HRD+KP+N L DE+ + DF ++ + + ++ + G+ Y+APE+ Y
Sbjct: 138 HRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSFDEAPWPSLSSEARDF 395
S D WS+GV AY LL G RP+ R+ + I ++ P + S E
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY---P-SAWSQEMVSL 250
Query: 396 VKRLLNKDPRKRLTAAQAL-SHPWIKNSN 423
+K+LL +P +R + + + P++ + N
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-51
Identities = 83/314 (26%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVK---------VIPKHKMTTAIAIEDV 205
KYE ++G G +G + + GQ VA+K VI K A+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESEDDPVIKK----IAL----- 50
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV 265
RE+++L+ L H NLV + + +++V E C+ +L + E K++
Sbjct: 51 -REIRMLKQLK-HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSI 107
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVG 324
Q L V FCH +HRD+KPEN L ++SV+K DFG + P + +D V
Sbjct: 108 TWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVA 164
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTE----SGIFRAV---- 373
+ +Y +PE+L Y DVW+IG + LL G P W +++ I + +
Sbjct: 165 TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDLI 223
Query: 374 ---------LKADPSFDEAPW----------PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ P++S A +K L+ DP +RLT Q L
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283
Query: 415 SHPWIKNSNDVKVP 428
HP+ +N +++
Sbjct: 284 HHPYFENIREIEDL 297
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 73/303 (24%), Positives = 123/303 (40%), Gaps = 55/303 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ Y+L ++GRG + A ++V VK++ K RE+KIL
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKKKKIK------REIKILEN 86
Query: 215 LTGHNNLVKFFDAYEDTDN---VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L G N++ D +D + V + ++ T+ D + M +IL
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNN--TDFKQLYQ---TLTDYDIRFYMYEILK 141
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
+ +CH G++HRD+KP N + E+ L+ ID+GL++F P + N V S Y+ P
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 199
Query: 332 EVL--HRSYSTEADVWSIGVIAYILLCGSRPF-------------------------WAR 364
E+L ++ Y D+WS+G + ++ PF +
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259
Query: 365 TESGIFRAVLKADPSFDEAPW---------PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ W +S EA DF+ +LL D + RLTA +A+
Sbjct: 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319
Query: 416 HPW 418
HP+
Sbjct: 320 HPY 322
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-50
Identities = 80/300 (26%), Positives = 141/300 (47%), Gaps = 38/300 (12%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A +EL E VG G +G + K GQ A+KV+ T E++++E+ +L+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMD----VTGDEEEEIKQEINMLK 75
Query: 214 ALTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVM 266
+ H N+ ++ A+ D +++VME C G + D I ++G E+ +
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGS 325
+IL ++ H V+HRD+K +N L T EN+ +K +DFG+S R R N +G+
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 326 AYYVAPEVLHR------SYSTEADVWSIGVIAYIL------LCGSRPFWARTESGIFRAV 373
Y++APEV+ +Y ++D+WS+G+ A + LC P A +F
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIP 247
Query: 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVII 433
P W S + + F++ L K+ +R Q + HP+I++ + + +
Sbjct: 248 RNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLK 304
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 84/296 (28%), Positives = 150/296 (50%), Gaps = 28/296 (9%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ ++G G G C A+ K G+QVAVK++ + E + EV I+R
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMD---LRKQQRRELLFNEVVIMRDY 99
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+V+ + +Y + ++V+ME +GG L D + + E+ V +L +A+
Sbjct: 100 Q-HFNVVEMYKSYLVGEELWVLMEFLQGGALTD--IVSQVRLNEEQIATVCEAVLQALAY 156
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVL 334
H QGV+HRD+K ++ L T + +K DFG + D + +VG+ Y++APEV+
Sbjct: 157 LHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 335 HRS-YSTEADVWSIGVIAYILLCGSRPFW----ARTESGIFRAVLKADPSFDEAPWPSLS 389
RS Y+TE D+WS+G++ ++ G P++ + + R P +S
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLRDSPPPKLKN--SHKVS 268
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSS 445
RDF++R+L +DP++R TA + L HP++ + + + L++ Y + +S
Sbjct: 269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE-----CLVPLIQLYRKQTS 319
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 32/290 (11%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ YEL E +G G AA K ++VA+K I K T++ +++ +E++ +
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKCQTSM--DELLKEIQAMS 68
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-------RILSRGGKYTEDDAKAVM 266
H N+V ++ ++ D +++VM+L GG +LD + + G E ++
Sbjct: 69 QCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-------DFVRPDERL 319
++L + + H G +HRD+K N L E+ ++ DFG+S D R R
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVR- 183
Query: 320 NDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377
VG+ ++APEV+ + Y +AD+WS G+ A L G+ P+ + L+ D
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243
Query: 378 P------SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
P D+ R + L KDP KR TAA+ L H + +
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 86/293 (29%), Positives = 137/293 (46%), Gaps = 36/293 (12%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+E+ E+G G FG AK K+ G A KVI + +ED E++IL
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIE---TKSEEELEDYIVEIEILATC 73
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H +VK AY +++++E C GG + +L TE + V Q+L + F
Sbjct: 74 D-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLNDIVGSAYYVAPEVL 334
H + ++HRDLK N L T ++ DFG+S ++ + +G+ Y++APEV+
Sbjct: 133 LHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 335 HR------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL---KADPSFDEAPW 385
Y +AD+WS+G+ + P E R +L K+DP
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAKSDP------- 239
Query: 386 PSL------SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
P+L S E RDF+K L+K+P R +AAQ L HP++ + K +++
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELV 292
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-49
Identities = 83/298 (27%), Positives = 125/298 (41%), Gaps = 47/298 (15%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI---PKHKMTTAIAIEDVRREVKI 211
KYE VG G +G + K G+ VA+K KM IA+ RE+K+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESDDDKMVKKIAM----REIKL 77
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
L+ L H NLV + + Y+V E + +LD + + + QI+N
Sbjct: 78 LKQLR-HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVA 330
+ FCH ++HRD+KPEN L ++ V+K DFG + P E +D V + +Y A
Sbjct: 136 GIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRA 192
Query: 331 PEVL--HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTE----SGIFRAV--LKAD--PS 379
PE+L Y DVW+IG + + G P + ++ I + L
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251
Query: 380 FDEAPW-------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
F++ P P LS D K+ L+ DP KR A+ L H +
Sbjct: 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-49
Identities = 77/280 (27%), Positives = 132/280 (47%), Gaps = 17/280 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
KY E++G+G G A GQ+VA++ + + E + E+ ++R
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMN---LQQQPKKELIINEILVMREN 74
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+ N+V + D+Y D ++VVME GG L D + E AV + L + F
Sbjct: 75 K-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD--VVTETCMDEGQIAAVCRECLQALEF 131
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVL 334
H V+HRD+K +N L + +K DFG + P++ + + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 335 HRS-YSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWPSLSSEA 392
R Y + D+WS+G++A ++ G P+ ++ P LS+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN--PEKLSAIF 246
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
RDF+ R L D KR +A + L H ++K + + +I
Sbjct: 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-49
Identities = 78/273 (28%), Positives = 131/273 (47%), Gaps = 20/273 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
++ + +G G FG K K+ G A+K++ K K+ IE E +IL+A+
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
LVK +++D N+Y+VME GGE+ L R G+++E A+ QI+ +
Sbjct: 100 -FPFLVKLEFSFKDNSNLYMVMEYVAGGEMF-SHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR 336
H +++RDLKPEN L D+ ++ DFG + V R + G+ +APE++
Sbjct: 158 HSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILS 212
Query: 337 S-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y+ D W++GV+ Y + G PF+A I+ ++ F P SS+ +D
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDL 268
Query: 396 VKRLLNKDPRKRLTAAQA-----LSHPWIKNSN 423
++ LL D KR + +H W ++
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-48
Identities = 77/283 (27%), Positives = 140/283 (49%), Gaps = 23/283 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+++ E++G G +G A K+ GQ VA+K +P ++++ +E+ I++
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVES-----DLQEIIKEISIMQQC 81
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
++VK++ +Y ++++VME C G + D I R TED+ ++ L + +
Sbjct: 82 D-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 334
H +HRD+K N L K DFG++ + N ++G+ +++APEV+
Sbjct: 141 LHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 335 HRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDEAPWPSLS 389
Y+ AD+WS+G+ A + G P+ + RA+ P+F + S
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYA---DIHPMRAIFMIPTNPPPTFRKPEL--WS 252
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
DFVK+ L K P +R TA Q L HP+++++ V + D+I
Sbjct: 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLI 295
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 6e-48
Identities = 78/304 (25%), Positives = 141/304 (46%), Gaps = 23/304 (7%)
Query: 135 SEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH 194
+ +GL + E++G+G FG + + VA+K+I
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLE 58
Query: 195 KMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG 254
+ I ED+++E+ +L + K++ +Y ++++ME GG LD L
Sbjct: 59 EAEDEI--EDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEP 113
Query: 255 GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFV 313
G E ++ +IL + + H + +HRD+K N L + E+ +K DFG++
Sbjct: 114 GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLT 170
Query: 314 RPDERLNDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372
+ N VG+ +++APEV+ +S Y ++AD+WS+G+ A L G P E +
Sbjct: 171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS---ELHPMKV 227
Query: 373 VL---KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI-KNSNDVKVP 428
+ K +P E + S ++FV+ LNK+P R TA + L H +I +N+
Sbjct: 228 LFLIPKNNPPTLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYL 284
Query: 429 LDVI 432
++I
Sbjct: 285 TELI 288
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 164 bits (419), Expect = 9e-48
Identities = 92/307 (29%), Positives = 141/307 (45%), Gaps = 58/307 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIEDVR 206
KY E++G G +G A+ GE A+K I ++ +T I
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET----FALKKI---RLEKEDEGIPSTTI------ 48
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKA 264
RE+ IL+ L H+N+VK +D + +V E + +LLD G AK+
Sbjct: 49 REISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKS 104
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
++Q+LN +A+CH + V+HRDLKP+N L + LK DFGL+ F P + +
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEI 161
Query: 324 GSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRA----- 372
+ +Y AP+VL + YST D+WS+G I ++ G+ F +E IFR
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN 221
Query: 373 ------VLK---ADPSFDEAP-------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
V + DP+F L D + ++L DP +R+TA QAL H
Sbjct: 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
Query: 417 PWIKNSN 423
+ K +N
Sbjct: 282 AYFKENN 288
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-47
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 25/285 (8%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ E+G G FG A+ + + VA+K + + +D+ +EV+ L+ L
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N +++ Y ++VME C G D + E + AV L +A+
Sbjct: 112 R-HPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH 335
H ++HRD+K N L + E ++K DFG + + N VG+ Y++APEV+
Sbjct: 170 LHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVIL 223
Query: 336 RS----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL----KADPSFDEAPWPS 387
Y + DVWS+G+ L P + A+ P+ W
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNESPALQSGHW-- 278
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
S R+FV L K P+ R T+ L H ++ V +D+I
Sbjct: 279 -SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 322
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-47
Identities = 79/264 (29%), Positives = 129/264 (48%), Gaps = 14/264 (5%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+FKK Q A+K + K + +E E ++L H L
Sbjct: 25 LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
F ++ +N++ VME GG+L+ I K+ A +I+ + F H +G+V
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHSKGIV 140
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N L D++ +K DFG+ + + D + N G+ Y+APE+L Y+
Sbjct: 141 YRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 197
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D WS GV+ Y +L G PF + E +F ++ +P + P L EA+D + +L
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---P-RWLEKEAKDLLVKLF 253
Query: 401 NKDPRKRLTAAQAL-SHPWIKNSN 423
++P KRL + HP + N
Sbjct: 254 VREPEKRLGVRGDIRQHPLFREIN 277
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 20/273 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+++ +G G FG + + G+ A+KV+ K + +E E +L +T
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H +++ + ++D ++++M+ EGGEL L + ++ AK ++ + +
Sbjct: 65 -HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR 336
H + +++RDLKPEN L D+N +K DFG + +V + + G+ Y+APEV+
Sbjct: 123 HSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVST 177
Query: 337 S-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y+ D WS G++ Y +L G PF+ + +L A+ F P P + + +D
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNEDVKDL 233
Query: 396 VKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
+ RL+ +D +RL +HPW K
Sbjct: 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-47
Identities = 57/276 (20%), Positives = 103/276 (37%), Gaps = 27/276 (9%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+ R + K E + +++ ++ +++ + + N V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTV 124
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA--VMIQILNVVAFCHLQG 280
+Y+ M+LC L D + R + + IQI V F H +G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLS-------------DFVRPDERLNDIVGSAY 327
++HRDLKP N F + V+K DFGL + VG+
Sbjct: 185 LMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 328 YVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPW 385
Y++PE +H +YS + D++S+G+I + LL F + E I V +
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLL---F 295
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ V+ +L+ P +R A + + +N
Sbjct: 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 27/92 (29%), Positives = 41/92 (44%), Gaps = 6/92 (6%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ + +E + +GRG FG AK K + A+K I A E V REV
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNK---VDDCNYAIKRIRLPNREL--AREKVMREV 55
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241
K L L H +V++F+A+ +T E+
Sbjct: 56 KALAKL-EHPGIVRYFNAWLETPPEKWQEEMD 86
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-47
Identities = 75/314 (23%), Positives = 125/314 (39%), Gaps = 36/314 (11%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA-IEDVRREVKIL 212
N E E+G G G +F+K G +AVK + + + + ++ ++
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKT---GHVIAVKQMR---RSGNKEENKRILMDLDVV 77
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
+V+ F + +V++ MEL G E + + I+
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTC-AEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 273 VAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
+ + + GV+HRD+KP N L + + +K DFG+S + D+ + G A Y+AP
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAAYMAP 193
Query: 332 EVL------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR---AVLKADPSFDE 382
E + Y ADVWS+G+ L G P+ + F VL+ +P
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEP---- 247
Query: 383 APWPSL------SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKL 436
P L S + + FVK L KD RKR + L H +IK ++V + +
Sbjct: 248 ---PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDV 304
Query: 437 MKAYMRSSSLRKAA 450
M S +
Sbjct: 305 MAKTESPRSGPSSG 318
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-47
Identities = 70/301 (23%), Positives = 118/301 (39%), Gaps = 31/301 (10%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA-IEDVRREVKIL 212
A + E+GRG +G K GQ +AVK I T + + ++ ++
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPS---GQIMAVKRIR---STVDEKEQKQLLMDLDVV 74
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILS-----RGGKYTEDDAKAVMI 267
+ +V+F+ A + ++ MEL D+ E+ + +
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 268 QILNVVAFCHLQG-VVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGS 325
+ + ++HRD+KP N L +K DFG+S V + D G
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGISGQLVDSIAKTRD-AGC 188
Query: 326 AYYVAPEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA---VLKAD 377
Y+APE + + Y +DVWS+G+ Y L G P+ + +F V+K D
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGD 246
Query: 378 -PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKL 436
P + S +FV L KD KR + L HP+I + V + + K+
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKI 306
Query: 437 M 437
+
Sbjct: 307 L 307
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 9e-47
Identities = 67/287 (23%), Positives = 121/287 (42%), Gaps = 27/287 (9%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA-IEDVRREVKIL 212
A+ E E+GRG +G + GQ +AVK I T + + ++ I
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPS---GQIMAVKRIR---ATVNSQEQKRLLMDLDIS 59
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQIL 270
V F+ A +V++ MEL + + +++ +G ED + + I+
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 271 NVVAFCHLQG-VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
+ H + V+HRD+KP N L + +K DFG+S ++ D + G Y+
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYM 176
Query: 330 APEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA----VLKADPSF 380
APE ++ + YS ++D+WS+G+ L P+ + F+ V + P
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQL 234
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427
+ S+E DF + L K+ ++R T + + HP+
Sbjct: 235 PADKF---SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 75/271 (27%), Positives = 121/271 (44%), Gaps = 20/271 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG + K + A+K++ K +M E I+ A +V
Sbjct: 77 IGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVV 132
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ F A++D +Y+VME GG+L+ ++S E A+ +++ + H G +
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVL-----H 335
HRD+KP+N L D++ LK DFG + + R + VG+ Y++PEVL
Sbjct: 191 HRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 336 RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
Y E D WS+GV Y +L G PF+A + G + ++ S +S EA++
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 396 VKRLLNKDPRKRLTAAQAL---SHPWIKNSN 423
+ L D RL H + KN
Sbjct: 308 ICAFL-TDREVRLGRNGVEEIKRHLFFKNDQ 337
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 22/275 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG F K K+ GQ A+K++ K M + R E +L +
Sbjct: 69 IGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVL-VNGDRRWIT 124
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ A++D + +Y+VME GG+LL + G + + A+ + +I+ + H G V
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV 184
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLHR---- 336
HRD+KP+N L D ++ DFG +R D R VG+ Y++PE+L
Sbjct: 185 HRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 337 ----SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSE 391
SY E D W++GV AY + G PF+A + + + ++ + E
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEE 301
Query: 392 ARDFVKRLLNKDPRKRLTAAQAL---SHPWIKNSN 423
ARDF++RLL P RL A +HP+ +
Sbjct: 302 ARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 85/308 (27%), Positives = 138/308 (44%), Gaps = 58/308 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIEDVR 206
KYE E++G G +G AK ++ + VA+K + ++ ++A+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRV---RLDDDDEGVPSSAL------ 49
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKA 264
RE+ +L+ L H N+V+ D + +V E C+ + D S G + K+
Sbjct: 50 REICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD---SCNGDLDPEIVKS 105
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIV 323
+ Q+L + FCH + V+HRDLKP+N L + N LK +FGL+ F P + V
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEV 162
Query: 324 GSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWARTE----SGIFRAV--- 373
+ +Y P+VL + YST D+WS G I L RP F IFR +
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 374 -------LKADPSFDEAP-----------WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ P + P P L++ RD ++ LL +P +R++A +AL
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
Query: 416 HPWIKNSN 423
HP+ +
Sbjct: 283 HPYFSDFC 290
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-46
Identities = 76/362 (20%), Positives = 139/362 (38%), Gaps = 19/362 (5%)
Query: 69 FPFYSPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNE 128
F + +F P PP + + +
Sbjct: 256 FMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGT 315
Query: 129 AAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAV 188
A PE + + + + + +G+G FG ++ K + AV
Sbjct: 316 KA-PEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAV 371
Query: 189 KVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD 248
K++ K + +E E ++L L + ++ D +Y VME GG+L+
Sbjct: 372 KILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 431
Query: 249 RILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
I + G++ E A +I + F +G+++RDLK +N + D +K DFG
Sbjct: 432 HI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFG 487
Query: 309 LS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTE 366
+ + + G+ Y+APE++ Y D W+ GV+ Y +L G PF E
Sbjct: 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547
Query: 367 SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQA-----LSHPWIKN 421
+F+++++ + ++ P S+S EA K L+ K P KRL H + +
Sbjct: 548 DELFQSIMEHNVAY---P-KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
Query: 422 SN 423
+
Sbjct: 604 ID 605
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-46
Identities = 68/268 (25%), Positives = 121/268 (45%), Gaps = 18/268 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG ++ K + AVK++ K + +E E ++L L
Sbjct: 28 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ ++ D +Y VME GG+L+ I + G++ E A +I + F +G++
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGII 143
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N + D +K DFG+ + + G+ Y+APE++ Y
Sbjct: 144 YRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 200
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W+ GV+ Y +L G PF E +F+++++ + ++ P S+S EA K L+
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICKGLM 256
Query: 401 NKDPRKRLTAAQA-----LSHPWIKNSN 423
K P KRL H + + +
Sbjct: 257 TKHPGKRLGCGPEGERDIKEHAFFRYID 284
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-46
Identities = 78/269 (28%), Positives = 127/269 (47%), Gaps = 19/269 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K+ G AVKV+ K + +E E +IL H L
Sbjct: 31 LGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+ F ++ D ++ VME GG+L+ I + ++ E A+ +I++ + F H +G++
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEIISALMFLHDKGII 146
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N L D K DFG+ + + G+ Y+APE+L Y
Sbjct: 147 YRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGP 203
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W++GV+ Y +LCG PF A E +F A+L + + P L +A +K +
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY---P-TWLHEDATGILKSFM 259
Query: 401 NKDPRKRL-----TAAQAL-SHPWIKNSN 423
K+P RL A+ HP+ K +
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPFFKEID 288
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 7e-46
Identities = 78/270 (28%), Positives = 130/270 (48%), Gaps = 21/270 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV--RREVKILRALTGHNN 220
+G+G FG K G Q A+KV+ K + + V + E IL H
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDIL-VEVNHPF 87
Query: 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG 280
+VK A++ +Y++++ GG+L R LS+ +TE+D K + ++ + H G
Sbjct: 88 IVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLHSLG 146
Query: 281 VVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-Y 338
+++RDLKPEN L DE +K DFGLS + + +++ G+ Y+APEV++R +
Sbjct: 147 IIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 339 STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398
+ AD WS GV+ + +L G+ PF + +LKA P LS EA+ ++
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEAQSLLRM 259
Query: 399 LLNKDPRKRL-----TAAQALSHPWIKNSN 423
L ++P RL + H + +
Sbjct: 260 LFKRNPANRLGAGPDGVEEIKRHSFFSTID 289
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-46
Identities = 82/313 (26%), Positives = 131/313 (41%), Gaps = 57/313 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-------TTAIAIEDVRR 207
Y +++G G + K K VA+K I ++ TAI R
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKL---TDNLVALKEI---RLEHEEGAPCTAI------R 49
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKAV 265
EV +L+ L H N+V D ++ +V E + + LD G + K
Sbjct: 50 EVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD---DCGNIINMHNVKLF 105
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVG 324
+ Q+L +A+CH Q V+HRDLKP+N L +E LK DFGL+ P + ++ V
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVV 162
Query: 325 SAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAV----- 373
+ +Y P++L YST+ D+W +G I Y + G F T IFR +
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE 222
Query: 374 -----LKADPSFDEAP------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
+ ++ F P L S+ D + +LL + R R++A A+ H
Sbjct: 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282
Query: 417 PWIKNSNDVKVPL 429
P+ + + L
Sbjct: 283 PFFLSLGERIHKL 295
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 9e-46
Identities = 85/330 (25%), Positives = 138/330 (41%), Gaps = 62/330 (18%)
Query: 135 SEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH 194
++ + ++ S S ++Y ++G G +G A + VA+K I
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTV---TNETVAIKRI--- 67
Query: 195 KM--------TTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGEL 246
++ TAI REV +L+ L H N+++ ++++ E E
Sbjct: 68 RLEHEEEGVPGTAI------REVSLLKELQ-HRNIIELKSVIHHNHRLHLIFEYAEND-- 118
Query: 247 LDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS--VLKA 304
L + + + + K+ + Q++N V FCH + +HRDLKP+N L + D + VLK
Sbjct: 119 LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKI 178
Query: 305 IDFGLS-DFVRPDERLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPF 361
DFGL+ F P + + + +Y PE+L R YST D+WSI I +L + F
Sbjct: 179 GDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238
Query: 362 WARTE----SGIFRAVLKADPSFDEAPWP--------------------------SLSSE 391
+E IF VL P + WP L E
Sbjct: 239 PGDSEIDQLFKIFE-VLGL-PD--DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDE 294
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
D + +L DP KR++A AL HP+ +
Sbjct: 295 GLDLLTAMLEMDPVKRISAKNALEHPYFSH 324
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 1e-45
Identities = 70/273 (25%), Positives = 120/273 (43%), Gaps = 20/273 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG K K + A+K++ K +M R E +L +
Sbjct: 82 IGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVL-VNGDSKWIT 137
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
A++D +N+Y+VM+ GG+LL + + E+ A+ + +++ + H V
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV 197
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVL------ 334
HRD+KP+N L D N ++ DFG + D + + VG+ Y++PE+L
Sbjct: 198 HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 335 HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSSEAR 393
Y E D WS+GV Y +L G PF+A + + ++ F + +S A+
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314
Query: 394 DFVKRLLNKDPRKRLTAAQAL---SHPWIKNSN 423
D ++RL+ RL HP+ +
Sbjct: 315 DLIRRLICSRE-HRLGQNGIEDFKKHPFFSGID 346
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 87/314 (27%), Positives = 137/314 (43%), Gaps = 59/314 (18%)
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAI 200
+ + KY+ E+VG G +G AK +G + VA+K I ++ +TAI
Sbjct: 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRI----VALKRI---RLDAEDEGIPSTAI 67
Query: 201 AIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYT 258
RE+ +L+ L H N+V D + +V E E ++LD
Sbjct: 68 ------REISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLD---ENKTGLQ 117
Query: 259 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDE 317
+ K + Q+L VA CH ++HRDLKP+N L + + LK DFGL+ F P
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVR 174
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFR 371
V + +Y AP+VL + YST D+WSIG I ++ G F T+ IF
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234
Query: 372 AV----------LKADPSFDEAP------------WPSLSSEARDFVKRLLNKDPRKRLT 409
+ ++ P + + P E D + +L DP KR++
Sbjct: 235 ILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294
Query: 410 AAQALSHPWIKNSN 423
A A++HP+ K+ +
Sbjct: 295 ARDAMNHPYFKDLD 308
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 17/269 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPK-HKMTTAIAIEDVRREVKILRALTGHNNL 221
+G+G +G + G G+ A+KV+ K + A + E IL H +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL-EEVKHPFI 83
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V A++ +Y+++E GGEL + L R G + ED A + +I + H +G+
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQ-LEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-YS 339
++RDLKPEN + + +K DFGL + + + G+ Y+APE+L RS ++
Sbjct: 143 IYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHN 199
Query: 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399
D WS+G + Y +L G+ PF +LK + P P L+ EARD +K+L
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEARDLLKKL 255
Query: 400 LNKDPRKRLTAAQA-----LSHPWIKNSN 423
L ++ RL A +HP+ ++ N
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFFRHIN 284
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-45
Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 25/275 (9%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG FG A + K G+ A K + K ++ + E KIL A +V
Sbjct: 193 LGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIV 248
Query: 223 KFFDAYEDTDNVYVVMELCEGGEL---LDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ 279
A+E ++ +VM + GG++ + + + E A QI++ + H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-S 337
+++RDLKPEN L D++ ++ D GL+ + + G+ ++APE+L
Sbjct: 309 NIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 338 YSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSFDEAPWPSLSSEAR 393
Y D +++GV Y ++ PF AR E + + VL+ ++ S ++
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPASK 421
Query: 394 DFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
DF + LL KDP KRL + +HP ++ +
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-45
Identities = 80/360 (22%), Positives = 142/360 (39%), Gaps = 39/360 (10%)
Query: 91 SANSTPNRFFKRPFPPPSPAKHIKAVLARRHGS---VKPNEAAIPEGSEPEPAAGLNKS- 146
S +H++ L ++ +P I + + +S
Sbjct: 110 DTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESD 169
Query: 147 ----FGFSKHFANKYELGEE-------VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK 195
F K+ L +GRG FG + G+ A+K + K +
Sbjct: 170 KFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKR 226
Query: 196 MTTAIAIEDVRREVKILRALTGHNN--LVKFFDAYEDTDNVYVVMELCEGGELLDRILSR 253
+ E +L ++ + +V A+ D + +++L GG+L LS+
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQ 285
Query: 254 GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313
G ++E D + +I+ + H + VV+RDLKP N L DE+ ++ D GL+
Sbjct: 286 HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDF 342
Query: 314 RPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESG--- 368
++ + VG+ Y+APEVL + +Y + AD +S+G + + LL G PF
Sbjct: 343 -SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401
Query: 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
I R L S S E R ++ LL +D +RL A + P+ ++ +
Sbjct: 402 IDRMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 6e-45
Identities = 78/268 (29%), Positives = 130/268 (48%), Gaps = 19/268 (7%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG + K G+ A+K++ K + + E ++L T H L
Sbjct: 13 LGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLT 68
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
A++ D + VME GGEL LSR +TE+ A+ +I++ + + H + VV
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RD+K EN + D++ +K DFGL + + + G+ Y+APEVL Y
Sbjct: 128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +GV+ Y ++CG PF+ + +F +L + F P +LS EA+ + LL
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---P-RTLSPEAKSLLAGLL 240
Query: 401 NKDPRKRLTAAQA-----LSHPWIKNSN 423
KDP++RL + + H + + N
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 84/306 (27%), Positives = 127/306 (41%), Gaps = 55/306 (17%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--------TAIAIEDV 205
A +YE + +G G F A+ K Q VA+K I + TA+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTAL----- 60
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAK 263
RE+K+L+ L+ H N++ DA+ N+ +V + E ++ T K
Sbjct: 61 -REIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIK 115
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDI 322
A M+ L + + H ++HRDLKP N L DEN VLK DFGL+ F P+
Sbjct: 116 AYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQ 172
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWA-RTE----SGIFRAV-- 373
V + +Y APE+L R Y D+W++G I LL PF ++ + IF +
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLDQLTRIFETLGT 231
Query: 374 --------------LKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
SF P + + D ++ L +P R+TA QAL
Sbjct: 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291
Query: 416 HPWIKN 421
+ N
Sbjct: 292 MKYFSN 297
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 63/313 (20%), Positives = 111/313 (35%), Gaps = 54/313 (17%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA-----IEDVR 206
+ Y + + G +G CA +G VA+K + +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGI----PVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 207 ---REVKILRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRIL-SRGGKY 257
RE+++L H N++ D +Y+V EL L +++ +
Sbjct: 75 RVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVI 131
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
+ + M IL + H GVVHRDL P N L +N+ + DF L+ D
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADA 188
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG------------------ 357
V +Y APE++ + ++ D+WS G + +
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248
Query: 358 -----SRPFWARTESGIFRAVLKAD-PSFDEAPW----PSLSSEARDFVKRLLNKDPRKR 407
S R L+ + W P+ A D + ++L +P++R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308
Query: 408 LTAAQALSHPWIK 420
++ QAL HP+ +
Sbjct: 309 ISTEQALRHPYFE 321
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-44
Identities = 74/278 (26%), Positives = 131/278 (47%), Gaps = 28/278 (10%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK + A+KV+ K + I+ V+ E + + H LV
Sbjct: 17 IGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ ++ V+E GG+L+ + R K E+ A+ +I + + H +G++
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 132
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L Y
Sbjct: 133 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 189
Query: 341 EADVWSIGVIAYILLCGSRPFW---------ARTESGIFRAVLKADPSFDEAPWPSLSSE 391
D W++GV+ + ++ G PF TE +F+ +L+ P SLS +
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLSVK 245
Query: 392 ARDFVKRLLNKDPRKRL-----TAAQAL-SHPWIKNSN 423
A +K LNKDP++RL T + HP+ +N +
Sbjct: 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 80/309 (25%), Positives = 130/309 (42%), Gaps = 60/309 (19%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-------TTAIAIEDVR 206
+++++ E++G G + K G VA+K + K+ +TAI
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKT---TGVYVALKEV---KLDSEEGTPSTAI------ 51
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEG--GELLD--RILSRGGKYTEDDA 262
RE+ +++ L H N+V+ +D + + +V E + + +D + + +
Sbjct: 52 REISLMKELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLV 110
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLND 321
K Q+L +AFCH ++HRDLKP+N L ++ LK DFGL+ F P +
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSS 167
Query: 322 IVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFR---- 371
V + +Y AP+VL R+YST D+WS G I ++ G F + IF
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227
Query: 372 ----------------AVLKADPS------FDEAPWPSLSSEARDFVKRLLNKDPRKRLT 409
++ P L DF+ LL +P RL+
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287
Query: 410 AAQALSHPW 418
A QAL HPW
Sbjct: 288 AKQALHHPW 296
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-43
Identities = 75/267 (28%), Positives = 123/267 (46%), Gaps = 17/267 (6%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG A+ K + AVKV+ K + + + E +L H LV
Sbjct: 46 IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
+++ D +Y V++ GGEL L R + E A+ +I + + + H +V
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARFYAAEIASALGYLHSLNIV 161
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHRS-YST 340
+RDLKPEN L D + DFGL + + + + G+ Y+APEVLH+ Y
Sbjct: 162 YRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLL 400
D W +G + Y +L G PF++R + ++ +L P++++ AR ++ LL
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL---K-PNITNSARHLLEGLL 274
Query: 401 NKDPRKRL----TAAQALSHPWIKNSN 423
KD KRL + SH + N
Sbjct: 275 QKDRTKRLGAKDDFMEIKSHVFFSLIN 301
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 73/278 (26%), Positives = 131/278 (47%), Gaps = 28/278 (10%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+GRG + + KK + A++V+ K + I+ V+ E + + H LV
Sbjct: 60 IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVV 282
++ ++ V+E GG+L+ + R K E+ A+ +I + + H +G++
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEHARFYSAEISLALNYLHERGII 175
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
+RDLK +N L D +K D+G+ + +RP + + G+ Y+APE+L Y
Sbjct: 176 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 232
Query: 341 EADVWSIGVIAYILLCGSRPFW---------ARTESGIFRAVLKADPSFDEAPWPSLSSE 391
D W++GV+ + ++ G PF TE +F+ +L+ P SLS +
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLSVK 288
Query: 392 ARDFVKRLLNKDPRKRL-----TAAQAL-SHPWIKNSN 423
A +K LNKDP++RL T + HP+ +N +
Sbjct: 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-43
Identities = 75/344 (21%), Positives = 131/344 (38%), Gaps = 61/344 (17%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ +E E+G G+ G K G +A K+I + RE+++L
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLE--IKPAIRNQIIRELQVLH 86
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+V F+ A+ + + ME +GG LD++L + G+ E V I ++ +
Sbjct: 87 ECN-SPYIVGFYGAFYSDGEISICMEHMDGG-SLDQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 274 AFCHLQG-VVHRDLKPENFLFTTKDENSVLKAIDFG----LSDFVRPDERLNDIVGSAYY 328
+ + ++HRD+KP N L ++ E +K DFG L D + N VG+ Y
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-----NSFVGTRSY 196
Query: 329 VAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPF--------------------WARTES 367
++PE L + YS ++D+WS+G+ + G P
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 368 GIFRAVLKADPSFDEAPWPSL--------------------SSEARDFVKRLLNKDPRKR 407
D P ++ S E +DFV + L K+P +R
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316
Query: 408 LTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAAL 451
Q + H +IK S+ +V + + S+ A +
Sbjct: 317 ADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGV 360
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 88/402 (21%), Positives = 166/402 (41%), Gaps = 49/402 (12%)
Query: 35 PAPSPLNAESQSNNN--RTNVKGNDDAVIEGKKSPFFP---FYSPSPAHYFFSKKSSPAR 89
+PLN S + +T + +I + F+ +P ++
Sbjct: 47 QREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETP------EEREEWT 100
Query: 90 SSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGF 149
++ + + L ++ + + P + ++ +
Sbjct: 101 TAIQTVADG------------------LKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPK 142
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ N++E + +G+G FG K K G+ A+K++ K + + E
Sbjct: 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTEN 199
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
++L + H L +++ D + VME GGEL LSR ++ED A+ +I
Sbjct: 200 RVL-QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEI 257
Query: 270 LNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAY 327
++ + + H + VV+RDLK EN + D++ +K DFGL + ++ + G+
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 314
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
Y+APEVL + Y D W +GV+ Y ++CG PF+ + +F +L + F P
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF---P-R 370
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQA-----LSHPWIKNSN 423
+L EA+ + LL KDP++RL + H +
Sbjct: 371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 85/311 (27%), Positives = 129/311 (41%), Gaps = 58/311 (18%)
Query: 148 GFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
G + Y + +G G FG AK G+ VA+K + + K R
Sbjct: 47 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKRFKN-------R 96
Query: 208 EVKILRALTGHNNLVK----FFDAYEDTDNVYV--VMELCEG--GELLDRILSRGGKYTE 259
E++I+R L H N+V+ F+ + E D VY+ V++ +
Sbjct: 97 ELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155
Query: 260 DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSDFVRPDER 318
K M Q+ +A+ H G+ HRD+KP+N L D ++ VLK DFG + + E
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSAKQLVRGEP 212
Query: 319 LNDIVGSAYYVAPEVLHRS--YSTEADVWSIG-VIAYILLCGSRPFWARTESG------I 369
+ S YY APE++ + Y++ DVWS G V+A +LL +P + +SG I
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG--QPIF-PGDSGVDQLVEI 269
Query: 370 FRAVL----KAD-------------PSFDEAPW-----PSLSSEARDFVKRLLNKDPRKR 407
+ VL + P PW P EA RLL P R
Sbjct: 270 IK-VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328
Query: 408 LTAAQALSHPW 418
LT +A +H +
Sbjct: 329 LTPLEACAHSF 339
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-43
Identities = 80/276 (28%), Positives = 137/276 (49%), Gaps = 23/276 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-MTTAIAIEDVRREVKILRALTGHNNL 221
+G G +G + G G+ A+KV+ K + A E R E ++L + L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V A++ ++++++ GGEL LS+ ++TE + + + +I+ + H G+
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTH-LSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLS--DFVRPDERLNDIVGSAYYVAPEVLHRS-- 337
++RD+K EN L D N + DFGLS ER D G+ Y+AP+++
Sbjct: 181 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 237
Query: 338 -YSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRAVLKADPSFDEAPWPSLSSEA 392
+ D WS+GV+ Y LL G+ PF +++ I R +LK++P + P +S+ A
Sbjct: 238 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---P-QEMSALA 293
Query: 393 RDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
+D ++RLL KDP+KRL A + H + + N
Sbjct: 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 83/303 (27%), Positives = 126/303 (41%), Gaps = 57/303 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
Y + +G G FG AK ++ +VA+K + + K RE++I+R
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAK----LVESDEVAIKKVLQDK-------RFKNRELQIMRI 88
Query: 215 LTGHNNLVKFFDAY------EDTDNVYVVMELCEG--GELLDRILSRGGKYTEDDAKAVM 266
+ H N+V + +D + +V+E K M
Sbjct: 89 VK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSDFVRPDERLNDIVGS 325
Q+L +A+ H G+ HRD+KP+N L D S VLK IDFG + + E + S
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLL---DPPSGVLKLIDFGSAKILIAGEPNVSYICS 204
Query: 326 AYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESG------IFRAVL--- 374
YY APE++ + Y+T D+WS G + L+ G +P + ESG I + VL
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLF-PGESGIDQLVEIIK-VLGTP 261
Query: 375 -----------KADPSF---DEAPW-----PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ F P+ P +A D + RLL P RLTA +AL
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 416 HPW 418
HP+
Sbjct: 322 HPF 324
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-43
Identities = 82/318 (25%), Positives = 132/318 (41%), Gaps = 64/318 (20%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR--REV 209
++Y + +G G G +A ++VA+K I + RE+
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLTDPQSVK-----HALREI 59
Query: 210 KILRALTGHNNLVKFFD--------------AYEDTDNVYVVMELCEGGELLDRILSRGG 255
KI+R L H+N+VK F+ + + ++VY+V E E L +L G
Sbjct: 60 KIIRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVL-EQG 115
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
E+ A+ M Q+L + + H V+HRDLKP N T E+ VLK DFGL+ + P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDP 173
Query: 316 DERLNDI----VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG------------ 357
+ + +Y +P +L +Y+ D+W+ G I +L G
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233
Query: 358 -----------SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNK 402
S ++ D + P P +S EA DF++++L
Sbjct: 234 MQLILESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTF 292
Query: 403 DPRKRLTAAQALSHPWIK 420
P RLTA +ALSHP++
Sbjct: 293 SPMDRLTAEEALSHPYMS 310
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-43
Identities = 76/272 (27%), Positives = 121/272 (44%), Gaps = 22/272 (8%)
Query: 163 VGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV 222
+G+G FG CA + + G+ A K + K ++ E +IL +V
Sbjct: 192 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQIL-EKVNSRFVV 247
Query: 223 KFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGV 281
AYE D + +V+ L GG+L I G + E A +I + H + +
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYST 340
V+RDLKPEN L D++ ++ D GL+ V + + VG+ Y+APEV+ Y+
Sbjct: 308 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 364
Query: 341 EADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSFDEAPWPSLSSEARDFV 396
D W++G + Y ++ G PF R + + R V + + S +AR
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQARSLC 420
Query: 397 KRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
+LL KDP +RL +A + HP K N
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-42
Identities = 79/307 (25%), Positives = 136/307 (44%), Gaps = 54/307 (17%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVRREV 209
+Y+ VG G +G CAA K G +VAVK + + + A RE+
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRT---YREL 79
Query: 210 KILRALTGHNNLVKFFD------AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
++L+ + H N++ D + E+ ++VY+V L L+ I+ + K T+D +
Sbjct: 80 RLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--LNNIV-KCQKLTDDHVQ 135
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDI 322
++ QIL + + H ++HRDLKP N +E+ LK +DFGL+ R + +
Sbjct: 136 FLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA---RHTADEMTGY 189
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG----------------------- 357
V + +Y APE++ Y+ D+WS+G I LL G
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249
Query: 358 SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ S R +++ + + + A D ++++L D KR+TAAQA
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 309
Query: 414 LSHPWIK 420
L+H +
Sbjct: 310 LAHAYFA 316
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 8e-42
Identities = 83/320 (25%), Positives = 133/320 (41%), Gaps = 63/320 (19%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIED 204
+YE E+G G +G + K + + G+ VA+K + ++ + I
Sbjct: 11 QQYECVAEIGEGAYGKVF----KARDLKNGGRFVALKRV---RVQTGEEGMPLSTI---- 59
Query: 205 VRREVKILRAL--TGHNNLVKFFD-----AYEDTDNVYVVMELCEG--GELLDRILSRGG 255
REV +LR L H N+V+ FD + + +V E + LD++
Sbjct: 60 --REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEP 115
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ K +M Q+L + F H VVHRDLKP+N L + +K DFGL+
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSF 172
Query: 316 DERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRP-FWARTE----SGI 369
L +V + +Y APEVL SY+T D+WS+G I + +P F ++ I
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSSDVDQLGKI 231
Query: 370 FRAVLKAD----PSFDEAPW---------------PSLSSEARDFVKRLLNKDPRKRLTA 410
+ P P + +D + + L +P KR++A
Sbjct: 232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 291
Query: 411 AQALSHPWIKNSNDVKVPLD 430
ALSHP+ ++ K LD
Sbjct: 292 YSALSHPYFQDLERCKENLD 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-42
Identities = 81/304 (26%), Positives = 137/304 (45%), Gaps = 55/304 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVRREVKIL 212
Y VG G +G C+A K+ G++VA+K + + A RE+ +L
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPFQSEIFAKRA---YRELLLL 77
Query: 213 RALTGHNNLVKFFDA------YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
+ + H N++ D + + Y+VM + L +I+ K++E+ + ++
Sbjct: 78 KHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL--KFSEEKIQYLV 132
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP-DERLNDIVGS 325
Q+L + + H GVVHRDLKP N +E+ LK +DFGL+ R D + V +
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLA---RHADAEMTGYVVT 186
Query: 326 AYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG-----------------------SRP 360
+Y APEV+ Y+ D+WS+G I +L G
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 361 FWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
F + ++ +++ P + P S +A D ++++L D KRLTAAQAL+H
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306
Query: 417 PWIK 420
P+ +
Sbjct: 307 PFFE 310
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 77/308 (25%), Positives = 118/308 (38%), Gaps = 55/308 (17%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--------TAIAIEDVR 206
++YE E+G G +G A+ G VA+K + + +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVPNGGGGGGGLPISTV------ 59
Query: 207 REVKILRAL--TGHNNLVKFFD-----AYEDTDNVYVVMELCEG--GELLDRILSRGGKY 257
REV +LR L H N+V+ D + V +V E + LD+
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA--PPPGL 117
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
+ K +M Q L + F H +VHRDLKPEN L +K DFGL+
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQM 174
Query: 318 RLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRA 372
L +V + +Y APEVL +Y+T D+WS+G I + F +E IF
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234
Query: 373 VLKAD----PSFDEAPW---------------PSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ P P P + + +L +P KR++A +A
Sbjct: 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294
Query: 414 LSHPWIKN 421
L H ++
Sbjct: 295 LQHSYLHK 302
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-41
Identities = 61/352 (17%), Positives = 126/352 (35%), Gaps = 67/352 (19%)
Query: 154 ANKYELGEEVGRGH--FGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI 211
YEL +G+G A++K G+ V V+ I + + + ++ E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEACSNEM-VTFLQGELHV 79
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI-LSRGGKYTEDDAKAVMIQIL 270
+ H N+V + + + ++VV G D I E ++ +L
Sbjct: 80 SKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLN-------DI 322
+ + H G VHR +K + L + + + + + +R
Sbjct: 139 KALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 323 VGSAYYVAPEVLHRS---YSTEADVWSIGVIAYILLCGSRPF------------------ 361
V +++PEVL ++ Y ++D++S+G+ A L G PF
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255
Query: 362 ------------------WARTESGIFRAVLKADPSFDEAPWPS------LSSEARDFVK 397
+ SG+ ++ + P PS S FV+
Sbjct: 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE 315
Query: 398 RLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKA 449
+ L ++P R +A+ L+H + K +K + +L++ ++ +
Sbjct: 316 QCLQRNPDARPSASTLLNHSFFKQ---IKRRASEALPELLRPVTPITNFEGS 364
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 80/327 (24%), Positives = 142/327 (43%), Gaps = 57/327 (17%)
Query: 135 SEPEPAAGLNKSFGFSK---HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI 191
S P PA +K Y + VG G +G C+A + G +VA+K +
Sbjct: 2 SSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKL 58
Query: 192 PK--HKMTTAIAIEDVRREVKILRALTGHNNLVKFFDA------YEDTDNVYVVMELCEG 243
+ A RE+++L+ + H N++ D +D + Y+VM
Sbjct: 59 YRPFQSELFAKRA---YRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT 114
Query: 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303
L +++ + K ED + ++ Q+L + + H G++HRDLKP N +E+ LK
Sbjct: 115 D--LGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELK 168
Query: 304 AIDFGLSDFVRP-DERLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG--- 357
+DFGL+ R D + V + +Y APEV+ Y+ D+WS+G I ++ G
Sbjct: 169 ILDFGLA---RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 225
Query: 358 --------------------SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEAR 393
F R +S + +K P ++ + + S A
Sbjct: 226 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 285
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ ++++L D +R+TA +AL+HP+ +
Sbjct: 286 NLLEKMLVLDAEQRVTAGEALAHPYFE 312
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 75/322 (23%), Positives = 124/322 (38%), Gaps = 65/322 (20%)
Query: 145 KSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED 204
+ S+ +++++ G+G FG K K G VA+K + +
Sbjct: 13 AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQDPRFR------ 63
Query: 205 VRREVKILRALT--GHNNLVKFFDAY-----EDTDNVY--VVMELCEGGELLDRILSRGG 255
RE++I++ L H N+V+ + D ++Y VVME + L R
Sbjct: 64 -NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYY 120
Query: 256 KY----TEDDAKAVMIQILNVVAFCHLQ--GVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
+ K + Q++ + HL V HRD+KP N L + LK DFG
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTLKLCDFGS 178
Query: 310 SDFVRPDERLNDIVGSAYYVAPEVL--HRSYSTEADVWSIG-VIAYILL-----CG---- 357
+ + P E + S YY APE++ ++ Y+T D+WS+G + A ++L G
Sbjct: 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 358 -------------SRPFWARTESGIFRAVLKADPSFDEAPW--------PSLSSEARDFV 396
SR + + PW + EA D +
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTD---VDLYNSKGIPWSNVFSDHSLKDAKEAYDLL 295
Query: 397 KRLLNKDPRKRLTAAQALSHPW 418
LL P +R+ +AL HP+
Sbjct: 296 SALLQYLPEERMKPYEALCHPY 317
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-41
Identities = 74/262 (28%), Positives = 116/262 (44%), Gaps = 30/262 (11%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ E+ E VGRG FG C K + + + VA+K I + E++ L
Sbjct: 8 KEIEVEEVVGRGAFGVVC-----KAKWRAKDVAIKQIESESE-----RKAFIVELRQLSR 57
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQILNV 272
+ H N+VK + A + V +VME EGG L + + A A+ +Q
Sbjct: 58 VN-HPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 273 VAFCH---LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
VA+ H + ++HRDLKP N L +VLK DFG + + + + GSA ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDI--QTHMTNNKGSAAWM 170
Query: 330 APEVL-HRSYSTEADVWSIGVIAYILLCGSRPFW--ARTESGIFRAVLKAD-PSFDEAPW 385
APEV +YS + DV+S G+I + ++ +PF I AV P +
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 230
Query: 386 PSLSSEARDFVKRLLNKDPRKR 407
+ + R +KDP +R
Sbjct: 231 KPI----ESLMTRCWSKDPSQR 248
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALT 216
L E +G G FG K + G +VAVK + IE+VR+E K+ L
Sbjct: 10 TLEEIIGIGGFG-----KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N++ N+ +VME GG L + G + D +QI + +
Sbjct: 65 -HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYL 121
Query: 277 HLQG---VVHRDLKPENFLFTTKDE-----NSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
H + ++HRDLK N L K E N +LK DFGL+ +++ G+ +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAW 180
Query: 329 VAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPF 361
+APEV+ +S +DVWS GV+ + LL G PF
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 65/258 (25%), Positives = 110/258 (42%), Gaps = 22/258 (8%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ E++G G FG + E G VAVK++ + + + REV I++ L
Sbjct: 40 NIKEKIGAGSFG-----TVHRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLR- 92
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQILNVVAF 275
H N+V F A N+ +V E G L + G + D+ + + + + +
Sbjct: 93 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 276 CHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-LNDIVGSAYYVAPE 332
H + +VHR+LK N L D+ +K DFGLS G+ ++APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209
Query: 333 VL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PSFDEAPWPSLS 389
VL + ++DV+S GVI + L +P+ + + AV E P +L+
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL---EIP-RNLN 265
Query: 390 SEARDFVKRLLNKDPRKR 407
+ ++ +P KR
Sbjct: 266 PQVAAIIEGCWTNEPWKR 283
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 82/307 (26%), Positives = 129/307 (42%), Gaps = 56/307 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVR--REVKI 211
+Y +G G +G C+A +VA+K I P T R RE+KI
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPFEHQTYCQ-----RTLREIKI 78
Query: 212 LRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
L H N++ D E +VY+V +L E L ++L + + D +
Sbjct: 79 LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL-KTQHLSNDHICYFL 134
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI---- 322
QIL + + H V+HRDLKP N L + LK DFGL+ PD
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 323 VGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCG----------------------- 357
V + +Y APE++ + Y+ D+WS+G I +L
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 358 SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQA 413
S+ + R L + P ++ PW P+ S+A D + ++L +P KR+ QA
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 414 LSHPWIK 420
L+HP+++
Sbjct: 312 LAHPYLE 318
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 90/319 (28%), Positives = 140/319 (43%), Gaps = 66/319 (20%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVR--RE 208
+ ++ ++L +G G +G C+A K G+ VA+K I P K A+ R RE
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPFDKPLFAL-----RTLRE 59
Query: 209 VKILRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
+KIL+ H N++ F+ ++E+ + VY++ EL + L R++ ++D +
Sbjct: 60 IKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVI-STQMLSDDHIQ 115
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+ Q L V H V+HRDLKP N L + N LK DFGL+ + N
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 324 GSA-----------YYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFW-------- 362
+Y APEV+ YS DVWS G I L RP +
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRDYRHQ 231
Query: 363 -----------------ARTESGIFRAVLKADPSFDEAPW----PSLSSEARDFVKRLLN 401
ES R +K+ P + AP P ++ + D ++R+L
Sbjct: 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV 291
Query: 402 KDPRKRLTAAQALSHPWIK 420
DP KR+TA +AL HP+++
Sbjct: 292 FDPAKRITAKEALEHPYLQ 310
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-40
Identities = 72/335 (21%), Positives = 125/335 (37%), Gaps = 50/335 (14%)
Query: 103 PFPPPSPAKHIKAVLA-------RRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHF-- 153
P P + A++ +R + + G G F
Sbjct: 14 RAPDIDPLE---ALMTNPVVPESKRFCWNCGRPVGRSDSETKGASEGWCPYCGSPYSFLP 70
Query: 154 --------ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV 205
A +YE+ + G G+ A + + G+ V +K + A A
Sbjct: 71 QLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRN--VNGRPVVLKGL--VHSGDAEAQAMA 126
Query: 206 RREVKILRALTGHNNLVKFFDAYEDTDN-----VYVVMELCEGGELLDRILSRGGKYTED 260
E + L + H ++V+ F+ E TD Y+VME G L G K
Sbjct: 127 MAERQFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVA 182
Query: 261 DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320
+A A +++IL +++ H G+V+ DLKPEN + T E + K ID G V
Sbjct: 183 EAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---EEQL-KLIDLGA---VSRINSFG 235
Query: 321 DIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380
+ G+ + APE++ + D++++G L R + P
Sbjct: 236 YLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRY--------VDGLP-- 285
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
++ P ++R ++ DPR+R T A+ +S
Sbjct: 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS 320
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-40
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKH----KMTTAIAIEDVRREVKILR 213
E +++G+G FG + K VA+K + + ++ +REV I+
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L H N+VK + + +VME G+L R+L + +M+ I +
Sbjct: 79 NLN-HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 274 AFCHLQG--VVHRDLKPENFLFTTKDENS--VLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
+ Q +VHRDL+ N + DEN+ K DFGLS ++ ++G+ ++
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQWM 193
Query: 330 APEVL---HRSYSTEADVWSIGVIAYILLCGSRPF 361
APE + SY+ +AD +S +I Y +L G PF
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-40
Identities = 58/267 (21%), Positives = 111/267 (41%), Gaps = 32/267 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E+GE +G+G FG + G G+ VA+++I + ++ +REV R
Sbjct: 36 EIGELIGKGRFG-----QVYHGRWHGE-VAIRLIDIERDNED-QLKAFKREVMAYRQTR- 87
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N+V F A ++ ++ LC+G L + + + + +I+ + + H
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS------DFVRPDERLNDIVGSAYYVAP 331
+G++H+DLK +N + +N + DFGL R +++L G ++AP
Sbjct: 148 AKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 332 EVL----------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK-ADPSF 380
E++ +S +DV+++G I Y L PF + I + P+
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263
Query: 381 DEAPWPSLSSEARDFVKRLLNKDPRKR 407
+ E D + + +R
Sbjct: 264 ---SQIGMGKEISDILLFCWAFEQEER 287
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 73/316 (23%), Positives = 130/316 (41%), Gaps = 67/316 (21%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVR--REVK 210
+Y+ + +G G G CAA + VA+K + + T A R RE+
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAK-----RAYRELV 76
Query: 211 ILRALTGHNNLVKFFDA------YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
+++ + H N++ + E+ +VY+VMEL + L +++ + +
Sbjct: 77 LMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHERMSY 131
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
++ Q+L + H G++HRDLKP N + + LK +DFGL+ + V
Sbjct: 132 LLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVV 188
Query: 325 SAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCG-----------------------SRP 360
+ YY APEV L Y D+WS+G I ++ G
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 248
Query: 361 FWARTESGIFRAVLKADPSFDEAPW----------------PSLSSEARDFVKRLLNKDP 404
F + + + R ++ P + + +S+ARD + ++L D
Sbjct: 249 FMKKLQPTV-RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307
Query: 405 RKRLTAAQALSHPWIK 420
KR++ +AL HP+I
Sbjct: 308 SKRISVDEALQHPYIN 323
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 62/262 (23%), Positives = 109/262 (41%), Gaps = 27/262 (10%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+G+ +G G FG Y KG+ G VAVK++ T ++ + EV +LR
Sbjct: 27 TVGQRIGSGSFGTVY-------KGKWHGD-VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKT 77
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N++ F + +V + CEG L + + K+ + Q + +
Sbjct: 78 R-HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS---DFVRPDERLNDIVGSAYYVAPE 332
H + ++HRDLK N E++ +K DFGL+ + + GS ++APE
Sbjct: 136 LHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 333 VL----HRSYSTEADVWSIGVIAYILLCGSRPFWART-ESGIFRAVLKAD--PSFDEAPW 385
V+ YS ++DV++ G++ Y L+ G P+ I V + P +
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR- 251
Query: 386 PSLSSEARDFVKRLLNKDPRKR 407
+ + + L K +R
Sbjct: 252 SNCPKRMKRLMAECLKKKRDER 273
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 71/269 (26%), Positives = 117/269 (43%), Gaps = 14/269 (5%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K +Y++ +++G G A+ + +VA+K I ++ REV
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAE---DTILNIKVAIKAIFIPPREKEETLKRFEREVH 63
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
L+ H N+V D E+ D Y+VME EG L + + G + D A QIL
Sbjct: 64 NSSQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSE-YIESHGPLSVDTAINFTNQIL 121
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL---NDIVGSAY 327
+ + H +VHRD+KP+N L N LK DFG++ + + L N ++G+
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQ 177
Query: 328 YVAPEVLHRSYSTEA-DVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDEAPW 385
Y +PE + E D++SIG++ Y +L G PF T I + + + P+
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
+ + + R KD R Q +
Sbjct: 238 KDIPQSLSNVILRATEKDKANRYKTIQEM 266
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 75/315 (23%), Positives = 131/315 (41%), Gaps = 67/315 (21%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVR--REVKI 211
+Y+ + +G G G CAA + VA+K + + T A R RE+ +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAK-----RAYRELVL 114
Query: 212 LRALTGHNNLVKFFDA------YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV 265
++ + H N++ + E+ +VY+VMEL + L +++ + + +
Sbjct: 115 MKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM--ELDHERMSYL 169
Query: 266 MIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGS 325
+ Q+L + H G++HRDLKP N + + LK +DFGL+ + V +
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVT 226
Query: 326 AYYVAPEV-LHRSYSTEADVWSIGVIAYILLCG-----------------------SRPF 361
YY APEV L Y D+WS+G I ++ F
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286
Query: 362 WARTESGIFRAVLKADPSFDEAPWPSL----------------SSEARDFVKRLLNKDPR 405
+ + + R ++ P + +P L +S+ARD + ++L DP
Sbjct: 287 MKKLQPTV-RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345
Query: 406 KRLTAAQALSHPWIK 420
KR++ AL HP+I
Sbjct: 346 KRISVDDALQHPYIN 360
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-38
Identities = 79/335 (23%), Positives = 131/335 (39%), Gaps = 74/335 (22%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI 211
+ +Y L ++G GHF AK VA+K++ K+ T A + E+K+
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDKVYTEAAED----EIKL 68
Query: 212 LRALT----------GHNNLVKFFDAYE----DTDNVYVVMELCEGGELLDRI-LSRGGK 256
L+ + G N+++K D + + +V +V E+ G LL I
Sbjct: 69 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG 127
Query: 257 YTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDEN---SVLKAIDFGLSDF 312
K + Q+L + + H + G++H D+KPEN L D +K D G + +
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 313 VRPDERLNDIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 371
DE + + + Y +PEV L + AD+WS + + L+ G F +
Sbjct: 188 Y--DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 372 ---------AVLKADPS------------FDE----------APWP----------SLSS 390
+L PS F+ WP
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 391 EAR---DFVKRLLNKDPRKRLTAAQALSHPWIKNS 422
EA+ DF+ +L DPRKR A ++HPW+K++
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-38
Identities = 77/346 (22%), Positives = 130/346 (37%), Gaps = 95/346 (27%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR----- 206
H KYEL +++G+G +G + ++ G+ VAVK I A ++
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFD-------AFQNSTDAQRT 55
Query: 207 -REVKILRALTGHNNLVKFFDAY--EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAK 263
RE+ IL L+GH N+V + ++ +VY+V + E L ++ R +
Sbjct: 56 FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVI-RANILEPVHKQ 112
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
V+ Q++ V+ + H G++HRD+KP N L + +K DFGLS R+ + +
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 324 GSA----------------------YYVAPEVL--HRSYSTEADVWSIGVI--------- 350
+ +Y APE+L Y+ D+WS+G I
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
Query: 351 -----------------------------------AYILLCGSRPFWARTESGIFRAVLK 375
I + +S K
Sbjct: 230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKV--EIRQSNKRDIFTK 287
Query: 376 ADPSFDEA-PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ P + EA D + +LL +P KR++A AL HP++
Sbjct: 288 WKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-38
Identities = 70/337 (20%), Positives = 125/337 (37%), Gaps = 90/337 (26%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ KY LG+ +G G FG C + G++ A+K + + RE+ I++
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPRYK-------NRELDIMK 55
Query: 214 ALTGHNNLVKFFDAY--------------------------------------EDTDNVY 235
L H N++K D + +
Sbjct: 56 VLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 236 VVMELCEGGELLDRILSRGGKY----TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291
V+ME + L ++L + + + Q+ V F H G+ HRD+KP+N
Sbjct: 115 VIMEYVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 292 LFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIG- 348
L + +++ LK DFG + + P E + S +Y APE++ Y+ D+WSIG
Sbjct: 173 LVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 349 VIAYILL-----CG-----------------SRPFWARTESGIFRAVLKADPSFDEAPWP 386
V ++L G ++ R P+ W
Sbjct: 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF---PTLKAKDWR 287
Query: 387 SL-----SSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
+ S A D ++++L +P R+ +A++HP+
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 5e-37
Identities = 74/273 (27%), Positives = 118/273 (43%), Gaps = 17/273 (6%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
H +++YELGE +G G A+ + VAVKV+ RRE +
Sbjct: 8 SHLSDRYELGEILGFGGMSEVHLAR---DLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 211 ILRALTGHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
AL H +V +D E Y+VME +G L D I+ G T A V+
Sbjct: 65 NAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVI 122
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL----SDFVRPDERLNDI 322
+ F H G++HRD+KP N + + + +K +DFG+ +D + +
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 323 VGSAYYVAPEVLHRSYSTEA-DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
+G+A Y++PE DV+S+G + Y +L G PF + + ++ DP
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 239
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
A LS++ V + L K+P R A +
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-37
Identities = 82/330 (24%), Positives = 124/330 (37%), Gaps = 88/330 (26%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIEDV 205
+KYE ++G+G FG A+ +K GQ+VA+K K M TA+
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALK---KVLMENEKEGFPITAL----- 64
Query: 206 RREVKILRALTGHNNLVKFFD--------AYEDTDNVYVVMELCEG--GELLDRILSRGG 255
RE+KIL+ L H N+V + ++Y+V + CE LL +
Sbjct: 65 -REIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLV 119
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
K+T + K VM +LN + + H ++HRD+K N L + VLK DFGL+
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSL 176
Query: 316 DERLNDIVGSAY--------YVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWAR 364
+ + Y Y PE+L R Y D+W G I + P
Sbjct: 177 AKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGN 232
Query: 365 TESG----IFRAVLKADPSFDEAPWP----------------------------SLSSEA 392
TE I + S WP A
Sbjct: 233 TEQHQLALISQLC----GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 288
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422
D + +LL DP +R+ + AL+H + +
Sbjct: 289 LDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 54/262 (20%), Positives = 96/262 (36%), Gaps = 31/262 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
++ H G KG +G + VKV+ +T D E LR +
Sbjct: 13 NFLTKLNENHSGELW-----KGRWQGNDIVVKVLKVRDWSTRK-SRDFNEECPRLRIFS- 65
Query: 218 HNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQILNVV 273
H N++ A + + ++ G L + +L G + D ++AV + + +
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 274 AFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
AF H + L + + DE+ + + + + + +VAP
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFS----FQSPGRMYAPAWVAP 177
Query: 332 EVLHRS----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PSFDEAPW 385
E L + AD+WS V+ + L+ PF + I V P+ P
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI---P- 233
Query: 386 PSLSSEARDFVKRLLNKDPRKR 407
P +S +K +N+DP KR
Sbjct: 234 PGISPHVSKLMKICMNEDPAKR 255
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 77/302 (25%), Positives = 124/302 (41%), Gaps = 26/302 (8%)
Query: 120 RHGSVKPNEAAIPEG---SEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKF 176
H + E G FG Y L VGRG G A+
Sbjct: 5 HHHHHHSSGLVPRGSHMDGTAESREG--TQFG-------PYRLRRLVGRGGMGDVYEAE- 54
Query: 177 KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236
++ + VA+K++ + + + ++RE + L ++V D E +YV
Sbjct: 55 --DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYV 111
Query: 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296
M L G +L +L R G A A++ QI + + H G HRD+KPEN L +
Sbjct: 112 DMRLINGVDL-AAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD 170
Query: 297 DENSVLKAIDFGLSDFVRPDERL---NDIVGSAYYVAPEVLHRSYSTE-ADVWSIGVIAY 352
D +DFG++ DE+L + VG+ YY+APE S++T AD++++ + Y
Sbjct: 171 D---FAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLY 226
Query: 353 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
L GS P+ S + + +A P P + + R + K+P R
Sbjct: 227 ECLTGSPPYQGDQLSVMGAHINQAIPRPSTVR-PGIPVAFDAVIARGMAKNPEDRYVTCG 285
Query: 413 AL 414
L
Sbjct: 286 DL 287
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 78/330 (23%), Positives = 130/330 (39%), Gaps = 71/330 (21%)
Query: 154 ANKYE-LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTAIAIEDVRREVKI 211
+ +E G +VGRG +G+ AK K G+ + A+K I + +A RE+ +
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGTGISMSAC------REIAL 71
Query: 212 LRALTGHNNLVKFFDA-YEDTDN-VYVVMELCEG--GELLD-----RILSRGGKYTEDDA 262
LR L H N++ D V+++ + E ++ + + +
Sbjct: 72 LRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DENSVLKAIDFGL----SDFVRPDE 317
K+++ QIL+ + + H V+HRDLKP N L + E +K D G + ++P
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190
Query: 318 RLNDIVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVL 374
L+ +V + +Y APE+L R Y+ D+W+IG I LL P F R E
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPY 249
Query: 375 KAD-----------------PSFDEAPW--------------------------PSLSSE 391
D + P S+
Sbjct: 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309
Query: 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
A +++LL DP KR+T+ QA+ P+
Sbjct: 310 AFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-36
Identities = 75/359 (20%), Positives = 132/359 (36%), Gaps = 103/359 (28%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPK--HKMTTAIAIEDVR--R 207
H + Y + +GRG +GY A K + VA+K + + + R R
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRMFEDLIDCK-----RILR 74
Query: 208 EVKILRALTGHNNLVKFFD-----AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDA 262
E+ IL L + +++ +D D +Y+V+E+ + L ++ TE+
Sbjct: 75 EITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEEHI 131
Query: 263 KAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
K ++ +L F H G++HRDLKP N L +++ +K DFGL+ + ++ N +
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 323 VGSA-----------------------YYVAPEVL--HRSYSTEADVWSIGVIAYILLCG 357
+Y APE++ +Y+ D+WS G I LL
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 358 SRPFWARTESG--------------------------------IF--------------- 370
+ + IF
Sbjct: 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN 308
Query: 371 ----RAVLKADPSFDEAPW----PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+K P PS+S + + ++ +L +P KR+T QAL HP++K+
Sbjct: 309 KPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-36
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
GE +G+G FG K + + + + +EVK++R L
Sbjct: 13 IHGEVLGKGCFGQAI-----KVTHRETGEVMVMKELIRFDEE-TQRTFLKEVKVMRCLE- 65
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N++KF + + E +GG L I S +Y + I + +A+ H
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND---------------I 322
++HRDL N L EN + DFGL+ + ++ + +
Sbjct: 126 SMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 323 VGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPF 361
VG+ Y++APE++ RSY + DV+S G++ ++
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 78/334 (23%), Positives = 122/334 (36%), Gaps = 76/334 (22%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVK 210
+ +YE+ + +G G FG K G+ VAVK++ + A E ++
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNVDRYCEAARSE-----IQ 63
Query: 211 ILRAL-----TGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAK 263
+L L V+ + +E ++ +V EL + + + D +
Sbjct: 64 VLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP--FRLDHIR 121
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----------------ENSVLKAIDF 307
+ QI V F H + H DLKPEN LF D N +K +DF
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 308 GLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTE 366
G + + DE + +V + +Y APEV L +S DVWSIG I G F
Sbjct: 182 GSATYD--DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239
Query: 367 S----------GIF-RAVLKADPS-----FDEAPWPSLSSEAR----------------- 393
G + +++ D W SS R
Sbjct: 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 394 -------DFVKRLLNKDPRKRLTAAQALSHPWIK 420
D ++++L DP KR+T +AL HP+
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 74/335 (22%), Positives = 116/335 (34%), Gaps = 76/335 (22%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVK 210
+YE+ +G G FG QVA+K+I K A +E +
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARG--KSQVALKIIRNVGKYREAARLE-----IN 68
Query: 211 ILRAL-----TGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAK 263
+L+ + V D + ++ + EL E L + Y +
Sbjct: 69 VLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP--YPLPHVR 126
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD----------------ENSVLKAIDF 307
+ Q+ + + F H + H DLKPEN LF + +N+ ++ DF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 308 GLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTE 366
G + F E IV + +Y PEV L ++ DVWSIG I + G F
Sbjct: 187 GSATFD--HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244
Query: 367 ---------------SGIFRAVLKADPSFDE-APWPSLSSEAR----------------- 393
S + K + W SS+ R
Sbjct: 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304
Query: 394 -------DFVKRLLNKDPRKRLTAAQALSHPWIKN 421
D ++R+L DP +R+T A+AL HP+
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 72/342 (21%), Positives = 122/342 (35%), Gaps = 86/342 (25%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVK 210
N + + ++G G FG + + AVKV+ K T + IE
Sbjct: 32 LLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNIKKYTRSAKIE-----AD 83
Query: 211 ILRAL----TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY---TEDDAK 263
IL+ + +NN+VK+ + D++ ++ E G L + + Y +D K
Sbjct: 84 ILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYE--IITRNNYNGFHIEDIK 140
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFT----------------------TKDENSV 301
I+IL + + + H DLKPEN L + +++
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRP 360
+K IDFG + F + I+ + Y APEV L+ + +D+WS G + L GS
Sbjct: 201 IKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258
Query: 361 FWARTE---------------SGIFRAVLKADPSF------DEAPWPSLSSEAR------ 393
F + K + S + WP +S
Sbjct: 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318
Query: 394 ---------------DFVKRLLNKDPRKRLTAAQALSHPWIK 420
DF+ +L DP R + A+ L H +++
Sbjct: 319 KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 82/402 (20%), Positives = 143/402 (35%), Gaps = 111/402 (27%)
Query: 118 ARRHGSVKPNEAAIPEGSEPEPAAGLNKSFGFSKHF--ANKYELGEEVGRGHFGYTCAAK 175
+ +V ++ + + + + ++YE+ +G G +G+ C A
Sbjct: 14 SGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAY 73
Query: 176 FKKGELKGQQVAVKVIPK---HKMTTAIAIEDVRREVKILRALTGHNNLVKFFD-----A 227
K + + VA+K I + + + RE+ IL L H+++VK D
Sbjct: 74 DKL---EKRVVAIKKILRVFEDLIDCKRIL----REIAILNRL-NHDHVVKVLDIVIPKD 125
Query: 228 YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287
E D +YVV+E+ + ++ TE K ++ +L V + H G++HRDLK
Sbjct: 126 VEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLK 183
Query: 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA--------------------- 326
P N L +++ +K DFGL+ V E N + +
Sbjct: 184 PANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQL 240
Query: 327 -------YYVAPEVL--HRSYSTEADVWSIGVI-AYILLC----------------GSRP 360
+Y APE++ +Y+ DVWSIG I A +L GS
Sbjct: 241 TGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSC 300
Query: 361 FWARTESGIFRAVLKADPSF--------------DEAPWPSLSSE-ARDFVKR------- 398
F + E +L E A+ +++
Sbjct: 301 FPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360
Query: 399 ---------------LLNK----DPRKRLTAAQALSHPWIKN 421
LL + +P KR+T + L+HP+ K
Sbjct: 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 77/333 (23%), Positives = 124/333 (37%), Gaps = 77/333 (23%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVI-PKHKMTTAIAIEDVRREVK 210
H A +YE+ + +G+G FG A K Q VA+K++ + + A E ++
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNEKRFHRQAAEE-----IR 145
Query: 211 ILRAL-----TGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAK 263
IL L N++ + + +++ + EL EL+ + +G ++ +
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG--FSLPLVR 203
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
IL + H ++H DLKPEN L + S +K IDFG S + +R+ +
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-RSGIKVIDFGSSCYE--HQRVYTYI 260
Query: 324 GSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTE---------------S 367
S +Y APEV L Y D+WS+G I LL G E
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320
Query: 368 GIFRAVLKADPSFDEAPWP-------------------------SLSSEARDFVKRLLNK 402
+ A +A +P E+R++ L
Sbjct: 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGC 380
Query: 403 D---------------PRKRLTAAQALSHPWIK 420
D P R+T QAL HPW++
Sbjct: 381 DDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 38/291 (13%), Positives = 69/291 (23%), Gaps = 47/291 (16%)
Query: 126 PNEAAIPEGSEPEPAAGLNKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ 185
+A P+ + P A + +Y L G A +Q
Sbjct: 11 RESSAPPDDVQLVPGARI---------ANGRYRLLIFHGGVPPLQFWQAL---DTALDRQ 58
Query: 186 VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGE 245
VA+ + + +++ L + + + D VV E GG
Sbjct: 59 VALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGGLVVAEWIRGGS 117
Query: 246 LLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305
L + + + A M + H GV P
Sbjct: 118 LQEVADTSP---SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVR------------- 161
Query: 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWART 365
V D + ++ + + + D+ IG Y LL P
Sbjct: 162 -------VSIDGDV--VLAYPATMPDA------NPQDDIRGIGASLYALLVNRWPLPEAG 206
Query: 366 ESGIFRAVLKADPSFDEAPW---PSLSSEARDFVKRLLNKDPRKRLTAAQA 413
+ P + + R + D R +
Sbjct: 207 VRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 68/315 (21%), Positives = 123/315 (39%), Gaps = 62/315 (19%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
L E +G+G FG +G+ +G++VAVK+ + + E+ L
Sbjct: 45 VLQESIGKGRFGEVW-----RGKWRGEEVAVKIFSSREERSWFR----EAEIYQTVMLR- 94
Query: 218 HNNLVKFFDAYEDTDNV----YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H N++ F A + ++V + E G L D L+R T + + + + +
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNR-YTVTVEGMIKLALSTASGL 152
Query: 274 AFCHLQ--------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI--- 322
A H++ + HRDLK +N L +N D GL+ DI
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 323 --VGSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI-FRA 372
VG+ Y+APEVL H AD++++G++ + + + + +
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 373 VLKADPSFDEA-------------PWPSLSSEARDFVKRLL----NKDPRKRLTAAQA-- 413
++ +DPS +E P S EA + +++ + RLTA +
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
Query: 414 -LSHPWIKNSNDVKV 427
LS + +K+
Sbjct: 330 TLSQ--LSQQEGIKM 342
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-30
Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 25/231 (10%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
L E++G G FG ++ K VAVK + ++ A++D REV + +L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD- 79
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H NL++ + T + +V EL G LLDR+ G + +Q+ + +
Sbjct: 80 HRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+ +HRDL N L ++K DFGL + ++ Y +
Sbjct: 139 SKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQND-------DHYVMQEHRKVPF 188
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE L R++S +D W GV + + G P+ S I + K
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 61/301 (20%), Positives = 114/301 (37%), Gaps = 59/301 (19%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR-ALT 216
L E VG+G +G + +G +G+ VAVK+ + RE ++ +
Sbjct: 11 TLLECVGKGRYG-----EVWRGSWQGENVAVKIFSSRDE------KSWFRETELYNTVML 59
Query: 217 GHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
H N++ F + + + ++++ E G L D + + +++ I +
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASG 117
Query: 273 VAFCHLQ--------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI-- 322
+A H++ + HRDLK +N L +N D GL+ D+
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 323 ---VGSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI-FR 371
VG+ Y+APEVL D+W+ G++ + + + F
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 372 AVLKADPSFDEA-----------PWPS--LSSEARDFVKRLL----NKDPRKRLTAAQAL 414
V+ DPSF++ P+ S + +L+ ++P RLTA +
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
Query: 415 S 415
Sbjct: 295 K 295
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 32/232 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
LGE++GRG+FG + + + VAVK + +E +IL+ +
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADN---TLVAVKSCRETLPPDLK--AKFLQEARILKQYS- 170
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N+V+ +Y+VMEL +GG+ L + + G + ++ + +
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+ +HRDL N L T E +VLK DFG+S Y
Sbjct: 231 SKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGV---------YAASGGLRQVP 278
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE L + YS+E+DVWS G++ + G+ P+ + V K
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 71/375 (18%), Positives = 127/375 (33%), Gaps = 118/375 (31%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA--IEDVRREVK 210
F +Y + ++G GHF + + + VA+KV+ + E E++
Sbjct: 35 FNGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVV------KSAEHYTETALDEIR 85
Query: 211 ILRALT-------GHNNLVKFFDAYEDT----DNVYVVMELCEGGELLD-RILSRGGKYT 258
+L+++ +V+ D ++ + ++ +V E+ G LL I S
Sbjct: 86 LLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLP 144
Query: 259 EDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKD-------------------- 297
K ++ Q+L + + H + ++H D+KPEN L + +
Sbjct: 145 LPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204
Query: 298 --------------------------ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 331
E +K D G + + + + + Y +
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYRSL 262
Query: 332 EV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR---------AVLKADPS-- 379
EV + Y+T AD+WS +A+ L G F + R +L P
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 380 ----------FDE----------APWPSLSS----------EAR---DFVKRLLNKDPRK 406
F + PW EA DF+ +L P K
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382
Query: 407 RLTAAQALSHPWIKN 421
R TAA+ L HPW+ +
Sbjct: 383 RATAAECLRHPWLNS 397
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 68/316 (21%), Positives = 124/316 (39%), Gaps = 64/316 (20%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR-ALT 216
++ +++G+G +G + G+ +G++VAVKV + RE +I + L
Sbjct: 40 QMVKQIGKGRYG-----EVWMGKWRGEKVAVKVFFTTEE------ASWFRETEIYQTVLM 88
Query: 217 GHNNLVKFFDA----YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
H N++ F A +Y++ + E G L D + + + ++
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSG 146
Query: 273 VAFCHLQ--------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI-- 322
+ H + + HRDLK +N L +N D GL+ D DI
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 323 ---VGSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI-FR 371
VG+ Y+ PEVL H AD++S G+I + + E + +
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
Query: 372 AVLKADPSFDEA-------------PWPSLSSEARDFVKRLL----NKDPRKRLTAAQ-- 412
++ +DPS+++ P S E + +L+ +P RLTA +
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
Query: 413 -ALSHPWIKNSNDVKV 427
L+ + S D+K+
Sbjct: 324 KTLAK--MSESQDIKL 337
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 22/225 (9%)
Query: 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI 211
+ ++YE+ +G+G FG A + + + VA+K+I K A + EV++
Sbjct: 51 KWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNKKAFLNQA----QIEVRL 103
Query: 212 LRAL-----TGHNNLVKFFDAYEDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKA 264
L + +V + +++ +V E+ +LL RG + + +
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG--VSLNLTRK 161
Query: 265 VMIQILNVVAFCHLQ--GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322
Q+ + F ++H DLKPEN L S +K +DFG S + +R+
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPK-RSAIKIVDFGSSCQL--GQRIYQY 218
Query: 323 VGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFWARTE 366
+ S +Y +PEV L Y D+WS+G I + G F E
Sbjct: 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 11/31 (35%), Positives = 18/31 (58%)
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
D + R+L+ DP+ R+ AL H + K + D
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 36/230 (15%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+G G FG G + +VA+K I + M+ ED E +++ L+
Sbjct: 11 TFVQEIGSGQFGLVH-----LGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLS 61
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H LV+ + + + +V E E G L D + ++ G + + + + + +A+
Sbjct: 62 -HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
V+HRDL N L EN V+K DFG++ FV D+ Y
Sbjct: 121 EEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ---------YTSSTGTKFP 168
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+PEV YS+++DVWS GV+ + + G P+ R+ S + +
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 36/229 (15%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
L +E+G G FG G+ KGQ VAVK+I + M+ ++ +E + + L+
Sbjct: 12 LLKELGSGQFGVVK-----LGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLS- 61
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H LVKF+ +Y+V E G LL+ + S G + + +AF
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+HRDL N L D + +K DFG++ +V D+ Y
Sbjct: 122 SHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPV 169
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APEV + YS+++DVW+ G++ + + G P+ T S + V
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 51/230 (22%), Positives = 94/230 (40%), Gaps = 29/230 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ + +G G FG + +GE VA+K + + T+ A +++ E ++ ++
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+ ++ + T V ++ +L G LLD + +QI + +
Sbjct: 76 -NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +VHRDL N L +K DFGL+ + +E Y
Sbjct: 134 EDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEE--------KEYHAEGGKVP 182
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
A E + HR Y+ ++DVWS GV + ++ GS+P+ S I +
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 36/232 (15%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+G G FG G+ +GQ VA+K+I + M+ ++ E K++ L+
Sbjct: 27 TFLKELGTGQFGVVK-----YGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLS 77
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H LV+ + ++++ E G LL+ + ++ + + + +
Sbjct: 78 -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +HRDL N L ++ V+K DFGLS +V DE Y
Sbjct: 137 ESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE---------YTSSVGSKFP 184
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
PEVL + +S+++D+W+ GV+ + I G P+ T S + +
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 43/234 (18%), Positives = 78/234 (33%), Gaps = 31/234 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFK----KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
E +G+G F + G+L +V +KV+ K + E ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAASMMS 67
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L+ H +LV + D +V E + G L + V Q+ +
Sbjct: 68 KLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAM 126
Query: 274 AFCHLQGVVHRDLKPENFLFTTKD-----ENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
F ++H ++ +N L ++ +K D G+S V P +
Sbjct: 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---------IL 177
Query: 329 ------VAPEVLH--RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
V PE + ++ + D WS G + I G +P A +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 26/229 (11%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ + +G G G C + + + VA+K + T D E I+
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQFD- 108
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H N+++ +V E E G L + + G++T ++ + + +
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
G VHRDL N L D N V K DFGLS + D A Y
Sbjct: 169 DLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDP-------DAAYTTTGGKIPI 218
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + R++S+ +DVWS GV+ + +L G RP+W T + +V
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 56/229 (24%), Positives = 85/229 (37%), Gaps = 29/229 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
L +G G FG + + + VAVK K T E E I++ L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLD- 71
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H ++VK + + +++MEL GEL + +QI +A+
Sbjct: 72 HPHIVKLI-GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
VHRD+ N L +K DFGLS R I YY
Sbjct: 131 SINCVHRDIAVRNILV---ASPECVKLGDFGLS---R------YIEDEDYYKASVTRLPI 178
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+PE + R ++T +DVW V + IL G +PF+ + +
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 32/242 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ ++G+G+FG ++ G+ G VAVK + + + D +RE++IL+AL
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKAL- 81
Query: 217 GHNNLVKFFDAYEDT--DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ +VK+ ++ +VME G L D + + QI +
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + VHRDL N L + +K DFGL+ + D+ YYV
Sbjct: 142 YLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDK--------DYYVVREPG 190
Query: 330 -------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSF 380
APE L +S ++DVWS GV+ Y + + E + P+
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 381 DE 382
Sbjct: 251 SR 252
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 26/228 (11%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
+ + VG G FG C+ + K K VA+K + T D E I+ H
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFD-H 105
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
N+++ + V +V E E G L + ++T ++ I + + +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV--------- 329
G VHRDL N L + N V K DFGL + D A Y
Sbjct: 166 MGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDP-------EAAYTTRGGKIPIR 215
Query: 330 --APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
+PE + +R +++ +DVWS G++ + ++ G RP+W + + +AV
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 29/229 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
ELG +G G FG + E VA+K + E +E +R
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFD- 74
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H ++VK + V+++MELC GEL + R Q+ +A+
Sbjct: 75 HPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+ VHRD+ N L + N +K DFGLS R + S YY
Sbjct: 134 SKRFVHRDIAARNVLVS---SNDCVKLGDFGLS---R------YMEDSTYYKASKGKLPI 181
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + R +++ +DVW GV + IL+ G +PF + + +
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 34/229 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L + +G+G FG G+ +G +VAVK I + E ++ L
Sbjct: 196 KLLQTIGKGEFGDVM-----LGDYRGNKVAVKCIKNDATA-----QAFLAEASVMTQLR- 244
Query: 218 HNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H+NLV+ E+ +Y+V E G L+D + SRG D + + + +
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
VHRDL N L + E++V K DFGL+ + + +
Sbjct: 305 LEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---K------EASSTQDTGKLPVKW 352
Query: 330 -APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE L + +ST++DVWS G++ + I G P+ + V K
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 29/232 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ + +G G FG + K + VA+K + + T+ A +++ E ++ ++
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
+ ++ + T V ++ +L G LLD + +QI + +
Sbjct: 76 -NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +VHRDL N L +K DFGL+ + +E Y
Sbjct: 134 EDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEE--------KEYHAEGGKVP 182
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E + HR Y+ ++DVWS GV + ++ GS+P+ S I + K
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 55/235 (23%), Positives = 96/235 (40%), Gaps = 32/235 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E +GRGHFG + K AVK + +++T + E I++ +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFS- 84
Query: 218 HNNLVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N++ ++ VV+ + G+L + I + T D +Q+ + +
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ VHRDL N + DE +K DFGL+ R D+ YY
Sbjct: 145 ASKKFVHRDLAARNCML---DEKFTVKVADFGLA---R------DMYDKEYYSVHNKTGA 192
Query: 330 -------APEVLH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E L + ++T++DVWS GV+ + ++ G+ P+ I +L+
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 34/232 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ ++G G +G +KK L VAVK + + M E+ +E +++ +
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKEDTMEV----EEFLKEAAVMKEIK- 67
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAFC 276
H NLV+ Y++ E G LLD + + + + QI + + +
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ +HRDL N L EN ++K DFGLS + D Y
Sbjct: 128 EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT---------YTAHAGAKFP 175
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE L + +S ++DVW+ GV+ + I G P+ S ++ + K
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 34/227 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+L + +G+G FG G+ +G +VAVK I + E ++ L
Sbjct: 24 KLLQTIGKGEFGDVM-----LGDYRGNKVAVKCIKNDATA-----QAFLAEASVMTQLR- 72
Query: 218 HNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H+NLV+ E+ +Y+V E G L+D + SRG D + + + +
Sbjct: 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
VHRDL N L E++V K DFGL+ + + +
Sbjct: 133 LEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT---K------EASSTQDTGKLPVKW 180
Query: 330 -APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE L + +ST++DVWS G++ + I G P+ + V
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 65/313 (20%), Positives = 110/313 (35%), Gaps = 74/313 (23%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+ +L E +GRG +G Y KG L + VAVKV ++ E I
Sbjct: 13 DNLKLLELIGRGRYGAVY-------KGSLDERPVAVKVFSFANR------QNFINEKNIY 59
Query: 213 R-ALTGHNNLVKFFDA-----YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
R L H+N+ +F + +VME G L + + +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLA 117
Query: 267 IQILNVVAFCHLQ---------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
+ +A+ H + + HRDL N L + DFGLS + +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNR 174
Query: 318 RL---------NDIVGSAYYVAPEVL--------HRSYSTEADVWSIGVIAYILL---CG 357
+ VG+ Y+APEVL S + D++++G+I + +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 358 SRPFWARTESGI-FRAVLKADPSFDE---------------APWPSLSSEARDFVKRLL- 400
P + E + F+ + P+F++ W S R + +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 401 --NKDPRKRLTAA 411
++D RLTA
Sbjct: 295 CWDQDAEARLTAQ 307
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 54/238 (22%), Positives = 94/238 (39%), Gaps = 34/238 (14%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
L +G G FG Y + QVAVK +P+ D E I+
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIISKF 90
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQILNVV 273
H N+V+ + +++MEL GG+L + + ++ + A+ ++ + +
Sbjct: 91 N-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 274 AF--CHL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
A +L +HRD+ N L T V K DFG++ R DI ++YY
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRASYYR 200
Query: 330 ------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
PE ++++ D WS GV+ + I G P+ +++ + V
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 16/223 (7%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ ++G G +G +KK VAVK + + M E+ +E +++ +
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIK- 274
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAFC 276
H NLV+ Y++ E G LLD + + + + QI + + +
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY--VAPEVL 334
+ +HR+L N L EN ++K DFGLS + D APE L
Sbjct: 335 EKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391
Query: 335 -HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
+ +S ++DVW+ GV+ + I G P+ S ++ + K
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 59/300 (19%), Positives = 102/300 (34%), Gaps = 57/300 (19%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+L E RG FG K +L + VAVK+ P EV L
Sbjct: 24 MPLQLLEVKARGRFGCVW-----KAQLLNEYVAVKIFP----IQDKQSWQNEYEVYSLPG 74
Query: 215 LTGHNNLVKFFDAYEDTDNVYV----VMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
+ H N+++F A + +V V + E G L D + + + ++ + +
Sbjct: 75 MK-HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMA 131
Query: 271 NVVAFCHLQ----------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320
+A+ H + HRD+K +N L N DFGL+ +
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEAGKSAG 188
Query: 321 DI---VGSAYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGI-- 369
D VG+ Y+APEVL R D++++G++ + L + +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 370 FRAVLKADPSFDEA-----------PWPS--LSSEARDFVKRLLNK----DPRKRLTAAQ 412
F + PS ++ + + + D RL+A
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 53/229 (23%), Positives = 93/229 (40%), Gaps = 27/229 (11%)
Query: 159 LGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+ +G G FG K K VA+K + T D E I+ +
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQFS- 104
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H+N+++ + ++ E E G L + + G+++ ++ I + +
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
VHRDL N L + N V K DFGLS + D A Y
Sbjct: 165 NMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDP-------EATYTTSGGKIPI 214
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + +R +++ +DVWS G++ + ++ G RP+W + + +A+
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 54/226 (23%), Positives = 96/226 (42%), Gaps = 30/226 (13%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G+FG ++ + K VA+KV+ + T E++ RE +I+ L + +
Sbjct: 17 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLD-NPYI 72
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ + + +VME+ GG L ++ + + + ++ Q+ + + +
Sbjct: 73 VRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------------ 329
VHRDL N L K DFGLS + D+ +YY
Sbjct: 132 VHRDLAARNVLL---VNRHYAKISDFGLSKALGADD--------SYYTARSAGKWPLKWY 180
Query: 330 APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + R +S+ +DVWS GV + L G +P+ + +
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 31/227 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ ++G GHFG ++ +G+ G+QVAVK + + I D+++E++ILR L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNLY 81
Query: 217 GHNNLVKFFDA--YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N+VK+ + + + ++ME G L + + K +QI +
Sbjct: 82 -HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + VHRDL N L + +K DFGL+ + D+ YY
Sbjct: 141 YLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDK--------EYYTVKDDR 189
Query: 330 -------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTES 367
APE L + +DVWS GV + +L
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+L E +G G FG G G +VAVK + + M+ + E +++ L
Sbjct: 16 KLVERLGAGQFGEVW-----MGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQ 66
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H LV+ + A + +Y++ E E G L+D + + G T + + QI +AF
Sbjct: 67 -HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
+ +HRDL+ N L + K DFGL+ + +E Y
Sbjct: 125 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE---------YTAREGAKF 172
Query: 330 -----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE + + +++ ++DVWS G++ I+ G P+ T + + + +
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ +++G+G+FG ++ + G+ VAVK + + +T + D RE++IL++L
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ 100
Query: 217 GHNNLVKFFDA--YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H+N+VK+ N+ ++ME G L D + + QI +
Sbjct: 101 -HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + +HRDL N L + + +K DFGL+ + D+ YY
Sbjct: 160 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK--------EYYKVKEPG 208
Query: 330 -------APEVL-HRSYSTEADVWSIGVIAY 352
APE L +S +DVWS GV+ Y
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 53/241 (21%), Positives = 94/241 (39%), Gaps = 34/241 (14%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
L +G G FG Y + QVAVK +P+ + D E I+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALII 128
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAV--MIQIL 270
H N+V+ + ++++EL GG+L + + ++ + A+ ++ +
Sbjct: 129 SKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 271 NVVAF--CHL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
+A +L +HRD+ N L T V K DFG++ R DI +
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRAG 238
Query: 327 YYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRA 372
YY PE ++++ D WS GV+ + I G P+ +++ +
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 298
Query: 373 V 373
V
Sbjct: 299 V 299
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ +++G+G+FG ++ + G+ VAVK + + +T + D RE++IL++L
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ 69
Query: 217 GHNNLVKFFDA--YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H+N+VK+ N+ ++ME G L D + + QI +
Sbjct: 70 -HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV----- 329
+ + +HRDL N L + + +K DFGL+ + D+ ++
Sbjct: 129 YLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK--------EFFKVKEPG 177
Query: 330 -------APEVL-HRSYSTEADVWSIGVIAY 352
APE L +S +DVWS GV+ Y
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 48/232 (20%), Positives = 91/232 (39%), Gaps = 29/232 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFK-KGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ +G G FG + +GE V +KVI + + + V + + +L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSLD 73
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H ++V+ ++ +V + G LLD + G +QI + +
Sbjct: 74 -HAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
G+VHR+L N L S ++ DFG++D + PD+ +
Sbjct: 132 EEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDD--------KQLLYSEAKTP 180
Query: 330 ----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E + Y+ ++DVWS GV + ++ G+ P+ + + + K
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 55/243 (22%), Positives = 92/243 (37%), Gaps = 39/243 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
LG +G+G FG A+ K+ + +VAVK++ K + + IE+ RE ++
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFD- 83
Query: 218 HNNLVKFF------DAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVM 266
H ++ K A V++ + G+L RI M
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
+ I + + + +HRDL N + E+ + DFGLS R I
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLS---R------KIYSGD 191
Query: 327 YYV------------APEVLH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRA 372
YY A E L Y+ +DVW+ GV + I+ G P+ + I+
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 373 VLK 375
++
Sbjct: 252 LIG 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 63/248 (25%), Positives = 104/248 (41%), Gaps = 47/248 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N + + +G G+FG A+ KK L+ A+K + ++ + D E+++L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLR-MDAAIKRMKEY--ASKDDHRDFAGELEVLCK 81
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVMIQI 269
L H N++ A E +Y+ +E G LLD R+L + ++ A +
Sbjct: 82 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 270 LNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319
++ F +L + +HRDL N L EN V K DFGLS R
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-------RG 191
Query: 320 NDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWART 365
+ YV A E L + Y+T +DVWS GV+ + I+ G P+ T
Sbjct: 192 QE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246
Query: 366 ESGIFRAV 373
+ ++ +
Sbjct: 247 CAELYEKL 254
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 57/235 (24%), Positives = 97/235 (41%), Gaps = 32/235 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
+G+GHFG ++ Q A+K + + T +E RE ++R L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN- 80
Query: 218 HNNLVKFFDAYEDTDNV-YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N++ + + +V++ G+LL I S T D + +Q+ + +
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
Q VHRDL N + DE+ +K DFGL+ R DI+ YY
Sbjct: 141 AEQKFVHRDLAARNCML---DESFTVKVADFGLA---R------DILDREYYSVQQHRHA 188
Query: 330 -------APEVLH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E L ++T++DVWS GV+ + +L G+ P+ + + +
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 62/235 (26%), Positives = 94/235 (40%), Gaps = 43/235 (18%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N + G+ +G G FG A E +VAVK++ A E + E+KI+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIM 103
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L H N+V A V V+ E C G+LL+ + + D A A+ +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 273 ---VAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319
+ F L + +HRD+ N L T V K DFGL+ R
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLA-------R- 212
Query: 320 NDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRP 360
DI+ + Y+ APE + Y+ ++DVWS G++ + I G P
Sbjct: 213 -DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 51/245 (20%), Positives = 94/245 (38%), Gaps = 38/245 (15%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N LG+ +G G FG K+ + +VAVK + K ++ IE+ E ++
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKD 92
Query: 215 LTGHNNLVKFF-----DAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKA 264
+ H N+++ + + V++ + G+L R+ +
Sbjct: 93 FS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
M+ I + + + +HRDL N + ++ + DFGLS + I
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLS---K------KIYS 199
Query: 325 SAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIF 370
YY A E L R Y++++DVW+ GV + I G P+ ++
Sbjct: 200 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 371 RAVLK 375
+L
Sbjct: 260 DYLLH 264
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 38/233 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L ++G+G FG G G +VA+K + M+ E +E ++++ L
Sbjct: 187 RLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLR 237
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H LV+ + + + +Y+V E G LLD + GKY + QI + +A+
Sbjct: 238 -HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
VHRDL+ N L EN V K DFGL+ + +E Y
Sbjct: 296 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE---------YTARQGAKF 343
Query: 330 -----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE + ++ ++DVWS G++ + G P+ + V +
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 57/233 (24%), Positives = 94/233 (40%), Gaps = 38/233 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+L +++G G FG +VAVK + M+ E E +++ L
Sbjct: 191 KLEKKLGAGQFGEVW-----MATYNKHTKVAVKTMKPGSMSV----EAFLAEANVMKTLQ 241
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H+ LVK + +Y++ E G LLD + S G QI +AF
Sbjct: 242 -HDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
+ +HRDL+ N L + V K DFGL+ + +E Y
Sbjct: 300 IEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE---------YTAREGAKF 347
Query: 330 -----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE + S++ ++DVWS G++ I+ G P+ + + RA+ +
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 32/235 (13%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
E +GRGHFG + K AVK + +++T + E I++ +
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFS- 148
Query: 218 HNNLVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N++ ++ VV+ + G+L + I + T D +Q+ + F
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------- 329
+ VHRDL N + DE +K DFGL+ R D+ +
Sbjct: 209 ASKKFVHRDLAARNCML---DEKFTVKVADFGLA---R------DMYDKEFDSVHNKTGA 256
Query: 330 -------APEVLH-RSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
A E L + ++T++DVWS GV+ + ++ G+ P+ I +L+
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 70/363 (19%), Positives = 125/363 (34%), Gaps = 52/363 (14%)
Query: 29 ANGTPIPAPSPLNAESQSNNNRTNVKGNDDAVIEGKKSPFFPFYSPSPAHYFFSKKSSPA 88
GT L + + + + PAH P
Sbjct: 224 PEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLT--HPQ 281
Query: 89 RSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIPEGSEPEPAAGLNKSFG 148
R + + P SP K P + ++ E +P +K
Sbjct: 282 RRIDTLNSDGYTPEPARITSPDKP----------RPMPMDTSVFESPFSDPEELKDKKLF 331
Query: 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQ----QVAVKVIPKHKMTTAIAIED 204
+ N E+G G+FG +G + + VA+KV+ + T E+
Sbjct: 332 LKRD--NLLIADIELGCGNFGSVR-----QGVYRMRKKQIDVAIKVL--KQGTEKADTEE 382
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
+ RE +I+ L + +V+ + + +VME+ GG L ++ + + +
Sbjct: 383 MMREAQIMHQLD-NPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 440
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
++ Q+ + + + VHR+L N L K DFGLS + D+
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALGADD------- 490
Query: 325 SAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIF 370
+YY APE + R +S+ +DVWS GV + L G +P+ +
Sbjct: 491 -SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 549
Query: 371 RAV 373
+
Sbjct: 550 AFI 552
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 29/229 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG 217
ELG +G G FG + E VA+K T+ E +E +R
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQFD- 449
Query: 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH 277
H ++VK + + V+++MELC GEL + R Q+ +A+
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV-------- 329
+ VHRD+ N L + N +K DFGLS + S YY
Sbjct: 509 SKRFVHRDIAARNVLVS---SNDCVKLGDFGLSR---------YMEDSTYYKASKGKLPI 556
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + R +++ +DVW GV + IL+ G +PF + + +
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-23
Identities = 52/229 (22%), Positives = 98/229 (42%), Gaps = 30/229 (13%)
Query: 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH 218
+E+G G+FG ++ + + VAVK++ K++ +++ E +++ L +
Sbjct: 21 EDKELGSGNFGTVKKGYYQ-MKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLD-N 77
Query: 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
+V+ + ++ +VME+ E G L L + + + ++ Q+ + +
Sbjct: 78 PYIVRMI-GICEAESWMLVMEMAELGPLNKY-LQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV--------- 329
VHRDL N L K DFGLS +R DE YY
Sbjct: 136 SNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADE--------NYYKAQTHGKWPV 184
Query: 330 ---APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE + + +S+++DVWS GV+ + G +P+ S + +
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 46/240 (19%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
++ +LG+ +GRG FG A + VAVK++ + T + E+KIL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKIL 84
Query: 213 RALTGHNNLVKFFDAYEDTDN-VYVVMELCEGGELLD-----RILSRGGKYTEDDAKAVM 266
+ H N+V A + V++E C+ G L R K +D
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 267 IQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316
+ + +++ + L + +HRDL N L + E +V+K DFGL+
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA------ 195
Query: 317 ERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFW 362
R DI YV APE + R Y+ ++DVWS GV+ + I G+ P+
Sbjct: 196 -R--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 58/239 (24%), Positives = 91/239 (38%), Gaps = 47/239 (19%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N+ G+ +G G FG A VAVK++ E + E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVL 80
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-------RILSRGGKYTEDDAKAV 265
L H N+V A V+ E C G+LL+ + + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 266 MIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ + ++++F L + +HRDL N L T + K DFGL+ R
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA---R- 193
Query: 316 DERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRP 360
DI + YV APE + + Y+ E+DVWS G+ + + GS P
Sbjct: 194 -----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 54/246 (21%), Positives = 99/246 (40%), Gaps = 40/246 (16%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
K + E+G+G FG Y AK + +VA+K + + + + E ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVM 82
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA-------- 264
+ +++V+ V+MEL G+L + S + A
Sbjct: 83 KEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 265 -VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIV 323
+ +I + +A+ + VHRDL N + E+ +K DFG++ R DI
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---R------DIY 189
Query: 324 GSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGI 369
+ YY +PE L ++T +DVWS GV+ + I +P+ + +
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249
Query: 370 FRAVLK 375
R V++
Sbjct: 250 LRFVME 255
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 9e-23
Identities = 55/234 (23%), Positives = 84/234 (35%), Gaps = 35/234 (14%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+ ++G GHFG + G+ VAVK + ++E+ ILR L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYD-PTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTL 90
Query: 216 TGHNNLVKFFDA--YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H +++K+ ++ +VME G L D + QI +
Sbjct: 91 Y-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGM 147
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV---- 329
A+ H Q +HRDL N L + ++K DFGL+ V YY
Sbjct: 148 AYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHE--------YYRVRED 196
Query: 330 --------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
APE L + +DVWS GV Y +L T+ +
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 51/239 (21%), Positives = 84/239 (35%), Gaps = 46/239 (19%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
EE+G FG Y + Q VA+K + E+ R E + L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEFRHEAMLRARL 69
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD--RILSRGGKYTEDDAKAVMIQILNVV 273
H N+V + ++ C G+L + + S D + L
Sbjct: 70 Q-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 274 AFCHL-------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLN 320
F HL VVH+DL N L + +K D GL R
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF-------R-- 176
Query: 321 DIVGSAYYV------------APE-VLHRSYSTEADVWSIGVIAY-ILLCGSRPFWART 365
++ + YY APE +++ +S ++D+WS GV+ + + G +P+ +
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 1e-22
Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 38/233 (16%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQ-QVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L ++G+G FG G G +VA+K + M+ E +E ++++ L
Sbjct: 270 RLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLR 320
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNVVAF 275
H LV+ + + + +Y+V E G LLD + GKY + QI + +A+
Sbjct: 321 -HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV------ 329
VHRDL+ N L EN V K DFGL+ + +E Y
Sbjct: 379 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE---------YTARQGAKF 426
Query: 330 -----APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 375
APE + ++ ++DVWS G++ + G P+ + V +
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 60/232 (25%), Positives = 93/232 (40%), Gaps = 51/232 (21%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
E G+ +G G FG A QVAVK++ + + E + E+K++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMM 102
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD------------RILSRGGKYTED 260
L H N+V A + +Y++ E C G+LL+ I K E+
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 261 DAKAVMIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310
+ ++ +++ F L + VHRDL N L T V+K DFGL+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLA 219
Query: 311 DFVRPDERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGV 349
R DI+ + YV APE L Y+ ++DVWS G+
Sbjct: 220 ---R------DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 46/227 (20%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAIAIEDVRREVK 210
+K LG+ +G G FG A + + VAVK++ T + D+ E++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 92
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAV 265
+++ + H N++ A +YV++E G L + R Y +
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 266 MIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ ++V+ +L Q +HRDL N L T EN+V+K DFGL+ R
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R- 205
Query: 316 DERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGV 349
DI YY APE L R Y+ ++DVWS GV
Sbjct: 206 -----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 62/252 (24%), Positives = 104/252 (41%), Gaps = 47/252 (18%)
Query: 155 NKYELGEEVGRGHFG--YTCAAK--FKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
++ LG+ +G G FG A K + +VAVK++ T + D+ E++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEME 126
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAV 265
+++ + H N++ A +YV++E G L + R Y
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 266 MIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ ++V+ +L + +HRDL N L T E++V+K DFGL+ R
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA---R- 239
Query: 316 DERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
DI YY APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 240 -----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294
Query: 362 WARTESGIFRAV 373
+F+ +
Sbjct: 295 PGVPVEELFKLL 306
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 63/256 (24%), Positives = 101/256 (39%), Gaps = 48/256 (18%)
Query: 142 GLNKSFGFSKHFA-NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTT 198
G S +H L E+G G FG + VAVK + +
Sbjct: 1 GAMHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA- 59
Query: 199 AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSR 253
A +D +RE ++L L H ++VKF+ D D + +V E + G+L +
Sbjct: 60 --ARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAM 116
Query: 254 GGKYTEDDAKAVMIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLK 303
+ + + ++ +L Q VHRDL N L N ++K
Sbjct: 117 ILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVK 173
Query: 304 AIDFGLSDFVRPDERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVI 350
DFG+S R D+ + YY PE + +R ++TE+DVWS GVI
Sbjct: 174 IGDFGMS-------R--DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 224
Query: 351 AY-ILLCGSRPFWART 365
+ I G +P++ +
Sbjct: 225 LWEIFTYGKQPWFQLS 240
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 47/252 (18%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQ--QVAVKVIPKHKMTTAIAIEDVRREVK 210
+K LG+ +G G FG A + + VAVK++ T + D+ E++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEME 138
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-----RILSRGGKYTEDDAKAV 265
+++ + H N++ A +YV++E G L + R Y +
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 266 MIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ ++V+ +L Q +HRDL N L T EN+V+K DFGL+ R
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R- 251
Query: 316 DERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPF 361
DI YY APE L R Y+ ++DVWS GV+ + I G P+
Sbjct: 252 -----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306
Query: 362 WARTESGIFRAV 373
+F+ +
Sbjct: 307 PGIPVEELFKLL 318
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 58/258 (22%), Positives = 99/258 (38%), Gaps = 54/258 (20%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
LG+ +G G FG A KG VAVK++ ++ + + D+ E +L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVL 80
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-------------RILSRGGKYTE 259
+ + H +++K + A + +++E + G L +
Sbjct: 81 KQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 260 DDAKAVMIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
D + + ++++F +L +VHRDL N L E +K DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGL 196
Query: 310 SDFVRPDERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILL 355
S R D+ YV A E L Y+T++DVWS GV+ + I+
Sbjct: 197 S---R------DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 356 CGSRPFWARTESGIFRAV 373
G P+ +F +
Sbjct: 248 LGGNPYPGIPPERLFNLL 265
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 7e-21
Identities = 60/238 (25%), Positives = 97/238 (40%), Gaps = 46/238 (19%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
L E+G G FG + E VAVK + + + A +D +RE ++L L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTML 100
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD----RILSRGGKYTEDDAKAVMIQILN 271
H ++V+FF + + +V E G+L +D + +
Sbjct: 101 Q-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 272 VVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
++A +L VHRDL N L + V+K DFG+S R D
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMS-------R--D 207
Query: 322 IVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWART 365
I + YY PE + +R ++TE+DVWS GV+ + I G +P++ +
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 54/247 (21%), Positives = 89/247 (36%), Gaps = 54/247 (21%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
E ++G G FG + A VAVK++ + +A D +RE ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEF 107
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLD-------------RILSRGGKYTEDDA 262
+ N+VK + ++ E G+L + +
Sbjct: 108 -DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 263 KAVMIQILNVVAFC--------HL--QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312
+ + +L + VHRDL N L EN V+K DFGLS
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS-- 221
Query: 313 VRPDERLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGS 358
R +I + YY PE + + Y+TE+DVW+ GV+ + I G
Sbjct: 222 -R------NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274
Query: 359 RPFWART 365
+P++
Sbjct: 275 QPYYGMA 281
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 49/224 (21%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKV-IPKHKMTTAIAIEDVRREVKI 211
+ +G+++G G+FG K + VA+K+ K + + E +
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKSRAPQ------LHLEYRF 57
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
+ L + + + + +V+EL G L D ++ + IQ+++
Sbjct: 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLIS 116
Query: 272 VVAFCHLQGVVHRDLKPENFLF---TTKDENSVLKAIDFGLS-DFVRPDERL-------N 320
+ + H + +++RD+KPENFL K + V+ IDF L+ +++ P+ +
Sbjct: 117 RMEYVHSKNLIYRDVKPENFLIGRPGNKTQQ-VIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 321 DIVGSAYYVAPEV-LHRSYSTEADVWSIG-VIAYILLCGSRPFW 362
+ G+A Y++ L + S D+ ++G + Y L GS P W
Sbjct: 176 SLTGTARYMSINTHLGKEQSRRDDLEALGHMFMY-FLRGSLP-W 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 23/221 (10%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKV-IPKHKMTTAIAIEDVRREVKI 211
N+Y LG ++G G FG G++VA+K+ K K + E KI
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAA---GEEVAIKLECVKTKHPQ------LHIESKI 57
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
+ + G + + D +VMEL G L D K++ + Q+++
Sbjct: 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMIS 116
Query: 272 VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR--------PDERLNDIV 323
+ + H + +HRD+KP+NFL + +++ IDFGL+ R P ++
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 324 GSAYYVAPEV-LHRSYSTEADVWSIG-VIAYILLCGSRPFW 362
G+A Y + L S D+ S+G V+ Y GS P W
Sbjct: 177 GTARYASINTHLGIEQSRRDDLESLGYVLMY-FNLGSLP-W 215
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-18
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP-KHKMTTAIAIEDVRREVKI 211
Y++G +G G FG QQVA+K P + +R E +
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLN---NQQVAIKFEPRRSDAPQ------LRDEYRT 58
Query: 212 LRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILN 271
+ L G + + ++ + +V++L G L D + G K++ Q+L
Sbjct: 59 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLA 117
Query: 272 VVAFCHLQGVVHRDLKPENFLF---TTKDENSVLKAIDFGLS-DFVRPDERL-------N 320
V H + +V+RD+KP+NFL +K+ N + +DFG+ + P +
Sbjct: 118 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIY-VVDFGMVKFYRDPVTKQHIPYREKK 176
Query: 321 DIVGSAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFW 362
++ G+A Y++ L R S D+ ++G + L GS P W
Sbjct: 177 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 50/239 (20%), Positives = 90/239 (37%), Gaps = 42/239 (17%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N++ LG+++G G FG A K + VKV + + E+K
Sbjct: 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP-------LFSELKFY 87
Query: 213 RALTGHNNLVKFFD------------------AYEDTDNVYVVMELCEGGELLDRILSRG 254
+ + + + K+ + ++ ++VME G L +I +
Sbjct: 88 QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQN 145
Query: 255 GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314
G + + + I++L+V+ + H VH D+K N L K+ + V D+GLS
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY-LADYGLSYRYC 204
Query: 315 PDERLNDI--------VGSAYYVAPEVLHRSY--STEADVWSIG-VIAYILLCGSRPFW 362
P+ G+ + H+ S +DV +G + LCG P W
Sbjct: 205 PNGNHKQYQENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLR-WLCGKLP-W 260
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 42/244 (17%), Positives = 85/244 (34%), Gaps = 49/244 (20%)
Query: 153 FANKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIP-KHKMTTAIAIEDVRREV 209
A +++G +G+G FG Y + VKV P + + E+
Sbjct: 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG--------PLFTEL 84
Query: 210 KILRALTGHNNL----------------VKFFDAYEDTDNVY--VVMELCEGGELLDRIL 251
K + + ++ Y ++M+ G +L
Sbjct: 85 KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYE 143
Query: 252 SRGGKYTEDDAKAVM---IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
+ +++ K V+ ++IL+++ + H VH D+K N L K+ + V +D+G
Sbjct: 144 ANAKRFSR---KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY-LVDYG 199
Query: 309 LSDFVRPDERLNDI--------VGSAYYVAPEV-LHRSYSTEADVWSIG-VIAYILLCGS 358
L+ P+ G+ + + + + S D+ +G + L G
Sbjct: 200 LAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ-WLTGH 258
Query: 359 RPFW 362
P W
Sbjct: 259 LP-W 261
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 21/219 (9%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP-KHKMTTAIAIEDVRREVKIL 212
NK+ LG ++G G FG + ++VA+K+ K K + E KI
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKHPQ------LLYESKIY 56
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
R L G + + D +VM+L G L D K + + Q++N
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR--------PDERLNDIVG 324
V F H + +HRD+KP+NFL + + IDFGL+ R P ++ G
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 325 SAYYVAPEV-LHRSYSTEADVWSIGVIAYILLCGSRPFW 362
+A Y + L S D+ S+G + L GS P W
Sbjct: 176 TARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 70/332 (21%), Positives = 108/332 (32%), Gaps = 98/332 (29%)
Query: 133 EGSEPEPAAGLNKSFGFS------KHFANKYELGEE--VGRGHFG--YTCAAKFKKGELK 182
E E + SF F +F + +G G FG Y KG +
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVY-------KGYVN 53
Query: 183 GQQVAVKVIPKHKMTTAIAIEDV------RREVKILRALTGHNNLVKFFDAYEDTDN--- 233
VAVK K+ + I +E+K++ H NLV+ + +
Sbjct: 54 NTTVAVK-----KLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELL-GFSSDGDDLC 106
Query: 234 -VYVVMELCEGGELLDRILSRGGKYT----------EDDAKAVMIQILNVVAFCHLQGVV 282
VY G LLDR+ G + A + F H +
Sbjct: 107 LVY---VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI--------NFLHENHHI 155
Query: 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND----------IVGSAYYVAPE 332
HRD+K N L DE K DFGL+ R ++ IVG+ Y+APE
Sbjct: 156 HRDIKSANILL---DEAFTAKISDFGLA-------RASEKFAQTVMTSRIVGTTAYMAPE 205
Query: 333 VLHRSYSTEADVWSIGVIAYILLCGSRPF-----------WAR---TESGIFRAVLKADP 378
L + ++D++S GV+ ++ G E D
Sbjct: 206 ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY--IDK 263
Query: 379 SFDEAPWPSLSSEARDFVK---RLLNKDPRKR 407
++A S+ + L++ KR
Sbjct: 264 KMNDAD----STSVEAMYSVASQCLHEKKNKR 291
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 42/234 (17%), Positives = 77/234 (32%), Gaps = 33/234 (14%)
Query: 155 NKYELGEEVGRGHFG-----YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR-- 207
+++L R + G + + Q+ ++K+ K R
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 208 --EVKILRALTGHNNL----VKFFDAYEDTDNVYVVMELCEGGELLDRIL--SRGGKYTE 259
+V + L L F ++D ++V+ G L L S +E
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSL--GRSLQSALDVSPKHVLSE 158
Query: 260 DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD--- 316
V ++L+ + F H VH ++ EN +D++ V +G + P
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVT-LAGYGFAFRYCPSGKH 217
Query: 317 ----ERLND-IVGSAYYVAPEVLHRSY--STEADVWSIG-VIAYILLCGSRPFW 362
E G + LH+ S +D+ S+G + L G P W
Sbjct: 218 VAYVEGSRSPHEGDLEF-ISMDLHKGCGPSRRSDLQSLGYCMLK-WLYGFLP-W 268
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.3 bits (171), Expect = 2e-13
Identities = 49/318 (15%), Positives = 97/318 (30%), Gaps = 74/318 (23%)
Query: 149 FSKHFA-NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----I 200
FS K + E++G G FG + + VA+K+I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVF-------QTIADHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 201 AIEDVRREVKILRALTGHNN-------------------------LVKFFDAYEDT---- 231
E++ E+ I + L+ + L+K +D Y T
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 232 ---------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GV 281
D +++V+E GG L+++ ++ + AK+++ Q+ +A
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASLRF 183
Query: 282 VHRDLKPENFLFTT--------KDENSVLKAIDFGLS----DFVRP-DERLNDIVGSAYY 328
HRDL N L GL D+ ER +V
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVS 243
Query: 329 VAPEVLHRSYSTEADVWSI-GVIAYILLCGSRP----FWARTESGIFRAVLKADPSFDEA 383
+ ++ + D++ + P W + + +
Sbjct: 244 MDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303
Query: 384 PWPSLSSEARDFVKRLLN 401
+ + ++F + +LN
Sbjct: 304 AMKQIKRKIQEFHRTMLN 321
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 64/298 (21%), Positives = 107/298 (35%), Gaps = 75/298 (25%)
Query: 125 KPNEAAIPEGSEPEPAAGLNKSFGFS------KHFANKYELGEEVGRGHFG--YTCAAKF 176
K + S + +F +K+ +G G FG Y
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGH----GVFGKVY------ 56
Query: 177 KKGELK-GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235
KG L+ G +VA+K ++ IE+ E++ L H +LV ++ + +
Sbjct: 57 -KGVLRDGAKVALKRR---TPESSQGIEEFETEIETLSFCR-HPHLVSLIGFCDERNEMI 111
Query: 236 VVMELCEGGELLDRILSRGGKYTE------------DDAKAVMIQILNVVAFCHLQGVVH 283
++ + E G L L T A+ + + H + ++H
Sbjct: 112 LIYKYMENGNLKRH-LYGSDLPTMSMSWEQRLEICIGAARGL--------HYLHTRAIIH 162
Query: 284 RDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDE-----RLNDIVGSAYYVAPEVLHRS 337
RD+K N L DEN V K DFG+S D+ + G+ Y+ PE +
Sbjct: 163 RDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTV---VKGTLGYIDPEYFIKG 216
Query: 338 YSTE-ADVWSIGVIAYILLCGSRPF-------------WART--ESGIFRAVLKADPS 379
TE +DV+S GV+ + +LC WA +G + DP+
Sbjct: 217 RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI--VDPN 272
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 68/293 (23%), Positives = 108/293 (36%), Gaps = 58/293 (19%)
Query: 131 IPEGSEPEPAAGLNKSFGFS------KHFANKYELGEEVGRGHFG--YTCAAKFKKGELK 182
+P +PE G K F +F+NK LG G FG Y KG L
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGR----GGFGKVY-------KGRLA 52
Query: 183 -GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELC 241
G VAVK + K + T ++ + EV+++ H NL++ +V
Sbjct: 53 DGTLVAVKRL-KEERTQGGELQ-FQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYM 109
Query: 242 EGGELLDRILSRGGKYTEDDAKAVMIQILNV---VAFCHLQG---VVHRDLKPENFLFTT 295
G + + R D L +A+ H ++HRD+K N L
Sbjct: 110 ANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL-- 167
Query: 296 KDENSVLKAIDFGLSDFVRPDERLN---DIVGSAYYVAPEVLHRSYSTE-ADVWSIGVIA 351
DE DFGL+ + + + + G+ ++APE L S+E DV+ GV+
Sbjct: 168 -DEEFEAVVGDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 225
Query: 352 YILLCGSRPF---------------WART--ESGIFRAV----LKADPSFDEA 383
L+ G R F W + + A+ L+ + +E
Sbjct: 226 LELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV 278
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 35/117 (29%), Positives = 51/117 (43%), Gaps = 26/117 (22%)
Query: 258 TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE 317
T + Q+ + F + +HRDL N L + E +V+K DFGL+
Sbjct: 191 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA------- 240
Query: 318 RLNDIVGSAYYV------------APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRP 360
R DI YV APE + R Y+ ++DVWS GV+ + I G+ P
Sbjct: 241 R--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 37/186 (19%), Positives = 68/186 (36%), Gaps = 20/186 (10%)
Query: 158 ELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
+LG+ +GRG FG A + VAVK++ + T + E+KIL +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHI 82
Query: 216 TGHNNLVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N+V A + V++E C+ G L + S+ ++ +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-----VPYKTKGARFRQ 137
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----------LNDIVG 324
G + DLK T+ ++ ++ V +E L ++
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC 197
Query: 325 SAYYVA 330
++ VA
Sbjct: 198 YSFQVA 203
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 1e-06
Identities = 53/390 (13%), Positives = 106/390 (27%), Gaps = 122/390 (31%)
Query: 73 SPSPAHYFFSKKSSPARSSANSTPNRFFKRPFPPPSPAKHIKAVLARRHGSVKPNEAAIP 132
PS + ++ R + F K P ++ L ++P + +
Sbjct: 104 QPSMMTRMYIEQ----RDRLYNDNQVFAKYNVSRLQPYLKLRQALLE----LRPAKNVLI 155
Query: 133 EGSEPEPAAGLNKS---------FGFSKHFANK-YELGEEVGRGHFGYTCAAKFKKGELK 182
+G G K+ + K + L + + + L+
Sbjct: 156 DG-----VLGSGKTWVALDVCLSYKVQCKMDFKIFWL-------NLKNCNSPE---TVLE 200
Query: 183 GQQVAVKVI-------PKHKMTTAIAIEDVRREVKILRALTGHNN--LV-------KFFD 226
Q + I H + I ++ E++ L + N LV K ++
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN 260
Query: 227 AYED--------TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL 278
A+ + T V L + T D+ K+++++ L+
Sbjct: 261 AF-NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ--- 316
Query: 279 QGVVHRDLKPENFLFTTKDENSVLKAIDFG--LSDFV-RPD-------ERLNDIVGSAY- 327
DL E N +I + D + D ++L I+ S+
Sbjct: 317 ------DLPRE-----VLTTNPRRLSI-IAESIRDGLATWDNWKHVNCDKLTTIIESSLN 364
Query: 328 YVAPEVLHRSYST----EADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383
+ P + + I ILL W
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSAH----IPTILLS---LIW--------------------- 396
Query: 384 PWPSLSSEARDFV-----KRLLNKDPRKRL 408
+ + S+ V L+ K P++
Sbjct: 397 -FDVIKSDVMVVVNKLHKYSLVEKQPKEST 425
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 1e-05
Identities = 43/329 (13%), Positives = 93/329 (28%), Gaps = 100/329 (30%)
Query: 188 VKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVV---M------ 238
+V K+ +V R L+ L E V+ +
Sbjct: 123 NQVFAKY---------NVSRLQPYLKL---RQAL------LELRPAKNVLIDGVLGSGKT 164
Query: 239 ----ELCEGGELLDRILSRG------GKYTEDDAKAVMIQIL------NVVAFC-HLQGV 281
++C ++ + + + M+Q L N + H +
Sbjct: 165 WVALDVCLSYKVQCK-MDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 282 VHR--DLKPE-NFLFTTKD-ENS-----------VLKAIDFGLSDFV--RPDERLNDIVG 324
R ++ E L +K EN A + + R +++ D +
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTR-FKQVTDFLS 282
Query: 325 SAYYVAPEVLHRSYS-TEADVWSIGVIAYILLCGSR--PFWARTES----GIFRAVLKAD 377
+A + H S + T + ++ L C + P T + I ++
Sbjct: 283 AATTTHISLDHHSMTLTPDE--VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG 340
Query: 378 PS-FDEAPWPSLSSEA-----RDFVKRLLNKDPRKRLTAAQALS-HPWIKNSNDVKVPLD 430
+ +D W ++ + + L + RK LS P +P
Sbjct: 341 LATWD--NWKHVNCDKLTTIIESSLNVLEPAEYRKMF---DRLSVFP-----PSAHIPTI 390
Query: 431 VI-----------IFKLMKAYMRSSSLRK 448
++ + ++ + S + K
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSLVEK 419
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 3e-05
Identities = 32/176 (18%), Positives = 58/176 (32%), Gaps = 34/176 (19%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV----------- 205
+G + G A K +AVK+ +++ T+ +
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDG-KPVAMAVKI---YRIETSEFDKMDEYLYGDERFDM 104
Query: 206 ----RREVKILRALTGHNNLVKFFDA-------YEDTDNVYVVMELCEGGEL-LDRILSR 253
+E + NL + +A Y NV ++ME EL ++
Sbjct: 105 RRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNV-LLMEFIGEDELPAPTLVEL 163
Query: 254 GGKYTEDDAKAVMIQILN-VVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308
G + E D + + ++ V +VH DL N ++ K + ID G
Sbjct: 164 GRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK-----VYFIDMG 214
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 37/147 (25%), Positives = 54/147 (36%), Gaps = 18/147 (12%)
Query: 163 VGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
C KF K G ++V K + +AI R E + L+ L G
Sbjct: 108 NCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---- 163
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
+ Y N V+MEL + EL ++ V+ IL VA + +G+
Sbjct: 164 LAVPKVYAWEGNA-VLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGI 214
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFG 308
VH DL N L + + IDF
Sbjct: 215 VHGDLSQYNVLVS----EEGIWIIDFP 237
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 6/41 (14%), Positives = 14/41 (34%), Gaps = 1/41 (2%)
Query: 414 LSHPWIKNSNDV-KVPLDVIIFKLMKAYMRSSSLRKAALRV 453
+ H +S + + + K Y +K A+ +
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTI 41
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 455 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.84 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.74 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.71 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.35 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.33 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.16 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.98 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.74 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.55 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.51 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.49 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.37 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.33 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.14 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.03 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.95 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.71 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.69 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.92 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.73 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.89 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 80.9 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-63 Score=481.59 Aligned_cols=261 Identities=31% Similarity=0.579 Sum_probs=233.5
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|++++++|+ |||||+++++|++++.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEecccCeEEEEEEECC---CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEE
Confidence 579999999999999999999776 68999999996543333334567899999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|||||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+...
T Consensus 108 yivmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecC
Confidence 999999999999998864 4679999999999999999999999999999999999999 788999999999998875
Q ss_pred CCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 315 PDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 315 ~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
... .....+||+.|||||++. ..|+.++|||||||+||||++|+.||.+.+..+.+..+++....++. .+++
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~ 259 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFP 259 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCH
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCH
Confidence 332 346779999999999987 56999999999999999999999999999999999999988766654 6899
Q ss_pred HHHHHHHHhccCCccCCCCHHH------HHcCcccCCCCCCCC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQ------ALSHPWIKNSNDVKV 427 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~e------lL~hp~~~~~~~~~~ 427 (455)
++++||++||+.||++|||+.| |++||||++.++..+
T Consensus 260 ~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 9999999999999999999987 689999999876554
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-62 Score=465.04 Aligned_cols=254 Identities=35% Similarity=0.630 Sum_probs=211.5
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|+... +|+.||||++.+.........+.+.+|++++++++ |||||++++++.+++.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT---TCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 579999999999999999999765 68999999998766555556678999999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
||||||| +|+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++++||+|||+|+...
T Consensus 89 ~ivmEy~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EEEEECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC----
T ss_pred EEEEeCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecC
Confidence 9999999 6799998864 5679999999999999999999999999999999999999 788899999999998877
Q ss_pred CCCcccccccCCCcccccccCC-CC-CCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 315 PDERLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~~-~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
........+||+.|||||++.+ .| +.++|||||||++|+|++|+.||.+.+....++.+.+....++. .+++++
T Consensus 164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 239 (275)
T 3hyh_A 164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGA 239 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TSCHHH
T ss_pred CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHH
Confidence 6666677899999999999875 44 67999999999999999999999999888888888887765543 689999
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.+||++||+.||++|||+.|+|+||||+.
T Consensus 240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 240 AGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 99999999999999999999999999985
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=478.43 Aligned_cols=259 Identities=26% Similarity=0.518 Sum_probs=225.8
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|+++++||+|+||.||+|+++. +|+.||||++.+... .....+.+.+|++++++|+ |||||+++++|++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTE---DGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETT---TCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEE
Confidence 689999999999999999999776 689999999977553 4455778999999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 235 YVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
|||||||+||+|.+++..+. ..+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+..
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVL 175 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceee
Confidence 99999999999999997654 468999999999999999999999999999999999999 78889999999999877
Q ss_pred CCCC-cccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
.... .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+.+..+.+..+.+..... .+..++.+
T Consensus 176 ~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~ 252 (350)
T 4b9d_A 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYD 252 (350)
T ss_dssp CHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHH
T ss_pred cCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHH
Confidence 5432 2356789999999999875 69999999999999999999999999999999988888876432 23478999
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
+.+||.+||+.||++|||+.|+|+||||+...+
T Consensus 253 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHHhhcCCC
Confidence 999999999999999999999999999986533
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-61 Score=474.12 Aligned_cols=257 Identities=30% Similarity=0.569 Sum_probs=227.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.++||+|+||.||+|+++. +|+.||||++....... .+.+.+|+++|++|+ |||||+++++|.+++.
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~ 145 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQ-HENVVEMYNSYLVGDE 145 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECC---CCCEEEEEEEecCchhH---HHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 3579999999999999999999876 68999999996543222 345789999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|||||||+||+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+..
T Consensus 146 ~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQV 220 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceec
Confidence 9999999999999998754 469999999999999999999999999999999999999 78889999999999877
Q ss_pred CCC-CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
... ......+||+.|||||++. ..|+.++|||||||+||||++|+.||.+.+..+.+..+...... ....+..++++
T Consensus 221 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~s~~ 299 (346)
T 4fih_A 221 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPS 299 (346)
T ss_dssp CSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCSCGGGSCHH
T ss_pred CCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccccCCHH
Confidence 543 3456789999999999987 56999999999999999999999999999888888877765432 22334578999
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+.+||.+||+.||++|||+.|+|+||||+...
T Consensus 300 ~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 300 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999999999754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-60 Score=457.82 Aligned_cols=257 Identities=21% Similarity=0.360 Sum_probs=217.5
Q ss_pred CCe-EEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee---
Q 012825 155 NKY-ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (455)
Q Consensus 155 ~~y-~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--- 230 (455)
.+| ++.++||+|+||.||+|++.. +++.||+|++.... ......+.+.+|++++++|+ |||||+++++|.+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~-~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVK 99 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEET
T ss_pred CceEEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhh-CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccC
Confidence 444 788899999999999999776 68999999997543 34555678999999999998 9999999999875
Q ss_pred -CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeeccCCceEEeecCCCceEEEeec
Q 012825 231 -TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 231 -~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
++.+|||||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||++| ||||||||+||||+ +.++.+||+||
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DF 176 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDL 176 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCT
T ss_pred CCcEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeC
Confidence 3468999999999999998854 467999999999999999999999998 99999999999994 24688999999
Q ss_pred ccccccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
|+|+... .......+||+.|||||++.+.|+.++|||||||+||||+||+.||.+......+...+..... +......
T Consensus 177 Gla~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~-~~~~~~~ 254 (290)
T 3fpq_A 177 GLATLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKV 254 (290)
T ss_dssp TGGGGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGGGGC
T ss_pred cCCEeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC-CCCCCcc
Confidence 9998654 3445677999999999999989999999999999999999999999776555444443333221 1122345
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 7899999999999999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-61 Score=469.94 Aligned_cols=259 Identities=29% Similarity=0.516 Sum_probs=223.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++++.||+|+||.||+|+...+..+++.||||++.+...... ....+.+|++++++|+ |||||++++++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 679999999999999999999876555789999999975432221 1235778999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|||||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 102 ~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC--
T ss_pred EEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceecc
Confidence 999999999999998864 4579999999999999999999999999999999999999 788999999999998754
Q ss_pred C-CCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 315 P-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 315 ~-~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
. .......+||+.|||||++. ..|+.++|||||||+||||++|+.||.+.+..+.+..+.+....++. .+++++
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 253 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEA 253 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----cCCHHH
Confidence 3 33456789999999999986 56999999999999999999999999999999999999887765543 689999
Q ss_pred HHHHHHhccCCccCCCC-----HHHHHcCcccCCCC
Q 012825 393 RDFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps-----~~elL~hp~~~~~~ 423 (455)
.+||++||+.||++||| ++|+++||||++.+
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 99999999999999998 58999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-60 Score=476.00 Aligned_cols=257 Identities=30% Similarity=0.569 Sum_probs=228.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|+++++||+|+||.||+|+++. +|+.||||++....... .+.+.+|+.+|++|+ |||||+++++|.+++.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQ-HENVVEMYNSYLVGDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECC---CCCEEEEEEEeccchhH---HHHHHHHHHHHHhCC-CCCCCceEEEEEECCE
Confidence 4679999999999999999999876 68999999997643332 356889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|||||||+||+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.+
T Consensus 223 ~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQV 297 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceEC
Confidence 9999999999999998753 469999999999999999999999999999999999999 78889999999999877
Q ss_pred CCC-CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
... ......+||+.|||||++. ..|+.++|||||||++|||++|+.||.+.+..+.+..+...... ....+..++++
T Consensus 298 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~s~~ 376 (423)
T 4fie_A 298 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPS 376 (423)
T ss_dssp CSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSCTTSSCHH
T ss_pred CCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCcccccCCHH
Confidence 543 3456789999999999987 56999999999999999999999999999888888877765432 23334579999
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+.+||.+||+.||++|||+.|+|+||||+...
T Consensus 377 ~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 377 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 99999999999999999999999999999753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-59 Score=456.23 Aligned_cols=256 Identities=26% Similarity=0.368 Sum_probs=221.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.+.|++.++||+|+||.||+|+++. +|+.||||++...... .+|+.++++|+ |||||+++++|.+++.
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~---~g~~vAiK~i~~~~~~--------~~E~~il~~l~-HpnIV~l~~~~~~~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVRLEVFR--------VEELVACAGLS-SPRIVPLYGAVREGPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCC--------THHHHTTTTCC-CTTBCCEEEEEEETTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECC---CCCEEEEEEECHHHhH--------HHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 4679999999999999999999776 6899999999765332 36999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCc-eEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS-VLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~-~vkL~DfG~a~~ 312 (455)
+|||||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||++|||||||||+|||| +.++ .+||+|||+|+.
T Consensus 125 ~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALC 200 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEE
T ss_pred EEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeE
Confidence 9999999999999998865 4579999999999999999999999999999999999999 6665 699999999987
Q ss_pred cCCCCc------ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 313 VRPDER------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 313 ~~~~~~------~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
...+.. ....+||+.|||||++. ..|+.++|||||||+||||++|+.||.+.+....+..+........ ..+
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~ 279 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIP 279 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSC
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcC
Confidence 754322 23468999999999987 4699999999999999999999999998887777778877654432 234
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHH-------------HcCcccCCCCCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQA-------------LSHPWIKNSNDVK 426 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~el-------------L~hp~~~~~~~~~ 426 (455)
+.+++++.+||.+||+.||++|||+.|+ |+|||++...+.+
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 5799999999999999999999999998 5799999876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-57 Score=454.12 Aligned_cols=262 Identities=29% Similarity=0.499 Sum_probs=224.2
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~- 230 (455)
.++++|++++.||+|+||.||+|+++. +|+.||||++.+.. ......+.+.+|+++|+.|+ |||||++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~---t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRL---TGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPT 125 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECC---CCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcC-CCCcceEeeeeecc
Confidence 356899999999999999999999776 68999999997643 44555678889999999998 9999999998763
Q ss_pred -----CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 231 -----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 231 -----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
.+.+|||||||+ |+|.+++. ..+.+++..++.|+.||+.||.|||++|||||||||+|||+ +.++.+||+
T Consensus 126 ~~~~~~~~~~ivmE~~~-g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~ 200 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLME-SDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIG 200 (398)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEEC
T ss_pred cccccCCEEEEEEeCCC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEe
Confidence 367999999996 68888774 56789999999999999999999999999999999999999 788999999
Q ss_pred ecccccccCCC-----CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC
Q 012825 306 DFGLSDFVRPD-----ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (455)
Q Consensus 306 DfG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (455)
|||+|+.+... ......+||+.|||||++.+ .++.++||||+||++|||++|+.||.+.+..+.+..++....
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g 280 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999876432 23456799999999998764 479999999999999999999999999998888888766433
Q ss_pred CCCCC---------------------------CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 379 SFDEA---------------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 379 ~~~~~---------------------------~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
..... .++.+++++.+||.+||.+||++|||+.|+|+||||+...
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 22211 1245789999999999999999999999999999999764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=446.41 Aligned_cols=261 Identities=25% Similarity=0.474 Sum_probs=212.7
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.++||+|+||.||+|+.+....+++.||||++.+.. . ..++.+|+++++.+.+|||||+++++|.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--H---PIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--C---HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--C---HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 45688999999999999999999987544468899999986532 1 245789999999997799999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+++|||||||+||+|.+++ +.+++.+++.++.||+.||.|||++||+||||||+|||++ .+.+.+||+|||+|+
T Consensus 93 ~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQ 166 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCE
T ss_pred CEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCc
Confidence 9999999999999999987 3599999999999999999999999999999999999994 334789999999997
Q ss_pred ccCCCC-----------------------------cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCC
Q 012825 312 FVRPDE-----------------------------RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRP 360 (455)
Q Consensus 312 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~P 360 (455)
...... .....+||+.|||||++.+ .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 653221 1234589999999999864 489999999999999999999999
Q ss_pred CCCCC-hhHHHHHHHhcC--------------------------------------------------CCCCCCCCCCCC
Q 012825 361 FWART-ESGIFRAVLKAD--------------------------------------------------PSFDEAPWPSLS 389 (455)
Q Consensus 361 f~~~~-~~~~~~~i~~~~--------------------------------------------------~~~~~~~~~~~s 389 (455)
|.... +.+.+..+.... .......+..++
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 96544 333333332100 001112345789
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+++.|||++||++||++|+|+.|+|+||||++.+
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999999999753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-56 Score=432.43 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=210.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.+++++.++||+|+||.||+|++. ..||||+++... .+.+..+.|.+|++++++|+ |||||++++++.+ +.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~------~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH------GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS------SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC------CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-Ce
Confidence 468899999999999999999743 359999986543 45666788999999999998 9999999998854 56
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|||||||+||+|.+++......+++..+..|+.||+.||.|||+++||||||||+|||| ++++.+||+|||+|+..
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVK 182 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC-
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceec
Confidence 899999999999999998877889999999999999999999999999999999999999 78899999999999876
Q ss_pred CCC---CcccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC--CCC
Q 012825 314 RPD---ERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--EAP 384 (455)
Q Consensus 314 ~~~---~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~ 384 (455)
... ......+||+.|||||++. +.|+.++|||||||+||||+||+.||.+......+..+.......+ ...
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 432 2345678999999999984 3489999999999999999999999988776665555554432222 233
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+..+++++.+||.+||+.||++|||+.|++++
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 45789999999999999999999999987543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=432.37 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=219.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|.+.++||+|+||.||+|++... ..+++.||||++.. ......++|.+|++++++|+ |||||+++|+|.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~---~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS---CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC---CChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeC
Confidence 46899999999999999999987642 23588999999964 34566788999999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCC
Q 012825 232 DNVYVVMELCEGGELLDRILSR------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~------------~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~ 299 (455)
+.+|||||||++|+|.+++... ...+++.++..|+.||+.||.|||+++||||||||+|||| +.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCC
Confidence 9999999999999999999753 2479999999999999999999999999999999999999 788
Q ss_pred ceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 012825 300 SVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVL 374 (455)
Q Consensus 300 ~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~ 374 (455)
+.+||+|||+|+....... .....||+.|||||++. +.|+.++|||||||+||||+| |+.||.+.+..+.+..+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999987644332 23456999999999986 679999999999999999998 899999999888888887
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 375 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
...... ....+++++.+||.+||+.||++|||+.++ ++||+.
T Consensus 245 ~~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 245 QGRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred cCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 765322 224689999999999999999999999999 456653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-56 Score=468.91 Aligned_cols=264 Identities=34% Similarity=0.636 Sum_probs=241.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++++.||+|+||.||+|+.+. +|+.||||++... .....+.+.+|+++|+.|+ |||||+++++|.+++
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~---tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN 227 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSS
T ss_pred CccccEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEecc---chhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence 45789999999999999999999876 6899999999653 3445577899999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+|||||||+||+|.+++..+.+.+++.+++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++.
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEE
T ss_pred EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeE
Confidence 999999999999999998777788999999999999999999999999999999999999953 2347899999999999
Q ss_pred cCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
+.........+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+.+..+.+..+......+....+..++++
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 887777778899999999999874 6899999999999999999999999999999999999988888877777889999
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
+++||++||+.||++|||+.|+|+||||+..+.
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 999999999999999999999999999997654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=435.11 Aligned_cols=255 Identities=31% Similarity=0.501 Sum_probs=199.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC-
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~- 232 (455)
.++|++++.||+|+||.||+|+.+. +|+.||||++... ......+.+.+|++++++|+ |||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~--~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKV---DDCNYAIKRIRLP--NRELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETT---TCCEEEEEEEEEC--SSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-
T ss_pred chhCEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEecc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCc
Confidence 3579999999999999999999776 6899999999654 34555678999999999998 999999999997654
Q ss_pred -----------ceEEEEeecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCC
Q 012825 233 -----------NVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (455)
Q Consensus 233 -----------~~~lV~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~ 299 (455)
.+|||||||+||+|.+++..+.. ...+..++.|+.||+.||+|||++|||||||||+|||| +.+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~ 154 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMD 154 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTT
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCC
Confidence 37999999999999998865432 35667789999999999999999999999999999999 778
Q ss_pred ceEEEeecccccccCCCCc-------------ccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 012825 300 SVLKAIDFGLSDFVRPDER-------------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART 365 (455)
Q Consensus 300 ~~vkL~DfG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~ 365 (455)
+.+||+|||+|+....... ....+||+.|||||++.+ .|+.++|||||||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 8999999999987654321 234589999999999874 69999999999999999996 786433
Q ss_pred hhH-HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 366 ESG-IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 366 ~~~-~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+.. .+..+... .++. .+...++.+.+||++||+.||++|||+.|+|+||||++..
T Consensus 232 ~~~~~~~~~~~~--~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 232 ERVRTLTDVRNL--KFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHHHHHTT--CCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHHHHHhcC--CCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 221 22222221 1111 1123567788999999999999999999999999999763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-56 Score=431.12 Aligned_cols=255 Identities=20% Similarity=0.301 Sum_probs=217.5
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
-.+++++.++||+|+||.||+|++.. ...+++.||||++... ......++|.+|+.++++|+ |||||+++|+|.+
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~--~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTK 100 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC---CCC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc--cChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEE
Confidence 35678999999999999999998753 2235789999999654 23344578999999999998 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEee
Q 012825 231 TDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~ 295 (455)
++.++||||||++|+|.+++..+. ..+++.++..|+.||+.||.|||+++||||||||+||||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl-- 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV-- 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE--
Confidence 999999999999999999996532 468999999999999999999999999999999999999
Q ss_pred cCCCceEEEeecccccccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 012825 296 KDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIF 370 (455)
Q Consensus 296 ~~~~~~vkL~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~ 370 (455)
++++.+||+|||+++...... .....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+.+..+.+
T Consensus 179 -~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 179 -YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp -CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred -CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 788999999999998764332 234568999999999876 679999999999999999998 89999999988888
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 371 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..+....... ....++.++.+|+.+||+.||++|||+.||+++
T Consensus 258 ~~i~~~~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 258 EMIRNRQVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7776654321 234789999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=434.29 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=212.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|.+.++||+|+||.||+|++.. ...+++.||||++.. .+....++|.+|++++++|+ |||||+++|+|.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~---~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEG 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC---CSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc---CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 4689999999999999999998763 223588999999964 35566788999999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC
Q 012825 232 DNVYVVMELCEGGELLDRILSRG--------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~ 297 (455)
+.+|||||||++|+|.+++.... +.+++.++..|+.||+.||.|||+++||||||||+|||| +
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---G 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---E
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---C
Confidence 99999999999999999986532 469999999999999999999999999999999999999 7
Q ss_pred CCceEEEeecccccccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 012825 298 ENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRA 372 (455)
Q Consensus 298 ~~~~vkL~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~ 372 (455)
+++.+||+|||+++...... .....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+....+.+..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 88999999999998764333 224567999999999987 569999999999999999998 8999999988888887
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+....... ....+++++.+||.+||+.||++|||+.||+++
T Consensus 273 i~~g~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGRELE---RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCCCC---CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCCCC---CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 77654221 224689999999999999999999999999764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=462.81 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=217.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHH---HHHHHHhcCCCCeeEEeEEEee
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRRE---VKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E---i~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
-++|++++.||+|+||.||+|+.+. +|+.||||++.+...........+.+| +.+++.+. |||||+++++|.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~---tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHT 263 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEEC
T ss_pred hHHeEEEEEEecccCeEEEEEEECC---CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEEEEE
Confidence 4789999999999999999999876 699999999965432211222233344 55555555 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
.+.+|||||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++|||||||||+|||| +.++++||+|||+|
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA 339 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLA 339 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEeccccee
Confidence 9999999999999999998865 4679999999999999999999999999999999999999 88999999999999
Q ss_pred cccCCCCcccccccCCCcccccccC-C-CCCCcchHHHHHHHHHHHHcCCCCCCCC---ChhHHHHHHHhcCCCCCCCCC
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~sDiwSlG~~l~elltg~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~ 385 (455)
+.... ......+||+.|||||++. + .|+.++|||||||+||||++|+.||.+. ........+......++
T Consensus 340 ~~~~~-~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p---- 414 (689)
T 3v5w_A 340 CDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---- 414 (689)
T ss_dssp EECSS-CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----
T ss_pred eecCC-CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----
Confidence 87753 3445679999999999985 3 5999999999999999999999999753 23345556666555444
Q ss_pred CCCCHHHHHHHHHhccCCccCCCC-----HHHHHcCcccCCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps-----~~elL~hp~~~~~~ 423 (455)
..+++++++||.+||+.||.+|++ +.||++||||++.+
T Consensus 415 ~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 368999999999999999999998 79999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=428.21 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=216.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCc--ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.++||+|+||.||+|++.... ..++.||||++... ......+.+.+|++++.++.+|||||+++|+|.+.
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~--~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 578999999999999999999987532 34678999999754 34455678999999999998679999999999764
Q ss_pred -CceEEEEeecCCCcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEee
Q 012825 232 -DNVYVVMELCEGGELLDRILSR---------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295 (455)
Q Consensus 232 -~~~~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~ 295 (455)
+.+|||||||++|+|.+++... ...+++..+..|+.||+.||.|||+++||||||||+|||+
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl-- 218 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 218 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee--
Confidence 5689999999999999999753 2358999999999999999999999999999999999999
Q ss_pred cCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 012825 296 KDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIF 370 (455)
Q Consensus 296 ~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~ 370 (455)
++++.+||+|||+|+....+.. ....+||+.|||||++. +.|+.++|||||||+||||+| |+.||.+......+
T Consensus 219 -~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 219 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp -CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred -CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 7888999999999987654432 24567999999999886 679999999999999999998 99999887655555
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 371 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
...+........ ...+++++.+||.+||+.||++|||+.||++|
T Consensus 298 ~~~i~~g~~~~~--p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 298 CRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCC--CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 554444332221 23689999999999999999999999999987
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=417.86 Aligned_cols=297 Identities=34% Similarity=0.649 Sum_probs=256.0
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
..+.++|++.+.||+|+||.||+|.... +|+.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~ 99 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQE 99 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEe
Confidence 3456889999999999999999998765 589999999976543 4455678999999999998 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
++..|+||||++|++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 100 ESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp SSEEEEEECCCCSCBHHHHHT-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CCEEEEEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 999999999999999998875 4467999999999999999999999999999999999999965555677999999999
Q ss_pred cccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
.............||+.|+|||++.+ .++.++|||||||++|+|++|..||........+..+......+....+..++
T Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (362)
T 2bdw_A 179 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258 (362)
T ss_dssp BCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSC
T ss_pred eEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 88776666667789999999999875 69999999999999999999999999998888888888887777666667899
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC-CCCchhHHHHHHHHHHHhccHHHHHHHhh
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND-VKVPLDVIIFKLMKAYMRSSSLRKAALRV 453 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~-~~~p~~~~~~~~~~~~~~~~~l~~~~~~~ 453 (455)
.++.+||.+||+.||++||++.++|+||||+.... ..........+.++.+..+..++++++.+
T Consensus 259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 323 (362)
T 2bdw_A 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTT 323 (362)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999986421 11122334567777777778888877754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=425.91 Aligned_cols=296 Identities=34% Similarity=0.639 Sum_probs=253.6
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|.... +|+.||+|++.... ......+.+.+|+.+++.++ ||||+++++++.++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~---~~~~~a~K~i~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKK-LSARDHQKLEREARICRLLK-HPNIVRLHDSISEE 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETT---TTEEEEEEEEESCS-CHHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECC---CCcEEEEEEEEccc-CCHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEEC
Confidence 467899999999999999999998766 68999999997654 23445677899999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..|+|||||+||+|.+.+... +.+++..+..++.||+.||.|||++||+||||||+|||++....++.+||+|||++.
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred CEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999999999988654 579999999999999999999999999999999999999755567899999999998
Q ss_pred ccCCCC-cccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FVRPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........+..+......+....+..++
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 241 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCC
Confidence 765433 3356789999999999875 69999999999999999999999999999999999999888888777788899
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC-CCCchhHHHHHHHHHHHhccHHHHHHHhh
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND-VKVPLDVIIFKLMKAYMRSSSLRKAALRV 453 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~-~~~p~~~~~~~~~~~~~~~~~l~~~~~~~ 453 (455)
+++.+||.+||+.||++|||+.|+|+||||+.... ..........+.++.+..+..|+++++.+
T Consensus 242 ~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~ 306 (444)
T 3soa_A 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTV 306 (444)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCE
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999985421 11122345567777777777777776654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=406.25 Aligned_cols=290 Identities=38% Similarity=0.663 Sum_probs=232.1
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|+... +++.||||++.... ..+.+.+|+.+++++. |+||+++++++.+.
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKG---TQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETP 120 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEECS
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECC---CCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEecC
Confidence 456889999999999999999999776 57899999986432 2356789999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..++||||+++++|.+++. ..+.+++..++.++.||+.||.|||+.||+||||||+|||++..+.++.+||+|||+++
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIV-EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHT-TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred CeEEEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 99999999999999999874 44679999999999999999999999999999999999999654558899999999998
Q ss_pred ccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhH-HHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s 389 (455)
............||+.|+|||++.+ .++.++|||||||++|+|++|..||....... .+..+......+....+..++
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 200 IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred ccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 7765555566789999999999874 68999999999999999999999997766554 566666666655555667899
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHHHHHHHHHHhccHHHHHHHh
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~~~~~~~~~~~~~l~~~~~~ 452 (455)
.++.+||++||+.||++|||+.|+|+||||+......+.++ ..++.++++..+..++++.-.
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 341 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMD-TAQKKLQEFNARRKLKAAVKA 341 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCSCCH-HHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchhhhc-chHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999876666554 556677788888888877543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=431.51 Aligned_cols=299 Identities=37% Similarity=0.668 Sum_probs=263.5
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
..+.++|++.+.||+|+||.||+|+... +|+.||||++.+.........+.+.+|+.+++++. ||||+++++++.+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 97 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFED 97 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECC---CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence 3467899999999999999999999775 68999999997655444445577899999999997 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
.+..|+||||+.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred CCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999999999998854 467999999999999999999999999999999999999976567789999999999
Q ss_pred cccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
............+||+.|+|||++.+.++.++|||||||++|+|++|..||......+.+..+......+....|..++.
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 177 THFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp HHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred EEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 88776666667789999999999988999999999999999999999999999999999999988877777666778999
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC----CCCchhHHHHHHHHHHHhccHHHHHHHhhh
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND----VKVPLDVIIFKLMKAYMRSSSLRKAALRVS 454 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~----~~~p~~~~~~~~~~~~~~~~~l~~~~~~~~ 454 (455)
++.+||++||+.||.+|||+.|+|+||||+.... ...|........++++.....|+++++..+
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i 324 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYM 324 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHH
Confidence 9999999999999999999999999999987543 244555666777788888888888887653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=402.66 Aligned_cols=258 Identities=34% Similarity=0.635 Sum_probs=231.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|++.. +|+.||||++.+.. ......+.+.+|+++++.++ ||||+++++++.+.+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHIL---TGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence 45789999999999999999999765 58999999997643 34556678899999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNE 163 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGG
T ss_pred EEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCcee
Confidence 999999999999999988654 569999999999999999999999999999999999999 7888999999999988
Q ss_pred cCCCCcccccccCCCcccccccCC-CC-CCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
..........+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+.........+.......+. .++.
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 239 (328)
T 3fe3_A 164 FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMST 239 (328)
T ss_dssp GSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCH
T ss_pred cCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCH
Confidence 776666777899999999999864 44 47899999999999999999999999988888888887655443 5789
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
++.+||++||+.||.+|||+.|+|+||||+...
T Consensus 240 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999999999999998653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=411.38 Aligned_cols=267 Identities=37% Similarity=0.664 Sum_probs=234.6
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCH---HHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
.+.++|++.+.||+|+||.||+|+.+. +|+.||+|++.+...... ...+.+.+|+.+++++. ||||+++++++
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~ 84 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVY 84 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECC---CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEE
Confidence 467889999999999999999999776 689999999976543221 13467889999999998 99999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCC-CceEEEeec
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDF 307 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~-~~~vkL~Df 307 (455)
.+.+.+|+||||++|++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+...+. ...+||+||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHT-TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EeCCEEEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999999999874 4567999999999999999999999999999999999999942211 127999999
Q ss_pred ccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
|++............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+.+..+......+....+.
T Consensus 164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp SSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred CCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 9998877666667788999999999987 469999999999999999999999999999998888888877766655566
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.++.++.+||++||..||++|||+.|+|+||||+...
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 8999999999999999999999999999999999653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-52 Score=406.52 Aligned_cols=262 Identities=30% Similarity=0.590 Sum_probs=235.4
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|.... +++.||+|++... ......+.+|+.+++.+. ||||+++++++.+.
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESM 73 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEET
T ss_pred chhhceEeeeEEecCCCeEEEEEEECC---CCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecC
Confidence 457899999999999999999999776 6899999998643 234467889999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+.+++||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.. .++.+||+|||++.
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQAR 152 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCe
Confidence 99999999999999999887666689999999999999999999999999999999999999421 26889999999999
Q ss_pred ccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
............||+.|+|||++.+ .++.++|||||||++|+|++|..||........+..+......+....++.++.
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence 8876666667789999999999875 478999999999999999999999999999999999988887776666678999
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 99999999999999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=410.72 Aligned_cols=259 Identities=30% Similarity=0.550 Sum_probs=224.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|..++..+.+||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcC---CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 5789999999999999999999776 5899999999654323333456688999999998679999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+||||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCS
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeec
Confidence 99999999999999988554 679999999999999999999999999999999999999 78899999999999864
Q ss_pred CC-CCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RP-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
.. .......+||+.|+|||++. ..++.++|||||||++|||++|+.||...+..+.+..+......++. .++.+
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~ 250 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHED 250 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHH
Confidence 32 33445678999999999987 46999999999999999999999999999999999999887766553 58899
Q ss_pred HHHHHHHhccCCccCCCCH------HHHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTA------AQALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~------~elL~hp~~~~~~ 423 (455)
+.+||++||+.||.+||++ .++++||||++.+
T Consensus 251 ~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp HHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred HHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 9999999999999999999 8999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=427.58 Aligned_cols=297 Identities=37% Similarity=0.692 Sum_probs=256.4
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|+... +++.||||++.+..... .....+.+|+++++++. ||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKN-KDTSTILREVELLKKLD-HPNIMKLFEILEDS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETT---TCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECC---CCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcC
Confidence 467899999999999999999999765 58999999985432111 12467889999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+.+|+|||||.+++|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999999999988654 579999999999999999999999999999999999999766667789999999998
Q ss_pred ccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
...........+||+.|+|||++.+.++.++|||||||++|+|++|..||.+....+.+..+......+....|..++.+
T Consensus 173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp TBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred ECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 87766666677899999999999989999999999999999999999999999999999988888777776667789999
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCC-----CchhHHHHHHHHHHHhccHHHHHHHhhh
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK-----VPLDVIIFKLMKAYMRSSSLRKAALRVS 454 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~-----~p~~~~~~~~~~~~~~~~~l~~~~~~~~ 454 (455)
+.+||++||+.||.+|||+.++|+||||+...... ++........++++.....+++++|..+
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i 320 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYM 320 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999765432 3344556667778888888998887653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-52 Score=430.26 Aligned_cols=297 Identities=38% Similarity=0.691 Sum_probs=255.2
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++++.||+|+||.||+|+... ++..||||++.+.... ......+.+|+.+++.+. ||||++++++|.+.
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 108 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKV---THVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDK 108 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETT---TCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECC---CCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence 456789999999999999999999776 5889999999764322 222466889999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..|+|||||++|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999999999988654 569999999999999999999999999999999999999765567789999999998
Q ss_pred ccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
...........+||+.|+|||++.+.++.++|||||||++|+|++|..||......+.+..+......+....|..++..
T Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 188 VFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp ECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred ECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 87766666778899999999999988999999999999999999999999999999999999888877777777889999
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCC-----CCCCchhHHHHHHHHHHHhccHHHHHHHhhh
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN-----DVKVPLDVIIFKLMKAYMRSSSLRKAALRVS 454 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~-----~~~~p~~~~~~~~~~~~~~~~~l~~~~~~~~ 454 (455)
+.+||++||+.||.+|||+.++|+||||+... ...+|....+.+.++.+.....++++++..+
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~i 335 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYM 335 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHH
Confidence 99999999999999999999999999998642 2345556667777888888888998887653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=403.13 Aligned_cols=258 Identities=29% Similarity=0.543 Sum_probs=226.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++++.||+|+||.||+|+.+. +|+.||||++.+...........+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~ 79 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDR 79 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCE
Confidence 4689999999999999999999765 68999999986532212223456889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 80 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCS
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhc
Confidence 9999999999999988754 4579999999999999999999999999999999999999 78889999999999864
Q ss_pred C-CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 R-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
. ........+||+.|+|||++. ..++.++|||||||++|||++|+.||........+..+......++. .++.+
T Consensus 156 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 231 (337)
T 1o6l_A 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPE 231 (337)
T ss_dssp CCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHH
Confidence 3 334456778999999999987 46899999999999999999999999998888888888877655443 68999
Q ss_pred HHHHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
+.+||.+||+.||++|| ++.++++||||+..+
T Consensus 232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 99999999999999999 999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-52 Score=411.68 Aligned_cols=296 Identities=32% Similarity=0.612 Sum_probs=235.1
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc--CCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
.+.++|++.+.||+|+||.||+|+... +|+.||||++..... ......+.+.+|+.+++.++ ||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 96 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYS 96 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence 346789999999999999999998776 589999999853211 11112467889999999998 999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 230 DTDNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
+++.+|+|||||+|++|.+.+... +..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEec
Confidence 999999999999999998877643 34689999999999999999999999999999999999996555556799999
Q ss_pred cccccccCCCCc-ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 012825 307 FGLSDFVRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (455)
Q Consensus 307 fG~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (455)
||++........ ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||... ....+..+...........
T Consensus 177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~ 255 (351)
T 3c0i_A 177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQ 255 (351)
T ss_dssp CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHH
T ss_pred CcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccc
Confidence 999987754433 34568999999999987 46899999999999999999999999874 4455666666655554444
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC--CCCchhHHHHHHHHHHHhccHHHHHHHhh
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND--VKVPLDVIIFKLMKAYMRSSSLRKAALRV 453 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~--~~~p~~~~~~~~~~~~~~~~~l~~~~~~~ 453 (455)
+..++.++.+||++||+.||++|||+.++|+||||+.... ....+ ....+.++.+..+..++++++.+
T Consensus 256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~ 325 (351)
T 3c0i_A 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHL-PETVEQLRKFNARRKLKGAVLAA 325 (351)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCC-HHHHHHHHHHHHHHC--------
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccc-hHHHHHHHHHHHHHHHHHHHHHH
Confidence 5678999999999999999999999999999999987431 11222 23345566666666677666654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=395.43 Aligned_cols=266 Identities=29% Similarity=0.473 Sum_probs=221.8
Q ss_pred cccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 149 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
..+.+.++|++++.||+|+||.||+|++.. |+.||||++.... ......+.+.+|++++++++ ||||+++++++
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 88 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQ----GRIVALKRIRLDA-EDEGIPSTAIREISLLKELH-HPNIVSLIDVI 88 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEETT----SCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEECC----CCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcC-CCCEeeeeeEE
Confidence 356678999999999999999999998743 7899999986543 23334467889999999998 99999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
.+++..++||||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg 164 (311)
T 3niz_A 89 HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFG 164 (311)
T ss_dssp CCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred ccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCc
Confidence 999999999999975 8888887777789999999999999999999999999999999999999 778899999999
Q ss_pred cccccCCC-CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCC--
Q 012825 309 LSDFVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA-- 383 (455)
Q Consensus 309 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-- 383 (455)
++...... .......||..|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+..........
T Consensus 165 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 165 LARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp TCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred CceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 99876533 33455678999999998864 58999999999999999999999998877777666665422111110
Q ss_pred ------------------------CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 384 ------------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 384 ------------------------~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
..+.+++++.+||++||++||++|||+.|+|+||||++.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 12357889999999999999999999999999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=423.06 Aligned_cols=298 Identities=38% Similarity=0.638 Sum_probs=251.0
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCH----------HHHHHHHHHHHHHHHhcCCCC
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA----------IAIEDVRREVKILRALTGHNN 220 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~----------~~~~~~~~Ei~~l~~l~~hp~ 220 (455)
..+.++|+++++||+|+||.||+|+... +++.||||++.+...... ...+.+.+|+.+++++. |||
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn 107 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKN---GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPN 107 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTT
T ss_pred CCcccceEEEeEecccCCeEEEEEEECC---CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCC
Confidence 3467899999999999999999999776 588999999976432211 23467889999999998 999
Q ss_pred eeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCc
Q 012825 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (455)
Q Consensus 221 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~ 300 (455)
|+++++++.+.+..|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++..+...
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999999999988654 5699999999999999999999999999999999999996444445
Q ss_pred eEEEeecccccccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC
Q 012825 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380 (455)
Q Consensus 301 ~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 380 (455)
.+||+|||++.............||+.|+|||++.+.++.++|||||||++|+|++|..||.+....+.+..+......+
T Consensus 187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 79999999999887666667788999999999999889999999999999999999999999999999999988887766
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCc----hhHHHHHHHHHHHhccHHHHHHHhh
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP----LDVIIFKLMKAYMRSSSLRKAALRV 453 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p----~~~~~~~~~~~~~~~~~l~~~~~~~ 453 (455)
....|..++.++.+||++||+.||.+|||+.|+|+||||+......-. ........++.+..+..|+++++..
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~ 343 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILF 343 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHH
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 655567899999999999999999999999999999999976543222 2233444555555667788877654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=410.48 Aligned_cols=260 Identities=33% Similarity=0.640 Sum_probs=213.2
Q ss_pred cCCCeEEe-ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-
Q 012825 153 FANKYELG-EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (455)
Q Consensus 153 ~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~- 230 (455)
+.++|.+. +.||+|+||.||+|++.. +|+.||||++... ..+.+|+.++.++.+|+||++++++|..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~---~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECC---CCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 35678776 789999999999999766 6899999998532 3567899988777669999999999875
Q ss_pred ---CCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 231 ---TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 231 ---~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
.+.+|||||||+||+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++..+.++.+||+|
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 567999999999999999987653 4699999999999999999999999999999999999996444478999999
Q ss_pred cccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh----HHHHHHHhcCCCCC
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES----GIFRAVLKADPSFD 381 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~----~~~~~i~~~~~~~~ 381 (455)
||+++...........+||+.|+|||++. +.++.++|||||||++|+|++|+.||...... .....+......+.
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp CTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred cccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence 99998776555566778999999999986 56999999999999999999999999765432 24455566665666
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 382 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
...+..++.++.+||++||+.||++|||+.|+|+||||+...
T Consensus 288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 556678999999999999999999999999999999998653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=408.46 Aligned_cols=259 Identities=28% Similarity=0.533 Sum_probs=223.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++++.||+|+||.||+|+.+. +++.||||++.+.........+.+.+|..++.++.+||||+++++++.+.+.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 4789999999999999999999876 5899999999876555555666788999999998669999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+||||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 128 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred EEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeec
Confidence 9999999999999988754 4679999999999999999999999999999999999999 78899999999999863
Q ss_pred -CCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCC---------ChhHHHHHHHhcCCCCCC
Q 012825 314 -RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR---------TESGIFRAVLKADPSFDE 382 (455)
Q Consensus 314 -~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~ 382 (455)
.........+||+.|+|||++. ..++.++|||||||++|||++|+.||... ........+......++.
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 3344566789999999999987 46899999999999999999999999532 233355666666555443
Q ss_pred CCCCCCCHHHHHHHHHhccCCccCCCCH------HHHHcCcccCCCC
Q 012825 383 APWPSLSSEARDFVKRLLNKDPRKRLTA------AQALSHPWIKNSN 423 (455)
Q Consensus 383 ~~~~~~s~~l~~li~~~L~~dP~~Rps~------~elL~hp~~~~~~ 423 (455)
.++.++.+||++||+.||++|+++ .|+++||||+..+
T Consensus 284 ----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 284 ----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp ----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred ----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 589999999999999999999985 7999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=398.15 Aligned_cols=267 Identities=37% Similarity=0.679 Sum_probs=232.2
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC---HHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
.+.++|++.+.||+|+||.||+|+... +|+.||||++....... ....+.+.+|+.++++++ ||||+++++++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 83 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVY 83 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred CcccceEeceEEeeCCCeEEEEEEECC---CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence 456789999999999999999999776 58999999997543221 113467889999999998 99999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC-CCceEEEeec
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDF 307 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~-~~~~vkL~Df 307 (455)
.+.+..++||||+++++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+...+ ....+||+||
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHT-TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EeCCEEEEEEEcCCCCCHHHHHH-hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999999999874 456799999999999999999999999999999999999994221 1227999999
Q ss_pred ccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
|++.............||+.|+|||++. ..++.++|||||||++|+|++|..||......+.+..+......+....+.
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 9998876666666778999999999987 568999999999999999999999999988888888887776666555556
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.++..+.+||++||+.||++|||+.++|+||||+...
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 7899999999999999999999999999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=384.38 Aligned_cols=267 Identities=36% Similarity=0.717 Sum_probs=238.4
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|.+.. +|+.||+|++.... ......+.+.+|+.++++++ |+||+++++++.++
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKK-LSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGG-CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcC---CCceEEEEEeeccc-CCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcC
Confidence 467899999999999999999998776 58899999986543 34555678899999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..++||||+++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||++.
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 9999999999999999887654 569999999999999999999999999999999999999655555679999999998
Q ss_pred ccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
............||..|+|||++.+ .++.++||||||+++|+|++|+.||...........+...........+..+++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 8776666667789999999999874 589999999999999999999999999998888888888777776666678999
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
++.+||.+||+.||++|||+.|+|+||||+...+
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 9999999999999999999999999999998654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=397.10 Aligned_cols=259 Identities=28% Similarity=0.526 Sum_probs=225.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+.+. +++.||||++.+.........+.+.+|+.++.++.+||||+++++++.+.+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 4789999999999999999999776 5899999999876666777778899999999998569999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCS
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccc
Confidence 9999999999999998854 3579999999999999999999999999999999999999 78889999999999864
Q ss_pred C-CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCC---------CChhHHHHHHHhcCCCCCC
Q 012825 314 R-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWA---------RTESGIFRAVLKADPSFDE 382 (455)
Q Consensus 314 ~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~---------~~~~~~~~~i~~~~~~~~~ 382 (455)
. ........+||+.|+|||++. ..++.++|||||||++|||++|+.||.. .........+......++
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p- 239 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP- 239 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC-
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC-
Confidence 3 334456678999999999987 4689999999999999999999999965 233345555666554443
Q ss_pred CCCCCCCHHHHHHHHHhccCCccCCCCH------HHHHcCcccCCCC
Q 012825 383 APWPSLSSEARDFVKRLLNKDPRKRLTA------AQALSHPWIKNSN 423 (455)
Q Consensus 383 ~~~~~~s~~l~~li~~~L~~dP~~Rps~------~elL~hp~~~~~~ 423 (455)
..++.++.+||++||+.||.+||++ .++++||||+...
T Consensus 240 ---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 240 ---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp ---TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred ---CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 3689999999999999999999995 8999999999754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=401.43 Aligned_cols=259 Identities=31% Similarity=0.538 Sum_probs=227.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|..++..+.+||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 5789999999999999999999876 6899999998653221122345678899999988559999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhc
Confidence 9999999999999998854 3579999999999999999999999999999999999999 78889999999999864
Q ss_pred CC-CCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RP-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
.. .......+||+.|+|||++. ..++.++|||||||++|||++|+.||...+....+..+......++. .++.+
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 244 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKE 244 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHH
Confidence 32 33456678999999999987 46899999999999999999999999999988888888877655543 58999
Q ss_pred HHHHHHHhccCCccCCCCHH-HHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAA-QALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~-elL~hp~~~~~~ 423 (455)
+.+||++||+.||++||++. ++++||||+..+
T Consensus 245 ~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 99999999999999999998 999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=403.60 Aligned_cols=263 Identities=36% Similarity=0.617 Sum_probs=234.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+.++|++.+.||+|+||.||+|.... +|+.||+|++... .......+.+|+.++++++ |+||+++++++.+.+
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTP---YPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKY 121 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSS
T ss_pred cccceEEEEEEecCCCEEEEEEEECC---CCCEEEEEEeccc---chhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCC
Confidence 45789999999999999999998776 5889999998643 3344567899999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||++|++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||++..
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEeccccee
Confidence 999999999999999988766668999999999999999999999999999999999999942 1356799999999988
Q ss_pred cCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
...........||+.|+|||++. ..++.++|||||||++|+|++|..||........+..+......+....+..++.+
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 77665566678999999999987 46899999999999999999999999998888888888887777776667789999
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+.+||.+||+.||++|||+.|+|+||||+...
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 99999999999999999999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=391.92 Aligned_cols=260 Identities=26% Similarity=0.337 Sum_probs=216.4
Q ss_pred cccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 149 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
.++.+.++|++.++||+|+||.||+|++.. +|+.||||++.... ...........|+..+.++..|+||++++++|
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKE---DGRLYAVKRSMSPF-RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETT---TSCEEEEEEESSSC-CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECC---CCeEEEEEEecccc-cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 345567899999999999999999999776 58999999986543 34444556667777777775699999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
.+++..++||||+ +++|.+++...+..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG 202 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFG 202 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCT
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccce
Confidence 9999999999999 679999988888889999999999999999999999999999999999999 778899999999
Q ss_pred cccccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 309 LSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
++.............||+.|+|||++.+.++.++|||||||++|||++|..++..... ...+.... ........+
T Consensus 203 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~--~~~~~~~~~ 277 (311)
T 3p1a_A 203 LLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGY--LPPEFTAGL 277 (311)
T ss_dssp TCEECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTC--CCHHHHTTS
T ss_pred eeeecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccC--CCcccccCC
Confidence 9988765555566779999999999998999999999999999999999877754322 22222211 111122468
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
+.++.+||.+||++||++|||+.|+|+||||+.
T Consensus 278 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 278 SSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 899999999999999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=416.04 Aligned_cols=266 Identities=26% Similarity=0.459 Sum_probs=227.8
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.++||+|+||.||+|+.+. +++.||||++.+...........+.+|+.++..+. |+||++++++|.++
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDD 146 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECS
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcC---CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeC
Confidence 346899999999999999999999876 58999999985422111112234788999999997 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+.+|||||||+||+|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCL 223 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhh
Confidence 99999999999999999997767889999999999999999999999999999999999999 788999999999997
Q ss_pred ccCCCCc--ccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcC--CCCC
Q 012825 312 FVRPDER--LNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PSFD 381 (455)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~ 381 (455)
....... ....+||+.|+|||++. +.++.++|||||||++|||++|+.||......+.+..++... ..++
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence 7654433 23468999999999874 458999999999999999999999999999888888887543 2222
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccC--CCCHHHHHcCcccCCCCCC
Q 012825 382 EAPWPSLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 382 ~~~~~~~s~~l~~li~~~L~~dP~~--Rps~~elL~hp~~~~~~~~ 425 (455)
. .+..+++++.+||++||+.+|++ |+++.|+++||||++.++.
T Consensus 304 ~-~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 304 T-QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp S-SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred c-ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 2 22468999999999999999998 9999999999999987543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=385.24 Aligned_cols=260 Identities=30% Similarity=0.502 Sum_probs=219.0
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|+... +|+.||||++.... ......+.+.+|+.++++++ |+||+++++++.+++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDD-DDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC---CCceEEEEeeeccC-CcCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEE
Confidence 589999999999999999999776 58999999997654 33344567889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++ ++.+.+....+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecC
Confidence 999999965 7788787777889999999999999999999999999999999999999 788899999999998764
Q ss_pred CC-CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCC-CCCChhHHHHHHHhcCCCCCC--------
Q 012825 315 PD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPF-WARTESGIFRAVLKADPSFDE-------- 382 (455)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf-~~~~~~~~~~~i~~~~~~~~~-------- 382 (455)
.. .......||..|+|||++.+ .++.++|||||||++|+|++|..|| ......+.+..+.+.......
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 33 33455688999999998864 3899999999999999999988885 555555555555543211111
Q ss_pred -----------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 383 -----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 383 -----------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
...+.++.++.+||++||+.||++|||+.|+|+||||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 11235789999999999999999999999999999999753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=395.21 Aligned_cols=256 Identities=27% Similarity=0.586 Sum_probs=225.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+... +|+.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~ 80 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQ 80 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCE
Confidence 4689999999999999999999765 58999999986432222223456789999999997 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 81 ~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYV 156 (318)
T ss_dssp EEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEEC
T ss_pred EEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceec
Confidence 9999999999999998754 5679999999999999999999999999999999999999 78899999999999876
Q ss_pred CCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
.. .....+||+.|+|||++. ..++.++|||||||++|||++|+.||........+..++.....++ ..++.++
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~ 230 (318)
T 1fot_A 157 PD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDV 230 (318)
T ss_dssp SS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred CC--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHH
Confidence 42 344568999999999887 4689999999999999999999999999988888888888765544 3689999
Q ss_pred HHHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 393 RDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
.+||++||+.||++|+ ++.++++||||++..
T Consensus 231 ~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp HHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 9999999999999999 999999999999764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=394.67 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=190.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC-
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~- 232 (455)
.++|.+.++||+|+||.||+|++ +|+.||||++... .......+.|+..+.+++ |||||++++++.+++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-----~g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR----EERSWFREAEIYQTVMLR-HENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-----TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECcc----chhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCC
Confidence 46799999999999999999975 3789999998542 122223445666677787 999999999998664
Q ss_pred ---ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCEEeeccCCceEEeecCCCce
Q 012825 233 ---NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ--------GVVHRDLKPENFLFTTKDENSV 301 (455)
Q Consensus 233 ---~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~--------~ivHrDikp~NILl~~~~~~~~ 301 (455)
.+|||||||++|+|.+++.. ..+++..+.+++.|++.||.|||++ +||||||||+|||| +.+++
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~ 146 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT 146 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSC
T ss_pred CceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCC
Confidence 58999999999999999865 4589999999999999999999987 89999999999999 88899
Q ss_pred EEEeecccccccCCCCc-----ccccccCCCcccccccCCC-------CCCcchHHHHHHHHHHHHcCCCCCCCCC----
Q 012825 302 LKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHRS-------YSTEADVWSIGVIAYILLCGSRPFWART---- 365 (455)
Q Consensus 302 vkL~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~sDiwSlG~~l~elltg~~Pf~~~~---- 365 (455)
+||+|||+++....... ....+||+.|||||++.+. ++.++|||||||+||||+||..||....
T Consensus 147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~ 226 (303)
T 3hmm_A 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence 99999999987654332 2346899999999998643 5678999999999999999976653211
Q ss_pred ----------hhHHHHHHH-hcCC--CCCCCC-CCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 366 ----------ESGIFRAVL-KADP--SFDEAP-WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 366 ----------~~~~~~~i~-~~~~--~~~~~~-~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
....+.... .... ..+... .......+.+|+.+||+.||++|||+.|+++.
T Consensus 227 p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 112222222 2211 111110 01233578899999999999999999999753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=388.21 Aligned_cols=263 Identities=37% Similarity=0.711 Sum_probs=223.1
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|+... ++..||+|++...... ...+.+.+|++++++++ ||||+++++++.+.
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDY 92 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred ChhhheeecceeccCCCeEEEEEEEcc---CCceEEEEEeeccccc--hhHHHHHHHHHHHHhCC-CchHHhHHHheecC
Confidence 356889999999999999999999766 5889999998654322 23467889999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 232 DNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
+..++||||+++++|.+++.. .+..+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 999999999999999998854 34779999999999999999999999999999999999999755567889999999
Q ss_pred cccccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 309 LSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
++.............||..|+|||++.+.++.++||||||+++|+|++|+.||...........+.......... ...+
T Consensus 173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~ 251 (285)
T 3is5_A 173 LAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPL 251 (285)
T ss_dssp CCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCC
T ss_pred cceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcC
Confidence 998876666666778999999999998889999999999999999999999999888777776666655444332 2347
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 899999999999999999999999999999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=401.03 Aligned_cols=259 Identities=26% Similarity=0.468 Sum_probs=227.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|..++..+..||||+++++++.+.+.
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT---EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 5789999999999999999999775 5889999998653222222345678899999888669999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+||||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCccccc
Confidence 99999999999999988644 569999999999999999999999999999999999999 78889999999999864
Q ss_pred C-CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 R-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
. ........+||+.|+|||++. ..++.++|||||||++|||++|+.||......+.+..++.....++. .++.+
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 247 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKE 247 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence 3 233456678999999999987 56899999999999999999999999999988888888887765543 68999
Q ss_pred HHHHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
+.+||++||+.||.+|| ++.++++||||+...
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 99999999999999999 479999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=387.48 Aligned_cols=258 Identities=29% Similarity=0.490 Sum_probs=222.6
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|++.. +|+.||||++....... .+.+.+|+.+++++. ||||+++++++..++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPK---KELIINEILVMRENK-NPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTT---TCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hhhceeeeeeeccCCCeEEEEEEECC---CCcEEEEEEeecccccH---HHHHHHHHHHHhcCC-CCCCCeEeEEEEECC
Confidence 45789999999999999999998655 68999999986543222 356889999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQ 165 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCcee
Confidence 999999999999999988653 58999999999999999999999999999999999999 7788999999999887
Q ss_pred cCCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 313 VRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 313 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
..... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+........ .....++.
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 244 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSA 244 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SCGGGSCH
T ss_pred cCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-CCccccCH
Confidence 65433 345568999999999876 5689999999999999999999999988887766666555433221 22246899
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.+.+||.+||+.||++|||+.|+|+||||+...
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 999999999999999999999999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=411.68 Aligned_cols=263 Identities=28% Similarity=0.468 Sum_probs=225.4
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|+.+. +++.||+|++.+.........+.+.+|+.+++.++ ||||++++++|.+++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDR 142 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECC---CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence 46789999999999999999999776 58999999985421111111234778999999997 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+|||||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMK 217 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEe
Confidence 99999999999999998754 468999999999999999999999999999999999999 7889999999999987
Q ss_pred cCCCC--cccccccCCCcccccccCC-C----CCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 313 VRPDE--RLNDIVGSAYYVAPEVLHR-S----YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~~-~----~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
..... .....+||+.|+|||++.+ . ++.++|||||||++|||++|+.||........+..++..........+
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence 65443 2346789999999998753 2 788999999999999999999999999988888888765432222233
Q ss_pred CCCCHHHHHHHHHhccCCccC--CCCHHHHHcCcccCCCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRK--RLTAAQALSHPWIKNSND 424 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~--Rps~~elL~hp~~~~~~~ 424 (455)
..++.++.+||++||+.+|.+ |+++.||++||||++...
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 478999999999999999998 999999999999998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=409.41 Aligned_cols=266 Identities=29% Similarity=0.485 Sum_probs=226.6
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|..++..+. |+||+++++++.+.+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~---~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDEN 134 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCC
Confidence 46889999999999999999999775 68999999986432222222345789999999997 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+||||||++||+|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++++||+|||+++.
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLK 211 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhhee
Confidence 9999999999999999998776789999999999999999999999999999999999999 7889999999999987
Q ss_pred cCCCCc--ccccccCCCcccccccC--------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcC--CCC
Q 012825 313 VRPDER--LNDIVGSAYYVAPEVLH--------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--PSF 380 (455)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~--~~~ 380 (455)
...... ....+||+.|+|||++. +.++.++|||||||++|||++|+.||...+..+.+..++... ..+
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence 754433 23468999999999875 358999999999999999999999999998888888877532 222
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCC---CCHHHHHcCcccCCCCCCCC
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKR---LTAAQALSHPWIKNSNDVKV 427 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~R---ps~~elL~hp~~~~~~~~~~ 427 (455)
+. ....++.++.+||++||+ +|.+| +++.|+++||||++.++..+
T Consensus 292 p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 292 PL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp C-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred Cc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 21 124689999999999999 99998 59999999999998765443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=399.67 Aligned_cols=261 Identities=34% Similarity=0.619 Sum_probs=227.2
Q ss_pred CCCeEE--eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYEL--GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~--~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.|.+ .+.||+|+||.||+|+... +|+.||+|++... .....+.+.+|++++++++ |+||+++++++.+.
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~---~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 158 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETA---TGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLD-HANLIQLYDAFESK 158 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETT---TCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred ccceeeecceEEecCcCEEEEEEEEcC---CCcEEEEEEEccc---ccccHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC
Confidence 344555 6789999999999998766 5899999999653 3345678999999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..+|||||+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+.. +.++.+||+|||+++
T Consensus 159 ~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~ 237 (373)
T 2x4f_A 159 NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLAR 237 (373)
T ss_dssp SEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCE
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCce
Confidence 9999999999999999998877778999999999999999999999999999999999999953 346789999999999
Q ss_pred ccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
............||+.|+|||++. +.++.++|||||||++|||++|+.||......+.+..++.....+....+..++.
T Consensus 238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 238 RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp ECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred ecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence 877666666678999999999887 4688899999999999999999999999998888888888776666655678999
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 99999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=382.79 Aligned_cols=263 Identities=40% Similarity=0.770 Sum_probs=235.1
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|.... ++..||+|++....... .+.+.+|++++++++ ||||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKG---TRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLD-HPNIIRLYETFEDN 78 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCC---CCcEEEEEeehhhccch---HHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 356789999999999999999998766 57899999986543222 457889999999997 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..++.++.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred CeEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 999999999999999998755 4569999999999999999999999999999999999999766678899999999998
Q ss_pred ccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
............||+.|+|||++.+.++.++||||||+++|+|++|+.||......+....+......+....+..++++
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 158 RFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp ECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred eccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 87766666777899999999999888999999999999999999999999999888888888887766665555578999
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+.+||.+||+.||++||++.++|+||||+..
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=394.48 Aligned_cols=278 Identities=30% Similarity=0.542 Sum_probs=237.0
Q ss_pred CcCcccccCCCeEEe-ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEE
Q 012825 146 SFGFSKHFANKYELG-EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKF 224 (455)
Q Consensus 146 ~~~~~~~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l 224 (455)
.+...+.+.++|.+. +.||+|+||.||+|+... +|+.||||++..... .......+.+|+.++..+.+|+||+++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---TGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---CCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 445567788999998 899999999999999776 589999999875432 223346788999999999878999999
Q ss_pred eEEEeeCCceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEE
Q 012825 225 FDAYEDTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (455)
Q Consensus 225 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vk 303 (455)
++++.+.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++....++.+|
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999999877543 46799999999999999999999999999999999999995433478899
Q ss_pred EeecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC
Q 012825 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382 (455)
Q Consensus 304 L~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (455)
|+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|+.||...........+.........
T Consensus 175 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254 (327)
T ss_dssp ECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred EeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence 99999998876665666678999999999987 56899999999999999999999999999988888888887777777
Q ss_pred CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCC
Q 012825 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (455)
Q Consensus 383 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~ 427 (455)
..+..++..+.+||.+||+.||++|||+.++|+||||+......+
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 777789999999999999999999999999999999998765544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=397.37 Aligned_cols=256 Identities=29% Similarity=0.565 Sum_probs=226.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++++.||+|+||.||+|+... +|+.||||++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSN 115 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCE
Confidence 4789999999999999999999776 58999999986432222233467889999999997 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceec
Confidence 99999999999999988654 569999999999999999999999999999999999999 78889999999999876
Q ss_pred CCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 314 RPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
.. .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||........+..+......++. .++.++
T Consensus 192 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~ 265 (350)
T 1rdq_E 192 KG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDL 265 (350)
T ss_dssp SS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHH
T ss_pred cC--CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHH
Confidence 43 334568999999999886 56899999999999999999999999999888888888887655543 689999
Q ss_pred HHHHHHhccCCccCCCC-----HHHHHcCcccCCCC
Q 012825 393 RDFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps-----~~elL~hp~~~~~~ 423 (455)
.+||++||+.||.+||+ +.++++||||+...
T Consensus 266 ~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred HHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 99999999999999998 99999999999753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=388.57 Aligned_cols=262 Identities=29% Similarity=0.519 Sum_probs=218.2
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-CHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
..++|++.+.||+|+||.||+|+...+..+|+.||+|++.+.... .......+.+|+.+++.++ ||||+++++++.++
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTG 93 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcC
Confidence 357899999999999999999998755557899999999765322 2334456789999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCK 169 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC-
T ss_pred CEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCccc
Confidence 999999999999999998854 4568999999999999999999999999999999999999 778899999999997
Q ss_pred ccCCC-CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FVRPD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
..... ......+||+.|+|||++. ..++.++||||||+++|+|++|+.||........+..+.+....++ +.++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~ 245 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLT 245 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCC
Confidence 64332 3345568999999999886 5689999999999999999999999999888888888887665444 3689
Q ss_pred HHHHHHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 390 SEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
.++.+||.+||+.||.+|| ++.++++||||+..+
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 9999999999999999999 899999999999763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=384.57 Aligned_cols=258 Identities=30% Similarity=0.494 Sum_probs=214.7
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.+.||+|+||.||+|+.. +|+.||+|++..... .....+.+.+|++++++++ ||||+++++++.+.+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEcC----CCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeE
Confidence 58999999999999999999863 488999999865432 2222356789999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++ +|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFG 151 (288)
T ss_dssp EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHC
T ss_pred EEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccC
Confidence 999999975 9999887777889999999999999999999999999999999999999 788899999999998764
Q ss_pred CC-CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC---------
Q 012825 315 PD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE--------- 382 (455)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 382 (455)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+.+.......
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 32 23345678999999999864 5899999999999999999999999988877777666542111100
Q ss_pred ----------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 383 ----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 383 ----------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.....++.++.+||++||+.||++|||+.|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 1123578999999999999999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=399.43 Aligned_cols=258 Identities=26% Similarity=0.561 Sum_probs=223.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+... +++.||+|++.+.........+.+.+|+.+++.+. ||||++++++|.+.+.
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEED 89 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCE
Confidence 5789999999999999999999776 58999999986433222233467889999999997 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+||||+.||+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEECCCTTEEHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeec
Confidence 999999999999998775 45679999999999999999999999999999999999999 78899999999999987
Q ss_pred CCCCcccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCC---hhHHHHHHHhcCCCCCCCCCC
Q 012825 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~ 386 (455)
.........+||+.|+|||++. ..++.++|||||||++|+|++|+.||.... .......+......++ .
T Consensus 166 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~ 241 (384)
T 4fr4_A 166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----S 241 (384)
T ss_dssp CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----T
T ss_pred cCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----C
Confidence 7666777889999999999985 248999999999999999999999997433 3344444444444333 3
Q ss_pred CCCHHHHHHHHHhccCCccCCCC-HHHHHcCcccCCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLT-AAQALSHPWIKNSN 423 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps-~~elL~hp~~~~~~ 423 (455)
.++.++.+||++||+.||.+||+ +.++++||||++.+
T Consensus 242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 68999999999999999999998 99999999999753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=390.28 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=227.1
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|+... +|+.||||++...........+.+.+|++++++++ ||||+++++++.+++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 127 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREH 127 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hhhheeeeeEEccCCCEEEEEEEEcc---CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECC
Confidence 45679999999999999999998765 58999999997665455666678999999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..+|||||+. |+|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 128 ~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 128 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASI 203 (348)
T ss_dssp EEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBS
T ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCcee
Confidence 9999999997 58888887777889999999999999999999999999999999999999 6788999999999987
Q ss_pred cCCCCcccccccCCCccccccc----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDERLNDIVGSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
.... ....||+.|+|||++ .+.++.++|||||||++|||++|+.||........+..+........ ....+
T Consensus 204 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 278 (348)
T 1u5q_A 204 MAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHW 278 (348)
T ss_dssp SSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTS
T ss_pred cCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCC
Confidence 6432 346799999999987 35689999999999999999999999988887776666665543222 22468
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~ 426 (455)
+..+.+||.+||+.||++|||+.++|+||||.......
T Consensus 279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~ 316 (348)
T 1u5q_A 279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 316 (348)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcc
Confidence 99999999999999999999999999999998764433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=396.57 Aligned_cols=258 Identities=29% Similarity=0.518 Sum_probs=217.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHH-HHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL-RALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l-~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.++|++++.||+|+||.||+|+.+. +++.||||++.+...........+.+|..++ +.+. ||||+++++++.+.+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTAD 112 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETT---TCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCC
Confidence 5789999999999999999999776 5889999999776555555556677788774 4555 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++++||+|||+++.
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGG
T ss_pred EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccc
Confidence 99999999999999998754 4578999999999999999999999999999999999999 7888999999999986
Q ss_pred cC-CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 313 VR-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 313 ~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
.. ........+||+.|+|||++. ..++.++|||||||++|||++|..||...+..+.+..++.....+. +.++.
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 264 (373)
T 2r5t_A 189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITN 264 (373)
T ss_dssp GBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCH
T ss_pred cccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCH
Confidence 43 334556778999999999987 4689999999999999999999999999998888888888765443 36899
Q ss_pred HHHHHHHHhccCCccCCCCH----HHHHcCcccCCCC
Q 012825 391 EARDFVKRLLNKDPRKRLTA----AQALSHPWIKNSN 423 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~----~elL~hp~~~~~~ 423 (455)
++.+||++||+.||.+||++ .++++||||+..+
T Consensus 265 ~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 265 SARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp HHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 99999999999999999986 6999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=391.14 Aligned_cols=261 Identities=36% Similarity=0.675 Sum_probs=203.6
Q ss_pred cCCCeEEe---ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 153 FANKYELG---EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 153 ~~~~y~~~---~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
+-++|++. +.||+|+||.||+|.... +|+.||||++.+. ....+.+|+.+++.+.+||||+++++++.
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~ 76 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFH 76 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETT---TCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred chhccccccCCCccccCCCeEEEEEEECC---CCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 34678875 789999999999999776 5899999998542 23567789999999988999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
+++..|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+..+||+|||+
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 77 DQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGF 155 (325)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred cCCEEEEEEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccc
Confidence 99999999999999999998855 46799999999999999999999999999999999999997555555899999999
Q ss_pred ccccCCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCh-------hHHHHHHHhcCCCC
Q 012825 310 SDFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE-------SGIFRAVLKADPSF 380 (455)
Q Consensus 310 a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~-------~~~~~~i~~~~~~~ 380 (455)
+....... .....+||..|+|||++. ..++.++||||||+++|+|++|+.||..... .+.+..+......+
T Consensus 156 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~ 235 (325)
T 3kn6_A 156 ARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235 (325)
T ss_dssp CEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred ceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence 98664432 345667899999999987 4689999999999999999999999976433 34555665555555
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
....+..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 5544557899999999999999999999999999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=393.27 Aligned_cols=259 Identities=39% Similarity=0.666 Sum_probs=224.4
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|..+. +|+.||||++.+.... ..+|++++.++.+||||+++++++.++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 356889999999999999999999776 6899999999765322 346888898886699999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC-CCceEEEeecccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFGLS 310 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~-~~~~vkL~DfG~a 310 (455)
+.+|+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+...+ ..+.+||+|||++
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999999998854 46799999999999999999999999999999999999985322 2346999999999
Q ss_pred cccCCC-CcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCC---CChhHHHHHHHhcCCCCCCCCC
Q 012825 311 DFVRPD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWA---RTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 311 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~---~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. ....+.+..+......+....+
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 876543 33456789999999999874 588899999999999999999999975 3456677777777777776677
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
..++.++.+||++||+.||++||++.++|+||||+.
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 889999999999999999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=384.88 Aligned_cols=267 Identities=27% Similarity=0.416 Sum_probs=215.7
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC--CHHHHHHHHHHHHHHHHhc--CCCCeeEEe
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--TAIAIEDVRREVKILRALT--GHNNLVKFF 225 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~--~hp~Iv~l~ 225 (455)
+..+.++|++.+.||+|+||.||+|++.. +|+.||||++...... .......+.+|+.+++.+. .||||++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~ 80 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM 80 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTT---TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence 34567899999999999999999998655 6899999998632211 1111234567777776665 399999999
Q ss_pred EEEeeCC-----ceEEEEeecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCC
Q 012825 226 DAYEDTD-----NVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (455)
Q Consensus 226 ~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~ 299 (455)
+++...+ ..++||||+. ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~ 156 (308)
T 3g33_A 81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSG 156 (308)
T ss_dssp EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTT
T ss_pred eeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCC
Confidence 9998765 5899999996 599998866543 49999999999999999999999999999999999999 778
Q ss_pred ceEEEeecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC
Q 012825 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (455)
Q Consensus 300 ~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (455)
+.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||........+..+.....
T Consensus 157 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 157 GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp SCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 899999999998877666667788999999999875 6799999999999999999999999999888888777765432
Q ss_pred CCCCCC-----------------------CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 379 SFDEAP-----------------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 379 ~~~~~~-----------------------~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
...... .+.++.++.+||.+||++||++|||+.|+|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 222211 135789999999999999999999999999999999753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=400.05 Aligned_cols=258 Identities=33% Similarity=0.604 Sum_probs=218.0
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.+.||+|+||.||+|++.. +|+.||||++.+...........+.+|+.+++.++ ||||+++++++.+.
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 81 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYK---TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTP 81 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence 446789999999999999999999766 58999999985432111222356889999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..++||||+ +|+|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 82 TDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSN 156 (336)
T ss_dssp SEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTB
T ss_pred CEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccce
Confidence 9999999999 77999988654 569999999999999999999999999999999999999 788899999999998
Q ss_pred ccCCCCcccccccCCCcccccccCCC-C-CCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHRS-Y-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
...........+||+.|+|||++.+. + +.++|||||||++|+|++|+.||...........+.... ......++
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~----~~~p~~~s 232 (336)
T 3h4j_B 157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV----YVMPDFLS 232 (336)
T ss_dssp TTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSC----CCCCTTSC
T ss_pred eccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC----CCCcccCC
Confidence 88766667778899999999998754 3 678999999999999999999997655433222221111 11223589
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+++.+||++||+.||.+|||+.|+++||||+..
T Consensus 233 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 999999999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=377.32 Aligned_cols=267 Identities=35% Similarity=0.618 Sum_probs=233.3
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC------CHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT------TAIAIEDVRREVKILRALTGHNNLVKFF 225 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~ 225 (455)
.+.++|++.+.||+|+||.||+|+... +|+.||||++...... .....+.+.+|+++++++.+||||++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcC---cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 457899999999999999999999766 5899999999654311 1233466889999999997799999999
Q ss_pred EEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 226 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
+++.+++..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~ 166 (298)
T 1phk_A 91 DTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLT 166 (298)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEEC
T ss_pred eeeccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEe
Confidence 999999999999999999999998865 4579999999999999999999999999999999999999 778899999
Q ss_pred ecccccccCCCCcccccccCCCcccccccC-------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (455)
|||++.............|+..|+|||++. ..++.++||||||+++|+|++|+.||...........+.....
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 167 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 999998877666666778999999999873 3578899999999999999999999999888888888887776
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCC
Q 012825 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 379 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~ 425 (455)
.+....+..++..+.+||.+||+.||++|||+.++|+||||+.....
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 66655556789999999999999999999999999999999986543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=386.94 Aligned_cols=264 Identities=37% Similarity=0.675 Sum_probs=230.6
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCH---HHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
.+.++|++.+.||+|+||.||+|+... +|+.||||++........ ...+.+.+|+.+++++. ||||+++++++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 84 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVY 84 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECC---CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEE
Confidence 456889999999999999999999776 589999999975433221 13467899999999998 99999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCc----eEEE
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS----VLKA 304 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~----~vkL 304 (455)
.+.+..++||||+++++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++ .+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~---~~~~~~~~~~kl 160 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML---LDKNIPIPHIKL 160 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHH-TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---SCTTSSSCCEEE
T ss_pred ecCCEEEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEE---ecCCCCcCCEEE
Confidence 99999999999999999999875 45679999999999999999999999999999999999999 4444 7999
Q ss_pred eecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 012825 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (455)
Q Consensus 305 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (455)
+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||......+.+..+......+...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 240 (321)
T 2a2a_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240 (321)
T ss_dssp CCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred ccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh
Confidence 9999998876665566778999999999987 568999999999999999999999999988888887777765555443
Q ss_pred CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 384 ~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.+..++..+.+||.+||+.||++|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 3457899999999999999999999999999999999764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=387.07 Aligned_cols=261 Identities=28% Similarity=0.467 Sum_probs=206.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++++.||+|+||.||+|.... +|+.||||++..... ....+.+.+|+++++++. ||||+++++++.+++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT---TGVYVALKEVKLDSE--EGTPSTAIREISLMKELK-HENIVRLYDVIHTENK 77 (317)
T ss_dssp ---------------CEEEEEECSS---SCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECC---CCcEEEEEEeecccc--cccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCe
Confidence 4689999999999999999998665 689999999965432 222356789999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 234 VYVVMELCEGGELLDRILSRG-----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
.++||||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg 153 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFG 153 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCS
T ss_pred EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCc
Confidence 999999997 59998886542 469999999999999999999999999999999999999 778899999999
Q ss_pred cccccCCC-CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCC--
Q 012825 309 LSDFVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA-- 383 (455)
Q Consensus 309 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-- 383 (455)
++...... .......||..|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+..........
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 154 LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 99876433 23455689999999999864 58999999999999999999999999988887777665432111100
Q ss_pred ----------------------------CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 384 ----------------------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 384 ----------------------------~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
....++.++.+||.+||+.||++|||+.|+|+||||+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 11257889999999999999999999999999999998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=381.85 Aligned_cols=257 Identities=30% Similarity=0.588 Sum_probs=214.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC-----------------------HHHHHHHHHHHH
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-----------------------AIAIEDVRREVK 210 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~-----------------------~~~~~~~~~Ei~ 210 (455)
.++|++.+.||+|+||.||+|+... +|+.||||++....... ....+.+.+|++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN---DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT---TTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC---CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 5789999999999999999998765 58999999996543211 122456889999
Q ss_pred HHHHhcCCCCeeEEeEEEee--CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccC
Q 012825 211 ILRALTGHNNLVKFFDAYED--TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKP 288 (455)
Q Consensus 211 ~l~~l~~hp~Iv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp 288 (455)
++++++ ||||+++++++.+ ++..++||||+++++|.+++ ....+++..++.++.||+.||.|||++||+||||||
T Consensus 89 ~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 89 ILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp HHHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 999998 9999999999986 56799999999999987743 445799999999999999999999999999999999
Q ss_pred CceEEeecCCCceEEEeecccccccCCCC-cccccccCCCcccccccCCC----CCCcchHHHHHHHHHHHHcCCCCCCC
Q 012825 289 ENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLHRS----YSTEADVWSIGVIAYILLCGSRPFWA 363 (455)
Q Consensus 289 ~NILl~~~~~~~~vkL~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~sDiwSlG~~l~elltg~~Pf~~ 363 (455)
+|||+ +.++.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||..
T Consensus 166 ~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 166 SNLLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGEEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHEEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999 778899999999998765433 33456899999999998743 36789999999999999999999988
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.........+......+.. .+.++.++.+||.+||+.||++||++.|+|+||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 243 ERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp SSHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred ccHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 8777666666665444332 2478999999999999999999999999999999963
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=407.16 Aligned_cols=259 Identities=29% Similarity=0.531 Sum_probs=217.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|+... +|+.||||++.............+.+|+.+++.++ ||||+++++++.+.+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHD 221 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETT
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcC---CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCC
Confidence 35789999999999999999999766 68999999996543334445567789999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
.+||||||+++++|.+++.. .+.+++..++.++.||+.||.|||+ .||+||||||+|||| +.++.+||+|||+++
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCK 297 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCC
T ss_pred EEEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCce
Confidence 99999999999999988754 4579999999999999999999998 899999999999999 778899999999998
Q ss_pred ccCC-CCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FVRP-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
.... .......+||+.|+|||++. ..++.++|||||||++|||++|+.||........+..+......++. .++
T Consensus 298 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~ 373 (446)
T 4ejn_A 298 EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLG 373 (446)
T ss_dssp TTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSC
T ss_pred eccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCC
Confidence 6432 33456678999999999876 56999999999999999999999999999888888888877665543 689
Q ss_pred HHHHHHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 390 SEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
+++.+||.+||+.||.+|| ++.|+|+||||++..
T Consensus 374 ~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 9999999999999999999 999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=386.44 Aligned_cols=265 Identities=28% Similarity=0.449 Sum_probs=213.1
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|+... +|+.||||++.... ......+.+.+|+.++++++ |+||+++++++.+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTV---TNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNH 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETT
T ss_pred chhhEEEEEEEEecCCeEEEEEEECC---CCceEEEEEEcccc-cccccchhHHHHHHHHHHcC-CCCcceEEEEEecCC
Confidence 35789999999999999999998766 58999999996543 23334566789999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec--CCCceEEEeecccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK--DENSVLKAIDFGLS 310 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~--~~~~~vkL~DfG~a 310 (455)
..+|||||+++ +|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.. +..+.+||+|||++
T Consensus 107 ~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 107 RLHLIFEYAEN-DLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEEEEECCSE-EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEEEEecCCC-CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99999999975 99988754 4569999999999999999999999999999999999999643 34567999999999
Q ss_pred cccCCC-CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC-
Q 012825 311 DFVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP- 386 (455)
Q Consensus 311 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~- 386 (455)
...... .......||..|+|||++.+ .++.++|||||||++|+|++|+.||......+.+..+...........++
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 876432 23455678999999999864 48999999999999999999999999988888777776543222221111
Q ss_pred -------------------------CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 387 -------------------------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 387 -------------------------~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
.++.++.+||.+||+.||++|||+.|+|+||||+....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 16789999999999999999999999999999998653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=388.95 Aligned_cols=261 Identities=29% Similarity=0.479 Sum_probs=215.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++++.||+|+||.||+|+... +++.||||++.... .......+.+|+.++++++ |+||+++++++.+++..
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL---TDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECC---CCcEEEEEEEeccc--ccccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEE
Confidence 579999999999999999999775 58899999986432 1122224567999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||++ ++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 76 TLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKS 151 (324)
T ss_dssp EEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-
T ss_pred EEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCccccccc
Confidence 99999997 59999888877789999999999999999999999999999999999999 778899999999997654
Q ss_pred CC-CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC------
Q 012825 315 PD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW------ 385 (455)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------ 385 (455)
.. .......||..|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.+.........|
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 32 23345678999999998764 5899999999999999999999999998888877776654332222211
Q ss_pred --------------------CCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCC
Q 012825 386 --------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 386 --------------------~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~ 425 (455)
+.++.++.+||++||+.||++|||+.|+|+||||+...+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 2468899999999999999999999999999999987654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=396.87 Aligned_cols=264 Identities=30% Similarity=0.527 Sum_probs=212.2
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
.+.+.++|++++.||+|+||.||+|.+.. +|+.||||++... .......+.+.+|+.+++.+.+|+||+++++++.
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 79 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLR 79 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETT---TCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECC---CCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEe
Confidence 34567899999999999999999998776 6899999998653 3455666788899999999988999999999997
Q ss_pred eCC--ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeec
Q 012825 230 DTD--NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 230 ~~~--~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
..+ .+|+|||||+ ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+||
T Consensus 80 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DF 153 (388)
T 3oz6_A 80 ADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADF 153 (388)
T ss_dssp CTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCC
T ss_pred cCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCC
Confidence 544 6899999997 588887754 479999999999999999999999999999999999999 78889999999
Q ss_pred ccccccCC----------------------CCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCC
Q 012825 308 GLSDFVRP----------------------DERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWA 363 (455)
Q Consensus 308 G~a~~~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~ 363 (455)
|+++.... .......+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 99976532 112344689999999998864 589999999999999999999999998
Q ss_pred CChhHHHHHHHhcCCCCC------------------------------C-------------CCCCCCCHHHHHHHHHhc
Q 012825 364 RTESGIFRAVLKADPSFD------------------------------E-------------APWPSLSSEARDFVKRLL 400 (455)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~------------------------------~-------------~~~~~~s~~l~~li~~~L 400 (455)
......+..++....... . .....+++++.+||++||
T Consensus 234 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 888777766654221110 0 011267899999999999
Q ss_pred cCCccCCCCHHHHHcCcccCCCC
Q 012825 401 NKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 401 ~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+.||++|||+.|+|+||||+...
T Consensus 314 ~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp CSSGGGSCCHHHHTTSTTTTTTC
T ss_pred ccCcccCCCHHHHhCCHHHHHhc
Confidence 99999999999999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=385.45 Aligned_cols=267 Identities=34% Similarity=0.611 Sum_probs=215.4
Q ss_pred ccccCCCeEEe-ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 150 SKHFANKYELG-EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 150 ~~~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
...+.++|++. +.||+|+||.||+|.... +++.||||++..... ...+.+.+|+.++.++.+||||+++++++
T Consensus 7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~ 80 (316)
T 2ac3_A 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLI---TSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFF 80 (316)
T ss_dssp CCCTTTSCEECCCCCCCCSSEEEEEEECSS---SCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcccceeEEecCceecCCceEEEEEEEEcC---CCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34567899995 789999999999998665 589999999965432 23457889999999976699999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
.+++..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 81 EEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred eeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 9999999999999999999988654 569999999999999999999999999999999999999543334459999999
Q ss_pred cccccCCCC--------cccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCh--------
Q 012825 309 LSDFVRPDE--------RLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTE-------- 366 (455)
Q Consensus 309 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~-------- 366 (455)
++....... .....+||..|+|||++. ..++.++|||||||++|+|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 987654221 123456999999999875 3488999999999999999999999976542
Q ss_pred -------hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 367 -------SGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 367 -------~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
...+..+......+....+..++.++.+||++||+.||++|||+.|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 234555555555444433456899999999999999999999999999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=389.00 Aligned_cols=267 Identities=25% Similarity=0.408 Sum_probs=223.4
Q ss_pred CCCcCcccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc----CCC
Q 012825 144 NKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT----GHN 219 (455)
Q Consensus 144 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~----~hp 219 (455)
..++..+..+.++|++.++||+|+||.||+|++.. +++.||||++.. .....+.+..|+.+++.+. +|+
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---CCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCC
Confidence 44566677789999999999999999999999766 588999999853 3445567788999999997 599
Q ss_pred CeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec--
Q 012825 220 NLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-- 296 (455)
Q Consensus 220 ~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~-- 296 (455)
||+++++++...+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTC
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccc
Confidence 9999999999999999999999 889999887654 469999999999999999999999999999999999999421
Q ss_pred --------------------CCCceEEEeecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHH
Q 012825 297 --------------------DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILL 355 (455)
Q Consensus 297 --------------------~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ell 355 (455)
..++.+||+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 1267899999999986542 334568999999999886 46999999999999999999
Q ss_pred cCCCCCCCCChhHHHHHHHhcCCCCCCC---------------------CCC---------------------CCCHHHH
Q 012825 356 CGSRPFWARTESGIFRAVLKADPSFDEA---------------------PWP---------------------SLSSEAR 393 (455)
Q Consensus 356 tg~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------------~~~---------------------~~s~~l~ 393 (455)
+|+.||......+.+..+.......+.. .++ ..++.+.
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 9999999888777666655443222110 000 1247788
Q ss_pred HHHHHhccCCccCCCCHHHHHcCcccC
Q 012825 394 DFVKRLLNKDPRKRLTAAQALSHPWIK 420 (455)
Q Consensus 394 ~li~~~L~~dP~~Rps~~elL~hp~~~ 420 (455)
+||.+||+.||++|||+.|+|+||||+
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999999996
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=387.46 Aligned_cols=260 Identities=31% Similarity=0.556 Sum_probs=215.4
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+.++|++.+.||+|+||.||+|++.. +++.||||++..... ....+.+.+|+.+++.+. |+||+++++++.+++
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECC---CCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 56899999999999999999998776 588999999865422 223466889999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..|+||||+++++|.+++ .....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATV 154 (323)
T ss_dssp EEEEEEECCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccce
Confidence 999999999999999877 345579999999999999999999999999999999999999 7788999999999976
Q ss_pred cCCCC---cccccccCCCcccccccCC-C-CCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 313 VRPDE---RLNDIVGSAYYVAPEVLHR-S-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 313 ~~~~~---~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
..... ......||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.................. ....+..
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~ 233 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKK 233 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT-TSTTGGG
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc-cCCcccc
Confidence 53222 2346689999999999864 3 477899999999999999999999876554332222222222 2223456
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
++.++.+||.+||+.||++|||+.|+++||||+...
T Consensus 234 ~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 234 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 899999999999999999999999999999998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=393.22 Aligned_cols=263 Identities=21% Similarity=0.329 Sum_probs=217.1
Q ss_pred CCCeEEeceEeec--CCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRG--HFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G--~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++++.||+| +||.||+|+... +|+.||||++.... ......+.+.+|+.+++.++ ||||+++++++.++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEA-CSNEMVTFLQGELHVSKLFN-HPNIVPYRATFIAD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT---TCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC---CCCEEEEEEecccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEEC
Confidence 6789999999999 999999999876 58999999997643 34566778899999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 232 DNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
+.+|+|||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSN 175 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccc
Confidence 9999999999999999988664 3579999999999999999999999999999999999999 78889999999987
Q ss_pred cccCCCC--------cccccccCCCcccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC
Q 012825 311 DFVRPDE--------RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (455)
Q Consensus 311 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 379 (455)
....... ......||..|+|||++.+ .++.++|||||||++|+|++|+.||........+..++.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 6542211 1233478999999999864 5899999999999999999999999876655544433322110
Q ss_pred C------------------------------------------CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCc
Q 012825 380 F------------------------------------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (455)
Q Consensus 380 ~------------------------------------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp 417 (455)
. .......++.++.+||++||+.||++|||+.|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 0 0012235789999999999999999999999999999
Q ss_pred ccCCCCC
Q 012825 418 WIKNSND 424 (455)
Q Consensus 418 ~~~~~~~ 424 (455)
||+....
T Consensus 336 ~f~~~~~ 342 (389)
T 3gni_B 336 FFKQIKR 342 (389)
T ss_dssp GGGGC--
T ss_pred HHHHHhh
Confidence 9998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=390.15 Aligned_cols=264 Identities=36% Similarity=0.694 Sum_probs=230.5
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-C----HHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-T----AIAIEDVRREVKILRALTGHNNLVKFF 225 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~----~~~~~~~~~Ei~~l~~l~~hp~Iv~l~ 225 (455)
..+.++|++.+.||+|+||.||+|++.. +|+.||||++...... . ....+.+.+|+.+++++.+||||++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRA---TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECC---CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 3456789999999999999999999765 5899999998654321 1 223456889999999995699999999
Q ss_pred EEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 226 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
+++...+..|+||||++|++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~ 242 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLS 242 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEEC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEE
Confidence 999999999999999999999998864 4579999999999999999999999999999999999999 788899999
Q ss_pred ecccccccCCCCcccccccCCCcccccccC-------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (455)
|||++.............||+.|+|||++. ..++.++|||||||++|+|++|+.||........+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 999998877666667788999999999874 2478899999999999999999999999888888877777665
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 379 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.+....+..++..+.+||++||+.||++||++.++|+||||+.
T Consensus 323 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 5544444578899999999999999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=378.95 Aligned_cols=263 Identities=29% Similarity=0.518 Sum_probs=214.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+... +|+.||||++.... ......+.+.+|+.++++++ |+||+++++++.+.+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCC---CCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCe
Confidence 4789999999999999999999766 58999999986543 44555677889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++ .....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 77 ~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELD-RYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLL 152 (311)
T ss_dssp EEEEEECCSEEHHHHHH-HTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCchHHHHH-hhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhc
Confidence 99999999988877755 455679999999999999999999999999999999999999 77889999999999876
Q ss_pred CCC-CcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC-----------
Q 012825 314 RPD-ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----------- 379 (455)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~----------- 379 (455)
... .......||..|+|||++. ..++.++||||||+++|+|++|+.||......+....+.+....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 533 2345567999999999875 45899999999999999999999999888877665554432110
Q ss_pred --------CCC--------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCC
Q 012825 380 --------FDE--------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 380 --------~~~--------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~ 425 (455)
... ...+.++.++.+||++||+.||++|||+.|+|+||||+...+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 000 0124688999999999999999999999999999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=389.11 Aligned_cols=255 Identities=33% Similarity=0.590 Sum_probs=203.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+++... +++.||||++....... +.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 90 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL---TKELVAVKYIERGAAID----ENVQREIINHRSLR-HPNIVRFKEVILTPTH 90 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT---TCCEEEEEEEESSTTSC----HHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEecCcccc----HHHHHHHHHHHhCC-CCCCCcEEEEEeeCCE
Confidence 5789999999999999999999775 58999999997644333 45789999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCc--eEEEeeccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS--VLKAIDFGLSD 311 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~--~vkL~DfG~a~ 311 (455)
.++||||+++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||+++
T Consensus 91 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill---~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL---DGSPAPRLKICDFGYSK 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEE---CSSSSCCEEECCCCCC-
T ss_pred EEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCceEEEeecCccc
Confidence 9999999999999998854 4569999999999999999999999999999999999999 4444 49999999998
Q ss_pred ccCCCCcccccccCCCcccccccC-CCCCCc-chHHHHHHHHHHHHcCCCCCCCCCh----hHHHHHHHhcCCCCCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTE-ADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~-sDiwSlG~~l~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~ 385 (455)
............||+.|+|||++. ..++.+ +|||||||++|+|++|+.||..... ...+..+......++. .
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~ 244 (361)
T 3uc3_A 167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--D 244 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--T
T ss_pred cccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--c
Confidence 655455556678999999999875 455555 8999999999999999999976544 2334444444333332 2
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
..++.++.+||++||+.||++|||+.|+++||||+..
T Consensus 245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 3689999999999999999999999999999999654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=405.85 Aligned_cols=259 Identities=35% Similarity=0.619 Sum_probs=227.4
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|.+.+.||+|+||.||+|+... +|+.||||++.............+.+|+.+++.++ ||||+++++++.+.
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHEL---TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTP 88 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETT---TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 346789999999999999999999765 68999999986432222223467889999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+.+|+||||++|++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSN 164 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTT-SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCE
T ss_pred CEEEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchh
Confidence 99999999999999999874 45679999999999999999999999999999999999999 788899999999998
Q ss_pred ccCCCCcccccccCCCcccccccCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
...........+||+.|+|||++.+. .+.++|||||||++|+|++|+.||........+..+.......+ ..++
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 240 (476)
T 2y94_A 165 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLN 240 (476)
T ss_dssp ECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCC
T ss_pred hccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCC
Confidence 87766666778899999999998754 36789999999999999999999998888888887776654333 3578
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.++.+||++||+.||++|||+.++++||||+..
T Consensus 241 ~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 241 PSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=375.55 Aligned_cols=260 Identities=30% Similarity=0.597 Sum_probs=222.0
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|.... +++.||||++.............+.+|+.+++++. ||||+++++++.+.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDAT 82 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCC
Confidence 35789999999999999999998776 57899999985432222223467889999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVH 158 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESC
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEecccccc
Confidence 999999999999999988554 569999999999999999999999999999999999999 7888999999999866
Q ss_pred cCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
... .......|+..|+|||++.+ .++.++||||||+++|+|++|..||...........+......++. .++..
T Consensus 159 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 233 (279)
T 3fdn_A 159 APS-SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEG 233 (279)
T ss_dssp C---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHH
T ss_pred CCc-ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHH
Confidence 543 23345679999999998874 5788999999999999999999999988888877777776555443 57899
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~ 425 (455)
+.+||.+||+.||++||++.|+|+||||+.....
T Consensus 234 ~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 234 ARDLISRLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred HHHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence 9999999999999999999999999999975443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=378.23 Aligned_cols=267 Identities=39% Similarity=0.750 Sum_probs=233.6
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
..+.++|++.+.||+|+||.||+|+... +++.||||++...... ....+.+.+|++++++++ |+||+++++++.+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 92 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAK-NKDTSTILREVELLKKLD-HPNIMKLFEILED 92 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcC---CCcEEEEEEecccccc-hHHHHHHHHHHHHHHhcc-CCCccEEEEEEeC
Confidence 3457899999999999999999998765 5889999998654322 223467889999999997 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+|||++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred CCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999999999987654 46999999999999999999999999999999999999965555668999999999
Q ss_pred cccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
.............|+..|+|||++.+.++.++||||||+++|+|++|..||...........+......+....+..++.
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred eeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 88765555556678999999999998899999999999999999999999999888888877777765555544567899
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
++.+||++||+.||++|||+.++|+||||+...
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 999999999999999999999999999998654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=383.15 Aligned_cols=260 Identities=32% Similarity=0.491 Sum_probs=228.9
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|.+.+.||+|+||.||++++.. +++.||+|++...........+.+.+|+.+++.+. |+||+++++++.+.
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 113 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDN 113 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecC
Confidence 346789999999999999999999776 58899999997665556677788999999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLAT 189 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CeEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCce
Confidence 999999999999999987754 4679999999999999999999999999999999999999 778899999999998
Q ss_pred ccCCC-CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FVRPD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
..... .......||..|+|||++. ..++.++||||||+++|+|++|+.||......+....+........ ..++
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~ 265 (335)
T 2owb_A 190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHIN 265 (335)
T ss_dssp ECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSC
T ss_pred ecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCC
Confidence 76533 3345567999999999876 4688999999999999999999999998887777777766654433 3678
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
..+.+||++||+.||++||++.|+|+|+||+...
T Consensus 266 ~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 266 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 9999999999999999999999999999998753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=413.33 Aligned_cols=260 Identities=30% Similarity=0.497 Sum_probs=224.0
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|+... +|+.||||++.+...........+.+|+.+++++. ||||+++++++.+.+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKD 257 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCC
Confidence 35789999999999999999999776 68999999986432222223456789999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
.+||||||++||+|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++.
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~ 334 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAV 334 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccce
Confidence 9999999999999999886543 359999999999999999999999999999999999999 788999999999998
Q ss_pred ccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCC----hhHHHHHHHhcCCCCCCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 386 (455)
...........+||+.|+|||++.+ .++.++|||||||++|||++|+.||.... .......+......+. .
T Consensus 335 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~ 410 (576)
T 2acx_A 335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----E 410 (576)
T ss_dssp ECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----T
T ss_pred ecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----c
Confidence 8766666667799999999999874 68999999999999999999999997753 2344455554443333 4
Q ss_pred CCCHHHHHHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
.++.++.+||++||+.||.+|| ++.|+++||||+..+
T Consensus 411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 6899999999999999999999 899999999999853
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=422.09 Aligned_cols=260 Identities=26% Similarity=0.463 Sum_probs=229.8
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++++.||+|+||.||+|+.+. +++.||||++.+.........+.+..|..++..+.+|++|+++++++.+.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESS---SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred cccceEEEEEEccCCCEEEEEEEECC---CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 35789999999999999999999876 588999999865322222334567889999998877999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+||||||++||+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEE
T ss_pred EEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeec
Confidence 999999999999999988654 579999999999999999999999999999999999999 7888999999999986
Q ss_pred cC-CCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 313 VR-PDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 313 ~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
.. ........+||+.|+|||++. ..|+.++|||||||+||||++|+.||.+.+..+.+..++.....++. .++.
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 567 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSK 567 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCH
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCH
Confidence 43 334456778999999999987 57999999999999999999999999999999999999887766554 6899
Q ss_pred HHHHHHHHhccCCccCCCCH-----HHHHcCcccCCCC
Q 012825 391 EARDFVKRLLNKDPRKRLTA-----AQALSHPWIKNSN 423 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~-----~elL~hp~~~~~~ 423 (455)
++.+||++||+.||++|+++ .||++||||+..+
T Consensus 568 ~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred HHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 99999999999999999997 9999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=398.30 Aligned_cols=262 Identities=31% Similarity=0.504 Sum_probs=200.0
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~- 230 (455)
.+.++|++++.||+|+||.||+|++.. +|+.||||++... .......+.+.+|++++++++ |+||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 124 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKL---EKRVVAIKKILRV-FEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPK 124 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC-----CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECC---CCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecC
Confidence 346899999999999999999999776 5899999998653 345666788999999999998 9999999999853
Q ss_pred ----CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 231 ----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
.+.+|+||||+ +++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||| +.++.+||+|
T Consensus 125 ~~~~~~~~~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~D 199 (458)
T 3rp9_A 125 DVEKFDELYVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCD 199 (458)
T ss_dssp CTTTCCCEEEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECC
T ss_pred CcccCceEEEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecc
Confidence 35699999999 568888774 45679999999999999999999999999999999999999 7888999999
Q ss_pred cccccccCCCC----------------------------cccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHc
Q 012825 307 FGLSDFVRPDE----------------------------RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLC 356 (455)
Q Consensus 307 fG~a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~ellt 356 (455)
||+++...... .....+||+.|+|||++. ..++.++|||||||+||||++
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 99998764221 234567899999999763 469999999999999999999
Q ss_pred -----------CCCCCCCCCh--------------------hHHHHHHHhc-----------------------CCC---
Q 012825 357 -----------GSRPFWARTE--------------------SGIFRAVLKA-----------------------DPS--- 379 (455)
Q Consensus 357 -----------g~~Pf~~~~~--------------------~~~~~~i~~~-----------------------~~~--- 379 (455)
|+.+|.+... .+.+..+.+. .+.
T Consensus 280 g~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (458)
T 3rp9_A 280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREG 359 (458)
T ss_dssp TSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCC
T ss_pred hccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCC
Confidence 6666654331 1222222111 000
Q ss_pred -CCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 380 -FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 380 -~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.....++.++.++.+||++||.+||++|||+.|+|+||||+...
T Consensus 360 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 360 TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 01112356799999999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=390.80 Aligned_cols=269 Identities=35% Similarity=0.632 Sum_probs=226.3
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc--CCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--TTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
..+.++|++.+.||+|+||.||+|.... +++.||+|++..... ......+.+.+|++++++++ ||||+++++++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 97 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQ---TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVY 97 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hhhhhheeecceeeecCCeEEEEEEECC---CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhh
Confidence 3467899999999999999999998765 588999999854321 12344578899999999998 99999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHH
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSR---------------------------------------GGKYTEDDAKAVMIQI 269 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~qi 269 (455)
.+.+..++||||++|++|.+++... ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 9999999999999999999877310 1124678899999999
Q ss_pred HHHHHHHHHcCCEEeeccCCceEEeecCCCc--eEEEeecccccccCCCC-----cccccccCCCcccccccC---CCCC
Q 012825 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENS--VLKAIDFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLH---RSYS 339 (455)
Q Consensus 270 ~~gL~~LH~~~ivHrDikp~NILl~~~~~~~--~vkL~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~ 339 (455)
+.||.|||++||+||||||+|||+ +.++ .+||+|||++....... ......||+.|+|||++. ..++
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLF---STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEE---SCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHHHCCccccCCChhhEEE---ecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence 999999999999999999999999 4444 89999999998653211 234567999999999885 4688
Q ss_pred CcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 340 TEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 340 ~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
.++||||||+++|+|++|+.||......+....+......+....+..++.++.+||.+||+.||.+||++.++|+||||
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence 99999999999999999999999999988888888887776666556689999999999999999999999999999999
Q ss_pred CCCCCCC
Q 012825 420 KNSNDVK 426 (455)
Q Consensus 420 ~~~~~~~ 426 (455)
+...++.
T Consensus 335 ~~~~~~~ 341 (345)
T 3hko_A 335 SQFSDKI 341 (345)
T ss_dssp HTTSSCS
T ss_pred ccChHhh
Confidence 9876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=402.65 Aligned_cols=259 Identities=27% Similarity=0.480 Sum_probs=211.1
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++++.||+|+||.||+|++.. +|+.||||++.+. .......+.+.+|+.+++.++ ||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQ 133 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccC
Confidence 346899999999999999999998776 6899999999754 245566778899999999998 99999999999654
Q ss_pred ------CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 232 ------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 232 ------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
+.+||||||+++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 134 ~~~~~~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~ 206 (464)
T 3ttj_A 134 KTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKIL 206 (464)
T ss_dssp CSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEEC
T ss_pred CccccCCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEE
Confidence 457999999976 5666553 348999999999999999999999999999999999999 788899999
Q ss_pred ecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC----
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF---- 380 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~---- 380 (455)
|||+++...........+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+....+.+..+++.....
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp CCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred EEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999998877666667789999999999887 469999999999999999999999999888777766665432111
Q ss_pred ------------------CCCCC----CC------------CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 381 ------------------DEAPW----PS------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 381 ------------------~~~~~----~~------------~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
....+ +. .+.++.+||++||++||++|||+.|+|+||||+..
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 10000 00 15678999999999999999999999999999853
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=376.03 Aligned_cols=263 Identities=29% Similarity=0.606 Sum_probs=227.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+... +++.||||++...........+.+.+|+++++.++ |+||+++++++.+++.
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKR 88 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred hhhceeeheecCCCCeEEEEEEEcC---CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCE
Confidence 5789999999999999999998765 58899999985432111222457889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHA 164 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccC
Confidence 99999999999999988654 569999999999999999999999999999999999999 77889999999998765
Q ss_pred CCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 314 RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
.. .......|+..|+|||++.+ .++.++||||||+++|+|++|..||...........+......+. ..++.++
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 239 (284)
T 2vgo_A 165 PS-LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGS 239 (284)
T ss_dssp SS-SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHH
T ss_pred cc-cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHH
Confidence 43 23345679999999999874 689999999999999999999999998888877777776654433 3689999
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCch
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPL 429 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~ 429 (455)
.+||.+||+.||.+||++.++++||||+....+.+|-
T Consensus 240 ~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~ 276 (284)
T 2vgo_A 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP 276 (284)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred HHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCC
Confidence 9999999999999999999999999999876665543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=400.76 Aligned_cols=265 Identities=34% Similarity=0.635 Sum_probs=212.2
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-----CHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRALTGHNNLVKFF 225 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~ 225 (455)
+.+.++|.+.+.||+|+||.||+|.... +++.||||++.+.... .......+.+|+.++++++ ||||++++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~ 206 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK 206 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCC
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECC---CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEE
Confidence 4567899999999999999999999776 5899999998654321 2223345789999999997 99999999
Q ss_pred EEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 226 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
+++. .+..|+||||+++++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+
T Consensus 207 ~~~~-~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 207 NFFD-AEDYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp EEEE-SSEEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred EEEe-cCceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEe
Confidence 9985 455899999999999988764 45679999999999999999999999999999999999999765566779999
Q ss_pred ecccccccCCCCcccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhH-HHHHHHhcCCCC
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSF 380 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~-~~~~i~~~~~~~ 380 (455)
|||+++...........+||+.|+|||++. ..++.++|||||||++|+|++|..||....... ....+......+
T Consensus 285 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~ 364 (419)
T 3i6u_A 285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364 (419)
T ss_dssp CSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC
T ss_pred ecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC
Confidence 999999877666666788999999999874 457889999999999999999999997654433 333444444333
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
....+..++..+.+||++||+.||++||++.|+|+||||++
T Consensus 365 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 33334578999999999999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=384.15 Aligned_cols=261 Identities=29% Similarity=0.469 Sum_probs=220.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee---
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--- 230 (455)
.++|++++.||+|+||.||+|+... +|+.||||++...... ......+.+|+.+++.++ |+||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKAS 90 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETT---TCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC--
T ss_pred ccceeEEEEEecCCCcEEEEEEECC---CCCEEEEEEEeccccc-ccchHHHHHHHHHHHhcc-CCCcccHhheeecccc
Confidence 4789999999999999999999766 5899999998654322 222346778999999998 9999999999987
Q ss_pred -----CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 231 -----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 231 -----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
.+.+++||||+++ +|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~ 166 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLA 166 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEEC
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEc
Confidence 4568999999975 8888887777789999999999999999999999999999999999999 788899999
Q ss_pred ecccccccCCC-----CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC
Q 012825 306 DFGLSDFVRPD-----ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (455)
Q Consensus 306 DfG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (455)
|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+.....
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99999875422 23345678999999998864 589999999999999999999999999888887777766544
Q ss_pred CCCCCCCCC----------------------------CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 379 SFDEAPWPS----------------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 379 ~~~~~~~~~----------------------------~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
......++. .++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 443333332 267899999999999999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=373.79 Aligned_cols=266 Identities=38% Similarity=0.710 Sum_probs=223.8
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC---HHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
+.++|++.+.||+|+||.||+|+... +|+.||+|++....... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 78 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFE 78 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcC---CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheec
Confidence 35689999999999999999999776 58899999987543322 113567899999999998 999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC-CCceEEEeecc
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDFG 308 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~-~~~~vkL~DfG 308 (455)
+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CCCeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999999998854 45799999999999999999999999999999999999994321 12379999999
Q ss_pred cccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
++.............|+..|+|||++. +.++.++||||||+++|+|++|..||...........+...........+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 998876555556678999999999987 5689999999999999999999999999888887777766655544434457
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
++..+.+||.+||+.||++||++.++|+||||+...
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 899999999999999999999999999999999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=374.66 Aligned_cols=259 Identities=32% Similarity=0.588 Sum_probs=197.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+... +|+.||||++...........+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNY 85 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSE
T ss_pred cccceeeeeecCCCceEEEEEEEcc---CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCe
Confidence 3679999999999999999998765 58899999985432111222467889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeec
Confidence 999999999999999987777789999999999999999999999999999999999999 77889999999999876
Q ss_pred CCC-CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
... .......||..|+|||++. ..++.++||||||+++|+|++|+.||...........+...... ....++.+
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 238 (278)
T 3cok_A 163 KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE----MPSFLSIE 238 (278)
T ss_dssp C----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCC----CCTTSCHH
T ss_pred cCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccC----CccccCHH
Confidence 432 2234567899999999887 46888999999999999999999999876655444433322221 22358899
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+.+||.+||+.||++||++.++|+||||+...
T Consensus 239 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 99999999999999999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=383.37 Aligned_cols=265 Identities=28% Similarity=0.467 Sum_probs=223.4
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
...+.++|++.+.||+|+||.||+|++.. +++.||||++.............+.+|+.+++++. ||||+++++++.
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 82 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLR---DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGE 82 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECC---CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeee
Confidence 34568899999999999999999999766 58999999998766666777788999999999998 999999999988
Q ss_pred eCCc----eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 230 DTDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 230 ~~~~----~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
..+. .|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~ 158 (311)
T 3ork_A 83 AETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVM 158 (311)
T ss_dssp EEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEEC
T ss_pred ccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEe
Confidence 6654 49999999999999988644 579999999999999999999999999999999999999 677889999
Q ss_pred ecccccccCCCC----cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC
Q 012825 306 DFGLSDFVRPDE----RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380 (455)
Q Consensus 306 DfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 380 (455)
|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||...................
T Consensus 159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238 (311)
T ss_dssp CCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred eccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC
Confidence 999998764332 223457899999999876 468999999999999999999999999988888777777766555
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.......++.++.+||.+||+.||++||++.++|.|+|++..
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 444445789999999999999999999999999999999854
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=382.03 Aligned_cols=266 Identities=34% Similarity=0.639 Sum_probs=216.7
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-----CHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRALTGHNNLVKFF 225 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~ 225 (455)
+.+.++|++.+.||+|+||.||+|+... +++.||||++...... .......+.+|+++++++. |+||++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~ 81 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK 81 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcC---CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEe
Confidence 4456899999999999999999999776 5899999998654321 2223345889999999997 99999999
Q ss_pred EEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 226 DAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 226 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
+++..++ .|+||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+
T Consensus 82 ~~~~~~~-~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 82 NFFDAED-YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EEEESSS-EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred eEEcCCc-eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 9987655 899999999999998774 45679999999999999999999999999999999999999654455569999
Q ss_pred ecccccccCCCCcccccccCCCccccccc----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCChh-HHHHHHHhcCCCC
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSF 380 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~-~~~~~i~~~~~~~ 380 (455)
|||++.............||..|+|||++ ...++.++|||||||++|+|++|..||...... .....+......+
T Consensus 160 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (322)
T 2ycf_A 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239 (322)
T ss_dssp CCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC
T ss_pred cCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc
Confidence 99999887655444566799999999986 246899999999999999999999999765443 2333344433333
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
....+..++.++.+||.+||+.||++||++.++|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 222334689999999999999999999999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=376.12 Aligned_cols=255 Identities=31% Similarity=0.566 Sum_probs=219.7
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
.|+..+.||+|+||.||+|+... +|+.||||++...... ..+.+.+|+.++++++ |+||+++++++...+..+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~---~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred hhhccEEeccCCCeEEEEEEECC---CCcEEEEEEEeccchh---HHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEE
Confidence 48888899999999999999765 5899999998654322 2456889999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCC
Q 012825 236 VVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~ 315 (455)
+||||+++++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.....
T Consensus 119 lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 119 VLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISK 193 (321)
T ss_dssp EEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeeccc
Confidence 9999999999999763 3569999999999999999999999999999999999999 7788999999999987654
Q ss_pred CC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 316 DE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 316 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
.. ......||+.|+|||++. +.++.++||||||+++|+|++|+.||........+..+........ .....++..+.
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 272 (321)
T 2c30_A 194 DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLR 272 (321)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHH
T ss_pred CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHH
Confidence 32 335568999999999987 4689999999999999999999999998887777666655433221 22235789999
Q ss_pred HHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 394 DFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 394 ~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+||.+||+.||++|||+.++|+||||+...
T Consensus 273 ~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 273 DFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999999999998653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=383.20 Aligned_cols=262 Identities=29% Similarity=0.421 Sum_probs=215.7
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC--HHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT--AIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
..++|++.+.||+|+||.||+|++.. +|+.||||++....... ....+.+.+|++++++++ |+||+++++++.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGH 83 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECC---CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEee
Confidence 35789999999999999999999765 58999999986533221 112346789999999998 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
.+..++||||+++ +|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLA 159 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGG
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccc
Confidence 9999999999976 8888887666789999999999999999999999999999999999999 77889999999999
Q ss_pred cccCCC-CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCC---
Q 012825 311 DFVRPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP--- 384 (455)
Q Consensus 311 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--- 384 (455)
...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+...........
T Consensus 160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 876433 33455689999999999863 488899999999999999999999999888887777765422221111
Q ss_pred ---------------------CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 385 ---------------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 385 ---------------------~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+..++.++.+||++||+.||++|||+.|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13567899999999999999999999999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=370.67 Aligned_cols=260 Identities=32% Similarity=0.491 Sum_probs=228.3
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.+.||+|+||.||+|++.. +++.||+|++...........+.+.+|+.+++.+. |+||+++++++.++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 87 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDN 87 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred CcccceEEEEEEeecCCEEEEEEEECC---CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccC
Confidence 346789999999999999999999776 58899999997665556677788999999999997 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLAT 163 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCce
Confidence 999999999999999987754 4579999999999999999999999999999999999999 778899999999998
Q ss_pred ccCCC-CcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FVRPD-ERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
..... .......||..|+|||++.+ .++.++||||||+++|+|++|+.||......+....+........ ..++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 239 (294)
T 2rku_A 164 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHIN 239 (294)
T ss_dssp ECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSC
T ss_pred ecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccC
Confidence 76532 23445679999999999874 588999999999999999999999998887777776666554333 3678
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
..+.+||.+||+.||++|||+.++++||||+...
T Consensus 240 ~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 240 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 9999999999999999999999999999998653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=388.51 Aligned_cols=262 Identities=28% Similarity=0.527 Sum_probs=209.7
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|++.. +|+.||||++... .......+.+.+|++++++++ |+||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRM-FEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPD 97 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCS
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecC
Confidence 357899999999999999999999776 6899999999653 345666788999999999998 99999999999766
Q ss_pred -----CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 232 -----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 232 -----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
+.+|+||||++ ++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~D 172 (432)
T 3n9x_A 98 DLLKFDELYIVLEIAD-SDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCD 172 (432)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECC
T ss_pred CCCcCCeEEEEEecCC-cCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEcc
Confidence 57999999996 59988774 45679999999999999999999999999999999999999 7888999999
Q ss_pred cccccccCCCC-----------------------cccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCC
Q 012825 307 FGLSDFVRPDE-----------------------RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPF 361 (455)
Q Consensus 307 fG~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf 361 (455)
||+++...... .....+||..|+|||++. ..++.++|||||||++|||++|..||
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 99998765332 235678999999999863 46999999999999999999854443
Q ss_pred -----------CCCC-----------------hhHHHHHHHh-----------------------cCCCCCC----CCCC
Q 012825 362 -----------WART-----------------ESGIFRAVLK-----------------------ADPSFDE----APWP 386 (455)
Q Consensus 362 -----------~~~~-----------------~~~~~~~i~~-----------------------~~~~~~~----~~~~ 386 (455)
.+.. ..+.+..+++ ..+.... ..++
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence 2222 0112222211 1111110 0124
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.+++++.+||++||+.||++|||+.|+|+||||+...
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 6899999999999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=386.98 Aligned_cols=258 Identities=26% Similarity=0.473 Sum_probs=213.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcC-CCCeeEEeEEEeeC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG-HNNLVKFFDAYEDT 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~-hp~Iv~l~~~~~~~ 231 (455)
...+|++.+.||+|+||.||+|.... ++.||||++.... ......+.+.+|+.++++|.+ |+||+++++++..+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~ 128 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK----KQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 128 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT----CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC----CCEEEEEEEeccc-ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence 35679999999999999999998543 7899999997643 355667889999999999984 69999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+.+||||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ + ++.+||+|||+++
T Consensus 129 ~~~~lv~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 129 QYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI---V-DGMLKLIDFGIAN 202 (390)
T ss_dssp SEEEEEEE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE---S-SSCEEECCCSSSC
T ss_pred CEEEEEEe-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---E-CCeEEEEecCccc
Confidence 99999999 557899998865 4578999999999999999999999999999999999999 3 4679999999998
Q ss_pred ccCCCC---cccccccCCCcccccccCC------------CCCCcchHHHHHHHHHHHHcCCCCCCCCChh-HHHHHHHh
Q 012825 312 FVRPDE---RLNDIVGSAYYVAPEVLHR------------SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLK 375 (455)
Q Consensus 312 ~~~~~~---~~~~~~gt~~y~aPE~~~~------------~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~-~~~~~i~~ 375 (455)
...... .....+||+.|+|||++.+ .++.++|||||||+||||++|+.||...... ..+..++.
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 765433 2345689999999998753 5888999999999999999999999875433 44444544
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 376 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
....... ....+.++.+||.+||+.||++||++.|+|+||||+...
T Consensus 283 ~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 283 PNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp TTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ccccCCC--CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 3332222 234578999999999999999999999999999998654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=383.71 Aligned_cols=259 Identities=27% Similarity=0.510 Sum_probs=215.2
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+.+|+++++.++ |+||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPD 96 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSC
T ss_pred eecceEEEeEEeeecCCeEEEEEEECC---CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecC
Confidence 356899999999999999999998765 68999999986542 45566678899999999998 99999999999765
Q ss_pred C------ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 232 D------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 232 ~------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
+ .+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~ 170 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKIL 170 (367)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEEC
T ss_pred CccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEE
Confidence 3 469999999 7899988754 569999999999999999999999999999999999999 778899999
Q ss_pred ecccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC---
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF--- 380 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~--- 380 (455)
|||+++.... .....++|..|+|||++.+ .++.++|||||||++|||++|+.||.+....+.+..+.+.....
T Consensus 171 Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 171 DFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp CCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999987643 3455688999999998754 68999999999999999999999999888777666655422111
Q ss_pred --------------------C----CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 381 --------------------D----EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 381 --------------------~----~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
. ...++.+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 1 112346789999999999999999999999999999999764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=370.84 Aligned_cols=260 Identities=34% Similarity=0.619 Sum_probs=215.0
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
+...++|++.+.||+|+||.||+|+... +|+.||||++...........+.+.+|+.+++.+. |+||+++++++.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQL---TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVIST 82 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECC---CCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEec
Confidence 3456899999999999999999999765 58899999985432212223457889999999998 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
.+..++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~ 158 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLS 158 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGG
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccc
Confidence 99999999999999999988654 568999999999999999999999999999999999999 77889999999999
Q ss_pred cccCCCCcccccccCCCcccccccCCC-C-CCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLHRS-Y-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
.............|+..|+|||++.+. + +.++||||||+++|+|++|+.||...........+.......+ ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~ 234 (276)
T 2h6d_A 159 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYL 234 (276)
T ss_dssp GCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTS
T ss_pred cccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhc
Confidence 887655555567899999999998754 3 5789999999999999999999988887777777666544333 357
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+..+.+||.+||+.||++|||+.++++||||+..
T Consensus 235 ~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 8999999999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=401.82 Aligned_cols=258 Identities=27% Similarity=0.452 Sum_probs=222.6
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|++++++++ ||||+++++++.+.+.
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTD 259 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCE
Confidence 4789999999999999999999765 58999999986533222233467889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 234 VYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
+|+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeeccee
Confidence 99999999999999988654 3469999999999999999999999999999999999999 78899999999999
Q ss_pred cccCCCCc-ccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCC----hhHHHHHHHhcCCCCCCCC
Q 012825 311 DFVRPDER-LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFDEAP 384 (455)
Q Consensus 311 ~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~ 384 (455)
+....... ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.... .......+......++
T Consensus 337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--- 413 (543)
T 3c4z_A 337 VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--- 413 (543)
T ss_dssp EECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC---
T ss_pred eeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC---
Confidence 87754443 345689999999999874 68999999999999999999999997653 3456666666554443
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCC-----HHHHHcCcccCCC
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNS 422 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps-----~~elL~hp~~~~~ 422 (455)
..++.++.+||++||+.||.+||+ +.++++||||+..
T Consensus 414 -~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 414 -DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred -cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 368999999999999999999996 5899999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=366.43 Aligned_cols=259 Identities=20% Similarity=0.344 Sum_probs=217.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee---
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--- 230 (455)
...|++.+.||+|+||.||+|.+.. ++..||+|++.... ......+.+.+|+.++++++ ||||+++++++..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~va~k~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVK 99 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESS
T ss_pred ceeEEeeeeccCCCCeEEEEeEecC---CceEEEEEEecchh-hCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccC
Confidence 5679999999999999999998766 58899999986543 34556778999999999998 9999999999875
Q ss_pred -CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeeccCCceEEeecCCCceEEEeec
Q 012825 231 -TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 231 -~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.| |+||||||+|||++ +.++.+||+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Df 176 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDL 176 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCT
T ss_pred CCceEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeC
Confidence 3568999999999999998854 366999999999999999999999999 99999999999993 26788999999
Q ss_pred ccccccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
|++..... .......||+.|+|||++.+.++.++||||||+++|+|++|+.||.................. .......
T Consensus 177 g~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~ 254 (290)
T 1t4h_A 177 GLATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKV 254 (290)
T ss_dssp TGGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGGGGC
T ss_pred CCcccccc-cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-ccccCCC
Confidence 99976543 334456799999999999888999999999999999999999999876555444444333221 1112235
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 67899999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=372.50 Aligned_cols=268 Identities=26% Similarity=0.405 Sum_probs=223.4
Q ss_pred cccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 149 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
.++.+.++|++.+.||+|+||.||+|++.. +++.||+|++...........+.+.+|+.+++++. ||||+++++++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~ 80 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTI---LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVD 80 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETT---TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEE
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECC---CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEee
Confidence 356678999999999999999999998765 58899999997766667777889999999999998 99999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
.+++..|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg 156 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFG 156 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCS
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCC
Confidence 9999999999999999999988554 579999999999999999999999999999999999999 778899999999
Q ss_pred cccccCCCC--cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC-CCCC
Q 012825 309 LSDFVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF-DEAP 384 (455)
Q Consensus 309 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~ 384 (455)
++....... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||................... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T 4eqm_A 157 IAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDV 236 (294)
T ss_dssp SSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHS
T ss_pred CccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhc
Confidence 998765332 234467999999999876 468899999999999999999999999888776665555443222 1223
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
...++..+.++|.+||+.||.+||+..+.+.+.|..-..+
T Consensus 237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 4568999999999999999999997777777777665443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=372.39 Aligned_cols=257 Identities=29% Similarity=0.521 Sum_probs=212.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee--
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~-- 230 (455)
..++|++.+.||+|+||.||+|+... +++.||||++.... .+.+.+|+.+++++.+|+||+++++++.+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECC---CCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 35889999999999999999998766 58999999986432 25688999999999889999999999987
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
....++||||+++++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++ .+...+||+|||++
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLA 178 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCc
Confidence 667899999999999988763 489999999999999999999999999999999999994 23348999999999
Q ss_pred cccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCh-hHHHHHHHh------------
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTE-SGIFRAVLK------------ 375 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~-~~~~~~i~~------------ 375 (455)
.............|+..|+|||++.+ .++.++|||||||++|+|++|+.||..... .+.+..+..
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 179 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred eEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 88776666677789999999998764 589999999999999999999999954432 222222111
Q ss_pred -cCCCC--------------------CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 376 -ADPSF--------------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 376 -~~~~~--------------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
..... .......++.++.+||++||++||++|||+.|+|+||||+...+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 11000 00111237899999999999999999999999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=370.79 Aligned_cols=262 Identities=30% Similarity=0.497 Sum_probs=219.9
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.+.||+|+||.||+|+... +|+.||+|++.... ....+.+.+|+.+++.+. ||||+++++++.++
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIETKS---EEELEDYIVEIEILATCD-HPYIVKLLGAYYHD 88 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETT---TCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC
T ss_pred CCccceeecceeccCCCeEEEEEEEcC---CCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeC
Confidence 457899999999999999999999776 58899999986432 233467889999999997 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..++||||+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSA 165 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCc
Confidence 99999999999999999888777889999999999999999999999999999999999999 778899999999875
Q ss_pred ccCCC-CcccccccCCCccccccc------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 012825 312 FVRPD-ERLNDIVGSAYYVAPEVL------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (455)
Q Consensus 312 ~~~~~-~~~~~~~gt~~y~aPE~~------~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (455)
..... .......||..|+|||++ ...++.++||||||+++|+|++|..||...........+........ ..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 244 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LT 244 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SS
T ss_pred cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CC
Confidence 43211 122345789999999987 34688999999999999999999999998887777766666543322 12
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
...++..+.+||.+||+.||++|||+.++++||||+....
T Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 2357899999999999999999999999999999998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=367.15 Aligned_cols=263 Identities=25% Similarity=0.380 Sum_probs=201.6
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHH-HHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDV-RREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~-~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
..++|++.+.||+|+||.||+|+... +|+.||||++.... ......++ .++...++.+. ||||+++++++.++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~~ 78 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVP---SGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVD-CPFTVTFYGALFRE 78 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecC---CCeEEEEEEeeccc--CcHHHHHHHHHHHHHHHhCC-CCeEEEEeeeeecc
Confidence 46889999999999999999999766 58999999986542 23333334 44444455555 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeec
Q 012825 232 DNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
+..++||||+++ +|.+++.. .+..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 79 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Df 154 (290)
T 3fme_A 79 GDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDF 154 (290)
T ss_dssp SSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC
T ss_pred CCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeec
Confidence 999999999975 88776643 567899999999999999999999998 99999999999999 77889999999
Q ss_pred ccccccCCCCcccccccCCCcccccccC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCC-ChhHHHHHHHhcCCCCC
Q 012825 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFD 381 (455)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~sDiwSlG~~l~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~ 381 (455)
|++.............||+.|+|||++. ..++.++||||||+++|+|++|+.||... .....+..........
T Consensus 155 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 233 (290)
T 3fme_A 155 GISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ- 233 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-
T ss_pred CCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-
Confidence 9998876555555668999999999962 35888999999999999999999999763 3334444444433222
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCC
Q 012825 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (455)
Q Consensus 382 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~ 427 (455)
.....++.++.+||.+||+.||++|||+.|+++||||+.......
T Consensus 234 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~~~ 278 (290)
T 3fme_A 234 -LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278 (290)
T ss_dssp -CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCC
T ss_pred -cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCccccc
Confidence 222468999999999999999999999999999999997544443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=382.82 Aligned_cols=272 Identities=25% Similarity=0.417 Sum_probs=224.6
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
++...++|++.+.||+|+||.||+|++.. +++.||+|++... ......+.+.+|+.+++++. |+||+++++++.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 101 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLE--IKPAIRNQIIRELQVLHECN-SPYIVGFYGAFY 101 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECC---CCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEE
Confidence 34557899999999999999999999775 5899999999754 34566678999999999997 999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
+++..++||||+++++|.+++... +.+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+||+|||
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg 177 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFG 177 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCC
T ss_pred ECCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECC
Confidence 999999999999999999988554 5699999999999999999999996 99999999999999 778899999999
Q ss_pred cccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHH----------------
Q 012825 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR---------------- 371 (455)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~---------------- 371 (455)
++..... .......||..|+|||++. ..++.++||||||+++|+|++|+.||..........
T Consensus 178 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3eqc_A 178 VSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256 (360)
T ss_dssp CCHHHHH-HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred CCccccc-ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence 9875532 2334568999999999987 468999999999999999999999997765543221
Q ss_pred --------------------------HHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCC
Q 012825 372 --------------------------AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 372 --------------------------~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~ 425 (455)
.+..... .......++.++.+||++||+.||++|||+.|+|+||||+.....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp -----------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred cccCCCcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 1111111 111223578999999999999999999999999999999987766
Q ss_pred CCchhHHHH
Q 012825 426 KVPLDVIIF 434 (455)
Q Consensus 426 ~~p~~~~~~ 434 (455)
.+.....+.
T Consensus 335 ~~~~~~~~~ 343 (360)
T 3eqc_A 335 EVDFAGWLC 343 (360)
T ss_dssp CCCHHHHHH
T ss_pred hhhHHHHHh
Confidence 666544443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=375.99 Aligned_cols=258 Identities=26% Similarity=0.463 Sum_probs=210.2
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCC-CCeeEEeEEEeeC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-NNLVKFFDAYEDT 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-p~Iv~l~~~~~~~ 231 (455)
..++|++.+.||+|+||.||++... +++.||||++.... ......+.+.+|+.++.++.+| +||+++++++.++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT----TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC----CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 4678999999999999999999864 37899999987543 4556678899999999999832 9999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+.++||||+ .+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.
T Consensus 82 ~~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 82 QYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIAN 155 (343)
T ss_dssp SEEEEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSC
T ss_pred CEEEEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeeccccc
Confidence 999999995 47899998865 56799999999999999999999999999999999999993 4679999999998
Q ss_pred ccCCCCc---ccccccCCCcccccccC------------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh-HHHHHHHh
Q 012825 312 FVRPDER---LNDIVGSAYYVAPEVLH------------RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLK 375 (455)
Q Consensus 312 ~~~~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~-~~~~~i~~ 375 (455)
....... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||...... ..+..+..
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 7654332 24567999999999874 45788999999999999999999999765443 33333333
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 376 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.... .......+.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 236 ~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 236 PNHE--IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp TTSC--CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCcc--cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 2222 222235678999999999999999999999999999998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=369.52 Aligned_cols=261 Identities=28% Similarity=0.507 Sum_probs=215.0
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
....++|++.+.||+|+||.||+|+... +|+.||||++...... .+.+.+|+.+++++.+|+||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECC---CCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 3457899999999999999999999765 5889999998654322 35688999999999669999999999986
Q ss_pred ------CCceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEE
Q 012825 231 ------TDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (455)
Q Consensus 231 ------~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vk 303 (455)
.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEE
Confidence 56799999999999999988764 3579999999999999999999999999999999999999 7788999
Q ss_pred EeecccccccCCCC-cccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhc
Q 012825 304 AIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (455)
Q Consensus 304 L~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~ 376 (455)
|+|||++....... ......||..|+|||++. ..++.++||||||+++|+|++|..||...........+...
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 99999988764322 234567999999999874 45889999999999999999999999887776666555544
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 377 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.... .....++..+.+||.+||+.||.+||++.++++||||+...
T Consensus 250 ~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 250 PAPR--LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp CCCC--CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred cccc--CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 3222 22346899999999999999999999999999999999753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=376.99 Aligned_cols=260 Identities=29% Similarity=0.484 Sum_probs=215.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+... +|+.||||++.... ......+.+.+|+.+++++. |+||+++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETT---TCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECC---CCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCE
Confidence 5789999999999999999999766 58999999986543 44555677889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++ .....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 99 ~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EEEEEECCSEEHHHHHH-HSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC---
T ss_pred EEEEEecCCcchHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceee
Confidence 99999999887776654 455679999999999999999999999999999999999999 77889999999999776
Q ss_pred CCC-CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC-----------
Q 012825 314 RPD-ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----------- 379 (455)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~----------- 379 (455)
... .......||..|+|||++.+ .++.++||||||+++|+|++|+.||......+.+..+......
T Consensus 175 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 433 23455679999999999874 5899999999999999999999999988877666555432111
Q ss_pred ---CCC-------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 380 ---FDE-------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 380 ---~~~-------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+.. ..++.++..+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 000 0123578999999999999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=378.12 Aligned_cols=256 Identities=31% Similarity=0.502 Sum_probs=205.8
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+.++|++.+.||+|+||.||+|++.. +|+.||||++.... .....+.+.+|+.++++++ ||||++++++|.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKV---DDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETT---TCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECC
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcC---CCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEec
Confidence 45789999999999999999999775 58999999997543 3334577899999999998 999999999986544
Q ss_pred ---------------------------------------------------------ceEEEEeecCCCcHHHHHHhcCC
Q 012825 233 ---------------------------------------------------------NVYVVMELCEGGELLDRILSRGG 255 (455)
Q Consensus 233 ---------------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~~ 255 (455)
..++|||||++++|.+++.....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 28999999999999998865432
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCC-------------ccc
Q 012825 256 --KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-------------RLN 320 (455)
Q Consensus 256 --~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~-------------~~~ 320 (455)
...+..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... ...
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 45677899999999999999999999999999999999 778899999999998775442 223
Q ss_pred ccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 012825 321 DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRL 399 (455)
Q Consensus 321 ~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~ 399 (455)
...||+.|+|||++. ..++.++||||||+++|+|++|..|+... ......+.... .. ......++++.+||.+|
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~--~~-~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLK--FP-LLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTC--CC-HHHHHHCHHHHHHHHHH
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccC--CC-cccccCChhHHHHHHHH
Confidence 457999999999876 46899999999999999999987664211 11122222211 11 11124567889999999
Q ss_pred ccCCccCCCCHHHHHcCcccCCC
Q 012825 400 LNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 400 L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
|+.||++|||+.|+|+||||++.
T Consensus 310 l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 310 LSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp HCSSGGGSCCHHHHHHSTTCCCC
T ss_pred ccCCCCcCCCHHHHhhchhhhcC
Confidence 99999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=363.88 Aligned_cols=261 Identities=21% Similarity=0.349 Sum_probs=212.9
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
...+.++|++.+.||+|+||.||+|+... +++.||||++..... .......+.+|+..+..+..||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~ 81 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRL---DGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWA 81 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcC---CCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 34567899999999999999999999765 589999999976543 33445678899999999955999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC---------
Q 012825 230 DTDNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--------- 297 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~--------- 297 (455)
+.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence 999999999999999999988654 36799999999999999999999999999999999999995332
Q ss_pred -------CCceEEEeecccccccCCCCcccccccCCCcccccccCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCChhH
Q 012825 298 -------ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESG 368 (455)
Q Consensus 298 -------~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~ 368 (455)
....+||+|||++....... ...||..|+|||++.+. ++.++||||||+++|+|++|..++....
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--- 235 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--- 235 (289)
T ss_dssp --------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred ccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence 45579999999998765432 34689999999998754 5579999999999999999988775432
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
....+...... .....++.++.+||.+||+.||++|||+.++|+||||+...
T Consensus 236 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 236 QWHEIRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHHHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHHHHHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 23333333221 12246899999999999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=385.67 Aligned_cols=262 Identities=31% Similarity=0.542 Sum_probs=218.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-CHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.++|++.+.||+|+||.||+|+...+..+|+.||||++.+.... .....+.+.+|+++++++.+|+||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 47899999999999999999998655557899999998643211 11223456789999999966999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..+|||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence 999999999999999988654 569999999999999999999999999999999999999 7888999999999986
Q ss_pred cCCCC--cccccccCCCcccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCC----hhHHHHHHHhcCCCCCCC
Q 012825 313 VRPDE--RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAVLKADPSFDEA 383 (455)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~ 383 (455)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... .......+......+.
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP-- 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--
Confidence 54322 2345679999999999874 37889999999999999999999996433 2344445555444333
Q ss_pred CCCCCCHHHHHHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 384 PWPSLSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 384 ~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
..++..+.+||.+||+.||++|| ++.++++|+||+..+
T Consensus 287 --~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 287 --QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred --cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 36889999999999999999999 999999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=387.88 Aligned_cols=261 Identities=28% Similarity=0.430 Sum_probs=216.7
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc-----CCCCeeEE
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-----GHNNLVKF 224 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----~hp~Iv~l 224 (455)
.+.+..+|++.+.||+|+||.||+|.+.. +++.||||++.. .....+.+.+|+.+++.+. +|+||+++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~---~~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETT---TTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECC---CCcEEEEEEECC----ccchHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 34567899999999999999999998776 589999999854 3445567888999998885 37799999
Q ss_pred eEEEeeCCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCce--
Q 012825 225 FDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV-- 301 (455)
Q Consensus 225 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~-- 301 (455)
++++...+.+++||||+. ++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||| +.++.
T Consensus 165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl---~~~~~~~ 240 (429)
T 3kvw_A 165 LENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL---KQQGRSG 240 (429)
T ss_dssp EEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE---SSTTSCC
T ss_pred EeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---ccCCCcc
Confidence 999999999999999995 58998887654 459999999999999999999999999999999999999 55555
Q ss_pred EEEeecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC
Q 012825 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 380 (455)
Q Consensus 302 vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 380 (455)
+||+|||++.... ......+||+.|+|||++. ..++.++|||||||++|||++|..||......+.+..+.......
T Consensus 241 vkL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 241 IKVIDFGSSCYEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp EEECCCTTCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eEEeecccceecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999999997653 3344568999999999876 469999999999999999999999999888877766655421110
Q ss_pred CC-------------------------------------------------------CCCCCCCHHHHHHHHHhccCCcc
Q 012825 381 DE-------------------------------------------------------APWPSLSSEARDFVKRLLNKDPR 405 (455)
Q Consensus 381 ~~-------------------------------------------------------~~~~~~s~~l~~li~~~L~~dP~ 405 (455)
.. ......++++.+||++||++||+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~ 398 (429)
T 3kvw_A 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398 (429)
T ss_dssp CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence 00 00012478899999999999999
Q ss_pred CCCCHHHHHcCcccCCCC
Q 012825 406 KRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 406 ~Rps~~elL~hp~~~~~~ 423 (455)
+|||+.|+|+||||+...
T Consensus 399 ~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 399 VRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp TSCCHHHHHTSTTTC---
T ss_pred hCCCHHHHhCChhhccCC
Confidence 999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=381.06 Aligned_cols=257 Identities=27% Similarity=0.474 Sum_probs=205.7
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+.++|++.+.||+|+||.||+|+... +|+.||||++.... ......+.+.+|+.+++.+. ||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQK 97 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECC---CCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeecccc
Confidence 46899999999999999999998765 58999999997543 44556678899999999998 999999999997654
Q ss_pred ------ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 233 ------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 233 ------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
..|+||||+++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~D 170 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILD 170 (371)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECC
T ss_pred ccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEE
Confidence 68999999965 7888774 358999999999999999999999999999999999999 7788999999
Q ss_pred cccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC-----
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF----- 380 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~----- 380 (455)
||++.............||..|+|||++. ..++.++|||||||++|+|++|+.||.+......+..+++.....
T Consensus 171 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 171 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp CCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred eecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99998776555556678999999999887 468999999999999999999999999888777766665432211
Q ss_pred -----------------CCC---------CCC-------CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 381 -----------------DEA---------PWP-------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 381 -----------------~~~---------~~~-------~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
... ..+ ..+.++.+||++||+.||++|||+.|+|+||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 000 000 01567899999999999999999999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=381.47 Aligned_cols=254 Identities=30% Similarity=0.522 Sum_probs=215.8
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCH-----HHHHHHHHHHHHHHHhcCCCCeeEEeE
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----IAIEDVRREVKILRALTGHNNLVKFFD 226 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~~hp~Iv~l~~ 226 (455)
.+.++|++.+.||+|+||.||+|++.. +++.||||++........ ...+.+.+|+.++++++ |+||+++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~ 96 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKE---KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLD 96 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETT---TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECC---CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEE
Confidence 456899999999999999999998766 589999999976543221 12345678999999997 999999999
Q ss_pred EEeeCCceEEEEeecCCC-cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 227 AYEDTDNVYVVMELCEGG-ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 227 ~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
++.+.+..++||||+.+| +|.+++. ....+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~ 172 (335)
T 3dls_A 97 IFENQGFFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLI 172 (335)
T ss_dssp EEECSSEEEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEEC
T ss_pred EEeeCCEEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEe
Confidence 999999999999999766 8888764 55679999999999999999999999999999999999999 778899999
Q ss_pred ecccccccCCCCcccccccCCCcccccccCC-CC-CCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (455)
|||++.............||+.|+|||++.+ .+ +.++||||||+++|+|++|+.||...... .. ....
T Consensus 173 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~----~~~~ 242 (335)
T 3dls_A 173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE----AAIH 242 (335)
T ss_dssp CCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT----TCCC
T ss_pred ecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh----hccC
Confidence 9999988776666667789999999999874 34 77899999999999999999999753221 11 1112
Q ss_pred CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 384 ~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
....++.++.+||.+||+.||++|||+.++|+||||+...
T Consensus 243 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 2235899999999999999999999999999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=370.12 Aligned_cols=264 Identities=28% Similarity=0.522 Sum_probs=218.4
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
+...++|++.+.||+|+||.||+|.... +|+.||||++.... ..+.+.+|+.+++++. |+||+++++++.+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 95 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFK 95 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETT---TCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECC---CCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEe
Confidence 3457889999999999999999998765 58999999986542 1356889999999997 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.||+|+||||+|||+ +.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~ 172 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVA 172 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccc
Confidence 999999999999999999987777889999999999999999999999999999999999999 77889999999999
Q ss_pred cccCCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 311 DFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 311 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
....... ......|+..|+|||++. ..++.++||||||+++|+|++|..||...........+....... ......+
T Consensus 173 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 251 (314)
T 3com_A 173 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT-FRKPELW 251 (314)
T ss_dssp EECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGGGS
T ss_pred hhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc-cCCcccC
Confidence 7765332 234567899999999987 468999999999999999999999998877666555444433221 1222357
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~ 427 (455)
+..+.+||.+||+.||.+|||+.++|+||||+......+
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~ 290 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGG
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchH
Confidence 899999999999999999999999999999998654433
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=364.26 Aligned_cols=273 Identities=26% Similarity=0.468 Sum_probs=228.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|+... +++.||||++...... ...+.+.+|+.+++.+. |+||+++++++.+++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDT 93 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECC---CCcEEEEEEecccccH--HHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence 45789999999999999999998765 5889999999755322 33567899999999997 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++. .+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 94 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~ 168 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQ 168 (303)
T ss_dssp EEEEEEECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeeccccee
Confidence 9999999999999999773 4579999999999999999999999999999999999999 7788999999999987
Q ss_pred cCCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 313 VRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 313 ~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
..... ......||..|+|||++. ..++.++||||||+++|+|++|+.||...........+....... ....++.
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 245 (303)
T 3a7i_A 169 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSK 245 (303)
T ss_dssp CBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---CCSSCCH
T ss_pred cCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---CccccCH
Confidence 65433 334567999999999987 468899999999999999999999998887776666655544322 2246899
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHHHHHHHHH
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAY 440 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~~~~~~~~ 440 (455)
.+.+||.+||+.||++|||+.++++|+||.......-.+ ..+.+.+++.
T Consensus 246 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~-~~~~~~~~~~ 294 (303)
T 3a7i_A 246 PLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYL-TELIDRYKRW 294 (303)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCGGGG-HHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCccHHH-HHHHHHHHHh
Confidence 999999999999999999999999999998764443333 3333444443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=370.44 Aligned_cols=256 Identities=24% Similarity=0.355 Sum_probs=219.2
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.+.||+|+||.||+|++......+..||||++... ......+.+.+|+.++++++ |+||+++++++.++
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRG 122 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence 3468899999999999999999998765445678999999654 34556678999999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..+|||||+++++|.+++....+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSR 199 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCccc
Confidence 99999999999999999997777889999999999999999999999999999999999999 788899999999998
Q ss_pred ccCCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 312 FVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 312 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
....... .....+|..|+|||++. ..++.++||||||+++|+|++ |..||...........+....... ..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 276 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---AP 276 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---CC
Confidence 7654322 22334677899999987 568999999999999999999 999999988888777776653222 22
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..++..+.+||.+||+.||++||++.++++.
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4689999999999999999999999999763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=373.77 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=215.0
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.+.||+|+||.||+|++.. +|+.||||++...... ...+.+.+|++++++++ ||||+++++++...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLN-HKNIVKLFAIEEET 79 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCC-CTTBCCEEEEEECT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECC---CCcEEEEEEecccccc--chHHHHHHHHHHHHhcC-CCCcceEEEEeecC
Confidence 457899999999999999999999776 5889999998653322 22466789999999998 99999999999876
Q ss_pred C--ceEEEEeecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEee-cCCCceEEEee
Q 012825 232 D--NVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT-KDENSVLKAID 306 (455)
Q Consensus 232 ~--~~~lV~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~-~~~~~~vkL~D 306 (455)
+ ..++||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+.. .+.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 5 78999999999999998875433 3999999999999999999999999999999999999843 34667899999
Q ss_pred cccccccCCCCcccccccCCCcccccccC---------CCCCCcchHHHHHHHHHHHHcCCCCCCCCC----hhHHHHHH
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH---------RSYSTEADVWSIGVIAYILLCGSRPFWART----ESGIFRAV 373 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~----~~~~~~~i 373 (455)
||+++............||..|+|||++. ..++.++|||||||++|||++|+.||.... ....+..+
T Consensus 160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 99999887666666778999999999873 568899999999999999999999996433 34455556
Q ss_pred HhcCCCCC---------------------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCc
Q 012825 374 LKADPSFD---------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (455)
Q Consensus 374 ~~~~~~~~---------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp 417 (455)
+...+... ......++..+.+||++||+.||++|||+.|+|+||
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 55443210 011113456789999999999999999999999996
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=381.85 Aligned_cols=260 Identities=28% Similarity=0.452 Sum_probs=213.0
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
++....+|++.+.||+|+||.||+|+... +..||+|.+...... ..+|+++++.++ |+||+++++++.
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~----~~~~aikk~~~~~~~-------~~~E~~il~~l~-h~niv~l~~~~~ 102 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVE----SDEVAIKKVLQDKRF-------KNRELQIMRIVK-HPNVVDLKAFFY 102 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETT----TEEEEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEE
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECC----CCeEEEEEEecCcch-------HHHHHHHHHhCC-CCCcceEEEEEE
Confidence 34556789999999999999999998765 345888887543211 236999999998 999999999996
Q ss_pred eCCc------eEEEEeecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCc
Q 012825 230 DTDN------VYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (455)
Q Consensus 230 ~~~~------~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~ 300 (455)
..+. +++||||+++ ++.+.+. .....+++..++.++.||+.||.|||++||+||||||+|||++ ..++
T Consensus 103 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~ 179 (394)
T 4e7w_A 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSG 179 (394)
T ss_dssp EESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTT
T ss_pred ecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCC
Confidence 5443 8899999976 4444332 3466899999999999999999999999999999999999993 2688
Q ss_pred eEEEeecccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC
Q 012825 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (455)
Q Consensus 301 ~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (455)
.+||+|||+++............||..|+|||++.+ .++.++|||||||++|||++|+.||.+....+.+..+.+...
T Consensus 180 ~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 259 (394)
T 4e7w_A 180 VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259 (394)
T ss_dssp EEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999999988766666667789999999998864 589999999999999999999999999887777666654211
Q ss_pred C-----------------CCC--------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 379 S-----------------FDE--------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 379 ~-----------------~~~--------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
. +.. ...+.++.++.+||.+||+.||.+|||+.|+|+||||+...+
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 0 000 012347899999999999999999999999999999998653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=384.94 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=212.1
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
...+|++.+.||+|+||.||+|++.. +|+.||||++..... ...+|+++++.++ |+||++++++|...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECC---CCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccC
Confidence 35679999999999999999999876 589999999865421 2347999999998 99999999998542
Q ss_pred -----CceEEEEeecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEE
Q 012825 232 -----DNVYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (455)
Q Consensus 232 -----~~~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vk 303 (455)
..+++||||+++ +|.+.+. .....+++..++.++.||+.||.|||++||+||||||+||||+ .+.+.+|
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~k 197 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLK 197 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEE
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEE
Confidence 236799999975 6666554 3467899999999999999999999999999999999999994 2456799
Q ss_pred EeecccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhc-----
Q 012825 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA----- 376 (455)
Q Consensus 304 L~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~----- 376 (455)
|+|||+++...........+||..|+|||++.+ .++.++|||||||+||||++|+.||.+....+.+..+++.
T Consensus 198 l~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 198 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277 (420)
T ss_dssp ECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred eccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999999988765555666789999999998863 6899999999999999999999999988877766665542
Q ss_pred -------CCCCCCC-------------CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 377 -------DPSFDEA-------------PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 377 -------~~~~~~~-------------~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.+.+... ..+.++.++.+||.+||+.||.+||++.|+|+||||+...
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 1111111 1135689999999999999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=363.79 Aligned_cols=261 Identities=31% Similarity=0.559 Sum_probs=217.8
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+.++|++.+.||+|+||.||+|+... +++.||||++..... ....+.+.+|+.+++.+. |+||+++++++.+++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGN 78 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred eecceEEEEEeecCCCcEEEEEEECC---CCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCC
Confidence 45789999999999999999998765 588999999864432 234567899999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++ .....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATV 154 (276)
T ss_dssp EEEEEEECCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEEecCCCcHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccc
Confidence 999999999999998876 345579999999999999999999999999999999999999 7788999999999976
Q ss_pred cCCCC---cccccccCCCcccccccCC-C-CCCcchHHHHHHHHHHHHcCCCCCCCCChhH-HHHHHHhcCCCCCCCCCC
Q 012825 313 VRPDE---RLNDIVGSAYYVAPEVLHR-S-YSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 313 ~~~~~---~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 386 (455)
..... ......|+..|+|||++.+ . ++.++||||||+++|+|++|+.||....... .+......... ...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 232 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWK 232 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGG
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchh
Confidence 53222 2345678999999999874 3 4678999999999999999999998765542 23333322211 22234
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~ 425 (455)
.++..+.+||.+||+.||++|||+.|+++||||+...+.
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 271 (276)
T 2yex_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 271 (276)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred hcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence 689999999999999999999999999999999987544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=379.63 Aligned_cols=257 Identities=27% Similarity=0.470 Sum_probs=213.2
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~- 230 (455)
...++|++.+.||+|+||.||+|++.. +|+.||||++..... ...+|+++++.++ |+||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~~~-------~~~~E~~il~~l~-hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPR-------YKNRELDIMKVLD-HVNIIKLVDYFYTT 72 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETT---TCCEEEEEEEECCTT-------SCCHHHHHHTTCC-CTTBCCEEEEEEEC
T ss_pred cccceEEEEEEEEeccCEEEEEEEECC---CCCEEEEEEEecCcc-------hHHHHHHHHHHcC-CCCccchhheeeec
Confidence 346899999999999999999999766 689999999865422 1237999999998 9999999999843
Q ss_pred -------------------------------------CCceEEEEeecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHH
Q 012825 231 -------------------------------------TDNVYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQIL 270 (455)
Q Consensus 231 -------------------------------------~~~~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qi~ 270 (455)
+..+++||||+++ +|.+.+. ..+..+++..++.++.||+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 3348899999974 8776664 3467899999999999999
Q ss_pred HHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHH
Q 012825 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIG 348 (455)
Q Consensus 271 ~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG 348 (455)
.||.|||++||+||||||+|||++ ..++.+||+|||+++............||..|+|||++.+ .++.++||||||
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 999999999999999999999994 3578999999999998776666677789999999998764 489999999999
Q ss_pred HHHHHHHcCCCCCCCCChhHHHHHHHhcCC------------CCCCC-------------CCCCCCHHHHHHHHHhccCC
Q 012825 349 VIAYILLCGSRPFWARTESGIFRAVLKADP------------SFDEA-------------PWPSLSSEARDFVKRLLNKD 403 (455)
Q Consensus 349 ~~l~elltg~~Pf~~~~~~~~~~~i~~~~~------------~~~~~-------------~~~~~s~~l~~li~~~L~~d 403 (455)
|++|+|++|+.||.+....+.+..+.+... .+... ....++.++.+||.+||+.|
T Consensus 230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999999999888777766654211 11110 11247889999999999999
Q ss_pred ccCCCCHHHHHcCcccCCC
Q 012825 404 PRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 404 P~~Rps~~elL~hp~~~~~ 422 (455)
|++|||+.|+|+||||+..
T Consensus 310 P~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 310 PDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp GGGSCCHHHHHTSGGGHHH
T ss_pred hhhCCCHHHHhcCHHHHHH
Confidence 9999999999999999854
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=376.26 Aligned_cols=258 Identities=29% Similarity=0.505 Sum_probs=217.5
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
+.++|++++.||+|+||.||+|+... +++.||||++... ......+.+.+|++++++++ |+||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPF--EHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPT 98 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSS
T ss_pred ccccEEEEEEeecCCCeEEEEEEECC---CCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCC
Confidence 35799999999999999999998765 5899999998643 44556678899999999998 99999999999754
Q ss_pred ----CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeec
Q 012825 232 ----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 232 ----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
...|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 99 ~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Df 172 (364)
T 3qyz_A 99 IEQMKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDF 172 (364)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCC
T ss_pred ccccceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeC
Confidence 36899999996 589988754 469999999999999999999999999999999999999 77889999999
Q ss_pred ccccccCCCCc----ccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC
Q 012825 308 GLSDFVRPDER----LNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (455)
Q Consensus 308 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (455)
|++........ .....||+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+.+..+........
T Consensus 173 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252 (364)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC
T ss_pred cceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99987653322 34568999999999864 3489999999999999999999999988877776666543211110
Q ss_pred -----------------------C----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 382 -----------------------E----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 382 -----------------------~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
. ...+.++.++.+||.+||++||++|||+.|+|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0 0124678999999999999999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=378.08 Aligned_cols=268 Identities=24% Similarity=0.426 Sum_probs=218.9
Q ss_pred CcCcccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCC-----C
Q 012825 146 SFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-----N 220 (455)
Q Consensus 146 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-----~ 220 (455)
.+..++.+.++|++.+.||+|+||.||+|+... +++.||||++.. .......+.+|+.+++.+..|+ +
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~ 117 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYY 117 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHCSSGGGGG
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcC---CCcEEEEEEEec----cHHHHHHHHHHHHHHHHHHhccccccee
Confidence 344556778999999999999999999998765 589999999853 3445677888999999887566 4
Q ss_pred eeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HcCCEEeeccCCceEEeecC
Q 012825 221 LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCH--LQGVVHRDLKPENFLFTTKD 297 (455)
Q Consensus 221 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH--~~~ivHrDikp~NILl~~~~ 297 (455)
|+++++++...+..||||||++ ++|.+++.... ..+++..++.++.||+.||.||| +.||+||||||+|||+.. +
T Consensus 118 iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~ 195 (382)
T 2vx3_A 118 IVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-P 195 (382)
T ss_dssp BCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-T
T ss_pred EEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-C
Confidence 9999999999999999999996 59999887654 56999999999999999999999 579999999999999942 2
Q ss_pred CCceEEEeecccccccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhc
Q 012825 298 ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (455)
Q Consensus 298 ~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~ 376 (455)
.++.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+.+..+...
T Consensus 196 ~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 273 (382)
T 2vx3_A 196 KRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273 (382)
T ss_dssp TSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCCcEEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 367899999999987642 3445689999999999874 6899999999999999999999999988887777666543
Q ss_pred CCCCCC------------------CCC--------------CC----------------------------CCHHHHHHH
Q 012825 377 DPSFDE------------------APW--------------PS----------------------------LSSEARDFV 396 (455)
Q Consensus 377 ~~~~~~------------------~~~--------------~~----------------------------~s~~l~~li 396 (455)
...... ..| +. ...++.+||
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 353 (382)
T 2vx3_A 274 LGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI 353 (382)
T ss_dssp HCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHH
T ss_pred hCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHH
Confidence 211100 000 00 013789999
Q ss_pred HHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 397 KRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 397 ~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
.+||++||++|||+.|+|+||||+...+
T Consensus 354 ~~mL~~dP~~Rpta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 354 LRMLDYDPKTRIQPYYALQHSFFKKTAD 381 (382)
T ss_dssp HHHTCSCTTTSCCHHHHTTSGGGCC---
T ss_pred HHhcCCChhhCCCHHHHhcCcccccCCC
Confidence 9999999999999999999999997643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=380.07 Aligned_cols=259 Identities=30% Similarity=0.531 Sum_probs=202.7
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+.+|+.+++.++ |+||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA 100 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETT---TTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECC---CCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC
Confidence 456899999999999999999998765 68999999986532 45556678899999999998 99999999998654
Q ss_pred ------CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 232 ------DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 232 ------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
...|+|||++ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+
T Consensus 101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~ 174 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKIL 174 (367)
T ss_dssp SSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred CccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEe
Confidence 5689999999 7799887743 579999999999999999999999999999999999999 778899999
Q ss_pred ecccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC---
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF--- 380 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~--- 380 (455)
|||+++.... ......||..|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.+.....
T Consensus 175 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 175 DFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp C-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999987542 3445689999999998764 68999999999999999999999999888777666665421111
Q ss_pred --------------------CC----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 381 --------------------DE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 381 --------------------~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.. ..++.+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 00 01235688999999999999999999999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=369.68 Aligned_cols=268 Identities=29% Similarity=0.419 Sum_probs=220.7
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEeEEEe-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYE- 229 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hp~Iv~l~~~~~- 229 (455)
+.++|++.+.||+|+||.||+|+.... +|+.||||++....... .....+.+|+.+++.+. .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCC--CCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 458899999999999999999997532 47899999986432111 11124567888887773 4999999999987
Q ss_pred ----eCCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEE
Q 012825 230 ----DTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (455)
Q Consensus 230 ----~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL 304 (455)
.....++||||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl 161 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKL 161 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEE
Confidence 4567999999997 59999887654 459999999999999999999999999999999999999 77889999
Q ss_pred eecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC---
Q 012825 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF--- 380 (455)
Q Consensus 305 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~--- 380 (455)
+|||++.............||..|+|||++. +.++.++||||||+++|+|++|+.||........+..++......
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 9999998776555556678999999999876 568999999999999999999999999888877777766421110
Q ss_pred --------------------CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCC
Q 012825 381 --------------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (455)
Q Consensus 381 --------------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~ 427 (455)
.......++..+.+||.+||+.||++||++.++|+||||+.......
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 308 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence 01123468899999999999999999999999999999998765543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=380.60 Aligned_cols=268 Identities=24% Similarity=0.411 Sum_probs=213.0
Q ss_pred CCCcCcccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcC------
Q 012825 144 NKSFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG------ 217 (455)
Q Consensus 144 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~------ 217 (455)
...+..++.+.++|++.++||+|+||.||+|+... +++.||||++.. .....+.+.+|+.+++.+..
T Consensus 26 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~ 98 (397)
T 1wak_A 26 YHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSDPNDP 98 (397)
T ss_dssp CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHSCTTCG
T ss_pred ceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecC---CCeEEEEEEEec----CCcchHHHHHHHHHHHHHhhcCCCCC
Confidence 44566677888999999999999999999998766 589999999853 34456778999999999962
Q ss_pred -CCCeeEEeEEEe----eCCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCc
Q 012825 218 -HNNLVKFFDAYE----DTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPEN 290 (455)
Q Consensus 218 -hp~Iv~l~~~~~----~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~N 290 (455)
|+||+++++++. ....+|+||||+ +++|.+.+.... ..+++..++.|+.||+.||.|||++ ||+||||||+|
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N 177 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 788999999987 456799999999 567777776554 6799999999999999999999999 99999999999
Q ss_pred eEEeecC----------------------------------------------CCceEEEeecccccccCCCCccccccc
Q 012825 291 FLFTTKD----------------------------------------------ENSVLKAIDFGLSDFVRPDERLNDIVG 324 (455)
Q Consensus 291 ILl~~~~----------------------------------------------~~~~vkL~DfG~a~~~~~~~~~~~~~g 324 (455)
||++.++ ....+||+|||++..... ......|
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~g 255 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQ 255 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCS
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCC
Confidence 9994211 113799999999987643 3445689
Q ss_pred CCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCh------hHHHHHHHhcCCCCCC---------------
Q 012825 325 SAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE------SGIFRAVLKADPSFDE--------------- 382 (455)
Q Consensus 325 t~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~------~~~~~~i~~~~~~~~~--------------- 382 (455)
|..|+|||++. ..++.++|||||||+||+|++|+.||..... ...+..+.......+.
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 335 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence 99999999876 4699999999999999999999999975442 2222222221111000
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 383 -----------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 383 -----------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
......+..+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 001123467889999999999999999999999999973
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=376.34 Aligned_cols=257 Identities=31% Similarity=0.562 Sum_probs=214.7
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|.+.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+.+|+.+++.++ |+||+++++++...
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 113 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPA 113 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred cccccEEEEeEEecCCCeEEEEEEECC---CCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheecc
Confidence 356899999999999999999999776 68999999997543 45566778899999999998 99999999999877
Q ss_pred Cce------EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 232 DNV------YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 232 ~~~------~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
+.. |+||||+. ++|.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~ 186 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKIL 186 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEEC
T ss_pred CCcccceeEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEE
Confidence 654 99999996 5887755 3459999999999999999999999999999999999999 788899999
Q ss_pred ecccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC---
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF--- 380 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~--- 380 (455)
|||+++.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.......
T Consensus 187 Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 187 DFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp STTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 9999986542 3445678999999998764 68999999999999999999999999888777666665422111
Q ss_pred --------------------CC----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 381 --------------------DE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 381 --------------------~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.. ..++.++.++.+||++||+.||++|||+.|+|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 00 0123578999999999999999999999999999999965
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=376.94 Aligned_cols=265 Identities=19% Similarity=0.263 Sum_probs=223.7
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
+...++|++.+.||+|+||.||+|++.. ...+++.||||++... ........+.+|+.++++++ |+||+++++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~ 143 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVS 143 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence 3446889999999999999999999654 2235789999998643 45556678899999999997 99999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceE
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRG------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~v 302 (455)
.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999987654 459999999999999999999999999999999999999654456679
Q ss_pred EEeecccccccCCC---CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcC
Q 012825 303 KAIDFGLSDFVRPD---ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 377 (455)
Q Consensus 303 kL~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~ 377 (455)
||+|||+++..... .......||+.|+|||++. +.++.++|||||||++|||++ |..||......+.+..+....
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999754221 2234456889999999875 678999999999999999998 999999988888777776654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 378 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.... ...++..+.+||.+||+.||++||++.+++++.|+..
T Consensus 304 ~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 304 RMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 3222 2368899999999999999999999999999977654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=375.82 Aligned_cols=263 Identities=24% Similarity=0.414 Sum_probs=211.8
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc--------CCHHHHHHHHHHHHHHHHhcCCCCee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM--------TTAIAIEDVRREVKILRALTGHNNLV 222 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~~~~Ei~~l~~l~~hp~Iv 222 (455)
..+.++|++.+.||+|+||.||+|.... |+.||||++..... ......+.+.+|+.++++++ ||||+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv 92 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE----GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNIL 92 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT----SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBC
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC----CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCcc
Confidence 4567899999999999999999998643 88999999854321 23445578999999999998 99999
Q ss_pred EEeEEEee-----CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC
Q 012825 223 KFFDAYED-----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (455)
Q Consensus 223 ~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~ 297 (455)
++++++.. ...+|+||||++ ++|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~ 168 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---A 168 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---C
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---c
Confidence 99999854 335899999997 58999888777789999999999999999999999999999999999999 7
Q ss_pred CCceEEEeecccccccCCCCcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHh
Q 012825 298 ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 375 (455)
Q Consensus 298 ~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~ 375 (455)
.++.+||+|||++.............||..|+|||++. ..++.++|||||||++|+|++|+.||......+.+..+..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp TTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 78899999999998766555566678999999999876 4689999999999999999999999998887777666654
Q ss_pred cCCCC------------------------CC----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 376 ADPSF------------------------DE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 376 ~~~~~------------------------~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
..... .. ...+.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 21111 00 0123568899999999999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=372.28 Aligned_cols=261 Identities=30% Similarity=0.526 Sum_probs=216.5
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
..+.++|++.+.||+|+||.||+|+... +|+.||||++... ........+.+|+.++++++ |+||+++++++..
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPF--DKPLFALRTLREIKILKHFK-HENIITIFNIQRP 80 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCC
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECC---CCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecc
Confidence 3467899999999999999999998765 5899999999643 44556677889999999998 9999999998875
Q ss_pred C-----CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 231 T-----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 231 ~-----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
. +..++||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~ 154 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVC 154 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEEC
T ss_pred cccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEE
Confidence 4 67899999996 589887754 469999999999999999999999999999999999999 778899999
Q ss_pred ecccccccCCCC-----------cccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 012825 306 DFGLSDFVRPDE-----------RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA 372 (455)
Q Consensus 306 DfG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~ 372 (455)
|||++....... ......||..|+|||++. ..++.++|||||||++|+|++|+.||.+......+..
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999998764322 122357899999999864 4688999999999999999999999988876665554
Q ss_pred HHhcCCC------------------------CCC----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 373 VLKADPS------------------------FDE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 373 i~~~~~~------------------------~~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+...... ... ..++.++.++.+||++||+.||++|||+.++|+||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 4332111 000 01246889999999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=373.60 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=217.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecC----cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKG----ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
.++|++.+.||+|+||.||+|++... ..++..||||++... ......+.+.+|+.+++++..||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 57899999999999999999987531 224678999999654 355667789999999999955999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEe
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~ 294 (455)
+.+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll- 236 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV- 236 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE-
Confidence 9999999999999999999987643 358999999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecccccccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 012825 295 TKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (455)
Q Consensus 295 ~~~~~~~vkL~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 369 (455)
+.++.+||+|||+++...... ......+|+.|+|||++. ..++.++|||||||++|||++ |..||......+.
T Consensus 237 --~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 237 --TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp --CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred --CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 788899999999998665332 223446778999999876 568999999999999999999 9999988887777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+..+....... ....++.++.+||.+||+.||.+||++.|++++
T Consensus 315 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 315 FKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66665543221 224688999999999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=368.63 Aligned_cols=264 Identities=29% Similarity=0.525 Sum_probs=200.6
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|+... +++.||||++.... .....+++.+|+.+++++. ||||+++++++...+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKD 86 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC-------CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSS
T ss_pred chhhhhhhheeccccceEEEEEEECC---CCcEEEEEEEEhhh--cchhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecC
Confidence 36789999999999999999998665 57899999986542 2334567889999999997 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 233 NVYVVMELCEGGELLDRILS-------RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~-------~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEE
Confidence 99999999999999998864 34569999999999999999999999999999999999999 778899999
Q ss_pred ecccccccCCCC------cccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcC
Q 012825 306 DFGLSDFVRPDE------RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 377 (455)
Q Consensus 306 DfG~a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~ 377 (455)
|||++....... ......||..|+|||++. ..++.++||||||+++|+|++|+.||................
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 999987654322 123457999999999886 368999999999999999999999998877766665555543
Q ss_pred CCCCC------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCC
Q 012825 378 PSFDE------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 378 ~~~~~------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~ 425 (455)
..... .....++.++.+||.+||+.||.+||++.++++||||+...+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 32211 2234688999999999999999999999999999999986543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=373.39 Aligned_cols=259 Identities=37% Similarity=0.682 Sum_probs=188.3
Q ss_pred ccCCCeEEec-eEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 152 HFANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 152 ~~~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
.+.++|++.+ .||+|+||.||+|++.. +|+.||||++... . ...+|+..+.++.+|+||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~----~----~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRR---TGQKCALKLLYDS----P----KARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESS----H----HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECC---CCCEEEEEEecCc----H----HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 3568899965 69999999999999776 5899999998542 2 223444444444459999999999976
Q ss_pred ----CCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 231 ----TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 231 ----~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
++..++||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 445899999999999999987654 469999999999999999999999999999999999999765567789999
Q ss_pred ecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHH----HHHHHhcCCCC
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGI----FRAVLKADPSF 380 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~----~~~i~~~~~~~ 380 (455)
|||++..... .......||+.|+|||++. ..++.++||||||+++|+|++|..||........ ...+......+
T Consensus 174 Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 174 DFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp CCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred ccccceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 9999987653 3344567899999999986 4688899999999999999999999976654433 22222333334
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 381 DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 381 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
....+..++.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 444456789999999999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=372.01 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=216.2
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
...++|++.+.||+|+||.||+|++.. ...+++.||||++... ......+.+.+|++++.++.+||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 346899999999999999999998764 3346789999999654 345556789999999999966999999999998
Q ss_pred eCCc-eEEEEeecCCCcHHHHHHhcCC-----------------------------------------------------
Q 012825 230 DTDN-VYVVMELCEGGELLDRILSRGG----------------------------------------------------- 255 (455)
Q Consensus 230 ~~~~-~~lV~E~~~ggsL~~~l~~~~~----------------------------------------------------- 255 (455)
+.+. .++||||+++|+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 7654 9999999999999999875432
Q ss_pred ------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCC---ccc
Q 012825 256 ------------KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLN 320 (455)
Q Consensus 256 ------------~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~---~~~ 320 (455)
.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... ...
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccchhcc
Confidence 18999999999999999999999999999999999999 778899999999998764332 234
Q ss_pred ccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 012825 321 DIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKR 398 (455)
Q Consensus 321 ~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~ 398 (455)
...||..|+|||++. ..++.++||||||+++|||++ |..||........+...+........ ...+++++.+||.+
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLD 331 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHH
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC--CCCCCHHHHHHHHH
Confidence 456889999999876 578999999999999999998 99999887765555555554433222 23688999999999
Q ss_pred hccCCccCCCCHHHHHcC
Q 012825 399 LLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 399 ~L~~dP~~Rps~~elL~h 416 (455)
||+.||.+|||+.++++|
T Consensus 332 ~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCChhhCCCHHHHHHH
Confidence 999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=366.52 Aligned_cols=266 Identities=28% Similarity=0.446 Sum_probs=217.8
Q ss_pred CcccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCC------Ce
Q 012825 148 GFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN------NL 221 (455)
Q Consensus 148 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp------~I 221 (455)
..++.+.++|++.+.||+|+||.||+|.+... +++.||||++.. .....+.+.+|+.+++.+. |+ ++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~-~~~~~~~~~i 79 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKA--GGRHVAVKIVKN----VDRYCEAARSEIQVLEHLN-TTDPNSTFRC 79 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECS----SHHHHHHHHHHHHHHHHHH-HHCTTCTTCB
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCC--CCcEEEEEEEec----CCchhHHHHHHHHHHHHhh-hcCCCCceee
Confidence 44567789999999999999999999987432 488999999853 2445677889999999987 54 59
Q ss_pred eEEeEEEeeCCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCC--
Q 012825 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-- 298 (455)
Q Consensus 222 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~-- 298 (455)
+++++++.+.+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 80 VQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEE
T ss_pred EeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccc
Confidence 99999999999999999999 889999887654 36899999999999999999999999999999999999953221
Q ss_pred --------------CceEEEeecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 012825 299 --------------NSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWA 363 (455)
Q Consensus 299 --------------~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~ 363 (455)
++.+||+|||++.... .......||..|+|||++. ..++.++||||||+++|||++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCCccccccccccCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 5679999999998653 2334568999999999987 4689999999999999999999999988
Q ss_pred CChhHHHHHHHhcCCCCCC----------------------------------------CCCCCCCHHHHHHHHHhccCC
Q 012825 364 RTESGIFRAVLKADPSFDE----------------------------------------APWPSLSSEARDFVKRLLNKD 403 (455)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~----------------------------------------~~~~~~s~~l~~li~~~L~~d 403 (455)
....+....+.......+. ......++++.+||.+||+.|
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 7776655444332111110 000123467899999999999
Q ss_pred ccCCCCHHHHHcCcccCCCC
Q 012825 404 PRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 404 P~~Rps~~elL~hp~~~~~~ 423 (455)
|.+|||+.|+|+||||+...
T Consensus 317 P~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 317 PAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp TTTSCCHHHHTTSGGGGGGG
T ss_pred cccccCHHHHhcCHHHHHHh
Confidence 99999999999999999764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=386.04 Aligned_cols=263 Identities=28% Similarity=0.484 Sum_probs=198.0
Q ss_pred ccCCCeEE-eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 152 HFANKYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 152 ~~~~~y~~-~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
.+.+.|++ .++||+|+||.||+|+.+... +++.||||++..... . ..+.+|+.++++|+ ||||+++++++..
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~-~----~~~~~E~~~l~~l~-hpniv~~~~~~~~ 89 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGTGI-S----MSACREIALLRELK-HPNVISLQKVFLS 89 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSS-CCCCEEEEECSSSSC-C----HHHHHHHHHHHHCC-CTTBCCCCEEEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCC-CCeEEEEEEECCCCC-C----HHHHHHHHHHHhcC-CCCeeeEeeEEec
Confidence 34567887 558999999999999876422 578999999965432 1 35778999999998 9999999999954
Q ss_pred --CCceEEEEeecCCCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec-CCC
Q 012825 231 --TDNVYVVMELCEGGELLDRILSR--------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-DEN 299 (455)
Q Consensus 231 --~~~~~lV~E~~~ggsL~~~l~~~--------~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~-~~~ 299 (455)
+..+||||||+. ++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||||... +.+
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 678999999996 4888877532 2259999999999999999999999999999999999999643 456
Q ss_pred ceEEEeecccccccCCC----CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCh-------
Q 012825 300 SVLKAIDFGLSDFVRPD----ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTE------- 366 (455)
Q Consensus 300 ~~vkL~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~------- 366 (455)
+.+||+|||+++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 89999999999876532 23345689999999998864 489999999999999999999999976544
Q ss_pred --hHHHHHHHhcCCCCCCCCCC----------------------------------CCCHHHHHHHHHhccCCccCCCCH
Q 012825 367 --SGIFRAVLKADPSFDEAPWP----------------------------------SLSSEARDFVKRLLNKDPRKRLTA 410 (455)
Q Consensus 367 --~~~~~~i~~~~~~~~~~~~~----------------------------------~~s~~l~~li~~~L~~dP~~Rps~ 410 (455)
.+.+..+...........|. ..+..+.+||++||++||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 24444444332222222221 126788999999999999999999
Q ss_pred HHHHcCcccCCC
Q 012825 411 AQALSHPWIKNS 422 (455)
Q Consensus 411 ~elL~hp~~~~~ 422 (455)
.|+|+||||+..
T Consensus 329 ~e~L~hp~f~~~ 340 (405)
T 3rgf_A 329 EQAMQDPYFLED 340 (405)
T ss_dssp HHHHTSGGGTSS
T ss_pred HHHhcChhhccC
Confidence 999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=382.87 Aligned_cols=260 Identities=18% Similarity=0.193 Sum_probs=199.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc-CCCCeeEEe-------
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-GHNNLVKFF------- 225 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-~hp~Iv~l~------- 225 (455)
..+|++.+.||+|+||.||+|++.. +|+.||||++...........+.+.+|+.+++.|. .||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVE---RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECC---CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 3459999999999999999999776 58999999998766556666778889976666664 499988755
Q ss_pred EEEeeC-----------------CceEEEEeecCCCcHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHHcCCE
Q 012825 226 DAYEDT-----------------DNVYVVMELCEGGELLDRILSRGGKYTEDDA------KAVMIQILNVVAFCHLQGVV 282 (455)
Q Consensus 226 ~~~~~~-----------------~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~------~~i~~qi~~gL~~LH~~~iv 282 (455)
+++... ..+||||||++ ++|.+++...+..+.+..+ ..++.||+.||.|||++||+
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv 216 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV 216 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence 454433 33899999998 7999999776555666666 78889999999999999999
Q ss_pred EeeccCCceEEeecCCCceEEEeecccccccCCCCcccccccCCCcccccccCC---CCCCcchHHHHHHHHHHHHcCCC
Q 012825 283 HRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSR 359 (455)
Q Consensus 283 HrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~ 359 (455)
||||||+|||+ +.++.+||+|||+++.... ......+|..|+|||++.+ .++.++|||||||++|+|++|+.
T Consensus 217 HrDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFI---MPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEE---CTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEE---CCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999 7888999999999987642 2224567799999999864 58999999999999999999999
Q ss_pred CCCCCChhHH--HHH---HHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 360 PFWARTESGI--FRA---VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 360 Pf~~~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
||........ +.. ............++.++..+.+||.+||+.||++|||+.++|+||||+..
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 9976533210 000 00111122222335789999999999999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=364.20 Aligned_cols=271 Identities=28% Similarity=0.426 Sum_probs=204.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHH-HHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED-VRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~-~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.++|++.+.||+|+||.||+|++.. +|+.||||++.... ......+ +.++..+++.+. |+||+++++++.+++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRK---TGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHD-CPYIVQCFGTFITNT 97 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETT---TCCEEEEEEEETTS--CHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSS
T ss_pred hccccccceeeecCCeeEEEEEEec---CCeEEEEEEecccc--cchHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCC
Confidence 5789999999999999999999776 58899999997543 2333333 444444566665 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
..++||||+ ++.+..........+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++.
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISG 173 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC-
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCch
Confidence 999999999 5566665555577899999999999999999999996 99999999999999 778899999999998
Q ss_pred ccCCCCcccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCC-ChhHHHHHHHhcCCCCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDEAP 384 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~ 384 (455)
............||..|+|||++. ..++.++||||||+++|+|++|+.||... .....+..+......... .
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~ 252 (318)
T 2dyl_A 174 RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP-G 252 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC-S
T ss_pred hccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC-c
Confidence 776555555668999999999974 35888999999999999999999999874 444555555555433221 2
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHHHH
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFK 435 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~~~ 435 (455)
...++.++.+||.+||+.||.+||++.++++||||+......+.......+
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~ 303 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKD 303 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSCCCHHHHHHH
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccccchhHHHhhc
Confidence 236899999999999999999999999999999999876665555444443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=361.87 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=210.2
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.+.||+|+||.||+|+. .|+.||||++.... ......+.+.+|++++++++ |+||+++++++.+.
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-----HGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQP 106 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECCCC-CSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECST
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-----CCCcEEEEEecCCC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEC
Confidence 3467899999999999999999974 37889999987653 34556678999999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC--CEEeeccCCceEEeecCCCceEEEeec
Q 012825 232 DNVYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qi~~gL~~LH~~~--ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
+..++||||+++++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCC
Confidence 999999999999999998865432 3999999999999999999999999 9999999999999 78889999999
Q ss_pred ccccccCCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 308 GLSDFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 308 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
|+++...... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||...........+........ ..
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~ 261 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--IP 261 (309)
T ss_dssp C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC--CC
T ss_pred CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CC
Confidence 9997654332 234567999999999987 4589999999999999999999999998888777666654433322 22
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHc--CcccCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALS--HPWIKN 421 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~--hp~~~~ 421 (455)
..++.++.+||++||+.||.+|||+.++++ +.|++.
T Consensus 262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 468999999999999999999999999987 455543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=354.77 Aligned_cols=248 Identities=25% Similarity=0.442 Sum_probs=216.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+... ++.||+|++...... .+.+.+|++++++++ ||||+++++++.+++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN----KDKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAP 79 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEEECTTSBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred hhhceeeheecCCCccEEEEEEecC----CCeEEEEEecccccC----HHHHHHHHHHHHhCC-CCCEeeEEEEEecCCc
Confidence 4789999999999999999998764 678999999754322 256889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGB
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEeccccccccc
Confidence 999999999999999998777889999999999999999999999999999999999999 67788999999999876
Q ss_pred CCCC--cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 314 RPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
.... ......++..|+|||++. ..++.++||||||+++|+|++ |+.||...........+........ ...++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 233 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAS 233 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSC
T ss_pred cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCC
Confidence 5332 223445677899999987 678999999999999999999 9999999888887777766533222 23578
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.++.+||.+||+.||++||++.++++|
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=361.32 Aligned_cols=256 Identities=29% Similarity=0.517 Sum_probs=210.2
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee--
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-- 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~-- 230 (455)
+.++|++.+.||+|+||.||+|+... +|+.||||++.. .....+.+.+|+.+++++. ||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNAL---DSRYYAIKKIRH----TEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERR 75 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECC
T ss_pred ccccchhhheeccCCcEEEEEEEEcC---CCeEEEEEEEec----cHHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhc
Confidence 45789999999999999999998765 589999999853 3455678899999999998 9999999998865
Q ss_pred -----------CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCC
Q 012825 231 -----------TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (455)
Q Consensus 231 -----------~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~ 299 (455)
.+..|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~ 152 (303)
T 1zy4_A 76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DES 152 (303)
T ss_dssp CCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTT
T ss_pred chhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCC
Confidence 356899999999999999998777788999999999999999999999999999999999999 778
Q ss_pred ceEEEeecccccccCCC---------------CcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCC
Q 012825 300 SVLKAIDFGLSDFVRPD---------------ERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFW 362 (455)
Q Consensus 300 ~~vkL~DfG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~ 362 (455)
+.+||+|||++...... .......||..|+|||++.+ .++.++||||||+++|+|++ ||.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 89999999999776422 12344578999999999863 58999999999999999998 554
Q ss_pred CCC-hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 363 ART-ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 363 ~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
... .......+......++......++..+.+||++||+.||.+|||+.++++||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp SHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred CchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 332 233444444444444444455678899999999999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=365.43 Aligned_cols=260 Identities=32% Similarity=0.529 Sum_probs=212.8
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe-
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE- 229 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~- 229 (455)
..+.++|++.+.||+|+||.||+|.... +|+.||||++.. ......+.+.+|++++++++ ||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~---~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 79 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVL---TDPQSVKHALREIKIIRRLD-HDNIVKVFEILGP 79 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETT---TTEEEEEEEEEC---CSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECT
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECC---CCeEEEEEEEec---CChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccc
Confidence 4567899999999999999999999766 589999999854 34566778999999999998 999999999873
Q ss_pred -------------eCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec
Q 012825 230 -------------DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (455)
Q Consensus 230 -------------~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~ 296 (455)
+.+..++||||++ ++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-- 154 (320)
T 2i6l_A 80 SGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN-- 154 (320)
T ss_dssp TSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--
T ss_pred cccccccccccccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--
Confidence 3467899999997 59998773 46799999999999999999999999999999999999994
Q ss_pred CCCceEEEeecccccccCCC----CcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 012825 297 DENSVLKAIDFGLSDFVRPD----ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIF 370 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~ 370 (455)
.+++.+||+|||++...... .......+|..|+|||++. ..++.++||||||+++|+|++|+.||........+
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 35678999999999876432 2234456799999999874 46889999999999999999999999988887777
Q ss_pred HHHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 371 RAVLKADPSFDE--------------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 371 ~~i~~~~~~~~~--------------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
..+....+.... ...+.++.++.+||++||+.||++|||+.|+|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 666654322110 1124689999999999999999999999999999999965
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=356.18 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=207.1
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.+.||+|+||.||+|.+......+..||+|++... ......+.+.+|+.+++++. ||||+++++++. +
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-E 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-S
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-c
Confidence 3468999999999999999999998765555788999998653 44566678999999999998 999999999984 5
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSR 164 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-----
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE---CCCCCEEECcccccc
Confidence 67899999999999999998777789999999999999999999999999999999999999 567889999999998
Q ss_pred ccCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
....... .....+++.|+|||++. ..++.++||||||+++|+|++ |..||......+....+....... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~ 241 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPN 241 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---CCCC
Confidence 7654332 23345678899999886 578999999999999999996 999999888877777666543221 2347
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++.++.+||.+||+.||++|||+.+++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=357.10 Aligned_cols=258 Identities=30% Similarity=0.491 Sum_probs=219.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee--C
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--~ 231 (455)
.++|++.+.||+|+||.||+|+... +|+.||+|++.... ......+.+.+|+.++++++ ||||+++++++.+ +
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTN 79 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGG
T ss_pred hhheeeehhccCCCCcEEEEEEECC---CCcEEEEEEEEccc-CCHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCC
Confidence 4789999999999999999998775 58999999997654 34556678999999999998 9999999998854 5
Q ss_pred CceEEEEeecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC-----CEEeeccCCceEEeecCCCceEE
Q 012825 232 DNVYVVMELCEGGELLDRILSR---GGKYTEDDAKAVMIQILNVVAFCHLQG-----VVHRDLKPENFLFTTKDENSVLK 303 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~---~~~l~~~~~~~i~~qi~~gL~~LH~~~-----ivHrDikp~NILl~~~~~~~~vk 303 (455)
+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.| |+||||||+|||+ +.++.+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~k 156 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVK 156 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEE
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEE
Confidence 6799999999999999988653 345999999999999999999999999 9999999999999 7788999
Q ss_pred EeecccccccCCCCc-ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC
Q 012825 304 AIDFGLSDFVRPDER-LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (455)
Q Consensus 304 L~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (455)
|+|||++........ .....|+..|+|||++. ..++.++||||||+++|+|++|+.||...........+.......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~- 235 (279)
T 2w5a_A 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR- 235 (279)
T ss_dssp ECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-
T ss_pred EecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc-
Confidence 999999987654322 23457899999999876 468899999999999999999999999888777766666654321
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 382 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
....++.++.+||.+||+.||++||++.|+|+|+|+.+.
T Consensus 236 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 236 --IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred --CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 123689999999999999999999999999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=386.75 Aligned_cols=250 Identities=18% Similarity=0.235 Sum_probs=200.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEe------
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFF------ 225 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hp~Iv~l~------ 225 (455)
.++|++.+.||+|+||.||+|++.. +|+.||||++...........+.+.+|+.+++.+. .||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CceEEEcceeecCCCEEEEEEEECC---CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 5789999999999999999999765 58999999997654455556678999996555443 399999998
Q ss_pred -EEEeeCC-----------------ceEEEEeecCCCcHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHcCC
Q 012825 226 -DAYEDTD-----------------NVYVVMELCEGGELLDRILSRGG------KYTEDDAKAVMIQILNVVAFCHLQGV 281 (455)
Q Consensus 226 -~~~~~~~-----------------~~~lV~E~~~ggsL~~~l~~~~~------~l~~~~~~~i~~qi~~gL~~LH~~~i 281 (455)
+++.+.+ ..||||||+ +|+|.+++..... .+++..++.|+.||+.||.|||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 6666553 289999999 6799998865421 23358888999999999999999999
Q ss_pred EEeeccCCceEEeecCCCceEEEeecccccccCCCCcccccccCCCcccccccC-C-----------CCCCcchHHHHHH
Q 012825 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-R-----------SYSTEADVWSIGV 349 (455)
Q Consensus 282 vHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----------~~~~~sDiwSlG~ 349 (455)
+||||||+|||+ +.++.+||+|||+++... .......| ..|+|||++. . .++.++|||||||
T Consensus 228 vHrDikp~NIll---~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVL---DQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEE---CTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEE---cCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999 778899999999998643 34455678 9999999986 3 5899999999999
Q ss_pred HHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 350 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 350 ~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
++|||++|+.||...........+. ..+..+++++.+||.+||+.||++||++.++|+||||+.
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 9999999999996654332222211 122478999999999999999999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=352.05 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=215.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|.... +..||||++...... .+++.+|++++++++ ||||+++++++.+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 76 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKG----QYDVAVKMIKEGSMS----EDEFFQEAQTMMKLS-HPKLVKFYGVCSKEY 76 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT----TEEEEEEEECBTTBC----HHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred chhheeeeeeeccCCCceEEEEEecC----ceeEEEEEeccCCCc----HHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence 36789999999999999999997654 678999999754322 256889999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRY 153 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEE
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCcccee
Confidence 9999999999999999998777779999999999999999999999999999999999999 7888999999999987
Q ss_pred cCCCCcc--cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDERL--NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
....... ....+|..|+|||++. ..++.++||||||+++|+|++ |+.||...........+......... ..+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 230 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLA 230 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTS
T ss_pred cchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcC
Confidence 6544322 2344667899999987 468999999999999999999 99999988888777776665433322 357
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++.+.+||.+||+.||.+|||+.+++++
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=375.22 Aligned_cols=264 Identities=23% Similarity=0.462 Sum_probs=220.7
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCH--------------HHHHHHHHHHHHHHHh
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA--------------IAIEDVRREVKILRAL 215 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~--------------~~~~~~~~Ei~~l~~l 215 (455)
.+...++|++.+.||+|+||.||+|+. +|+.||||++........ ...+.+.+|+.+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 100 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence 345568999999999999999999987 389999999854321111 1126788999999999
Q ss_pred cCCCCeeEEeEEEeeCCceEEEEeecCCCcHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeecc
Q 012825 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDR------ILSR-GGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLK 287 (455)
Q Consensus 216 ~~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDik 287 (455)
+ |+||+++++++.+.+..++||||+++++|.++ +... ...+++..++.++.||+.||.|||+ .||+|||||
T Consensus 101 ~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~ 179 (348)
T 2pml_X 101 K-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179 (348)
T ss_dssp C-CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCC
T ss_pred C-CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCC
Confidence 8 99999999999999999999999999999887 4332 5679999999999999999999999 999999999
Q ss_pred CCceEEeecCCCceEEEeecccccccCCCCcccccccCCCcccccccCCC--CCC-cchHHHHHHHHHHHHcCCCCCCCC
Q 012825 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS--YST-EADVWSIGVIAYILLCGSRPFWAR 364 (455)
Q Consensus 288 p~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~sDiwSlG~~l~elltg~~Pf~~~ 364 (455)
|+|||+ +.++.+||+|||++...... ......|+..|+|||++.+. ++. ++||||||+++|+|++|+.||...
T Consensus 180 p~Nil~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 180 PSNILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hHhEEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999 78889999999999876533 44556799999999998753 555 899999999999999999999887
Q ss_pred Ch-hHHHHHHHhcCCCCCCCC---------------CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 365 TE-SGIFRAVLKADPSFDEAP---------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 365 ~~-~~~~~~i~~~~~~~~~~~---------------~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.. ......+......+.... ...++.++.+||.+||+.||.+||++.|+|+||||+..+
T Consensus 256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp SCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred CcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 76 555666555444333210 146899999999999999999999999999999999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=365.88 Aligned_cols=268 Identities=25% Similarity=0.421 Sum_probs=218.4
Q ss_pred CcCcccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCC-----
Q 012825 146 SFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN----- 220 (455)
Q Consensus 146 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~----- 220 (455)
....++.+.++|++.+.||+|+||.||+|..... .++.||||++.. .....+.+.+|+.+++++. |++
T Consensus 10 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~-~~~~~~~~ 82 (355)
T 2eu9_A 10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHAR--GKSQVALKIIRN----VGKYREAARLEINVLKKIK-EKDKENKF 82 (355)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECS----CHHHHHHHHHHHHHHHHHH-HHCTTSCS
T ss_pred ccccCceecccEEEEEEeeccCCeEEEEEEecCC--CceEEEEEEEcc----cccchhHHHHHHHHHHHHh-hcCCCCce
Confidence 3445667889999999999999999999987652 247999999853 2445577889999999997 554
Q ss_pred -eeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec--
Q 012825 221 -LVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK-- 296 (455)
Q Consensus 221 -Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~-- 296 (455)
++.+++++...+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+...
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~ 161 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF 161 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCE
T ss_pred eEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccc
Confidence 999999999999999999999 667777776654 579999999999999999999999999999999999999432
Q ss_pred --------------CCCceEEEeecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCC
Q 012825 297 --------------DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPF 361 (455)
Q Consensus 297 --------------~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf 361 (455)
+.++.+||+|||++.... .......||..|+|||++. ..++.++|||||||++|||++|+.||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp EEEECCC-CCCEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccccccCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 346789999999998653 2334568999999999886 56899999999999999999999999
Q ss_pred CCCChhHHHHHHHhcCCCCCC----------------CCC------------------------CCCCHHHHHHHHHhcc
Q 012825 362 WARTESGIFRAVLKADPSFDE----------------APW------------------------PSLSSEARDFVKRLLN 401 (455)
Q Consensus 362 ~~~~~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~s~~l~~li~~~L~ 401 (455)
........+..+.+.....+. ..| ...+.++.+||++||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 888776655544332211110 000 1124578899999999
Q ss_pred CCccCCCCHHHHHcCcccCCCC
Q 012825 402 KDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 402 ~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.||++|||+.|+|+||||+...
T Consensus 320 ~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp SSTTTSCCHHHHTTSGGGGGCC
T ss_pred CChhhCcCHHHHhcChhhcCCC
Confidence 9999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=369.13 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=219.4
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecC----cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKG----ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
..++|++.+.||+|+||.||+|++... ...+..||||++... ......+.+.+|+++++++.+||||+++++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 467999999999999999999997542 124578999999654 45566788999999999995599999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEE
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl 293 (455)
.+++..++||||+++++|.+++.... ..+++..++.|+.||+.||.|||+.||+||||||+|||+
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 99999999999999999999987654 359999999999999999999999999999999999999
Q ss_pred eecCCCceEEEeecccccccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhH
Q 012825 294 TTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESG 368 (455)
Q Consensus 294 ~~~~~~~~vkL~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~ 368 (455)
+.++.+||+|||+++...... ......+|..|+|||++. ..++.++|||||||++|+|++ |..||......+
T Consensus 225 ---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 225 ---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp ---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred ---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 778899999999998765432 233456788999999876 568999999999999999999 999999888777
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
....+........ ...++.++.+||.+||+.||++|||+.+++++
T Consensus 302 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7766655432222 24689999999999999999999999999976
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=364.23 Aligned_cols=268 Identities=21% Similarity=0.345 Sum_probs=199.7
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.+.||+|+||.||+|++.........||||++..... .....+.+.+|++++++++ |+||+++++++...
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRS 97 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCC-CCceehhhceeecc
Confidence 446789999999999999999999776432334899999965432 3345678999999999997 99999999999877
Q ss_pred Cce------EEEEeecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCc
Q 012825 232 DNV------YVVMELCEGGELLDRILSRG-----GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENS 300 (455)
Q Consensus 232 ~~~------~lV~E~~~ggsL~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~ 300 (455)
+.. ++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCC
Confidence 655 99999999999999886432 259999999999999999999999999999999999999 7788
Q ss_pred eEEEeecccccccCCCCcc---cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHh
Q 012825 301 VLKAIDFGLSDFVRPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLK 375 (455)
Q Consensus 301 ~vkL~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~ 375 (455)
.+||+|||++......... ....++..|+|||++. ..++.++|||||||++|+|++ |..||...........+..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 9999999999876543322 2345677899999886 568999999999999999999 9999998888877777766
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCC-------HHHHHcCcccCCCCCCCC
Q 012825 376 ADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLT-------AAQALSHPWIKNSNDVKV 427 (455)
Q Consensus 376 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-------~~elL~hp~~~~~~~~~~ 427 (455)
...... .+.++.++.+||.+||+.||++||| +++++.|+|+.......+
T Consensus 255 ~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 255 GNRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp TCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred CCCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 543222 2468899999999999999999999 888999999998765554
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=368.61 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=203.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|++.. +|+.||||++....... ....+|++.+..+. |+||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~-h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQDPRFR----NRELQIMQDLAVLH-HPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHTTEEEC----------CEEEEETT---TCCEEEEEEEECCTTCC----CHHHHHHHHHHHHC-CTTBCCEEEEEEEEC
T ss_pred hccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEecCcccc----HHHHHHHHHHHhcC-CCCcccHHHhhhccc
Confidence 35789999999999999999999776 58899999986543222 34557788888887 999999999997644
Q ss_pred c-------eEEEEeecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH--HcCCEEeeccCCceEEeecCCCc
Q 012825 233 N-------VYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCH--LQGVVHRDLKPENFLFTTKDENS 300 (455)
Q Consensus 233 ~-------~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qi~~gL~~LH--~~~ivHrDikp~NILl~~~~~~~ 300 (455)
. +++||||+++ +|.+.+. .....+++..++.++.||+.||.||| +.||+||||||+|||++ ..++
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~ 169 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADG 169 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCC
Confidence 3 8899999976 5555443 35667999999999999999999999 99999999999999994 2378
Q ss_pred eEEEeecccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC
Q 012825 301 VLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (455)
Q Consensus 301 ~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (455)
.+||+|||++.............||..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+.+...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 999999999998876666667789999999998753 489999999999999999999999999888777766654211
Q ss_pred CCC----------------------------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 379 SFD----------------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 379 ~~~----------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
... ......++.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 110 001123568899999999999999999999999999999753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=363.41 Aligned_cols=259 Identities=25% Similarity=0.487 Sum_probs=215.8
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-CHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe--
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYE-- 229 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~-- 229 (455)
+.++|++.+.||+|+||.||+|.... +++.||+|++...... .....+.+.+|++++++++ |+||+++++++.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSE---TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNE 78 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTT---TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC
T ss_pred cccceeEeeEEecCCCeEEEEEEECC---CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcC
Confidence 45789999999999999999998665 5889999998543211 1234567899999999998 999999999984
Q ss_pred eCCceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 230 DTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
+.+..++||||++++ |.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg 154 (305)
T 2wtk_C 79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALG 154 (305)
T ss_dssp ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCT
T ss_pred CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccc
Confidence 556799999999875 67766543 4579999999999999999999999999999999999999 778899999999
Q ss_pred cccccCCC---CcccccccCCCcccccccCC-C--CCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC
Q 012825 309 LSDFVRPD---ERLNDIVGSAYYVAPEVLHR-S--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382 (455)
Q Consensus 309 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~--~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (455)
++...... .......||..|+|||++.+ . ++.++||||||+++|+|++|+.||...........+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~- 233 (305)
T 2wtk_C 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP- 233 (305)
T ss_dssp TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC-
T ss_pred cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC-
Confidence 99876432 22345678999999999864 2 47789999999999999999999998888877777776654433
Q ss_pred CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 383 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
..++..+.+||++||+.||.+|||+.++++||||+...
T Consensus 234 ---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 234 ---GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp ---SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred ---CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 36889999999999999999999999999999998753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=365.55 Aligned_cols=257 Identities=31% Similarity=0.556 Sum_probs=213.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+.++|.+.+.||+|+||.||+|++.. +|+.||||++.... ......+.+.+|+.+++.++ ||||+++++++...+
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPAS 96 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred cCceEEEeeeEecCCCeEEEEEEECC---CCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccc
Confidence 46889999999999999999998766 68999999996543 45556678899999999998 999999999998765
Q ss_pred c------eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 233 N------VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 233 ~------~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
. .|+||||+. ++|.+++ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~D 169 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILD 169 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECS
T ss_pred ccccceeEEEEecccc-CCHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEee
Confidence 4 499999996 5887655 2359999999999999999999999999999999999999 7788999999
Q ss_pred cccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC------
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP------ 378 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~------ 378 (455)
||++..... ......||..|+|||++.+ .++.++||||||+++|+|++|+.||.+....+.+..+.+...
T Consensus 170 fg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 170 FGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred cccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999987542 2345678999999998764 689999999999999999999999988877666655543210
Q ss_pred -----------------C----CCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 379 -----------------S----FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 379 -----------------~----~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
. .....++.++.++.+||.+||+.||++|||+.++|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0 01122346799999999999999999999999999999999753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=356.90 Aligned_cols=257 Identities=26% Similarity=0.374 Sum_probs=217.7
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
..++|++.+.||+|+||.||+|++.. ...+++.||||++... ......+.+.+|+.+++++.+||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc--hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 35789999999999999999998753 2335789999999654 3445567899999999999559999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEE
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGG-----------------KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~-----------------~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl 293 (455)
++..++||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 9999999999999999999876543 48999999999999999999999999999999999999
Q ss_pred eecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhH
Q 012825 294 TTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESG 368 (455)
Q Consensus 294 ~~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~ 368 (455)
+.++.+||+|||++........ .....+|..|+|||++. ..++.++||||||+++|+|++ |+.||.......
T Consensus 179 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 179 ---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp ---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 6788999999999987654432 23445778899999875 578999999999999999998 999998877666
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.+............ ...++.++.+||.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 55555554433222 24688999999999999999999999999865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=363.15 Aligned_cols=256 Identities=22% Similarity=0.303 Sum_probs=218.1
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCc--ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
...++|++.+.||+|+||.||+|+..... .+++.||||++... ......+.+.+|+.++++++ ||||+++++++.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 120 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD-NPNIVKLLGVCA 120 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEc
Confidence 34688999999999999999999987421 24689999999754 34556678999999999997 999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeec
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRG-----------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDL 286 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDi 286 (455)
+++..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 9999999999999999999987642 57999999999999999999999999999999
Q ss_pred cCCceEEeecCCCceEEEeecccccccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCC
Q 012825 287 KPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPF 361 (455)
Q Consensus 287 kp~NILl~~~~~~~~vkL~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf 361 (455)
||+|||+ +.++.+||+|||++....... ......+|..|+|||++. +.++.++||||||+++|+|++ |..||
T Consensus 201 kp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 201 ATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999 778899999999997654322 223456788999999876 578999999999999999999 99999
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 362 WARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 362 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
......+....+....... ....++.++.+||++||+.||++||++.+++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCChHHHHHHHhCCCcCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9888877777766554322 223688999999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=357.77 Aligned_cols=261 Identities=27% Similarity=0.427 Sum_probs=207.5
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
+|.....||+|+||.||+|.+.. +++.||||++... .....+.+.+|+.+++.+. |+||+++++++.+.+..+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLS---NQVRIAIKEIPER---DSRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETT---TCCEEEEEEEECC---CC---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECC---CCeEEEEEEccCC---chHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEE
Confidence 34455699999999999999765 5889999998654 2334567889999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 236 VVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEES
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeeccccccc
Confidence 99999999999998876543 567999999999999999999999999999999999994 23778999999999876
Q ss_pred CCCC-cccccccCCCcccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHH-HHHHHhcCCCCCCCCCCCC
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 388 (455)
.... ......|+..|+|||++.+ .++.++||||||+++|+|++|+.||........ ........ ........+
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~ 251 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIPESM 251 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC--CCCCCCTTS
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc--ccccccccC
Confidence 5332 2345678999999999863 378899999999999999999999976443322 11111111 111122468
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKV 427 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~ 427 (455)
+.++.+||.+||+.||++||++.++|+|+||+...+.+.
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 290 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKK 290 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC------
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccCC
Confidence 999999999999999999999999999999998765544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=353.71 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=212.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||++.... +..||||++...... .+++.+|+++++++. |+||+++++++.+.+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEGSMS----EDEFIEEAKVMMNLS-HEKLVQLYGVCTKQR 92 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETT----TEEEEEEEECTTSBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcC----CCeEEEEEecCCCCC----HHHHHHHHHHHhcCC-CCCEeeEEEEEecCC
Confidence 36789999999999999999997654 678999999754322 256889999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRY 169 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGG
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccc
Confidence 9999999999999999997766789999999999999999999999999999999999999 7888999999999987
Q ss_pred cCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
...... .....+|..|+|||++. ..++.++||||||+++|+|++ |+.||...........+......... ..+
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 246 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLA 246 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTC
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcC
Confidence 653321 23345677899999886 678999999999999999998 99999988888777777665433222 357
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++.+.+||.+||+.||.+|||+.++++|
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 8999999999999999999999999976
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=356.89 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=208.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|.+.. +++.||+|++.. ......+.+.+|++++++++ ||||+++++++.+++.
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~---~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 81 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE---TGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKR 81 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred hhHeeccceecCCCCEEEEEEEECC---CCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCe
Confidence 5789999999999999999999776 588999998843 45667788999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLM 158 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEEC
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceec
Confidence 999999999999999998877889999999999999999999999999999999999999 78889999999999876
Q ss_pred CCCCcc---------------cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhH-----HHHH
Q 012825 314 RPDERL---------------NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESG-----IFRA 372 (455)
Q Consensus 314 ~~~~~~---------------~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~-----~~~~ 372 (455)
...... ....||+.|+|||++. ..++.++||||||+++|+|++|..||....... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 238 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence 433221 1467999999999987 468999999999999999999999985432211 1111
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
..... ..+.+++.+.+||.+||+.||++|||+.++++
T Consensus 239 ~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 239 FLDRY------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHT------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccc------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11111 12357888999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=364.08 Aligned_cols=273 Identities=24% Similarity=0.373 Sum_probs=198.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|.... +|+.||||++... .......++..|+..+.+..+|+||+++++++.+.+.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP---SGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT---TTEEEEEEEEECC--CCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcC---CCCEEEEEEeecc--cCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 5789999999999999999999765 5899999999754 3344455666777744443349999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 234 VYVVMELCEGGELLDRILS----RGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~----~~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
.++||||+++ +|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCC
Confidence 9999999975 77776653 256799999999999999999999999 99999999999999 678899999999
Q ss_pred cccccCCCCcccccccCCCcccccccC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh-HHHHHHHhcC-CCCC
Q 012825 309 LSDFVRPDERLNDIVGSAYYVAPEVLH-----RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKAD-PSFD 381 (455)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~-~~~~~i~~~~-~~~~ 381 (455)
++.............||..|+|||++. ..++.++||||||+++|+|++|+.||...... +.+..+.... ..+.
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251 (327)
T ss_dssp SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 998776554455567999999999973 45899999999999999999999999764322 1111111111 1122
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHHHH
Q 012825 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFK 435 (455)
Q Consensus 382 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~~~ 435 (455)
......++.++.+||.+||+.||++||++.++++||||+...+..+.....+.+
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~ 305 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCK 305 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCCHHHHHHH
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhHHHHHHHHHH
Confidence 222346899999999999999999999999999999999876666654443333
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=362.11 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=214.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
..++|++.+.||+|+||.||+|++... ...+..||||++... ......+.+.+|+.+++++.+||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 368899999999999999999997532 224678999999643 2334457789999999999559999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccC
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGG----------------------KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKP 288 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~----------------------~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp 288 (455)
.+..++||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 9999999999999999999876543 379999999999999999999999999999999
Q ss_pred CceEEeecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCC
Q 012825 289 ENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWA 363 (455)
Q Consensus 289 ~NILl~~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~ 363 (455)
+|||+ +.++.+||+|||++........ .....||+.|+|||++. +.++.++||||||+++|+|++ |..||..
T Consensus 201 ~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 201 RNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp GGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999 6788999999999987643332 23456788999999875 678999999999999999998 9999988
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCc
Q 012825 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (455)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp 417 (455)
......+..++........ ...++.++.+||.+||+.||.+||++.++++|-
T Consensus 278 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 7766666666555433222 236899999999999999999999999999873
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=351.95 Aligned_cols=254 Identities=25% Similarity=0.409 Sum_probs=208.9
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHH----HHHHHHHHHHHHhcCCCCeeEEeEE
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAI----EDVRREVKILRALTGHNNLVKFFDA 227 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~----~~~~~Ei~~l~~l~~hp~Iv~l~~~ 227 (455)
...++|++.+.||+|+||.||+|++.. +++.||||++........... +.+.+|+.++++++ |+||++++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~ 91 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGL 91 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETT---TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred hhhccceehhccccCCceeEEEEEEcC---CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhhee
Confidence 346899999999999999999999776 588999999865543332222 67899999999998 9999999999
Q ss_pred EeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeeccCCceEEeecC--CCceEE
Q 012825 228 YEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKD--ENSVLK 303 (455)
Q Consensus 228 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--ivHrDikp~NILl~~~~--~~~~vk 303 (455)
+.+.. ++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++..+ ....+|
T Consensus 92 ~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 92 MHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp ETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred ecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 86655 7999999999999999888888999999999999999999999999 99999999999994221 122399
Q ss_pred EeecccccccCCCCcccccccCCCcccccccC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHH--HHHHHhcCC
Q 012825 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH---RSYSTEADVWSIGVIAYILLCGSRPFWARTESGI--FRAVLKADP 378 (455)
Q Consensus 304 L~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~--~~~i~~~~~ 378 (455)
|+|||+++... .......||..|+|||++. ..++.++||||||+++|+|++|+.||........ ...+.....
T Consensus 170 l~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 170 VADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp ECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred eCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 99999997543 2345568999999999984 3478899999999999999999999977654443 333333222
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 379 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.......+++++.+||.+||+.||.+|||+.++++
T Consensus 248 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 --RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22233478999999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=356.13 Aligned_cols=261 Identities=25% Similarity=0.450 Sum_probs=211.1
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcC-CCCeeEEeEEE
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG-HNNLVKFFDAY 228 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~-hp~Iv~l~~~~ 228 (455)
.....++|++.+.||+|+||.||++.... ++.||||++.... ......+.+.+|+.++.++.+ |+||+++++++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEK----KQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTT----CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCC----CcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 34457889999999999999999998643 7899999996543 345667889999999999984 69999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
.+++..++|||+ .+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 98 ~~~~~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg 171 (313)
T 3cek_A 98 ITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFG 171 (313)
T ss_dssp ECSSEEEEEECC-CSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCS
T ss_pred ecCCEEEEEEec-CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeecc
Confidence 999999999994 57899998864 45799999999999999999999999999999999999993 3789999999
Q ss_pred cccccCCCCc---ccccccCCCcccccccCC------------CCCCcchHHHHHHHHHHHHcCCCCCCCCChh-HHHHH
Q 012825 309 LSDFVRPDER---LNDIVGSAYYVAPEVLHR------------SYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRA 372 (455)
Q Consensus 309 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~-~~~~~ 372 (455)
++........ .....||..|+|||++.+ .++.++||||||+++|+|++|+.||...... ..+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence 9987654322 234578999999999764 5788999999999999999999999765443 33333
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 373 VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 373 i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+....... ......+.++.+||.+||+.||++||++.++|+||||+...
T Consensus 252 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 252 IIDPNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HHCTTSCC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HHhccccc--CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 33322221 22235688999999999999999999999999999999754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=369.22 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=206.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+.......+..||||++... ......+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCc
Confidence 57899999999999999999987744445788999998654 34556678999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCcccccc
Confidence 999999999999999998777789999999999999999999999999999999999999 78889999999999876
Q ss_pred CCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 314 RPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 314 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
..... .....++..|+|||++. +.++.++||||||+++|||++ |+.||...........+....... ....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~ 274 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP---PPMD 274 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC---CCTT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence 54321 12234567899999886 678999999999999999998 999999888877776665442211 1236
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
++..+.+||.+||+.||++||++.++++
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 8899999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=370.46 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=214.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|++.. +++.||||++... ......+.+.+|+++++++. ||||+++++++.+++.
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRA---DNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEec---CCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCC
Confidence 5789999999999999999999875 5889999998643 34455667889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.|+||||+++|+|.+++...+..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREE 263 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceec
Confidence 999999999999999998777789999999999999999999999999999999999999 77889999999999865
Q ss_pred CCCCcc---cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 314 RPDERL---NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 314 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
...... ....++..|+|||++. +.++.++|||||||++|||++ |..||...........+....... ....+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 340 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP---CPELC 340 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC---CCTTC
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCC
Confidence 432211 1223567899999886 668999999999999999998 999998887776665555433211 12358
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+.++.+||.+||+.||++|||+.++++
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=348.86 Aligned_cols=254 Identities=23% Similarity=0.333 Sum_probs=214.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|.+......+..||||++... ......+.+.+|+.++++++ ||||+++++++.+ +
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~ 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEE-E 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT--SCHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECS-S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc--cCchHHHHHHHHHHHHHhCC-CCCcceEEEEEcC-C
Confidence 357899999999999999999998765555678999998654 34556678999999999998 9999999999865 4
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRY 162 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---EETTEEEECCCCGGGC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---CCCCcEEeCccCCCcc
Confidence 5799999999999999998777789999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
...... .....++..|+|||++. ..++.++||||||+++|+|++ |+.||...........+........ ...+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 239 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---PDLC 239 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---CTTC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---CCCC
Confidence 654332 23445788899999886 578999999999999999998 9999987777766666555432221 2358
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++.+.+||.+||+.||++||++.+++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 8999999999999999999999999876
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=354.66 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=216.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
..++|++.+.||+|+||.||+|..... ...++.||||++... ......+.+.+|++++++++ ||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQ 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEec
Confidence 368899999999999999999987532 235689999999654 34566788999999999997 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeecc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRG-----------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDik 287 (455)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 999999999999999999987643 248999999999999999999999999999999
Q ss_pred CCceEEeecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCC
Q 012825 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFW 362 (455)
Q Consensus 288 p~NILl~~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~ 362 (455)
|+|||+ +.++.+||+|||++........ .....++..|+|||++. ..++.++||||||+++|+|++ |..||.
T Consensus 178 p~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 178 ARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp GGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred hheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999 6788999999999987654332 23345778899999876 568999999999999999999 999998
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 363 ARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 363 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..........+...... .....++.++.+||.+||+.||.+||++.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88877766655544322 1224689999999999999999999999999876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=359.62 Aligned_cols=265 Identities=20% Similarity=0.275 Sum_probs=218.4
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
+...++|++.+.||+|+||.||+|++.. ...+++.||||++... ........+.+|+.+++++. ||||+++++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 102 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVS 102 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCC-CCCCCeEEEEE
Confidence 3457899999999999999999998543 2235889999998643 34556678899999999997 99999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceE
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRG------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~v 302 (455)
.+.+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++..+.+..+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999987654 458999999999999999999999999999999999999654466789
Q ss_pred EEeecccccccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcC
Q 012825 303 KAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 377 (455)
Q Consensus 303 kL~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~ 377 (455)
||+|||++....... ......|+..|+|||++. +.++.++||||||+++|+|++ |..||...........+....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999999987543222 223456788999999875 678999999999999999998 999998888777766666543
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 378 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
... ....++..+.+||.+||+.||.+||++.++++|.|+..
T Consensus 263 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 263 RMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 222 22468999999999999999999999999999988754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=355.03 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=215.1
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
...++|++.+.||+|+||.||+|++.. ...+++.||||++... ......+.+.+|+.++.++.+||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC--CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 346899999999999999999998754 2336789999999754 345556789999999999966999999999988
Q ss_pred eCC-ceEEEEeecCCCcHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEE
Q 012825 230 DTD-NVYVVMELCEGGELLDRILSRGGK---------------YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293 (455)
Q Consensus 230 ~~~-~~~lV~E~~~ggsL~~~l~~~~~~---------------l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl 293 (455)
..+ ..++||||+++++|.+++...... +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 755 599999999999999988765432 8999999999999999999999999999999999999
Q ss_pred eecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhH
Q 012825 294 TTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESG 368 (455)
Q Consensus 294 ~~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~ 368 (455)
+.++.+||+|||++........ .....||..|+|||++. ..++.++||||||+++|+|++ |..||.......
T Consensus 182 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 182 ---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp ---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 6788999999999987644332 23456788999999876 568999999999999999998 999998776555
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.+...+........ ...++.++.++|.+||+.||.+|||+.++++|
T Consensus 259 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 259 EFCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCccCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 44444443322221 23578999999999999999999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=350.66 Aligned_cols=256 Identities=22% Similarity=0.392 Sum_probs=203.7
Q ss_pred cccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 149 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
..+...++|++.+.||+|+||.||+|+.. ..||||++.... ......+.+.+|+.++++++ |+||+++++++
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~------~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 89 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS 89 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS------SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc------CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec
Confidence 34556789999999999999999999743 359999986543 45666788999999999998 99999999965
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
..+..++||||+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 90 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg 165 (289)
T 3og7_A 90 -TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFG 165 (289)
T ss_dssp -CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC
T ss_pred -cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccce
Confidence 5567899999999999999887777789999999999999999999999999999999999999 677899999999
Q ss_pred cccccCCC---CcccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC-
Q 012825 309 LSDFVRPD---ERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF- 380 (455)
Q Consensus 309 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~- 380 (455)
++...... .......||..|+|||++. ..++.++||||||+++|+|++|+.||........+..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP 245 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc
Confidence 99765432 2334567999999999874 357889999999999999999999998876665555554433221
Q ss_pred -CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 381 -DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 381 -~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.......+++.+.+||.+||+.||.+|||+.++++.
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 222335788999999999999999999999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=361.29 Aligned_cols=250 Identities=18% Similarity=0.265 Sum_probs=206.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+.++|++.+.||+|+||.||+|+... +|+.||||++...... +.+.+|+.++++|.+|+||+++++++.+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETT---TTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred EcCCeEEEEEeeccCCceEEEEEECC---CCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 46899999999999999999999765 5899999998654321 357899999999955999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCce-----EEEeec
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV-----LKAIDF 307 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~-----vkL~Df 307 (455)
..++||||+ +++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++. +||+||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill---~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI---GRPGNKTQQVIHIIDF 154 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CCGGGTCTTSEEECCC
T ss_pred ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---ccCCCCCCceEEEEEc
Confidence 999999999 899999987767789999999999999999999999999999999999999 55555 999999
Q ss_pred ccccccCCCCc--------ccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCh---hHHHHHHHh
Q 012825 308 GLSDFVRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLK 375 (455)
Q Consensus 308 G~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~---~~~~~~i~~ 375 (455)
|+++....... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ...+..+..
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 99987643322 245689999999999874 689999999999999999999999987433 333444433
Q ss_pred cCCCCCC-CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 376 ADPSFDE-APWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 376 ~~~~~~~-~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
....... .....++ ++.+||..||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2211111 1112344 9999999999999999999998876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=350.85 Aligned_cols=255 Identities=26% Similarity=0.508 Sum_probs=202.8
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|.... +|+.||||++...........+.+.+|+.++++++ |+||+++++++.+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDN 105 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETT---TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred cccceEEEEeecCCCCceEEEEEEcC---CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCC
Confidence 45789999999999999999998765 58899999997655566777788999999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 233 NVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGL 182 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC--
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccc
Confidence 99999999999999998754 35679999999999999999999999999999999999999 7788999999999
Q ss_pred ccccCCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCh--hHHHHHHHhcCCCCCCCCC
Q 012825 310 SDFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 310 a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~ 385 (455)
+....... ......|+..|+|||++. +.++.++||||||+++|+|++|..||..... ......+.... +.....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~ 260 (310)
T 2wqm_A 183 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPS 260 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--SCCCCT
T ss_pred eeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--CCCCcc
Confidence 97764332 234557899999999886 5688999999999999999999999975432 23333333322 222223
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..++.++.+||.+||+.||++||++.+++++
T Consensus 261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 261 DHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 4689999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=353.20 Aligned_cols=255 Identities=17% Similarity=0.229 Sum_probs=208.3
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCc----ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeE
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD 226 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~ 226 (455)
+...++|++.+.||+|+||.||+|+..... ..+..||+|++... .....+.+.+|+.++++++ |+||+++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~ 79 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLS-HKHLVLNYG 79 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSC-CTTBCCEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCC-CCCEeEEEE
Confidence 344689999999999999999999887632 12367999998543 2334567899999999998 999999999
Q ss_pred EEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCC-----Cce
Q 012825 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-----NSV 301 (455)
Q Consensus 227 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~-----~~~ 301 (455)
++.+++..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. .+.
T Consensus 80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 80 VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp EECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999999999776666999999999999999999999999999999999999953321 122
Q ss_pred EEEeecccccccCCCCcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC
Q 012825 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (455)
Q Consensus 302 vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 379 (455)
+||+|||++...... ....||..|+|||++. ..++.++||||||+++|+|++|..|+..................
T Consensus 160 ~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (289)
T 4fvq_A 160 IKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236 (289)
T ss_dssp EEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred eeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence 999999998765432 3346889999999886 45899999999999999999966655554444444444444333
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 380 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
... .++.++.+||.+||+.||++|||+.++++|
T Consensus 237 ~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 237 LPA----PKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 332 457789999999999999999999999976
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=350.78 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=205.3
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEec-CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
...++|++.+.||+|+||.||+|++.. ...+++.||||++.. ......+.+.+|++++++++ |+||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYS 82 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC---CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc---CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec
Confidence 346899999999999999999998642 223689999999854 34566678999999999998 9999999999864
Q ss_pred --CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 231 --TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 231 --~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
...+++||||+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg 159 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFG 159 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE---cCCCeEEEccCc
Confidence 356899999999999999998777779999999999999999999999999999999999999 667889999999
Q ss_pred cccccCCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhH---------------
Q 012825 309 LSDFVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESG--------------- 368 (455)
Q Consensus 309 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~--------------- 368 (455)
++........ .....++..|+|||++. ..++.++||||||+++|+|++|..||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 9987654322 23345777899999886 578999999999999999999999985432110
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.....+...... .....++.++.+||.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 240 HLIELLKNNGRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHHHHTTCCC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhccCcC--CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 111112222222 2234689999999999999999999999999853
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=345.70 Aligned_cols=252 Identities=28% Similarity=0.414 Sum_probs=201.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC-HHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT-AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.++|++.+.||+|+||.||+|.+. |+.||||++....... ....+.+.+|+++++.++ ||||+++++++.+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEP 79 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-----TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC-
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-----CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCC
Confidence 578999999999999999999843 6889999986543222 233567899999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CEEeeccCCceEEeecC-----CCceEEE
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG---VVHRDLKPENFLFTTKD-----ENSVLKA 304 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~---ivHrDikp~NILl~~~~-----~~~~vkL 304 (455)
..++||||+++++|.+++ ....+++..++.++.||+.||.|||++| |+||||||+|||++... .++.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp -CEEEEECCTTEEHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred ceEEEEEcCCCCCHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 999999999999998877 3567999999999999999999999999 99999999999995321 2678999
Q ss_pred eecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 012825 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383 (455)
Q Consensus 305 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 383 (455)
+|||++....... .....||..|+|||++. ..++.++||||||+++|+|++|+.||...........+........
T Consensus 158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 234 (271)
T 3dtc_A 158 TDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP-- 234 (271)
T ss_dssp CCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC--
T ss_pred ccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC--
Confidence 9999998765332 23557999999999886 5689999999999999999999999998887776666655543332
Q ss_pred CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 384 ~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
....++..+.+||.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 224689999999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=358.44 Aligned_cols=256 Identities=30% Similarity=0.567 Sum_probs=202.6
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCH---HHHHHHHHHHHHHHHhc---CCCCeeEE
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRALT---GHNNLVKF 224 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~---~hp~Iv~l 224 (455)
+.+.++|++.+.||+|+||.||+|++.. +++.||||++........ .....+.+|+.++.++. +|+||+++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLT---DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTT---TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEcc---CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 4567899999999999999999998665 588999999966543221 22334668999999993 39999999
Q ss_pred eEEEeeCCceEEEEee-cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEE
Q 012825 225 FDAYEDTDNVYVVMEL-CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLK 303 (455)
Q Consensus 225 ~~~~~~~~~~~lV~E~-~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vk 303 (455)
++++.+.+..++|||| +.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+|
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~k 180 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAK 180 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEE
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEE
Confidence 9999999999999999 7889999988654 5699999999999999999999999999999999999994 2678999
Q ss_pred EeecccccccCCCCcccccccCCCcccccccC-CCC-CCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC
Q 012825 304 AIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (455)
Q Consensus 304 L~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (455)
|+|||++..... .......|+..|+|||++. ..+ +.++||||||+++|+|++|+.||.... .+......+.
T Consensus 181 l~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~ 253 (312)
T 2iwi_A 181 LIDFGSGALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP 253 (312)
T ss_dssp ECCCSSCEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC
T ss_pred EEEcchhhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc
Confidence 999999987653 3345567999999999876 333 458999999999999999999996532 2333332222
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 382 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
..++.++.+||.+||+.||++||++.|+++||||+...
T Consensus 254 ----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 254 ----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp ----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ----ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 36899999999999999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=362.21 Aligned_cols=256 Identities=28% Similarity=0.524 Sum_probs=212.4
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCH---HHHHHHHHHHHHHHHhc-CCCCeeEEe
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRALT-GHNNLVKFF 225 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~-~hp~Iv~l~ 225 (455)
.+.+.++|++.+.||+|+||.||+|+... +++.||||++........ ...+.+.+|+.+++++. +|+||++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETT---TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 44567899999999999999999998766 589999999865432211 11234678999999997 379999999
Q ss_pred EEEeeCCceEEEEeecCC-CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEE
Q 012825 226 DAYEDTDNVYVVMELCEG-GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKA 304 (455)
Q Consensus 226 ~~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL 304 (455)
+++.+.+..++|||++.+ ++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++ ..++.+||
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL 191 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKL 191 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEE
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEE
Confidence 999999999999999976 799998865 46799999999999999999999999999999999999994 26788999
Q ss_pred eecccccccCCCCcccccccCCCcccccccC-CC-CCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC
Q 012825 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382 (455)
Q Consensus 305 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (455)
+|||++..... .......||..|+|||++. .. ++.++||||||+++|||++|+.||.... .+......+
T Consensus 192 ~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~-- 262 (320)
T 3a99_A 192 IDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF-- 262 (320)
T ss_dssp CCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC--
T ss_pred eeCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccc--
Confidence 99999987653 3344567999999999876 33 4678999999999999999999996532 223332222
Q ss_pred CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 383 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
...++.++.+||++||+.||++|||+.++++||||+..
T Consensus 263 --~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 263 --RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp --SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 23689999999999999999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=358.91 Aligned_cols=253 Identities=20% Similarity=0.280 Sum_probs=207.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCc-ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.++|++.+.||+|+||.||+|++.... .....||+|.+... ......+.+.+|+.++++++ ||||+++++++.+++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence 578999999999999999999976521 12345688887543 23344577899999999998 999999999998755
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.++|+||+.+|+|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCcceeE
Confidence 789999999999999998888889999999999999999999999999999999999999 6678899999999987
Q ss_pred cCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 313 VRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 313 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
...... .....+|..|+|||++. +.++.++|||||||++|||++ |+.||...........+....... ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 243 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPI 243 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---CCcc
Confidence 654332 23345678999999876 568999999999999999999 999998877776655554443221 2246
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++.++.+||.+||+.||++||++.+++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 88999999999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=363.69 Aligned_cols=260 Identities=26% Similarity=0.436 Sum_probs=207.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc----------CCCCeeE
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT----------GHNNLVK 223 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~----------~hp~Iv~ 223 (455)
.++|++.+.||+|+||.||+|++.. +++.||||++.. .....+.+.+|+.+++++. +|+||++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC---CCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 5789999999999999999998765 589999999853 3345567889999998876 2789999
Q ss_pred EeEEEeeCC----ceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeec-
Q 012825 224 FFDAYEDTD----NVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTK- 296 (455)
Q Consensus 224 l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~- 296 (455)
+++++...+ .+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++..
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999998654 789999999 88999988764 35699999999999999999999998 99999999999999643
Q ss_pred --CCCceEEEeecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC------hh
Q 012825 297 --DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART------ES 367 (455)
Q Consensus 297 --~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~------~~ 367 (455)
+..+.+||+|||++..... ......||..|+|||++. ..++.++|||||||++|||++|+.||.... ..
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 3445899999999987642 334568999999999876 468999999999999999999999997544 22
Q ss_pred HHHHHHHhcCCCCCC--------------------------------------CCCCCCCHHHHHHHHHhccCCccCCCC
Q 012825 368 GIFRAVLKADPSFDE--------------------------------------APWPSLSSEARDFVKRLLNKDPRKRLT 409 (455)
Q Consensus 368 ~~~~~i~~~~~~~~~--------------------------------------~~~~~~s~~l~~li~~~L~~dP~~Rps 409 (455)
..+..+.......+. .....++.++.+||.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 222232221110000 001134578899999999999999999
Q ss_pred HHHHHcCcccCCCC
Q 012825 410 AAQALSHPWIKNSN 423 (455)
Q Consensus 410 ~~elL~hp~~~~~~ 423 (455)
+.|+|+||||+...
T Consensus 328 ~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 328 AGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHTCGGGTTCT
T ss_pred HHHHhhChhhhccc
Confidence 99999999999853
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=354.11 Aligned_cols=258 Identities=21% Similarity=0.298 Sum_probs=210.6
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
...+.++|++.+.||+|+||.||+|+... +|+.||||++..... .+.+.+|+.+++.+.+|+|++++++++.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 34567899999999999999999999765 589999999865432 1347789999999977999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec--CCCceEEEeec
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK--DENSVLKAIDF 307 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~--~~~~~vkL~Df 307 (455)
+++..++||||+ +++|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++.+ +....+||+||
T Consensus 77 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 77 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 999999999999 899999998777789999999999999999999999999999999999999432 12234999999
Q ss_pred ccccccCCCCc--------ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCC---hhHHHHHHHh
Q 012825 308 GLSDFVRPDER--------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWART---ESGIFRAVLK 375 (455)
Q Consensus 308 G~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~---~~~~~~~i~~ 375 (455)
|++........ .....||..|+|||++. ..++.++||||||+++|+|++|+.||.... ....+..+..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence 99987654322 34567999999999987 468999999999999999999999997743 3333333332
Q ss_pred cCC-CCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 376 ADP-SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 376 ~~~-~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
... .........++.++.+||.+||+.||++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 211 11111123688999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=347.74 Aligned_cols=253 Identities=22% Similarity=0.348 Sum_probs=214.4
Q ss_pred CCCeEEec-eEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.++|.+.+ .||+|+||.||+|.+.... +++.||||++... ......+.+.+|++++++++ ||||+++++++ ..+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAE 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCC-CcceEEEEecCCc--cchhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCC
Confidence 46788877 9999999999999865322 4789999999754 35566788999999999997 99999999999 556
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKA 159 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE---cCCCCEEECcccceee
Confidence 7999999999999999887777789999999999999999999999999999999999999 5678999999999987
Q ss_pred cCCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 313 VRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 313 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
...... .....+|..|+|||++. ..++.++||||||+++|+|++ |+.||......+....+...... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~~~ 236 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPP 236 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCT
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CCCC
Confidence 654332 22345688999999886 568999999999999999998 99999888877776666554322 1224
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCc
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp 417 (455)
.++.++.+||.+||+.||++||++.+++++.
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 7899999999999999999999999999773
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=352.66 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=205.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+... +++.||||++...........+.+.+|+.+++++. ||||+++++++.+++.
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV---RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC---CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCe
Confidence 4789999999999999999998765 58999999997655556666788999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC----
T ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCccc
Confidence 99999999999999988643 579999999999999999999999999999999999999 77889999999999776
Q ss_pred CCCC--cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 314 RPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
.... ......|+..|+|||++. +.++.++||||||+++|+|++|+.||...... .+...+...........+.++.
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPV 263 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCT
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCCH
Confidence 5332 234567899999999886 46899999999999999999999999876654 3444444443333344467899
Q ss_pred HHHHHHHHhccCCccCCC-CHHHHHc
Q 012825 391 EARDFVKRLLNKDPRKRL-TAAQALS 415 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rp-s~~elL~ 415 (455)
++.+||.+||+.||++|| ++.++++
T Consensus 264 ~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 264 AFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999999999999 7877764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=352.23 Aligned_cols=263 Identities=19% Similarity=0.290 Sum_probs=211.0
Q ss_pred CcCcccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEe
Q 012825 146 SFGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFF 225 (455)
Q Consensus 146 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~ 225 (455)
.+.......++|.+.+.||+|+||.||+|.......+++.||||++.... ......+.+.+|+.++++++ ||||++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~ 102 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFS-HPNVIRLL 102 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCC-CTTBCCCC
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCC-CCCeeeee
Confidence 33333445689999999999999999999888765567899999986543 34556678999999999998 99999999
Q ss_pred EEEeeCC-----ceEEEEeecCCCcHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEee
Q 012825 226 DAYEDTD-----NVYVVMELCEGGELLDRILS-----RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295 (455)
Q Consensus 226 ~~~~~~~-----~~~lV~E~~~ggsL~~~l~~-----~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~ 295 (455)
+++.+.+ ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli-- 180 (313)
T 3brb_A 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML-- 180 (313)
T ss_dssp EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE--
T ss_pred EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE--
Confidence 9998655 35999999999999998853 33579999999999999999999999999999999999999
Q ss_pred cCCCceEEEeecccccccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 012825 296 KDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIF 370 (455)
Q Consensus 296 ~~~~~~vkL~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~ 370 (455)
+.++.+||+|||++....... ......++..|+|||++. ..++.++||||||+++|+|++ |..||.........
T Consensus 181 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 259 (313)
T 3brb_A 181 -RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259 (313)
T ss_dssp -CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred -cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence 778899999999998764332 123345778899999876 568999999999999999999 99999888887777
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 371 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..+....... ....++.++.+||.+||+.||.+||++.+++++
T Consensus 260 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 260 DYLLHGHRLK---QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHTTCCCC---CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCC---CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7666554222 224688999999999999999999999999865
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=343.64 Aligned_cols=248 Identities=25% Similarity=0.439 Sum_probs=214.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|.... ++.||+|++...... .+.+.+|++++++++ ||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLN----KDKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAP 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----TEEEEEEEECTTTBC----HHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred hhheeeeeEecCCCceeEEEEEecC----CCeEEEEEccccCCC----HHHHHHHHHHHHhCC-CCCEeeEEEEEccCCC
Confidence 4789999999999999999998754 678999999764322 256889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFV 154 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGB
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEccccccccc
Confidence 999999999999999998777789999999999999999999999999999999999999 77888999999999876
Q ss_pred CCCC--cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 314 RPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
.... ......++..|+|||++. ..++.++||||||+++|+|++ |+.||...........+........ ...++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~ 231 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAS 231 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSC
T ss_pred ccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCc
Confidence 4322 223445778899999986 578999999999999999999 8999998888777777665533222 23578
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..+.+||.+||+.||++||++.+++++
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 232 THVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999999865
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=354.06 Aligned_cols=256 Identities=24% Similarity=0.389 Sum_probs=216.2
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecC----cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKG----ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
..++|++.+.||+|+||.||+|++... ..+++.||||++... ......+.+.+|+.+++++..||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC--CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 368999999999999999999987531 135789999999654 34566778999999999995599999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEE
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLF 293 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl 293 (455)
.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 99999999999999999999887543 248999999999999999999999999999999999999
Q ss_pred eecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhH
Q 012825 294 TTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESG 368 (455)
Q Consensus 294 ~~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~ 368 (455)
+.++.+||+|||++........ .....++..|+|||++. +.++.++||||||+++|+|++ |..||......+
T Consensus 191 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 191 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp ---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred ---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 7788999999999987654332 23345778899999876 568999999999999999999 999999888777
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
....+....... ....++.++.+||.+||+.||.+||++.+++++
T Consensus 268 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 268 LFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 766666554222 224688999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=353.27 Aligned_cols=257 Identities=19% Similarity=0.299 Sum_probs=218.1
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
+...++|++.+.||+|+||.||+|.... ....++.||||++... ........+.+|+.+++++. |+||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 97 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVV 97 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcC-CCCEeeeEEEE
Confidence 3456899999999999999999998763 2235789999998654 34555667899999999998 99999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCC
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~ 299 (455)
.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCC
Confidence 99999999999999999999886532 467999999999999999999999999999999999999 778
Q ss_pred ceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 012825 300 SVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVL 374 (455)
Q Consensus 300 ~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~ 374 (455)
+.+||+|||++........ .....+|..|+|||++. +.++.++||||||+++|+|++ |..||...........+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 8999999999976543321 23345788999999886 568999999999999999999 899998888777777666
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 375 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
...... ....++..+.+||.+||+.||.+|||+.++++|
T Consensus 255 ~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 EGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 544322 124688999999999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=351.53 Aligned_cols=256 Identities=23% Similarity=0.380 Sum_probs=208.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|++......+..||||++...........+.+.+|+++++++. |+||+++++++.+.+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence 578999999999999999999876543345579999987654445566788999999999998 999999999998765
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEccccccccc
Confidence 899999999999999998777789999999999999999999999999999999999999 56778999999999876
Q ss_pred CCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 314 RPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 314 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
..... .....+|..|+|||++. ..++.++||||||+++|+|++ |+.||...........+......... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 249 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED 249 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcC
Confidence 54332 23345778899999886 468889999999999999999 99999988888877777665443332 246
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++.++.++|.+||+.||.+||++.+++++
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 89999999999999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=353.69 Aligned_cols=255 Identities=22% Similarity=0.344 Sum_probs=211.4
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCc-ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
..++|++.+.||+|+||.||+|...... ..+..||||++... ........+.+|+.+++++. |+||+++++++.+.
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKY 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC
Confidence 4678999999999999999999877532 23567999998654 34555678899999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcch
Confidence 99999999999999999998777889999999999999999999999999999999999999 778899999999998
Q ss_pred ccCCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 312 FVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 312 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
....... .....+|..|+|||++. +.++.++||||||+++|+|++ |+.||......+....+....... ..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~---~~ 272 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP---TP 272 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC---Cc
Confidence 7653321 12234677899999876 568999999999999999998 999999888877776665543211 12
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..++..+.+||.+||+.||++||++.+++++
T Consensus 273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3688999999999999999999999999865
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=357.03 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=209.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeE--EEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQ--VAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~--vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.+.||+|+||.||+|+... +|.. ||||++... ......+.+.+|+++++++.+||||+++++++.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred HHHccceeeeecCCCceEEEEEEcc---CCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 4789999999999999999999876 4554 499998643 33444567899999999995599999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec
Q 012825 232 DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~ 296 (455)
+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~--- 175 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--- 175 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---
Confidence 99999999999999999886543 479999999999999999999999999999999999999
Q ss_pred CCCceEEEeecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 012825 297 DENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVL 374 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~ 374 (455)
+.++.+||+|||++.............++..|+|||++. ..++.++||||||+++|+|++ |+.||...........+.
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 778899999999997554333334456788999999886 458899999999999999998 999999888777666554
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 375 KADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 375 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..... .....++.++.+||.+||+.||.+||++.+++++
T Consensus 256 ~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43211 2224688999999999999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=347.26 Aligned_cols=254 Identities=22% Similarity=0.312 Sum_probs=210.6
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe-eCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE-DTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~-~~~ 232 (455)
..+|++.+.||+|+||.||+|++......+..||+|.+... ......+.+.+|+.++++++ ||||+++++++. .++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCC
Confidence 46799999999999999999997765445667999998653 45566778999999999998 999999999864 566
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARD 177 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECccccccc
Confidence 7899999999999999997777789999999999999999999999999999999999999 7888999999999987
Q ss_pred cCCCCc-----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 313 VRPDER-----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 313 ~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
...... .....+|..|+|||++. ..++.++||||||+++|+|++ |..||......+....+.........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 254 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--- 254 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---
Confidence 654321 23446778899999886 568999999999999999999 56677666666666666555433322
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..++..+.++|.+||+.||++||++.++++.
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3578999999999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=353.70 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=215.9
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCc--ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGE--LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
...++|++.+.||+|+||.||+|...... ..+..||+|++... ......+.+.+|+.+++++.+||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc--cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34688999999999999999999876532 13468999998654 345566789999999999955999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec
Q 012825 230 DTDNVYVVMELCEGGELLDRILSR-------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK 296 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~-------------~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~ 296 (455)
+.+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~--- 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--- 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE---
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE---
Confidence 999999999999999999988653 3468999999999999999999999999999999999999
Q ss_pred CCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 012825 297 DENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFR 371 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~ 371 (455)
+.++.+||+|||++........ .....+|..|+|||++. ..++.++||||||+++|+|++ |..||........+.
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 6778999999999986543322 23445778899999876 578999999999999999998 999998877666666
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.+......... ...++..+.+||.+||+.||.+|||+.+++++
T Consensus 278 ~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 278 KLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 66555433222 23578999999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=371.87 Aligned_cols=257 Identities=25% Similarity=0.378 Sum_probs=200.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
..+|++.+.||+|+||.||..... +|+.||||++..... ..+.+|+++++++.+||||+++++++.+.+.
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~----~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMF----DNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEES----SSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred cEEEecCCeeecCcCEEEEEEEEe----CCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 457999999999999997643322 488999999865432 2256899999999569999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC--CCceEEEeeccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFGLSD 311 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~--~~~~vkL~DfG~a~ 311 (455)
.|||||||. |+|.+++......+.+..++.++.||+.||.|||++||+||||||+|||++..+ ....+||+|||+++
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 999999996 599999987766777778889999999999999999999999999999996432 23468899999998
Q ss_pred ccCCCC----cccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCC
Q 012825 312 FVRPDE----RLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDE 382 (455)
Q Consensus 312 ~~~~~~----~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (455)
...... ......||+.|+|||++. ..++.++|||||||++|||++ |..||........ ..+.........
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~~~~~~~~~ 250 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILLGACSLDCL 250 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHTTCCCCTTS
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHhccCCcccc
Confidence 765432 234567999999999986 346789999999999999999 9999965544332 222222111111
Q ss_pred CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 383 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
......+..+.+||.+||+.||++|||+.++|+||||...
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 1112345668999999999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=345.66 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=210.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.-.|++.+.||+|+||.||+|++......+..||+|++... ......+.+.+|+.++++++ |+||+++++++.+.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEG 96 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCC
Confidence 34678889999999999999998775555668999998643 45566788999999999998 9999999999987666
Q ss_pred e-EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 V-YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~-~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
. ++||||+.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARD 173 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCccc
Confidence 5 99999999999999997777889999999999999999999999999999999999999 7888999999999986
Q ss_pred cCCCC-----cccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCC-CCCChhHHHHHHHhcCCCCCCCCC
Q 012825 313 VRPDE-----RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPF-WARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 313 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
..... ......++..|+|||++.+ .++.++||||||+++|+|++|..|+ ...........+....... ..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~ 250 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP---QP 250 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC---CC
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC---CC
Confidence 54322 2234567889999999874 6899999999999999999965554 4444444444444433221 12
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..++..+.+||.+||+.||.+|||+.++++.
T Consensus 251 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3688999999999999999999999999764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=360.36 Aligned_cols=253 Identities=20% Similarity=0.305 Sum_probs=208.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcc-cCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.++|++.+.||+|+||.||+|++..... ....||+|++.... .....+.+.+|+.+++++. |+||+++++++. ++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-BS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-CC
Confidence 5789999999999999999999765321 22348888875432 1222345678999999998 999999999886 56
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++....+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence 6899999999999999987766789999999999999999999999999999999999999 7788999999999987
Q ss_pred cCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 313 VRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 313 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
..... ......++..|+|||++. +.++.++||||||+++|+|++ |+.||...........+......... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---Cc
Confidence 65433 224456788999999987 678999999999999999999 99999888777766666554322221 24
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++.++.+||.+||+.||.+||++.+++++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 67789999999999999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=345.11 Aligned_cols=252 Identities=22% Similarity=0.363 Sum_probs=215.7
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
+...++|++.+.||+|+||.||+|.+.. ++..||+|++... ....+.+.+|++++++++ |+||+++++++.+
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTR 80 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGG---GTEEEEEEEECSC----STHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred cccccceeEEeecCCCCceeEEEeEecC---CCEEEEEEecCcC----HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcc
Confidence 3457889999999999999999999876 5899999998643 224567889999999998 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
++..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGL 157 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCG
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCcc
Confidence 999999999999999999987643 469999999999999999999999999999999999999 7788899999999
Q ss_pred ccccCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 310 SDFVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 310 a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
+........ .....++..|+|||++. +.++.++||||||+++|+|++ |..||...........+...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~ 234 (288)
T 3kfa_A 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERP 234 (288)
T ss_dssp GGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCC
T ss_pred ceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCC
Confidence 987654332 23345678899999886 678999999999999999999 99999887777666655544222 222
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..+++.+.+||++||+.||.+|||+.++++.
T Consensus 235 ~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 4689999999999999999999999999753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=345.78 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=206.7
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEec-CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
..++|++.+.||+|+||.||+|++.. +..+++.||||++.... .....+.+.+|+.++++++ |+||+++++++.+.
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTED 95 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC-
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecC
Confidence 35779999999999999999998543 22368999999996542 2233467899999999998 99999999999876
Q ss_pred --CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 232 --DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 232 --~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
+.+++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGL 172 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE---cCCCCEEECcccc
Confidence 66899999999999999997777889999999999999999999999999999999999999 5677899999999
Q ss_pred ccccCCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCC--------------ChhHHH
Q 012825 310 SDFVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR--------------TESGIF 370 (455)
Q Consensus 310 a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~--------------~~~~~~ 370 (455)
+........ .....||..|+|||++. ..++.++||||||+++|+|++|..|+... .....+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 987754432 23456788899999876 56888999999999999999999876321 112222
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 371 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.......... .....+++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 253 VNTLKEGKRL--PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHhccCCC--CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2222222222 223478999999999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=368.47 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=212.2
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
....++|++.+.||+|+||.||+|++.. +|+.||||++...... ...+.+.+|++++++++ |+||+++++++.+
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 78 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLN-HKNIVKLFAIEEE 78 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECC---CCcEEEEEEecccccc--chHHHHHHHHHHHHhcC-CCCCCeEEEeecc
Confidence 3457899999999999999999999776 5899999998653322 22456789999999998 9999999999987
Q ss_pred CC--ceEEEEeecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEee-cCCCceEEEe
Q 012825 231 TD--NVYVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT-KDENSVLKAI 305 (455)
Q Consensus 231 ~~--~~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~-~~~~~~vkL~ 305 (455)
.+ ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+.. .+.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence 65 7899999999999999886433 23999999999999999999999999999999999999843 3456789999
Q ss_pred ecccccccCCCCcccccccCCCcccccccC---------CCCCCcchHHHHHHHHHHHHcCCCCCCC----CChhHHHHH
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH---------RSYSTEADVWSIGVIAYILLCGSRPFWA----RTESGIFRA 372 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~sDiwSlG~~l~elltg~~Pf~~----~~~~~~~~~ 372 (455)
|||+++............||..|+|||++. ..++.++|||||||++|||++|+.||.. ....+.+..
T Consensus 159 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp CGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred cCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 999998877666666778999999999875 3467899999999999999999999964 333455666
Q ss_pred HHhcCCCCCC---------------------CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 373 VLKADPSFDE---------------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 373 i~~~~~~~~~---------------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++...+.... .....++..+.+||++||++||++||++.+++++
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 6655432110 0011245678899999999999999999998543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=361.60 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=204.1
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe-eCCc
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE-DTDN 233 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~-~~~~ 233 (455)
.+|++.+.||+|+||.||+|.+......+..||||.+... ......+.+.+|+.++++++ ||||+++++++. .++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCC
Confidence 4689999999999999999998765444567999998643 34456678999999999998 999999999875 4567
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccc
Confidence 899999999999999997777789999999999999999999999999999999999999 78889999999999865
Q ss_pred CCCCc-----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 314 RPDER-----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 314 ~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
..... .....++..|+|||++. +.++.++||||||+++|||++ |..||......+....+........ ..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p~ 319 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PE 319 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---CT
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence 43321 23345778899999886 578999999999999999999 6778877666665555555433222 23
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.++..+.++|.+||+.||++||++.+++++
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 688999999999999999999999999865
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=339.59 Aligned_cols=247 Identities=18% Similarity=0.251 Sum_probs=210.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC--
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-- 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~-- 231 (455)
.++|++.+.||+|+||.||+|++. ++.||||++.... ......+.+.+|+.++++++ ||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-----GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPA 81 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-----TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-----CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCC
Confidence 578999999999999999999853 6889999997643 34556678999999999998 99999999999877
Q ss_pred CceEEEEeecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC--CEEeeccCCceEEeecCCCceEEEeecc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~--ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
+..++||||+++++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~ 158 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMAD 158 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGG
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEecc
Confidence 788999999999999999876543 5999999999999999999999999 9999999999999 778889999998
Q ss_pred cccccCCCCcccccccCCCcccccccCCC-C---CCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 012825 309 LSDFVRPDERLNDIVGSAYYVAPEVLHRS-Y---STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384 (455)
Q Consensus 309 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~---~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 384 (455)
++..... ....||+.|+|||++.+. + +.++||||||+++|+|++|+.||...........+........ .
T Consensus 159 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 232 (271)
T 3kmu_A 159 VKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--I 232 (271)
T ss_dssp SCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--C
T ss_pred ceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--C
Confidence 8765332 345789999999988642 3 3379999999999999999999998888777766665543332 2
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
...++.++.+||.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34689999999999999999999999999853
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=369.52 Aligned_cols=251 Identities=22% Similarity=0.365 Sum_probs=214.3
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.+.||+|+||.||+|.+.. ++..||||++..... ..+.+.+|+.++++++ ||||+++++++.+.
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 288 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE 288 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGG---GTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcC---CCeEEEEEEecCccc----chHHHHHHHHHHHhcC-CCCEeeEEEEEecC
Confidence 346789999999999999999999876 578999999965432 2467899999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
+.++|||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a 365 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLS 365 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCE
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccc
Confidence 99999999999999999987643 569999999999999999999999999999999999999 77889999999999
Q ss_pred cccCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 311 DFVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 311 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
+....... .....++..|+|||++. +.++.++|||||||+||||++ |..||...........+..... . ....
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~ 442 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-M--ERPE 442 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-C--CCCT
T ss_pred eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--CCCC
Confidence 87653322 22344677899999886 568999999999999999999 9999988877766655544322 1 2234
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.++.++.+||.+||+.||++|||+.++++.
T Consensus 443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 689999999999999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=361.24 Aligned_cols=261 Identities=16% Similarity=0.229 Sum_probs=198.1
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcc--cCeEEEEEEccCCCcCCHHHH--------HHHHHHHHHHHHhcCCCCe
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGEL--KGQQVAVKVIPKHKMTTAIAI--------EDVRREVKILRALTGHNNL 221 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~--~g~~vavK~~~~~~~~~~~~~--------~~~~~Ei~~l~~l~~hp~I 221 (455)
...++|++.+.||+|+||.||+|.+..+.. .++.||||++........... ..+..|+..+..+. |+||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~i 110 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGV 110 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCS
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCC
Confidence 446799999999999999999998876421 368999999865421000000 11223444445555 9999
Q ss_pred eEEeEEEeeC----CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC
Q 012825 222 VKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (455)
Q Consensus 222 v~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~ 297 (455)
+++++++... ...||||||+ |++|.+++....+.+++..++.|+.||+.||.|||++||+||||||+|||++. +
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~ 188 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K 188 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence 9999998765 4589999999 99999999877788999999999999999999999999999999999999942 1
Q ss_pred CCceEEEeecccccccCCCCc--------ccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhH
Q 012825 298 ENSVLKAIDFGLSDFVRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESG 368 (455)
Q Consensus 298 ~~~~vkL~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~ 368 (455)
.++.+||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 678899999999977643321 133459999999999874 58999999999999999999999997543332
Q ss_pred HHHHHHhcC--CCCC-----CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 369 IFRAVLKAD--PSFD-----EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 369 ~~~~i~~~~--~~~~-----~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
......... .... ......++.++.+||..||+.||.+||++.+|++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 221111100 0000 0001367899999999999999999999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=345.98 Aligned_cols=240 Identities=33% Similarity=0.623 Sum_probs=192.3
Q ss_pred cCCCeEEe-ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-
Q 012825 153 FANKYELG-EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (455)
Q Consensus 153 ~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~- 230 (455)
+.++|.+. +.||+|+||.||+|.... +++.||||++... ..+.+|+.++.++.+|+||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcC---CCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 45678877 789999999999999766 5899999998532 3567899998666669999999999987
Q ss_pred ---CCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 231 ---TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 231 ---~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 677999999999999999987654 4799999999999999999999999999999999999996444478999999
Q ss_pred cccccccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcC----CCCCC
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD----PSFDE 382 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~----~~~~~ 382 (455)
||++..... ..++.++|||||||++|+|++|+.||................ ..+..
T Consensus 164 fg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 164 FGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp CTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred ccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 999865431 346778999999999999999999997655433211111110 01111
Q ss_pred CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 383 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
..+..++.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 11136899999999999999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=342.89 Aligned_cols=256 Identities=21% Similarity=0.287 Sum_probs=206.1
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|+... +|+.||||++...... +.+.+|+.+++.+.+|+++..+..++.++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcC---CCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence 457899999999999999999999765 5899999998654322 35789999999999444455555555677
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 8899999999 889999997777789999999999999999999999999999999999999654577889999999998
Q ss_pred ccCCCCc--------ccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCh---hHHHHHHHhcCCC
Q 012825 312 FVRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADPS 379 (455)
Q Consensus 312 ~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~---~~~~~~i~~~~~~ 379 (455)
....... .....||..|+|||++.+ .++.++||||||+++|+|++|+.||..... ...+..+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 7654332 245679999999999874 689999999999999999999999976332 2223333222111
Q ss_pred CC-CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 380 FD-EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 380 ~~-~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.. ......+++++.+||.+||+.||++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 11 11123688999999999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=366.83 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=211.6
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.++++++ ||||+++++++. .
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNK----HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVKLHAVVT-K 254 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETT----TEEEEEEEECTTSB----CHHHHHHHHHHHTTCC-CTTBCCEEEEEC-S
T ss_pred echHHeEEEEEcccCCceEEEEEEECC----ccEEEEEEecCCCc----cHHHHHHHHHHHhhCC-CCCEeeEEEEEe-C
Confidence 346889999999999999999998754 67899999975432 2467899999999998 999999999986 6
Q ss_pred CceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
+..+|||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLA 331 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCc
Confidence 67899999999999999986543 368999999999999999999999999999999999999 77889999999999
Q ss_pred cccCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 311 DFVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 311 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
+....... .....++..|+|||++. +.++.++|||||||+||||++ |+.||.+....+....+....... ...
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---~~~ 408 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP---RPE 408 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC---CCT
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCC
Confidence 87653321 22344677899999986 679999999999999999999 999999888888777766543221 124
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.++.++.+||.+||+.||++|||+.+|++
T Consensus 409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 409 NCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 68999999999999999999999999974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=363.14 Aligned_cols=259 Identities=29% Similarity=0.435 Sum_probs=199.2
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
.+.+.+.|.+.+.||+|+||+||.+... +|+.||||++... ..+.+.+|+.+++++.+||||+++++++.
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~~~----~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 79 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQGSF----QGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSET 79 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEEES----SSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEEEE----CCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 3445677888999999999999865432 4899999998542 12457789999998856999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeec-------
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRGGK------YTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTK------- 296 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~~~------l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~------- 296 (455)
+++.+|||||||. |+|.+++...... .++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence 9999999999995 5999988654321 1334567899999999999999999999999999999643
Q ss_pred ---CCCceEEEeecccccccCCCCc-----ccccccCCCcccccccC--------CCCCCcchHHHHHHHHHHHHc-CCC
Q 012825 297 ---DENSVLKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLH--------RSYSTEADVWSIGVIAYILLC-GSR 359 (455)
Q Consensus 297 ---~~~~~vkL~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~--------~~~~~~sDiwSlG~~l~ellt-g~~ 359 (455)
+.+..+||+|||++........ .....||+.|+|||++. +.++.++|||||||++|||++ |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 2456899999999987754332 23457999999999875 358889999999999999999 999
Q ss_pred CCCCCChhHHHHHHHhcCCCCCCCC---CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 360 PFWARTESGIFRAVLKADPSFDEAP---WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 360 Pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
||....... ..++.......... ...++.++.+||.+||+.||.+|||+.++++||||..
T Consensus 239 Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 239 PFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 997655443 33444433322211 1134578999999999999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=358.42 Aligned_cols=254 Identities=20% Similarity=0.334 Sum_probs=205.9
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR----DGAKVALKRRTPE---SSQGIEEFETEIETLSFCR-HPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT----TCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCT
T ss_pred HHHhccCccceeecCCCeeEEEEEEC----CCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCC
Confidence 45789999999999999999999854 3789999998653 2334567899999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 232 DNVYVVMELCEGGELLDRILSRG---GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeecc
Confidence 99999999999999998775432 358999999999999999999999999999999999999 788899999999
Q ss_pred cccccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHH---H--HHHhcCCC
Q 012825 309 LSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIF---R--AVLKADPS 379 (455)
Q Consensus 309 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~---~--~i~~~~~~ 379 (455)
++....... ......||..|+|||++. +.++.++||||||+++|+|++|+.||......... . ........
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 997654222 223456899999999875 67999999999999999999999999754432111 0 00111111
Q ss_pred C--------CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 380 F--------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 380 ~--------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
. .....+.++..+.++|.+||+.||++|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 111112345678999999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=345.18 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=211.5
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
.+.+..+|++.+.||+|+||.||+|+... +|+.||||++.... +.+.+|+++++++. |+||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~ 74 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWD 74 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETT---TCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcC---CCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEe
Confidence 45677899999999999999999999765 58999999986542 34678999999998 999999999886
Q ss_pred e----------------CCceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceE
Q 012825 230 D----------------TDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFL 292 (455)
Q Consensus 230 ~----------------~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NIL 292 (455)
. ....++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil 154 (284)
T 2a19_B 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154 (284)
T ss_dssp EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEE
Confidence 4 44589999999999999998754 467999999999999999999999999999999999999
Q ss_pred EeecCCCceEEEeecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 012825 293 FTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 371 (455)
Q Consensus 293 l~~~~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~ 371 (455)
+ +.++.+||+|||++.............||..|+|||++. ..++.++||||||+++|+|++|..||... .....
T Consensus 155 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~ 229 (284)
T 2a19_B 155 L---VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFT 229 (284)
T ss_dssp E---EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHH
T ss_pred E---cCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHH
Confidence 9 567789999999998876665556678999999999876 56899999999999999999999887422 12222
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.+... .. ...++..+.+||.+||+.||.+||++.++++|.|.-..
T Consensus 230 ~~~~~--~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 230 DLRDG--II----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHTT--CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred Hhhcc--cc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 22221 11 23578999999999999999999999999999776543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=350.41 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=209.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEec-CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe--e
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE--D 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~--~ 230 (455)
.++|++.+.||+|+||.||+|++.. +..+++.||||++.. ......+.+.+|++++++++ |+||+++++++. +
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS---CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc---CCHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Confidence 5789999999999999999998643 223689999999864 34556678999999999997 999999999886 4
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEcccccc
Confidence 566899999999999999997766779999999999999999999999999999999999999 66788999999999
Q ss_pred cccCCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh--------------HHHH
Q 012825 311 DFVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES--------------GIFR 371 (455)
Q Consensus 311 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~--------------~~~~ 371 (455)
........ .....||..|+|||++. ..++.++||||||+++|+|++|+.||...... ....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 87654332 23446788899999886 45888999999999999999999998543321 1122
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
......... .....++.++.+||.+||+.||++|||+.+++++
T Consensus 255 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEGQRL--PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcccCC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222222222 2234789999999999999999999999999654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=363.70 Aligned_cols=243 Identities=26% Similarity=0.401 Sum_probs=206.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC-
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~- 232 (455)
.++|++.+.||+|+||.||+|... |+.||||++.... ..+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 260 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----TEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTS
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-----CCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCC
Confidence 578999999999999999999753 6799999996542 2357889999999998 999999999987665
Q ss_pred ceEEEEeecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
.+||||||+++|+|.+++...+. .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 337 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcc
Confidence 79999999999999999977654 47999999999999999999999999999999999999 778899999999998
Q ss_pred ccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
..... .....++..|+|||++. +.++.++||||||++||||++ |+.||......+....+...... .....++
T Consensus 338 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~p~~~~ 412 (450)
T 1k9a_A 338 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCP 412 (450)
T ss_dssp ECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC---CCCTTCC
T ss_pred ccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCC
Confidence 65432 22336788999999886 579999999999999999998 99999888777776666554321 2234689
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.++.+||.+||+.||.+|||+.++++
T Consensus 413 ~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 413 PAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=345.48 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=200.8
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|++.. +++.||||++..... ...+.+|+.+++.+.+|+++..+..++.++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcC---CCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 457899999999999999999999765 589999998754322 234778999999999444555555556778
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 8899999999 889999987777789999999999999999999999999999999999999655577889999999998
Q ss_pred ccCCCCc--------ccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChh---HHHHHHHhcCCC
Q 012825 312 FVRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTES---GIFRAVLKADPS 379 (455)
Q Consensus 312 ~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~---~~~~~i~~~~~~ 379 (455)
....... .....||..|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+..+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 7654322 235679999999999874 6899999999999999999999999764322 222222221111
Q ss_pred CC-CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 380 FD-EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 380 ~~-~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.. ......+++++.+||.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11 1112357899999999999999999999999976
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=341.22 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=208.1
Q ss_pred CCCeEEec-eEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.++|++.+ .||+|+||.||+|.+.... .++.||||++.... ......+.+.+|+.+++.+. ||||+++++++ +.+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAE 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSS-SEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESS
T ss_pred chhhhhccCccccccCeeeEeeeecCCC-ceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCC
Confidence 46899998 9999999999999765322 47899999996543 33345678999999999997 99999999999 667
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKA 166 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE---eCCCcEEEccCCccee
Confidence 78999999999999998854 5679999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCCcc----cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 313 VRPDERL----NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 313 ~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
....... ....++..|+|||++. ..++.++||||||+++|+|++ |+.||...........+...... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 243 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPA 243 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCT
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 6543321 2234678899999886 468889999999999999999 99999988877766666554322 1224
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.++..+.+||.+||+.||++||++.++++
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 68999999999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=339.22 Aligned_cols=247 Identities=23% Similarity=0.381 Sum_probs=209.1
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|.... ++.||||++..... ..+.+.+|++++++++ |+||+++++++. .+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNG----HTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVT-QE 80 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT----TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEEC-SS
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcC----CcEEEEEEecCCcc----cHHHHHHHHHHHHhCC-CcCcceEEEEEc-CC
Confidence 35789999999999999999998653 67899999865432 2356889999999998 999999999886 45
Q ss_pred ceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLAR 157 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccc
Confidence 6899999999999999875432 269999999999999999999999999999999999999 788899999999998
Q ss_pred ccCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
....... .....++..|+|||++. +.++.++||||||+++|+|++ |+.||......+....+....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 234 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDN 234 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTT
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---Cccc
Confidence 7654332 23345678899999986 568899999999999999999 999999888777776665543222 2246
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
++.++.+||.+||+.||++|||+.++++
T Consensus 235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 235 CPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 8899999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=350.67 Aligned_cols=253 Identities=20% Similarity=0.283 Sum_probs=204.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcc-cCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.++|++.+.||+|+||.||+|++..... ....||+|.+.... .....+.+.+|+.+++++. ||||+++++++..++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC
Confidence 5789999999999999999999765321 12346888775432 2334567889999999998 999999999998765
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.++|+||+.+++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCcceeE
Confidence 889999999999999998888889999999999999999999999999999999999999 6677899999999987
Q ss_pred cCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 313 VRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 313 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
...... .....+|..|+|||++. ..++.++||||||+++|+|++ |..||...........+........ ...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 243 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPI 243 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence 643332 23345677899999876 568999999999999999999 9999988877776665554432221 246
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++.++.+||++||+.||.+||++.++++.
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 88999999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=346.95 Aligned_cols=254 Identities=25% Similarity=0.358 Sum_probs=206.3
Q ss_pred ccCCCe-EEeceEeecCCeEEEEEEEec-CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 152 HFANKY-ELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 152 ~~~~~y-~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
.+.++| ++++.||+|+||.||++.+.. ...+++.||||++... ......+.+.+|+++++++. |+||+++++++.
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 103 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCE 103 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCC-CcchhhEEEEEe
Confidence 345566 999999999999999987653 2336899999999754 44566778999999999998 999999999998
Q ss_pred eC--CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeec
Q 012825 230 DT--DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 230 ~~--~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
+. ..+++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+||
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Df 178 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDF 178 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCG
T ss_pred cCCCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCc
Confidence 74 578999999999999998744 349999999999999999999999999999999999999 77889999999
Q ss_pred ccccccCCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh--------------H
Q 012825 308 GLSDFVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES--------------G 368 (455)
Q Consensus 308 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~--------------~ 368 (455)
|++........ .....+|..|+|||++. ..++.++||||||+++|+|++|+.||...... .
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence 99987754432 23456788899999886 46888999999999999999999999643221 1
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 369 IFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 369 ~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.+...+..... ......++.++.+||++||+.||++|||+.++++
T Consensus 259 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 259 RLTELLERGER--LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcccC--CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11222222222 2223468999999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=351.16 Aligned_cols=248 Identities=21% Similarity=0.299 Sum_probs=196.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC-
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~- 232 (455)
.++|++.+.||+|+||.||+|++. ++.||||++... ........+|+.++++++ ||||+++++++.+..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-----NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTS 92 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-----TEEEEEEEECGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred hhhchhhheecccCceEEEEEEEC-----CCEEEEEEeecC----chHHHHHHHHHHHHhcCC-CCCchhhcceeccCCC
Confidence 578999999999999999999743 689999998532 233445667999999998 999999999998754
Q ss_pred ---ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc----------CCEEeeccCCceEEeecCCC
Q 012825 233 ---NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ----------GVVHRDLKPENFLFTTKDEN 299 (455)
Q Consensus 233 ---~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~----------~ivHrDikp~NILl~~~~~~ 299 (455)
.+++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||+ +.+
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~ 167 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNN 167 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTT
T ss_pred CCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCC
Confidence 37999999999999998855 3599999999999999999999999 99999999999999 788
Q ss_pred ceEEEeecccccccCCCCc---ccccccCCCcccccccCC------CCCCcchHHHHHHHHHHHHcCCCCCCCCCh----
Q 012825 300 SVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLHR------SYSTEADVWSIGVIAYILLCGSRPFWARTE---- 366 (455)
Q Consensus 300 ~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~Pf~~~~~---- 366 (455)
+.+||+|||+++....... .....||..|+|||++.+ .++.++|||||||++|||++|+.||.....
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 8999999999977654332 334679999999999875 355678999999999999999999965322
Q ss_pred -----------hHHHHHHHhcCCCCCCC--CC--CCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 367 -----------SGIFRAVLKADPSFDEA--PW--PSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 367 -----------~~~~~~i~~~~~~~~~~--~~--~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
...+............. .+ ...+.++.+||.+||+.||++|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11122222111111110 00 0123559999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=348.90 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=203.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee---
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--- 230 (455)
.++|++.+.||+|+||.||+++... +|+.||||++.. ......+.+.+|+++++.+. |+||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLH---DGHFYALKRILC---HEQQDREEAQREADMHRLFN-HPNILRLVAYCLRERG 100 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEE---SSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEET
T ss_pred CeEEEEEEEecCCCCeEEEEEEecC---CCcEEEEEEEec---CCHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccC
Confidence 5789999999999999999999765 589999999854 34566678999999999997 9999999999873
Q ss_pred -CCceEEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 231 -TDNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 231 -~~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
.+..++||||+++++|.+++.. .+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~d 177 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMD 177 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECC
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEe
Confidence 3478999999999999998865 35679999999999999999999999999999999999999 7788999999
Q ss_pred cccccccCCCCc----------ccccccCCCcccccccCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCChh-HHHH
Q 012825 307 FGLSDFVRPDER----------LNDIVGSAYYVAPEVLHRS----YSTEADVWSIGVIAYILLCGSRPFWARTES-GIFR 371 (455)
Q Consensus 307 fG~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~----~~~~sDiwSlG~~l~elltg~~Pf~~~~~~-~~~~ 371 (455)
||++........ .....||..|+|||++.+. ++.++||||||+++|+|++|+.||...... ....
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 999876532111 1234579999999998642 688999999999999999999999531110 0111
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
......... .....++.++.+||.+||+.||.+||++.+++++
T Consensus 258 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 258 LAVQNQLSI--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHHCC--C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhccCCC--CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 222222222 2234689999999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=352.95 Aligned_cols=266 Identities=18% Similarity=0.238 Sum_probs=208.9
Q ss_pred cccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 149 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
..+...++|++.+.||+|+||.||+|+.. +|+.||||++..... ......+.+|+++++.+. |+||+++++++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 96 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFC 96 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCS----SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEE
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEec----CCCEEEEEEeccccC--chHHHHHHHHHHHHHhcc-CCCccceEEEE
Confidence 34456789999999999999999999743 378999999865422 112235889999999998 99999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCEEeeccCCceEEeecCCCceE
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRG---GKYTEDDAKAVMIQILNVVAFCHLQ---GVVHRDLKPENFLFTTKDENSVL 302 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~---~~l~~~~~~~i~~qi~~gL~~LH~~---~ivHrDikp~NILl~~~~~~~~v 302 (455)
.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~ 173 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEA 173 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCE
Confidence 99999999999999999999887543 3499999999999999999999999 99999999999999 778899
Q ss_pred EEeecccccccCCCC--cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCC----ChhHHHHHHHh
Q 012825 303 KAIDFGLSDFVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWAR----TESGIFRAVLK 375 (455)
Q Consensus 303 kL~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~----~~~~~~~~i~~ 375 (455)
||+|||++....... ......||..|+|||++. +.++.++||||||+++|+|++|+.||... ...........
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999998764332 234456999999999885 56899999999999999999999999511 11111111111
Q ss_pred cCC---CCC--------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 376 ADP---SFD--------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 376 ~~~---~~~--------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
... ... .......+..+.+||.+||+.||.+|||+.++++|-+-....+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 110 000 0011123467999999999999999999999999876555433
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=362.13 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=209.2
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|.+.. +..||||++..... . .+.+.+|+.++++++ ||||+++++++.+ +
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~---~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM-S---PEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E 251 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSS-C---HHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC----CceEEEEEeccCCC-C---HHHHHHHHHHHHhCC-CCCEeeEEEEEcC-C
Confidence 46789999999999999999998765 56799999975432 2 356889999999998 9999999999876 6
Q ss_pred ceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
..+|||||+++|+|.+++... +..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 328 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccce
Confidence 789999999999999988643 3569999999999999999999999999999999999999 778899999999998
Q ss_pred ccCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
....... .....++..|+|||++. +.++.++||||||+++|||++ |+.||.+....+....+...... .....
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~ 405 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPE 405 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTT
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCC
Confidence 7653321 22345678899999876 679999999999999999999 99999988887777776554321 12246
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcC--cccCCC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH--PWIKNS 422 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~h--p~~~~~ 422 (455)
++..+.+||.+||+.||++|||+.++++. .++...
T Consensus 406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 89999999999999999999999999863 555543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=348.91 Aligned_cols=249 Identities=23% Similarity=0.403 Sum_probs=188.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe---
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE--- 229 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~--- 229 (455)
...+|++.+.||+|+||.||+|++.. +|+.||||++.. ......+.+.+|+.+++++.+|+||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVG---SGREYALKRLLS---NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEE---SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred cCceEEEEEEEccCCceEEEEEEECC---CCcEEEEEEecC---CchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 35689999999999999999999766 588999999844 345566788999999999977999999999984
Q ss_pred -----eCCceEEEEeecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeeccCCceEEeecCCCc
Q 012825 230 -----DTDNVYVVMELCEGGELLDRILS--RGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENS 300 (455)
Q Consensus 230 -----~~~~~~lV~E~~~ggsL~~~l~~--~~~~l~~~~~~~i~~qi~~gL~~LH~~~--ivHrDikp~NILl~~~~~~~ 300 (455)
....+++||||+. |+|.+++.. ..+.+++..++.++.||+.||.|||+.| |+||||||+|||+ +.++
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~ 175 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQG 175 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTS
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCC
Confidence 3345899999995 699888864 4567999999999999999999999999 9999999999999 7788
Q ss_pred eEEEeecccccccCCCCcc-------------cccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 012825 301 VLKAIDFGLSDFVRPDERL-------------NDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWA 363 (455)
Q Consensus 301 ~vkL~DfG~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~ 363 (455)
.+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++|+.||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999876543221 1456899999999872 3578899999999999999999999976
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCc
Q 012825 364 RTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHP 417 (455)
Q Consensus 364 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp 417 (455)
........ .... ......++..+.+||++||+.||.+||++.|+++|-
T Consensus 256 ~~~~~~~~----~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 256 GAKLRIVN----GKYS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp --------------CC--CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hhHHHhhc----Cccc--CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 54433222 1111 112235678899999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=373.16 Aligned_cols=250 Identities=21% Similarity=0.350 Sum_probs=207.9
Q ss_pred CCCeEEec-eEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.+++.+.+ .||+|+||.||+|.+.... ++..||||++.... .....+.+.+|++++++++ |+|||++++++.. +
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-E 408 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSS-CEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-S
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCC-CcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-C
Confidence 45666666 8999999999999876432 46789999997642 2334577899999999997 9999999999976 5
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.++|||||+++|+|.+++......+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKA 485 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTT
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCccc
Confidence 6999999999999999987777789999999999999999999999999999999999999 6778999999999987
Q ss_pred cCCCCcc----cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 313 VRPDERL----NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 313 ~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
....... ....++..|+|||++. +.++.++|||||||+||||++ |+.||......+....+...... ....
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~ 562 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPP 562 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC---CCCT
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 6533221 2234568899999986 679999999999999999998 99999988888877777655422 1224
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHH
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL 414 (455)
.++.++.+||.+||+.||++||++.+++
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 6899999999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=342.04 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=197.1
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHH--hcCCCCeeEEeEEE
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA--LTGHNNLVKFFDAY 228 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~~hp~Iv~l~~~~ 228 (455)
+.+.++|++.+.||+|+||.||+|+. +|+.||||++... ....+.+|.+++.. +. ||||+++++++
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~niv~~~~~~ 71 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW-----QGENVAVKIFSSR------DEKSWFRETELYNTVMLR-HENILGFIASD 71 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCC-CTTBCCEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE-----CCEEEEEEEeccc------cchhhHHHHHHHHHhhcc-CcCeeeEEEee
Confidence 45678999999999999999999975 3789999998532 22445667777776 55 99999999987
Q ss_pred eeC----CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCEEeeccCCceEEeec
Q 012825 229 EDT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH--------LQGVVHRDLKPENFLFTTK 296 (455)
Q Consensus 229 ~~~----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH--------~~~ivHrDikp~NILl~~~ 296 (455)
.+. +..++||||+++|+|.+++ +...+++..++.++.||+.||.||| +.||+||||||+|||+
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill--- 146 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV--- 146 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHH--TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---
T ss_pred ccccCCCceeEEehhhccCCCHHHHH--hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---
Confidence 543 4589999999999999988 3457999999999999999999999 9999999999999999
Q ss_pred CCCceEEEeecccccccCCCCc-----ccccccCCCcccccccCCC-------CCCcchHHHHHHHHHHHHcC-------
Q 012825 297 DENSVLKAIDFGLSDFVRPDER-----LNDIVGSAYYVAPEVLHRS-------YSTEADVWSIGVIAYILLCG------- 357 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~sDiwSlG~~l~elltg------- 357 (455)
+.++.+||+|||++........ .....||+.|+|||++.+. ++.++||||||+++|||++|
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 7888999999999976543322 2344799999999998753 34689999999999999999
Q ss_pred ---CCCCCCCC----hhHHHHHHHhcCCCCCCCC----CCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 358 ---SRPFWART----ESGIFRAVLKADPSFDEAP----WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 358 ---~~Pf~~~~----~~~~~~~i~~~~~~~~~~~----~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..||.... ....+.............. ...++.++.+||.+||+.||++|||+.++++.
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 88885432 2233333333322222111 01245789999999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=363.30 Aligned_cols=255 Identities=23% Similarity=0.284 Sum_probs=210.2
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.++||+|+||.||+|++.. +++.||||++...... .++.+|+++++.|.+|++|..+..++.+.
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETT---TCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECC---CCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 457899999999999999999999765 5889999998654322 24778999999999678888888888889
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..+|||||+ +++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||...+.++.+||+|||+++
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 9999999999 889999998777889999999999999999999999999999999999999655577899999999998
Q ss_pred ccCCCCc--------ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCh---hHHHHHHHhcCC-
Q 012825 312 FVRPDER--------LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKADP- 378 (455)
Q Consensus 312 ~~~~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~---~~~~~~i~~~~~- 378 (455)
....... .....||..|+|||++. ..++.++|||||||+||||++|+.||..... ...+..+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 7654332 22567999999999987 4689999999999999999999999976543 223333322211
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 379 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.........++.++.+||..||+.||++||++.+|++
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1111111367899999999999999999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=368.29 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=213.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.++||+|+||.||+|.+.. +..||||++...... .+.+.+|++++++|+ |+||+++++++.+ +
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E 334 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT----TEEEEEEEECTTSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred chhhhhhheecccCCCeEEEEEEECC----CceEEEEEeCCCCCC----HHHHHHHHHHHHhCC-CCCEeeEEEEEee-c
Confidence 35789999999999999999998765 567999999754322 356889999999998 9999999999876 6
Q ss_pred ceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
.+||||||+++|+|.+++... +..+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 411 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTT
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccce
Confidence 789999999999999998643 3569999999999999999999999999999999999999 778899999999998
Q ss_pred ccCCCC--cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 312 FVRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 312 ~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
...... ......++..|+|||++. +.++.++|||||||+||||++ |+.||......+.+..+...... .....
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~ 488 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPE 488 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTT
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCC
Confidence 765322 122345678899999876 679999999999999999999 99999988888777776554321 12246
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcC--cccCCC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH--PWIKNS 422 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~h--p~~~~~ 422 (455)
++.++.+||.+||+.||++|||+.+|++. .+|...
T Consensus 489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 89999999999999999999999999864 555543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=339.98 Aligned_cols=241 Identities=32% Similarity=0.500 Sum_probs=193.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+.. ++.||||++... ...+.+.+|++++++++ ||||+++++++. +.
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~--~~ 73 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-----AKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLYGACL--NP 73 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-----TEEEEEEECSST-----THHHHHHHHHHHHHHCC-CTTBCCEEEBCT--TT
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-----CeeEEEEEecCh-----hHHHHHHHHHHHHhcCC-CCCcCeEEEEEc--CC
Confidence 478999999999999999999753 678999998532 24567899999999998 999999999886 45
Q ss_pred eEEEEeecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---cCCEEeeccCCceEEeecCCCc-eEEEeec
Q 012825 234 VYVVMELCEGGELLDRILSRGG--KYTEDDAKAVMIQILNVVAFCHL---QGVVHRDLKPENFLFTTKDENS-VLKAIDF 307 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~--~l~~~~~~~i~~qi~~gL~~LH~---~~ivHrDikp~NILl~~~~~~~-~vkL~Df 307 (455)
.++||||+++++|.+++..... .+++..++.++.||+.||.|||+ +||+||||||+|||++ .++ .+||+||
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Df 150 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDF 150 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCC
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEccc
Confidence 8999999999999998865432 47899999999999999999999 8999999999999994 444 5899999
Q ss_pred ccccccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhH--HHHHHHhcCCCCCCCC
Q 012825 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESG--IFRAVLKADPSFDEAP 384 (455)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~--~~~~i~~~~~~~~~~~ 384 (455)
|++..... ......||..|+|||++.+ .++.++||||||+++|+|++|+.||....... ....+..... ...
T Consensus 151 g~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 225 (307)
T 2eva_A 151 GTACDIQT--HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPL 225 (307)
T ss_dssp CC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC---CCC
T ss_pred cccccccc--ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC---CCc
Confidence 99976542 2334569999999999874 68999999999999999999999997644332 2222222221 122
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
...++..+.+||.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3468999999999999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=354.23 Aligned_cols=259 Identities=20% Similarity=0.223 Sum_probs=196.9
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHH--------HHHHHHHHHHHHHHhcCCCCeeE
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAI--------AIEDVRREVKILRALTGHNNLVK 223 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~--------~~~~~~~Ei~~l~~l~~hp~Iv~ 223 (455)
...++|++.+.||+|+||.||+|+.......+..||||++......... ....+.+|+..++.+. |+||++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~ 112 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPL 112 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcce
Confidence 3468999999999999999999998865556889999998654211111 1123557888888887 999999
Q ss_pred EeEEEee----CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCC
Q 012825 224 FFDAYED----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (455)
Q Consensus 224 l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~ 299 (455)
+++++.+ .+..|+||||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~ 187 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG---YK 187 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---SS
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc---cC
Confidence 9999987 67899999999 99999987543 4899999999999999999999999999999999999994 44
Q ss_pred c--eEEEeecccccccCCCCc--------ccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChh-
Q 012825 300 S--VLKAIDFGLSDFVRPDER--------LNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTES- 367 (455)
Q Consensus 300 ~--~vkL~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~- 367 (455)
+ .+||+|||+++....... .....||..|+|||++.+ .++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 4 899999999977643221 244579999999999874 5899999999999999999999999653222
Q ss_pred -HHHHHHHhcCCCCCC-----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 368 -GIFRAVLKADPSFDE-----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 368 -~~~~~i~~~~~~~~~-----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
............... .....++.++.+||.+||+.||++||++.++++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 111111111111110 0011688999999999999999999999999764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=337.04 Aligned_cols=243 Identities=25% Similarity=0.393 Sum_probs=199.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-C
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT-D 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~-~ 232 (455)
.++|++.+.||+|+||.||++.. +|+.||||++.... ..+.+.+|+.++++++ |+||+++++++.+. +
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 88 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred hhhceEEeEEecCCCceEEEEEE-----cCCEEEEEEecchh-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCC
Confidence 57899999999999999999974 37899999986432 3467889999999998 99999999987654 5
Q ss_pred ceEEEEeecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~-~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
..++||||+++++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 165 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccc
Confidence 79999999999999998865433 38999999999999999999999999999999999999 778899999999987
Q ss_pred ccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
..... .....++..|+|||++. ..++.++||||||+++|+|++ |+.||...........+..... ......++
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 240 (278)
T 1byg_A 166 EASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCP 240 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCC
T ss_pred ccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCC
Confidence 65432 23346788999999886 568999999999999999998 9999988777766655544322 22234689
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+.+.++|++||+.||++||++.++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999999976
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=341.83 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=203.7
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCC-cCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHK-MTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
|...+.||+|+||.||+|.. +++.||||++.... .......+.+.+|+.++++++ ||||+++++++.+.+..+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 106 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLC 106 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES-----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCE
T ss_pred cccCCccccCCCeEEEEEEE-----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceE
Confidence 34458999999999999974 37899999986533 233445678999999999998 999999999999999999
Q ss_pred EEEeecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 236 VVMELCEGGELLDRILSR--GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 236 lV~E~~~ggsL~~~l~~~--~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++...
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~ 183 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARAS 183 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeeccccccc
Confidence 999999999999988643 3569999999999999999999999999999999999999 78889999999999776
Q ss_pred CCCCc---ccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhH----HHHHHHhcCCCC------
Q 012825 314 RPDER---LNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPSF------ 380 (455)
Q Consensus 314 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~----~~~~i~~~~~~~------ 380 (455)
..... .....||..|+|||++.+.++.++||||||+++|+|++|..||....... ....+.......
T Consensus 184 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (307)
T 2nru_A 184 EKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK 263 (307)
T ss_dssp CSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS
T ss_pred ccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc
Confidence 43222 23457899999999998889999999999999999999999997654332 112221111100
Q ss_pred -CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 381 -DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 381 -~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.......++..+.++|.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011112345678999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=350.55 Aligned_cols=250 Identities=15% Similarity=0.183 Sum_probs=200.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcc-----cCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeE-----
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-----KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVK----- 223 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~----- 223 (455)
.++|++.+.||+|+||.||+|+...... .++.||||++... +.+.+|+++++++. |+||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence 5799999999999999999999875311 3789999998643 35779999999998 998887
Q ss_pred ----------EeEEEee-CCceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCce
Q 012825 224 ----------FFDAYED-TDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291 (455)
Q Consensus 224 ----------l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NI 291 (455)
+++++.. ++..|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6777776 67899999999 99999998754 46799999999999999999999999999999999999
Q ss_pred EEeecCCCc--eEEEeecccccccCCCC--------cccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCC
Q 012825 292 LFTTKDENS--VLKAIDFGLSDFVRPDE--------RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRP 360 (455)
Q Consensus 292 Ll~~~~~~~--~vkL~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~P 360 (455)
|+ +.++ .+||+|||+++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.|
T Consensus 191 l~---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 191 FV---DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EE---ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EE---cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99 5566 89999999997764332 1234579999999999875 689999999999999999999999
Q ss_pred CCCCC--hhHHHHHHH---hcCCCCCC--CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 361 FWART--ESGIFRAVL---KADPSFDE--APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 361 f~~~~--~~~~~~~i~---~~~~~~~~--~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
|.... ......... .....+.. ..+..++.++.+||.+||+.||++||++.++++.
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 97654 222222221 11111111 1123578999999999999999999999999753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=368.20 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=205.0
Q ss_pred CeEE-eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 156 KYEL-GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 156 ~y~~-~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
.+.+ .++||+|+||.||+|.+.... .++.||||+++... ......+++.+|++++++++ |+|||++++++.. +..
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~ 444 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESW 444 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSS-CEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCC-cceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCE
Confidence 3444 348999999999999765432 47899999986542 33344578999999999998 9999999999964 568
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+|||||+++|+|.+++. ....+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++...
T Consensus 445 ~lv~E~~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEEEECCTTEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTT
T ss_pred EEEEEccCCCCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCccccc
Confidence 99999999999999885 45679999999999999999999999999999999999999 667899999999998765
Q ss_pred CCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 315 PDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 315 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
.... .....+|..|+|||++. ..++.++|||||||+||||++ |+.||.+....+....+....... ....+
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~ 597 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGC 597 (635)
T ss_dssp C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTC
T ss_pred cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCC
Confidence 4332 22335678899999987 579999999999999999998 999999988888777776654222 22368
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+.++.+||.+||+.||++||++.++++
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=369.24 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=215.7
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
...++|++.+.||+|+||.||+|.+......+..||||.+... ......+.+.+|+.+++++. ||||+++++++. +
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-E 462 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-S
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe-c
Confidence 3467899999999999999999998765556788999998643 44556678999999999998 999999999985 4
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl---~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSR 539 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---eCCCCEEEEecCCCe
Confidence 66899999999999999998777789999999999999999999999999999999999999 567899999999998
Q ss_pred ccCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 312 FVRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 312 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
....... .....+|..|+|||++. +.++.++||||||+++|||++ |..||.+....+....+....... ..+.
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~ 616 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPN 616 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---CCTT
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence 7654332 22345678999999886 578999999999999999997 999999888888777776654322 2246
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++..+.+||.+||+.||++||++.++++.
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 89999999999999999999999999753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=352.22 Aligned_cols=251 Identities=18% Similarity=0.222 Sum_probs=197.8
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcC--CCCeeEEeEE
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTG--HNNLVKFFDA 227 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~--hp~Iv~l~~~ 227 (455)
...++|++.+.||+|+||.||+|.... ....++.||||++... . ..++.+|++++..+.. |+||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---N---PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---C---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---C---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 346889999999999999999996432 1236899999998643 2 2456778888777763 8999999999
Q ss_pred EeeCCceEEEEeecCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEee--------
Q 012825 228 YEDTDNVYVVMELCEGGELLDRILS----RGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT-------- 295 (455)
Q Consensus 228 ~~~~~~~~lV~E~~~ggsL~~~l~~----~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~-------- 295 (455)
+...+..|||||||++|+|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999999865 3567999999999999999999999999999999999999943
Q ss_pred cCCCceEEEeecccccccC---CCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 012825 296 KDENSVLKAIDFGLSDFVR---PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR 371 (455)
Q Consensus 296 ~~~~~~vkL~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~ 371 (455)
.+.++.+||+|||+++... ........+||..|+|||++.+ .++.++|||||||++|||++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 1227899999999996543 2334456789999999999874 58999999999999999999999995433211
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 372 ~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
......+... ..++.+.+++..||+.+|.+|++..+.|.+
T Consensus 293 --~~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 293 --CKPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp --EEECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred --eeechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 0011111111 246789999999999999999765555543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=378.25 Aligned_cols=263 Identities=25% Similarity=0.432 Sum_probs=211.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee---
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--- 230 (455)
.++|++.+.||+|+||.||+|.+.. +|+.||||++... ......+.+.+|++++++++ ||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~---tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQD---TGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQK 86 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTT---TTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeeccccc
Confidence 4789999999999999999998665 5889999998654 35566778999999999998 9999999998765
Q ss_pred ---CCceEEEEeecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 231 ---TDNVYVVMELCEGGELLDRILSRG--GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 231 ---~~~~~lV~E~~~ggsL~~~l~~~~--~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
++..++||||++|++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++....+||+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 677899999999999999886543 369999999999999999999999999999999999999755556679999
Q ss_pred ecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHH---------HH-
Q 012825 306 DFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA---------VL- 374 (455)
Q Consensus 306 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~---------i~- 374 (455)
|||++.............||..|+|||++. +.++.++||||||+++|+|++|..||........... +.
T Consensus 167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 999999877666666778999999999987 5789999999999999999999999976432211100 00
Q ss_pred ----hcCCCC------CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 375 ----KADPSF------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 375 ----~~~~~~------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.....+ .......++..+.+||.+||++||++|||+.++++||||+..
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 000001 111122367889999999999999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=339.87 Aligned_cols=254 Identities=23% Similarity=0.338 Sum_probs=206.5
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEec-CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
..++|++++.||+|+||.||+|++.. ...+|+.||||++... .....+.+.+|++++++++ |+||+++++++...
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA 114 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC-
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEec
Confidence 35789999999999999999998542 2236899999998653 3455678999999999998 99999999998754
Q ss_pred C--ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccc
Q 012825 232 D--NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309 (455)
Q Consensus 232 ~--~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~ 309 (455)
+ ..++||||+++++|.+++......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGL 191 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEEecCcc
Confidence 4 7899999999999999998777789999999999999999999999999999999999999 5678899999999
Q ss_pred ccccCCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh------------H---H
Q 012825 310 SDFVRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES------------G---I 369 (455)
Q Consensus 310 a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~------------~---~ 369 (455)
+........ .....++..|+|||++. ..++.++||||||+++|+|++|..||...... . .
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 987654432 22345677899999886 46888999999999999999999988532110 0 1
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+...+....... ....++.++.+||++||+.||++||++.++++
T Consensus 272 ~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCCCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112222222221 23468999999999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=345.46 Aligned_cols=250 Identities=22% Similarity=0.381 Sum_probs=206.1
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|++.+.||+|+||.||+|.... .||+|++..... .....+.+.+|+.++++++ |+||+++++++.+.+
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG------EVAIRLIDIERD-NEDQLKAFKREVMAYRQTR-HENVVLFMGACMSPP 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS------SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSS
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC------eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCC
Confidence 36889999999999999999998543 499999865432 2222345778999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||++..
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~---~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY---D-NGKVVITDFGLFSI 178 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE---C---CCEECCCSCCC-
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE---e-CCCEEEeecCCccc
Confidence 9999999999999999886666689999999999999999999999999999999999999 4 56899999999876
Q ss_pred cCCC------CcccccccCCCcccccccCC----------CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhc
Q 012825 313 VRPD------ERLNDIVGSAYYVAPEVLHR----------SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 376 (455)
Q Consensus 313 ~~~~------~~~~~~~gt~~y~aPE~~~~----------~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~ 376 (455)
.... .......|+..|+|||++.+ .++.++||||||+++|+|++|+.||...........+...
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 4321 22334568999999998753 3688999999999999999999999988877777666554
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 377 DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 377 ~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..... ....++.++.+||.+||+.||++|||+.++++.
T Consensus 259 ~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 259 MKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCCC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 33222 223578899999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=338.81 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=193.8
Q ss_pred ccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc-CCCCeeEEeEEE
Q 012825 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT-GHNNLVKFFDAY 228 (455)
Q Consensus 150 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-~hp~Iv~l~~~~ 228 (455)
.+.+.++|++.+.||+|+||.||+|+.. |+.||||++... . ...+.+|.+++..+. .|+||+++++++
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~----~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 100 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-----GEKVAVKVFFTT----E--EASWFRETEIYQTVLMRHENILGFIAAD 100 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-----TEEEEEEEEEGG----G--HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-----CceEEEEEEecc----c--cchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence 3456789999999999999999999753 789999998532 1 133445555555441 499999999999
Q ss_pred eeC----CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCEEeeccCCceEEeec
Q 012825 229 EDT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ--------GVVHRDLKPENFLFTTK 296 (455)
Q Consensus 229 ~~~----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~--------~ivHrDikp~NILl~~~ 296 (455)
.+. +..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||+
T Consensus 101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill--- 175 (337)
T 3mdy_A 101 IKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV--- 175 (337)
T ss_dssp EESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---
T ss_pred ccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---
Confidence 877 789999999999999998854 3699999999999999999999999 99999999999999
Q ss_pred CCCceEEEeecccccccCCCCcc-----cccccCCCcccccccCCC-CCCc------chHHHHHHHHHHHHcC-------
Q 012825 297 DENSVLKAIDFGLSDFVRPDERL-----NDIVGSAYYVAPEVLHRS-YSTE------ADVWSIGVIAYILLCG------- 357 (455)
Q Consensus 297 ~~~~~vkL~DfG~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~------sDiwSlG~~l~elltg------- 357 (455)
+.++.+||+|||++......... ....||..|+|||++.+. +... +|||||||++|||++|
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 77889999999999766433321 345799999999998753 4443 8999999999999999
Q ss_pred ---CCCCCCCC----hhHHHHHHHhcCCCCCCCC----CCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 358 ---SRPFWART----ESGIFRAVLKADPSFDEAP----WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 358 ---~~Pf~~~~----~~~~~~~i~~~~~~~~~~~----~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..||.... ................... ...++.++.+||.+||+.||.+|||+.++++|
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 77775432 1222333332221111111 11356779999999999999999999999876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=357.03 Aligned_cols=251 Identities=18% Similarity=0.225 Sum_probs=194.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCee-----------
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLV----------- 222 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv----------- 222 (455)
..+|.+.+.||+|+||.||+|++.. +|+.||||++...........+.+.+|+.+++.+.+++|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred ceeEEEecccccCCCEEEEEEEecC---CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 3568899999999999999999776 58899999987544444445677999999999887223211
Q ss_pred ----E------EeEEEee-----CCceEEEEeecCCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 012825 223 ----K------FFDAYED-----TDNVYVVMELCEGGELLDRILS------RGGKYTEDDAKAVMIQILNVVAFCHLQGV 281 (455)
Q Consensus 223 ----~------l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~------~~~~l~~~~~~~i~~qi~~gL~~LH~~~i 281 (455)
. ++.++.. ....+++|+++ +++|.+++.. .+..+++..+..++.||+.||.|||++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 1 1111111 22467788877 6799888742 24457888999999999999999999999
Q ss_pred EEeeccCCceEEeecCCCceEEEeecccccccCCCCcccccccCCCccccccc----------CC-CCCCcchHHHHHHH
Q 012825 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL----------HR-SYSTEADVWSIGVI 350 (455)
Q Consensus 282 vHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~sDiwSlG~~ 350 (455)
+||||||+|||| +.++.+||+|||+++..... ....+| +.|+|||++ .+ .++.++|||||||+
T Consensus 233 iHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999 77888999999998875432 455678 999999988 32 37889999999999
Q ss_pred HHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 351 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 351 l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+|||++|+.||...........++. .+..+++++.+||.+||+.||++||++.++++||||+..
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 9999999999977654433222221 223688999999999999999999999999999999753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=339.07 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=189.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHH--HHHhcCCCCeeEEeEEEee-
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKI--LRALTGHNNLVKFFDAYED- 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~--l~~l~~hp~Iv~l~~~~~~- 230 (455)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..+. |+||+++++++..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-----DERPVAVKVFSFAN------RQNFINEKNIYRVPLME-HDNIARFIVGDERV 79 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-----CCeEEEEEEeeccc------hhhHHHHHHHHHHHhcc-Ccchhhheeccccc
Confidence 57899999999999999999964 47899999985321 1233334444 44466 9999999986542
Q ss_pred ----CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCEEeeccCCceEEeecC
Q 012825 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ---------GVVHRDLKPENFLFTTKD 297 (455)
Q Consensus 231 ----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~---------~ivHrDikp~NILl~~~~ 297 (455)
...+++||||+++|+|.+++... ..++..++.++.||+.||.|||+. ||+||||||+|||+ +
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~ 154 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---K 154 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---C
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---c
Confidence 23578999999999999988544 358999999999999999999999 99999999999999 7
Q ss_pred CCceEEEeecccccccCCCC---------cccccccCCCcccccccCC--------CCCCcchHHHHHHHHHHHHcCCCC
Q 012825 298 ENSVLKAIDFGLSDFVRPDE---------RLNDIVGSAYYVAPEVLHR--------SYSTEADVWSIGVIAYILLCGSRP 360 (455)
Q Consensus 298 ~~~~vkL~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~sDiwSlG~~l~elltg~~P 360 (455)
.++.+||+|||++....... ......||..|+|||++.+ .++.++|||||||++|||++|..|
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 78899999999998764322 2234579999999999875 356689999999999999999877
Q ss_pred CCCCCh-----------------hHHHHHHHhcCC---CCCCCC--CCCCCHHHHHHHHHhccCCccCCCCHHHH-----
Q 012825 361 FWARTE-----------------SGIFRAVLKADP---SFDEAP--WPSLSSEARDFVKRLLNKDPRKRLTAAQA----- 413 (455)
Q Consensus 361 f~~~~~-----------------~~~~~~i~~~~~---~~~~~~--~~~~s~~l~~li~~~L~~dP~~Rps~~el----- 413 (455)
|..... ............ .+.... ...++.++.+||.+||+.||++|||+.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 633211 111122222111 111110 11244579999999999999999999999
Q ss_pred -HcCcccCCCCC
Q 012825 414 -LSHPWIKNSND 424 (455)
Q Consensus 414 -L~hp~~~~~~~ 424 (455)
+.++|-++...
T Consensus 315 ~ll~~~~~~~~~ 326 (336)
T 3g2f_A 315 ELMMIWERNKSV 326 (336)
T ss_dssp HHHHCCCC----
T ss_pred HHHHHHHhcccC
Confidence 55788776543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=344.05 Aligned_cols=251 Identities=19% Similarity=0.233 Sum_probs=195.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-----CHHHHHHHHHHHHHHHHhc--------CCCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-----TAIAIEDVRREVKILRALT--------GHNN 220 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~--------~hp~ 220 (455)
.++|++.+.||+|+||.||+|++ +|+.||||++...... .....+.+.+|+.+++.++ .|+|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccchheeeecccCceEEEEEEe-----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 47899999999999999999985 3799999999764321 2223467889999999886 4888
Q ss_pred eeEEeEEEe------------------------------eCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHH
Q 012825 221 LVKFFDAYE------------------------------DTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270 (455)
Q Consensus 221 Iv~l~~~~~------------------------------~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~ 270 (455)
|+++++++. +.+.+|||||||++|++++.+.. ..+++..++.|+.||+
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLT 171 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHH
Confidence 888777643 26789999999999987776633 6689999999999999
Q ss_pred HHHHHHH-HcCCEEeeccCCceEEeecC-----------------CCceEEEeecccccccCCCCcccccccCCCccccc
Q 012825 271 NVVAFCH-LQGVVHRDLKPENFLFTTKD-----------------ENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332 (455)
Q Consensus 271 ~gL~~LH-~~~ivHrDikp~NILl~~~~-----------------~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE 332 (455)
.||.||| ++||+||||||+|||++..+ ....+||+|||+++..... ..+||+.|+|||
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE 247 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSG
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChh
Confidence 9999999 99999999999999996432 1238999999999876532 348999999999
Q ss_pred ccCCCCCCcchHHHHHHH-HHHHHcCCCCCCCCCh-hHHHHHHHhcCCCC---CCCCCCCCCHHHHHHHHHhccCCccCC
Q 012825 333 VLHRSYSTEADVWSIGVI-AYILLCGSRPFWARTE-SGIFRAVLKADPSF---DEAPWPSLSSEARDFVKRLLNKDPRKR 407 (455)
Q Consensus 333 ~~~~~~~~~sDiwSlG~~-l~elltg~~Pf~~~~~-~~~~~~i~~~~~~~---~~~~~~~~s~~l~~li~~~L~~dP~~R 407 (455)
++.+..+.++||||||++ .++++.|..||..... ......+....... ....++.+++++.+||++||++|
T Consensus 248 ~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 248 LFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 998777889999998777 6778889999843211 11222333221111 11112246789999999999987
Q ss_pred CCHHHHH-cCcccC
Q 012825 408 LTAAQAL-SHPWIK 420 (455)
Q Consensus 408 ps~~elL-~hp~~~ 420 (455)
|+.|+| +||||+
T Consensus 324 -sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 -SATDLLCQHSLFK 336 (336)
T ss_dssp -SHHHHHHHCGGGC
T ss_pred -CHHHHHhcCCCcC
Confidence 999999 999996
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.47 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=200.6
Q ss_pred cccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHH--hcCCCCeeEEeE
Q 012825 149 FSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA--LTGHNNLVKFFD 226 (455)
Q Consensus 149 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~~hp~Iv~l~~ 226 (455)
..+.+.++|++.+.||+|+||.||+|+. +|+.||||++... ....+.+|++++.. +. |+||+++++
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~ni~~~~~ 103 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR------EERSWFREAEIYQTVMLR-HENILGFIA 103 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCC-CTTBCCEEE
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-----cCccEEEEEeCch------hHHHHHHHHHHHHHhhcC-CCcEEEEEe
Confidence 3455678999999999999999999975 3789999998532 23567789999888 55 999999999
Q ss_pred EEeeCC----ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCEEeeccCCceEEe
Q 012825 227 AYEDTD----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH--------LQGVVHRDLKPENFLFT 294 (455)
Q Consensus 227 ~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH--------~~~ivHrDikp~NILl~ 294 (455)
++...+ ..++||||+++++|.+++.. ..+++..++.++.||+.||.||| +.||+||||||+|||+
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll- 180 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV- 180 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE-
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE-
Confidence 998776 79999999999999998854 46899999999999999999999 8899999999999999
Q ss_pred ecCCCceEEEeecccccccCCCC-----cccccccCCCcccccccCCC-------CCCcchHHHHHHHHHHHHcC-----
Q 012825 295 TKDENSVLKAIDFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLHRS-------YSTEADVWSIGVIAYILLCG----- 357 (455)
Q Consensus 295 ~~~~~~~vkL~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~sDiwSlG~~l~elltg----- 357 (455)
+.++.+||+|||++....... ......||..|+|||++.+. ++.++||||||+++|||++|
T Consensus 181 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 181 --KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp --CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred --CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 778899999999997765433 23455799999999998754 23579999999999999999
Q ss_pred -----CCCCCCCCh----hHHHHHHHhcCCCCCCCC----CCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 358 -----SRPFWARTE----SGIFRAVLKADPSFDEAP----WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 358 -----~~Pf~~~~~----~~~~~~i~~~~~~~~~~~----~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..||..... ...+.............. ...++..+.+||.+||+.||++|||+.++++|
T Consensus 259 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 788865422 222222222211111100 01234679999999999999999999999876
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=329.19 Aligned_cols=229 Identities=15% Similarity=0.082 Sum_probs=189.3
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|++.. +|+.||||++...........+.+.+|+.++.++. |+||+++++++.++
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTA---LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTR 103 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETT---TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEET
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecC---CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEEC
Confidence 567899999999999999999999765 58999999998766566777788999999999997 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+..|+||||++|++|.+++.. + ....++..|+.||+.||.|||++||+||||||+|||+ +.++.+||+++|.
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~~-- 175 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPAT-- 175 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCCC--
T ss_pred CcEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEeccc--
Confidence 999999999999999998732 2 4666789999999999999999999999999999999 6778899985543
Q ss_pred ccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHH---HHHhcCCCCCCCCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFR---AVLKADPSFDEAPWPSL 388 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~ 388 (455)
++ .++.++|||||||++|+|++|+.||........+. ..............+.+
T Consensus 176 -----------------~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T 3uqc_A 176 -----------------MP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232 (286)
T ss_dssp -----------------CT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS
T ss_pred -----------------cC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC
Confidence 33 36889999999999999999999998765432110 00111111111123468
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+.++.+||.+||+.||++| |+.++++.
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 9999999999999999999 99999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=368.38 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=204.7
Q ss_pred cCcccccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeE
Q 012825 147 FGFSKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFD 226 (455)
Q Consensus 147 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~ 226 (455)
+..++.+.++|++.+.||+|+||.||+|++... +|+.||||++... ........+.+|+.++++++ ||||+++++
T Consensus 72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~ 146 (681)
T 2pzi_A 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNV--NGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVV-HPSIVQIFN 146 (681)
T ss_dssp SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGG--TTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCC-CTTBCCEEE
T ss_pred CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCC--CCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcC-CCCcCeEee
Confidence 344566789999999999999999999987642 4789999998643 34566678899999999998 999999999
Q ss_pred EEeeCCc-----eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCce
Q 012825 227 AYEDTDN-----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (455)
Q Consensus 227 ~~~~~~~-----~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~ 301 (455)
++.+.+. .||||||++|++|.+++.. .+++..++.|+.||+.||.|||++||+||||||+|||+ +.+ .
T Consensus 147 ~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll---~~~-~ 219 (681)
T 2pzi_A 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML---TEE-Q 219 (681)
T ss_dssp EEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSS-C
T ss_pred eEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEE---eCC-c
Confidence 9987765 7999999999999886533 79999999999999999999999999999999999999 443 7
Q ss_pred EEEeecccccccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC
Q 012825 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (455)
Q Consensus 302 vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (455)
+||+|||+++..... ....||+.|+|||++.+.++.++|||||||++|+|++|..||....... ...
T Consensus 220 ~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~~ 286 (681)
T 2pzi_A 220 LKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPE 286 (681)
T ss_dssp EEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CCT
T ss_pred EEEEecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccc----------ccc
Confidence 999999999876533 4567999999999988777889999999999999999998886422110 000
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccC
Q 012825 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (455)
Q Consensus 382 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~ 420 (455)
......++..+.+||.+||+.||++||+..+.+.|+|+.
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 001112457899999999999999999999998888764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=308.76 Aligned_cols=187 Identities=19% Similarity=0.147 Sum_probs=133.1
Q ss_pred eEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-------CHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-------TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-------~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
.++.|++|.+..++..- .|+.||||++.+.... .....+++.+|+++|+++..|+||+++++++++++..
T Consensus 241 ~~~~~~~~~h~~~rr~~---fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYF---FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp C-C--------CCEEEE---ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred ccccCCccccccccccc---ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 45566666655544333 5889999999754321 2344567999999999997799999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
||||||++|++|.+++. .++.+++. +|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+...
T Consensus 318 yLVMEyv~G~~L~d~i~-~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLA-AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEEEECCCSEEHHHHHH-TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC
T ss_pred EEEEecCCCCcHHHHHH-hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCC
Confidence 99999999999999885 45667664 588999999999999999999999999999 788899999999998765
Q ss_pred CC-CcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCC
Q 012825 315 PD-ERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGS 358 (455)
Q Consensus 315 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~ 358 (455)
.. ......+||+.|||||++.+.+..++|+|++|++++++.++.
T Consensus 391 ~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 391 QDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC-----------------CCCCTTH
T ss_pred CCCccccCceechhhccHHHhCCCCCCcccccccccchhhhcccc
Confidence 43 344567899999999999998888999999999988776553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=257.88 Aligned_cols=184 Identities=22% Similarity=0.255 Sum_probs=144.5
Q ss_pred EEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCH-----HHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA-----IAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
...+.||+|+||.||++.. .++.+++|.......... ...+++.+|++++++++ |+||+++..++...+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~ 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLD 412 (540)
T ss_dssp ---------CCEEEEEEEC-----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETT
T ss_pred CCCCEEeeCCCEEEEEEEE-----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCC
Confidence 4467899999999999942 367899998754433322 22456899999999998 999996666666788
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..||||||++|++|.+++.. +..++.||+.||.|||++||+||||||+|||+ +. .+||+|||+++.
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl---~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF---DK--DLYIIDFGLGKI 478 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE---SS--SEEECCCTTCEE
T ss_pred ccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE---CC--eEEEEECccCEE
Confidence 88999999999999998744 67899999999999999999999999999999 44 899999999998
Q ss_pred cCCCCc--------ccccccCCCcccccccCC---CCCCcchHHHHHHHHHHHHcCCCCC
Q 012825 313 VRPDER--------LNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPF 361 (455)
Q Consensus 313 ~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~Pf 361 (455)
...... .....||+.|||||++.. .|+...|+|+..+-.++.+.++.+|
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 765332 235689999999999863 5788899999999988888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-25 Score=212.75 Aligned_cols=149 Identities=25% Similarity=0.249 Sum_probs=117.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCH---------------HHHHHHHHHHHHHHHhcCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---------------IAIEDVRREVKILRALTGH 218 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~---------------~~~~~~~~Ei~~l~~l~~h 218 (455)
...|++.+.||+|+||.||+|.. . +|+.||||++........ .....+.+|+.+++++. |
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~---~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~ 163 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-E---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G 163 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-T---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T
T ss_pred CeEEEecCEeccCCCceEEEEEe-C---CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C
Confidence 34566779999999999999997 3 589999999864321110 24567899999999998 4
Q ss_pred CCeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCC
Q 012825 219 NNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE 298 (455)
Q Consensus 219 p~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~ 298 (455)
+++.+++.. +..|+||||++|++|.+ + .......++.||+.||.|||+.||+||||||+|||+ +
T Consensus 164 ---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l-------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~- 227 (282)
T 1zar_A 164 ---LAVPKVYAW-EGNAVLMELIDAKELYR-V-------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S- 227 (282)
T ss_dssp ---SSSCCEEEE-ETTEEEEECCCCEEGGG-C-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-
T ss_pred ---CCcCeEEec-cceEEEEEecCCCcHHH-c-------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-
Confidence 555554433 56799999999999877 3 123456799999999999999999999999999999 5
Q ss_pred CceEEEeecccccccCCCCcccccccCCCcccccccC
Q 012825 299 NSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH 335 (455)
Q Consensus 299 ~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 335 (455)
++.+||+|||+++. +..++|||++.
T Consensus 228 ~~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 78899999999864 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=185.79 Aligned_cols=141 Identities=16% Similarity=0.151 Sum_probs=107.6
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeE--EEEEEccCCCcC---------------------CHHHHHHHHHHHHHH
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQ--VAVKVIPKHKMT---------------------TAIAIEDVRREVKIL 212 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~--vavK~~~~~~~~---------------------~~~~~~~~~~Ei~~l 212 (455)
-|++.+.||+|+||.||+|.... +|+. ||||++...... .......+.+|+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~---~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVF---DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEE---TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcC---CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 47899999999999999998744 4788 999997543111 012224678999999
Q ss_pred HHhcCCCCe--eEEeEEEeeCCceEEEEeecCC-C----cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCEEe
Q 012825 213 RALTGHNNL--VKFFDAYEDTDNVYVVMELCEG-G----ELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH-LQGVVHR 284 (455)
Q Consensus 213 ~~l~~hp~I--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH-~~~ivHr 284 (455)
.++. |+++ +.++++ +..+|||||+.+ | +|.+.... .++..+..++.||+.+|.||| +.||+||
T Consensus 125 ~~l~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHr 195 (258)
T 1zth_A 125 ERAK-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHA 195 (258)
T ss_dssp HHHH-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred HHHH-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 9998 7653 444432 357999999942 3 66654322 245678899999999999999 9999999
Q ss_pred eccCCceEEeecCCCceEEEeeccccccc
Q 012825 285 DLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 285 Dikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
||||+|||+ +. .++|+|||+|...
T Consensus 196 Dlkp~NILl---~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMY---ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEE---SS--SEEECCCTTCEET
T ss_pred CCCHHHEEE---cC--cEEEEECcccccC
Confidence 999999999 44 7999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2.4e-18 Score=170.65 Aligned_cols=143 Identities=15% Similarity=0.199 Sum_probs=99.5
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC--------------C-HHH----HHHHHHHHHHHHHhcC
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT--------------T-AIA----IEDVRREVKILRALTG 217 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~--------------~-~~~----~~~~~~Ei~~l~~l~~ 217 (455)
|++.+.||.|+||.||+|... +|+.||||+++..... . ... .-...+|...|.+|.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~----~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~- 171 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE----KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY- 171 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT----TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred EEecCEeeeCCceEEEEEECC----CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-
Confidence 899999999999999999864 3899999997532110 0 000 111245777777775
Q ss_pred CCCeeEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC
Q 012825 218 HNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD 297 (455)
Q Consensus 218 hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~ 297 (455)
+.++....- +.. ...+|||||++|+.|.+.. .......++.||+.+|.+||+.|||||||||.|||++.++
T Consensus 172 ~~gv~vp~p-~~~-~~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 172 EEGFPVPEP-IAQ-SRHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp HTTCSCCCE-EEE-ETTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred hcCCCCCee-eec-cCceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence 444322111 111 2248999999998875422 2234567899999999999999999999999999996432
Q ss_pred C-------CceEEEeeccccccc
Q 012825 298 E-------NSVLKAIDFGLSDFV 313 (455)
Q Consensus 298 ~-------~~~vkL~DfG~a~~~ 313 (455)
+ ...+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 1 114899999977554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=1.4e-12 Score=123.04 Aligned_cols=141 Identities=17% Similarity=0.148 Sum_probs=111.3
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
..|++...++.|+++.||++.. .++.+++|+........ ...+.+|+.+++.|.++..+.++++++.+.+..
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~-----~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC-----SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred ccceeEeeccCCCCCeEEEEEC-----CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 4688889999999999999862 25789999985421111 135889999999997677888999999998999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL------------------------------------ 278 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~------------------------------------ 278 (455)
|+||||++|.+|.+.+ .+......++.+++++|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEEecCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999999999887642 1223345788999999999998
Q ss_pred -----------------------cCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 279 -----------------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 279 -----------------------~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++|+|+++.|||+ +++..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE---ETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEE---ECCcEEEEEEchhccc
Confidence 448999999999999 4456677999997753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=6.7e-12 Score=117.74 Aligned_cols=136 Identities=14% Similarity=0.124 Sum_probs=97.9
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCC-eeEEeEEEeeCCc
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN-LVKFFDAYEDTDN 233 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~-Iv~l~~~~~~~~~ 233 (455)
..|.+....+.|..+.||++... +|..+++|+..... ...+.+|+.+++.+..+.- +.++++++..++.
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~----~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~ 89 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQ----GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR 89 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECT----TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred CCCceEecccCCCCceEEEEecC----CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence 44665444445666899998642 36789999975431 1357789999999985522 5678888888888
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---------------------------------
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--------------------------------- 280 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--------------------------------- 280 (455)
.++||||++|.+|. . . ... ...++.+++..|..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~-~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--S-S---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp EEEEEECCSSEETT--T-S---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CEEEEEecCCcccC--c-C---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 99999999998873 1 1 111 2356677777777777643
Q ss_pred -------------------------CEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 281 -------------------------VVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 281 -------------------------ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
++|+|++|.|||+ ++++.+.|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMV---ENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEE---ECCcEEEEEcchhccc
Confidence 9999999999999 4556677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=9.2e-11 Score=115.96 Aligned_cols=144 Identities=24% Similarity=0.386 Sum_probs=104.5
Q ss_pred EeceEeecCCeEEEEEEEecCcccCeEEEEEEcc--CCCcCCHHHHHHHHHHHHHHHHhcC-CCCeeEEeEEEeeC---C
Q 012825 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP--KHKMTTAIAIEDVRREVKILRALTG-HNNLVKFFDAYEDT---D 232 (455)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~--~~~~~~~~~~~~~~~Ei~~l~~l~~-hp~Iv~l~~~~~~~---~ 232 (455)
..+.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+++.|.. +..+++++.++.+. +
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-----~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g 114 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-----GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG 114 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-----SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred eEEEcCCcccceEEEEEEC-----CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence 3567899999999987643 4578889875 3211 1123568899999999984 24578899888766 4
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL---------------------------------- 278 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~---------------------------------- 278 (455)
..|+||||++|..+.+. ....++......++.+++..|..||+
T Consensus 115 ~~~~vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp SCEEEEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred CeEEEEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 58999999998776431 22347888899999999999999997
Q ss_pred ------------------------cCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 279 ------------------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 279 ------------------------~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
..++|+|+++.|||++.++ ...+.|+||+.+...
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-PRVLAVLDWELSTLG 249 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-SCEEEECCCTTCEEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-CcEEEEECccccccC
Confidence 3589999999999994211 135799999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=7.2e-11 Score=114.01 Aligned_cols=185 Identities=17% Similarity=0.243 Sum_probs=122.8
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCC--eeEEeEEEeeCC---ce
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNN--LVKFFDAYEDTD---NV 234 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~--Iv~l~~~~~~~~---~~ 234 (455)
++.++.|....||++. ..+++|+.. .......+.+|..+++.+..+.. +.+++......+ ..
T Consensus 25 i~~~~~G~~n~v~~v~--------~~~vlR~~~-----~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~ 91 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN--------RDFIFKFPK-----HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS 91 (304)
T ss_dssp CCEEEECSSEEEEEST--------TSEEEEEES-----SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred eEecCCCCcceEEEEC--------CEEEEEecC-----CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence 3568999999998753 358899853 23455778999999999853433 345555443333 35
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL------------------------------------ 278 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~------------------------------------ 278 (455)
|+|||+++|..|.+... ..++..+...++.+++..|..||+
T Consensus 92 ~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 92 FAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred eEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 89999999988765332 346788888888899888888886
Q ss_pred ----------------------cCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCcccccccCCCcccccccC-
Q 012825 279 ----------------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH- 335 (455)
Q Consensus 279 ----------------------~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~- 335 (455)
..++|+|+++.|||++.+ ....+.|+||+.+.................-..++...
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence 136999999999999421 15678999999886643221111111000002232211
Q ss_pred --CCC------------CCcchHHHHHHHHHHHHcCCCCC
Q 012825 336 --RSY------------STEADVWSIGVIAYILLCGSRPF 361 (455)
Q Consensus 336 --~~~------------~~~sDiwSlG~~l~elltg~~Pf 361 (455)
..| ....+.|+++.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 11258999999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=7.4e-08 Score=90.81 Aligned_cols=134 Identities=19% Similarity=0.202 Sum_probs=96.2
Q ss_pred eEeecCCe-EEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 162 EVGRGHFG-YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 162 ~LG~G~fg-~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
.+..|..| .||+..... .+..++||+-.. .....+.+|...|+.|..+--+.++++++.+.+..++|||+
T Consensus 31 ~~~~G~S~~~v~rl~~~~---~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~ 101 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP---NAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA 101 (272)
T ss_dssp EEECSSSSCEEEEEECCT---TCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred EccCCCcCCeEEEEEecC---CCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence 34445544 688876443 367899998632 23457889999999998655577899999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL------------------------------------------ 278 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~------------------------------------------ 278 (455)
++|.++.+..... ......++.++...|.-||.
T Consensus 102 l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 102 IPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9998877654321 22234455666666666661
Q ss_pred ---------c-------CCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 279 ---------Q-------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 279 ---------~-------~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
. .++|+|+++.|||+ +.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~---~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIF---DEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEE---ECCeEEEEEECccccc
Confidence 1 27999999999999 5566778999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=2.3e-07 Score=89.44 Aligned_cols=138 Identities=18% Similarity=0.308 Sum_probs=93.5
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCC--CeeEEeEEEe-eCCceEE
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN--NLVKFFDAYE-DTDNVYV 236 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp--~Iv~l~~~~~-~~~~~~l 236 (455)
.+.++.|....||+. |..++||+- ........+.+|..+++.|..|- .+.+.+.++. ..+..++
T Consensus 24 v~~l~~G~~n~v~~v--------g~~~VlR~~-----~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------NGDWVFRFP-----KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE--------TTTEEEEEE-----SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEE
T ss_pred eeecCCCcceeEEEE--------CCEEEEEec-----CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEE
Confidence 456788888889876 346888874 23345578899999999998442 3566776664 4556789
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ------------------------------------- 279 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~------------------------------------- 279 (455)
||||++|..+.+... ..++......++.++...|..||+.
T Consensus 91 v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp EEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred EEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 999999988765321 1234455555555555555555532
Q ss_pred -----------------------CCEEeeccCCceEEeecCC-CceEEEeeccccccc
Q 012825 280 -----------------------GVVHRDLKPENFLFTTKDE-NSVLKAIDFGLSDFV 313 (455)
Q Consensus 280 -----------------------~ivHrDikp~NILl~~~~~-~~~vkL~DfG~a~~~ 313 (455)
.++|+|+++.|||+..++. ...+.|+||+.+...
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999942111 344589999988654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.4e-07 Score=91.01 Aligned_cols=87 Identities=13% Similarity=0.135 Sum_probs=56.9
Q ss_pred eEEeceE-eecCCeEEEEEEEe---cCcccCeEEEEEEccCCC---cCCHHHHHHHHHHHHHHHHhcCC--CCeeEEeEE
Q 012825 157 YELGEEV-GRGHFGYTCAAKFK---KGELKGQQVAVKVIPKHK---MTTAIAIEDVRREVKILRALTGH--NNLVKFFDA 227 (455)
Q Consensus 157 y~~~~~L-G~G~fg~V~~~~~~---~~~~~g~~vavK~~~~~~---~~~~~~~~~~~~Ei~~l~~l~~h--p~Iv~l~~~ 227 (455)
....+.| +.|....+|++... .+...+..+++|+..... ... ...+.+|+.+++.|..+ -.+.+++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 3445677 78888899987654 111015679999864321 001 13467899999888754 246778887
Q ss_pred EeeC---CceEEEEeecCCCcH
Q 012825 228 YEDT---DNVYVVMELCEGGEL 246 (455)
Q Consensus 228 ~~~~---~~~~lV~E~~~ggsL 246 (455)
+.+. +..++||||++|..+
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCC
T ss_pred ccCCCccCCceEEEEecCCCCh
Confidence 7655 357899999988654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.2e-06 Score=87.52 Aligned_cols=81 Identities=20% Similarity=0.223 Sum_probs=50.7
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc-CCH---HHHHHHHHHHHHHHHhcCC-C-CeeEEeEEEeeCCc
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM-TTA---IAIEDVRREVKILRALTGH-N-NLVKFFDAYEDTDN 233 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~-~~~---~~~~~~~~Ei~~l~~l~~h-p-~Iv~l~~~~~~~~~ 233 (455)
.+.||.|..+.||++.... .++.|+||....... ... .....+..|.++++.+..+ + .+.+++.+ +.+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred EEECCCCceEEEEEEEECC---CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc
Confidence 5678999999999997543 357899998643211 000 1123567799999888643 3 34456543 3455
Q ss_pred eEEEEeecCCCc
Q 012825 234 VYVVMELCEGGE 245 (455)
Q Consensus 234 ~~lV~E~~~ggs 245 (455)
.++|||++++..
T Consensus 110 ~~lvmE~l~g~~ 121 (397)
T 2olc_A 110 AVTVMEDLSHLK 121 (397)
T ss_dssp TEEEECCCTTSE
T ss_pred cEEEEEeCCCcc
Confidence 789999997743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.16 E-value=2e-05 Score=76.32 Aligned_cols=138 Identities=14% Similarity=0.120 Sum_probs=77.6
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCC-CCeeEEeE------EEeeCC
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH-NNLVKFFD------AYEDTD 232 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-p~Iv~l~~------~~~~~~ 232 (455)
.+.|+.|..+.||++... +..+++|+... .. ..+..|+.+++.|..+ -.+.+++. +....+
T Consensus 37 ~~~l~gG~~n~~~~v~~~-----~~~~vlk~~~~----~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~ 104 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD-----SGAVCLKRIHR----PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGS 104 (346)
T ss_dssp EEECC----CEEEEEEET-----TEEEEEEEECS----CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETT
T ss_pred eeeccccccCcEEEEEeC-----CCCEEEEecCC----CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECC
Confidence 345666678899988643 23589999854 12 2344566666655421 13344443 123466
Q ss_pred ceEEEEeecCCCcHH--------------HHHHhcCCC-------------CCHHH------------------------
Q 012825 233 NVYVVMELCEGGELL--------------DRILSRGGK-------------YTEDD------------------------ 261 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~--------------~~l~~~~~~-------------l~~~~------------------------ 261 (455)
..++||||++|..+. ..++..... -.+..
T Consensus 105 ~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 184 (346)
T 2q83_A 105 FLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPF 184 (346)
T ss_dssp EEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHH
T ss_pred EEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcH
Confidence 789999999986431 112211110 01111
Q ss_pred -------HHHHHHHHHHHHHHHHH-------------cCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 262 -------AKAVMIQILNVVAFCHL-------------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 262 -------~~~i~~qi~~gL~~LH~-------------~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+..+..++..++.+|++ ..++|+|+++.|||+ +.++.+.|+||+.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 185 SQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLL---GENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEE---CGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEE---eCCCcEEEEehhhccc
Confidence 11112234445666653 469999999999999 5567799999997743
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.98 E-value=5.1e-05 Score=68.31 Aligned_cols=123 Identities=17% Similarity=0.085 Sum_probs=82.7
Q ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCccccc
Q 012825 244 GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDI 322 (455)
Q Consensus 244 gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~ 322 (455)
.+|.+.|...+.+++++++|.++.|.+..|.-+-. +.-..+=+.+..|++ ..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------
Confidence 38999999999999999999999999999877622 122233445688888 5677776553 1110
Q ss_pred ccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccC
Q 012825 323 VGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNK 402 (455)
Q Consensus 323 ~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 402 (455)
.....+.+||......+.+.-|||||++||..+--..| ...-+.+|+.+.+||..|..-
T Consensus 98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence 12334678888765667889999999999988743322 111237899999999999866
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.87 E-value=5.3e-05 Score=76.11 Aligned_cols=76 Identities=14% Similarity=0.128 Sum_probs=44.4
Q ss_pred HcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCccccccc--CCCcccccccCCC----CCCcchHHHHHHHH
Q 012825 278 LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG--SAYYVAPEVLHRS----YSTEADVWSIGVIA 351 (455)
Q Consensus 278 ~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~----~~~~sDiwSlG~~l 351 (455)
...++|+|+++.|||+ +.++ ++|+||+.+.............. ...|++++..... .....++..+...+
T Consensus 231 ~~~liHGDl~~~Nil~---~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMV---TQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEE---CSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEE---eCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 3469999999999999 4444 99999998865432211111111 1235566544311 11124455677777
Q ss_pred HHHHcC
Q 012825 352 YILLCG 357 (455)
Q Consensus 352 ~elltg 357 (455)
|+.+.+
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 776653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.0001 Score=70.93 Aligned_cols=77 Identities=16% Similarity=0.112 Sum_probs=59.8
Q ss_pred EeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCC--CCeeEEeEEEeeCCceEE
Q 012825 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGH--NNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h--p~Iv~l~~~~~~~~~~~l 236 (455)
-.+.|+.|....+|+... .+..++||+.... ....+..|...|+.|..+ -.+++.+.++...+..++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-----~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~l 108 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-----EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFL 108 (312)
T ss_dssp EEEEECCSSSSEEEEEES-----SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEE
T ss_pred eeEEeCCccceeeeEEEE-----CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEE
Confidence 456789999999999863 2567889986432 245688999999988643 568889988888888999
Q ss_pred EEeecCCCcH
Q 012825 237 VMELCEGGEL 246 (455)
Q Consensus 237 V~E~~~ggsL 246 (455)
||||++|..+
T Consensus 109 vme~l~G~~~ 118 (312)
T 3jr1_A 109 LLEALNKSKN 118 (312)
T ss_dssp EEECCCCCCC
T ss_pred EEEeccCCCC
Confidence 9999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00024 Score=67.26 Aligned_cols=82 Identities=16% Similarity=0.054 Sum_probs=57.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCC--CeeEEeEEEee
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN--NLVKFFDAYED 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp--~Iv~l~~~~~~ 230 (455)
.+.+..-++.+|.|..+.||+++..+ |+.|+||+........ ...+..|...|+.|...- -+.+.+++.
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~D----G~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-- 83 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELAD----GTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD-- 83 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETT----SCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECC----CCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--
Confidence 35667778999999999999998654 7899999865432221 234778999999986332 245555532
Q ss_pred CCceEEEEeecCCCc
Q 012825 231 TDNVYVVMELCEGGE 245 (455)
Q Consensus 231 ~~~~~lV~E~~~ggs 245 (455)
.-++||||++++.
T Consensus 84 --~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 84 --DRTLAMEWVDERP 96 (288)
T ss_dssp --TTEEEEECCCCCC
T ss_pred --CceEEEEeecccC
Confidence 2488999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.51 E-value=8.7e-05 Score=70.90 Aligned_cols=72 Identities=10% Similarity=-0.018 Sum_probs=45.7
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEe
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E 239 (455)
.+.|+.|....+|++ ..+++|+..... .......+|+.+++.+..+.-..+++.+. .+.-++|+|
T Consensus 23 i~~l~gG~tN~~~~~---------~~~vlR~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---------GDLCLRIPGKGT----EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE---------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEE
T ss_pred eeEcCCcccccccee---------eeEEEECCCCCc----cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEe
Confidence 678888999999987 248889875321 11112356888888777443335666543 434578999
Q ss_pred ec-CCCcH
Q 012825 240 LC-EGGEL 246 (455)
Q Consensus 240 ~~-~ggsL 246 (455)
|+ +|.++
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 66544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00014 Score=69.96 Aligned_cols=142 Identities=14% Similarity=0.102 Sum_probs=79.1
Q ss_pred EEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCC-CeeEEeEE------Eee
Q 012825 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDA------YED 230 (455)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-~Iv~l~~~------~~~ 230 (455)
.-.+.|+.|....+|++.... | .+++|+.... .....+..|+.++..|..+. .+.+++.. ...
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~----g-~~vlk~~~~~-----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTK----D-PLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp EEEEEECC---EEEEEEEESS----C-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred eEeeccCCCcccceEEEEeCC----c-cEEEEEeCCC-----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 345667778888999886432 3 6889988542 11234567888888776331 13344321 123
Q ss_pred CCceEEEEeecCCCcHH--------------HHHHhcCCC--------CC---HHHHHH------------HHHHHHHHH
Q 012825 231 TDNVYVVMELCEGGELL--------------DRILSRGGK--------YT---EDDAKA------------VMIQILNVV 273 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~--------------~~l~~~~~~--------l~---~~~~~~------------i~~qi~~gL 273 (455)
.+..+++|+|++|..+. ..++..... .. |..... +...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 45678999999885421 112211111 11 111000 001234455
Q ss_pred HHHHH-------cCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 274 AFCHL-------QGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 274 ~~LH~-------~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+|++ .+++|+|+++.|||+ +.+..+.|+||+.+..
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~---~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFF---LGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEE---eCCceEEEecchhccC
Confidence 66653 359999999999999 4455568999997754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00027 Score=68.36 Aligned_cols=34 Identities=29% Similarity=0.440 Sum_probs=26.1
Q ss_pred CCEEeeccCCceEEeecCC-CceEEEeeccccccc
Q 012825 280 GVVHRDLKPENFLFTTKDE-NSVLKAIDFGLSDFV 313 (455)
Q Consensus 280 ~ivHrDikp~NILl~~~~~-~~~vkL~DfG~a~~~ 313 (455)
.++|+|+.+.|||+..+.. .+.+.|+||+.+...
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5999999999999942100 267899999988654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00034 Score=67.37 Aligned_cols=75 Identities=9% Similarity=0.080 Sum_probs=46.6
Q ss_pred eEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCC-CeeEEeEE-----EeeCCceE
Q 012825 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDA-----YEDTDNVY 235 (455)
Q Consensus 162 ~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-~Iv~l~~~-----~~~~~~~~ 235 (455)
.|+ |....||++... +|+.+++|+...... . ...+..|..+++.|..+. .+++++.. ...++..+
T Consensus 33 ~l~-g~~n~~y~v~~~----~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~ 103 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE----DRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYF 103 (328)
T ss_dssp EEC-CSSSEEEEECCT----TCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEE
T ss_pred eec-CcccceEEEEcC----CCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEE
Confidence 455 777789876533 256799999853221 2 245667888888876331 24444443 22345668
Q ss_pred EEEeecCCCc
Q 012825 236 VVMELCEGGE 245 (455)
Q Consensus 236 lV~E~~~ggs 245 (455)
+|||+++|..
T Consensus 104 ~l~~~i~G~~ 113 (328)
T 1zyl_A 104 AVFPSVGGRQ 113 (328)
T ss_dssp EEEECCCCEE
T ss_pred EEEEecCCCC
Confidence 8999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00076 Score=66.67 Aligned_cols=144 Identities=11% Similarity=0.133 Sum_probs=82.8
Q ss_pred ceEeecCCeEEEEEEEecC----cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 161 EEVGRGHFGYTCAAKFKKG----ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
+.|.-|-...+|++....+ ...++.|++|+.... . .....+.+|..+++.|..+.-..++++++.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--L--QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--c--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 4555566667888775421 113578999986321 1 1234556899999988865555677776643 39
Q ss_pred EEeecCCCcHH--------------HH---HHhcC----CCC--CHHHHHHHHHHHHH-------------------HHH
Q 012825 237 VMELCEGGELL--------------DR---ILSRG----GKY--TEDDAKAVMIQILN-------------------VVA 274 (455)
Q Consensus 237 V~E~~~ggsL~--------------~~---l~~~~----~~l--~~~~~~~i~~qi~~-------------------gL~ 274 (455)
||||++|..|. +. ++... ... -+..+.++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999875432 11 11111 112 24556666654422 234
Q ss_pred HHHH----c----CCEEeeccCCceEEeec-CCCceEEEeecccccc
Q 012825 275 FCHL----Q----GVVHRDLKPENFLFTTK-DENSVLKAIDFGLSDF 312 (455)
Q Consensus 275 ~LH~----~----~ivHrDikp~NILl~~~-~~~~~vkL~DfG~a~~ 312 (455)
.|.+ . .++|+|+.+.|||+..+ +..+.+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 4432 2 48999999999999532 1236799999998854
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0025 Score=64.07 Aligned_cols=77 Identities=12% Similarity=0.059 Sum_probs=50.7
Q ss_pred eceEeecCCeEEEEEEEecCc----ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 160 GEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
++.|+.|....+|++....+. ..+..|++|+.... .. ...+.+|..+++.|..+.-..++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 467788888899998765311 12568999987331 11 13445799999988755444677776542 3
Q ss_pred EEEeecCCCc
Q 012825 236 VVMELCEGGE 245 (455)
Q Consensus 236 lV~E~~~ggs 245 (455)
+|+||++|.+
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8999998643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00083 Score=65.97 Aligned_cols=78 Identities=10% Similarity=0.109 Sum_probs=45.4
Q ss_pred eceEeecCCeEEEEEEEecCc-----ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 160 GEEVGRGHFGYTCAAKFKKGE-----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
.+.|+.|..-.+|++....+. ..+..+++|+..... ........|..+++.|..+.-..++++.. . -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 456777777899988754311 013678999874321 11112457888888887443345676544 2 2
Q ss_pred EEEEeecCCCc
Q 012825 235 YVVMELCEGGE 245 (455)
Q Consensus 235 ~lV~E~~~ggs 245 (455)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 78999998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.015 Score=58.84 Aligned_cols=76 Identities=18% Similarity=0.141 Sum_probs=48.1
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEe
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVME 239 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E 239 (455)
++.|+.|-...+|++.... .+..|++|+..... .. .-...+|..+++.|..+.-..++++.+. + .+|||
T Consensus 113 i~~lsgG~tN~~y~v~~~~---~~~~~vLRi~g~~~-~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e 181 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS---KQAKYLIRLYGPKT-DE---IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEE 181 (458)
T ss_dssp EEEECC--CEEEEEEEETT---TTEEEEEEEECC-C-CS---CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEE
T ss_pred EEEcCCCeEeEEEEEEECC---CCceEEEEECCCCh-hh---hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEE
Confidence 4577778888999987543 24789999874321 11 0012589999999985544467887763 2 35999
Q ss_pred ecCCCcH
Q 012825 240 LCEGGEL 246 (455)
Q Consensus 240 ~~~ggsL 246 (455)
|++|..|
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9987443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0039 Score=60.51 Aligned_cols=31 Identities=19% Similarity=0.324 Sum_probs=26.3
Q ss_pred CCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 280 ~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++|+|+.+.|||+ +.++.+.|+||+.+...
T Consensus 207 ~~~HgD~~~~N~l~---~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLV---GNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEE---CGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEE---eCCCeEEEEECCCCeeC
Confidence 59999999999999 55667999999877653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.73 E-value=0.026 Score=56.44 Aligned_cols=78 Identities=13% Similarity=0.184 Sum_probs=48.6
Q ss_pred eceEeecCCeEEEEEEEecCccc----CeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceE
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELK----GQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVY 235 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~ 235 (455)
++.|..|-...+|++....+..+ +..|++|+..... ...-...+|..+++.|..+.-..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 45566666778998876532212 5789999864321 11112357888888887554456676543 22 7
Q ss_pred EEEeecCCCc
Q 012825 236 VVMELCEGGE 245 (455)
Q Consensus 236 lV~E~~~ggs 245 (455)
+||||++|..
T Consensus 147 ~I~efI~G~~ 156 (424)
T 3mes_A 147 RIEEFIDGEP 156 (424)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEeCCcc
Confidence 8999998865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.89 E-value=0.11 Score=51.45 Aligned_cols=32 Identities=31% Similarity=0.496 Sum_probs=26.2
Q ss_pred CEEeeccCCceEEee---cCCCceEEEeecccccc
Q 012825 281 VVHRDLKPENFLFTT---KDENSVLKAIDFGLSDF 312 (455)
Q Consensus 281 ivHrDikp~NILl~~---~~~~~~vkL~DfG~a~~ 312 (455)
++|+|+.+.|||+.. .+++..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 689999999999953 24567799999998864
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=80.90 E-value=6 Score=37.66 Aligned_cols=141 Identities=13% Similarity=0.063 Sum_probs=76.8
Q ss_pred CeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEE---E----
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDA---Y---- 228 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~---~---- 228 (455)
+++.++..-.|..| ||.+.. ++..|+||-. .....+.+-.++...-.+. .|...-+... +
T Consensus 70 ~v~~I~~s~~Gstg-vff~~t-----d~~~~VVK~s------~~l~~E~l~s~LA~~LGlp-iP~~Riv~~~~~E~~e~~ 136 (342)
T 1cja_A 70 QFKGIERSEKGTEG-LFFVET-----ESGVFIVKRS------TNIESETFCSLLCMRLGLH-APKVRVVSSNSEEGTNML 136 (342)
T ss_dssp GEEEEEECCSTTSC-EEEEEE-----SSCEEEEECC------TTHHHHHHHHHHHHHHTCC-CCCEEEEESSSHHHHHHH
T ss_pred CeeEEEeccCCCCC-eEEEEe-----CCCEEEEeCc------HHHHHHHHHHHHHHHhCCC-CCCeeEEeeCcHHHHHHH
Confidence 47777777777765 444443 2668999943 1234455666666666665 6664333211 0
Q ss_pred ---------------eeCCceEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC-----CEEeecc
Q 012825 229 ---------------EDTDNVYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQG-----VVHRDLK 287 (455)
Q Consensus 229 ---------------~~~~~~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~-----ivHrDik 287 (455)
...+..+++|||.+|..|...-... ...+..+....+. -+-++..+..++ +-+.--.
T Consensus 137 ~~L~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG--~Ii~FDi~InN~DR~Pl~W~n~GN 214 (342)
T 1cja_A 137 ECLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG--SLMALDVIVNNSDRLPIAWTNEGN 214 (342)
T ss_dssp HHHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH--HHHHHHHHHTCCSSSCSSSCSCCC
T ss_pred HHHHHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhc--hhheehhhhcCCccCcccccCCCC
Confidence 0122466999999876654310000 0112323322211 134556666553 1222357
Q ss_pred CCceEEeecCCCceEEEeeccccccc
Q 012825 288 PENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 288 p~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
++|||+.. .++.+.++|-+.+...
T Consensus 215 ~~NIL~~~--~n~~~~~IDhn~af~~ 238 (342)
T 1cja_A 215 LDNIMLSE--RGATVVPIDSKIIPLD 238 (342)
T ss_dssp GGGEEEES--BTTCEEECSCCCCCCC
T ss_pred hhheEEeC--CCCeEEEEcCCccccC
Confidence 89999973 3446889999988653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 455 | ||||
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-90 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-89 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-87 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-87 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-85 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-84 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-82 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-80 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-79 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-79 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-79 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-78 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-77 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-76 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-74 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-74 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-74 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-74 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-74 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-71 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-69 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-67 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-67 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-66 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-66 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-66 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-64 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-63 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-63 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-63 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-63 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-62 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-62 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-62 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-61 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-60 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-60 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-55 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-54 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-54 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-43 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 3e-05 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 0.004 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 273 bits (700), Expect = 6e-90
Identities = 114/301 (37%), Positives = 168/301 (55%), Gaps = 8/301 (2%)
Query: 150 SKHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
++ + Y+ + +G G F A+ K+ + VA+K I K + + E+
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRT---QKLVAIKCIAKKALEGKE--GSMENEI 58
Query: 210 KILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQI 269
+L + H N+V D YE ++Y++M+L GGEL DRI+ +G YTE DA ++ Q+
Sbjct: 59 AVLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQV 116
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L+ V + H G+VHRDLKPEN L+ + DE+S + DFGLS P L+ G+ YV
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 176
Query: 330 APEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
APEVL + YS D WSIGVIAYILLCG PF+ ++ +F +LKA+ FD W +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 389 SSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRK 448
S A+DF++ L+ KDP KR T QAL HPWI + + + + +K S ++
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQ 296
Query: 449 A 449
A
Sbjct: 297 A 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 272 bits (697), Expect = 7e-89
Identities = 93/289 (32%), Positives = 145/289 (50%), Gaps = 9/289 (3%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
H + Y++ EE+G G FG + G A K + + E VR+E++
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHES---DKETVRKEIQ 75
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
+ L H LV DA+ED + + ++ E GGEL +++ K +ED+A M Q+
Sbjct: 76 TMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVA 330
+ H VH DLKPEN +FTT ++ LK IDFGL+ + P + + G+A + A
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
Query: 331 PEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
PEV + D+WS+GV++YILL G PF + R V D + D++ + +S
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMK 438
+ +DF+++LL DP R+T QAL HPW+ N + + K
Sbjct: 254 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTK 302
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 269 bits (688), Expect = 2e-87
Identities = 99/303 (32%), Positives = 154/303 (50%), Gaps = 10/303 (3%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ Y++ EE+G G FG K G+ K I + V+ E+ I+
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYP---LDKYTVKNEISIMNQ 82
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H L+ DA+ED + +++E GGEL DRI + K +E + M Q +
Sbjct: 83 LH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
H +VH D+KPEN + TK +SV K IDFGL+ + PDE + +A + APE++
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSV-KIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200
Query: 335 HRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
R D+W+IGV+ Y+LL G PF + + V + D FDE + S+S EA+
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWIK-NSNDVKVPLDVIIFKLMKAYMRSSSLRKAALR 452
DF+K LL K+PRKRLT AL HPW+K + +++ + + ++ ++ A +
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQ 320
Query: 453 VSI 455
+I
Sbjct: 321 PAI 323
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 265 bits (677), Expect = 7e-87
Identities = 95/281 (33%), Positives = 142/281 (50%), Gaps = 20/281 (7%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIA------IEDVR 206
F YE E +GRG K ++ AVK+I + A E
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELREATL 57
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
+EV ILR ++GH N+++ D YE ++V +L + GEL D + + +E + + +M
Sbjct: 58 KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIM 116
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSA 326
+L V+ H +VHRDLKPEN L D++ +K DFG S + P E+L ++ G+
Sbjct: 117 RALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTP 173
Query: 327 YYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379
Y+APE++ H Y E D+WS GVI Y LL GS PFW R + + R ++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
F W S +D V R L P+KR TA +AL+HP+ +
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 262 bits (671), Expect = 3e-85
Identities = 88/306 (28%), Positives = 152/306 (49%), Gaps = 13/306 (4%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K KY + E++GRG FG + K + V++E+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSS---KKTYMAKFVKVKGTDQ----VLVKKEIS 53
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
IL H N++ +++E + + ++ E G ++ +RI + + E + + + Q+
Sbjct: 54 ILNIA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVA 330
+ F H + H D++PEN ++ T +S +K I+FG + ++P + + + Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 331 PEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
PEV H ST D+WS+G + Y+LL G PF A T I ++ A+ +FDE + +S
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRKA 449
EA DFV RLL K+ + R+TA++AL HPW+K + +V VI + +K +L K
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE-RVSTKVI--RTLKHRRYYHTLIKK 288
Query: 450 ALRVSI 455
L + +
Sbjct: 289 DLNMVV 294
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 256 bits (655), Expect = 9e-84
Identities = 81/270 (30%), Positives = 138/270 (51%), Gaps = 14/270 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+E+G +G+G FG A+ K+ +A+KV+ K ++ A +RREV+I
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQS---KFILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N+++ + + D VY+++E G + R L + K+ E + ++ N ++
Sbjct: 63 L-RHPNILRLYGYFHDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALS 120
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+CH + V+HRD+KPEN L LK DFG S P R + G+ Y+ PE++
Sbjct: 121 YCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMI 176
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
R + + D+WS+GV+ Y L G PF A T ++ + + + +F ++ AR
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGAR 232
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423
D + RLL +P +R + L HPWI ++
Sbjct: 233 DLISRLLKHNPSQRPMLREVLEHPWITANS 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (647), Expect = 3e-82
Identities = 84/284 (29%), Positives = 135/284 (47%), Gaps = 20/284 (7%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+E+ E+G G FG A+ K+ A KVI +ED E+ IL +
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKET---SVLAAAKVIDTKSEE---ELEDYMVEIDILASCD 67
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H N+VK DA+ +N+++++E C GG + +L TE + V Q L+ + +
Sbjct: 68 -HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVLH 335
H ++HRDLK N LF + +K DFG+S R +R + +G+ Y++APEV+
Sbjct: 127 HDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 336 ------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
R Y +ADVWS+G+ + P + + K++P P S
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWS 242
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVII 433
S +DF+K+ L K+ R T +Q L HP++ D P+ +I
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVT--VDSNKPIRELI 284
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 9e-80
Identities = 100/281 (35%), Positives = 157/281 (55%), Gaps = 11/281 (3%)
Query: 149 FSK-HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIED 204
F + + + Y+ GEE+G G F + K G Q A K I K + ++ ++ ED
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 205 VRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKA 264
+ REV IL+ + H N++ + YE+ +V +++EL GGEL D + + TE++A
Sbjct: 60 IEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE 117
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDE-NSVLKAIDFGLSDFVRPDERLNDIV 323
+ QILN V + H + H DLKPEN + ++ +K IDFGL+ + +I
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177
Query: 324 GSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
G+ +VAPE++ + EAD+WSIGVI YILL G+ PF T+ V + F++
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423
+ + S+ A+DF++RLL KDP+KR+T +L HPWIK +
Sbjct: 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (623), Expect = 6e-79
Identities = 83/273 (30%), Positives = 134/273 (49%), Gaps = 16/273 (5%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
F ++L + +G G +G A + + VAVK++ + E++++E+ I
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVT---EEAVAVKIVDMKRAVDCP--ENIKKEICIN 57
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
+ L H N+VKF+ + + Y+ +E C GGEL DRI G E DA+ Q++
Sbjct: 58 KMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYV 329
V + H G+ HRD+KPEN L DE LK DFGL+ R + R LN + G+ YV
Sbjct: 116 VVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 330 APEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE+L R ++ DVWS G++ +L G P+ ++S + K ++ PW
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKK 231
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ S + ++L ++P R+T W
Sbjct: 232 IDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 245 bits (626), Expect = 7e-79
Identities = 73/289 (25%), Positives = 120/289 (41%), Gaps = 18/289 (6%)
Query: 149 FSKH-FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRR 207
F K + E+G G FG A+ + + VA+K + + +D+ +
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRN---SEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 208 EVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
EV+ L+ L H N +++ Y ++VME C G D + E + AV
Sbjct: 65 EVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTH 122
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
L +A+ H ++HRD+K N L E ++K DFG + + P N VG+ Y
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NSFVGTPY 176
Query: 328 YVAPEVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 383
++APEV+ Y + DVWS+G+ L P + + + +
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PAL 234
Query: 384 PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
S R+FV L K P+ R T+ L H ++ V +D+I
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (624), Expect = 7e-79
Identities = 80/275 (29%), Positives = 138/275 (50%), Gaps = 16/275 (5%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
K ++ G+ +G G F A+ ++ A+K++ K + + V RE
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQIL 270
++ L H VK + ++D + +Y + + GELL I + G + E + +I+
Sbjct: 61 VMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIV 118
Query: 271 NVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAY 327
+ + + H +G++HRDLKPEN L +E+ ++ DFG + + P+ R N VG+A
Sbjct: 119 SALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 328 YVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
YV+PE+L +S +D+W++G I Y L+ G PF A E IF+ ++K + F E
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---- 231
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ARD V++LL D KRL + + +K
Sbjct: 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (621), Expect = 3e-78
Identities = 75/280 (26%), Positives = 135/280 (48%), Gaps = 15/280 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
KY E++G+G G A GQ+VA++ + + E + E+ ++R
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQP---KKELIINEILVMRE 73
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ N+V + D+Y D ++VVME GG L D + E AV + L +
Sbjct: 74 N-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALE 130
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDIVGSAYYVAPEV 333
F H V+HRD+K +N L + +K DFG + P++ + + +VG+ Y++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 334 L-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
+ ++Y + D+WS+G++A ++ G P+ + + + + LS+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIF 246
Query: 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVI 432
RDF+ R L+ D KR +A + L H ++K + + +I
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (620), Expect = 2e-77
Identities = 89/286 (31%), Positives = 139/286 (48%), Gaps = 22/286 (7%)
Query: 151 KHFANKYELGEEV-GRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREV 209
+ Y++ +V G G G K+ ++ A+K++ RREV
Sbjct: 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDCPK--------ARREV 55
Query: 210 KILRALTGHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGK-YTEDDAKA 264
++ + ++V+ D YE+ + +VME +GGEL RI RG + +TE +A
Sbjct: 56 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115
Query: 265 VMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVG 324
+M I + + H + HRD+KPEN L+T+K N++LK DFG + L
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 175
Query: 325 SAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPS 379
+ YYVAPEVL Y D+WS+GVI YILLCG PF++ G+ +
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425
F W +S E + ++ LL +P +R+T + ++HPWI S V
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 236 bits (604), Expect = 5e-76
Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 11/276 (3%)
Query: 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
H +++YELGE +G G A+ + + VAVKV+ RRE +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 211 ILRALTGHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
AL H +V +D E Y+VME +G L D I+ G T A V+
Sbjct: 60 NAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTPKRAIEVI 117
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG-LSDFVRPDERLNDIVGS 325
+ F H G++HRD+KP N + + + V+ ++D + ++G+
Sbjct: 118 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
A Y++PE S +DV+S+G + Y +L G PF + + ++ DP A
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
LS++ V + L K+P R A + ++
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 1e-74
Identities = 73/317 (23%), Positives = 126/317 (39%), Gaps = 53/317 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +E E+G G+ G K G +A K+I + RE+++L
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLEIKPAIR--NQIIRELQVLHE 60
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+V F+ A+ + + ME +GG L D++L + G+ E V I ++ +
Sbjct: 61 CN-SPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLT 118
Query: 275 FCH-LQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 333
+ ++HRD+KP N L + +K DFG+S + D N VG+ Y++PE
Sbjct: 119 YLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 174
Query: 334 LH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES---GIFRAVLKADPSF--------- 380
L YS ++D+WS+G+ + G P +F ++ D +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 381 ----------------------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQ 412
+ P S E +DFV + L K+P +R Q
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 413 ALSHPWIKNSNDVKVPL 429
+ H +IK S+ +V
Sbjct: 295 LMVHAFIKRSDAEEVDF 311
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (594), Expect = 1e-74
Identities = 59/271 (21%), Positives = 113/271 (41%), Gaps = 18/271 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
+ E+GRG F + +VA + K+T + + + E ++L+ L
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQ 66
Query: 217 GHNNLVKFFDAYEDT----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
H N+V+F+D++E T + +V EL G L L R ++ QIL
Sbjct: 67 -HPNIVRFYDSWESTVKGKKCIVLVTELMTSG-TLKTYLKRFKVMKIKVLRSWCRQILKG 124
Query: 273 VAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVA 330
+ F H + ++HRDLK +N T +K D GL+ R ++G+ ++A
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMA 181
Query: 331 PEVLHRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDEAPWPSLS 389
PE+ Y DV++ G+ + P+ + + I+R V
Sbjct: 182 PEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAI 239
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
E ++ ++ + ++ +R + L+H + +
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 4e-74
Identities = 74/275 (26%), Positives = 130/275 (47%), Gaps = 22/275 (8%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIED---VRREV 209
++Y++G +G G FG + VA+K + K +++ + + V EV
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSD---NLPVAIKHVEKDRISDWGELPNGTRVPMEV 58
Query: 210 KILRAL-TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
+L+ + +G + +++ D +E D+ +++E E + L ++ G E+ A++ Q
Sbjct: 59 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+L V CH GV+HRD+K EN L LK IDFG + D D G+ Y
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALL-KDTVYTDFDGTRVY 175
Query: 329 VAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
PE + HR + A VWS+G++ Y ++CG PF E +++ F
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----Q 225
Query: 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+SSE + ++ L P R T + +HPW+++
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 8e-74
Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 14/272 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ L + +G+G FG A+FKK Q A+K + K + +E E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 58
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H L F ++ +N++ VME GG+L+ I K+ A +I+ +
Sbjct: 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQ 117
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
F H +G+V+RDLK +N L D++ +K DFG+ + + D + N G+ Y+APE+
Sbjct: 118 FLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174
Query: 334 L-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
L + Y+ D WS GV+ Y +L G PF + E +F ++ +P + L EA
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEA 230
Query: 393 RDFVKRLLNKDPRKRLTAAQA-LSHPWIKNSN 423
+D + +L ++P KRL HP + N
Sbjct: 231 KDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 9e-74
Identities = 81/278 (29%), Positives = 128/278 (46%), Gaps = 23/278 (8%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A YE+ +G G +G + K G+ + K + MT A + + EV +LR
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYGSMTEA-EKQMLVSEVNLLR 58
Query: 214 ALTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRI---LSRGGKYTEDDAKAVMIQ 268
L H N+V+++D D N +Y+VME CEGG+L I E+ VM Q
Sbjct: 59 ELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 269 ILNVVAFCHLQG-----VVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-RLNDI 322
+ + CH + V+HRDLKP N D +K DFGL+ + D
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAF 174
Query: 323 VGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381
VG+ YY++PE ++R SY+ ++D+WS+G + Y L PF A ++ + + +
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR- 233
Query: 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419
S E + + R+LN R + + L +P I
Sbjct: 234 --IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 8e-71
Identities = 61/271 (22%), Positives = 109/271 (40%), Gaps = 21/271 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +G+ +G G FG KG+ G VAVK++ T ++ + EV +LR
Sbjct: 8 GQITVGQRIGSGSFG-----TVYKGKWHGD-VAVKMLNVTAPTPQ-QLQAFKNEVGVLRK 60
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H N++ F Y + +V + CEG L + K+ + Q +
Sbjct: 61 TR-HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAP 331
+ H + ++HRDLK N E+ +K DFGL+ + + GS ++AP
Sbjct: 119 YLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 332 EVL----HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP--W 385
EV+ YS ++DV++ G++ Y L+ G P+ ++ +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
+ + + L K +R Q L+
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 223 bits (568), Expect = 2e-69
Identities = 69/278 (24%), Positives = 125/278 (44%), Gaps = 18/278 (6%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N + + +GRG FG + G+ A+K + K ++ E +L
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 215 LT--GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
++ +V A+ D + +++L GG+L LS+ G ++E D + +I+
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILG 119
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332
+ H + VV+RDLKP N L DE+ ++ D GL+ ++ + VG+ Y+APE
Sbjct: 120 LEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPE 175
Query: 333 VLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
VL + +Y + AD +S+G + + LL G PF + + + S S
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSP 234
Query: 391 EARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423
E R ++ LL +D +RL A + P+ ++ +
Sbjct: 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 216 bits (551), Expect = 1e-67
Identities = 70/275 (25%), Positives = 132/275 (48%), Gaps = 20/275 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+++ +G G FG + + G+ A+KV+ K + +E E +L
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+T H +++ + ++D ++++M+ EGGEL +L + ++ AK ++ +
Sbjct: 61 VT-HPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAAEVCLALE 118
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+ H + +++RDLKPEN L D+N +K DFG + +V + + G+ Y+APEV+
Sbjct: 119 YLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
+ Y+ D WS G++ Y +L G PF+ + +L A+ F P + + +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVK 229
Query: 394 DFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
D + RL+ +D +RL +HPW K
Sbjct: 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 7e-67
Identities = 78/298 (26%), Positives = 122/298 (40%), Gaps = 37/298 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+YE E+G G +G A+ K G+ VA+K + + REV +LR
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMP-LSTIREVAVLRH 63
Query: 215 LTG--HNNLVKFFDAYEDTDN-----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
L H N+V+ FD + + +V E + + K +M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
Q+L + F H VVHRDLKP+N L + +K DFGL+ L +V + +
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLW 180
Query: 328 YVAPEVLHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386
Y APEVL +S Y+T D+WS+G I + F ++ +L E WP
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 387 -----------------------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ +D + + L +P KR++A ALSHP+ ++
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 212 bits (539), Expect = 3e-66
Identities = 83/294 (28%), Positives = 132/294 (44%), Gaps = 38/294 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
KY E++G G +G A+ G + A+K I K I RE+ IL+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYG----ETFALKKIRLEKEDEGI-PSTTIREISILKE 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H+N+VK +D + +V E + +L + G AK+ ++Q+LN +A
Sbjct: 57 LK-HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEV 333
+CH + V+HRDLKP+N L + LK DFGL+ P + + + +Y AP+V
Sbjct: 115 YCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 334 LHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP----- 386
L S YST D+WS+G I ++ G+ F +E+ + + + + WP
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 387 --------------------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
L D + ++L DP +R+TA QAL H + K
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 4e-66
Identities = 77/280 (27%), Positives = 132/280 (47%), Gaps = 15/280 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILR 213
+EL + +G G +G + G G+ A+KV+ K + A E R E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+ LV A++ ++++++ GGEL LS+ ++TE + + + +I+ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP--DERLNDIVGSAYYVAP 331
H G+++RD+K EN L D N + DFGLS ER D G+ Y+AP
Sbjct: 143 EHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 332 EVL---HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388
+++ + D WS+GV+ Y LL G+ PF E + + + +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259
Query: 389 SSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
S+ A+D ++RLL KDP+KRL A + H + + N
Sbjct: 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 4e-66
Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 19/276 (6%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N ++ + +G+G FG + K G+ A+K++ K + + E ++L+
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H L A++ D + VME GGEL + SR +TE+ A+ +I++ +
Sbjct: 62 TR-HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALE 119
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR-PDERLNDIVGSAYYVAPEV 333
+ H + VV+RD+K EN + D++ +K DFGL + G+ Y+APEV
Sbjct: 120 YLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 334 LHRS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392
L + Y D W +GV+ Y ++CG PF+ + +F +L + F +LS EA
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEA 232
Query: 393 RDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
+ + LL KDP++RL A + + H + + N
Sbjct: 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 7e-65
Identities = 59/266 (22%), Positives = 100/266 (37%), Gaps = 13/266 (4%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
L E++G G FG ++ K VAVK + ++ A++D REV + +L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H NL++ + + +V EL G LLDR+ G + +Q+ + +
Sbjct: 70 -HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----RLNDIVGSAYYVAPE 332
+ +HRDL N L ++K DFGL + ++ + APE
Sbjct: 128 ESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 333 VL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
L R++S +D W GV + + G P+ S I + K
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCPQ 242
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSH 416
+ + + + P R T
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 8e-64
Identities = 62/266 (23%), Positives = 104/266 (39%), Gaps = 23/266 (8%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ +L + +G+G FG G+ +G +VAVK I + E ++
Sbjct: 7 KELKLLQTIGKGEFG-----DVMLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQ 56
Query: 215 LTGHNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKY-TEDDAKAVMIQILNV 272
L H+NLV+ E+ +Y+V E G L+D + SRG D + +
Sbjct: 57 LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332
+ + VHRDL N L E++V K DFGL+ + + APE
Sbjct: 116 MEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPE 170
Query: 333 VL-HRSYSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
L + +ST++DVWS G++ + + G P+ + V K +
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPP 227
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSH 416
+ +K + D R + Q
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-63
Identities = 78/293 (26%), Positives = 119/293 (40%), Gaps = 37/293 (12%)
Query: 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA--IAIEDVRREVKILRAL 215
E + +G G F A+ K Q VA+K I + A RE+K+L+ L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNT---NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+ H N++ DA+ N+ +V + E + I T KA M+ L + +
Sbjct: 58 S-HPNIIGLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEVL 334
H ++HRDLKP N L DEN VLK DFGL+ F P+ V + +Y APE+L
Sbjct: 116 LHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 172
Query: 335 --HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP------ 386
R Y D+W++G I LL ++ + + + E WP
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 387 ------------------SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ + D ++ L +P R+TA QAL + N
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 206 bits (525), Expect = 1e-63
Identities = 77/305 (25%), Positives = 133/305 (43%), Gaps = 53/305 (17%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ Y+L ++GRG + A ++V VK++ K + ++RE+KIL
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKPVKK------KKIKREIKILEN 85
Query: 215 LTGHNNLVKFFDAYEDTDN--VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNV 272
L G N++ D +D + +V E + T+ D + M +IL
Sbjct: 86 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKA 141
Query: 273 VAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPE 332
+ +CH G++HRD+KP N + E+ L+ ID+GL++F P + N V S Y+ PE
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 199
Query: 333 VL--HRSYSTEADVWSIGVIAYILLCGSRPFWA------------------RTESGIFRA 372
+L ++ Y D+WS+G + ++ PF+ I +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 373 VLKADPSFDE----------------APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
++ DP F++ +S EA DF+ +LL D + RLTA +A+ H
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319
Query: 417 PWIKN 421
P+
Sbjct: 320 PYFYT 324
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 8e-63
Identities = 78/310 (25%), Positives = 126/310 (40%), Gaps = 52/310 (16%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+KYE ++G+G FG A+ +K GQ+VA+K + I RE+KIL+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPIT-ALREIKILQL 65
Query: 215 LTGHNNLVKFFDAYEDTD--------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
L H N+V + ++Y+V + CE L + + K+T + K VM
Sbjct: 66 L-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVM 123
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-----RLND 321
+LN + + H ++HRD+K N L + VLK DFGL+ + R +
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 322 IVGSAYYVAPEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379
V + +Y PE+L R Y D+W G I + S TE + + S
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 380 FDEAPWPSL----------------------------SSEARDFVKRLLNKDPRKRLTAA 411
WP++ A D + +LL DP +R+ +
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 412 QALSHPWIKN 421
AL+H + +
Sbjct: 301 DALNHDFFWS 310
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 9e-63
Identities = 79/297 (26%), Positives = 126/297 (42%), Gaps = 36/297 (12%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
++ E++G G +G A+ K G+ VA+K I T + RE+ +L+ L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGV-PSTAIREISLLKEL 58
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
H N+VK D + +Y+V E S K+ + Q+L +AF
Sbjct: 59 -NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV-RPDERLNDIVGSAYYVAPEVL 334
CH V+HRDLKP+N L + +K DFGL+ P V + +Y APE+L
Sbjct: 118 CHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 335 HRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS----- 387
YST D+WS+G I ++ F +E + + + DE WP
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 388 --------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424
L + R + ++L+ DP KR++A AL+HP+ ++
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (516), Expect = 1e-62
Identities = 55/293 (18%), Positives = 104/293 (35%), Gaps = 25/293 (8%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
N+Y LG ++G G FG G++VA+K+ + E KI +
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTK-----HPQLHIESKIYK 57
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
+ G + + D +VMEL L D K++ + Q+++ +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPS-LEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--------RLNDIVGS 325
+ H + +HRD+KP+NFL + +++ IDFGL+ R ++ G+
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 326 AYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP 384
A Y + S D+ S+G + GS P+ + + + P
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 385 ----WPSLSSEARDFVKRLLNKDPRKRLTAA---QALSHPWIKNSNDVKVPLD 430
SE ++ + + + Q + + + D
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-62
Identities = 77/306 (25%), Positives = 123/306 (40%), Gaps = 50/306 (16%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+Y +G G +G C+A +VA+K I + T + RE+KIL
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVN---KVRVAIKKISPFEHQTYC--QRTLREIKILL 61
Query: 214 ALTGHNNLVKFFDAYEDTD-----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
H N++ D +VY+V L G +L + + + D + Q
Sbjct: 62 RFR-HENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLL--KTQHLSNDHICYFLYQ 117
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE----RLNDIVG 324
IL + + H V+HRDLKP N L + LK DFGL+ PD L + V
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 325 SAYYVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382
+ +Y APE++ S Y+ D+WS+G I +L F + +L S +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 383 APW---------------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
P+ S+A D + ++L +P KR+ QAL+
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
Query: 416 HPWIKN 421
HP+++
Sbjct: 295 HPYLEQ 300
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-62
Identities = 57/267 (21%), Positives = 110/267 (41%), Gaps = 21/267 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELK-GQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+E+G G FG K G+ + VA+K+I + M+ ++ E K++
Sbjct: 4 KDLTFLKELGTGQFG-----VVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMM 54
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L+ H LV+ + ++++ E G LL+ + ++ + + +
Sbjct: 55 NLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 113
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
+ + +HRDL N L ++ V+K DFGLS +V DE + P
Sbjct: 114 EYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 332 EVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
EVL + +S+++D+W+ GV+ + I G P+ T S + + + S
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLAS 227
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416
+ + ++ +R T LS+
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 8e-62
Identities = 68/291 (23%), Positives = 113/291 (38%), Gaps = 36/291 (12%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
E G+ +G G FG A QVAVK++ + ++ E + E+K++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER--EALMSELKMM 94
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTED------------ 260
L H N+V A + +Y++ E C G+LL+ + S+ K++ED
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 261 ----------DAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310
D Q+ + F + VHRDL N L V+K DFGL+
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLA 211
Query: 311 DFVRPDERL---NDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAY-ILLCGSRPFWART 365
+ D + ++APE L Y+ ++DVWS G++ + I G P+
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 366 ESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
F +++ D + E ++ D RKR + S
Sbjct: 272 VDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 9e-61
Identities = 68/306 (22%), Positives = 131/306 (42%), Gaps = 42/306 (13%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
Y + VG G +G C+A + G +VA+K + + + A + RE+++L
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQSELFA-KRAYRELRLL 71
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRI---LSRGGKYTEDDAKAVMIQI 269
+ + H N++ D + + + + + L + K ED + ++ Q+
Sbjct: 72 KHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 270 LNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYV 329
L + + H G++HRDLKP N +E+ LK +DFGL+ D + V + +Y
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ--ADSEMTGYVVTRWYR 185
Query: 330 APEVL--HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW-- 385
APEV+ Y+ D+WS+G I ++ G F + ++K +
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245
Query: 386 -------------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420
+ S A + ++++L D +R+TA +AL+HP+ +
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
Query: 421 NSNDVK 426
+ +D +
Sbjct: 306 SLHDTE 311
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 1e-60
Identities = 74/308 (24%), Positives = 117/308 (37%), Gaps = 48/308 (15%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT 216
Y + +G G FG AK G+ VA+K + + K RE++I+R L
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDK-------RFKNRELQIMRKL- 70
Query: 217 GHNNLVKFFDAY------EDTDNVYVVMELCEGG--ELLDRILSRGGKYTEDDAKAVMIQ 268
H N+V+ + +D + +V++ + K M Q
Sbjct: 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+ +A+ H G+ HRD+KP+N L + +VLK DFG + + E + S YY
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 329 VAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA---------- 376
APE++ + Y++ DVWS G + LL G F + ++K
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 377 ---------------DPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
+ + P EA RLL P RLT +A +H +
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308
Query: 422 SNDVKVPL 429
D V L
Sbjct: 309 LRDPNVKL 316
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (507), Expect = 1e-60
Identities = 77/275 (28%), Positives = 132/275 (48%), Gaps = 20/275 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
++++ + +G G FG K K+ G A+K++ K K+ IE E +IL+A
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ LVK +++D N+Y+VME GGE+ L R G+++E A+ QI+
Sbjct: 98 V-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS-HLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL 334
+ H +++RDLKPEN L D+ ++ DFG + R R + G+ +APE++
Sbjct: 156 YLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEII 210
Query: 335 -HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393
+ Y+ D W++GV+ Y + G PF+A I+ ++ F SS+ +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLK 266
Query: 394 DFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423
D ++ LL D KR +H W ++
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-60
Identities = 59/266 (22%), Positives = 112/266 (42%), Gaps = 19/266 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
++ +E+G G FG + +VA+K I + M+ ED E +++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREGAMSE----EDFIEEAEVMMK 56
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L+ H LV+ + + + +V E E G L D + ++ G + + + + + +A
Sbjct: 57 LS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND--IVGSAYYVAPE 332
+ V+HRDL N L EN V+K DFG++ FV D+ + + +PE
Sbjct: 116 YLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 333 VL-HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDEAPWPSLSS 390
V YS+++DVWS GV+ + + + + R+ S + + + S+
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAST 229
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSH 416
+ + P R ++ L
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (500), Expect = 2e-60
Identities = 80/296 (27%), Positives = 129/296 (43%), Gaps = 38/296 (12%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
KYE E++G G +G AK ++ + VA+K + + RE+ +L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRVRLDDDDEGV-PSSALREICLLKE 57
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
L H N+V+ D + +V E C+ G + K+ + Q+L +
Sbjct: 58 LK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLG 115
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS-DFVRPDERLNDIVGSAYYVAPEV 333
FCH + V+HRDLKP+N L + N LK +FGL+ F P + V + +Y P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 334 LHRS--YSTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVLKADPSFDEAPWPS--- 387
L + YST D+WS G I L RP F + + + + E WPS
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 388 ----------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421
L++ RD ++ LL +P +R++A +AL HP+ +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-60
Identities = 60/266 (22%), Positives = 105/266 (39%), Gaps = 14/266 (5%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ ELG +G G FG + E VA+K T+ E +E +R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQ 64
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
H ++VK + + V+++MELC GEL + R Q+ +A
Sbjct: 65 F-DHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAPE 332
+ + VHRD+ N L N +K DFGLS ++ + + ++APE
Sbjct: 123 YLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 333 VL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
+ R +++ +DVW GV + IL+ G +PF + + + + P+
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPNCPP 236
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSH 416
+ + DP +R + +
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (495), Expect = 2e-59
Identities = 67/290 (23%), Positives = 114/290 (39%), Gaps = 20/290 (6%)
Query: 148 GFSKHF-ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVR 206
F+K + ++ + +G G FG C+ K + VA+K + T D
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL--KSGYTEKQRRDFL 75
Query: 207 REVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVM 266
E I+ H N++ + V ++ E E G L + G++T ++
Sbjct: 76 SEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134
Query: 267 IQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND----- 321
I + + VHRDL N L + N V K DFGLS F+ D
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 322 -IVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADP 378
+ APE + +R +++ +DVWS G++ + ++ G RP+W T + A+ +
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ--- 248
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH--PWIKNSNDVK 426
+ P S + KD R Q ++ I+N N +K
Sbjct: 249 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-59
Identities = 57/281 (20%), Positives = 109/281 (38%), Gaps = 21/281 (7%)
Query: 155 NKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ + + E+G G+FG ++ + K VA+KV+ + T E++ RE +I+
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVL--KQGTEKADTEEMMREAQIMH 64
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L + +V+ + + + +VME+ GG L ++ + + + ++ Q+ +
Sbjct: 65 QLD-NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND----IVGSAYYV 329
+ + VHRDL N L K DFGLS + D+ +
Sbjct: 123 KYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 330 APEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE + R +S+ +DVWS GV + L G +P+ + + + P
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPE 236
Query: 388 LSSEARDFVKRLLNKDPRKRLTAA---QALSHPWIKNSNDV 425
E + R Q + + ++ V
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-59
Identities = 62/281 (22%), Positives = 110/281 (39%), Gaps = 23/281 (8%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
L ++G+G FG + +VA+K + M + E +E ++++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTM----SPEAFLQEAQVMKK 68
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYT-EDDAKAVMIQILNVV 273
L H LV+ + + + +Y+V E G LLD + GKY + QI + +
Sbjct: 69 L-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
A+ VHRDL+ N L EN V K DFGL+ + +E + AP
Sbjct: 127 AYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSFDEAPWPSLS 389
E + ++ ++DVWS G++ L R + + V + + P
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECP 240
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS--HPWIKNSNDVKVP 428
D + + K+P +R T + + ++ P
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 7e-58
Identities = 59/272 (21%), Positives = 111/272 (40%), Gaps = 20/272 (7%)
Query: 162 EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL 221
E+G G+FG ++ ++ + VAVK++ A+ +++ E +++ L + +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKV-VKTVAVKILKNEANDPAL-KDELLAEANVMQQLD-NPYI 70
Query: 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGV 281
V+ E ++ +VME+ E G L ++ L + + + ++ Q+ + +
Sbjct: 71 VRMIGICEA-ESWMLVMEMAELGPL-NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 282 VHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND----IVGSAYYVAPEVL-HR 336
VHRDL N L K DFGLS +R DE + APE + +
Sbjct: 129 VHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 337 SYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARDF 395
+S+++DVWS GV+ + G +P+ S + + K + E D
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGCPREMYDL 242
Query: 396 VKRLLNKDPRKRLTAAQ---ALSHPWIKNSND 424
+ D R A L + + N+
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 8e-57
Identities = 61/279 (21%), Positives = 110/279 (39%), Gaps = 26/279 (9%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
N + + +G G+FG A+ KK G ++ + + + D E+++L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRIL---------------SRGGKYTE 259
L H N++ A E +Y+ +E G LLD + S +
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 260 DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL 319
+ + + + +HRDL N L EN V K DFGLS +
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKK 183
Query: 320 NDIVGSAYYVAPEVLHRS-YSTEADVWSIGVIAYILL-CGSRPFWARTESGIFRAVLKAD 377
++A E L+ S Y+T +DVWS GV+ + ++ G P+ T + ++ + +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 242
Query: 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
+ + E D +++ + P +R + AQ L
Sbjct: 243 --YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-56
Identities = 64/284 (22%), Positives = 104/284 (36%), Gaps = 31/284 (10%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELK--GQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N+ G+ +G G FG A VAVK++ T E + E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVL 80
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY--------------- 257
L H N+V A V+ E C G+LL+ + + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 258 --TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+D + Q+ +AF + +HRDL N L + K DFGL+ ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLARDIKN 197
Query: 316 DERL---NDIVGSAYYVAPEVLHRSY-STEADVWSIGVIAYILLCGSRP-FWARTESGIF 370
D + ++APE + + E+DVWS G+ + L + F
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414
++K +E D +K + DP KR T Q +
Sbjct: 258 YKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-56
Identities = 57/266 (21%), Positives = 108/266 (40%), Gaps = 21/266 (7%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+L E +G G FG + +VAVK + + M+ + E +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGH----TKVAVKSLKQGSMSP----DAFLAEANLMKQ 64
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGG-KYTEDDAKAVMIQILNVV 273
L H LV+ + + +Y++ E E G L+D + + G K T + + QI +
Sbjct: 65 LQ-HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
AF + +HRDL+ N L + K DFGL+ + +E + AP
Sbjct: 123 AFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389
E + + +++ ++DVWS G++ ++ G P+ T + + + + +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNCP 236
Query: 390 SEARDFVKRLLNKDPRKRLTAAQALS 415
E ++ + P R T S
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 1e-55
Identities = 54/283 (19%), Positives = 113/283 (39%), Gaps = 26/283 (9%)
Query: 155 NKYELGEEVGRGHFGYTCAAKF----KKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVK 210
++ LG+ +G G FG A+ K + +VAVK++ T + D+ E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEME 70
Query: 211 ILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG---------------G 255
+++ + H N++ A +YV++E G L + + +R
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 256 KYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRP 315
+ + D + Q+ + + + +HRDL N L T + + +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 316 DERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAY-ILLCGSRPFWARTESGIFRAV 373
++ + ++APE L R Y+ ++DVWS GV+ + I G P+ +F+ +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 374 LKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
+ + ++E ++ + P +R T Q +
Sbjct: 251 KEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-55
Identities = 72/315 (22%), Positives = 126/315 (40%), Gaps = 57/315 (18%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+Y+ + +G G G CAA + VA+K + + + RE+ +++
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQT-HAKRAYRELVLMKC 72
Query: 215 LTGHNNLVKFFDAY------EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
+ H N++ + + E+ +VY+VMEL + + + ++ Q
Sbjct: 73 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQ 127
Query: 269 ILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYY 328
+L + H G++HRDLKP N + + LK +DFGL+ + V + YY
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 184
Query: 329 VAPE-VLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA----------- 376
APE +L Y D+WS+G I ++ F R + V++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 377 -----------DPSFDEAPWPSL----------------SSEARDFVKRLLNKDPRKRLT 409
P + +P L +S+ARD + ++L DP KR++
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 410 AAQALSHPWIKNSND 424
AL HP+I D
Sbjct: 305 VDDALQHPYINVWYD 319
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 182 bits (462), Expect = 1e-54
Identities = 55/275 (20%), Positives = 107/275 (38%), Gaps = 19/275 (6%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+ ++G G +G +KK VAVK + + M +E+ +E +++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKY---SLTVAVKTLKEDTM----EVEEFLKEAAVMKE 69
Query: 215 LTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVV 273
+ H NLV+ Y++ E G LLD + + + + QI + +
Sbjct: 70 IK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--RLNDIVGSAYYVAP 331
+ + +HRDL N L EN ++K DFGLS + D + AP
Sbjct: 129 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 332 EVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
E L + +S ++DVW+ GV+ + + + + +L+ D +
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME--RPEGCPE 243
Query: 391 EARDFVKRLLNKDPRKRLTAAQALS--HPWIKNSN 423
+ + ++ +P R + A+ + S+
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 181 bits (461), Expect = 1e-54
Identities = 55/277 (19%), Positives = 100/277 (36%), Gaps = 24/277 (8%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
Y++G +G G FG QQVA+K P+ +R E + +
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSD-----APQLRDEYRTYK 55
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
L G + + ++ + +V++L G L D + G K++ Q+L V
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114
Query: 274 AFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFGLSDFVRPDE--------RLNDIV 323
H + +V+RD+KP+NFL + +++ +DFG+ F R ++
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 324 GSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADP 378
G+A Y++ R S D+ ++G + L GS P+ + R K
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ E ++ N
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-54
Identities = 76/306 (24%), Positives = 132/306 (43%), Gaps = 46/306 (15%)
Query: 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
+Y+ VG G +G CAA K G +VAVK + + + I + RE+++L
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSI-IHAKRTYRELRLL 71
Query: 213 RALTGHNNLVKFFDAYED-----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMI 267
+ + H N++ D + N ++ G +L + + + K T+D + ++
Sbjct: 72 KHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIY 128
Query: 268 QILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAY 327
QIL + + H ++HRDLKP N +E+ LK +DFGL+ D+ + V + +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH--TDDEMTGYVATRW 183
Query: 328 YVAPEVLHRS--YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385
Y APE++ Y+ D+WS+G I LL G F + +L+ +
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 386 ---------------------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPW 418
+ A D ++++L D KR+TAAQAL+H +
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 419 IKNSND 424
+D
Sbjct: 304 FAQYHD 309
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (459), Expect = 3e-54
Identities = 56/291 (19%), Positives = 104/291 (35%), Gaps = 39/291 (13%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
N E ++G G FG + A VAVK++ + D +RE ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALM 70
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKY--------------- 257
+ N+VK + ++ E G+L + + S
Sbjct: 71 AEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 258 --------TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGL 309
+ + + Q+ +A+ + VHRDL N L EN V+K DFGL
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGL 186
Query: 310 SDFVRPDERL---NDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSR-PFWAR 364
S + + + ++ PE + + Y+TE+DVW+ GV+ + + P++
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246
Query: 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415
+ V + A + E + ++ +K P R +
Sbjct: 247 AHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-53
Identities = 54/266 (20%), Positives = 106/266 (39%), Gaps = 16/266 (6%)
Query: 157 YELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
++ + +G G FG + GE VA+K + + T+ A +++ E ++ ++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASV 68
Query: 216 TGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAF 275
+ ++ + V ++ +L G LLD + +QI + +
Sbjct: 69 D-NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 276 CHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPE 332
+ +VHRDL N L +K DFGL+ + +E+ ++A E
Sbjct: 127 LEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 333 VL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390
+ HR Y+ ++DVWS GV + L+ GS+P+ S I + K + P +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---LPQPPICTI 240
Query: 391 EARDFVKRLLNKDPRKRLTAAQALSH 416
+ + + D R + +
Sbjct: 241 DVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 6e-52
Identities = 55/269 (20%), Positives = 103/269 (38%), Gaps = 17/269 (6%)
Query: 156 KYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRAL 215
E +GRGHFG + K AVK + +++T + E I++
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF 85
Query: 216 TGHNNLVKFFDAYEDTDN-VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVA 274
+ H N++ ++ VV+ + G+L + I + T D +Q+ +
Sbjct: 86 S-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 275 FCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE-----RLNDIVGSAYYV 329
F + VHRDL N + DE +K DFGL+ + E ++
Sbjct: 145 FLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 330 APEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKADPSFDEAPWPS 387
A E L + ++T++DVWS GV+ + L+ P + I +L+
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EY 258
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALSH 416
+ + + + R + ++ +S
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 8e-50
Identities = 58/281 (20%), Positives = 110/281 (39%), Gaps = 18/281 (6%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKK-GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
+ + +G G FG K K VA+K + T D E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMG 64
Query: 214 ALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVV 273
H+N+++ + ++ E E G L + + G+++ ++ I +
Sbjct: 65 QF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 274 AFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER----LNDIVGSAYYV 329
+ VHRDL N L + N V K DFGLS + D + +
Sbjct: 124 KYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 330 APEVL-HRSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387
APE + +R +++ +DVWS G++ + ++ G RP+W + + +A+ + F
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---NDGFRLPTPMD 237
Query: 388 LSSEARDFVKRLLNKDPRKRLTAAQALS--HPWIKNSNDVK 426
S + + ++ +R A +S I+ + +K
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-49
Identities = 61/318 (19%), Positives = 117/318 (36%), Gaps = 60/318 (18%)
Query: 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILR 213
A L E +G+G FG + +G+ +G++VAVK+ + RE +I +
Sbjct: 2 ARTIVLQESIGKGRFG-----EVWRGKWRGEEVAVKIFSSREE------RSWFREAEIYQ 50
Query: 214 -ALTGHNNLVKFFDAYEDTDN----VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQ 268
+ H N++ F A + +++V + E G L D + T + + +
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALS 108
Query: 269 ILNVVAFCHLQ--------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDE--- 317
+ +A H++ + HRDLK +N L +N D GL+
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTI 165
Query: 318 --RLNDIVGSAYYVAPEVL-------HRSYSTEADVWSIGVIAYILLCGSRPFWARTESG 368
N VG+ Y+APEVL H AD++++G++ + + +
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
Query: 369 I-FRAVLKADPSFDE-----------------APWPSLSSEARDFVKRLLNKDPRKRLTA 410
+ + ++ +DPS +E ++ + RLTA
Sbjct: 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 411 AQALSH-PWIKNSNDVKV 427
+ + +K+
Sbjct: 286 LRIKKTLSQLSQQEGIKM 303
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-48
Identities = 51/291 (17%), Positives = 111/291 (38%), Gaps = 31/291 (10%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
K + E+G+G FG Y AK + +VA+K + + + E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 213 RALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGG---------KYTEDDAK 263
+ +++V+ V+MEL G+L + S +
Sbjct: 78 KEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 264 AVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERL---N 320
+ +I + +A+ + VHRDL N + E+ +K DFG++ + +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 321 DIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSR-PFWARTESGIFRAVLKADP 378
+ +++PE L ++T +DVWS GV+ + + + P+ + + R V++
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253
Query: 379 SFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS------HPWIKNSN 423
+ + ++ +P+ R + + +S P + +
Sbjct: 254 ---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-48
Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 30/285 (10%)
Query: 155 NKYELGEEVGRGHFG--YTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKIL 212
++ +LG+ +GRG FG A + VAVK++ + + + E+KIL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 70
Query: 213 RALTGHNNLVKFFDA-YEDTDNVYVVMELCEGGELLDRILSRGGKY-------------- 257
+ H N+V A + + V++E C+ G L + S+ ++
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 258 -TEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316
T + Q+ + F + +HRDL N L E +V+K DFGL+ + D
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKD 187
Query: 317 E---RLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSR-PFWARTESGIFR 371
R D ++APE + R Y+ ++DVWS GV+ + + P+ F
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 372 AVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416
LK + E + + +P +R T ++ + H
Sbjct: 248 RRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (390), Expect = 1e-43
Identities = 72/333 (21%), Positives = 120/333 (36%), Gaps = 68/333 (20%)
Query: 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA 214
+Y L ++G GHF AK VA+K++ K+ T E E+K+L+
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVN---NTHVAMKIVRGDKVYT----EAAEDEIKLLQR 65
Query: 215 L----------TGHNNLVK----FFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTED 260
+ G N+++K F + +V +V E+ L
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 261 DAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAI-DFGLSDFVRPDER 318
K + Q+L + + H + G++H D+KPEN L D L I L + DE
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 319 LNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIF------- 370
+ + + Y +PEVL + AD+WS + + L+ G F
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 371 --------------------------RAVLKADPSFDEAPW-----------PSLSSEAR 393
R +L+ P + E
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 394 DFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVK 426
DF+ +L DPRKR A ++HPW+K++ ++
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.4 bits (213), Expect = 2e-20
Identities = 45/214 (21%), Positives = 74/214 (34%), Gaps = 41/214 (19%)
Query: 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT---------------TAIA 201
+G+ +G G +K + VK + + +A
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKF----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA 57
Query: 202 IEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDD 261
I R E + L+ L + K + + V+MEL + + ++
Sbjct: 58 IRSARNEFRALQKL-QGLAVPKVYAWEGN----AVLMELIDAK--------ELYRVRVEN 104
Query: 262 AKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD-ERLN 320
V+ IL VA + +G+VH DL N L + + + IDF S V E
Sbjct: 105 PDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQS--VEVGEEGWR 158
Query: 321 DIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYIL 354
+I+ R+Y TE D+ S I IL
Sbjct: 159 EILERDVRNIITYFSRTYRTEKDINS--AIDRIL 190
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 43.1 bits (100), Expect = 3e-05
Identities = 22/184 (11%), Positives = 53/184 (28%), Gaps = 4/184 (2%)
Query: 172 CAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231
AK K + + + +K+ T DV RE ++ L G + K
Sbjct: 26 SPAKVYKLVGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHD 82
Query: 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENF 291
++M +G + + A I++ + + D +
Sbjct: 83 GWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAEL 142
Query: 292 LFTTKDENSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVL-HRSYSTEADVWSIGVI 350
+ ++ + + ++ + L D + + V H G +
Sbjct: 143 DYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV 202
Query: 351 AYIL 354
+ +
Sbjct: 203 SGFI 206
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 37.1 bits (85), Expect = 0.004
Identities = 23/165 (13%), Positives = 53/165 (32%), Gaps = 8/165 (4%)
Query: 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIP----KHKMTTAIAIEDVRREVKILRALT 216
+E+G G+ Y ++ + + +K + + I+ R E L
Sbjct: 32 QEIGDGNLNYVFHIYDQEH---DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQG 88
Query: 217 GHNNLVKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFC 276
H + Y DT+ VME ++ + L G+ ++ + + + +
Sbjct: 89 EHVPHLVPRVFYSDTEMAVTVMEDLSHLKIARKGL-IEGENYPHLSQHIGEFLGKTLFYS 147
Query: 277 HLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDERLND 321
+ + K FT + + + + F F +
Sbjct: 148 SDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDTNDFEE 192
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 455 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.65 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.92 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.25 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.86 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.22 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-61 Score=467.95 Aligned_cols=291 Identities=39% Similarity=0.715 Sum_probs=237.1
Q ss_pred cccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 151 KHFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 151 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
+.+.++|++.+.||+|+||.||+|+.+. +|+.||||++.+..... ..+.+.+|++++++++ |||||++++++.+
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKR---TQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIK-HPNIVALDDIYES 78 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETT---TCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence 3456889999999999999999999776 58999999997654322 3356889999999998 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
++.+|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+...++++.+||+|||++
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred CCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEecccee
Confidence 9999999999999999998854 567999999999999999999999999999999999999976667889999999999
Q ss_pred cccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
+...........+||+.|||||++. +.|+.++|||||||++|||++|+.||.+.........+++....+....++.++
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCC
Confidence 9877666667789999999999987 469999999999999999999999999999989899999888777777777899
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCchhHHHHHHHHHHHhccHHHH
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVPLDVIIFKLMKAYMRSSSLRK 448 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p~~~~~~~~~~~~~~~~~l~~ 448 (455)
+++.+||.+||+.||++|||+.|+|+||||++......++...+.+.++.......+++
T Consensus 238 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQ 296 (307)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCCCCCHHHHHHHHHHHSCCCTTTS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCccccccchhHHHHHHHHHHHhhhhh
Confidence 99999999999999999999999999999998666566677777777776665555443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-60 Score=451.38 Aligned_cols=255 Identities=30% Similarity=0.602 Sum_probs=227.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
-++|++++.||+|+||.||+|+++. +|+.||+|++.+.........+.+.+|++++++++ |||||++++++.+++.
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~ 80 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATR 80 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECC---CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCE
Confidence 3689999999999999999999876 58999999986543333334567889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|||||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 81 ~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCC
T ss_pred EEEEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeec
Confidence 9999999999999998854 4579999999999999999999999999999999999999 77889999999999876
Q ss_pred CCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 314 RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
.. .......||+.|+|||++.+ .++.++|||||||+||||++|+.||.+.+..+.+..+.+....++. .+++++
T Consensus 157 ~~-~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~ 231 (263)
T d2j4za1 157 PS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGA 231 (263)
T ss_dssp CC-CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHH
T ss_pred CC-CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHH
Confidence 53 34456789999999999885 5899999999999999999999999999888888888877665543 589999
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.+||.+||+.||++|||+.|+|+||||+.
T Consensus 232 ~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 232 RDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.2e-59 Score=460.65 Aligned_cols=263 Identities=35% Similarity=0.644 Sum_probs=238.7
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+.++|++++.||+|+||.||+|+... +|+.||||++... .....+.+.+|++++++|+ |||||++++++.+++
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~---~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETT
T ss_pred CccCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEccc---chhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 35789999999999999999999776 6899999999653 3445678899999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+|||||||+||+|.+++....+.+++..++.|+.||+.||.|||++|||||||||+|||+.. +.++.+||+|||+++.
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchhee
Confidence 999999999999999988777778999999999999999999999999999999999999953 2357899999999998
Q ss_pred cCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 313 VRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 313 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
...........||+.|||||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+......+....++.++++
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 87777777789999999999987 46899999999999999999999999999999999999988877776666789999
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+.+||++||+.||++|||+.|+|+||||+..+
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999999764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-59 Score=448.58 Aligned_cols=259 Identities=31% Similarity=0.573 Sum_probs=218.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+.++|++++.||+|+||.||+|+++. +|+.||||++.... ..+..+.+.+|++++++++ |||||++++++.+++
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~--~~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKR--AVDCPENIKKEICINKMLN-HENVVKFYGHRREGN 76 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETT
T ss_pred CCcceEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhh--cchHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCc
Confidence 35789999999999999999999876 58999999997653 2334467899999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+|||||||+||+|.+++ ...+.+++..++.++.||+.||.|||++||+||||||+|||+ ++++.+||+|||+|+.
T Consensus 77 ~~~ivmEy~~gg~L~~~l-~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATV 152 (271)
T ss_dssp EEEEEEECCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eeEEEEeccCCCcHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhhee
Confidence 999999999999999877 455679999999999999999999999999999999999999 7788999999999987
Q ss_pred cCCCC---cccccccCCCcccccccCC-CC-CCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 313 VRPDE---RLNDIVGSAYYVAPEVLHR-SY-STEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 313 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~-~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
..... .....+||+.|||||++.+ .+ +.++|||||||++|||++|+.||.................. ....+..
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKK 231 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-TSTTGGG
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCcccc
Confidence 64332 3456789999999999864 44 67899999999999999999999776654443333333322 2233457
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 232 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 89999999999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-58 Score=458.02 Aligned_cols=262 Identities=36% Similarity=0.625 Sum_probs=238.6
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++++.||+|+||.||+|+... +|+.||||++... .....+.+.+|+.++++|+ |||||+++++|.+++.
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTP---YPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYE 100 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSE
T ss_pred ccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECCc---chhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence 4679999999999999999999776 5899999999654 3344567889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|||||||+||+|.+++...+..+++.+++.|+.||+.||.|||++||+||||||+||||+. ..++.+||+|||+|...
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceec
Confidence 99999999999999988777778999999999999999999999999999999999999942 25678999999999998
Q ss_pred CCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 012825 314 RPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEA 392 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l 392 (455)
..........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+.+....+....+..+++++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 87777777899999999999874 69999999999999999999999999999999999999988888777778899999
Q ss_pred HHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 393 RDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 393 ~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.+||.+||++||.+|||+.|+|+||||++..
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 9999999999999999999999999999753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-59 Score=451.14 Aligned_cols=261 Identities=31% Similarity=0.579 Sum_probs=226.9
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|++++++++ ||||+++++++.+++.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEE
Confidence 679999999999999999999776 58999999986533222334467899999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ ++++.+||+|||+|+...
T Consensus 84 ~ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecc
Confidence 999999999999997754 4679999999999999999999999999999999999999 788899999999998765
Q ss_pred CCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 315 PDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 315 ~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
... .....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.+....+..+.+....++. .+++
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 235 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFP 235 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----TCCH
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----cCCH
Confidence 332 334568999999999986 46899999999999999999999999999998888888887665543 6899
Q ss_pred HHHHHHHHhccCCccCCCCHHH------HHcCcccCCCCCCCC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQ------ALSHPWIKNSNDVKV 427 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~e------lL~hp~~~~~~~~~~ 427 (455)
++.+||++||+.||++|||++| +++||||++.+..++
T Consensus 236 ~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278 (288)
T ss_dssp HHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence 9999999999999999999987 589999998765444
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-59 Score=448.19 Aligned_cols=258 Identities=31% Similarity=0.505 Sum_probs=227.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.+.|++++.||+|+||.||+|++.. +|+.||||++.... ....+.+.+|++++++++ |||||++++++.+++.
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKE---TSVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENN 83 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECC---CCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCe
Confidence 3579999999999999999999776 68999999996542 233567889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|||||||+||+|.+++.+..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+..
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKN 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhcc
Confidence 999999999999999887777889999999999999999999999999999999999999 77889999999999765
Q ss_pred CCC-CcccccccCCCcccccccC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 314 RPD-ERLNDIVGSAYYVAPEVLH------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
... .......||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+.+..+.+....... ...
T Consensus 161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~ 239 (288)
T d2jfla1 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-QPS 239 (288)
T ss_dssp HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS-SGG
T ss_pred CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-ccc
Confidence 322 2334678999999999873 34889999999999999999999999999888888888877643322 224
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.+++++.+||++||+.||++|||+.|+|+||||+..
T Consensus 240 ~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 689999999999999999999999999999999853
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-58 Score=447.01 Aligned_cols=267 Identities=37% Similarity=0.681 Sum_probs=235.2
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC---HHHHHHHHHHHHHHHHhcCCCCeeEEeEEE
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT---AIAIEDVRREVKILRALTGHNNLVKFFDAY 228 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~ 228 (455)
.+.++|++++.||+|+||.||+|+.+. +|+.||||++.+..... ....+.+.+|+.++++|+ |||||+++++|
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~ 82 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVY 82 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEE
Confidence 456889999999999999999999776 68999999997654322 223577899999999998 99999999999
Q ss_pred eeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC-CCceEEEeec
Q 012825 229 EDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD-ENSVLKAIDF 307 (455)
Q Consensus 229 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~-~~~~vkL~Df 307 (455)
.+.+.+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++..+ ....+||+||
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence 9999999999999999999988654 5799999999999999999999999999999999999995332 2236999999
Q ss_pred ccccccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
|++.............||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+..+.+..+......+....++
T Consensus 162 G~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 162 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp TTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 99998876667777889999999999874 68999999999999999999999999999999888888877766655556
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.++.++.+||++||+.||++|||+.|+|+||||+..+
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 7899999999999999999999999999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-58 Score=442.71 Aligned_cols=256 Identities=29% Similarity=0.501 Sum_probs=224.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.++||+|+||.||+|++.. +|+.||||++....... .+.+.+|++++++++ |||||+++++|.+++.
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPK---KELIINEILVMRENK-NPNIVNYLDSYLVGDE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTT---TCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred ccccEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEecccChH---HHHHHHHHHHHHhCC-CCCEeeEeEEEEECCE
Confidence 4689999999999999999999765 68999999986543332 356899999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|||||||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 92 ~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheee
Confidence 9999999999999987654 469999999999999999999999999999999999999 77889999999999877
Q ss_pred CCCC-cccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPDE-RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+........ ..+..++++
T Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~ 245 (293)
T d1yhwa1 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAI 245 (293)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SSGGGSCHH
T ss_pred ccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CCcccCCHH
Confidence 5433 4466789999999999874 689999999999999999999999998888777777666543222 223468999
Q ss_pred HHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
+++||.+||+.||++|||+.|+|+||||+..
T Consensus 246 ~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-58 Score=448.85 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=227.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.+.|+++++||+|+||.||+|+... +|+.||||++...........+.+.+|++++++|+ |||||++++++.+++.
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~ 89 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHT 89 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECC---CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCE
Confidence 3569999999999999999999776 58999999998776666677788999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|||||||++|+|..++ ...+.+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||++...
T Consensus 90 ~~iv~E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEEEEECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSS
T ss_pred EEEEEEecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeeccccccc
Confidence 99999999998876544 556789999999999999999999999999999999999999 67889999999999875
Q ss_pred CCCCcccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 314 RPDERLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 314 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
.. .....||+.|||||++. +.|+.++|||||||++|||++|+.||.+......+..+......... ...++
T Consensus 166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s 240 (309)
T d1u5ra_ 166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWS 240 (309)
T ss_dssp SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSC
T ss_pred CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCC
Confidence 43 34568999999999974 35899999999999999999999999998888887777776543322 24689
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
+++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 9999999999999999999999999999998643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-58 Score=437.81 Aligned_cols=256 Identities=21% Similarity=0.360 Sum_probs=215.9
Q ss_pred CCe-EEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee---
Q 012825 155 NKY-ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (455)
Q Consensus 155 ~~y-~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--- 230 (455)
.+| ++.++||+|+||.||+|++.. +++.||+|++.... ......+.+.+|++++++++ |||||+++++|.+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~---~~~~va~K~i~~~~-~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVK 82 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESS
T ss_pred CCEEEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhh-CCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccc
Confidence 344 778899999999999999776 58899999987643 34455678999999999998 9999999999875
Q ss_pred -CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CEEeeccCCceEEeecCCCceEEEeec
Q 012825 231 -TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQG--VVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 231 -~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
++.+|||||||++|+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ++++.+||+||
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DF 159 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDL 159 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCT
T ss_pred cCCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeec
Confidence 3468999999999999998854 467999999999999999999999998 99999999999994 35678999999
Q ss_pred ccccccCCCCcccccccCCCcccccccCCCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHRSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
|+++... .......+||+.|||||++.+.++.++|||||||++|||++|+.||........+...+..... +......
T Consensus 160 Gla~~~~-~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~-~~~~~~~ 237 (270)
T d1t4ha_ 160 GLATLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKV 237 (270)
T ss_dssp TGGGGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGGGGC
T ss_pred Ccceecc-CCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC-CcccCcc
Confidence 9998654 3344567899999999999989999999999999999999999999776554444333332221 1122235
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHcCcccC
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~ 420 (455)
+++++.+||.+||+.||++|||+.|+|+|||||
T Consensus 238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 789999999999999999999999999999997
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-57 Score=435.73 Aligned_cols=263 Identities=35% Similarity=0.640 Sum_probs=235.9
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC------HHHHHHHHHHHHHHHHhcCCCCeeEEeE
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT------AIAIEDVRREVKILRALTGHNNLVKFFD 226 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~------~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~ 226 (455)
|.++|++.+.||+|+||+||+|+... +|+.||||++.+..... ....+.+.+|+.++++|..||||+++++
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 77 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECC---CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence 45799999999999999999998766 58999999997654332 2234568899999999988999999999
Q ss_pred EEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 227 AYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 227 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
++.+++.+|||||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 78 ~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~D 153 (277)
T d1phka_ 78 TYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTD 153 (277)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECC
T ss_pred ecccCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEcc
Confidence 99999999999999999999998865 4579999999999999999999999999999999999999 7889999999
Q ss_pred cccccccCCCCcccccccCCCcccccccC-------CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-------RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 379 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~ 379 (455)
||+++............||..|+|||++. ..++.++||||+||++|||++|+.||.+.+.......++.....
T Consensus 154 FG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~ 233 (277)
T d1phka_ 154 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233 (277)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred chheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999887666667788999999999874 24688999999999999999999999999999988888888776
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 380 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.....++.+++++++||.+||+.||++|||+.|+|+||||+..
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 6666666899999999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-58 Score=436.66 Aligned_cols=255 Identities=31% Similarity=0.503 Sum_probs=213.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee--C
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--~ 231 (455)
.++|++.+.||+|+||.||+|+.+. +|+.||||++..... .....+.+.+|++++++++ |||||++++++.+ +
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC---
T ss_pred chhCEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCC
Confidence 4689999999999999999999776 689999999977543 4555678999999999998 9999999999864 4
Q ss_pred CceEEEEeecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CEEeeccCCceEEeecCCCceEE
Q 012825 232 DNVYVVMELCEGGELLDRILS---RGGKYTEDDAKAVMIQILNVVAFCHLQG-----VVHRDLKPENFLFTTKDENSVLK 303 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~-----ivHrDikp~NILl~~~~~~~~vk 303 (455)
+.+|||||||+||+|.+++.+ .+..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+|
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vk 154 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVK 154 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEE
Confidence 568999999999999998864 3567999999999999999999999986 9999999999999 7788999
Q ss_pred EeecccccccCCCC-cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC
Q 012825 304 AIDFGLSDFVRPDE-RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD 381 (455)
Q Consensus 304 L~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~ 381 (455)
|+|||+++...... .....+||+.|||||++. ..|+.++|||||||++|||++|+.||.+.+..+....+.......
T Consensus 155 l~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~- 233 (269)
T d2java1 155 LGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR- 233 (269)
T ss_dssp ECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-
T ss_pred EeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 99999998875443 345678999999999987 469999999999999999999999999988888888877765432
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCccc
Q 012825 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWI 419 (455)
Q Consensus 382 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~ 419 (455)
....+++++.+||++||+.||++|||+.|+|+|||+
T Consensus 234 --~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 234 --IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 224689999999999999999999999999999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=447.29 Aligned_cols=257 Identities=29% Similarity=0.540 Sum_probs=229.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
-++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.+|++++ ||||++++++|.+++.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~ 79 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDR 79 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccc
Confidence 4689999999999999999999776 68999999996543323334567889999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+..
T Consensus 80 ~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCS
T ss_pred cccceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeeccccccc
Confidence 9999999999999998754 5679999999999999999999999999999999999999 78899999999999876
Q ss_pred CC-CCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RP-DERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
.. .......+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+....+..+......++. .++++
T Consensus 156 ~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 231 (337)
T d1o6la_ 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPE 231 (337)
T ss_dssp CCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHH
Confidence 43 34556789999999999987 56999999999999999999999999999999988888887766543 68999
Q ss_pred HHHHHHHhccCCccCCCC-----HHHHHcCcccCCC
Q 012825 392 ARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNS 422 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps-----~~elL~hp~~~~~ 422 (455)
+.+||++||++||.+|++ +.|+++||||++.
T Consensus 232 ~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 999999999999999994 9999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-58 Score=449.40 Aligned_cols=264 Identities=26% Similarity=0.421 Sum_probs=218.2
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
..++|+++++||+|+||.||+|++.. +|+.||+|++.... .....+.+.+|+.++++++ |||||+++++|.+++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDG 77 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETT---TTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSS
T ss_pred CccCCEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 46789999999999999999999776 68999999997643 3334567899999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQ-GVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
++|||||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++ ||+||||||+|||| +.++.+||+|||+|+
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSG 153 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCH
T ss_pred EEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCcc
Confidence 99999999999999998864 45799999999999999999999974 99999999999999 778899999999998
Q ss_pred ccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHH------------------
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRA------------------ 372 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~------------------ 372 (455)
.... ......+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.........
T Consensus 154 ~~~~-~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 154 QLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHHH-HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred ccCC-CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 7642 3345679999999999987 4799999999999999999999999976554321100
Q ss_pred ------------------------HHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCc
Q 012825 373 ------------------------VLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428 (455)
Q Consensus 373 ------------------------i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p 428 (455)
+.... ........++.++.+||.+||+.||++|||+.|+|+||||+......+-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~d 310 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 310 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCCC
T ss_pred ccccccccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCccccc
Confidence 00000 0111112468999999999999999999999999999999976555543
Q ss_pred h
Q 012825 429 L 429 (455)
Q Consensus 429 ~ 429 (455)
+
T Consensus 311 ~ 311 (322)
T d1s9ja_ 311 F 311 (322)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=444.07 Aligned_cols=262 Identities=30% Similarity=0.583 Sum_probs=236.0
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+-++|++++.||+|+||.||+|+.+. +|+.||||++.... .....+.+|+++|+.++ |||||+++++|+++
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~---~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESM 73 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEET
T ss_pred CCccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEEC
Confidence 356889999999999999999999776 58999999996542 23356889999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
+.+|||||||+||+|.+++...+..+++.+++.|+.||+.||.|||++||+||||||+|||++. +....+||+|||+++
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQAR 152 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhh
Confidence 9999999999999999988766668999999999999999999999999999999999999943 235689999999999
Q ss_pred ccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
............+|+.|+|||++. ..++.++|||||||++|+|++|..||...+..+.+..+++....+....++.+++
T Consensus 153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 887666667778999999999887 4689999999999999999999999999999999999999887777766678999
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
++.+||++||..||++|||+.|+|+||||+..
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999999999999999754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-57 Score=441.74 Aligned_cols=255 Identities=27% Similarity=0.592 Sum_probs=227.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++++.||+|+||.||+|+.+. +|+.||||++.+.........+.+.+|+.++++++ |||||++++++.+++.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCee
Confidence 679999999999999999999776 68999999986543223334567899999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
|+|||||+||+|..++ .....+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+|+...
T Consensus 80 ~ivmE~~~gg~l~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 80 FMIMDYIEGGELFSLL-RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp EEEECCCCSCBHHHHH-HHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECS
T ss_pred eeEeeecCCccccccc-cccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEec
Confidence 9999999999988866 456678999999999999999999999999999999999999 788999999999998864
Q ss_pred CCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 315 PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
. .....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+..+.+..+++....++ +.+++++.
T Consensus 156 ~--~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 229 (316)
T d1fota_ 156 D--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVK 229 (316)
T ss_dssp S--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred c--ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 3 3446789999999999875 589999999999999999999999999999999999888765544 36899999
Q ss_pred HHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 394 DFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 394 ~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
++|.+||..||.+|+ |++++|+||||++.+
T Consensus 230 ~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 999999999999996 999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-56 Score=442.88 Aligned_cols=255 Identities=29% Similarity=0.565 Sum_probs=227.1
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++++.||+|+||.||+|+++. +|+.||||++.+.........+.+.+|+++++.+. |||||++++++.+.+.+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeeccccccccccc
Confidence 689999999999999999999776 68999999986433222334467889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+.||+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+...
T Consensus 117 ~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred ccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecc
Confidence 9999999999999988554 579999999999999999999999999999999999999 778899999999998875
Q ss_pred CCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 012825 315 PDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEAR 393 (455)
Q Consensus 315 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~ 393 (455)
. ......||+.|||||++.+ .++.++|||||||++|||++|+.||.+.+....+..+......++ ..+++++.
T Consensus 193 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 266 (350)
T d1rdqe_ 193 G--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLK 266 (350)
T ss_dssp S--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHH
T ss_pred c--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHH
Confidence 3 3446789999999999874 689999999999999999999999999998888888888766554 36899999
Q ss_pred HHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 394 DFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 394 ~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
+||++||+.||.+|+ |+.++++||||++.+
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred HHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 999999999999995 999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=440.92 Aligned_cols=260 Identities=33% Similarity=0.631 Sum_probs=217.7
Q ss_pred cCCCeEEec-eEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-
Q 012825 153 FANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED- 230 (455)
Q Consensus 153 ~~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~- 230 (455)
+.++|++.+ .||+|+||.||+|++.. +|+.||||++... ..+.+|++++.++.+|||||+++++|++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECC---CCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 457899875 59999999999999776 6899999998542 3567899998777669999999999875
Q ss_pred ---CCceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 231 ---TDNVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 231 ---~~~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
++.+|||||||+||+|.+++..++ ..+++.+++.|+.||+.||.|||++||+||||||+|||++..++.+.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 456899999999999999987654 4799999999999999999999999999999999999997666678899999
Q ss_pred cccccccCCCCcccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhc----CCCCC
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKA----DPSFD 381 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~----~~~~~ 381 (455)
||+++...........+||+.|+|||++.+ .|+.++|||||||+||+|+||+.||.+.........+... ...++
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~ 237 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 999998877777778899999999999875 6999999999999999999999999776655444433332 22233
Q ss_pred CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 382 EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 382 ~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
...+..+++++.+||++||+.||++|||+.|+|+||||+...
T Consensus 238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 333346899999999999999999999999999999997643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-56 Score=434.30 Aligned_cols=257 Identities=30% Similarity=0.540 Sum_probs=224.5
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHH-hcCCCCeeEEeEEEeeCCc
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRA-LTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~-l~~hp~Iv~l~~~~~~~~~ 233 (455)
++|++++.||+|+||+||+|+.+. +|+.||||++.+.........+.+.+|+.++.+ ++ |||||++++++.+++.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~-hp~Iv~~~~~~~~~~~ 77 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-HPFLTHMFCTFQTKEN 77 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT-CTTBCCEEEEEECSSE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCC-CCcEEEEEEEEccCCc
Confidence 579999999999999999999776 689999999965322222334566777777764 55 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|||||||++|+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++++||+|||+++..
T Consensus 78 ~yivmEy~~~g~L~~~i~-~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred eeEEEeecCCCcHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhc
Confidence 999999999999999875 44679999999999999999999999999999999999999 78889999999999876
Q ss_pred CCC-CcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 012825 314 RPD-ERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSE 391 (455)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 391 (455)
... .......||+.|+|||++. +.++.++|||||||++|||++|+.||.+.+....+..+....+.++. .++++
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~ 229 (320)
T d1xjda_ 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKE 229 (320)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred ccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHH
Confidence 543 3445578999999999987 47999999999999999999999999999998888888877665543 68999
Q ss_pred HHHHHHHhccCCccCCCCHH-HHHcCcccCCCC
Q 012825 392 ARDFVKRLLNKDPRKRLTAA-QALSHPWIKNSN 423 (455)
Q Consensus 392 l~~li~~~L~~dP~~Rps~~-elL~hp~~~~~~ 423 (455)
+.+||++||+.||++||++. ++++||||++.+
T Consensus 230 ~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 230 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 99999999999999999996 899999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=426.12 Aligned_cols=264 Identities=30% Similarity=0.504 Sum_probs=220.0
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|+++++||+|+||.||+|++.. +|+.||||++.... ......+++.+|++++++++ |||||++++++.+++++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDT-ETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC---CCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccce
Confidence 689999999999999999999876 68999999996543 22333567889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 235 YVVMELCEGGELLDRIL-SRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
|+||||+.+ .+.+++. .....+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++..
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHH
T ss_pred eEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceec
Confidence 999999976 4455444 445679999999999999999999999999999999999999 77889999999999877
Q ss_pred CCC-CcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCC------
Q 012825 314 RPD-ERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP------ 384 (455)
Q Consensus 314 ~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~------ 384 (455)
... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+......+..
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 543 3445678999999999865 3468899999999999999999999998888777777655322221111
Q ss_pred -------------------CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCCCCc
Q 012825 385 -------------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDVKVP 428 (455)
Q Consensus 385 -------------------~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~~~p 428 (455)
.+.++.++.+||++||+.||++|||+.|+|+||||++.++. +|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p-~p 294 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP-VP 294 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC-CC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC-CC
Confidence 13568899999999999999999999999999999988554 55
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8e-56 Score=439.57 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=214.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHH---HHHHHHhcCCCCeeEEeEEEee
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRRE---VKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~E---i~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
-++|++.+.||+|+||.||+|+... +|+.||||++.+...........+.+| +.+++.+. |||||+++++|.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~~ 78 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHT 78 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEEC
T ss_pred HHhCeeeeEEecCCCeEEEEEEECC---CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEEE
Confidence 3689999999999999999999776 689999999864332222222334444 55555555 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLS 310 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a 310 (455)
.+.+|||||||+||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla 154 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLA 154 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTC
T ss_pred CCEEEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeecee
Confidence 9999999999999999998854 4678999999999999999999999999999999999999 78889999999999
Q ss_pred cccCCCCcccccccCCCcccccccC-C-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 311 DFVRPDERLNDIVGSAYYVAPEVLH-R-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 311 ~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
+..... .....+||+.|+|||++. + .|+.++|||||||+||||++|+.||.......... +.+.........+..+
T Consensus 155 ~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~ 232 (364)
T d1omwa3 155 CDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSF 232 (364)
T ss_dssp EECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSS
T ss_pred eecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCC
Confidence 877543 445668999999999985 3 58999999999999999999999998755433322 2222223333334578
Q ss_pred CHHHHHHHHHhccCCccCCCC-----HHHHHcCcccCCCC
Q 012825 389 SSEARDFVKRLLNKDPRKRLT-----AAQALSHPWIKNSN 423 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps-----~~elL~hp~~~~~~ 423 (455)
++++.+||.+||+.||++||| +.|+++||||++.+
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 999999999999999999999 79999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-55 Score=423.14 Aligned_cols=257 Identities=28% Similarity=0.412 Sum_probs=213.5
Q ss_pred EeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCC--HHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEE
Q 012825 159 LGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTT--AIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYV 236 (455)
Q Consensus 159 ~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~l 236 (455)
.+++||+|+||+||+|+++. +|+.||||++....... ....+.+.+|++++++++ |||||++++++.+++.+||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~i 77 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISL 77 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEE
T ss_pred cceEeccCcCeEEEEEEECC---CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceee
Confidence 46899999999999999766 68999999996543222 122356889999999998 9999999999999999999
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCC
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~ 316 (455)
||||+.++++. .+...+..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 78 vmE~~~~~~~~-~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 78 VFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp EEECCSEEHHH-HHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSC
T ss_pred hhhhhcchHHh-hhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCC
Confidence 99999876654 455667789999999999999999999999999999999999999 78889999999999876543
Q ss_pred C-cccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCC---------
Q 012825 317 E-RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP--------- 384 (455)
Q Consensus 317 ~-~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 384 (455)
. .....+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+..+.+..+.+.........
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 3 345668999999999875 3579999999999999999999999999998888877765322111110
Q ss_pred ---------------CCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 385 ---------------WPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 385 ---------------~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.+.+++++.+||++||+.||++|||+.|+|+||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 135689999999999999999999999999999999653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=421.70 Aligned_cols=266 Identities=29% Similarity=0.402 Sum_probs=220.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc--CCCCeeEEeEEEee-
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT--GHNNLVKFFDAYED- 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hp~Iv~l~~~~~~- 230 (455)
.++|+++++||+|+||+||+|++... .++.||||++....... .....+.+|+.+++.|. .||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC--CCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 47899999999999999999997652 36789999986432221 11234567888877763 49999999999853
Q ss_pred ----CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 231 ----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 231 ----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
+..++++|||++++.+..........+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~d 159 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD 159 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecc
Confidence 346899999998877665555566789999999999999999999999999999999999999 7888999999
Q ss_pred cccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC----
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD---- 381 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---- 381 (455)
||+++............||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+.+..++.......
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 99998877666677889999999999876 5799999999999999999999999999988887777765321110
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCCC
Q 012825 382 -------------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSNDV 425 (455)
Q Consensus 382 -------------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~~ 425 (455)
......+++.+.+||++||++||++|||+.|+|+||||++....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence 11234578999999999999999999999999999999987543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-54 Score=419.12 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=209.2
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.++||+|+||.||+|+++........||||.+... ......+++.+|++++++|+ |||||+++|++.+++.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCE
Confidence 46899999999999999999998764334557999988644 44566678999999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+++|||||++|+|.+++....+.+++.++..|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence 999999999999999887777789999999999999999999999999999999999999 78899999999999876
Q ss_pred CCCCcc------cccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 314 RPDERL------NDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 314 ~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
...... ....||+.|||||++. +.++.++|||||||+||||+| |+.||.+....+.+..+....... ..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~~ 255 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP---PP 255 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CC
Confidence 543322 2245789999999876 679999999999999999998 899999988888777776543221 23
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
..++.++.+||.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 4689999999999999999999999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-55 Score=416.69 Aligned_cols=253 Identities=29% Similarity=0.540 Sum_probs=211.6
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCH---HHHHHHHHHHHHHHHhc-CCCCeeEEeEEE
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTA---IAIEDVRREVKILRALT-GHNNLVKFFDAY 228 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~-~hp~Iv~l~~~~ 228 (455)
+.++|++.++||+|+||.||+|+... +|+.||||++.+...... ....++.+|+.++++++ .|||||++++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 46789999999999999999999776 589999999865432221 11234678999999996 489999999999
Q ss_pred eeCCceEEEEeecCC-CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeec
Q 012825 229 EDTDNVYVVMELCEG-GELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 229 ~~~~~~~lV~E~~~g-gsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
.+.+..++||||+.+ +++.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++ .+++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DF 155 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDF 155 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCC
T ss_pred eeCCeEEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECcc
Confidence 999999999999986 46666654 456799999999999999999999999999999999999994 24578999999
Q ss_pred ccccccCCCCcccccccCCCcccccccC-CC-CCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 012825 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RS-YSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 385 (455)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~-~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 385 (455)
|+++... ........||+.|+|||++. .. ++.++|||||||++|||++|+.||... ..+.+....+.
T Consensus 156 G~a~~~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~---- 224 (273)
T d1xwsa_ 156 GSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR---- 224 (273)
T ss_dssp TTCEECC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----
T ss_pred ccceecc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----
Confidence 9998764 33445678999999999986 33 467799999999999999999999753 23444443333
Q ss_pred CCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 386 PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 386 ~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
..+++++.+||++||+.||++|||+.|+|+||||++.
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 3689999999999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=413.93 Aligned_cols=251 Identities=23% Similarity=0.399 Sum_probs=209.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+.. ..||||++.... .+....+.+.+|++++++++ |||||++++++. ++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS------SEEEEEECCCSS-CCTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC------CEEEEEEEEccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe-ccE
Confidence 478999999999999999999733 359999997554 33445678999999999998 999999999875 456
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
++||||||++|+|.+++......+++..+..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+..
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVK 154 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC-
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeec
Confidence 899999999999999998777889999999999999999999999999999999999999 67889999999999876
Q ss_pred CCCC---cccccccCCCcccccccC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC--CCC
Q 012825 314 RPDE---RLNDIVGSAYYVAPEVLH----RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD--EAP 384 (455)
Q Consensus 314 ~~~~---~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~ 384 (455)
.... ......||+.|||||++. +.|+.++|||||||+||||+||+.||.+......+..........+ ...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 5332 335568999999999985 2478899999999999999999999988776665555554432222 223
Q ss_pred CCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 385 WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 385 ~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
...+++++.+||.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 45789999999999999999999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-54 Score=413.72 Aligned_cols=261 Identities=28% Similarity=0.469 Sum_probs=221.7
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+.++|++.+.||+|+||.||+|++.. +|+.||||++.+....+....+.+.+|+++++.++ |||||++++++...
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAE 79 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEE
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeec
Confidence 457899999999999999999999776 68999999998776667777788999999999998 99999999999865
Q ss_pred C----ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeec
Q 012825 232 D----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 232 ~----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
+ ..|||||||+|++|.+++.. .+.+++.+++.|+.||+.||.|||++||+||||||+|||+ +.++.++|+||
T Consensus 80 ~~~~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~ 155 (277)
T d1o6ya_ 80 TPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDF 155 (277)
T ss_dssp CSSSEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCC
T ss_pred cCCCceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehh
Confidence 4 38999999999999987754 4579999999999999999999999999999999999999 67888999999
Q ss_pred ccccccCCCC----cccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCC
Q 012825 308 GLSDFVRPDE----RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 382 (455)
Q Consensus 308 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 382 (455)
|.+....... .....+||+.|+|||++.+ .++.++|||||||++|||+||+.||.+.+..+.+..+++.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG
T ss_pred hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc
Confidence 9987654322 3345689999999999874 6899999999999999999999999999988888888888877766
Q ss_pred CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccC
Q 012825 383 APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIK 420 (455)
Q Consensus 383 ~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~ 420 (455)
..++.+++++.+||.+||++||++||+..+.|.|+|++
T Consensus 236 ~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 236 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 66678999999999999999999999544555677765
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=406.28 Aligned_cols=247 Identities=25% Similarity=0.442 Sum_probs=204.8
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.++||+|+||.||+|++.. ++.||||++...... .+++.+|++++++++ |||||+++|+|.+++..
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~----~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN----KDKVAIKTIREGAMS----EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT----TEEEEEEECCSSSSC----HHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC----CCEEEEEEECCCcCc----HHHHHHHHHHHHhcC-CCCcccccceeccCCce
Confidence 679999999999999999998764 678999999754322 356899999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+||||||++|+|.+++......+++..+..|+.||+.||.|||+++|+||||||+|||+ ++++.+||+|||+++...
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC------
T ss_pred EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheecc
Confidence 99999999999999988777889999999999999999999999999999999999999 788999999999998765
Q ss_pred CCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 315 PDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
.... .....||..|+|||++. +.++.++|||||||++|||+| |..||........+..+........ ...+++
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~ 229 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLAST 229 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCH
T ss_pred CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCH
Confidence 4432 23467899999999987 569999999999999999999 5666766777677777666533222 235789
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++.+||.+||+.||++|||+.|+++|
T Consensus 230 ~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 230 HVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999999886
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-53 Score=409.36 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=212.1
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.++||+|+||.||+|++.. +|+.||||++..... ..+++.+|++++++++ |||||+++++|.+++.
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPP 87 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGG---GTEEEEEEECCTTCS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECC---CCeEEEEEEECCccc----hHHHHHHHHHHHHhCC-CCCEecCCccEeeCCe
Confidence 4789999999999999999999876 589999999865432 2357899999999998 9999999999999999
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
++||||||++|+|.+++... ...+++..+..|+.||+.||.|||++||+||||||+|||| ++++.+||+|||+++.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceee
Confidence 99999999999999988754 4579999999999999999999999999999999999999 7888999999999987
Q ss_pred cCCCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 313 VRPDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 313 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
...... .....|+..|+|||++. +.++.++|||||||++|||++|..||........+..++....... ....++
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~--~~~~~~ 242 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME--RPEGCP 242 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC--CCTTCC
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC--CCccch
Confidence 754432 23346889999999876 6799999999999999999998777655554444444444432222 234689
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+++.+||.+||+.||++|||+.|+++
T Consensus 243 ~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 243 EKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=408.80 Aligned_cols=256 Identities=21% Similarity=0.352 Sum_probs=216.6
Q ss_pred CCCeEEec-eEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGE-EVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.++|.+.+ +||+|+||.||+|.++... ++..||||++... ......+++.+|++++++++ |||||++++++.+ +
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-E 81 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES-S
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCC-CcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-C
Confidence 36788888 4999999999999875422 4678999999654 45566788999999999998 9999999999865 5
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+|||||||++|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKA 158 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhc
Confidence 6899999999999999887777789999999999999999999999999999999999999 6778999999999987
Q ss_pred cCCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 313 VRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 313 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
...... .....||+.|+|||++. +.++.++|||||||++|||+| |+.||.+....+.+..+.+.... ...+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~ 235 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPP 235 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCT
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 754432 23456889999999986 679999999999999999998 99999988887777776654422 1234
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHH---HcCcccC
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQA---LSHPWIK 420 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~el---L~hp~~~ 420 (455)
.+++++.+||.+||+.||++|||+.+| |+|.|+.
T Consensus 236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 789999999999999999999999888 5666653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-53 Score=410.56 Aligned_cols=257 Identities=31% Similarity=0.501 Sum_probs=214.8
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|+++++||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.++++++ |||||+++++|.+++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC----CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCce
Confidence 68999999999999999999875 378999999966432 2333467889999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
+++|||+.+ .+...+....+.+++..++.++.||+.||+|||+.|||||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~i~~e~~~~-~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 76 VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFG 151 (286)
T ss_dssp EEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHC
T ss_pred eEEEEeehh-hhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecc
Confidence 999999966 4555566777889999999999999999999999999999999999999 788999999999998765
Q ss_pred CCC-cccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC----------
Q 012825 315 PDE-RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD---------- 381 (455)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---------- 381 (455)
... ......|++.|+|||++. ..++.++|||||||++|||++|+.||......+.+..+.+......
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 433 344557899999999876 3579999999999999999999999998888777776654221111
Q ss_pred ---------------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 382 ---------------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 382 ---------------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
....+.+++++.+||++||++||++|||+.|+|+||||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0112357899999999999999999999999999999984
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=415.78 Aligned_cols=256 Identities=25% Similarity=0.386 Sum_probs=215.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcc--cCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL--KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.++||+|+||.||+|++..... ....||||.+... ........+.+|+.++.++.+|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc--cCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 4789999999999999999999875322 2457999998654 23344567899999999995599999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCC
Q 012825 232 DNVYVVMELCEGGELLDRILSRG----------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPE 289 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~ 289 (455)
+.+|||||||++|+|.+++..+. ..+++..++.|+.||+.||.|||++|||||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 99999999999999999987543 34899999999999999999999999999999999
Q ss_pred ceEEeecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCC
Q 012825 290 NFLFTTKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWAR 364 (455)
Q Consensus 290 NILl~~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~ 364 (455)
|||+ +.++.+||+|||+|+....... .....||+.|||||++. +.++.++|||||||+||||++ |+.||.+.
T Consensus 194 Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 194 NVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred cccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 9999 7788999999999987654332 23456899999999876 679999999999999999997 89999887
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 365 TESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 365 ~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
.....+..++........ ...+++++.+||.+||+.||++|||+.||++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 777777777666543322 34689999999999999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=401.34 Aligned_cols=247 Identities=22% Similarity=0.384 Sum_probs=218.2
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|+++++||+|+||.||+|+.+. ++.||||++++.... .+++.+|++++++++ ||||++++++|.+++.+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~----~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEGSMS----EDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETT----TEEEEEEEEESSSSC----HHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSE
T ss_pred HHCEEeEEEecCCCeEEEEEEECC----CCEEEEEEECcCcCC----HHHHHHHHHHHHhcC-CCceeeEEEEEeeCCce
Confidence 678999999999999999999753 789999999765432 256899999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++||||+++|+|.+++......+++..+++++.||++||.|||++||+||||||+|||+ ++++.+||+|||+++...
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCS
T ss_pred EEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheecc
Confidence 99999999999999988888889999999999999999999999999999999999999 788999999999998765
Q ss_pred CCCc--ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 012825 315 PDER--LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSS 390 (455)
Q Consensus 315 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 390 (455)
.... .....||..|+|||++. +.++.++|||||||++|||+| |+.||...+..+....+....... ....+++
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~ 228 (258)
T d1k2pa_ 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASE 228 (258)
T ss_dssp SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCH
T ss_pred CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---CcccccH
Confidence 4432 23467899999999886 679999999999999999998 899999999888887777654322 2246889
Q ss_pred HHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 391 EARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 391 ~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
++.+||++||+.||++|||+.++|+|
T Consensus 229 ~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 229 KVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=404.54 Aligned_cols=252 Identities=22% Similarity=0.387 Sum_probs=211.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+++. ++.||||++..... ..+.+.+|++++++++ |||||++++++.+ +.
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNG----HTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred HHHeEEeEEEecCCCcEEEEEEECC----CCEEEEEEEccCcC----CHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CC
Confidence 4789999999999999999998654 67899999965432 2356899999999998 9999999998754 56
Q ss_pred eEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
++||||||++|+|.+++.... ..+++..+..|+.||+.||.|||+++|+||||||+|||| ++++.+||+|||+|+.
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARL 158 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEE
Confidence 799999999999998765433 369999999999999999999999999999999999999 7889999999999988
Q ss_pred cCCCC--cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCC-CCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSR-PFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~-Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
..... ......||+.|+|||++. +.++.++|||||||++|||+||.. ||......+.+..+........ ...+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~ 235 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNC 235 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTC
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---cccC
Confidence 75443 234567899999999887 679999999999999999999654 5556666666666655432221 2468
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHc--CcccCC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALS--HPWIKN 421 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~--hp~~~~ 421 (455)
++++.+||.+||+.||++|||+.++++ |+||..
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999999999999997 788753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=403.58 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=206.1
Q ss_pred ceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCceEEEEee
Q 012825 161 EEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNVYVVMEL 240 (455)
Q Consensus 161 ~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~~lV~E~ 240 (455)
++||+|+||.||+|.+.... .++.||||++.... .+....+++.+|++++++++ |||||+++++|.+ +..+|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~-~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS-SEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES-SSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCC-cCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCC-CCCCceEEEEecc-CCEEEEEEc
Confidence 47999999999999876432 46899999996543 33445678999999999998 9999999999865 467999999
Q ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCCCc--
Q 012825 241 CEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPDER-- 318 (455)
Q Consensus 241 ~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~~~-- 318 (455)
|++|+|.+++. ....+++..+..|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 89 ~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 89 AELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp CTTEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEE
T ss_pred CCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccc
Confidence 99999999775 45679999999999999999999999999999999999999 6788999999999987654332
Q ss_pred --ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 012825 319 --LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSSEARD 394 (455)
Q Consensus 319 --~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~ 394 (455)
.....||+.|+|||++. +.++.++|||||||++|||++ |+.||.+....+....+.+..... ....++.++.+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~~~~ 241 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMYD 241 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccCHHHHH
Confidence 23456899999999886 668999999999999999998 899999988887777666543221 22468999999
Q ss_pred HHHHhccCCccCCCCHHHH---HcCcccC
Q 012825 395 FVKRLLNKDPRKRLTAAQA---LSHPWIK 420 (455)
Q Consensus 395 li~~~L~~dP~~Rps~~el---L~hp~~~ 420 (455)
||.+||+.||++|||+.+| |+|+|+.
T Consensus 242 li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 242 LMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 9999999999999999998 4566543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-52 Score=409.01 Aligned_cols=256 Identities=29% Similarity=0.519 Sum_probs=212.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee--C
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--T 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--~ 231 (455)
.++|+++++||+|+||+||+|++.. +|+.||||+++... .+++.+|+++|+++.+||||++++++|.. .
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 4789999999999999999999776 68999999986432 35688999999999889999999999974 4
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
..+++|||||.+++|.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++..+||+|||+++
T Consensus 105 ~~~~~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAE 178 (328)
T ss_dssp CSEEEEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCE
T ss_pred CceeEEEeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccce
Confidence 569999999999998653 35699999999999999999999999999999999999995 345579999999999
Q ss_pred ccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhH-HHHHHHh-------------
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESG-IFRAVLK------------- 375 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~-~~~~i~~------------- 375 (455)
...........++|..|+|||++.+ .++.++|||||||++|+|++|+.||....... ....+..
T Consensus 179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred eccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 8877777778899999999998763 48999999999999999999999997654332 1111111
Q ss_pred cCCC--------------------CCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 376 ADPS--------------------FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 376 ~~~~--------------------~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
.... ........+++++.+||++||++||++|||++|+|+||||+...+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0000 001112247899999999999999999999999999999998643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=399.25 Aligned_cols=253 Identities=23% Similarity=0.389 Sum_probs=209.0
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++++.||+|+||.||+|++......+..||||.+... ......+.+.+|++++++++ |||||++++++. ++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCe
Confidence 47899999999999999999998765545678999998543 45666778999999999998 999999999985 567
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
+|+||||+++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheec
Confidence 899999999999999888888889999999999999999999999999999999999999 67788999999999876
Q ss_pred CCCC--cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 314 RPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 314 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
.... ......||+.|+|||++. +.++.++|||||||++|||++ |..||......+.+..+.+.... ..++.++
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~ 235 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCP 235 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence 5333 234456899999999986 679999999999999999998 89999988888888777765432 2235789
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+++.+||.+||+.||++|||+.||++|
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999866
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=412.37 Aligned_cols=255 Identities=29% Similarity=0.428 Sum_probs=212.6
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC---
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT--- 231 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~--- 231 (455)
.+|+.+++||+|+||+||+|++.. +|+.||||++.+... ...+|++++++++ |+||++++++|...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSS-------SCCHHHHHHHHCC-CTTBCCEEEEEEEC--C
T ss_pred CCcEeeeEEeeCcCeEEEEEEECC---CCCEEEEEEECccch-------HHHHHHHHHHhcC-CCCCCcEEEEEEecCcc
Confidence 369999999999999999999876 689999999976432 2347999999998 99999999998542
Q ss_pred ---CceEEEEeecCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCC-ceEEE
Q 012825 232 ---DNVYVVMELCEGGELLDRIL---SRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN-SVLKA 304 (455)
Q Consensus 232 ---~~~~lV~E~~~ggsL~~~l~---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~-~~vkL 304 (455)
.++|||||||+++. .+.+. .....+++..++.|+.||+.||+|||++||+||||||+|||+ +.+ ..+||
T Consensus 89 ~~~~~~~lv~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl---~~~~~~~kl 164 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKL 164 (350)
T ss_dssp CSCCEEEEEEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTTCCEEE
T ss_pred CCceEEEEEEeccCCcc-HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEE---ecCCCceeE
Confidence 34799999997653 33332 345679999999999999999999999999999999999999 544 48999
Q ss_pred eecccccccCCCCcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC---
Q 012825 305 IDFGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS--- 379 (455)
Q Consensus 305 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~--- 379 (455)
+|||+++...........+||..|+|||++. ..++.++|||||||++|||++|+.||......+.+..+.+....
T Consensus 165 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 165 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp CCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence 9999999887677777789999999999865 35899999999999999999999999988887777666532110
Q ss_pred --------------CC--------CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCCC
Q 012825 380 --------------FD--------EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSND 424 (455)
Q Consensus 380 --------------~~--------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~~ 424 (455)
+. ....+.+++++.+||.+||++||++|||+.|+|+||||+...+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 00 1112457899999999999999999999999999999987643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=405.83 Aligned_cols=259 Identities=29% Similarity=0.469 Sum_probs=212.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee---
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--- 230 (455)
.++|+++++||+|+||+||+|++.. +|+.||||++..... .....+.+.+|++++++++ |+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKAS 83 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC---
T ss_pred cCCEEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhc-CCCccceEeeeecccc
Confidence 4789999999999999999999776 589999999865432 2233466789999999998 9999999998854
Q ss_pred -----CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEe
Q 012825 231 -----TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAI 305 (455)
Q Consensus 231 -----~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~ 305 (455)
++.+|+||||+.++. ...+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~-~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~ 159 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDL-AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLA 159 (318)
T ss_dssp -------CEEEEEECCCEEH-HHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEEC
T ss_pred cccccCceEEEEEeccCCCc-cchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEee
Confidence 456899999997654 44455666789999999999999999999999999999999999999 788899999
Q ss_pred ecccccccCCCC-----cccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCC
Q 012825 306 DFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 378 (455)
Q Consensus 306 DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~ 378 (455)
|||+++...... .....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.+.......+.+...
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~ 239 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999997654322 234457999999999875 3589999999999999999999999998888877776655433
Q ss_pred CCCCCCCCC----------------------------CCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 379 SFDEAPWPS----------------------------LSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 379 ~~~~~~~~~----------------------------~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.+....+.. .++++.+||.+||++||++|||+.|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 332222111 3678899999999999999999999999999995
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-52 Score=409.78 Aligned_cols=258 Identities=27% Similarity=0.515 Sum_probs=212.8
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
+.++|+++++||+|+||+||+|+++. +|+.||||++.+.. ......+.+.+|+++|++++ |||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE 90 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCc
Confidence 57899999999999999999999776 68999999997643 45566778999999999998 999999999997654
Q ss_pred ------ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEee
Q 012825 233 ------NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAID 306 (455)
Q Consensus 233 ------~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~D 306 (455)
++||||||| +.+|...+. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~D 164 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILD 164 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECC
T ss_pred cccccceEEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---cccccccccc
Confidence 579999999 667776553 3569999999999999999999999999999999999999 7889999999
Q ss_pred cccccccCCCCcccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC-----
Q 012825 307 FGLSDFVRPDERLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS----- 379 (455)
Q Consensus 307 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~----- 379 (455)
||+++... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 165 fg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 165 FGLARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CTTCEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccceeccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 99998764 3345678999999999875 35789999999999999999999999888776665544432111
Q ss_pred ------------------CC----CCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 380 ------------------FD----EAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 380 ------------------~~----~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.. ......+++++.+||++||..||++|||+.|+|+||||+..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 11 112246789999999999999999999999999999999754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=395.98 Aligned_cols=253 Identities=21% Similarity=0.326 Sum_probs=205.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcc-cCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGEL-KGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.+.|++.++||+|+||.||+|.++.... ....||||++... .......++.+|++++++++ |||||+++|++.+.+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYK 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc--cChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCC
Confidence 4679999999999999999998876321 2357999998654 34555677999999999998 999999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++|||||.++++.+.+......+++..+..++.||+.||.|||+++|+||||||+|||| +.++.+||+|||+++.
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhc
Confidence 9999999999999999888888889999999999999999999999999999999999999 7889999999999987
Q ss_pred cCCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCC-CCCCChhHHHHHHHhcCCCCCCCCCC
Q 012825 313 VRPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRP-FWARTESGIFRAVLKADPSFDEAPWP 386 (455)
Q Consensus 313 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~ 386 (455)
...... .....||..|+|||++. +.++.++|||||||++|||++|..| |......+.+..+..... .+ ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-~~--~~~ 236 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-LP--TPM 236 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CC--CCT
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-CC--Cch
Confidence 654322 23356899999999876 5799999999999999999996555 455555555555544322 11 224
Q ss_pred CCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 387 SLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 387 ~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.++.++.+||.+||+.||++|||+.||++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 68899999999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=398.75 Aligned_cols=255 Identities=23% Similarity=0.380 Sum_probs=210.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|+..........||||++.+......+..+++.+|+.++++++ ||||++++|++.+ +.
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PP 84 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-cc
Confidence 367999999999999999999887654455689999997766566677788999999999998 9999999999965 46
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.++|||||++|++.+++..+.+.+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll---~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEEC
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---ccccceeeccchhhhhc
Confidence 799999999999999988888889999999999999999999999999999999999999 56778999999999887
Q ss_pred CCCCc----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 314 RPDER----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 314 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
..... .....|+..|+|||++. +.++.++|||||||++|||+| |+.||.+.+..+.+..+.+.....+. ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~ 239 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED 239 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--ccc
Confidence 54432 23446788999999887 568999999999999999998 89999999999888888776544432 347
Q ss_pred CCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 388 LSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+++++.+||.+||+.||++|||+.+|++
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999999999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-53 Score=411.26 Aligned_cols=266 Identities=29% Similarity=0.470 Sum_probs=219.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC-CHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT-TAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
-++|++++.||+|+||.||+|+...+..+|+.||||++.+.... +....+.+.+|+++++++.+||||+++++++.+.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 37899999999999999999998776667999999998653321 12233567899999999985689999999999999
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
.+++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhh
Confidence 99999999999999998754 4567899999999999999999999999999999999999 7788999999999987
Q ss_pred cCCCC--cccccccCCCcccccccCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 012825 313 VRPDE--RLNDIVGSAYYVAPEVLHR---SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 387 (455)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 387 (455)
..... ......|++.|++||.+.+ .++.++|||||||+||+|++|+.||...........+.+............
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 64332 3355689999999998863 478899999999999999999999977655444444433322222222346
Q ss_pred CCHHHHHHHHHhccCCccCCC-----CHHHHHcCcccCCCC
Q 012825 388 LSSEARDFVKRLLNKDPRKRL-----TAAQALSHPWIKNSN 423 (455)
Q Consensus 388 ~s~~l~~li~~~L~~dP~~Rp-----s~~elL~hp~~~~~~ 423 (455)
+++++.+||++||++||.+|| |++|+|+||||+..+
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 899999999999999999999 589999999999754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=396.28 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=209.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.++|++.+.||+|+||.||+|++.. ++.||||++..... . .+.+.+|+.++++++ |+|||++++++.+ +.
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----~~~vAiK~l~~~~~-~---~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGTM-S---PEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EP 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTSS-C---HHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC----CCEEEEEEECcccC-C---HHHHHHHHHHHHhcc-cCCEeEEEEEEec-CC
Confidence 3689999999999999999998765 56799999965432 2 356899999999998 9999999999854 56
Q ss_pred eEEEEeecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 234 VYVVMELCEGGELLDRILSR-GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+++|||||++|+|..++... ...+++..+..|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARL 162 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC-
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhh
Confidence 89999999999998877543 4569999999999999999999999999999999999999 7788999999999987
Q ss_pred cCCCC--cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCC-CCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 313 VRPDE--RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPF-WARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 313 ~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
..... ......||+.|+|||++. +.++.++|||||||++|||++|..|| ......+.+..+.+... . .....+
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~-~--~~~~~~ 239 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-M--PCPPEC 239 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-C--CCCTTS
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-C--CCCccc
Confidence 64333 233467899999999886 67999999999999999999966555 55555555555554432 2 123478
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHc--CcccCCCCCCCCc
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALS--HPWIKNSNDVKVP 428 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~--hp~~~~~~~~~~p 428 (455)
++++.+||.+||+.||++||++.+|++ ++||......-.|
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 999999999999999999999999988 8999876544333
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=394.59 Aligned_cols=260 Identities=29% Similarity=0.476 Sum_probs=217.4
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|+++++||+|+||+||+|++.. +|+.||||+++... ......+.+.+|+.++++++ |+||++++++|.+.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDD-DDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---CCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccce
Confidence 689999999999999999999776 58999999997654 34455678999999999998 99999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccC
Q 012825 235 YVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVR 314 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~ 314 (455)
++|+|++.+++|..++ ...+.+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||.++...
T Consensus 77 ~iv~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred eEEeeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhccc
Confidence 9999999887766644 567789999999999999999999999999999999999999 677889999999998775
Q ss_pred CCC-cccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCC-CCChhHHHHHHHhcCCCC----------
Q 012825 315 PDE-RLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFW-ARTESGIFRAVLKADPSF---------- 380 (455)
Q Consensus 315 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~-~~~~~~~~~~i~~~~~~~---------- 380 (455)
... ......++..|+|||++.+ .++.++|||||||++|||++|+.||. +.+..+.+..+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 443 3344567888999998763 47899999999999999999999964 444444455443321111
Q ss_pred ---------------CCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 381 ---------------DEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 381 ---------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.....+.+++.+.+||++||++||++|||+.|+|+||||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 1112235789999999999999999999999999999999753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=405.31 Aligned_cols=259 Identities=27% Similarity=0.467 Sum_probs=211.8
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
++++|+++++||+|+||+||+|++.. +|+.||||++.+. ......+.+.+|+.+|++|+ ||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNV---NKVRVAIKKISPF--EHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPT 79 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETT---TCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSS
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECC---CCcEEEEEEEehh--cChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecc
Confidence 46889999999999999999999765 6899999999654 34566678999999999998 999999999997653
Q ss_pred ----ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecc
Q 012825 233 ----NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFG 308 (455)
Q Consensus 233 ----~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG 308 (455)
..+++++|+.+|+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG 154 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFG 154 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred ccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccC
Confidence 23455566679999998854 369999999999999999999999999999999999999 788899999999
Q ss_pred cccccCCCC----cccccccCCCcccccccC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCC--
Q 012825 309 LSDFVRPDE----RLNDIVGSAYYVAPEVLH--RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF-- 380 (455)
Q Consensus 309 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~-- 380 (455)
+++...... .....+||+.|+|||++. ..++.++||||+||++|+|++|+.||......+............
T Consensus 155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234 (345)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred ceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCCh
Confidence 998764332 235567999999999875 357889999999999999999999998877665554443211110
Q ss_pred ---------------------CC----CCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCC
Q 012825 381 ---------------------DE----APWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 381 ---------------------~~----~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~ 422 (455)
.. ..++.++.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00 1134678899999999999999999999999999999965
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=395.60 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=206.4
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.++||+|+||.||+|++... ..+++.||||++... ......+.+.+|+.++.++.+|+||+.+++++.+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 47899999999999999999998753 235689999998654 34555677889999999998799999999998754
Q ss_pred -CceEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEee
Q 012825 232 -DNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTT 295 (455)
Q Consensus 232 -~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~ 295 (455)
+.+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+||||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl-- 167 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 167 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--
Confidence 46899999999999999986532 358999999999999999999999999999999999999
Q ss_pred cCCCceEEEeecccccccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcC-CCCCCCCChhHHH
Q 012825 296 KDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG-SRPFWARTESGIF 370 (455)
Q Consensus 296 ~~~~~~vkL~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg-~~Pf~~~~~~~~~ 370 (455)
+.++++||+|||+|+...... ......||+.|+|||++. +.++.++|||||||++|||++| ..||........+
T Consensus 168 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 168 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp -CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred -CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 788899999999998654332 234567999999999886 5789999999999999999986 5678776666655
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 371 RAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 371 ~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
...+....... ....+++++.+||.+||+.||++|||+.|+++|
T Consensus 247 ~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 247 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55555443332 224689999999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=398.92 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=209.5
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCc-ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGE-LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
++|+++++||+|+||.||+|++.... .....||+|.+... .+....+++.+|++++++++ |||||+++++|.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-C
Confidence 57999999999999999999876521 12346899988643 23344578999999999998 99999999999765 5
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccccc
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFV 313 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~ 313 (455)
.+++|||+.+++|.+.+......+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceec
Confidence 688899999999999998888899999999999999999999999999999999999999 67889999999999876
Q ss_pred CCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 012825 314 RPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSL 388 (455)
Q Consensus 314 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 388 (455)
..... .....||..|+|||++. +.++.++|||||||++|||+| |..||.+....+....+.+..... ..+.+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~p~~~ 238 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPIC 238 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC---CCTTB
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCccc
Confidence 54332 23456899999999876 679999999999999999998 899998887777666665543221 12468
Q ss_pred CHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 389 SSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 389 s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+.++.+||.+||+.||++|||+.|+++|
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=404.91 Aligned_cols=259 Identities=29% Similarity=0.492 Sum_probs=215.0
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC-
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT- 231 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~- 231 (455)
+.++|+++++||+|+||+||+|++.. +|+.||||++.+.. .+....+.+.+|+++|++|+ |+|||++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 90 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETT---TTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCS
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeecc
Confidence 46899999999999999999999776 68999999997643 45556678899999999998 99999999998633
Q ss_pred ----CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeec
Q 012825 232 ----DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 232 ----~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
...+++|+|+.||+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|++||
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~df 165 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDF 165 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC
T ss_pred ccccCceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---ccccccccccc
Confidence 34566777888999999773 4579999999999999999999999999999999999999 78889999999
Q ss_pred ccccccCCCCcccccccCCCcccccccCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCCCC----
Q 012825 308 GLSDFVRPDERLNDIVGSAYYVAPEVLHR--SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD---- 381 (455)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---- 381 (455)
|++.... .......||..|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+++......
T Consensus 166 g~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 166 GLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp ----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred chhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 9997653 34455689999999998653 478899999999999999999999998887776666654422211
Q ss_pred -------------------CC----CCCCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCCCC
Q 012825 382 -------------------EA----PWPSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKNSN 423 (455)
Q Consensus 382 -------------------~~----~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~~~ 423 (455)
.. .+..+++++++||++||+.||++|||+.|+|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00 1235789999999999999999999999999999999753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=399.35 Aligned_cols=256 Identities=27% Similarity=0.479 Sum_probs=202.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee---
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED--- 230 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~--- 230 (455)
.++|+++++||+|+||+||+|++.. +|+.||||++.+.. .+....+++.+|+.++++++ |||||+++++|..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~---t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKT 90 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETT---TTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCcCeEEEEEEECC---CCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccc
Confidence 4889999999999999999999776 68999999997654 35566678999999999997 9999999999963
Q ss_pred ---CCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeec
Q 012825 231 ---TDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDF 307 (455)
Q Consensus 231 ---~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~Df 307 (455)
...+|+|||||.+ ++++.+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|++||
T Consensus 91 ~~~~~~~~iv~Ey~~~-~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df 163 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDA-NLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDF 163 (355)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC
T ss_pred cccCceeEEEEeccch-HHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeech
Confidence 3678999999966 555544 3568999999999999999999999999999999999999 77888999999
Q ss_pred ccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHhcCCC-------
Q 012825 308 GLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS------- 379 (455)
Q Consensus 308 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~~~~~~------- 379 (455)
|+++...........++|+.|+|||++. ..++.++||||+||++|+|++|+.||.+.+.......++.....
T Consensus 164 ~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 164 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp CC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 9998887767777788999999999987 46899999999999999999999999888776665554432111
Q ss_pred ---------------CCCCCC----------------CCCCHHHHHHHHHhccCCccCCCCHHHHHcCcccCC
Q 012825 380 ---------------FDEAPW----------------PSLSSEARDFVKRLLNKDPRKRLTAAQALSHPWIKN 421 (455)
Q Consensus 380 ---------------~~~~~~----------------~~~s~~l~~li~~~L~~dP~~Rps~~elL~hp~~~~ 421 (455)
.....+ ...++++.+||++||.+||++|||+.|+|+||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 111000 013567899999999999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=389.48 Aligned_cols=254 Identities=23% Similarity=0.419 Sum_probs=212.5
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCc----ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEe
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYE 229 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~ 229 (455)
.++|++++.||+|+||.||+|+..... .++..||||++.+. .......++.+|+..+.++.+|||||+++++|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc--cChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 478999999999999999999876532 23568999999754 445566789999999999966999999999999
Q ss_pred eCCceEEEEeecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEe
Q 012825 230 DTDNVYVVMELCEGGELLDRILSRG---------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (455)
Q Consensus 230 ~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~ 294 (455)
+++.+++|||||++|+|.+++..+. ..+++.+++.++.||+.||.|||+.+||||||||+|||+
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl- 168 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 168 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee-
Confidence 9999999999999999999987543 458999999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecccccccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 012825 295 TKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (455)
Q Consensus 295 ~~~~~~~vkL~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 369 (455)
+.++.+||+|||+++...... ......||+.|+|||++. +.|+.++|||||||++|||++ |..||........
T Consensus 169 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 169 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp --CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred --cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 788899999999998765433 234467899999999876 689999999999999999998 7889988887777
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+..+.... ... ....+++++.+||.+||+.||++|||+.||++
T Consensus 247 ~~~i~~~~-~~~--~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 247 FKLLKEGH-RMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTTC-CCC--CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCC-CCC--CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 66655432 222 22468999999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-50 Score=389.51 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=216.3
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED 230 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~ 230 (455)
-.++|++.+.||+|+||.||+|+.+.. ..+++.||||++... ...+..+++.+|++++++++ |+||++++++|.+
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~ 87 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFD-NPNIVKLLGVCAV 87 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcC-CCCcccceeeecc
Confidence 357899999999999999999997642 235789999998654 44556778999999999998 9999999999999
Q ss_pred CCceEEEEeecCCCcHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeecc
Q 012825 231 TDNVYVVMELCEGGELLDRILSRG-----------------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLK 287 (455)
Q Consensus 231 ~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDik 287 (455)
.+..++||||+++|+|.+++.... ..+++..+..|+.||+.||+|||+++|||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 999999999999999999886432 248999999999999999999999999999999
Q ss_pred CCceEEeecCCCceEEEeecccccccCCCC---cccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCC-CCCC
Q 012825 288 PENFLFTTKDENSVLKAIDFGLSDFVRPDE---RLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGS-RPFW 362 (455)
Q Consensus 288 p~NILl~~~~~~~~vkL~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~-~Pf~ 362 (455)
|+|||| +.++.+||+|||+++...... ......|++.|+|||++. ..++.++|||||||++|||++|. .||.
T Consensus 168 p~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 168 TRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp GGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999 788999999999998664332 234567889999999876 57999999999999999999985 6788
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 363 ARTESGIFRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 363 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
.....+....+....... ....+++++.+||.+||+.||++|||+.||++
T Consensus 245 ~~~~~e~~~~v~~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 245 GMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888888776654321 22468999999999999999999999999954
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=394.00 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=210.5
Q ss_pred CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCce
Q 012825 155 NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDNV 234 (455)
Q Consensus 155 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~~ 234 (455)
++|++.++||+|+||.||+|+++.+. ....||||.+... ......+.+.+|++++.++.+|||||+++++|.+++.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETT-EEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCC-eEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 78999999999999999999987631 1235788887543 33345567999999999995599999999999999999
Q ss_pred EEEEeecCCCcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCC
Q 012825 235 YVVMELCEGGELLDRILSR---------------GGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDEN 299 (455)
Q Consensus 235 ~lV~E~~~ggsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~ 299 (455)
++||||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCC
Confidence 9999999999999988643 3679999999999999999999999999999999999999 778
Q ss_pred ceEEEeecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCC-CCCCCCChhHHHHHHHhcC
Q 012825 300 SVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGS-RPFWARTESGIFRAVLKAD 377 (455)
Q Consensus 300 ~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~-~Pf~~~~~~~~~~~i~~~~ 377 (455)
+.+||+|||+++............||..|+|||.+. +.++.++|||||||++|||++|. .||...+..+.+..+.+..
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 899999999998776555555667999999999886 67999999999999999999975 5688888777777665542
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 378 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
. . ..+..+++++.+||.+||+.||++|||+.++++|
T Consensus 244 ~-~--~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 244 R-L--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp C-C--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-C--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2 1 2234689999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=386.00 Aligned_cols=255 Identities=26% Similarity=0.374 Sum_probs=216.8
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecC--cccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKG--ELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|+++++||+|+||.||+|++... ...++.||||++... .......++.+|+.+++++.+|||||++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc--cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 47999999999999999999987642 236789999999754 34555678999999999997799999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEe
Q 012825 232 DNVYVVMELCEGGELLDRILSRG-----------------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFT 294 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~-----------------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~ 294 (455)
+..+||||||++|+|.+++.... ..+++..+..++.||+.||.|||++|||||||||+|||+
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~- 178 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL- 178 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc-
Confidence 99999999999999999987543 258999999999999999999999999999999999999
Q ss_pred ecCCCceEEEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 012825 295 TKDENSVLKAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGI 369 (455)
Q Consensus 295 ~~~~~~~vkL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~ 369 (455)
+.++.+||+|||+++....... .....||+.|+|||++. +.++.++|||||||++|||+| |..+|......+.
T Consensus 179 --~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 179 --THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp --ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred --cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 6788999999999987654332 23467899999999886 678999999999999999998 5666666666666
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc
Q 012825 370 FRAVLKADPSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS 415 (455)
Q Consensus 370 ~~~i~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~ 415 (455)
+..+......... ...++.++.+||.+||+.||++|||+.+|++
T Consensus 257 ~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 257 FYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6666655433322 2368899999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=382.35 Aligned_cols=244 Identities=25% Similarity=0.396 Sum_probs=200.7
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-CC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-TD 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~-~~ 232 (455)
.++|++.+.||+|+||.||+|+++ |..||||++++.. ..+.+.+|++++++++ ||||++++|++.+ .+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKG 74 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----TEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-----CeEEEEEEECcHH-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCC
Confidence 467999999999999999999853 6789999996532 2367889999999998 9999999999865 46
Q ss_pred ceEEEEeecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeeccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRG-GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSD 311 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~ 311 (455)
.+|+||||+++|+|.+++..+. ..+++..+..|+.||+.||.|||+.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccce
Confidence 6899999999999999986543 358999999999999999999999999999999999999 788999999999998
Q ss_pred ccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 012825 312 FVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 312 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 389 (455)
.... ......++..|+|||++. +.++.++|||||||++|||+| |+.||......+....+.+.... .....++
T Consensus 152 ~~~~--~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~ 226 (262)
T d1byga_ 152 EASS--TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCP 226 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCC
T ss_pred ecCC--CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccCC
Confidence 7643 334457899999999875 679999999999999999998 78888888777777776553221 1224688
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+++.+||.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=384.36 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=206.3
Q ss_pred EEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEee-CCceEE
Q 012825 158 ELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYED-TDNVYV 236 (455)
Q Consensus 158 ~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~-~~~~~l 236 (455)
.+.++||+|+||+||+|++.....+...||||++.+. .+....+++.+|++++++++ ||||++++|++.+ ++..++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEE
Confidence 3467899999999999998765434567999998643 46667788999999999998 9999999999875 457999
Q ss_pred EEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccccCCC
Q 012825 237 VMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDFVRPD 316 (455)
Q Consensus 237 V~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~~~~~ 316 (455)
|||||++|+|.+++......+++..+..++.|++.||.|||+.+|+||||||+|||| ++++.+||+|||+++.....
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTT
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccc
Confidence 999999999999888777889999999999999999999999999999999999999 78899999999999876543
Q ss_pred Cc-----ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh-HHHHHHHhcCCCCCCCCCCCCC
Q 012825 317 ER-----LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLS 389 (455)
Q Consensus 317 ~~-----~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s 389 (455)
.. .....||..|+|||++. +.++.++||||||+++|||++|..||...... +....+....... ....++
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~---~p~~~~ 260 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---QPEYCP 260 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC---CCTTCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CcccCc
Confidence 32 22356899999999876 67999999999999999999988887654333 3344444433221 123678
Q ss_pred HHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 390 SEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 390 ~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
+++.+||.+||+.||++||++.|+++|
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=385.12 Aligned_cols=259 Identities=19% Similarity=0.306 Sum_probs=220.6
Q ss_pred CCCeEEeceEeecCCeEEEEEEEec--CcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKK--GELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++|++.+.||+|+||.||+|.+.. ...+++.||||++... ........+.+|++++++++ |||||++++++..+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecC
Confidence 4789999999999999999998763 2234689999999654 45556678999999999998 99999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceE
Q 012825 232 DNVYVVMELCEGGELLDRILSRG---------GKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVL 302 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~v 302 (455)
+..++|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceE
Confidence 99999999999999999886431 357999999999999999999999999999999999999 888999
Q ss_pred EEeecccccccCCCCc---ccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcC-CCCCCCCChhHHHHHHHhcC
Q 012825 303 KAIDFGLSDFVRPDER---LNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCG-SRPFWARTESGIFRAVLKAD 377 (455)
Q Consensus 303 kL~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg-~~Pf~~~~~~~~~~~i~~~~ 377 (455)
||+|||+++....... .....||+.|+|||.+. +.++.++||||||+++|||+|| ..||.+.+..+.+..+.+..
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999987644332 34457899999999876 5688899999999999999998 57888888888887777654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHHc------CcccCC
Q 012825 378 PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQALS------HPWIKN 421 (455)
Q Consensus 378 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL~------hp~~~~ 421 (455)
... ....++..+.+||.+||+.||++|||+.+|++ +|+|+.
T Consensus 253 ~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 253 LLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred CCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 322 22468899999999999999999999999997 666653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-49 Score=381.93 Aligned_cols=269 Identities=21% Similarity=0.275 Sum_probs=213.6
Q ss_pred cCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC
Q 012825 153 FANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD 232 (455)
Q Consensus 153 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~ 232 (455)
.+++|++++.||+|+||.||+|++.. +|+.||||++...... +++.+|+++++.+++|++|+.+.+++.+++
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECC---CCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 46789999999999999999999766 5899999998654322 347789999999985666777777788889
Q ss_pred ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 233 NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 233 ~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
..++||||+ +++|.+.+....+.+++..+..++.||+.||+|||++||+||||||+|||++..+.+..+||+|||+|+.
T Consensus 77 ~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 999999999 5688888877788999999999999999999999999999999999999997666777899999999987
Q ss_pred cCCCC--------cccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH---hcC-CC
Q 012825 313 VRPDE--------RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVL---KAD-PS 379 (455)
Q Consensus 313 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~~~~~~i~---~~~-~~ 379 (455)
..... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...........+. ... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 65432 2245679999999999875 58999999999999999999999997655443322221 111 01
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCccCCCCHH---HHHcCcccCCCCCCCCchh
Q 012825 380 FDEAPWPSLSSEARDFVKRLLNKDPRKRLTAA---QALSHPWIKNSNDVKVPLD 430 (455)
Q Consensus 380 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~---elL~hp~~~~~~~~~~p~~ 430 (455)
........+++++.+||.+||+.||++||++. ++|+|+|.+..-....+.|
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~D 289 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCH
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 11112346889999999999999999999986 5578888765434444444
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.8e-47 Score=363.87 Aligned_cols=254 Identities=20% Similarity=0.300 Sum_probs=208.0
Q ss_pred ccCCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 152 HFANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 152 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.++++|++++.||+|+||.||+|++.. +|+.||||++...... ..+.+|++.++.|.+|+|++.+++++.++
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 73 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG 73 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence 357899999999999999999999776 5899999998654321 34678999999999779999999999999
Q ss_pred CceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecC--CCceEEEeeccc
Q 012825 232 DNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKD--ENSVLKAIDFGL 309 (455)
Q Consensus 232 ~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~--~~~~vkL~DfG~ 309 (455)
+..++||||+ +++|.+++...+..+++..+..++.|++.||+|||++||+||||||+|||++... ..+.+||+|||+
T Consensus 74 ~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 74 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred CccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccce
Confidence 9999999999 7799998887778899999999999999999999999999999999999996422 357899999999
Q ss_pred ccccCCCC--------cccccccCCCcccccccCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCh---hHHHHHHHhcC
Q 012825 310 SDFVRPDE--------RLNDIVGSAYYVAPEVLHR-SYSTEADVWSIGVIAYILLCGSRPFWARTE---SGIFRAVLKAD 377 (455)
Q Consensus 310 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~Pf~~~~~---~~~~~~i~~~~ 377 (455)
|+...... .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+... ......+....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~ 232 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence 98764321 2345679999999999874 599999999999999999999999975433 22233332211
Q ss_pred -CCCCCCCCCCCCHHHHHHHHHhccCCccCCCCHHHHH
Q 012825 378 -PSFDEAPWPSLSSEARDFVKRLLNKDPRKRLTAAQAL 414 (455)
Q Consensus 378 -~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~elL 414 (455)
........+.+++++.+++..|+..+|++||+...+.
T Consensus 233 ~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 1111122346889999999999999999999877664
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-47 Score=365.89 Aligned_cols=248 Identities=23% Similarity=0.290 Sum_probs=189.9
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCC-
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTD- 232 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~- 232 (455)
..+|.+.+.||+|+||.||+|+. +|+.||||++... .......+.|+..+.+++ |||||++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-----~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR----EERSWFREAEIYQTVMLR-HENILGFIAADNKDNG 71 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECcc----chhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCC
Confidence 46799999999999999999984 3789999998532 122222344555556777 999999999998654
Q ss_pred ---ceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------cCCEEeeccCCceEEeecCCCce
Q 012825 233 ---NVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHL--------QGVVHRDLKPENFLFTTKDENSV 301 (455)
Q Consensus 233 ---~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~--------~~ivHrDikp~NILl~~~~~~~~ 301 (455)
.+|||||||++|+|.+++.+. .+++..+..++.|++.||.|||+ +|||||||||+|||| +.++.
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~ 146 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT 146 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSC
T ss_pred cceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCC
Confidence 589999999999999998653 58999999999999999999996 589999999999999 78899
Q ss_pred EEEeecccccccCCCC-----cccccccCCCcccccccCCC-------CCCcchHHHHHHHHHHHHcCCCCCCCCC----
Q 012825 302 LKAIDFGLSDFVRPDE-----RLNDIVGSAYYVAPEVLHRS-------YSTEADVWSIGVIAYILLCGSRPFWART---- 365 (455)
Q Consensus 302 vkL~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~sDiwSlG~~l~elltg~~Pf~~~~---- 365 (455)
+||+|||+++...... .....+||+.|+|||++.+. ++.++|||||||+||||+||..||....
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 9999999998764433 23456899999999998643 4668999999999999999988763211
Q ss_pred ----------hhHHHHHHHhcCCCCC---CCC-CCCCCHHHHHHHHHhccCCccCCCCHHHHHcC
Q 012825 366 ----------ESGIFRAVLKADPSFD---EAP-WPSLSSEARDFVKRLLNKDPRKRLTAAQALSH 416 (455)
Q Consensus 366 ----------~~~~~~~i~~~~~~~~---~~~-~~~~s~~l~~li~~~L~~dP~~Rps~~elL~h 416 (455)
...............+ ... .......+.+|+.+||+.||++|||+.||+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1122233332221111 100 01123468999999999999999999999764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.8e-45 Score=359.60 Aligned_cols=266 Identities=26% Similarity=0.396 Sum_probs=199.8
Q ss_pred CcccccC-CCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhc----------
Q 012825 148 GFSKHFA-NKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALT---------- 216 (455)
Q Consensus 148 ~~~~~~~-~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~---------- 216 (455)
..++.+. +||+++++||+|+||+||+|+... +|+.||||++.+. ....+.+.+|+++++.+.
T Consensus 5 ~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~---~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~ 77 (362)
T d1q8ya_ 5 FKGEPYKDARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSM 77 (362)
T ss_dssp CTTCEETTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHH
T ss_pred CCCCCccCCcEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhc
Confidence 4456665 579999999999999999999776 6899999999643 334466788999988875
Q ss_pred CCCCeeEEeEEEee--CCceEEEEeecCCCcHHHH--HHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCEEeeccCCce
Q 012825 217 GHNNLVKFFDAYED--TDNVYVVMELCEGGELLDR--ILSRGGKYTEDDAKAVMIQILNVVAFCHL-QGVVHRDLKPENF 291 (455)
Q Consensus 217 ~hp~Iv~l~~~~~~--~~~~~lV~E~~~ggsL~~~--l~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~ivHrDikp~NI 291 (455)
+|+||+++++++.. ....+++|+++..+..... .......+++..++.++.||+.||.|||+ .||+||||||+||
T Consensus 78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NI 157 (362)
T d1q8ya_ 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 157 (362)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred CcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHe
Confidence 26889999998864 3456777777655543332 23345689999999999999999999998 8999999999999
Q ss_pred EEeecCC---CceEEEeecccccccCCCCcccccccCCCcccccccC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCChh
Q 012825 292 LFTTKDE---NSVLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLH-RSYSTEADVWSIGVIAYILLCGSRPFWARTES 367 (455)
Q Consensus 292 Ll~~~~~---~~~vkL~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~elltg~~Pf~~~~~~ 367 (455)
||+..+. ...++|+|||.+.... ......+||+.|+|||++. ..++.++||||+||++++|++|+.||......
T Consensus 158 ll~~~~~~~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 158 LMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred eeeccCcccccceeeEeecccccccc--cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccc
Confidence 9964322 1359999999987653 3345668999999999876 57999999999999999999999999643321
Q ss_pred ------HHHHHHHhcCCC--------------------C----C--------------CCCCCCCCHHHHHHHHHhccCC
Q 012825 368 ------GIFRAVLKADPS--------------------F----D--------------EAPWPSLSSEARDFVKRLLNKD 403 (455)
Q Consensus 368 ------~~~~~i~~~~~~--------------------~----~--------------~~~~~~~s~~l~~li~~~L~~d 403 (455)
..+......... . . .......++++.+||.+||.+|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 111111110000 0 0 0001124578999999999999
Q ss_pred ccCCCCHHHHHcCcccCCC
Q 012825 404 PRKRLTAAQALSHPWIKNS 422 (455)
Q Consensus 404 P~~Rps~~elL~hp~~~~~ 422 (455)
|.+|||+.|+|+||||++.
T Consensus 316 P~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp TTTCBCHHHHHTCGGGTTC
T ss_pred hhHCcCHHHHhcCcccCCC
Confidence 9999999999999999954
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=2.5e-26 Score=205.94 Aligned_cols=168 Identities=26% Similarity=0.252 Sum_probs=122.7
Q ss_pred eEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcC---------------CHHHHHHHHHHHHHHHHhcCCCCe
Q 012825 157 YELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMT---------------TAIAIEDVRREVKILRALTGHNNL 221 (455)
Q Consensus 157 y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~---------------~~~~~~~~~~Ei~~l~~l~~hp~I 221 (455)
+.++++||+|+||.||+|++.. |+.||||++...... .........+|...+.++. |.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~----g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v 76 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEK----FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAV 76 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETT----TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSS
T ss_pred chhCCEeeeCcceEEEEEECCC----CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCc
Confidence 4678999999999999998643 889999987532110 0112234567889999998 8999
Q ss_pred eEEeEEEeeCCceEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCEEeeccCCceEEeecCCCce
Q 012825 222 VKFFDAYEDTDNVYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFTTKDENSV 301 (455)
Q Consensus 222 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ivHrDikp~NILl~~~~~~~~ 301 (455)
+..+++. ..+++|||+++..+. .+++..+..++.||+.+|.|||++||+||||||+|||++ + ..
T Consensus 77 ~~~~~~~----~~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~---~-~~ 140 (191)
T d1zara2 77 PKVYAWE----GNAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS---E-EG 140 (191)
T ss_dssp CCEEEEE----TTEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---T-TE
T ss_pred ceEEEec----CCEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee---C-CC
Confidence 9887653 238999999876542 245666788999999999999999999999999999994 3 34
Q ss_pred EEEeecccccccCCCCcccccccCCCccc------ccccCCCCCCcchHHHHHHHHH
Q 012825 302 LKAIDFGLSDFVRPDERLNDIVGSAYYVA------PEVLHRSYSTEADVWSIGVIAY 352 (455)
Q Consensus 302 vkL~DfG~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~sDiwSlG~~l~ 352 (455)
++|+|||+|......... .|.. .+.+.+.|+.++|+||+.--++
T Consensus 141 ~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 141 IWIIDFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp EEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred EEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 899999999765432211 1111 1233467889999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.65 E-value=2.7e-08 Score=91.12 Aligned_cols=142 Identities=17% Similarity=0.156 Sum_probs=93.3
Q ss_pred CCCeEEeceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeCCc
Q 012825 154 ANKYELGEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDTDN 233 (455)
Q Consensus 154 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~~~ 233 (455)
.+.|+..+..+-++.+.||+... .++.++||+........ ...+.+|..++..|.++--+.+++.++.+++.
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-----~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-----SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-----CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 35667666544444568997652 35678889875432111 23467899999988766557888888888899
Q ss_pred eEEEEeecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH------------------------------------
Q 012825 234 VYVVMELCEGGELLDRILSRGGKYTEDDAKAVMIQILNVVAFCH------------------------------------ 277 (455)
Q Consensus 234 ~~lV~E~~~ggsL~~~l~~~~~~l~~~~~~~i~~qi~~gL~~LH------------------------------------ 277 (455)
.++||++++|..+.+.... ......++.++.+.|..||
T Consensus 85 ~~lv~~~l~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred eEEEEEecccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998876543211 1112223333333344444
Q ss_pred -----------------Hc------CCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 278 -----------------LQ------GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 278 -----------------~~------~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
+. .++|+|+.+.|||+ ++++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceee---cCCceEEEeechhccc
Confidence 21 27999999999999 5566667999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=2.1e-06 Score=77.57 Aligned_cols=75 Identities=12% Similarity=0.115 Sum_probs=51.7
Q ss_pred eEeecCC-eEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCC-CeeEEeEEEeeCCceEEEEe
Q 012825 162 EVGRGHF-GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHN-NLVKFFDAYEDTDNVYVVME 239 (455)
Q Consensus 162 ~LG~G~f-g~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-~Iv~l~~~~~~~~~~~lV~E 239 (455)
.+..|.. +.||+..... +..+++|....... ..+..|...++.|..+. .+.+++.+..+++..++||+
T Consensus 17 ~~~~G~s~~~v~r~~~~~----~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~ 86 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG----RPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 86 (255)
T ss_dssp ECSCTTSSCEEEEEECTT----SCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred EcCCcccCCeEEEEEeCC----CCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEE
Confidence 3344443 5788876433 66789998754432 23667888888777432 26678888888888999999
Q ss_pred ecCCCcH
Q 012825 240 LCEGGEL 246 (455)
Q Consensus 240 ~~~ggsL 246 (455)
+++|.++
T Consensus 87 ~i~G~~~ 93 (255)
T d1nd4a_ 87 EVPGQDL 93 (255)
T ss_dssp CCSSEET
T ss_pred eeecccc
Confidence 9987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.92 E-value=1.1e-05 Score=78.05 Aligned_cols=82 Identities=20% Similarity=0.238 Sum_probs=50.0
Q ss_pred eceEeecCCeEEEEEEEecCcccCeEEEEEEccCCCc----CCHHHHHHHHHHHHHHHHhcCC--CCeeEEeEEEeeCCc
Q 012825 160 GEEVGRGHFGYTCAAKFKKGELKGQQVAVKVIPKHKM----TTAIAIEDVRREVKILRALTGH--NNLVKFFDAYEDTDN 233 (455)
Q Consensus 160 ~~~LG~G~fg~V~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~~~~Ei~~l~~l~~h--p~Iv~l~~~~~~~~~ 233 (455)
.+.||.|..-.||++.... .++.|+||.-..... .-.....+...|.+.|+.+..+ ..+.+++.+ +.+.
T Consensus 31 ~~eig~G~~N~vfrV~~~~---~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC-------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred EEEeCCCceEeEEEEEeCC---CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC
Confidence 4568999999999987554 467899996421100 0011123455788888877644 345666654 4556
Q ss_pred eEEEEeecCCCcH
Q 012825 234 VYVVMELCEGGEL 246 (455)
Q Consensus 234 ~~lV~E~~~ggsL 246 (455)
.++|||++.+..+
T Consensus 106 ~~lvmE~L~~~~~ 118 (392)
T d2pula1 106 AVTVMEDLSHLKI 118 (392)
T ss_dssp TEEEECCCTTSEE
T ss_pred CEEEEeccCCccc
Confidence 6899999977554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.25 E-value=0.00014 Score=69.96 Aligned_cols=80 Identities=11% Similarity=0.103 Sum_probs=53.1
Q ss_pred CeEEeceEeecCCeEEEEEEEecCc----ccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCeeEEeEEEeeC
Q 012825 156 KYELGEEVGRGHFGYTCAAKFKKGE----LKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNLVKFFDAYEDT 231 (455)
Q Consensus 156 ~y~~~~~LG~G~fg~V~~~~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~Iv~l~~~~~~~ 231 (455)
.+++ +.|+-|--=.+|++....+. ...+.|.+++.... ... ....+|..+++.+..+.-..++++++.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETE---SHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 3444 56776776799998876542 12456888876421 222 2456899999998866555688887643
Q ss_pred CceEEEEeecCCCc
Q 012825 232 DNVYVVMELCEGGE 245 (455)
Q Consensus 232 ~~~~lV~E~~~ggs 245 (455)
++||||++|..
T Consensus 117 ---g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 ---GRLEEYIPSRP 127 (395)
T ss_dssp ---EEEECCCCEEE
T ss_pred ---ceEEEEecccc
Confidence 68999998753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.86 E-value=0.001 Score=61.92 Aligned_cols=67 Identities=10% Similarity=0.112 Sum_probs=42.5
Q ss_pred eEEEEEEEecCcccCeEEEEEEccCCCcCCHHHHHHHHHHHHHHHHhcCCCCe--eEEe-----EEEeeCCceEEEEeec
Q 012825 169 GYTCAAKFKKGELKGQQVAVKVIPKHKMTTAIAIEDVRREVKILRALTGHNNL--VKFF-----DAYEDTDNVYVVMELC 241 (455)
Q Consensus 169 g~V~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp~I--v~l~-----~~~~~~~~~~lV~E~~ 241 (455)
-.||+++..+ |+.|++|+...... + .+++..|...+..|..+ .| +..+ ..+..++..+.+++++
T Consensus 36 N~vy~v~~~d----g~~~VlK~~rp~~~-s---~~~i~~E~~~l~~L~~~-gipv~~p~~~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 36 NRVYQFQDED----RRRFVVKFYRPERW-T---ADQILEEHQFALQLVND-EVPVAAPVAFNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp SEEEEECCTT----CCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHT-TCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred ceeEEEEcCC----CCEEEEEEeCCCCC-C---HHHHHHHHHHHHHHHhc-CCCCCCceecCCCeeeeeeeEEEEEEeec
Confidence 4788887544 78899999854322 2 35577888888888732 22 1111 1223466788899998
Q ss_pred CCC
Q 012825 242 EGG 244 (455)
Q Consensus 242 ~gg 244 (455)
+|.
T Consensus 107 ~G~ 109 (325)
T d1zyla1 107 GGR 109 (325)
T ss_dssp CCE
T ss_pred CCc
Confidence 764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.22 E-value=0.0032 Score=57.88 Aligned_cols=30 Identities=33% Similarity=0.476 Sum_probs=25.8
Q ss_pred CCEEeeccCCceEEeecCCCceEEEeecccccc
Q 012825 280 GVVHRDLKPENFLFTTKDENSVLKAIDFGLSDF 312 (455)
Q Consensus 280 ~ivHrDikp~NILl~~~~~~~~vkL~DfG~a~~ 312 (455)
|+||+|+.++||++ +.+...-|+||+.+..
T Consensus 184 giIHgDl~~dNvl~---~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFF---LGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhc---ccccceeEeccccccc
Confidence 69999999999999 5666778999998753
|